data_6hpi_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6hpi _Structure_validation_residue.Date_analyzed 2019-09-27 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 119.671 -0.204 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.2 138.53 61.79 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 121.476 1.451 . . . . 0.0 110.229 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.61 109.83 18.32 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.55 133.93 52.85 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.308 1.043 . . . . 0.0 109.969 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.03 -124.38 0.71 Allowed Glycine 0 CA--C 1.523 0.543 0 CA-C-O 117.458 -1.746 . . . . 0.0 109.891 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.2 p -157.96 -165.11 1.66 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 121.517 2.658 . . . . 0.0 113.604 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.9 mt -145.18 -13.8 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.056 1.342 . . . . 0.0 108.277 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -55.17 -31.88 61.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 118.067 -0.968 . . . . 0.0 112.11 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.39 -19.12 3.12 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.584 1.554 . . . . 0.0 112.893 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.4 mt -64.06 -52.5 55.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.174 1.39 . . . . 0.0 113.47 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -148.41 31.54 0.82 Allowed 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 117.931 0.332 . . . . 0.0 110.189 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.0 m80 59.97 25.36 14.54 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.071 0.949 . . . . 0.0 112.054 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 mmt-85 -86.71 98.53 11.19 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.382 -1.449 . . . . 0.0 108.178 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.6 t -76.58 145.05 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -105.2 132.43 51.43 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.327 1.451 . . . . 0.0 109.134 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.7 t -137.05 129.69 44.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 119.168 0.895 . . . . 0.0 108.863 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.5 112.97 11.21 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 101.161 -3.644 . . . . 0.0 101.161 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -129.55 120.99 26.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.705 2.002 . . . . 0.0 108.153 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.5 t0 45.31 58.23 4.29 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.305 1.442 . . . . 0.0 110.945 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 57.15 20.11 5.35 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.637 1.975 . . . . 0.0 114.913 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.3 m -134.23 143.32 47.75 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.588 0.755 . . . . 0.0 109.329 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.2 mt -90.71 124.68 35.29 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.76 136.78 56.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.685 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.45 136.21 39.41 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -124.32 68.65 49.48 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.34 -6.24 14.47 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.828 2.352 . . . . 0.0 116.304 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.67 78.41 0.7 Allowed 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.597 1.159 . . . . 0.0 109.227 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -151.36 137.29 18.14 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 121.125 -0.984 . . . . 0.0 110.42 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -68.27 -34.6 76.46 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.816 0.846 . . . . 0.0 108.735 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.68 30.3 0.65 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.166 0.987 . . . . 0.0 112.793 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.7 ptp -73.33 167.2 21.72 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.7 t -153.22 121.58 3.12 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.12 151.21 49.24 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 N-CA-C 108.632 -1.334 . . . . 0.0 108.632 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.95 -174.35 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.19 154.87 50.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mm -126.72 111.44 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 C-N-CA 126.901 2.08 . . . . 0.0 108.384 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.74 130.47 41.25 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.509 1.924 . . . . 0.0 107.64 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -126.09 131.62 52.08 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.304 1.842 . . . . 0.0 108.894 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -149.36 145.86 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 124.838 1.255 . . . . 0.0 110.664 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.79 156.38 38.97 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 125.79 1.636 . . . . 0.0 109.001 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 85.4 m -92.78 106.47 18.44 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -67.99 -14.89 63.32 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -98.93 29.88 3.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.988 0.813 . . . . 0.0 111.21 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -62.4 -7.41 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 126.228 1.811 . . . . 0.0 113.251 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -55.75 -35.63 66.41 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.072 0.949 . . . . 0.0 112.614 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -98.56 0.52 45.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.774 1.23 . . . . 0.0 112.491 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.0 171.39 9.3 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 123.077 1.418 . . . . 0.0 109.616 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -74.85 157.01 35.83 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.421 -1.718 . . . . 0.0 107.453 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -129.29 -40.32 1.46 Allowed 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.703 -0.665 . . . . 0.0 109.956 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -50.63 -54.3 23.92 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.262 1.425 . . . . 0.0 113.313 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -60.39 -31.23 70.16 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.975 0.91 . . . . 0.0 112.293 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.24 169.45 11.75 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 125.886 1.708 . . . . 0.0 109.828 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -69.76 112.07 11.06 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 127.284 2.234 . . . . 0.0 115.763 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -80.98 131.78 8.12 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.714 2.943 . . . . 0.0 110.302 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 pp -137.82 178.44 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -134.92 153.77 51.94 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.712 1.142 . . . . 0.0 112.15 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.5 tt -145.68 157.03 44.0 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.284 1.434 . . . . 0.0 110.039 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.4 176.01 35.42 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.51 140.86 29.29 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -107.51 118.91 37.96 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 159.67 -75.67 0.2 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.02 19.59 14.86 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 60.94 72.41 0.52 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.952 1.251 . . . . 0.0 109.626 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.59 136.01 22.89 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.034 0.934 . . . . 0.0 110.381 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 17.7 m -144.97 169.67 17.63 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.184 -0.947 . . . . 0.0 110.534 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.5 mt -53.37 148.32 9.1 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.086 0.469 . . . . 0.0 110.39 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.0 ttp -160.71 120.99 2.81 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 93.4 m -82.12 138.15 34.83 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.2 -177.56 4.76 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.202 2.201 . . . . 0.0 106.845 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -143.8 140.5 29.92 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.9 m -90.15 26.64 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.45 5.9 56.59 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.259 0.933 . . . . 0.0 111.648 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -131.48 -57.03 1.01 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.976 1.71 . . . . 0.0 110.624 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -145.14 157.18 54.05 Favored Pre-proline 0 C--O 1.239 0.552 0 C-N-CA 124.416 1.086 . . . . 0.0 110.421 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.06 149.66 88.93 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.897 3.065 . . . . 0.0 113.639 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.1 p -148.61 168.35 23.04 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.908 1.683 . . . . 0.0 110.708 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mt -97.24 149.24 22.26 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.461 1.104 . . . . 0.0 108.856 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -143.83 78.1 1.58 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.43 94.1 9.76 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.69 -48.7 0.19 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.047 0.84 . . . . 0.0 112.6 -177.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -135.28 105.67 6.38 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.713 1.605 . . . . 0.0 107.486 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.06 154.87 0.91 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -127.66 139.98 52.38 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.0 pt -94.83 -41.51 12.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.835 1.654 . . . . 0.0 111.773 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.0 tpt -66.52 -23.14 66.19 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.757 0.708 . . . . 0.0 110.109 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.32 -52.48 18.53 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.525 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.1 mt -60.61 -26.22 66.83 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.175 0.988 . . . . 0.0 112.367 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -75.63 -51.19 13.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -59.67 -46.99 87.37 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.041 1.336 . . . . 0.0 112.67 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -100.74 148.92 35.68 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.706 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -75.4 68.01 6.15 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.036 2.491 . . . . 0.0 109.532 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -128.12 68.19 75.83 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 126.074 1.75 . . . . 0.0 108.556 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.55 83.0 2.25 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.608 2.205 . . . . 0.0 106.552 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.4 t -78.17 103.14 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -52.37 -30.56 29.47 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.914 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.05 -15.67 34.99 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.136 0.88 . . . . 0.0 111.982 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -117.72 -15.91 10.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.584 1.154 . . . . 0.0 110.326 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.4 mt -83.59 152.61 24.74 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.27 1.396 . . . . 0.0 111.103 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -139.15 128.42 24.08 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.066 0.947 . . . . 0.0 110.697 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.55 123.73 21.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -94.8 136.21 35.37 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 t -135.88 -177.99 4.93 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.976 1.311 . . . . 0.0 109.596 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -159.65 146.51 16.52 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.734 1.214 . . . . 0.0 109.637 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.17 76.34 1.32 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 124.463 1.102 . . . . 0.0 111.821 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.89 78.84 0.82 Allowed Glycine 0 C--N 1.335 0.509 0 O-C-N 121.152 -0.968 . . . . 0.0 112.065 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 56.51 13.76 1.45 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.359 1.464 . . . . 0.0 112.763 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -121.26 151.82 39.58 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.3 m -125.25 148.45 48.66 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 125.636 1.574 . . . . 0.0 106.957 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.99 157.05 47.04 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -138.83 116.11 11.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.673 1.189 . . . . 0.0 107.833 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -112.24 133.01 54.61 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.881 1.273 . . . . 0.0 110.089 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.9 m -52.31 122.22 8.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.886 2.074 . . . . 0.0 110.458 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.7 t -73.34 -46.09 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 O-C-N 120.105 -1.622 . . . . 0.0 110.869 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.76 -30.83 71.88 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.034 0.834 . . . . 0.0 111.146 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -133.94 81.51 51.76 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 123.747 0.819 . . . . 0.0 110.746 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.16 159.89 44.69 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 N-CA-C 108.421 -1.415 . . . . 0.0 108.421 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.45 -17.78 30.76 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.062 0.839 . . . . 0.0 112.22 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 30.9 m-90 -119.0 141.63 48.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.018 1.727 . . . . 0.0 111.245 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -118.5 142.44 47.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 128.82 2.848 . . . . 0.0 111.414 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.4 mt -69.01 134.18 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.4 114.5 28.72 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.537 0.608 . . . . 0.0 110.112 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.3 m -63.93 -19.15 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.5 m 61.19 63.6 1.21 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.953 1.835 . . . . 0.0 115.953 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 54.5 m -104.43 6.07 34.71 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 125.745 1.618 . . . . 0.0 113.18 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -82.01 -106.64 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.121 1.368 . . . . 0.0 107.563 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.42 -52.13 11.16 Favored Glycine 0 C--N 1.337 0.605 0 O-C-N 120.849 -1.157 . . . . 0.0 112.911 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 141.63 62.77 0.03 OUTLIER Glycine 0 CA--C 1.525 0.69 0 N-CA-C 106.491 -2.644 . . . . 0.0 106.491 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 19.6 m -93.56 166.96 14.86 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 119.105 -0.474 . . . . 0.0 110.701 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.14 157.64 46.16 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.746 2.964 . . . . 0.0 110.352 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.2 mt -76.84 111.59 12.54 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.79 179.77 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 125.861 1.664 . . . . 0.0 110.587 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -110.6 144.74 39.01 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.3 t -134.78 152.7 51.96 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -107.38 -32.73 7.63 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 N--CA 1.427 -1.585 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 -178.8 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.446 -0.63 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.98 96.11 4.82 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.605 0.762 . . . . 0.0 110.626 -177.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.5 p -98.52 -32.57 11.39 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.85 96.39 10.37 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.717 1.607 . . . . 0.0 112.374 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.42 175.66 13.43 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.805 -1.184 . . . . 0.0 112.661 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.79 -166.89 29.47 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.5 tp -137.67 161.59 36.09 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.31 34.46 5.21 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -63.38 140.38 58.87 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 18.0 mt -123.18 166.33 15.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 17.7 p90 . . . . . 0 C--O 1.244 0.796 0 CA-C-O 116.482 -1.723 . . . . 0.0 107.469 178.965 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.235 0.291 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.04 129.56 15.38 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.84 1.693 . . . . 0.0 108.019 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.55 115.21 29.49 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.61 135.65 53.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.966 0.506 . . . . 0.0 110.823 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.87 -125.82 0.8 Allowed Glycine 0 N--CA 1.46 0.246 0 CA-C-O 117.882 -1.51 . . . . 0.0 109.979 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.6 p -157.03 -173.97 4.7 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 120.276 2.038 . . . . 0.0 112.709 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.4 mt -141.98 -19.07 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.92 1.688 . . . . 0.0 108.437 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.468 HE21 HG23 ' A' ' 22' ' ' VAL . 5.9 pt20 -47.52 -39.99 17.56 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.147 -0.971 . . . . 0.0 113.459 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -51.32 -33.49 29.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.847 2.059 . . . . 0.0 114.866 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.4 mm -41.94 -55.44 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 127.146 2.178 . . . . 0.0 111.047 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.64 26.48 2.11 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.709 -0.619 . . . . 0.0 109.54 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 33.9 m80 60.46 25.05 14.64 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.34 2.256 . . . . 0.0 113.279 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.409 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 20.2 mmt180 -83.58 85.07 7.32 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 126.966 2.106 . . . . 0.0 107.493 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.468 HG23 HE21 ' A' ' 16' ' ' GLN . 93.6 t -69.5 136.7 25.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 120.726 -1.233 . . . . 0.0 108.572 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -95.59 135.01 37.81 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.722 1.209 . . . . 0.0 111.701 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.4 t -141.91 131.28 23.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.74 95.2 3.39 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -106.94 120.02 40.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 119.619 1.099 . . . . 0.0 108.506 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.6 t0 42.06 65.84 0.82 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.267 1.427 . . . . 0.0 111.615 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 57.3 8.7 0.61 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.679 1.591 . . . . 0.0 114.861 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 m -124.81 133.1 53.25 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 125.185 1.394 . . . . 0.0 110.129 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.8 mt -82.88 122.42 28.23 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -125.72 144.39 35.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.19 133.2 34.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -128.14 64.14 65.12 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.665 1.986 . . . . 0.0 111.435 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.14 -56.77 1.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.343 1.362 . . . . 0.0 111.693 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.6 mtp85 -117.73 109.0 16.08 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.558 1.072 . . . . 0.0 109.105 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -167.92 -162.44 0.43 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.668 1.187 . . . . 0.0 109.135 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -122.81 -50.56 1.95 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -66.13 20.66 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.66 1.984 . . . . 0.0 114.977 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.7 ptp -74.59 -178.8 3.74 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 120.49 -1.381 . . . . 0.0 109.434 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 t -174.24 128.34 0.45 Allowed Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.79 146.05 33.09 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 N-CA-C 107.224 -1.875 . . . . 0.0 107.224 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 m -133.45 171.19 18.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.63 163.92 16.65 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.3 mm -131.18 108.42 14.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 127.18 2.192 . . . . 0.0 108.472 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.49 124.75 44.93 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.194 1.398 . . . . 0.0 108.521 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 tt -117.2 138.06 51.94 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.308 1.843 . . . . 0.0 108.744 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 mt -142.2 146.09 22.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 126.498 1.919 . . . . 0.0 108.291 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 p -84.16 145.23 28.5 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.522 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 55.7 m -66.85 107.86 2.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.936 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.75 7.87 9.34 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.577 -1.327 . . . . 0.0 111.564 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.71 29.33 5.03 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.552 2.341 . . . . 0.0 113.624 -177.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.41 -7.83 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 O-C-N 120.078 -1.639 . . . . 0.0 114.312 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -48.41 -51.44 26.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 119.528 1.058 . . . . 0.0 112.594 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 t -82.21 2.7 30.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.713 1.205 . . . . 0.0 112.568 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.6 mt -104.69 176.17 5.25 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 120.356 -1.465 . . . . 0.0 112.017 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -93.02 151.84 19.66 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.599 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -124.03 -25.53 4.19 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.847 1.259 . . . . 0.0 110.018 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -61.81 -20.62 63.83 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.418 0.687 . . . . 0.0 111.05 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -75.99 -20.56 57.77 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.133 0.973 . . . . 0.0 111.143 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.4 -103.41 0.4 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 125.962 1.744 . . . . 0.0 111.574 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -144.76 99.07 4.78 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.581 -0.952 . . . . 0.0 112.885 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.62 131.37 18.55 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.377 2.051 . . . . 0.0 110.682 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pt -143.53 -178.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.802 0.841 . . . . 0.0 109.244 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.407 ' CD1' HD12 ' A' ' 95' ' ' LEU . 4.3 t80 -136.57 134.92 37.97 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.999 0.92 . . . . 0.0 110.076 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 tt -138.43 152.16 48.09 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.994 1.318 . . . . 0.0 109.214 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.56 174.51 33.61 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mt -88.58 139.12 30.8 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -109.46 102.09 10.99 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.87 -26.37 0.09 OUTLIER Glycine 0 CA--C 1.529 0.953 0 CA-C-O 117.945 -1.475 . . . . 0.0 113.335 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.01 19.84 0.58 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.643 1.722 . . . . 0.0 114.421 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.2 m120 62.51 62.1 1.16 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.385 1.474 . . . . 0.0 110.91 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.9 133.72 37.98 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.76 1.224 . . . . 0.0 109.299 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.8 m -136.64 174.65 10.39 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.654 0.661 . . . . 0.0 111.896 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.9 mt -64.6 150.22 47.36 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.782 0.433 . . . . 0.0 111.378 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.441 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 1.4 tmm? -160.85 144.67 13.49 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 117.999 -1.0 . . . . 0.0 108.516 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -110.98 122.38 47.75 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.961 0.788 . . . . 0.0 110.103 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.86 135.16 29.26 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.078 0.951 . . . . 0.0 110.652 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -70.02 117.79 12.03 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.0 p -69.68 -24.21 26.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.813 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.89 -70.34 0.11 Allowed Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 105.357 -3.097 . . . . 0.0 105.357 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -97.36 -23.1 16.26 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -145.4 159.53 48.17 Favored Pre-proline 0 CA--C 1.536 0.405 0 O-C-N 121.374 -0.829 . . . . 0.0 112.891 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.4 148.01 72.67 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.565 2.843 . . . . 0.0 111.681 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.5 p -145.56 170.45 16.4 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.038 1.735 . . . . 0.0 108.668 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.6 mt -83.96 150.88 25.37 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 122.493 0.317 . . . . 0.0 110.687 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -144.91 64.29 1.28 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.109 0.964 . . . . 0.0 110.029 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.06 118.96 25.85 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -171.66 -42.91 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.689 0.677 . . . . 0.0 112.269 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -134.49 101.99 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.852 1.261 . . . . 0.0 109.988 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 75' ' ' MET . 0.2 OUTLIER -163.82 171.36 15.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.696 1.589 . . . . 0.0 109.667 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -142.3 109.85 5.72 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.6 pt -70.77 -36.93 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 121.538 -0.726 . . . . 0.0 111.168 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -29.16 65.66 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.332 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -67.0 -50.0 63.59 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 118.61 0.641 . . . . 0.0 109.808 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.407 HD12 ' CD1' ' A' ' 64' ' ' TYR . 21.3 mt -64.28 -30.52 71.56 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -76.06 -26.85 56.93 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.545 -0.722 . . . . 0.0 109.849 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -86.87 -28.29 22.93 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -129.26 164.82 36.76 Favored Pre-proline 0 N--CA 1.456 -0.168 0 CA-C-N 121.177 1.808 . . . . 0.0 110.736 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.66 -161.65 0.13 Allowed 'Trans proline' 0 N--CA 1.445 -1.357 0 N-CA-C 107.109 -1.92 . . . . 0.0 107.109 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 77.46 70.75 0.2 Allowed Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 127.096 2.158 . . . . 0.0 109.859 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.17 107.45 0.66 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.517 2.145 . . . . 0.0 109.788 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 t -81.1 91.98 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -48.51 -32.32 7.73 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 125.021 1.328 . . . . 0.0 112.965 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.6 m -62.66 -14.33 42.31 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.333 1.053 . . . . 0.0 113.561 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -115.31 -20.87 10.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.319 1.448 . . . . 0.0 110.747 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.8 mt -80.92 154.23 27.13 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.776 0.83 . . . . 0.0 111.286 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -141.69 138.97 32.81 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.281 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -81.46 131.28 35.27 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.43 119.99 32.49 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 125.84 1.656 . . . . 0.0 107.726 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 t -123.1 -172.17 2.45 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -154.15 136.28 14.76 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.28 1.032 . . . . 0.0 108.576 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.98 69.74 1.45 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.78 -177.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 115' ' ' ASN . . . 85.31 70.04 1.34 Allowed Glycine 0 C--N 1.338 0.656 0 O-C-N 121.274 -0.892 . . . . 0.0 113.675 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? 67.39 -10.37 0.35 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 128.013 2.525 . . . . 0.0 112.978 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.476 ' H ' ' C ' ' A' ' 113' ' ' GLY . 14.5 m120 -107.39 144.14 34.72 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.181 0.992 . . . . 0.0 108.641 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.55 150.91 22.59 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.519 0.728 . . . . 0.0 110.929 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.61 166.86 12.21 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.518 1.927 . . . . 0.0 110.123 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -139.11 118.47 12.81 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -120.78 131.46 54.49 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.161 0.984 . . . . 0.0 110.248 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.8 t -52.99 116.94 2.62 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.778 1.631 . . . . 0.0 110.842 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.16 -45.82 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 119.227 0.921 . . . . 0.0 110.816 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.03 -26.49 68.58 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.555 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -145.9 87.19 6.86 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 119.202 0.91 . . . . 0.0 111.575 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -58.05 166.35 5.69 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.52 2.813 . . . . 0.0 114.032 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.65 -4.35 86.29 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 117.463 -1.743 . . . . 0.0 114.219 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 42.0 m95 -120.16 131.35 54.98 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.891 1.846 . . . . 0.0 107.843 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -114.9 144.37 43.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 126.037 1.735 . . . . 0.0 111.22 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 13.1 mt -77.11 123.32 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.737 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.74 120.09 32.17 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.38 0.609 . . . . 0.0 110.646 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.72 -23.29 27.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 C-N-CA 128.211 2.604 . . . . 0.0 111.051 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.458 ' HG ' ' CD2' ' A' ' 138' ' ' LEU . 1.4 m 60.9 87.0 0.09 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.911 1.339 . . . . 0.0 109.128 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.409 ' HA ' ' HG3' ' A' ' 21' ' ' ARG 0.271 1.7 m -109.76 4.1 21.48 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.696 -178.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -111.72 160.66 17.07 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 25.6 -87.54 0.01 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 128.043 2.735 . . . . 0.0 114.422 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -177.45 60.71 0.09 OUTLIER Glycine 0 CA--C 1.521 0.415 0 CA-C-O 117.795 -1.559 . . . . 0.0 109.38 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 4.9 m -85.08 161.42 52.53 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 119.455 1.627 . . . . 0.0 112.826 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.22 155.43 37.37 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 N-CA-C 108.553 -1.364 . . . . 0.0 108.553 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.458 ' CD2' ' HG ' ' A' ' 131' ' ' SER . 13.0 mt -82.98 112.22 19.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 pp -138.0 -173.15 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.975 1.71 . . . . 0.0 109.843 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.4 mt -109.14 156.8 19.41 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.609 1.164 . . . . 0.0 108.244 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.37 136.66 21.24 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -81.24 -40.51 23.67 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.895 0.878 . . . . 0.0 110.855 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 C--O 1.239 0.541 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -178.376 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.8 m120 . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.43 100.41 10.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.101 0.56 . . . . 0.0 109.588 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.7 p -95.78 -17.77 20.93 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -115.97 131.81 56.83 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.004 1.322 . . . . 0.0 110.013 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.334 0.1 OUTLIER -163.49 -135.75 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 119.066 -0.492 . . . . 0.0 112.153 177.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -146.22 179.33 23.3 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 125.794 1.664 . . . . 0.0 109.363 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.78 122.29 17.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.351 1.075 . . . . 0.0 110.725 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.3 m -79.42 34.72 0.26 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.602 1.561 . . . . 0.0 107.987 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -63.01 131.96 50.39 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 119.865 -1.772 . . . . 0.0 107.665 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 25.5 mt -109.25 165.95 11.23 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.351 1.06 . . . . 0.0 110.841 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 14.7 p90 . . . . . 0 C--O 1.254 1.335 0 C-N-CA 127.099 2.16 . . . . 0.0 107.694 179.894 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.64 0 CA-C-O 119.407 -0.33 . . . . 0.0 111.534 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.39 115.71 3.49 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 124.446 3.431 . . . . 0.0 110.252 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.76 118.59 35.84 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.031 0.933 . . . . 0.0 111.816 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -106.5 133.68 50.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.08 0.552 . . . . 0.0 111.18 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -157.82 -139.06 2.63 Favored Glycine 0 C--O 1.225 -0.429 0 O-C-N 120.825 -1.172 . . . . 0.0 112.921 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -151.87 169.39 22.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.927 0.863 . . . . 0.0 112.055 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.3 mt -121.29 -5.59 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 O-C-N 121.236 -0.915 . . . . 0.0 111.001 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -53.1 -34.29 56.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.733 1.213 . . . . 0.0 110.732 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -51.91 -2.8 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 131.339 3.856 . . . . 0.0 115.693 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.5 mm -93.07 -80.46 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.611 1.964 . . . . 0.0 108.888 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -119.29 29.81 7.45 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.818 0.847 . . . . 0.0 112.705 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.7 t60 61.53 25.73 15.6 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.783 2.033 . . . . 0.0 112.428 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -86.36 92.15 8.73 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 120.303 -1.498 . . . . 0.0 110.808 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.4 t -69.43 141.91 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -107.78 144.05 35.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.5 t -141.78 129.31 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 tp -72.33 106.83 4.63 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.405 ' NE2' HH11 ' A' ' 38' ' ' ARG . 0.7 OUTLIER -127.73 127.39 43.56 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.629 0.772 . . . . 0.0 108.956 -178.102 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t70 56.25 27.35 11.63 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 76.28 17.54 2.01 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 129.839 3.256 . . . . 0.0 112.892 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.42 131.41 43.58 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.082 1.353 . . . . 0.0 108.161 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.3 mt -75.42 115.96 15.63 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 120.603 -1.311 . . . . 0.0 107.71 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.01 144.19 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.337 0.655 . . . . 0.0 109.378 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.96 126.4 31.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.81 1.244 . . . . 0.0 109.446 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -126.86 70.13 73.22 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.135 1.774 . . . . 0.0 109.465 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.13 -30.67 37.88 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.843 1.695 . . . . 0.0 114.283 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -148.1 82.5 1.49 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -146.45 158.72 43.93 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 123.473 0.709 . . . . 0.0 109.222 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -76.82 -48.91 17.09 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.699 1.249 . . . . 0.0 108.905 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.405 HH11 ' NE2' ' A' ' 26' ' ' GLN . 14.0 ttm180 -77.4 52.65 0.97 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.608 1.563 . . . . 0.0 112.494 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -108.66 165.05 11.83 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.08 -1.013 . . . . 0.0 111.072 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -156.09 134.17 7.1 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.236 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.45 126.14 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.985 2.456 . . . . 0.0 108.323 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.9 m -121.58 161.09 22.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 125.065 1.346 . . . . 0.0 109.733 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.71 161.19 17.8 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.6 mm -130.2 100.98 5.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 129.282 3.033 . . . . 0.0 109.318 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.48 110.63 21.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.725 2.01 . . . . 0.0 108.163 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tt -107.91 140.53 40.88 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.813 2.045 . . . . 0.0 109.791 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -148.57 153.08 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.943 1.297 . . . . 0.0 109.841 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.4 p -96.88 127.35 42.76 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.184 1.394 . . . . 0.0 110.013 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 55.8 m -54.02 133.03 43.55 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.159 0.984 . . . . 0.0 109.133 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -98.95 -18.12 17.99 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 117.345 -1.312 . . . . 0.0 113.573 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -105.11 41.8 1.3 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.286 1.035 . . . . 0.0 108.772 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.5 m -69.31 -6.98 7.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 O-C-N 120.248 -1.533 . . . . 0.0 114.011 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -56.06 -46.52 78.93 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.172 0.989 . . . . 0.0 111.856 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.0 t -83.46 0.66 45.3 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.7 mt -98.23 174.9 6.28 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.947 -1.096 . . . . 0.0 109.625 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -77.99 155.97 30.44 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.679 -1.6 . . . . 0.0 109.371 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.79 -34.62 2.38 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.869 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.68 -38.52 85.24 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.318 0.963 . . . . 0.0 110.597 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -68.26 -18.52 64.57 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.87 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.473 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 119.18 174.52 15.85 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 126.103 1.811 . . . . 0.0 110.745 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -69.53 114.76 26.62 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.716 0.806 . . . . 0.0 111.829 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -84.16 138.07 7.58 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.423 2.749 . . . . 0.0 110.035 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -140.05 -179.04 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 123.977 0.911 . . . . 0.0 109.681 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -138.22 155.72 48.39 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 122.338 1.066 . . . . 0.0 109.393 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.22 151.86 30.56 Favored 'General case' 0 CA--C 1.507 -0.684 0 O-C-N 120.938 -1.101 . . . . 0.0 108.136 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.17 -179.89 24.5 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.119 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 mt -92.09 169.84 10.31 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -137.3 115.05 11.32 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 120.847 -1.158 . . . . 0.0 109.557 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 155.38 -28.63 0.62 Allowed Glycine 0 CA--C 1.527 0.819 0 CA-C-O 117.992 -1.449 . . . . 0.0 112.756 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.01 30.03 0.88 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.577 1.689 . . . . 0.0 112.123 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.2 m120 51.32 74.92 0.22 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.333 1.853 . . . . 0.0 112.51 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.03 141.82 34.27 Favored 'General case' 0 CA--C 1.517 -0.296 0 O-C-N 121.307 -0.87 . . . . 0.0 109.322 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.7 m -141.76 175.17 9.92 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.421 0.555 . . . . 0.0 111.007 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.433 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 12.5 mt -63.24 156.71 24.65 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.3 ttp -163.64 134.43 4.53 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.2 m -93.67 132.13 38.3 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.78 131.16 19.7 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.899 0.88 . . . . 0.0 108.98 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -87.45 138.82 31.15 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.152 0.887 . . . . 0.0 109.737 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.9 m -92.37 38.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.46 -51.74 4.25 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -83.13 -54.93 4.66 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -138.08 160.75 63.06 Favored Pre-proline 0 N--CA 1.471 0.617 0 C-N-CA 125.111 1.364 . . . . 0.0 112.649 -176.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.28 151.42 43.33 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.906 2.404 . . . . 0.0 110.707 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 71.1 p -144.84 179.33 7.39 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.876 1.671 . . . . 0.0 108.856 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.15 139.97 38.46 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 127.089 2.156 . . . . 0.0 107.075 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -140.48 72.0 1.38 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.433 ' CD2' ' HA ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -90.28 104.04 16.66 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 127.994 2.518 . . . . 0.0 107.669 -178.168 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.54 -25.58 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -146.72 81.67 1.56 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.838 1.255 . . . . 0.0 111.389 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -162.89 161.1 25.7 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 120.102 -1.624 . . . . 0.0 108.621 179.326 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -137.39 139.9 41.03 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.092 1.757 . . . . 0.0 108.201 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.6 mt -89.45 -42.65 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 126.058 1.743 . . . . 0.0 109.015 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.73 -34.83 63.01 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.468 1.507 . . . . 0.0 111.758 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -62.78 -61.88 2.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.6 1.96 . . . . 0.0 107.976 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 37.7 mt -60.9 -22.37 64.27 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -87.77 -33.57 18.62 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.517 0.727 . . . . 0.0 109.206 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -69.64 -43.65 72.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.202 -0.904 . . . . 0.0 109.145 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.9 152.69 38.21 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 118.713 -0.661 . . . . 0.0 109.813 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.09 38.49 0.54 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.923 3.082 . . . . 0.0 113.936 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -112.55 82.13 4.62 Favored Pre-proline 0 C--O 1.235 0.312 0 O-C-N 120.877 -1.139 . . . . 0.0 112.905 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.43 102.57 1.62 Allowed 'Trans proline' 0 N--CA 1.443 -1.444 0 N-CA-C 106.048 -2.328 . . . . 0.0 106.048 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.4 t -89.29 105.09 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -48.78 -31.26 6.72 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.366 1.466 . . . . 0.0 112.006 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.4 t -62.53 -13.58 32.29 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.6 1.16 . . . . 0.0 112.852 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -121.97 -2.09 9.26 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 119.789 1.177 . . . . 0.0 110.351 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.7 mt -94.91 153.91 17.46 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.605 1.093 . . . . 0.0 110.975 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -138.43 129.41 26.89 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.765 0.826 . . . . 0.0 109.721 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.473 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -71.13 127.26 31.99 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 104.405 -2.442 . . . . 0.0 104.405 177.787 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -103.88 131.87 50.68 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.11 -178.64 5.24 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.924 0.868 . . . . 0.0 109.948 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 0.0 OUTLIER -151.91 138.67 18.86 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.932 2.093 . . . . 0.0 107.808 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.48 70.33 1.17 Allowed 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.193 0.933 . . . . 0.0 112.472 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.46 64.12 0.93 Allowed Glycine 0 CA--C 1.525 0.686 0 O-C-N 121.787 -0.57 . . . . 0.0 114.198 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 67.71 -0.6 1.9 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.722 2.009 . . . . 0.0 113.24 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -120.01 155.11 33.51 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.386 1.474 . . . . 0.0 107.608 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 69.8 m -115.01 166.6 11.62 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.77 2.028 . . . . 0.0 110.559 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.61 164.46 32.58 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.504 1.121 . . . . 0.0 111.095 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -141.75 116.37 9.69 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 125.081 1.352 . . . . 0.0 110.605 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -115.16 122.94 47.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.635 1.574 . . . . 0.0 110.361 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.0 m -49.42 124.13 8.77 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.392 1.477 . . . . 0.0 112.488 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.5 t -70.0 -44.69 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 120.146 -1.596 . . . . 0.0 111.936 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.88 -25.56 67.23 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.398 -0.814 . . . . 0.0 112.971 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -140.39 80.17 19.67 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 125.381 1.472 . . . . 0.0 108.489 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -64.53 151.72 84.49 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.148 1.899 . . . . 0.0 110.123 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.48 -32.88 6.76 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.519 2.009 . . . . 0.0 110.211 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 25.5 m-90 -88.19 106.66 18.34 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 124.626 1.17 . . . . 0.0 111.006 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -91.03 152.8 20.53 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.724 1.21 . . . . 0.0 110.148 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.4 mt -82.25 131.71 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.29 132.85 43.43 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.18 0.446 . . . . 0.0 109.813 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -81.96 -15.38 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 127.06 2.144 . . . . 0.0 111.885 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.7 m 63.29 52.28 2.47 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.914 1.285 . . . . 0.0 113.729 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.3 m -89.31 24.22 2.27 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -96.01 -83.11 0.38 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.105 0.411 . . . . 0.0 110.352 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -103.68 -44.88 1.6 Allowed Glycine 0 C--N 1.336 0.583 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.08 63.52 0.02 OUTLIER Glycine 0 CA--C 1.521 0.433 0 N-CA-C 106.264 -2.734 . . . . 0.0 106.264 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 60.9 m -82.37 170.94 13.11 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.358 1.063 . . . . 0.0 110.113 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.2 153.13 16.32 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.859 1.706 . . . . 0.0 109.127 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 16.6 mt -75.52 106.16 6.93 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.93 171.42 15.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 124.347 1.059 . . . . 0.0 111.338 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 89.6 mt -84.83 156.12 21.46 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.8 t -146.11 136.16 23.6 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -85.56 -35.94 20.75 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.563 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 . . . . . 0 N--CA 1.477 0.914 0 CA-C-N 119.671 1.123 . . . . 0.0 113.173 -178.235 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.5 m -146.55 108.48 4.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.2 p -103.32 -15.79 15.84 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.402 1.081 . . . . 0.0 111.08 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -96.67 119.73 35.7 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 128.528 2.731 . . . . 0.0 108.178 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -157.94 -133.37 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.799 0.84 . . . . 0.0 112.893 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 177.14 -161.37 28.92 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 128.737 3.065 . . . . 0.0 108.299 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.73 142.87 23.23 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.083 1.942 . . . . 0.0 112.733 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.0 m -91.39 32.36 1.07 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.835 1.254 . . . . 0.0 107.842 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -60.0 110.71 1.26 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.464 1.906 . . . . 0.0 109.8 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 12.5 mt -89.67 160.01 16.82 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 126.226 1.811 . . . . 0.0 110.583 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 20.9 p90 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 126.023 1.729 . . . . 0.0 110.401 -179.707 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 117.771 -1.109 . . . . 0.0 111.419 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.14 131.54 18.13 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.329 2.019 . . . . 0.0 107.965 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.19 113.49 24.73 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.312 1.445 . . . . 0.0 109.839 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -109.49 144.94 37.05 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.191 0.996 . . . . 0.0 110.957 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.39 -131.21 1.41 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.135 1.35 . . . . 0.0 110.854 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.1 p -153.66 172.38 17.35 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 120.601 2.2 . . . . 0.0 113.112 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.0 mt -127.39 -12.38 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 125.005 1.322 . . . . 0.0 107.597 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.81 -28.22 69.31 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 120.413 -1.43 . . . . 0.0 112.292 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -57.34 -17.98 15.03 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.395 2.678 . . . . 0.0 115.003 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.1 mt -68.03 -69.71 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.29 1.036 . . . . 0.0 109.745 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.01 29.18 7.18 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.962 0.905 . . . . 0.0 111.102 -178.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 51.48 44.66 28.88 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.303 2.241 . . . . 0.0 110.097 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -100.68 88.15 3.53 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.8 t -70.66 138.46 21.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -101.18 145.47 28.76 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.082 0.953 . . . . 0.0 109.523 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -148.26 134.57 12.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.63 121.0 14.95 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 103.471 -2.788 . . . . 0.0 103.471 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -134.01 117.85 17.15 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . 0.267 1.3 t0 46.72 59.49 3.91 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 124.072 1.892 . . . . 0.0 111.43 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 55.29 17.91 2.29 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 113.406 -1.725 . . . . 0.0 113.783 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.6 m -132.25 137.95 47.71 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.143 1.777 . . . . 0.0 107.812 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.8 mt -80.51 129.8 34.74 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.081 -1.637 . . . . 0.0 108.205 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.7 mm -131.36 140.47 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.653 0.66 . . . . 0.0 111.275 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.57 127.18 31.78 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.379 1.472 . . . . 0.0 109.108 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 m -123.09 62.8 20.51 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.213 1.805 . . . . 0.0 109.493 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.61 6.1 0.48 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.413 3.409 . . . . 0.0 116.641 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.4 ptt85 171.7 88.2 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 130.2 3.4 . . . . 0.0 104.92 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.85 139.13 24.75 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.8 -50.22 73.0 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -85.8 53.93 2.95 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.935 1.294 . . . . 0.0 112.663 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -104.51 155.56 18.71 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -150.97 132.69 7.87 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.94 148.61 64.28 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 N-CA-C 107.952 -1.595 . . . . 0.0 107.952 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.98 165.55 27.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -119.74 157.65 28.13 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.0 mm -115.85 147.45 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.92 130.12 47.96 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 104.659 -2.348 . . . . 0.0 104.659 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 tt -127.28 140.09 52.45 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 mt -146.03 138.07 19.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 125.091 1.356 . . . . 0.0 109.212 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p -79.63 132.96 36.39 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.816 0.846 . . . . 0.0 109.027 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 98.4 m -69.88 113.74 7.4 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 120.891 -1.13 . . . . 0.0 108.602 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -86.01 -9.96 55.89 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 118.68 -0.676 . . . . 0.0 112.443 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -97.45 34.64 1.77 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.768 1.627 . . . . 0.0 110.085 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.85 -10.74 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 127.212 2.205 . . . . 0.0 114.28 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.01 -10.75 4.54 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.202 1.801 . . . . 0.0 114.304 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.7 t -128.51 19.89 6.21 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.357 1.463 . . . . 0.0 110.417 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.3 mt -116.45 169.58 9.21 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.749 0.82 . . . . 0.0 109.659 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -70.88 145.88 49.95 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -116.37 -41.22 3.14 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.29 -37.24 77.2 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.619 1.568 . . . . 0.0 112.383 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -11.01 59.81 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 117.993 -1.003 . . . . 0.0 111.411 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.415 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 119.93 173.42 15.19 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -82.7 118.57 72.26 Favored Pre-proline 0 CA--C 1.542 0.64 0 O-C-N 122.039 -0.683 . . . . 0.0 111.19 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -79.85 146.5 18.6 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.87 3.047 . . . . 0.0 110.739 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 pp -139.53 177.72 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.07 1.748 . . . . 0.0 109.308 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.41 ' CE1' ' HA ' ' A' ' 92' ' ' ILE . 1.1 t80 -131.8 147.67 52.51 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.2 tt -144.87 148.26 33.74 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.6 -179.31 25.34 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 mt -98.4 145.74 26.42 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.29 105.99 14.08 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 120.341 1.428 . . . . 0.0 108.549 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.92 -24.16 0.18 Allowed Glycine 0 CA--C 1.525 0.66 0 CA-C-O 117.294 -1.837 . . . . 0.0 116.289 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.8 20.53 1.15 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 119.664 1.732 . . . . 0.0 113.273 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.48 64.35 0.94 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.956 2.102 . . . . 0.0 110.971 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.84 143.19 33.26 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.718 1.207 . . . . 0.0 110.562 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.3 m -144.97 179.47 7.32 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.026 0.531 . . . . 0.0 110.918 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.09 152.47 28.19 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.944 -0.473 . . . . 0.0 110.134 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.3 ttp -159.64 127.65 4.87 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.4 m -85.61 116.76 24.09 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.13 148.71 52.49 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -92.06 123.75 35.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.4 -33.48 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.94 -62.04 0.31 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 105.66 -2.976 . . . . 0.0 105.66 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -82.58 -36.36 26.29 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -145.95 166.32 17.63 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.57 142.12 47.9 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.003 2.469 . . . . 0.0 110.031 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.6 p -146.65 -174.77 4.56 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 125.311 1.444 . . . . 0.0 107.943 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 mt -103.22 145.13 30.4 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.043 1.337 . . . . 0.0 109.471 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -143.89 66.04 1.29 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.62 115.07 19.94 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.7 pttp 179.63 -20.9 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -156.15 87.34 1.05 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.981 1.313 . . . . 0.0 110.41 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -169.2 164.97 11.1 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 120.568 -1.332 . . . . 0.0 108.433 178.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -141.01 125.9 18.14 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.526 1.13 . . . . 0.0 108.78 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.41 ' HA ' ' CE1' ' A' ' 64' ' ' TYR . 27.6 pt -79.51 -37.31 18.52 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 125.935 1.694 . . . . 0.0 111.762 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -36.7 81.64 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 118.476 0.58 . . . . 0.0 111.187 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -56.96 -56.24 24.33 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.5 mt -62.39 -32.87 73.76 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -71.67 -36.36 70.6 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.507 -0.745 . . . . 0.0 110.285 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -75.45 -41.01 56.76 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.527 1.131 . . . . 0.0 113.062 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -112.68 157.0 41.6 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.56 63.53 5.58 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.542 2.828 . . . . 0.0 114.142 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -124.21 63.35 32.66 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.977 1.711 . . . . 0.0 109.308 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.3 77.35 3.86 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.365 2.71 . . . . 0.0 106.289 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.94 104.59 5.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 125.388 1.475 . . . . 0.0 107.996 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -49.9 -30.25 9.76 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.373 0.669 . . . . 0.0 111.952 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.95 -8.58 23.42 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.215 1.006 . . . . 0.0 113.229 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -123.73 -3.06 8.27 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.587 1.155 . . . . 0.0 109.04 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.7 mt -103.03 149.53 24.48 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.894 1.224 . . . . 0.0 111.521 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.402 ' CD2' ' HA ' ' A' ' 120' ' ' SER . 76.3 m-85 -135.32 127.08 29.2 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.172 0.989 . . . . 0.0 110.769 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.415 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -70.52 111.98 6.45 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 178.117 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -94.41 145.2 24.94 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.38 179.48 7.62 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.403 1.481 . . . . 0.0 108.283 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.3 137.11 11.29 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.494 0.718 . . . . 0.0 109.102 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.32 89.37 1.57 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.03 61.04 1.22 Allowed Glycine 0 C--N 1.336 0.545 0 O-C-N 121.37 -0.831 . . . . 0.0 111.351 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 60.09 11.08 2.53 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.306 2.243 . . . . 0.0 113.901 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -125.37 159.45 31.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.977 0.911 . . . . 0.0 108.773 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.6 m -116.49 165.7 12.93 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.095 1.758 . . . . 0.0 110.024 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.81 159.14 42.83 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 126.43 1.892 . . . . 0.0 107.398 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -146.28 119.7 9.03 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.321 1.048 . . . . 0.0 109.045 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -116.82 130.45 56.72 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.943 2.097 . . . . 0.0 110.454 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.402 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 43.5 t -56.84 122.28 11.83 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.586 0.754 . . . . 0.0 109.296 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.5 t -70.27 -38.2 73.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.37 -40.28 93.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.684 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -129.45 79.99 72.87 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 124.482 1.113 . . . . 0.0 110.099 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -61.68 148.32 93.3 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.812 2.341 . . . . 0.0 109.86 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.78 -14.05 26.98 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.163 1.364 . . . . 0.0 112.153 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -110.2 147.11 34.4 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.836 2.054 . . . . 0.0 109.164 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -122.23 147.4 46.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.816 1.646 . . . . 0.0 108.218 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 9.9 mm -73.5 124.18 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.46 133.85 33.69 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.644 1.111 . . . . 0.0 108.834 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.2 t -85.91 -21.16 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.695 1.998 . . . . 0.0 111.907 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m 56.08 67.34 1.02 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 123.425 1.583 . . . . 0.0 112.216 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.1 m -96.26 16.8 17.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.164 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.59 146.48 49.64 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.948 1.699 . . . . 0.0 107.023 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 57.99 -81.98 0.01 OUTLIER Glycine 0 C--N 1.334 0.425 0 C-N-CA 127.005 2.24 . . . . 0.0 111.693 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.03 66.87 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.246 2 N-CA-C 102.566 -4.213 . . . . 0.0 102.566 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 79.0 m -91.48 170.24 9.94 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 118.326 1.063 . . . . 0.0 111.576 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -81.12 154.32 19.21 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.558 2.172 . . . . 0.0 112.075 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 38.4 mt -82.57 107.38 15.17 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.08 175.1 9.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 125.039 1.335 . . . . 0.0 108.325 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.7 mt -88.74 166.56 13.97 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t -160.72 125.41 3.68 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -91.2 -22.22 20.74 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 123.543 0.527 . . . . 0.0 110.104 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 CA--C 1.536 0.431 0 CA-C-N 119.001 0.818 . . . . 0.0 110.905 -178.687 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 CA--C 1.512 -0.517 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.82 132.11 35.46 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.413 0.685 . . . . 0.0 109.225 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 p -124.2 -9.09 7.6 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.175 0.99 . . . . 0.0 108.655 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -127.51 125.96 41.37 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.557 1.543 . . . . 0.0 110.059 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 176.29 178.57 0.21 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.931 2.092 . . . . 0.0 110.504 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.34 -166.61 31.22 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.846 1.212 . . . . 0.0 111.694 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.61 125.71 19.91 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.289 1.436 . . . . 0.0 107.641 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.3 m -81.97 44.13 0.82 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.847 1.659 . . . . 0.0 106.88 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -67.68 147.54 52.54 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.3 mt -124.61 170.73 10.66 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.194 1.798 . . . . 0.0 108.388 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.8 p90 . . . . . 0 C--O 1.243 0.761 0 N-CA-C 104.187 -2.523 . . . . 0.0 104.187 179.422 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 118.421 -0.799 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.96 132.84 27.42 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.38 1.387 . . . . 0.0 109.534 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.46 117.34 30.1 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -112.86 146.98 37.95 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.846 0.459 . . . . 0.0 109.852 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.86 -125.99 0.97 Allowed Glycine 0 CA--C 1.523 0.535 0 C-N-CA 124.595 1.093 . . . . 0.0 111.883 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.8 p -156.07 -170.1 3.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.975 1.887 . . . . 0.0 112.565 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -146.65 1.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.225 1.01 . . . . 0.0 110.383 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -67.34 -28.92 68.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -54.61 -30.87 56.03 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.19 1.396 . . . . 0.0 111.44 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.5 mm -44.95 -67.61 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.749 2.02 . . . . 0.0 111.625 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.55 26.15 3.73 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.86 -0.525 . . . . 0.0 111.324 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 25.7 m170 60.93 39.56 16.55 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.425 1.49 . . . . 0.0 110.098 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mmt-85 -109.32 97.67 7.22 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.153 0.981 . . . . 0.0 109.932 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 t -82.47 156.46 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -108.75 137.1 47.23 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.772 1.229 . . . . 0.0 107.707 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.97 128.03 52.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.4 100.4 1.75 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -115.62 126.21 53.89 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 126.0 1.72 . . . . 0.0 109.117 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.3 t0 42.53 58.79 2.97 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.535 1.134 . . . . 0.0 112.898 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 58.86 13.44 2.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.942 1.297 . . . . 0.0 114.363 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.7 m -131.78 149.86 52.33 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 120.688 1.586 . . . . 0.0 108.287 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.8 mt -89.96 125.5 35.4 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.5 mm -119.72 140.27 44.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.54 141.67 36.44 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 m -120.3 71.72 18.0 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -63.67 97.35 0.22 Allowed 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.452 2.101 . . . . 0.0 109.958 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 49.55 43.73 24.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.671 1.189 . . . . 0.0 111.165 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -88.67 148.12 24.17 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -65.89 -11.64 48.51 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.259 30.0 ptt180 -117.11 25.15 10.69 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.682 0.793 . . . . 0.0 110.334 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -75.92 148.16 38.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.2 t -145.91 129.98 8.64 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.52 145.29 52.31 Favored 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.045 1.163 . . . . 0.0 112.123 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.4 m -126.31 175.49 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.35 161.72 28.76 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.4 mm -124.82 147.78 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.15 134.5 52.4 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.01 133.88 47.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.833 1.253 . . . . 0.0 107.999 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.67 134.11 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.022 0.529 . . . . 0.0 110.59 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.8 t -72.44 159.77 33.42 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 122.514 1.149 . . . . 0.0 109.427 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.3 m -83.6 100.48 10.84 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.749 1.22 . . . . 0.0 109.653 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 ptt85 -82.94 13.77 3.73 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.54 -1.35 . . . . 0.0 112.428 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -132.48 33.76 3.78 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.723 2.009 . . . . 0.0 111.536 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -73.06 3.81 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 120.326 -1.484 . . . . 0.0 114.641 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -48.75 -33.46 10.33 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -102.6 0.17 32.93 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 120.114 1.325 . . . . 0.0 112.454 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.6 mt -95.48 163.14 13.35 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 120.256 -1.528 . . . . 0.0 111.457 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -70.62 155.36 40.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -120.62 -23.66 5.98 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.26 -13.53 46.46 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.195 0.998 . . . . 0.0 113.507 -178.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.2 mtm-85 -84.29 7.64 18.63 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.452 1.101 . . . . 0.0 112.915 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.0 -173.46 15.57 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -92.62 105.35 14.17 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-O 117.708 -1.139 . . . . 0.0 109.844 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -69.67 128.92 16.81 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.239 2.626 . . . . 0.0 110.319 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.5 pt -139.64 177.71 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.5 1.52 . . . . 0.0 109.218 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -133.01 158.62 42.25 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.6 tt -155.45 155.91 34.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.623 1.569 . . . . 0.0 108.609 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.41 178.46 38.19 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -87.18 177.73 7.09 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -140.62 111.39 6.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.062 -1.024 . . . . 0.0 108.832 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 153.39 -18.57 0.7 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-O 117.962 -1.465 . . . . 0.0 115.403 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.28 24.47 0.62 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.574 1.687 . . . . 0.0 111.969 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 57.24 72.96 0.48 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.324 1.85 . . . . 0.0 109.07 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.42 125.87 10.9 Favored 'General case' 0 N--CA 1.461 0.107 0 O-C-N 121.215 -0.928 . . . . 0.0 111.559 -178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.458 ' HG ' ' CG2' ' A' ' 92' ' ' ILE . 24.3 m -133.05 172.85 12.09 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.106 0.962 . . . . 0.0 110.936 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.9 mt -55.68 150.91 11.72 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.8 ttp -157.18 117.37 3.5 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.3 m -84.5 115.89 22.82 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.598 1.09 . . . . 0.0 110.97 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.86 -170.43 1.83 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -149.35 128.57 12.85 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.1 m -81.84 38.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.59 -7.81 2.61 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 120.914 -1.116 . . . . 0.0 113.253 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -123.85 -50.63 1.83 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 127.653 2.381 . . . . 0.0 113.365 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -144.61 156.51 56.41 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 123.908 0.883 . . . . 0.0 108.965 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.46 160.03 44.83 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.467 1.445 . . . . 0.0 110.974 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.5 p -147.82 160.13 43.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.499 1.119 . . . . 0.0 109.394 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.7 mt -98.64 127.21 44.49 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -123.67 68.09 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.717 0.807 . . . . 0.0 109.838 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.18 102.68 12.78 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.3 -35.56 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.709 1.256 . . . . 0.0 111.342 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -137.3 90.92 2.56 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.61 1.164 . . . . 0.0 109.847 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -173.76 158.24 3.24 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 120.858 -1.151 . . . . 0.0 109.02 178.342 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -138.81 134.03 32.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.104 1.361 . . . . 0.0 107.518 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.458 ' CG2' ' HG ' ' A' ' 73' ' ' CYS . 37.0 pt -90.25 -33.53 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 C-N-CA 123.806 0.843 . . . . 0.0 111.003 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -32.3 73.89 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 118.299 0.5 . . . . 0.0 110.244 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -62.36 -54.31 42.26 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.624 0.647 . . . . 0.0 109.816 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.3 mt -60.22 -40.89 91.75 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -65.11 -31.54 72.79 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.06 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -77.5 -36.07 53.0 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 116.42 -1.752 . . . . 0.0 113.603 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.61 174.43 2.35 Favored Pre-proline 0 N--CA 1.472 0.637 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -175.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.6 -162.93 0.16 Allowed 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.829 2.353 . . . . 0.0 108.228 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 69.3 65.09 0.52 Allowed Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.888 1.675 . . . . 0.0 113.275 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -56.42 116.62 3.32 Favored 'Trans proline' 0 C--O 1.244 0.819 0 C-N-CA 121.903 1.736 . . . . 0.0 110.553 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.96 84.75 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -42.77 -33.77 0.81 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.535 1.934 . . . . 0.0 112.929 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -59.26 -15.25 14.51 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.905 1.682 . . . . 0.0 113.328 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.7 5.9 6.14 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.071 1.348 . . . . 0.0 110.438 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 39.4 mt -101.35 153.71 19.43 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 120.46 1.482 . . . . 0.0 109.208 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -140.73 131.57 25.9 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.259 0.623 . . . . 0.0 110.686 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.402 ' CE1' ' HA ' ' A' ' 121' ' ' VAL . 83.3 m-85 -76.86 123.09 25.74 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.061 0.945 . . . . 0.0 109.346 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -82.4 126.22 31.94 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.9 t -120.95 170.84 9.11 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -142.42 158.77 43.34 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.718 2.007 . . . . 0.0 109.018 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 80.7 p -124.14 -4.58 7.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.854 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.92 -44.17 1.27 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -137.82 10.48 2.87 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.47 1.108 . . . . 0.0 112.965 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -146.84 164.1 33.93 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 106.654 -1.609 . . . . 0.0 106.654 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 m -128.98 153.55 47.45 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.704 0.684 . . . . 0.0 110.527 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.4 170.15 11.13 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -139.19 109.29 6.4 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.916 1.686 . . . . 0.0 109.666 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -106.39 126.18 51.92 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.517 1.127 . . . . 0.0 110.164 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.9 t -50.9 127.58 18.98 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.448 0.699 . . . . 0.0 110.205 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.402 ' HA ' ' CE1' ' A' ' 108' ' ' TYR . 53.6 t -68.37 -48.12 74.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.71 -40.09 91.89 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.269 1.028 . . . . 0.0 112.842 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -127.94 84.74 62.44 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -69.24 160.88 48.12 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 N-CA-C 108.368 -1.436 . . . . 0.0 108.368 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.75 -32.03 7.47 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -95.82 140.28 30.83 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 118.03 0.915 . . . . 0.0 109.442 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -120.33 138.97 53.42 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 127.078 2.151 . . . . 0.0 108.597 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.3 mm -70.24 139.7 19.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -115.18 126.15 54.25 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.943 0.792 . . . . 0.0 111.399 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.8 m -73.74 -5.36 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.816 -1.178 . . . . 0.0 112.697 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.6 m 54.12 35.12 21.61 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.8 m -73.18 -1.97 19.75 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.807 1.243 . . . . 0.0 112.749 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -94.91 130.22 41.61 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 101.911 -3.366 . . . . 0.0 101.911 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.32 -84.78 0.05 OUTLIER Glycine 0 CA--C 1.531 1.04 0 C-N-CA 123.554 0.597 . . . . 0.0 111.913 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.33 68.0 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 129.219 3.295 . . . . 0.0 108.361 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 m -91.52 168.45 13.32 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 117.886 0.843 . . . . 0.0 110.523 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 55.7 Cg_endo -67.99 159.82 51.27 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 N-CA-C 107.888 -1.62 . . . . 0.0 107.888 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.9 mt -80.96 137.39 36.1 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -163.14 171.61 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 125.286 1.434 . . . . 0.0 109.354 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.12 171.14 8.92 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.4 t -157.89 145.56 18.5 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.47 -1.394 . . . . 0.0 108.441 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -106.02 -26.23 11.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.559 0.618 . . . . 0.0 109.797 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 N--CA 1.441 -0.902 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 179.401 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.5 p -108.91 97.36 7.01 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.23 1.012 . . . . 0.0 111.611 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.8 p -93.62 -31.76 14.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.815 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.67 113.42 26.55 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 118.413 -0.803 . . . . 0.0 112.893 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -161.26 178.79 8.89 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.07 1.305 . . . . 0.0 112.168 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.83 173.63 21.01 Favored Glycine 0 C--O 1.24 0.485 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.6 tp -120.98 138.88 53.94 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.3 m -89.99 41.92 1.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.02 167.49 15.83 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.2 mt -136.73 151.59 49.39 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.876 1.27 . . . . 0.0 107.699 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 55.4 p90 . . . . . 0 C--O 1.254 1.339 0 C-N-CA 125.191 1.397 . . . . 0.0 109.014 179.533 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 117.24 -1.362 . . . . 0.0 107.469 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.52 122.75 10.5 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.341 2.028 . . . . 0.0 108.982 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.73 138.4 40.41 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -135.19 148.44 49.67 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 119.086 0.857 . . . . 0.0 110.801 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.08 -130.43 1.26 Allowed Glycine 0 C--O 1.227 -0.339 0 CA-C-O 118.668 -1.073 . . . . 0.0 111.534 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.5 p -145.71 -177.7 5.72 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.875 1.338 . . . . 0.0 113.226 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mt -140.54 -11.56 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 126.403 1.881 . . . . 0.0 109.336 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -61.04 -17.98 55.3 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 119.778 -1.826 . . . . 0.0 113.687 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.73 -7.88 5.71 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.757 2.423 . . . . 0.0 113.838 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.6 mm -91.56 -41.51 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.97 23.14 0.86 Allowed 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 121.088 -1.008 . . . . 0.0 111.016 -176.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 62.59 27.83 16.38 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.629 0.728 . . . . 0.0 112.035 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.85 91.09 6.27 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.7 t -85.67 161.51 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -118.79 144.13 46.5 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 119.553 1.069 . . . . 0.0 110.953 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.7 t -142.65 134.45 25.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 tp -68.71 120.73 15.14 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 103.594 -2.743 . . . . 0.0 103.594 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -137.17 123.11 20.17 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.4 t0 47.07 49.41 15.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.001 1.32 . . . . 0.0 112.644 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 67.59 12.05 8.68 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.949 2.1 . . . . 0.0 115.623 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.1 m -132.42 143.54 49.88 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.652 1.115 . . . . 0.0 109.88 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 mt -81.96 121.95 27.17 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.41 -1.431 . . . . 0.0 107.872 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.79 136.76 53.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.54 136.98 40.56 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 124.59 1.182 . . . . 0.0 108.105 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 m -119.5 87.19 35.87 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.54 1.136 . . . . 0.0 108.569 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.66 -44.72 2.81 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.78 2.32 . . . . 0.0 112.927 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -153.22 44.13 0.63 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.49 1.516 . . . . 0.0 109.611 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.0 124.77 32.82 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -55.6 -32.95 63.51 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 123.981 0.801 . . . . 0.0 109.65 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -89.1 31.0 0.9 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.624 1.569 . . . . 0.0 112.513 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -80.2 168.06 19.55 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.068 -1.645 . . . . 0.0 109.97 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.81 147.97 18.26 Favored Pre-proline 0 N--CA 1.448 -0.56 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.39 159.58 46.37 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.286 2.657 . . . . 0.0 108.531 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.85 160.0 9.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 125.77 1.628 . . . . 0.0 108.115 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.04 154.42 27.71 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.964 1.706 . . . . 0.0 108.111 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mm -130.12 104.35 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.193 1.397 . . . . 0.0 108.088 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.97 141.36 28.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.5 tt -132.69 140.2 48.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.57 145.46 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.8 p -75.65 161.9 28.7 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 124.785 1.234 . . . . 0.0 107.824 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.94 176.01 9.61 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.19 -7.52 7.09 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -116.69 37.64 3.72 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.5 m -60.99 -16.29 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 125.253 1.421 . . . . 0.0 113.544 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.46 -18.41 65.3 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.948 0.499 . . . . 0.0 110.094 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.14 -0.82 49.61 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.117 0.967 . . . . 0.0 112.262 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.2 mt -106.69 179.25 4.32 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.262 0.937 . . . . 0.0 110.343 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.614 ' HB2' ' HH ' ' A' ' 108' ' ' TYR . 9.1 mt-10 -92.37 157.63 16.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.909 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.77 -19.46 6.77 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.816 1.247 . . . . 0.0 112.7 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.25 -31.63 72.83 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.506 1.122 . . . . 0.0 113.44 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -86.84 -5.67 59.03 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.536 0.734 . . . . 0.0 112.707 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 127.0 -158.12 20.85 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -102.09 107.77 54.05 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.42 123.5 9.17 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.532 2.821 . . . . 0.0 109.64 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.8 pt -132.91 -171.94 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.445 1.898 . . . . 0.0 108.434 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -134.15 158.62 43.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.588 1.155 . . . . 0.0 108.953 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.1 tt -149.59 150.06 31.63 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.425 1.49 . . . . 0.0 108.534 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.67 177.19 30.52 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 124.211 0.91 . . . . 0.0 111.945 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mt -97.96 132.25 43.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -96.53 35.69 1.46 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.425 1.011 . . . . 0.0 112.581 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -97.7 -96.87 1.96 Allowed Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.488 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.3 mt -87.8 13.87 9.82 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.885 1.674 . . . . 0.0 115.018 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 m120 72.37 70.88 0.15 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.437 1.895 . . . . 0.0 109.278 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.454 ' C ' ' HG ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -141.44 145.89 35.83 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 125.328 1.451 . . . . 0.0 107.976 -177.733 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.454 ' HG ' ' C ' ' A' ' 72' ' ' LEU . 56.9 m -143.72 174.05 11.14 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.202 0.91 . . . . 0.0 109.855 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.1 mt -59.9 150.97 27.08 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.015 0.37 . . . . 0.0 111.185 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.9 ttp -157.89 116.05 3.08 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 95.8 m -89.78 109.7 20.67 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 119.288 0.949 . . . . 0.0 109.46 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.53 -169.23 1.44 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -130.78 118.54 20.97 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.2 p -65.67 -9.97 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.45 -1.29 7.56 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 125.295 1.426 . . . . 0.0 110.981 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -150.09 -44.25 0.13 Allowed 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.072 0.949 . . . . 0.0 111.484 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -135.44 163.06 53.5 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 124.903 1.281 . . . . 0.0 111.504 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -71.95 146.89 48.35 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.396 2.064 . . . . 0.0 112.635 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.1 p -145.75 170.89 15.61 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.4 mt -98.0 132.53 43.48 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -126.15 73.35 1.36 Allowed 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.02 0.928 . . . . 0.0 108.806 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.84 107.82 17.84 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.08 -30.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.127 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -157.35 97.73 1.65 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.183 0.993 . . . . 0.0 110.666 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.84 161.54 4.64 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.509 1.524 . . . . 0.0 107.131 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.1 130.31 42.99 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.424 1.49 . . . . 0.0 112.431 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.1 pt -82.37 -39.67 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 126.233 1.813 . . . . 0.0 111.644 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.2 tpt -64.51 -34.55 78.49 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.297 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.51 -45.88 92.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.879 0.763 . . . . 0.0 109.356 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.1 mt -65.82 -33.69 76.44 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.758 0.708 . . . . 0.0 111.278 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -79.77 -16.39 55.63 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.468 0.576 . . . . 0.0 110.403 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -91.73 -36.42 13.59 Favored 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 125.371 1.468 . . . . 0.0 111.486 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.79 159.03 42.25 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 121.141 -0.975 . . . . 0.0 112.049 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -78.86 54.11 4.98 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.435 2.09 . . . . 0.0 112.172 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -116.24 71.85 4.63 Favored Pre-proline 0 N--CA 1.473 0.683 0 O-C-N 120.713 -1.242 . . . . 0.0 110.827 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -79.99 82.1 2.58 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.599 2.199 . . . . 0.0 109.166 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.2 t -74.36 106.01 3.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -50.98 -30.53 15.31 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.423 1.01 . . . . 0.0 111.255 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 m -70.83 -8.82 55.37 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -114.03 -22.6 9.98 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.159 -0.963 . . . . 0.0 109.134 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.3 mt -84.34 154.23 23.02 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.007 0.923 . . . . 0.0 113.024 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -140.28 133.17 29.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.022 0.929 . . . . 0.0 110.079 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.614 ' HH ' ' HB2' ' A' ' 56' ' ' GLU . 62.1 m-85 -77.41 118.45 19.88 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -81.17 141.06 34.58 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.0 m -138.87 174.38 10.58 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.465 1.106 . . . . 0.0 108.175 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -153.14 150.74 29.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.858 0.463 . . . . 0.0 110.142 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.01 107.07 0.35 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.36 56.92 3.28 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 126.121 1.819 . . . . 0.0 111.756 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 11.7 mtm-85 61.87 9.04 2.74 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.6 1.96 . . . . 0.0 109.798 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -117.5 162.35 18.12 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 119.903 1.228 . . . . 0.0 110.882 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.0 m -111.78 158.79 18.94 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.213 2.205 . . . . 0.0 108.632 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.65 162.82 34.55 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.474 1.909 . . . . 0.0 108.747 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -140.83 116.21 10.05 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -108.89 130.14 55.43 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.465 1.506 . . . . 0.0 109.226 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.9 t -56.69 117.69 4.14 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.356 1.462 . . . . 0.0 110.248 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.2 t -62.72 -40.68 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 119.076 0.853 . . . . 0.0 111.022 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.33 -42.02 88.78 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -133.2 86.49 41.7 Favored Pre-proline 0 C--O 1.237 0.414 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.04 168.8 11.59 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.285 2.656 . . . . 0.0 111.535 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.49 -21.67 31.2 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -101.03 118.03 36.19 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 127.444 2.298 . . . . 0.0 107.078 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -108.1 148.32 29.99 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.104 1.361 . . . . 0.0 108.902 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.4 mt -75.61 122.82 30.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.15 140.29 29.81 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.354 0.597 . . . . 0.0 110.494 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.4 m -90.58 -4.75 10.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 C-N-CA 124.548 1.139 . . . . 0.0 112.231 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.1 m 52.97 73.86 0.33 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 123.126 1.441 . . . . 0.0 113.571 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.0 t -93.83 6.12 49.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.676 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -115.36 136.22 53.32 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 53.84 -104.48 0.23 Allowed Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 107.561 -2.216 . . . . 0.0 107.561 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -173.35 66.43 0.11 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 106.394 -2.682 . . . . 0.0 106.394 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 56.5 m -82.0 157.74 68.35 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 117.534 0.667 . . . . 0.0 110.642 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -71.14 165.75 31.39 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 121.973 1.782 . . . . 0.0 108.521 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 22.6 mt -87.82 113.33 23.38 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.642 1.177 . . . . 0.0 112.06 -177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 pp -135.95 178.44 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 125.447 1.499 . . . . 0.0 109.455 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 35.6 mt -96.17 141.58 29.37 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.2 t -129.85 129.8 44.44 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -87.26 -23.47 24.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 122.315 1.055 . . . . 0.0 110.88 -177.977 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 55.8 m -109.8 118.51 36.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.7 p -108.07 -11.94 15.21 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.409 1.084 . . . . 0.0 110.099 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.69 126.84 48.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.759 1.223 . . . . 0.0 109.919 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -152.72 -165.08 2.1 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.333 -0.854 . . . . 0.0 109.41 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -148.1 127.59 2.63 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 106.055 -2.818 . . . . 0.0 106.055 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.52 114.47 26.01 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.8 m -78.41 39.59 0.33 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.588 2.355 . . . . 0.0 107.716 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -64.18 148.57 49.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.403 1.881 . . . . 0.0 107.999 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.1 mt -129.51 162.55 27.89 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.244 1.818 . . . . 0.0 108.43 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 22.9 p90 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 115.361 -2.257 . . . . 0.0 109.677 -179.592 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.94 132.15 22.45 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.442 2.094 . . . . 0.0 107.497 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.99 132.81 42.43 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -128.89 145.98 51.07 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.14 -139.19 2.67 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 95.0 p -143.96 -172.62 3.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.036 0.918 . . . . 0.0 112.796 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.3 mt -140.05 -10.6 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 126.443 1.897 . . . . 0.0 109.337 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -24.02 65.31 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 119.544 -1.972 . . . . 0.0 113.268 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -58.86 -16.38 17.06 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.917 2.087 . . . . 0.0 112.706 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.5 mt -74.79 -67.11 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.138 1.375 . . . . 0.0 112.8 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -136.7 32.09 2.75 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.149 0.976 . . . . 0.0 110.535 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 58.62 37.42 25.31 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.924 0.868 . . . . 0.0 110.643 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.1 mmt-85 -105.72 89.67 3.16 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.824 -1.173 . . . . 0.0 109.217 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.3 t -79.11 157.25 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 49.8 m0 -111.47 153.78 25.66 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.988 0.915 . . . . 0.0 108.673 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.5 t -146.62 135.65 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.1 tp -76.25 106.89 8.12 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -132.16 133.51 44.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 119.843 1.201 . . . . 0.0 111.293 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t0 47.83 42.79 16.5 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 123.641 1.686 . . . . 0.0 111.28 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 61.61 26.93 16.51 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 127.223 2.209 . . . . 0.0 115.122 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.1 m -138.71 154.79 48.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.8 mt -92.94 126.45 38.02 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mt -126.97 132.16 70.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 123.141 0.576 . . . . 0.0 110.736 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.34 136.38 46.17 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.951 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.7 m -112.96 81.44 4.57 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.786 1.235 . . . . 0.0 108.117 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.12 -33.36 25.34 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.559 2.172 . . . . 0.0 111.851 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -151.33 12.73 0.65 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -62.86 138.65 58.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 120.585 -1.322 . . . . 0.0 111.059 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -33.13 75.16 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.603 1.961 . . . . 0.0 109.038 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -102.08 71.59 1.27 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.7 ptm -106.7 163.07 13.21 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -157.43 141.12 11.37 Favored Pre-proline 0 N--CA 1.446 -0.652 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -71.91 163.78 37.74 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 N-CA-C 108.502 -1.384 . . . . 0.0 108.502 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.8 p -155.62 154.19 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.437 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 68' ' ' ASN . 0.7 OUTLIER -106.46 150.99 25.53 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 126.827 2.051 . . . . 0.0 110.355 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.3 mm -121.56 122.34 66.85 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.71 145.84 27.96 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.9 tt -140.18 138.01 34.82 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 80.9 mt -146.77 138.0 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 C-N-CA 126.129 1.772 . . . . 0.0 109.856 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.4 p -84.28 130.24 34.82 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 89.9 m -62.68 138.74 58.58 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -94.42 -28.36 15.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.858 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -90.85 40.73 1.03 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.2 m -68.22 -8.81 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 120.44 -1.412 . . . . 0.0 112.783 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -62.6 -7.37 4.61 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.032 2.133 . . . . 0.0 113.583 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 t -122.5 7.23 9.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.897 1.279 . . . . 0.0 111.605 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.6 mt -107.49 167.31 10.03 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.849 -1.157 . . . . 0.0 108.601 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -64.71 153.34 39.98 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.268 -1.333 . . . . 0.0 107.992 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -121.72 -47.01 2.22 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.091 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.16 -26.45 62.75 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 127.909 2.484 . . . . 0.0 113.315 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -85.04 -19.47 31.92 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.789 -0.57 . . . . 0.0 111.601 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.415 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 140.71 -167.44 25.59 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -97.45 102.1 11.9 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.683 0.793 . . . . 0.0 110.676 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.64 138.17 23.6 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 124.298 3.332 . . . . 0.0 112.741 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pp -146.08 -175.35 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 125.738 1.615 . . . . 0.0 110.246 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -134.16 156.46 48.29 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.678 0.791 . . . . 0.0 110.527 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.8 tt -154.3 151.82 29.55 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.599 1.56 . . . . 0.0 108.428 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.92 -176.67 34.26 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mt -83.47 171.03 13.82 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 176.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.414 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 10.5 t-20 -137.68 47.34 2.06 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.603 -1.311 . . . . 0.0 109.6 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.83 -75.99 0.54 Allowed Glycine 0 C--N 1.337 0.63 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.381 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.21 25.11 11.43 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -178.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 m120 66.88 72.96 0.36 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.662 1.185 . . . . 0.0 109.804 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.46 141.71 25.1 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.963 1.305 . . . . 0.0 110.573 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.3 m -144.04 165.48 27.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.02 0.827 . . . . 0.0 111.385 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.84 156.62 8.63 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.518 1.127 . . . . 0.0 110.174 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.1 tmm? -164.37 140.53 6.17 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.5 m -102.78 119.61 39.14 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.45 -171.75 2.44 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.124 1.37 . . . . 0.0 107.874 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -128.25 127.09 42.18 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.94 -8.04 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 123.437 0.461 . . . . 0.0 110.697 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.73 -82.44 0.1 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -117.17 7.66 13.05 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.968 0.89 . . . . 0.0 112.701 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -141.1 151.01 60.85 Favored Pre-proline 0 C--O 1.241 0.651 0 C-N-CA 124.807 1.243 . . . . 0.0 110.547 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.72 149.13 18.18 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.733 2.289 . . . . 0.0 108.978 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.5 p -144.14 170.61 15.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.957 0.903 . . . . 0.0 110.393 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.5 mt -91.79 151.24 20.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.399 1.08 . . . . 0.0 108.679 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -148.63 80.94 1.45 Allowed 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 125.079 1.351 . . . . 0.0 107.628 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.96 97.39 7.25 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 125.942 1.697 . . . . 0.0 108.858 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.08 -26.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.871 0.732 . . . . 0.0 112.274 -177.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -145.24 103.59 3.86 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.541 1.537 . . . . 0.0 109.482 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER 174.11 159.25 0.16 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.133 1.373 . . . . 0.0 108.915 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -136.35 127.74 28.44 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.181 0.593 . . . . 0.0 110.795 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 tt -68.26 -47.17 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 125.903 1.681 . . . . 0.0 114.25 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.8 tpt -62.95 -29.73 71.03 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.982 -0.532 . . . . 0.0 111.268 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.22 -54.51 32.35 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.034 0.533 . . . . 0.0 109.691 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.2 mt -63.87 -30.04 71.17 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -74.39 -52.42 12.17 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -60.63 -45.08 95.42 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 125.682 1.593 . . . . 0.0 112.685 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -92.99 145.37 29.99 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.64 50.0 2.59 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.439 2.76 . . . . 0.0 112.124 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -118.12 72.73 9.4 Favored Pre-proline 0 CA--C 1.537 0.48 0 O-C-N 120.745 -1.222 . . . . 0.0 109.332 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.94 92.28 1.05 Allowed 'Trans proline' 0 N--CA 1.45 -1.037 0 N-CA-C 105.284 -2.622 . . . . 0.0 105.284 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.5 t -88.35 97.72 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -50.55 -22.23 1.88 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.02 -17.34 64.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.209 0.604 . . . . 0.0 110.858 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -113.61 -22.07 10.46 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 119.164 0.893 . . . . 0.0 110.649 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.8 mt -78.97 164.37 24.46 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.698 1.199 . . . . 0.0 113.64 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.92 140.63 22.65 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 123.772 0.829 . . . . 0.0 111.016 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.415 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.5 OUTLIER -75.3 123.18 24.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 176.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.406 ' CD2' ' HB3' ' A' ' 116' ' ' SER . 3.9 t-160 -97.94 101.35 12.81 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.883 1.273 . . . . 0.0 107.577 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.51 170.9 13.0 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.925 1.29 . . . . 0.0 110.095 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -139.86 147.38 40.58 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.675 1.59 . . . . 0.0 110.044 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.4 p -135.59 15.4 3.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.823 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.5 -79.23 0.31 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -111.47 -1.41 15.9 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.18 0.992 . . . . 0.0 111.985 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -127.03 160.87 29.83 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.206 1.002 . . . . 0.0 108.357 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.406 ' HB3' ' CD2' ' A' ' 109' ' ' HIS . 49.9 m -132.5 151.66 51.83 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.234 1.814 . . . . 0.0 109.024 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.11 165.75 12.79 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -142.8 107.96 4.97 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -111.65 124.72 52.9 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.398 1.879 . . . . 0.0 110.056 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.8 t -53.01 130.23 33.13 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.304 -0.872 . . . . 0.0 110.032 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.2 t -68.87 -51.18 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.909 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.01 78.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -129.19 81.6 70.15 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 124.055 0.942 . . . . 0.0 109.903 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -65.38 161.61 37.2 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.671 2.247 . . . . 0.0 111.113 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.2 0.06 77.69 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.205 -0.775 . . . . 0.0 113.06 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -126.69 131.23 51.43 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.455 1.902 . . . . 0.0 107.753 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.6 149.97 33.77 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.948 1.299 . . . . 0.0 112.493 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 mt -81.51 119.25 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.609 0.764 . . . . 0.0 111.176 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.72 152.31 31.64 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.638 1.108 . . . . 0.0 109.965 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.9 t -103.48 -18.2 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 127.797 2.439 . . . . 0.0 109.754 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.533 ' HB3' ' H ' ' A' ' 136' ' ' CYS . 50.9 m 61.24 39.24 15.91 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.391 1.476 . . . . 0.0 114.295 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.1 m -76.76 -11.38 59.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.61 -66.99 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.77 1.628 . . . . 0.0 111.071 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -122.88 -48.49 0.25 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 124.321 0.963 . . . . 0.0 111.288 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 138.75 60.44 0.05 OUTLIER Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . 0.533 ' H ' ' HB3' ' A' ' 131' ' ' SER . 0.5 OUTLIER -90.45 174.16 4.91 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 123.95 0.9 . . . . 0.0 110.933 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.01 166.43 29.61 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 N-CA-C 108.928 -1.22 . . . . 0.0 108.928 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 21.9 mt -87.28 114.09 23.58 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.9 pp -137.93 172.02 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.078 1.351 . . . . 0.0 110.754 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 66.3 mt -97.72 159.89 14.65 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.37 161.33 41.22 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 125.321 1.448 . . . . 0.0 107.316 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -104.57 -45.66 4.56 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.126 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m120 . . . . . 0 N--CA 1.459 0.019 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.4 m -146.53 107.9 4.25 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 102.088 -3.301 . . . . 0.0 102.088 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.49 -9.12 14.23 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.389 1.076 . . . . 0.0 110.546 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -123.26 112.32 17.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.94 -176.62 5.0 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.085 0.954 . . . . 0.0 111.165 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.99 -169.04 32.13 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.347 0.975 . . . . 0.0 112.675 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.5 130.33 18.16 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.942 1.697 . . . . 0.0 106.769 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 39.2 m -90.34 51.32 2.0 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -68.73 138.13 54.64 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 40.8 mt -123.03 170.23 10.37 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.159 2.184 . . . . 0.0 107.95 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 1.8 p90 . . . . . 0 C--O 1.255 1.347 0 CA-C-O 117.416 -1.278 . . . . 0.0 108.677 -179.842 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.239 0.55 0 CA-C-O 119.581 -0.247 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.1 146.1 80.97 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.949 1.766 . . . . 0.0 107.833 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -141.23 108.77 5.59 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -111.15 145.18 39.08 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.303 0.641 . . . . 0.0 110.227 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.28 -117.99 0.48 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.0 p -160.45 167.58 26.97 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 119.118 1.459 . . . . 0.0 114.018 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.0 mt -127.19 -2.56 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 123.463 0.705 . . . . 0.0 109.37 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -62.52 -28.65 69.99 Favored 'General case' 0 C--N 1.334 -0.094 0 O-C-N 119.4 -2.062 . . . . 0.0 115.028 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.41 -19.79 16.59 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.205 1.802 . . . . 0.0 112.635 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.7 mm -56.69 -54.48 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 127.458 2.303 . . . . 0.0 115.292 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -151.27 35.17 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.12 16.58 3.02 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.643 1.977 . . . . 0.0 114.29 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -88.22 94.89 9.97 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.596 1.558 . . . . 0.0 109.78 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -75.67 157.73 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 17.5 m0 -108.21 147.9 30.71 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.1 t -142.6 127.93 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 tp -72.31 107.62 5.01 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -124.88 124.82 42.88 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 120.602 1.547 . . . . 0.0 110.37 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 t0 47.81 57.24 6.19 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.443 1.116 . . . . 0.0 111.229 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 51.75 24.9 2.64 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.228 1.011 . . . . 0.0 113.542 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.3 m -142.96 127.05 17.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.9 mt -74.66 144.06 43.99 Favored 'General case' 0 CA--C 1.518 -0.258 0 O-C-N 119.55 -1.969 . . . . 0.0 109.306 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.4 pt -125.14 153.07 32.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 123.895 0.878 . . . . 0.0 108.862 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.36 123.02 44.05 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.3 m -111.25 78.23 1.77 Allowed Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.043 0.937 . . . . 0.0 108.87 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.73 -50.12 2.62 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.57 1.513 . . . . 0.0 110.425 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -141.98 79.73 1.68 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.637 1.175 . . . . 0.0 108.176 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -140.98 132.78 27.42 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.39 -42.56 98.91 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.632 0.582 . . . . 0.0 112.01 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -71.73 22.34 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -73.15 163.73 27.71 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 120.444 -1.41 . . . . 0.0 110.317 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.0 t -156.53 132.43 5.81 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.14 144.99 59.29 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.841 2.361 . . . . 0.0 110.633 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.56 164.51 34.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.523 1.129 . . . . 0.0 108.244 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -115.49 156.2 26.11 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 mm -123.0 136.06 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.24 126.14 46.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 119.926 1.239 . . . . 0.0 107.944 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -118.96 136.86 53.87 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.608 1.163 . . . . 0.0 110.481 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 mt -148.96 142.33 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.941 1.296 . . . . 0.0 109.246 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.7 p -84.83 153.69 22.78 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.2 m -79.53 130.2 35.17 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 120.173 -1.58 . . . . 0.0 108.117 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -79.14 -32.18 44.3 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -97.34 44.8 1.04 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.967 1.307 . . . . 0.0 110.65 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 m -66.22 -7.53 5.48 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 O-C-N 120.412 -1.43 . . . . 0.0 113.636 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -55.5 -28.92 57.5 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.285 0.948 . . . . 0.0 112.662 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.4 t -95.44 -11.13 28.1 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.902 0.774 . . . . 0.0 111.569 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.52 168.24 11.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -82.05 154.44 25.63 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -119.84 -18.31 8.29 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.056 1.343 . . . . 0.0 111.062 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -57.51 -39.59 76.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.107 2.563 . . . . 0.0 114.191 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -85.06 -12.8 52.23 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.178 0.991 . . . . 0.0 111.396 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.06 -162.26 24.99 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -93.94 103.66 11.01 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 126.148 1.779 . . . . 0.0 109.862 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.08 135.73 25.74 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.447 2.098 . . . . 0.0 109.966 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -133.15 178.06 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -137.76 131.4 31.19 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.033 0.533 . . . . 0.0 109.567 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.72 158.7 38.67 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.43 -170.09 22.69 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mt -98.85 166.73 11.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -130.31 94.77 3.74 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.98 -16.23 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 CA-C-O 116.574 -2.236 . . . . 0.0 116.977 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.15 22.95 0.11 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 120.493 2.146 . . . . 0.0 111.914 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 61.45 63.37 1.2 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.786 1.634 . . . . 0.0 108.993 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.49 127.17 27.15 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.219 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 29.1 m -136.84 179.65 6.24 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.9 mt -64.08 153.54 37.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.185 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -161.09 133.57 6.07 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 89.6 m -101.0 125.76 47.63 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.81 -174.7 3.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 81' ' ' ASP . 10.2 tttt -117.48 148.39 41.87 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.7 p -121.67 -6.79 9.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 123.564 0.54 . . . . 0.0 111.458 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.5 72.31 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.421 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 8.4 t0 70.48 5.27 5.3 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.811 2.044 . . . . 0.0 114.34 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.71 143.85 42.13 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.164 1.786 . . . . 0.0 109.356 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -74.91 162.04 37.97 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.989 2.459 . . . . 0.0 113.277 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.1 p -156.8 169.1 25.53 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.342 1.457 . . . . 0.0 109.997 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.18 130.22 37.08 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 127.583 2.353 . . . . 0.0 105.164 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -136.99 70.38 1.4 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 122.118 0.961 . . . . 0.0 109.365 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.516 HD21 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -89.14 113.78 24.99 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 127.458 2.303 . . . . 0.0 109.067 -178.128 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.64 -28.5 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 O-C-N 124.745 1.278 . . . . 0.0 113.529 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -147.65 97.68 2.86 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.361 1.465 . . . . 0.0 109.43 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.95 159.21 2.64 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -135.23 134.03 39.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.5 pt -83.62 -40.38 15.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.7 tpt -63.98 -31.05 72.1 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.237 -0.887 . . . . 0.0 112.424 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.55 -50.18 73.69 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.1 mt -63.44 -35.6 80.96 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.528 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -75.38 -26.41 58.44 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.931 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -78.88 -31.45 45.47 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 120.711 -1.243 . . . . 0.0 113.217 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -112.29 158.07 38.18 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 118.949 0.795 . . . . 0.0 110.829 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -86.74 45.0 1.27 Allowed 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.287 2.658 . . . . 0.0 114.157 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -125.24 58.1 18.87 Favored Pre-proline 0 CA--C 1.553 1.064 0 O-C-N 120.608 -1.308 . . . . 0.0 112.195 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -62.21 117.96 4.83 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.946 3.097 . . . . 0.0 110.82 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.1 t -99.92 107.41 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 123.447 0.699 . . . . 0.0 110.621 -177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.82 -24.28 8.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 118.182 -0.914 . . . . 0.0 112.877 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.1 m -67.69 -11.35 58.12 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.363 0.983 . . . . 0.0 111.362 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -119.62 -16.1 8.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.256 1.422 . . . . 0.0 110.294 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.6 mt -83.74 154.9 23.35 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.08 0.854 . . . . 0.0 111.867 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -136.88 128.14 28.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.483 0.713 . . . . 0.0 110.212 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -71.29 126.46 29.69 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 103.698 -2.704 . . . . 0.0 103.698 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -104.35 145.53 30.12 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.749 0.704 . . . . 0.0 110.25 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.66 -175.22 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.854 -0.529 . . . . 0.0 109.96 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -143.99 151.05 39.22 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.884 1.674 . . . . 0.0 106.959 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.5 p -124.98 -7.11 7.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.89 -35.81 2.39 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -147.68 -5.4 0.48 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.028 1.331 . . . . 0.0 112.082 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -131.57 177.33 7.58 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 125.331 1.452 . . . . 0.0 108.787 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 m -140.64 145.82 37.11 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.552 1.541 . . . . 0.0 110.078 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.65 166.9 10.63 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.926 0.89 . . . . 0.0 108.623 178.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -147.34 114.21 6.11 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.057 1.343 . . . . 0.0 107.773 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -114.83 130.5 56.88 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 127.103 2.161 . . . . 0.0 112.11 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.3 t -53.02 124.01 13.14 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.37 0.668 . . . . 0.0 109.764 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 79.1 t -67.48 -54.11 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 O-C-N 121.08 -1.012 . . . . 0.0 110.137 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.44 -33.52 68.0 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.085 0.954 . . . . 0.0 113.182 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -135.95 80.91 41.0 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 124.647 1.179 . . . . 0.0 109.778 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.44 163.1 37.94 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.005 2.47 . . . . 0.0 109.848 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 96.77 -3.24 62.68 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.582 1.087 . . . . 0.0 110.653 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -125.63 121.82 34.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.731 1.612 . . . . 0.0 108.522 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -106.1 145.87 30.9 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.423 1.489 . . . . 0.0 109.575 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 pt -75.09 121.32 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.08 121.25 27.16 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 68.8 t -78.24 -20.06 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 127.656 2.382 . . . . 0.0 113.385 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m 59.21 66.11 1.09 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.406 1.098 . . . . 0.0 110.438 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.3 m -99.36 36.7 1.69 Allowed 'General case' 0 C--N 1.323 -0.575 0 O-C-N 120.963 -1.085 . . . . 0.0 112.239 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -126.37 -98.96 0.39 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.935 0.494 . . . . 0.0 109.957 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -94.17 23.96 29.13 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-O 117.058 -1.968 . . . . 0.0 117.133 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.38 52.02 6.97 Favored Glycine 0 C--O 1.238 0.376 0 CA-C-N 119.743 1.771 . . . . 0.0 113.306 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.29 164.65 40.03 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.27 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.32 156.87 37.31 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 N-CA-C 107.04 -1.946 . . . . 0.0 107.04 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.7 mt -82.94 118.68 23.64 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.537 1.135 . . . . 0.0 110.862 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.33 167.48 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 123.787 0.835 . . . . 0.0 111.458 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.5 mt -86.14 151.89 23.29 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.1 t -141.36 137.29 32.24 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -83.02 -33.98 26.38 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 122.154 0.978 . . . . 0.0 109.43 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.442 -0.852 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 p30 . . . . . 0 N--CA 1.444 -0.746 0 CA-C-O 121.373 0.606 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.77 106.52 1.53 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 117.317 -1.325 . . . . 0.0 108.898 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.7 p -100.9 -12.99 18.53 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 122.147 2.249 . . . . 0.0 111.108 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -101.69 103.96 14.76 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 130.135 3.374 . . . . 0.0 118.072 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -168.68 177.06 5.31 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.333 -0.854 . . . . 0.0 112.927 177.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.15 178.19 26.69 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.077 1.322 . . . . 0.0 111.675 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.77 144.91 50.81 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.474 1.509 . . . . 0.0 109.534 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.4 m -104.52 48.69 0.83 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.19 158.83 35.74 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.9 mt -129.55 159.49 36.17 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.95 1.3 . . . . 0.0 108.991 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 11.0 p90 . . . . . 0 C--O 1.245 0.834 0 CA-C-O 115.587 -2.149 . . . . 0.0 108.573 -179.858 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.238 0.499 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.63 156.12 58.03 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 N-CA-C 108.301 -1.461 . . . . 0.0 108.301 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.36 116.84 27.02 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 pm0 -113.3 142.47 45.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 122.568 0.347 . . . . 0.0 110.468 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.06 -125.97 0.89 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-O 118.27 -1.295 . . . . 0.0 111.284 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.8 p -154.05 -159.74 1.01 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 120.918 2.359 . . . . 0.0 111.188 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -153.84 -4.5 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 126.329 1.852 . . . . 0.0 109.122 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -62.93 -29.68 70.97 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.74 -16.47 40.3 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.637 1.175 . . . . 0.0 113.487 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mt -61.49 -45.73 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 C-N-CA 125.666 1.586 . . . . 0.0 112.383 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.82 21.84 1.0 Allowed 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.091 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.8 t60 63.95 43.78 5.09 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.414 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 0.1 OUTLIER -113.88 94.1 4.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.794 0.838 . . . . 0.0 109.558 178.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.58 143.67 11.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.407 ' CH2' ' HB2' ' A' ' 21' ' ' ARG . 5.2 m95 -100.53 139.63 35.93 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -135.67 141.07 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 tp -79.98 103.29 9.76 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.7 134.42 50.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.3 t0 39.16 65.76 0.63 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.202 1.401 . . . . 0.0 112.148 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 44.21 31.94 0.62 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.456 1.502 . . . . 0.0 114.597 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.6 m -144.57 162.97 35.28 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.837 1.655 . . . . 0.0 106.77 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.5 mt -103.06 120.29 40.4 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 1.4 mm -119.08 139.66 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 118.03 0.377 . . . . 0.0 110.331 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.62 138.25 39.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 m -122.37 60.66 13.65 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.372 1.069 . . . . 0.0 110.336 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -56.51 -37.64 96.97 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.199 1.933 . . . . 0.0 114.967 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -136.62 13.18 3.2 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.22 128.08 34.71 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.3 1.04 . . . . 0.0 108.369 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.45 6.14 1.51 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.335 1.854 . . . . 0.0 113.094 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -129.02 40.45 3.63 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.363 -1.461 . . . . 0.0 109.881 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.7 ptp -72.58 167.72 20.11 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.836 -0.54 . . . . 0.0 110.217 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.13 128.73 2.19 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.85 157.7 51.25 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.517 2.145 . . . . 0.0 110.474 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.5 m -144.54 166.52 12.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.96 162.73 16.04 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.7 mm -132.05 109.76 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 C-N-CA 126.951 2.1 . . . . 0.0 107.3 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.89 136.54 34.06 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.4 tt -129.38 132.59 47.07 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mt -142.26 141.34 28.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 124.797 1.239 . . . . 0.0 109.323 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.4 t -76.39 164.87 25.59 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.5 m -89.76 146.72 24.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -109.37 -20.92 12.75 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -105.75 39.84 1.69 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 122.475 1.131 . . . . 0.0 109.939 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 m -66.7 -6.03 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.52 1.128 . . . . 0.0 112.653 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -33.77 66.23 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.277 1.031 . . . . 0.0 111.855 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 t -101.79 13.67 34.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.649 1.179 . . . . 0.0 111.885 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.7 mt -107.14 179.58 4.22 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 120.713 -1.242 . . . . 0.0 111.006 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -84.3 153.07 23.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.639 1.176 . . . . 0.0 107.948 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -124.95 -37.78 2.41 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 123.606 0.762 . . . . 0.0 110.491 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -53.98 -44.28 70.67 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.741 1.216 . . . . 0.0 111.84 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -67.54 -27.28 66.83 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.086 -1.435 . . . . 0.0 112.2 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.51 178.84 16.6 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 126.415 1.959 . . . . 0.0 110.512 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.54 120.17 80.39 Favored Pre-proline 0 CA--C 1.541 0.619 0 O-C-N 121.561 -0.964 . . . . 0.0 111.883 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.63 141.79 15.76 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.51 2.807 . . . . 0.0 110.256 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -143.58 -179.47 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.888 2.075 . . . . 0.0 108.083 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -136.83 151.66 49.39 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 tt -145.36 154.87 42.77 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.19 -174.78 28.34 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.43 161.15 13.94 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -130.32 105.4 7.87 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.07 -31.24 0.11 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-O 118.45 -1.195 . . . . 0.0 113.513 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -153.35 37.02 0.47 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.142 1.471 . . . . 0.0 110.402 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 49.83 78.98 0.09 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.233 2.213 . . . . 0.0 111.582 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.75 141.85 31.82 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.233 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 36.5 m -141.16 170.07 16.42 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.323 0.965 . . . . 0.0 112.026 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.3 mt -56.2 149.66 15.72 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.243 1.383 . . . . 0.0 111.435 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.8 mtp -156.64 138.78 14.58 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.3 m -107.57 124.87 50.57 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.29 -178.94 5.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.29 1.436 . . . . 0.0 107.913 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -119.81 146.26 45.86 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 124.159 0.983 . . . . 0.0 109.219 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 p -119.28 6.63 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 O-C-N 123.893 0.746 . . . . 0.0 112.47 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.22 87.0 0.49 Allowed Glycine 0 C--O 1.223 -0.581 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 63.86 17.77 10.74 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.07 143.41 7.17 Favored Pre-proline 0 C--O 1.24 0.575 0 C-N-CA 123.093 0.557 . . . . 0.0 110.906 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.56 164.63 33.43 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.658 2.239 . . . . 0.0 112.604 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.81 160.63 34.05 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.696 1.598 . . . . 0.0 108.905 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 mt -75.87 148.96 37.92 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.28 33.8 2.55 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.96 0.904 . . . . 0.0 110.632 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.29 92.57 0.19 Allowed 'General case' 0 CA--C 1.496 -1.117 0 C-N-CA 129.686 3.195 . . . . 0.0 109.249 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.86 -45.97 0.05 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.691 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -128.78 98.2 4.91 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.463 1.105 . . . . 0.0 111.137 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -176.69 152.62 1.02 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.413 -1.429 . . . . 0.0 108.757 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -114.03 144.2 43.5 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.191 0.996 . . . . 0.0 109.942 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.2 tt -98.85 -44.98 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 125.166 1.386 . . . . 0.0 110.235 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -32.09 71.0 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.729 0.811 . . . . 0.0 110.406 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.3 -54.18 41.16 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.9 mt -59.66 -33.35 71.43 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 122.658 0.383 . . . . 0.0 111.699 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -73.79 -37.96 64.77 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -75.09 -36.73 61.71 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.657 1.583 . . . . 0.0 113.946 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -111.71 149.59 40.97 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 119.84 1.2 . . . . 0.0 111.718 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -76.63 56.68 5.27 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.177 3.251 . . . . 0.0 113.554 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -118.57 80.48 16.94 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.207 1.003 . . . . 0.0 108.441 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.86 74.98 5.02 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.807 3.004 . . . . 0.0 109.012 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -69.72 97.35 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 124.792 1.237 . . . . 0.0 109.314 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -52.45 -26.72 13.56 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.621 1.168 . . . . 0.0 112.9 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.0 -18.24 64.1 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.461 0.573 . . . . 0.0 112.239 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -115.96 -23.81 8.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.479 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.1 mt -72.89 153.8 40.86 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.162 0.892 . . . . 0.0 111.319 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -136.49 138.46 41.43 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.261 1.025 . . . . 0.0 110.516 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.98 123.15 29.68 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 103.528 -2.767 . . . . 0.0 103.528 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -103.39 143.83 32.17 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.258 0.623 . . . . 0.0 109.44 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.85 169.83 20.75 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -140.28 151.76 45.36 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.347 1.459 . . . . 0.0 111.601 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.19 79.18 0.75 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.901 0.858 . . . . 0.0 112.707 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.62 62.95 1.58 Allowed Glycine 0 C--N 1.334 0.46 0 O-C-N 120.954 -1.091 . . . . 0.0 111.639 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.32 4.13 1.58 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.72 1.208 . . . . 0.0 112.861 -178.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.58 163.48 12.44 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.0 m -146.16 152.48 39.32 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.39 159.9 41.18 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -132.18 120.1 21.78 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.407 ' HB2' ' CE2' ' A' ' 127' ' ' PHE . 4.1 tt0 -112.42 131.21 55.67 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.418 1.087 . . . . 0.0 109.116 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.4 121.67 8.8 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.725 1.61 . . . . 0.0 109.705 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.8 t -70.99 -40.61 76.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 O-C-N 120.7 -1.25 . . . . 0.0 111.954 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.62 -38.3 77.73 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.077 0.853 . . . . 0.0 111.918 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -139.2 97.36 8.64 Favored Pre-proline 0 C--O 1.24 0.568 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.02 174.3 10.8 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.366 2.044 . . . . 0.0 109.208 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 91.11 -3.42 80.32 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -125.19 129.74 50.72 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.033 1.333 . . . . 0.0 107.535 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.407 ' CE2' ' HB2' ' A' ' 119' ' ' GLU . 79.3 m-85 -114.92 142.24 46.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.29 1.836 . . . . 0.0 108.322 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 mt -74.02 136.12 25.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 O-C-N 121.999 -0.438 . . . . 0.0 110.511 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.29 141.2 30.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.218 0.532 . . . . 0.0 110.358 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.1 t -93.15 -13.44 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 126.557 1.943 . . . . 0.0 109.254 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.2 m 52.89 37.38 24.15 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.414 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 16.2 m -73.37 -2.01 20.49 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -74.08 -85.01 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 O-C-N 120.331 -1.481 . . . . 0.0 112.049 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -99.06 -22.52 13.04 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.659 1.123 . . . . 0.0 113.935 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 115.59 54.31 0.37 Allowed Glycine 0 CA--C 1.522 0.509 0 CA-C-N 118.543 1.171 . . . . 0.0 111.271 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.7 m -82.04 164.64 47.45 Favored Pre-proline 0 C--O 1.236 0.37 0 CA-C-N 117.715 0.757 . . . . 0.0 109.763 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 58.1 Cg_endo -68.93 171.59 13.29 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 N-CA-C 107.193 -1.887 . . . . 0.0 107.193 176.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.2 mt -96.0 109.12 21.56 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.073 0.949 . . . . 0.0 109.47 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.24 178.21 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.711 1.605 . . . . 0.0 110.678 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.79 169.93 10.3 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.0 t -162.06 149.88 14.53 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.109 1.364 . . . . 0.0 109.221 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -92.6 -40.38 10.8 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.894 0.878 . . . . 0.0 110.059 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 N--CA 1.444 -0.747 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -177.766 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 33.9 m120 . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 119.687 -0.197 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.6 p -61.37 99.22 0.1 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.584 1.554 . . . . 0.0 112.085 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.3 p -88.13 -35.12 17.62 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 121.405 1.911 . . . . 0.0 109.355 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -78.35 101.12 7.05 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 126.102 1.761 . . . . 0.0 111.971 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -167.77 177.57 5.71 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.132 0.878 . . . . 0.0 111.888 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.6 -160.98 30.01 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.8 tp -141.62 153.42 44.74 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.52 29.73 6.29 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.874 1.67 . . . . 0.0 109.355 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -65.9 142.68 57.82 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.5 mt -127.49 158.15 38.18 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.624 1.569 . . . . 0.0 110.345 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 27.8 p90 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 115.767 -2.063 . . . . 0.0 108.612 179.911 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.224 -0.285 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.64 135.63 26.5 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.462 2.108 . . . . 0.0 109.271 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.36 120.49 32.28 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.69 0.796 . . . . 0.0 108.985 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.01 137.0 52.51 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.314 0.646 . . . . 0.0 111.299 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.29 -125.21 0.76 Allowed Glycine 0 C--N 1.335 0.505 0 O-C-N 121.188 -0.945 . . . . 0.0 113.735 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 p -152.0 -170.22 3.58 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.991 1.395 . . . . 0.0 112.59 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.21 6.76 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 125.864 1.666 . . . . 0.0 110.952 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -59.3 -50.55 73.56 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 120.549 -1.344 . . . . 0.0 110.759 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -47.1 -0.17 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 1 C-N-CA 132.139 4.176 . . . . 0.0 118.554 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mt -85.51 -60.56 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 C-N-CA 127.86 2.464 . . . . 0.0 110.492 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.05 23.31 2.05 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.392 0.677 . . . . 0.0 110.138 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 72.26 12.14 5.81 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.46 2.704 . . . . 0.0 113.992 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.76 95.09 7.16 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 127.272 2.229 . . . . 0.0 113.086 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.8 t -79.39 159.49 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -107.44 142.79 36.73 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.0 t -138.14 119.16 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 123.851 0.861 . . . . 0.0 110.374 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 tp -75.47 108.08 8.03 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.559 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 37.6 tt0 -94.96 -175.42 3.54 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.559 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 3.1 t0 -46.11 90.01 0.0 OUTLIER 'General case' 0 C--O 1.234 0.243 0 C-N-CA 129.952 3.301 . . . . 0.0 109.585 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 46.46 32.92 1.74 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.841 1.656 . . . . 0.0 110.502 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.0 m -152.49 135.38 15.53 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mt -96.14 137.74 34.78 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 120.897 -1.127 . . . . 0.0 108.326 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.4 pt -136.49 151.44 28.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.805 0.842 . . . . 0.0 111.616 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.98 139.51 31.26 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.461 0.704 . . . . 0.0 110.225 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.9 m -123.72 108.81 30.64 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.9 -81.03 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.198 1.932 . . . . 0.0 110.871 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.13 6.65 16.41 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.631 1.573 . . . . 0.0 112.46 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -52.04 120.26 5.2 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -58.39 -31.24 67.48 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.089 0.956 . . . . 0.0 111.626 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.86 67.75 6.21 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -118.48 164.54 15.11 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.626 1.17 . . . . 0.0 108.899 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 t -141.63 135.42 14.72 Favored Pre-proline 0 N--CA 1.446 -0.636 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.81 134.78 24.45 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.544 2.829 . . . . 0.0 109.58 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.8 m -128.41 159.83 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 122.696 1.236 . . . . 0.0 108.413 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.15 158.29 23.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 113.139 -1.846 . . . . 0.0 107.64 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.0 mm -123.77 153.02 29.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.61 125.38 23.97 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.6 tt -123.45 141.33 52.11 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.653 1.181 . . . . 0.0 110.264 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.4 mt -149.93 152.9 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 126.253 1.821 . . . . 0.0 108.278 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.4 p -103.37 134.44 46.74 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.667 1.587 . . . . 0.0 109.389 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.9 m -54.53 109.34 0.49 Allowed 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.953 1.701 . . . . 0.0 114.126 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -75.95 -24.82 55.48 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 117.8 -1.095 . . . . 0.0 111.316 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -98.09 49.66 1.01 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-N 119.777 1.171 . . . . 0.0 110.366 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 m -73.79 -1.79 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.099 -1.001 . . . . 0.0 112.115 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -62.99 -0.91 0.77 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.549 1.94 . . . . 0.0 112.842 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 t -132.87 -1.27 3.36 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.859 1.664 . . . . 0.0 110.913 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.28 163.4 13.41 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.745 1.259 . . . . 0.0 109.565 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.506 ' HB2' ' HH ' ' A' ' 108' ' ' TYR . 10.2 mm-40 -82.05 152.4 26.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.654 -1.612 . . . . 0.0 107.641 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -118.83 -29.81 5.24 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.334 1.054 . . . . 0.0 111.095 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -67.85 -38.56 83.3 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.136 1.774 . . . . 0.0 112.312 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -68.1 -25.89 65.54 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.559 1.144 . . . . 0.0 112.84 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.99 -167.65 32.26 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -102.34 97.62 9.06 Favored Pre-proline 0 N--CA 1.466 0.346 0 CA-C-O 117.554 -1.213 . . . . 0.0 109.799 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.71 122.53 9.22 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.204 2.602 . . . . 0.0 109.851 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.13 -177.45 2.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 124.612 1.165 . . . . 0.0 109.821 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -139.78 140.31 36.65 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 122.285 1.041 . . . . 0.0 109.51 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tt -149.01 150.37 32.7 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.716 1.206 . . . . 0.0 110.034 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.78 -171.77 21.89 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.446 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.5 mt -93.74 146.02 24.15 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -110.05 113.45 26.17 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.26 -43.84 0.51 Allowed Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.514 -1.159 . . . . 0.0 113.861 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.33 24.8 4.15 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.572 1.686 . . . . 0.0 114.659 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 m120 60.04 63.87 1.36 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.219 0.918 . . . . 0.0 111.592 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.28 132.65 20.66 Favored 'General case' 0 CA--C 1.51 -0.569 0 O-C-N 120.336 -1.478 . . . . 0.0 110.405 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.441 ' H ' ' HB2' ' A' ' 90' ' ' LYS . 8.5 m -136.93 172.74 12.57 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.463 0.705 . . . . 0.0 112.071 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.464 ' HA ' ' HG ' ' A' ' 87' ' ' LEU . 13.9 mt -62.13 154.29 27.57 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.913 0.885 . . . . 0.0 111.699 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.529 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 3.2 tmm? -164.41 151.12 11.19 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 24.0 m -112.0 122.75 48.63 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.134 0.574 . . . . 0.0 109.608 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.25 151.26 50.43 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.226 1.01 . . . . 0.0 109.522 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.1 tttt -86.88 124.87 33.58 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.4 p -80.24 -17.19 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.48 -63.77 0.33 Allowed Glycine 0 CA--C 1.548 2.094 1 C-N-CA 133.252 5.215 . . . . 0.0 108.407 -177.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -103.34 -27.19 12.6 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 119.722 3.231 . . . . 0.0 119.722 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -133.48 155.91 80.19 Favored Pre-proline 0 CA--C 1.566 1.586 0 C-N-CA 130.001 3.32 . . . . 0.0 115.754 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -74.3 144.37 32.88 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.793 1.662 . . . . 0.0 108.971 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.9 p -140.84 169.62 17.29 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.271 1.428 . . . . 0.0 109.549 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.2 mt -90.71 150.22 21.73 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.27 75.69 1.52 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.765 1.226 . . . . 0.0 110.923 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.464 ' HG ' ' HA ' ' A' ' 74' ' ' LEU . 1.0 OUTLIER -94.65 116.0 28.23 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.13 -13.81 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -158.6 97.51 1.46 Allowed 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 117.67 -1.157 . . . . 0.0 109.607 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.529 ' HE3' ' HB2' ' A' ' 75' ' ' MET . 0.3 OUTLIER -171.21 149.16 2.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 121.393 1.906 . . . . 0.0 109.655 -179.214 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -129.07 114.55 16.51 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.172 0.989 . . . . 0.0 108.847 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.8 pt -62.06 -42.58 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 120.659 -1.275 . . . . 0.0 112.871 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.3 tpt -69.17 -16.28 63.6 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.108 1.363 . . . . 0.0 112.253 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -79.4 -52.04 8.6 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.277 0.944 . . . . 0.0 108.936 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 35.1 mt -65.96 -21.05 66.4 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.62 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -90.81 -34.33 15.35 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -63.41 -36.76 84.79 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.452 1.478 . . . . 0.0 109.423 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.68 156.02 43.07 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.067 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.52 59.54 5.56 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 123.745 2.963 . . . . 0.0 111.197 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -128.14 64.61 66.94 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.846 1.258 . . . . 0.0 112.128 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.4 95.4 0.86 Allowed 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 124.942 3.761 . . . . 0.0 109.849 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.1 t -84.78 106.36 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 O-C-N 120.983 -1.073 . . . . 0.0 109.7 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -51.52 -29.89 18.39 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.603 1.561 . . . . 0.0 113.269 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.4 m -67.32 -10.67 53.18 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.52 -17.86 7.98 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.619 0.768 . . . . 0.0 110.12 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.6 mt -79.68 154.08 28.87 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.428 1.091 . . . . 0.0 110.397 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -140.36 133.82 30.0 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 123.248 0.619 . . . . 0.0 110.851 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.506 ' HH ' ' HB2' ' A' ' 56' ' ' GLU . 63.2 m-85 -76.07 122.6 24.49 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -75.89 103.49 5.99 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.6 t -100.59 178.14 4.81 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.2 156.71 42.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.415 0.686 . . . . 0.0 111.523 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.6 p -132.27 42.13 3.15 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.14 0.976 . . . . 0.0 113.06 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.67 -55.18 2.32 Favored Glycine 0 C--N 1.333 0.396 0 O-C-N 120.215 -1.553 . . . . 0.0 113.435 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -131.19 2.13 4.25 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.644 1.222 . . . . 0.0 112.071 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -134.08 173.49 11.53 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.065 0.546 . . . . 0.0 111.237 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.8 m -116.89 153.87 31.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.846 1.658 . . . . 0.0 109.627 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.01 168.29 19.07 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -138.77 112.56 8.41 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -105.45 117.88 35.14 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 126.901 2.08 . . . . 0.0 109.651 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.9 t -51.16 122.15 7.24 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.293 0.637 . . . . 0.0 111.761 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.1 t -65.1 -45.57 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 O-C-N 121.739 -0.601 . . . . 0.0 110.34 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.23 -38.43 85.22 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.764 -0.585 . . . . 0.0 112.376 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -124.18 80.63 58.44 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.583 0.753 . . . . 0.0 108.992 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -66.94 143.4 66.1 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.55 3.5 . . . . 0.0 110.87 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.81 -22.43 14.62 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 128.449 2.928 . . . . 0.0 113.067 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -99.24 131.96 44.9 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.951 1.7 . . . . 0.0 111.585 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -111.51 142.15 44.16 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.434 1.094 . . . . 0.0 110.597 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.3 mt -73.67 133.87 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -103.23 147.94 26.43 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 6.5 m -91.83 -17.12 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.356 1.462 . . . . 0.0 114.591 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.45 90.56 0.07 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.325 1.85 . . . . 0.0 107.209 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . 0.259 0.0 OUTLIER -107.8 7.87 28.47 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.416 -0.802 . . . . 0.0 111.933 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -135.5 143.41 45.8 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.325 1.05 . . . . 0.0 109.837 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.97 -58.26 0.06 OUTLIER Glycine 0 CA--C 1.531 1.066 0 C-N-CA 127.073 2.273 . . . . 0.0 115.848 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 132.73 45.64 0.13 Allowed Glycine 0 CA--C 1.523 0.555 0 C-N-CA 129.093 3.235 . . . . 0.0 107.352 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 83.4 m -71.91 162.43 73.4 Favored Pre-proline 0 C--O 1.24 0.576 0 CA-C-N 118.064 0.932 . . . . 0.0 110.474 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.26 162.25 28.47 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 120.766 0.977 . . . . 0.0 111.598 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.4 mt -77.88 114.96 17.25 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.701 1.201 . . . . 0.0 109.031 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pp -146.24 176.26 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 123.161 0.584 . . . . 0.0 109.75 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 20.7 mt -101.35 150.01 23.45 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.543 0.737 . . . . 0.0 109.26 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.1 t -144.52 131.68 20.58 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -82.3 -24.73 34.5 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 122.235 -0.291 . . . . 0.0 111.197 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 C--O 1.234 0.237 0 C-N-CA 125.104 1.362 . . . . 0.0 107.345 -178.993 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.0 m120 . . . . . 0 C--O 1.223 -0.311 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.39 128.54 36.83 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.66 1.184 . . . . 0.0 109.906 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.6 p -114.71 -22.57 9.64 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.168 1.387 . . . . 0.0 112.922 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -118.45 129.06 55.18 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.304 0.641 . . . . 0.0 112.07 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -170.55 -176.47 2.13 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.462 1.905 . . . . 0.0 109.553 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.42 -159.75 31.07 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.7 tp -147.54 166.22 27.98 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.5 m -128.63 49.85 2.16 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.065 1.346 . . . . 0.0 107.921 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -75.21 141.2 43.61 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 22.8 mt -108.53 167.47 10.02 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.512 1.125 . . . . 0.0 108.05 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 31.3 p90 . . . . . 0 C--O 1.251 1.171 0 C-N-CA 126.911 2.084 . . . . 0.0 106.74 -179.564 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.02 149.01 71.12 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 N-CA-C 107.061 -1.938 . . . . 0.0 107.061 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.47 115.77 19.39 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.77 149.1 27.68 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.08 -137.41 2.9 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 120.045 1.293 . . . . 0.0 109.98 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.7 p -144.84 -168.33 2.89 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 119.15 1.475 . . . . 0.0 111.214 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.7 mt -142.51 -7.03 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 126.903 2.081 . . . . 0.0 107.753 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -45.61 -42.79 11.67 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 127.0 2.12 . . . . 0.0 112.283 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -55.57 -24.13 30.88 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.0 mm -54.65 -68.84 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 123.729 0.811 . . . . 0.0 112.149 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.52 29.64 3.89 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 123.718 0.637 . . . . 0.0 112.366 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.1 m80 61.8 47.86 5.85 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 -122.94 100.28 6.81 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.1 t -85.78 154.53 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -120.23 131.16 54.84 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.39 144.88 35.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 tp -78.14 102.04 7.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -120.48 133.95 55.34 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 t0 45.48 53.41 8.38 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.008 1.323 . . . . 0.0 112.373 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.446 ' HB3' ' HZ2' ' A' ' 88' ' ' LYS . 63.9 mm-40 52.59 29.05 6.72 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.7 m -143.17 159.79 41.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.021 1.728 . . . . 0.0 107.391 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.1 mt -96.49 125.48 41.01 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 119.666 -1.896 . . . . 0.0 106.325 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 1.2 mt -126.84 130.8 71.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 123.604 0.565 . . . . 0.0 110.731 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.98 135.8 49.78 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 m -126.56 74.21 74.42 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 123.839 0.855 . . . . 0.0 110.643 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.23 -43.15 15.48 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.7 2.267 . . . . 0.0 111.387 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -146.51 71.41 1.24 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.544 1.138 . . . . 0.0 108.91 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -120.84 124.22 44.5 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 102.035 -3.32 . . . . 0.0 102.035 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.52 -14.34 19.11 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.95 1.3 . . . . 0.0 113.312 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -113.87 30.43 7.26 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.658 1.183 . . . . 0.0 111.461 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -74.47 161.49 29.74 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.4 t -153.1 142.85 15.05 Favored Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.59 142.38 58.6 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.657 2.238 . . . . 0.0 108.767 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 t -143.61 136.23 24.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 105.915 -1.884 . . . . 0.0 105.915 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.75 162.46 16.22 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.966 0.906 . . . . 0.0 109.845 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.2 mm -130.4 121.99 52.26 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 C-N-CA 127.525 2.33 . . . . 0.0 108.748 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.06 129.98 46.17 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 120.69 1.587 . . . . 0.0 108.461 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.2 tt -122.48 132.24 54.24 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.132 1.773 . . . . 0.0 107.546 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.5 mp -144.09 141.92 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 124.669 1.187 . . . . 0.0 108.826 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 p -79.34 138.59 37.75 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.424 ' HA ' ' CZ ' ' A' ' 64' ' ' TYR . 58.8 m -60.11 124.06 19.08 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.23 -0.08 47.34 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -128.32 49.91 2.13 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.964 1.305 . . . . 0.0 110.272 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 m -72.88 6.57 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.684 1.194 . . . . 0.0 113.794 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -49.49 -32.42 12.08 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 128.051 2.54 . . . . 0.0 116.149 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.1 t -125.63 25.44 6.96 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.903 0.881 . . . . 0.0 110.607 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -116.2 155.77 27.71 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 121.183 -0.948 . . . . 0.0 108.917 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.98 152.15 46.31 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 mttm -124.99 -31.22 3.15 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.911 0.485 . . . . 0.0 110.644 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.45 -34.09 76.99 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.182 0.993 . . . . 0.0 112.118 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -64.24 -36.1 82.97 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.429 ' HA3' ' CD1' ' A' ' 108' ' ' TYR . . . 147.47 171.49 16.63 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 127.016 2.246 . . . . 0.0 110.755 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.51 116.38 30.84 Favored Pre-proline 0 C--O 1.238 0.484 0 O-C-N 121.463 -1.022 . . . . 0.0 109.372 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.72 136.15 18.65 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 N-CA-C 106.653 -2.095 . . . . 0.0 106.653 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.258 14.0 pt -137.74 170.69 16.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.424 ' CZ ' ' HA ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -131.41 147.98 52.61 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.769 0.795 . . . . 0.0 111.202 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 tt -148.26 157.14 43.31 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.344 1.058 . . . . 0.0 110.763 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.6 -173.61 30.46 Favored Glycine 0 C--O 1.226 -0.398 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -97.67 162.17 13.41 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.357 1.063 . . . . 0.0 110.441 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -132.09 84.08 2.13 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.234 -0.916 . . . . 0.0 108.765 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -158.44 -30.37 0.02 OUTLIER Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.795 -1.003 . . . . 0.0 113.013 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.15 19.45 0.57 Allowed 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.6 m120 68.16 68.41 0.33 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.943 1.697 . . . . 0.0 109.076 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.91 136.03 30.05 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.906 1.282 . . . . 0.0 109.89 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 32.2 m -142.09 175.1 10.0 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.773 0.715 . . . . 0.0 111.044 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.0 mt -58.75 149.95 24.98 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.899 0.772 . . . . 0.0 109.994 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.7 ttp -159.25 123.42 3.91 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 84.0 m -97.2 125.36 41.68 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 120.144 1.338 . . . . 0.0 109.079 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.81 146.29 31.11 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.08 0.952 . . . . 0.0 109.291 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -77.87 131.39 37.5 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 p -80.91 7.0 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.0 0.52 . . . . 0.0 111.508 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.82 10.35 49.96 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -148.03 -57.2 0.23 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.474 1.51 . . . . 0.0 109.772 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -140.3 162.44 49.74 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.065 1.746 . . . . 0.0 110.877 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.89 149.58 72.48 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.862 1.708 . . . . 0.0 110.521 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.9 p -147.3 166.06 28.23 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.91 1.684 . . . . 0.0 107.201 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.3 mt -92.57 148.14 22.32 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -138.97 64.87 1.46 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.446 ' H ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -81.86 102.77 11.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.446 ' HZ2' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -157.18 -39.44 0.07 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.143 0.977 . . . . 0.0 113.022 -178.045 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -145.1 104.69 3.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.755 1.622 . . . . 0.0 109.407 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.437 ' HE2' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -177.22 158.57 1.5 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 178.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.437 ' N ' ' HE2' ' A' ' 90' ' ' LYS . 1.4 m-20 -135.15 131.74 37.18 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.709 1.604 . . . . 0.0 109.687 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 mt -83.11 -37.18 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 118.175 0.443 . . . . 0.0 109.96 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.8 -25.26 66.44 Favored 'General case' 0 CA--C 1.524 -0.034 0 CA-C-O 117.982 -1.009 . . . . 0.0 112.565 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -72.0 -42.77 66.03 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 93.0 mt -62.87 -33.12 74.61 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.512 1.125 . . . . 0.0 108.378 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -75.8 -35.39 60.08 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -65.52 -46.0 81.32 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.202 -0.936 . . . . 0.0 110.767 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -125.31 152.16 70.79 Favored Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.85 83.35 1.39 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 123.621 2.881 . . . . 0.0 110.395 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -132.26 69.09 80.33 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.1 76.5 3.0 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.277 3.318 . . . . 0.0 107.833 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.4 t -83.09 102.14 8.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -177.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -49.99 -28.49 6.98 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.847 0.859 . . . . 0.0 112.023 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.7 m -63.8 -12.51 36.33 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -122.45 1.64 9.58 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.345 1.058 . . . . 0.0 109.98 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.3 mt -100.46 145.77 27.85 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -142.62 123.36 14.23 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.774 0.83 . . . . 0.0 109.454 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.429 ' CD1' ' HA3' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -67.7 124.96 24.73 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 127.765 2.426 . . . . 0.0 106.252 178.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -109.15 147.23 32.82 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.655 0.74 . . . . 0.0 110.052 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 t -138.64 172.14 13.32 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.12 1.768 . . . . 0.0 107.27 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.31 129.0 7.0 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.453 1.501 . . . . 0.0 109.508 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.0 p -141.94 79.54 1.68 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.05 58.85 1.54 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 124.02 0.819 . . . . 0.0 111.585 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 65.66 4.36 2.82 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.797 2.039 . . . . 0.0 112.694 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -112.86 127.92 56.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.4 m -108.68 155.54 20.6 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.197 1.399 . . . . 0.0 109.863 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 p -131.27 165.62 23.0 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.304 1.442 . . . . 0.0 111.661 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -142.65 110.31 5.81 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.607 1.163 . . . . 0.0 111.236 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -108.36 123.07 48.27 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.981 1.312 . . . . 0.0 109.462 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 59.6 m -53.64 125.71 19.2 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.747 1.219 . . . . 0.0 110.228 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.7 t -70.32 -41.3 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 O-C-N 121.175 -0.953 . . . . 0.0 111.623 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.47 -40.64 83.24 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.305 1.042 . . . . 0.0 112.242 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -136.3 90.61 17.63 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -65.9 165.07 24.84 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.025 1.817 . . . . 0.0 109.124 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.3 -18.58 56.62 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -100.85 121.08 41.1 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 118.628 1.214 . . . . 0.0 108.441 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -105.8 144.22 32.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 24.7 mt -71.42 142.47 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.26 113.79 27.53 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.577 0.703 . . . . 0.0 109.781 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.56 -10.71 14.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 C-N-CA 127.617 2.367 . . . . 0.0 112.482 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.5 m 46.02 84.31 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 118.394 2.739 . . . . 0.0 118.394 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 47.8 m -110.6 5.57 21.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -79.75 -93.78 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 O-C-N 121.067 -1.021 . . . . 0.0 112.437 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -99.64 4.78 58.15 Favored Glycine 0 C--N 1.342 0.91 0 C-N-CA 125.652 1.596 . . . . 0.0 116.575 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.31 49.23 2.44 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 18.1 m -80.29 161.99 63.04 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 124.231 1.013 . . . . 0.0 110.472 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 98.5 Cg_endo -73.83 155.33 48.71 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.192 1.261 . . . . 0.0 109.475 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.6 mt -84.72 122.41 29.06 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.241 1.016 . . . . 0.0 109.208 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.0 -168.99 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.32 1.448 . . . . 0.0 110.848 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.5 mt -103.44 153.72 20.2 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.411 1.484 . . . . 0.0 107.181 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.0 t -145.8 120.49 9.84 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.75 1.262 . . . . 0.0 108.796 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -78.76 -30.83 45.92 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.166 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 . . . . . 0 CA--C 1.534 0.327 0 CA-C-O 122.028 0.918 . . . . 0.0 112.217 -178.383 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . 0.294 75.4 p 113.93 93.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 1 C-N-CA 135.132 5.373 . . . . 0.0 112.643 178.678 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 p -104.6 -29.54 10.56 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.284 1.033 . . . . 0.0 110.686 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -117.72 123.66 46.6 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 127.882 2.473 . . . . 0.0 110.947 -177.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -171.56 -175.62 1.63 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.503 2.321 . . . . 0.0 110.08 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -101.53 -176.89 28.58 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.505 1.05 . . . . 0.0 113.687 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.16 132.03 41.12 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.5 m -88.52 58.38 4.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 18.9 ptp -69.31 162.17 27.78 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.249 0.62 . . . . 0.0 109.518 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.1 mt -142.36 175.25 9.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.102 2.161 . . . . 0.0 106.762 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 53.0 p90 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 124.582 1.153 . . . . 0.0 110.727 179.819 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.33 127.96 12.39 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.166 2.578 . . . . 0.0 110.093 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.36 111.21 23.56 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 123.782 0.676 . . . . 0.0 111.35 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -104.5 148.01 26.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.779 0.832 . . . . 0.0 110.618 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.46 -139.64 4.18 Favored Glycine 0 C--O 1.226 -0.396 0 O-C-N 121.255 -0.903 . . . . 0.0 111.226 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.2 p -152.33 -174.55 4.93 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 119.029 1.414 . . . . 0.0 113.684 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.67 5.28 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 125.319 1.448 . . . . 0.0 108.371 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -63.17 -38.63 91.93 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 119.923 -1.736 . . . . 0.0 109.293 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -51.5 -19.79 1.59 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 128.085 2.554 . . . . 0.0 114.086 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.2 mt -69.41 -67.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.811 1.644 . . . . 0.0 111.473 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.12 25.71 4.22 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.857 -0.527 . . . . 0.0 111.252 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.252 24.3 t60 57.62 41.09 26.12 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.514 2.726 . . . . 0.0 108.633 -177.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.28 109.86 20.47 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.947 -1.095 . . . . 0.0 110.981 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.4 t -91.86 158.42 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -115.84 106.86 14.31 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.303 1.041 . . . . 0.0 110.325 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.7 t -104.37 122.85 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 120.099 1.318 . . . . 0.0 108.578 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.8 tp -73.33 95.72 2.21 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 124.141 0.9 . . . . 0.0 108.626 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.99 174.79 8.85 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -8.89 -65.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 129.063 2.945 . . . . 0.0 114.935 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -142.05 18.24 2.11 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-O 117.691 -1.147 . . . . 0.0 109.279 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.65 134.71 14.87 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.685 1.129 . . . . 0.0 112.546 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mp -85.64 137.08 33.09 Favored 'General case' 0 CA--C 1.504 -0.795 0 O-C-N 121.514 -0.741 . . . . 0.0 109.27 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mm -131.39 140.51 48.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 O-C-N 124.094 0.871 . . . . 0.0 109.927 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.86 130.27 40.64 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -117.36 82.27 14.72 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 124.339 1.056 . . . . 0.0 108.738 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.25 -33.1 15.35 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.014 1.809 . . . . 0.0 113.778 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.8 ttm-85 -162.02 51.42 0.21 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.12 152.23 19.0 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 124.956 1.302 . . . . 0.0 107.622 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -61.36 1.8 Allowed 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 122.617 0.367 . . . . 0.0 110.473 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.8 ttm-85 -72.8 27.52 0.06 Allowed 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.696 1.198 . . . . 0.0 112.229 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -68.02 149.51 49.61 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.1 t -140.15 138.17 18.98 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -67.64 155.21 71.02 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 N-CA-C 108.055 -1.556 . . . . 0.0 108.055 178.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.7 m -146.38 155.32 12.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.91 158.76 20.68 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -125.69 116.28 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 125.507 1.523 . . . . 0.0 107.756 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.07 127.67 42.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 tt -125.25 145.64 49.9 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.388 1.075 . . . . 0.0 108.649 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.3 mt -148.03 154.22 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.662 1.985 . . . . 0.0 108.828 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.1 p -109.42 115.52 30.11 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.7 m -47.35 143.87 3.2 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.186 1.395 . . . . 0.0 111.915 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -103.99 -26.87 12.46 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 118.096 -0.954 . . . . 0.0 112.992 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -94.68 38.27 1.11 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.2 m -63.46 -17.18 19.45 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 O-C-N 120.597 -1.315 . . . . 0.0 111.293 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -42.8 -44.07 4.27 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 120.704 1.593 . . . . 0.0 114.203 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.7 t -78.5 -14.14 59.5 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.6 mt -88.22 -173.39 4.2 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 120.444 -1.41 . . . . 0.0 109.267 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.43 158.13 16.21 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.822 0.849 . . . . 0.0 109.485 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -124.78 -35.61 2.68 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.034 2.533 . . . . 0.0 111.085 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.81 -42.68 79.97 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.642 1.177 . . . . 0.0 109.35 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -62.6 -36.39 82.6 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.874 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 139.54 -171.09 23.91 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -79.08 114.78 47.38 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.91 135.2 8.69 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.619 2.879 . . . . 0.0 108.557 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.3 pt -138.26 178.28 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 121.372 -0.83 . . . . 0.0 110.616 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -134.44 154.97 51.11 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.198 0.908 . . . . 0.0 112.345 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 tt -156.91 163.48 39.11 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.237 1.015 . . . . 0.0 110.05 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.15 -174.43 36.98 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.825 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.42 135.46 41.82 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 126.105 1.762 . . . . 0.0 106.718 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -114.81 121.41 43.2 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.39 -39.68 0.26 Allowed Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.4 31.35 1.71 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.371 1.069 . . . . 0.0 113.783 -178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.1 m120 58.17 75.15 0.4 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.808 1.243 . . . . 0.0 112.476 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.33 140.78 27.97 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 121.297 -0.877 . . . . 0.0 110.307 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.8 m -147.96 174.49 11.84 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.254 -1.529 . . . . 0.0 111.024 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.42 ' HA ' ' HG ' ' A' ' 87' ' ' LEU . 5.3 mt -57.68 144.3 38.37 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -155.59 124.03 5.92 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 52.1 m -91.88 121.37 33.42 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.826 0.739 . . . . 0.0 110.409 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.37 168.52 19.6 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.252 0.478 . . . . 0.0 110.154 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -98.52 147.11 25.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.3 -2.56 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.556 0.743 . . . . 0.0 111.003 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.4 81.88 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.2 t70 66.56 9.62 6.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.429 1.891 . . . . 0.0 114.49 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.14 143.03 17.61 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.43 156.95 63.84 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 124.171 3.248 . . . . 0.0 113.87 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.3 p -158.47 164.76 35.89 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.017 1.727 . . . . 0.0 108.972 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.8 mt -95.18 138.12 33.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -129.43 67.16 1.44 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.368 1.067 . . . . 0.0 109.995 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.42 ' HG ' ' HA ' ' A' ' 74' ' ' LEU . 2.9 mp -81.97 105.57 13.19 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.59 -39.31 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -136.39 94.18 2.98 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 119.19 0.904 . . . . 0.0 111.653 -177.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -164.61 175.26 9.96 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 121.178 -0.951 . . . . 0.0 110.968 179.592 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.418 ' H ' ' HD3' ' A' ' 90' ' ' LYS . 17.6 m-20 -140.5 143.03 35.24 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.24 1.416 . . . . 0.0 107.469 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 tt -104.77 -39.29 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 125.063 1.345 . . . . 0.0 110.863 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -30.94 71.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.884 0.474 . . . . 0.0 110.57 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -66.21 -52.78 44.59 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.4 mt -61.87 -29.24 70.06 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 123.776 0.83 . . . . 0.0 111.184 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -79.94 -28.49 39.7 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -78.36 -42.11 31.4 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.322 -0.862 . . . . 0.0 112.01 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -107.03 152.08 40.9 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 123.774 0.829 . . . . 0.0 110.31 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.97 57.89 4.0 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.172 3.248 . . . . 0.0 113.12 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -118.29 73.6 10.47 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.587 1.155 . . . . 0.0 110.507 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.39 86.29 1.71 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.998 2.465 . . . . 0.0 106.179 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 66.7 t -80.74 93.93 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.45 -19.5 1.43 Allowed 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.367 1.067 . . . . 0.0 113.167 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -20.14 65.27 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.471 1.508 . . . . 0.0 110.596 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -115.1 -25.34 8.14 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.639 0.776 . . . . 0.0 110.756 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.6 mt -74.21 159.56 32.35 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.905 1.282 . . . . 0.0 112.093 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -147.65 143.46 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.194 0.998 . . . . 0.0 110.309 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.99 126.4 32.49 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 126.139 1.776 . . . . 0.0 108.644 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -102.13 150.24 23.46 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.6 t -142.02 -157.07 0.74 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -159.53 152.0 21.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.401 1.48 . . . . 0.0 108.112 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.8 p -123.61 6.58 8.86 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.468 1.507 . . . . 0.0 112.538 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.97 -85.13 0.36 Allowed Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 104.896 -3.282 . . . . 0.0 104.896 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.536 ' HG3' HH11 ' A' ' 114' ' ' ARG . 13.8 mtt85 -94.9 -7.8 39.01 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -126.19 172.56 9.95 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 119.119 0.872 . . . . 0.0 109.533 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.6 m -135.99 130.66 33.94 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 126.964 2.106 . . . . 0.0 110.622 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.27 161.13 16.56 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.3 1.04 . . . . 0.0 108.475 178.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -143.95 116.87 8.82 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -125.97 127.1 45.41 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.719 0.637 . . . . 0.0 110.06 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.6 m -51.23 131.67 28.1 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.305 1.042 . . . . 0.0 109.938 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.5 t -73.63 -53.6 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 O-C-N 122.225 -0.297 . . . . 0.0 110.915 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.55 74.54 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -124.4 80.71 59.79 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.63 160.01 48.21 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.868 2.378 . . . . 0.0 109.879 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.7 -20.79 48.12 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 126.399 1.952 . . . . 0.0 111.601 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -103.63 116.78 32.97 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 118.823 1.312 . . . . 0.0 110.467 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -90.11 157.02 17.96 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 125.045 1.338 . . . . 0.0 108.825 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 9.7 mm -86.06 129.03 38.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.21 117.01 30.47 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 119.321 0.964 . . . . 0.0 110.209 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.3 m -78.68 -25.66 13.51 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.304 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.2 m 67.39 55.36 0.66 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.537 1.535 . . . . 0.0 113.268 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 75.4 m -95.79 -2.91 46.7 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.334 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -68.06 -66.41 0.57 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.56 1.073 . . . . 0.0 111.353 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -124.17 -55.13 0.18 Allowed Glycine 0 C--N 1.333 0.388 0 CA-C-O 119.302 -0.721 . . . . 0.0 111.796 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.97 54.05 0.01 OUTLIER Glycine 0 CA--C 1.519 0.338 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.1 m -87.04 166.93 23.74 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 117.37 0.585 . . . . 0.0 110.697 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.13 168.49 24.67 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 N-CA-C 108.584 -1.352 . . . . 0.0 108.584 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.5 mt -87.0 111.26 20.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -146.33 -177.08 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.812 1.245 . . . . 0.0 110.987 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.7 mt -100.7 161.82 13.34 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -156.3 130.69 8.78 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -90.24 -38.22 13.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 119.603 -0.839 . . . . 0.0 108.764 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 . . . . . 0 CA--C 1.532 0.277 0 C-N-CA 126.034 1.734 . . . . 0.0 107.971 -178.724 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.463 0.201 0 CA-C-O 121.106 0.479 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.5 m -100.24 136.04 40.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.3 p -131.7 7.19 4.42 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.635 1.574 . . . . 0.0 112.267 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -144.4 112.19 6.22 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.98 -175.79 4.55 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.898 1.226 . . . . 0.0 113.146 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.34 -174.26 27.37 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.9 tp -141.04 146.7 37.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.5 m -100.6 48.24 0.91 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.815 1.246 . . . . 0.0 107.658 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.54 159.69 33.86 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.954 1.302 . . . . 0.0 108.493 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 8.9 mt -145.79 153.42 40.9 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.706 2.002 . . . . 0.0 108.496 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.337 0 CA-C-N 119.884 1.22 . . . . 0.0 112.653 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 117.459 -1.257 . . . . 0.0 109.186 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.26 140.55 24.87 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 N-CA-C 106.973 -1.972 . . . . 0.0 106.973 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.17 149.42 35.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -144.49 132.57 21.59 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.538 -1.351 . . . . 0.0 109.385 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.75 -122.1 0.59 Allowed Glycine 0 CA--C 1.518 0.28 0 CA-C-O 117.844 -1.531 . . . . 0.0 111.225 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.8 p -160.3 -168.78 2.27 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 120.725 2.263 . . . . 0.0 112.566 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.7 mt -145.22 4.52 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.32 1.448 . . . . 0.0 108.97 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.14 -25.13 63.32 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 119.806 -1.809 . . . . 0.0 111.077 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -75.27 46.15 0.32 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.557 1.543 . . . . 0.0 110.897 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mt -130.56 -61.95 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 126.293 1.837 . . . . 0.0 108.688 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.85 27.17 2.02 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.489 0.661 . . . . 0.0 110.646 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.35 11.06 4.29 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 128.88 2.872 . . . . 0.0 114.182 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -70.76 95.38 1.12 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.187 1.795 . . . . 0.0 109.43 -179.641 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.81 158.97 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 102.997 -2.964 . . . . 0.0 102.997 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -118.63 144.84 45.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 120.605 -1.309 . . . . 0.0 108.711 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.7 t -150.53 141.21 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.6 tp -75.77 119.05 19.24 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -133.06 123.2 25.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.7 t70 45.88 58.37 4.41 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.034 1.334 . . . . 0.0 112.845 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 54.23 23.9 4.59 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.021 1.329 . . . . 0.0 112.968 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.5 m -132.94 159.56 39.6 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.589 1.556 . . . . 0.0 107.607 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 mt -108.67 124.34 50.37 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 mm -127.14 141.96 44.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 O-C-N 123.87 0.731 . . . . 0.0 109.766 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.87 137.12 36.17 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.05 66.3 40.33 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.106 0.962 . . . . 0.0 108.439 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.46 -28.66 78.11 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 121.842 1.695 . . . . 0.0 112.193 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -149.54 95.61 2.37 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 125.003 1.321 . . . . 0.0 109.403 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.81 142.31 5.26 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.793 0.837 . . . . 0.0 109.55 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.52 -39.7 77.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 122.367 1.08 . . . . 0.0 108.945 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.8 tpp85 -79.4 62.67 3.8 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.494 1.518 . . . . 0.0 111.706 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.2 ptt? -126.39 168.57 14.0 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.802 1.241 . . . . 0.0 110.999 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 t -158.54 144.99 12.69 Favored Pre-proline 0 N--CA 1.452 -0.375 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.63 154.83 64.03 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 N-CA-C 107.891 -1.619 . . . . 0.0 107.891 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.39 156.95 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.4 m -118.07 161.57 19.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.233 -1.348 . . . . 0.0 108.504 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.3 mm -130.32 110.73 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 C-N-CA 126.157 1.783 . . . . 0.0 111.065 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.87 138.59 31.27 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 176.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 tt -130.53 131.77 45.24 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.5 mt -147.32 143.29 20.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 124.862 2.267 . . . . 0.0 106.933 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.2 p -73.7 162.27 29.36 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.517 -1.674 . . . . 0.0 108.881 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.7 m -91.17 149.58 21.73 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -102.1 -23.73 14.03 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -106.49 56.32 0.66 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.1 m -75.12 -10.73 13.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 120.98 -1.075 . . . . 0.0 111.185 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -69.99 4.09 2.3 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 125.925 1.69 . . . . 0.0 114.596 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 t -129.88 13.6 5.81 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.954 0.902 . . . . 0.0 108.939 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 98.3 mt -119.97 169.3 10.3 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.789 1.236 . . . . 0.0 108.095 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.9 155.35 37.56 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.698 1.199 . . . . 0.0 109.024 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.55 -32.39 2.65 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.226 1.011 . . . . 0.0 111.66 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -64.69 -36.01 82.89 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.535 1.134 . . . . 0.0 110.082 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -65.64 -25.68 67.47 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.463 1.105 . . . . 0.0 112.472 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.516 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 135.52 -173.52 21.7 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -87.13 111.59 41.88 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 123.957 0.903 . . . . 0.0 112.569 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.3 138.44 11.1 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.374 2.049 . . . . 0.0 110.898 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.429 HG13 ' CE1' ' A' ' 107' ' ' PHE . 15.6 pt -145.21 -174.26 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 124.354 1.062 . . . . 0.0 109.402 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.429 ' CD1' HD12 ' A' ' 95' ' ' LEU . 3.7 t80 -139.44 165.37 27.4 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.044 1.338 . . . . 0.0 113.028 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 tt -163.07 159.23 22.99 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.297 1.439 . . . . 0.0 111.148 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.27 176.17 38.67 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.219 0.914 . . . . 0.0 112.1 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mt -94.62 152.55 18.42 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.388 1.075 . . . . 0.0 109.285 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -116.85 120.41 38.4 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.38 -38.82 0.55 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.314 0.483 . . . . 0.0 112.812 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.74 31.5 1.17 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.373 1.087 . . . . 0.0 112.52 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.6 m120 50.24 79.5 0.08 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.573 1.949 . . . . 0.0 111.912 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.67 137.89 25.53 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.651 0.78 . . . . 0.0 110.141 -177.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.0 m -143.85 172.56 12.68 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 118.631 0.65 . . . . 0.0 110.861 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.7 mt -59.05 147.84 33.22 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.115 0.484 . . . . 0.0 111.501 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 mtp -157.6 139.87 14.49 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 92.3 m -115.06 115.47 26.86 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.61 -177.93 3.35 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.396 2.279 . . . . 0.0 107.118 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.4 tttt -122.51 126.8 48.57 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.46 -25.06 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.44 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.58 -49.9 0.2 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -130.04 -11.99 4.19 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.174 -1.192 . . . . 0.0 113.274 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -137.87 153.83 74.05 Favored Pre-proline 0 C--O 1.241 0.657 0 C-N-CA 123.881 0.872 . . . . 0.0 110.749 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -70.04 153.45 67.63 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.424 2.082 . . . . 0.0 108.325 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 p -149.22 158.49 44.22 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mt -80.4 146.18 31.61 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -145.54 63.81 1.26 Allowed 'General case' 0 N--CA 1.461 0.078 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.33 108.51 18.47 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.92 -41.39 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.097 0.559 . . . . 0.0 111.732 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -134.45 101.69 5.07 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 126.111 1.764 . . . . 0.0 109.929 -176.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.25 166.89 4.12 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.1 -1.0 . . . . 0.0 109.345 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.3 135.98 31.12 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 mt -87.68 -43.08 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 125.388 1.475 . . . . 0.0 109.173 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.6 tpt -61.64 -23.4 66.03 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 119.11 -0.471 . . . . 0.0 110.113 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -64.95 -51.2 63.12 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.429 HD12 ' CD1' ' A' ' 64' ' ' TYR . 13.5 mt -60.9 -35.49 76.79 Favored 'General case' 0 N--CA 1.461 0.091 0 O-C-N 121.717 -0.614 . . . . 0.0 110.181 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -78.87 -17.06 56.23 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.392 -0.817 . . . . 0.0 110.638 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -89.73 -42.78 11.13 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 120.504 -1.372 . . . . 0.0 111.181 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -107.01 150.09 39.39 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.433 0.693 . . . . 0.0 111.714 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.6 46.74 1.5 Allowed 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.552 3.502 . . . . 0.0 113.695 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -112.9 75.71 2.03 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.163 0.985 . . . . 0.0 111.134 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.99 71.18 7.16 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.599 3.533 . . . . 0.0 108.932 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 73.8 t -71.01 104.43 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.375 0.67 . . . . 0.0 110.172 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -50.96 -28.67 10.34 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 125.372 1.469 . . . . 0.0 111.029 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m -63.11 -13.63 38.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.327 1.451 . . . . 0.0 112.417 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -121.67 -28.63 4.51 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.769 0.828 . . . . 0.0 109.594 177.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.49 160.89 31.93 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.687 1.195 . . . . 0.0 111.035 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.429 ' CE1' HG13 ' A' ' 63' ' ' ILE . 9.9 p90 -151.16 148.38 28.19 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.57 0.748 . . . . 0.0 111.813 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.516 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -90.1 110.52 21.52 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 128.718 2.807 . . . . 0.0 107.923 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -79.38 141.83 36.55 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.4 t -137.95 -174.3 3.75 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.692 0.797 . . . . 0.0 109.526 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -151.24 163.08 39.68 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.285 1.434 . . . . 0.0 109.533 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.8 p -137.8 14.44 2.91 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.725 1.21 . . . . 0.0 111.825 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.72 -102.46 0.69 Allowed Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 105.452 -3.059 . . . . 0.0 105.452 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.07 -3.9 58.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.136 0.968 . . . . 0.0 113.115 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -117.6 159.47 22.85 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.405 1.002 . . . . 0.0 108.894 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 m -122.36 137.58 54.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.284 1.833 . . . . 0.0 108.963 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.01 166.84 10.72 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.524 1.13 . . . . 0.0 109.372 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -147.13 118.08 7.68 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -115.83 132.18 56.72 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 125.115 1.366 . . . . 0.0 110.554 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 t -59.84 133.93 56.56 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.118 0.967 . . . . 0.0 109.219 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.76 -45.95 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 O-C-N 120.649 -1.282 . . . . 0.0 110.191 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.53 70.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.63 -0.669 . . . . 0.0 111.946 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.16 82.92 46.52 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.919 0.888 . . . . 0.0 110.65 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.37 144.18 55.23 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.876 1.717 . . . . 0.0 107.854 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.31 -11.22 43.55 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.705 1.621 . . . . 0.0 109.208 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 25.3 m-90 -113.62 115.53 28.06 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.209 1.404 . . . . 0.0 107.646 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -105.16 156.76 17.79 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 125.024 1.329 . . . . 0.0 110.14 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.4 pt -85.56 127.86 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.932 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.71 119.75 25.61 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.5 t -79.49 -21.04 12.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 127.238 2.215 . . . . 0.0 112.223 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.5 m 54.95 90.93 0.03 OUTLIER 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.966 2.106 . . . . 0.0 110.892 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 m -135.58 43.67 2.59 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 126.174 1.79 . . . . 0.0 108.307 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -110.55 0.27 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.459 2.303 . . . . 0.0 107.036 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.32 7.46 80.64 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 117.744 1.857 . . . . 0.0 117.744 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.45 38.82 8.68 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 119.824 1.812 . . . . 0.0 112.164 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 93.6 m -77.14 163.59 64.03 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.93 1.292 . . . . 0.0 107.857 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.22 169.33 20.93 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.129 1.886 . . . . 0.0 110.5 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.3 mt -85.93 118.83 25.65 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.574 HD13 HD22 ' A' ' 148' ' ' ASN . 0.2 OUTLIER -141.69 172.86 9.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 124.407 1.083 . . . . 0.0 110.586 179.507 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 41.6 mt -91.91 163.6 13.96 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.9 t -149.09 150.14 32.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 177.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -101.79 -31.52 10.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 123.541 1.639 . . . . 0.0 108.09 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 . . . . . 0 N--CA 1.429 -1.478 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 -178.999 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.574 HD22 HD13 ' A' ' 139' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.421 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 55.98 79.45 0.17 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.517 0.599 . . . . 0.0 112.246 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.9 p -105.3 -8.33 18.32 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.058 -1.026 . . . . 0.0 111.612 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -115.52 103.14 10.44 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.091 1.356 . . . . 0.0 112.516 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.19 171.29 17.63 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.185 -1.572 . . . . 0.0 110.918 178.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -83.31 -173.27 49.57 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.96 120.76 11.24 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 14.8 m -78.91 41.94 0.45 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.896 1.679 . . . . 0.0 108.819 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -68.65 140.52 55.48 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.5 mt -115.0 162.07 17.48 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.92 1.688 . . . . 0.0 108.88 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 33.1 p90 . . . . . 0 C--O 1.245 0.849 0 C-N-CA 125.368 1.467 . . . . 0.0 108.108 178.831 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.5 p . . . . . 0 C--O 1.236 0.382 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.92 138.29 33.85 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.637 1.558 . . . . 0.0 108.866 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.39 117.47 21.45 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -114.38 143.61 44.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.39 -125.28 0.82 Allowed Glycine 0 C--O 1.226 -0.368 0 CA-C-O 117.988 -1.451 . . . . 0.0 110.356 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.4 p -154.05 -164.99 1.99 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 120.526 2.163 . . . . 0.0 113.628 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.6 mt -140.32 4.36 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.764 1.626 . . . . 0.0 108.033 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.447 ' C ' ' H ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -74.8 -26.85 60.02 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.361 -1.462 . . . . 0.0 111.88 -179.326 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -69.82 19.21 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 128.042 2.537 . . . . 0.0 113.695 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.447 ' H ' ' C ' ' A' ' 16' ' ' GLN . 5.7 mt -110.23 -60.58 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 127.165 2.186 . . . . 0.0 110.827 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -137.72 23.23 2.89 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.711 0.804 . . . . 0.0 110.524 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 61.41 36.81 17.17 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.296 1.038 . . . . 0.0 110.239 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.444 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 26.1 mmt-85 -104.19 86.36 2.54 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.904 -1.122 . . . . 0.0 110.322 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.9 t -73.88 129.36 36.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 32.0 m0 -81.9 137.54 35.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.044 0.938 . . . . 0.0 109.854 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.97 120.69 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-N 119.593 1.088 . . . . 0.0 109.705 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.03 100.31 4.15 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.433 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 4.0 tt0 -89.02 -172.93 3.87 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.433 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -52.59 96.77 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 124.232 1.013 . . . . 0.0 112.306 -178.529 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 52.85 26.12 4.38 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.744 2.017 . . . . 0.0 111.937 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.1 m -154.09 128.67 9.28 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 119.172 0.897 . . . . 0.0 111.23 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mt -84.3 131.96 34.67 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 pt -138.37 133.01 42.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 124.635 1.174 . . . . 0.0 111.134 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.07 146.36 47.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.18 80.78 15.86 Favored Pre-proline 0 N--CA 1.464 0.243 0 C-N-CA 124.031 0.932 . . . . 0.0 109.381 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.4 -31.87 21.24 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.883 1.722 . . . . 0.0 115.079 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 -165.91 84.25 0.32 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.409 1.884 . . . . 0.0 108.73 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -147.77 130.13 15.7 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -60.94 -13.62 17.21 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.308 1.043 . . . . 0.0 113.674 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -96.34 49.09 1.11 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.614 1.552 . . . . 0.0 106.922 177.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.5 mtp -65.25 156.9 30.45 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.554 -1.341 . . . . 0.0 109.402 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.3 t -159.89 87.5 1.97 Allowed Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.634 0.774 . . . . 0.0 109.841 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.42 137.23 46.18 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.015 1.81 . . . . 0.0 111.176 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 m -119.91 -174.18 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.9 m -132.62 155.25 49.06 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.2 mm -127.85 110.67 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 125.971 1.708 . . . . 0.0 108.857 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.7 139.32 30.65 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.168 1.787 . . . . 0.0 109.304 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.7 tt -134.41 129.41 35.3 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.605 1.162 . . . . 0.0 109.19 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.0 mt -144.91 127.93 11.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.932 1.293 . . . . 0.0 111.039 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.0 p -72.68 128.22 34.91 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 90.3 m -61.6 149.48 39.08 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -109.54 -10.09 14.88 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.486 1.114 . . . . 0.0 110.216 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -101.49 26.71 6.97 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.551 1.94 . . . . 0.0 109.918 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.3 m -71.22 -9.79 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 120.497 -1.377 . . . . 0.0 114.567 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.02 -35.92 48.48 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.45 1.1 . . . . 0.0 112.694 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 t -97.97 0.82 47.1 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.565 1.546 . . . . 0.0 111.821 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 72.7 mt -92.13 -179.58 5.3 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.02 -1.05 . . . . 0.0 109.974 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -79.52 162.03 25.65 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.556 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -139.5 -24.19 0.86 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.562 1.545 . . . . 0.0 111.586 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -78.67 9.07 4.42 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.062 1.745 . . . . 0.0 112.703 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -115.18 -50.11 2.76 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.73 -146.47 10.89 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -107.8 104.28 52.58 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.67 131.56 17.46 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.291 3.327 . . . . 0.0 111.267 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.79 177.35 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.36 0.664 . . . . 0.0 111.033 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -125.83 154.55 42.48 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.733 0.778 . . . . 0.0 109.963 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.9 tt -156.07 150.76 26.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.49 178.62 35.53 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mt -88.25 153.75 20.97 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 177.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -119.46 116.05 25.32 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 101.246 -3.613 . . . . 0.0 101.246 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.6 -18.97 0.37 Allowed Glycine 0 C--N 1.342 0.874 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.916 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.19 26.28 0.09 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.823 1.811 . . . . 0.0 112.336 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.0 m120 60.23 62.99 1.48 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.346 1.058 . . . . 0.0 109.322 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.36 137.41 27.09 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.436 -1.415 . . . . 0.0 112.298 -178.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.448 ' H ' ' HB2' ' A' ' 90' ' ' LYS . 5.4 m -143.14 176.23 9.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.145 0.978 . . . . 0.0 111.656 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 18.6 mt -61.3 151.38 32.11 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.322 1.049 . . . . 0.0 111.052 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.491 ' HG3' ' HZ2' ' A' ' 90' ' ' LYS . 4.9 tmm? -158.84 134.28 8.6 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 76.2 m -107.52 120.64 42.76 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 124.482 1.114 . . . . 0.0 109.57 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.21 -168.37 2.12 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -121.59 144.63 48.63 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.8 p -90.93 -24.17 5.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.43 -0.508 . . . . 0.0 109.668 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.24 -45.43 0.47 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -109.74 -40.75 4.72 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -132.97 164.95 40.28 Favored Pre-proline 0 C--O 1.242 0.692 0 C-N-CA 126.158 1.783 . . . . 0.0 112.125 -177.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -71.23 154.34 61.72 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.632 2.222 . . . . 0.0 112.38 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.4 p -151.21 171.9 16.68 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mt -91.86 152.98 19.84 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.425 0.69 . . . . 0.0 111.663 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -145.07 65.83 1.25 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.647 0.779 . . . . 0.0 110.224 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.11 116.71 26.49 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -177.97 -19.27 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.7 94.82 1.49 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.491 ' HZ2' ' HG3' ' A' ' 75' ' ' MET . 0.6 OUTLIER -173.65 162.63 4.15 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 121.503 1.956 . . . . 0.0 109.866 -177.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -142.77 136.79 29.23 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.849 0.459 . . . . 0.0 111.823 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.1 mp -80.91 -36.21 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.972 1.309 . . . . 0.0 110.846 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.8 mmt -59.7 -33.38 71.52 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.868 0.758 . . . . 0.0 109.831 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.8 -54.18 49.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.94 0.896 . . . . 0.0 109.159 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.9 mt -67.19 -29.67 69.41 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -80.7 -25.72 37.96 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.872 0.368 . . . . 0.0 110.698 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -83.69 -44.36 14.57 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.007 1.323 . . . . 0.0 111.524 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.48 154.71 46.53 Favored Pre-proline 0 N--CA 1.457 -0.111 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.059 -177.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.3 65.69 2.77 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 124.132 3.221 . . . . 0.0 113.01 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -119.79 69.78 13.17 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 125.054 1.342 . . . . 0.0 111.388 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.39 75.84 4.46 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.361 2.707 . . . . 0.0 105.95 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 t -88.43 94.34 4.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 O-C-N 120.858 -1.151 . . . . 0.0 109.496 -177.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -45.08 -28.09 0.67 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.242 2.217 . . . . 0.0 114.393 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 m -63.1 -22.28 66.75 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.355 1.462 . . . . 0.0 113.107 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.477 ' CE2' ' HG2' ' A' ' 75' ' ' MET . 20.6 m-85 -109.36 -18.52 13.54 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.658 1.983 . . . . 0.0 109.581 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.1 mt -85.68 155.19 21.19 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 125.717 1.607 . . . . 0.0 113.686 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -138.57 131.72 29.95 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.914 0.886 . . . . 0.0 109.71 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.51 116.35 18.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -90.73 144.23 25.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.402 ' HG ' ' CB ' ' A' ' 117' ' ' THR . 1.0 OUTLIER -128.79 178.24 6.5 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.09 0.956 . . . . 0.0 109.11 178.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -150.63 154.83 38.2 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.597 1.559 . . . . 0.0 110.799 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 57.6 p -132.38 8.9 4.32 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.322 -1.763 . . . . 0.0 113.459 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.79 -47.1 1.08 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.803 1.668 . . . . 0.0 112.159 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -132.82 -2.81 3.27 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -132.83 151.17 52.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.9 m -118.09 159.89 22.46 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.402 ' CB ' ' HG ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -126.2 166.14 17.63 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 177.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -147.87 112.88 5.47 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.02 133.29 55.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.487 1.515 . . . . 0.0 109.555 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.0 t -54.47 120.45 6.65 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.211 1.004 . . . . 0.0 108.652 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.4 t -65.71 -42.36 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.066 -1.021 . . . . 0.0 110.663 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.25 97.49 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -129.31 83.77 64.35 Favored Pre-proline 0 C--O 1.235 0.321 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -68.23 158.34 57.93 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.786 2.324 . . . . 0.0 108.456 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 104.34 -6.97 46.58 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 26.4 m-90 -124.28 142.15 51.49 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 126.157 1.783 . . . . 0.0 109.796 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -126.0 152.23 46.0 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.092 0.957 . . . . 0.0 111.519 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.0 pt -76.04 127.71 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.076 0.465 . . . . 0.0 110.949 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.88 110.0 20.69 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 t -68.21 -15.8 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.844 1.658 . . . . 0.0 113.882 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 m 65.79 33.13 8.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.0 1.32 . . . . 0.0 113.041 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.444 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 5.8 m -65.03 -21.1 66.79 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.353 0.597 . . . . 0.0 111.827 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -84.7 120.3 26.24 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 125.377 1.471 . . . . 0.0 107.787 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 67.57 -72.29 0.24 Allowed Glycine 0 N--CA 1.442 -0.933 0 O-C-N 125.466 1.729 . . . . 0.0 114.311 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.67 71.45 0.02 OUTLIER Glycine 0 CA--C 1.526 0.767 0 N-CA-C 105.837 -2.905 . . . . 0.0 105.837 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 63.9 m -95.0 174.68 3.36 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 124.956 1.302 . . . . 0.0 111.393 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.23 165.21 31.43 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.03 1.82 . . . . 0.0 111.593 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 28.8 mt -91.59 114.01 26.43 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.956 0.903 . . . . 0.0 108.564 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.7 pp -141.21 176.6 4.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 125.255 1.422 . . . . 0.0 107.191 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 20.2 mt -100.63 165.79 11.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.8 t -147.89 162.53 39.09 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -104.63 -42.53 5.38 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 . . . . . 0 N--CA 1.441 -0.881 0 CA-C-O 122.707 1.241 . . . . 0.0 109.014 179.312 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 90.9 m -137.29 131.52 32.39 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.3 p -110.37 -13.29 14.31 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.874 1.269 . . . . 0.0 111.689 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -120.63 109.12 14.85 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.767 0.712 . . . . 0.0 111.519 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.68 173.25 14.95 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.168 1.787 . . . . 0.0 111.206 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.38 -166.9 31.21 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.14 140.62 46.69 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 122.076 -0.661 . . . . 0.0 109.233 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.75 28.88 1.24 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.883 1.673 . . . . 0.0 109.837 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -59.45 150.65 26.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.663 1.185 . . . . 0.0 108.523 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 43.1 mt -132.86 160.88 35.69 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.62 1.168 . . . . 0.0 108.333 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 31.2 p90 . . . . . 0 C--O 1.245 0.819 0 CA-C-O 117.198 -1.382 . . . . 0.0 108.29 178.908 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.24 0.595 0 CA-C-O 119.598 -0.239 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.34 147.94 94.09 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 N-CA-C 108.131 -1.527 . . . . 0.0 108.131 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.98 107.16 15.01 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -110.21 134.9 51.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.486 0.66 . . . . 0.0 110.388 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -161.27 -129.05 0.99 Allowed Glycine 0 N--CA 1.451 -0.356 0 O-C-N 121.186 -0.946 . . . . 0.0 111.975 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.2 p -154.23 -172.47 4.22 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.364 1.082 . . . . 0.0 112.11 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -149.81 9.18 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 124.288 1.035 . . . . 0.0 111.575 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.32 -18.03 59.13 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 119.92 -1.738 . . . . 0.0 111.377 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.14 44.85 0.6 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.23 2.612 . . . . 0.0 110.528 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mt -131.71 -64.95 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 126.111 1.764 . . . . 0.0 111.148 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -139.87 27.42 2.21 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.406 1.083 . . . . 0.0 109.855 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 64.59 15.55 9.74 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -79.05 91.03 4.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.6 t -72.24 153.49 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -112.1 132.56 54.78 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 120.513 -1.367 . . . . 0.0 108.798 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.8 t -140.62 126.12 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 119.983 1.265 . . . . 0.0 111.837 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tp -76.41 104.7 7.06 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -88.92 -170.33 2.87 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.86 97.01 0.01 OUTLIER 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.604 1.962 . . . . 0.0 109.925 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 46.51 23.09 0.2 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.893 2.477 . . . . 0.0 112.669 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 m -153.93 128.55 9.32 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 119.412 1.006 . . . . 0.0 111.523 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mt -79.74 149.21 31.21 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.147 -0.971 . . . . 0.0 112.028 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 16.6 pt -143.15 149.37 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.168 1.387 . . . . 0.0 110.893 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.64 143.97 25.79 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.47 105.32 19.32 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.015 0.926 . . . . 0.0 110.285 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.83 -50.68 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.454 2.769 . . . . 0.0 116.351 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -147.05 57.71 1.15 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.07 130.82 50.33 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.22 -55.24 37.55 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.86 0.725 . . . . 0.0 109.082 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -79.44 60.36 3.18 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.218 1.407 . . . . 0.0 111.692 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -102.64 171.62 7.32 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 176.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t -159.68 133.01 4.79 Favored Pre-proline 0 N--CA 1.452 -0.373 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.69 155.04 59.25 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 N-CA-C 108.088 -1.543 . . . . 0.0 108.088 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m -140.07 -171.03 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 125.244 1.418 . . . . 0.0 107.535 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.92 156.16 48.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.0 mm -127.34 112.55 28.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 126.158 1.783 . . . . 0.0 107.905 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.16 140.74 29.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.8 tt -135.47 139.75 44.3 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.0 mt -150.37 139.72 15.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.287 1.035 . . . . 0.0 108.986 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.7 p -75.14 156.4 35.98 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.468 ' HG ' ' HA ' ' A' ' 63' ' ' ILE . 94.8 m -78.34 140.06 38.79 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 119.873 -1.767 . . . . 0.0 108.681 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -101.16 -21.28 14.99 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.44 -0.788 . . . . 0.0 112.541 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -111.66 67.77 0.65 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.884 1.274 . . . . 0.0 108.255 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.2 m -101.4 2.31 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.61 -18.71 65.16 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.635 1.174 . . . . 0.0 111.526 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 t -105.16 -5.0 21.13 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.764 2.026 . . . . 0.0 113.521 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.41 -178.59 6.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.594 -0.691 . . . . 0.0 110.205 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 58' ' ' ASP . 7.1 tt0 -82.37 -38.17 24.56 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.418 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.81 1.55 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.662 1 C-N-CA 132.328 4.251 . . . . 0.0 117.148 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 56' ' ' GLU . 57.6 m-20 -93.53 -14.43 26.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 127.227 2.211 . . . . 0.0 110.399 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.403 HH12 ' HB3' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -98.95 -0.52 42.0 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.928 0.785 . . . . 0.0 111.085 175.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.66 179.86 23.09 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 125.132 1.349 . . . . 0.0 110.389 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -86.62 112.58 47.7 Favored Pre-proline 0 CA--C 1.538 0.506 0 O-C-N 121.552 -0.969 . . . . 0.0 109.051 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -66.73 133.47 31.8 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.449 2.1 . . . . 0.0 114.461 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.468 ' HA ' ' HG ' ' A' ' 49' ' ' CYS . 1.9 pp -142.77 174.02 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 120.04 1.291 . . . . 0.0 109.788 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -131.94 153.4 50.33 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.1 tt -150.76 154.43 37.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.114 1.366 . . . . 0.0 108.23 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -163.65 -173.03 31.85 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.64 159.99 14.72 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -135.02 92.14 2.84 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 120.43 -1.419 . . . . 0.0 110.357 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.37 -7.83 0.02 OUTLIER Glycine 0 CA--C 1.536 1.394 0 CA-C-O 117.518 -1.712 . . . . 0.0 114.872 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -164.86 24.99 0.06 Allowed 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.528 2.164 . . . . 0.0 113.312 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.7 m120 58.7 67.84 0.89 Allowed 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.531 -1.355 . . . . 0.0 109.529 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.25 131.67 23.69 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.441 1.496 . . . . 0.0 109.888 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 61.5 m -140.38 177.99 7.62 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.23 1.812 . . . . 0.0 112.059 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.7 mt -61.71 154.72 24.66 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.284 -1.51 . . . . 0.0 110.772 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.2 ttp -162.46 132.15 4.47 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 93.2 m -103.33 121.96 43.83 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.313 0.96 . . . . 0.0 110.588 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.98 -171.91 2.39 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.926 1.69 . . . . 0.0 107.678 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -146.31 130.48 17.46 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.0 m -78.46 12.08 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 123.576 0.75 . . . . 0.0 112.227 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.02 -10.51 63.94 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.847 2.165 . . . . 0.0 111.687 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -129.08 -50.96 1.21 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.926 1.69 . . . . 0.0 110.857 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -131.48 155.76 81.04 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 125.058 1.343 . . . . 0.0 113.498 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.31 144.09 40.62 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 124.157 3.238 . . . . 0.0 111.769 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.7 p -148.43 147.65 29.42 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.171 0.896 . . . . 0.0 109.5 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.3 mt -71.69 160.08 33.27 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -150.97 64.09 0.91 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.061 0.944 . . . . 0.0 108.673 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.403 HD11 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -85.09 113.01 21.17 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.5 pttp -174.9 -36.16 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.929 1.292 . . . . 0.0 112.283 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -141.64 83.4 1.85 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.841 1.2 . . . . 0.0 113.959 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.47 147.71 6.37 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.36 -1.463 . . . . 0.0 109.014 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.29 140.99 48.16 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.225 1.01 . . . . 0.0 109.958 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.1 tt -87.18 -43.59 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 125.417 1.487 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.3 tpt -62.32 -27.89 69.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.923 -0.56 . . . . 0.0 111.396 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.88 -54.51 37.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.8 mt -60.05 -32.48 70.96 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.427 -0.796 . . . . 0.0 111.248 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -81.83 -15.97 52.35 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.238 -0.914 . . . . 0.0 112.215 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -94.49 -33.16 13.19 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 120.498 -1.376 . . . . 0.0 112.374 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -123.8 167.07 16.14 Favored Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 124.909 1.284 . . . . 0.0 110.799 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.24 -139.14 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 122.81 2.34 . . . . 0.0 109.59 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 56.99 60.77 7.05 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.952 1.701 . . . . 0.0 113.575 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.49 109.37 0.85 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.03 3.153 . . . . 0.0 109.262 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.3 t -88.11 98.7 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -49.53 -29.73 7.29 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.315 1.046 . . . . 0.0 112.286 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.5 m -62.54 -16.07 54.07 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.413 1.085 . . . . 0.0 113.453 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.52 -23.64 8.17 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.141 0.882 . . . . 0.0 111.69 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.5 mt -75.15 156.06 36.34 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.086 0.955 . . . . 0.0 112.801 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -138.93 128.72 24.86 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.644 0.778 . . . . 0.0 112.517 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -77.85 126.23 30.53 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.41 147.37 36.05 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 p -136.72 -177.1 4.59 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.777 1.631 . . . . 0.0 107.52 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -139.52 165.12 28.08 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.833 0.853 . . . . 0.0 109.193 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.5 p -149.84 35.98 0.69 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.753 1.283 . . . . 0.0 112.555 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.91 -56.27 1.85 Allowed Glycine 0 C--N 1.334 0.469 0 O-C-N 120.61 -1.307 . . . . 0.0 112.504 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -131.32 -1.08 4.0 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.508 -0.995 . . . . 0.0 112.669 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -134.05 179.92 5.95 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.752 0.821 . . . . 0.0 110.007 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 p -144.51 133.15 22.23 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.117 0.967 . . . . 0.0 112.435 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.52 170.82 9.08 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.202 1.401 . . . . 0.0 109.572 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -137.6 109.58 7.2 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.294 1.837 . . . . 0.0 106.98 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -98.52 128.08 44.72 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.926 2.09 . . . . 0.0 109.241 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.1 t -61.2 131.89 51.9 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.929 1.24 . . . . 0.0 111.957 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.33 -49.86 72.37 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 O-C-N 121.845 -0.534 . . . . 0.0 110.004 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.73 -27.52 68.97 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -136.29 84.73 28.69 Favored Pre-proline 0 N--CA 1.453 -0.28 0 CA-C-N 118.179 0.445 . . . . 0.0 110.186 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.403 ' HB3' HH12 ' A' ' 59' ' ' ARG . 10.6 Cg_endo -65.36 166.45 19.32 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.113 2.542 . . . . 0.0 111.663 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.19 1.36 90.48 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.443 -0.643 . . . . 0.0 112.546 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -130.56 146.12 52.01 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.092 1.357 . . . . 0.0 107.419 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -130.87 148.95 52.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.121 1.368 . . . . 0.0 110.578 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.4 pt -78.68 129.29 37.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.569 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.86 151.95 22.46 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.2 m -103.48 -17.27 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 125.149 1.38 . . . . 0.0 113.383 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.3 m 67.98 85.39 0.14 Allowed 'General case' 0 CA--C 1.533 0.308 0 O-C-N 124.413 1.07 . . . . 0.0 109.074 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 t -120.2 13.23 11.98 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.28 -1.512 . . . . 0.0 112.228 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -79.1 -52.22 8.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -161.55 -83.39 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.97 49.75 0.56 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 120.196 1.998 . . . . 0.0 113.261 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 32.0 m -78.13 165.85 47.51 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 118.229 1.014 . . . . 0.0 109.335 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 66.0 Cg_endo -78.12 163.92 27.53 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.404 2.07 . . . . 0.0 113.189 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 37.1 mt -85.64 107.9 17.75 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.7 1.2 . . . . 0.0 110.975 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.44 -172.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 124.292 1.037 . . . . 0.0 109.557 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.54 162.86 14.68 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t -148.97 172.92 13.94 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 125.804 1.642 . . . . 0.0 109.004 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -114.89 -44.98 3.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.339 1.856 . . . . 0.0 108.283 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -178.597 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.575 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.466 HG22 ' CE2' ' A' ' 152' ' ' PHE 0.289 12.9 m -112.28 140.42 47.01 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 178.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.33 -16.76 2.71 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 128.272 2.629 . . . . 0.0 109.815 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.35 122.56 37.18 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 124.147 0.979 . . . . 0.0 111.775 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.466 ' CE2' HG22 ' A' ' 149' ' ' THR . 0.2 OUTLIER -161.71 -173.71 3.86 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.439 1.096 . . . . 0.0 109.481 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.47 -172.42 33.59 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.3 tp -146.03 127.16 14.7 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.9 m -82.96 40.16 0.68 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.6 ptt? -62.75 138.46 58.52 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 44.1 mt -117.42 -177.12 3.15 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.99 1.716 . . . . 0.0 106.95 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.1 p90 . . . . . 0 C--O 1.239 0.533 0 CA-C-N 119.728 1.149 . . . . 0.0 112.301 -179.206 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.846 0 CA-C-O 121.498 0.666 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.28 103.34 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.143 2.562 . . . . 0.0 109.123 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.18 113.23 24.9 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -110.62 139.61 45.71 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.001 0.429 . . . . 0.0 110.744 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.93 -126.25 0.88 Allowed Glycine 0 C--O 1.224 -0.516 0 CA-C-O 117.618 -1.657 . . . . 0.0 112.389 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.4 p -161.68 -165.38 1.27 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 121.292 2.546 . . . . 0.0 112.376 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -142.18 0.5 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.176 0.59 . . . . 0.0 109.868 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -66.53 -20.68 66.09 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 120.34 -1.475 . . . . 0.0 111.256 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -60.58 -16.43 38.0 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.893 0.877 . . . . 0.0 112.394 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.0 mt -74.11 -69.02 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.126 0 C-N-CA 125.48 1.512 . . . . 0.0 113.958 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.04 21.27 6.83 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 67.06 30.38 7.45 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.567 1.147 . . . . 0.0 110.792 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.464 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 16.9 mmt-85 -98.3 102.87 14.74 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.068 1.347 . . . . 0.0 108.476 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.0 t -80.25 154.11 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' A' ' 21' ' ' ARG . 5.2 m95 -114.27 143.93 44.05 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.8 t -138.35 121.07 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tp -69.96 106.54 3.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -98.79 -174.19 2.72 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.52 96.29 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.893 1.224 . . . . 0.0 112.303 -178.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 45.45 28.14 0.45 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.583 2.753 . . . . 0.0 111.823 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.2 m -153.5 127.04 8.68 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.092 0.86 . . . . 0.0 110.694 -176.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.3 mt -83.27 127.9 34.04 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 120.93 -1.106 . . . . 0.0 111.164 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.9 mm -128.01 139.25 52.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 122.949 0.499 . . . . 0.0 109.788 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.18 142.81 39.46 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 m -119.9 77.15 22.35 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 124.662 1.185 . . . . 0.0 108.115 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.31 -37.23 10.55 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.837 2.358 . . . . 0.0 113.907 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.45 51.88 1.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.74 134.14 52.34 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -66.41 -41.68 88.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.111 0.482 . . . . 0.0 110.485 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.18 75.15 9.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -123.35 140.71 52.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.797 -1.547 . . . . 0.0 110.075 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.0 t -140.87 141.16 23.38 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.75 160.84 42.99 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 N-CA-C 108.589 -1.35 . . . . 0.0 108.589 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.0 m -143.82 166.91 13.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 126.5 1.92 . . . . 0.0 109.093 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.61 154.77 36.32 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.3 mm -129.95 109.4 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 125.648 1.579 . . . . 0.0 108.053 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.98 133.38 34.84 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.818 1.247 . . . . 0.0 108.537 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.8 tt -129.55 129.78 44.9 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.4 1.48 . . . . 0.0 109.193 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.415 ' HB ' ' CZ ' ' A' ' 64' ' ' TYR . 2.1 mt -142.17 142.71 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.949 0.88 . . . . 0.0 109.62 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.2 p -87.21 146.78 25.85 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 87.3 m -63.98 122.69 17.12 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.589 1.156 . . . . 0.0 110.943 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -81.77 -26.86 34.09 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.049 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -96.96 35.9 1.49 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.842 1.201 . . . . 0.0 111.474 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 m -57.06 -15.98 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.583 1.153 . . . . 0.0 112.418 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.18 -13.26 11.36 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.845 2.058 . . . . 0.0 111.227 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.59 -0.89 13.51 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.57 1.548 . . . . 0.0 111.819 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -113.27 164.25 13.79 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.864 1.666 . . . . 0.0 110.25 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -71.15 152.73 43.12 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.816 0.847 . . . . 0.0 109.246 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -112.18 -32.84 6.42 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -52.57 -35.0 53.04 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 128.592 2.757 . . . . 0.0 114.27 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.9 mtt85 -87.08 -1.5 57.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 118.548 -0.739 . . . . 0.0 112.785 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.73 -177.17 18.19 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -82.45 106.14 6.07 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 118.927 1.364 . . . . 0.0 111.699 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.76 134.96 20.85 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.232 2.622 . . . . 0.0 108.934 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.92 -179.16 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.717 1.607 . . . . 0.0 110.565 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.415 ' CZ ' ' HB ' ' A' ' 47' ' ' ILE . 5.1 p90 -133.78 158.68 42.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.578 1.151 . . . . 0.0 110.446 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.2 tt -151.64 143.26 23.61 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.124 1.37 . . . . 0.0 109.162 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.43 -174.85 16.01 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.192 1.377 . . . . 0.0 111.344 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mt -105.5 133.59 50.0 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -95.39 107.36 19.49 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.1 -76.77 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.073 -1.536 . . . . 0.0 111.084 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.19 22.09 16.53 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.266 1.026 . . . . 0.0 111.169 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.11 72.54 0.49 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.033 1.733 . . . . 0.0 110.206 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.13 150.29 39.25 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.775 1.23 . . . . 0.0 108.064 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.2 m -147.62 171.64 15.29 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 123.069 0.548 . . . . 0.0 109.937 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 76.7 mt -62.13 166.11 5.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.684 0.794 . . . . 0.0 109.274 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -172.64 137.06 0.78 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.0 m -96.98 128.67 44.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.429 0.633 . . . . 0.0 110.205 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -133.87 -174.9 3.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -131.16 118.01 19.86 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 103.032 -2.951 . . . . 0.0 103.032 178.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 p -72.01 -23.31 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.4 -38.97 0.17 Allowed Glycine 0 N--CA 1.453 -0.227 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -141.8 -17.39 0.77 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.924 0.89 . . . . 0.0 112.488 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -139.47 153.26 70.47 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.836 1.254 . . . . 0.0 113.558 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.93 142.49 88.44 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 124.951 3.767 . . . . 0.0 111.973 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.8 p -147.33 163.52 36.17 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 124.738 1.215 . . . . 0.0 110.218 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 mt -86.12 156.53 20.33 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -147.18 80.08 1.52 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.638 1.975 . . . . 0.0 108.721 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.01 104.63 14.82 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.41 -24.79 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -144.58 87.5 1.87 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.379 1.071 . . . . 0.0 111.72 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -165.86 165.84 18.01 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 119.402 -2.061 . . . . 0.0 108.388 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -137.07 165.41 26.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.9 pt -113.98 -49.66 5.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 124.765 1.226 . . . . 0.0 110.586 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.1 mmt -62.25 -18.84 62.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 117.913 -1.042 . . . . 0.0 109.25 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -71.42 -45.22 63.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.263 1.392 . . . . 0.0 110.299 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 23.4 mt -62.6 -25.94 68.35 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.727 1.211 . . . . 0.0 109.662 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -82.76 -34.89 26.97 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.646 -0.659 . . . . 0.0 109.784 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -65.42 -37.76 87.87 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.621 -1.18 . . . . 0.0 110.859 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -136.12 158.5 73.6 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.87 82.43 2.33 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.926 2.417 . . . . 0.0 111.062 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -135.56 59.91 33.91 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.822 1.649 . . . . 0.0 107.26 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.66 86.84 1.0 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.334 2.023 . . . . 0.0 108.68 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.5 t -73.35 101.74 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -53.08 -29.8 32.42 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 122.998 0.519 . . . . 0.0 111.151 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -65.84 -7.1 14.41 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 178.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -120.92 -33.14 3.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.598 1.09 . . . . 0.0 109.689 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.5 mt -68.32 153.19 44.24 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.239 0.472 . . . . 0.0 111.918 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.95 135.72 24.6 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.126 0.97 . . . . 0.0 111.264 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -74.09 113.75 11.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.716 2.407 . . . . 0.0 105.996 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -88.99 134.06 34.11 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.6 t -132.9 -178.68 5.06 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.77 146.72 20.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.943 0.897 . . . . 0.0 109.891 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.85 88.75 0.98 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.431 1.092 . . . . 0.0 111.843 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 115' ' ' ASN . . . 87.17 61.93 1.54 Allowed Glycine 0 C--N 1.339 0.75 0 C-N-CA 124.335 0.969 . . . . 0.0 112.641 177.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 61.64 0.27 0.47 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.06 2.144 . . . . 0.0 110.437 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 113' ' ' GLY . 89.7 m-20 -115.28 124.9 52.51 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 m -84.72 171.67 12.14 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.096 0.958 . . . . 0.0 109.497 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.14 161.7 41.45 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.053 2.141 . . . . 0.0 108.375 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -141.22 111.93 7.06 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.582 1.153 . . . . 0.0 109.478 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -105.18 128.8 53.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.463 1.905 . . . . 0.0 109.893 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.2 t -52.74 125.58 17.2 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.028 1.731 . . . . 0.0 110.882 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.17 -45.59 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.428 1.013 . . . . 0.0 109.772 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.5 -33.68 74.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.007 -0.997 . . . . 0.0 111.619 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -136.27 83.89 31.17 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.703 1.201 . . . . 0.0 110.269 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.26 157.22 61.09 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.43 1.42 . . . . 0.0 110.342 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 103.73 -34.88 5.42 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.544 1.545 . . . . 0.0 109.5 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 15.7 m-90 -85.95 140.03 30.7 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -123.99 141.45 52.03 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.384 1.074 . . . . 0.0 109.032 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.1 mt -78.73 143.43 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -107.08 158.92 16.69 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.6 t -110.93 1.24 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 126.991 2.117 . . . . 0.0 112.698 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.6 m 49.66 52.93 13.62 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 m -85.1 -15.4 44.06 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.034 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -58.11 -31.52 67.23 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -170.15 -79.72 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.86 57.35 0.22 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 84.3 m -88.37 163.01 38.09 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.73 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.07 164.23 34.67 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 N-CA-C 107.531 -1.757 . . . . 0.0 107.531 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.8 mt -91.29 113.8 26.16 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.2 174.15 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 124.597 1.159 . . . . 0.0 112.445 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.44 150.71 22.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 118.531 -0.747 . . . . 0.0 109.809 177.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.5 t -130.88 173.86 10.55 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.891 1.276 . . . . 0.0 109.307 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -114.64 -32.6 5.8 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.96 1.304 . . . . 0.0 111.028 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 . . . . . 0 C--O 1.237 0.42 0 CA-C-N 119.14 0.882 . . . . 0.0 109.816 -177.918 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.243 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.77 105.87 8.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.179 0.445 . . . . 0.0 110.644 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.5 p -97.79 -22.91 16.14 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -103.55 108.07 19.18 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.389 1.876 . . . . 0.0 112.963 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -173.36 -179.29 1.87 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.828 1.251 . . . . 0.0 111.732 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.69 -155.96 27.44 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 124.814 1.197 . . . . 0.0 112.323 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.5 tp -151.48 135.84 16.86 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.6 1.56 . . . . 0.0 107.411 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.5 m -93.74 42.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.317 1.447 . . . . 0.0 110.292 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -64.41 147.82 51.81 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.071 -1.018 . . . . 0.0 108.684 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 26.1 mt -125.0 165.29 18.4 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.612 1.565 . . . . 0.0 110.467 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 36.7 p90 . . . . . 0 C--O 1.252 1.236 0 C-N-CA 126.159 1.784 . . . . 0.0 108.785 179.474 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.445 -0.694 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.19 123.03 9.27 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 N-CA-C 106.965 -1.975 . . . . 0.0 106.965 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -114.75 110.39 19.64 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -90.17 156.63 18.2 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.987 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.8 -154.48 7.96 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.5 p -156.46 138.28 14.3 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.505 1.522 . . . . 0.0 110.048 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -98.28 1.04 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.0 0.92 . . . . 0.0 109.89 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -55.03 -36.45 65.53 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.036 -1.665 . . . . 0.0 111.412 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -4.71 0.24 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.7 mt -72.92 -61.56 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 CA-C-N 118.591 0.632 . . . . 0.0 109.78 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.73 29.92 1.1 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.489 1.116 . . . . 0.0 109.452 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 59.93 34.56 21.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.234 1.814 . . . . 0.0 111.45 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -99.86 107.77 19.87 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.4 t -88.71 160.38 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -113.78 139.57 49.01 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.419 0.554 . . . . 0.0 109.992 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.2 t -138.48 127.59 31.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.36 116.01 12.29 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 101.64 -3.467 . . . . 0.0 101.64 177.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -131.36 124.76 31.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.479 1.512 . . . . 0.0 108.003 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 t0 49.78 42.06 23.22 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 70.84 11.74 7.12 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.331 1.852 . . . . 0.0 113.863 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.5 m -133.05 138.55 46.8 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.602 1.546 . . . . 0.0 109.656 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mt -83.19 125.47 31.58 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 120.688 -1.258 . . . . 0.0 108.703 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.06 147.06 30.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.84 139.6 39.3 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.317 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.32 74.69 80.09 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 123.778 0.831 . . . . 0.0 110.559 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.29 -73.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.65 1.566 . . . . 0.0 112.976 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.27 12.45 32.92 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -72.45 129.03 37.38 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.247 0.619 . . . . 0.0 112.209 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -46.33 79.62 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.515 1.126 . . . . 0.0 108.492 177.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.63 24.37 0.21 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -69.38 177.6 2.77 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.001 0.819 . . . . 0.0 109.644 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.5 t -163.52 135.52 3.87 Favored Pre-proline 0 C--O 1.237 0.408 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.57 151.85 82.0 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.858 1.705 . . . . 0.0 110.434 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.5 p -141.2 156.58 21.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 m -120.82 157.39 29.86 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.05 105.81 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.206 1.002 . . . . 0.0 111.505 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . . . -94.88 120.47 35.15 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.396 1.078 . . . . 0.0 111.085 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.6 tt -106.06 139.39 40.66 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 125.522 1.529 . . . . 0.0 108.754 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.9 mt -137.46 145.48 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 124.778 1.299 . . . . 0.0 108.83 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.1 p -87.37 137.53 32.26 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.7 m -57.29 112.31 1.35 Allowed 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.097 -1.002 . . . . 0.0 109.984 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -94.79 -6.55 42.67 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.456 ' CE1' ' HA ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -117.95 64.48 0.75 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.056 1.742 . . . . 0.0 106.338 179.405 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.3 m -90.95 3.35 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -50.86 -26.69 6.11 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -117.58 18.45 14.23 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.085 1.354 . . . . 0.0 110.651 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -114.43 171.75 7.44 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 120.205 -1.559 . . . . 0.0 108.791 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.81 165.01 16.33 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -136.43 -39.6 0.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.824 1.25 . . . . 0.0 109.683 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -73.8 -17.35 61.09 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 123.554 0.534 . . . . 0.0 111.803 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -44.99 75.78 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.418 -0.801 . . . . 0.0 109.099 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 167.64 169.33 31.04 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 127.433 2.444 . . . . 0.0 107.384 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -73.62 110.16 8.29 Favored Pre-proline 0 CA--C 1.537 0.445 0 O-C-N 120.767 -1.431 . . . . 0.0 112.388 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.68 136.38 25.54 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 CA-C-N 121.862 1.701 . . . . 0.0 109.925 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 37.7 pt -146.06 -178.14 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.965 1.706 . . . . 0.0 108.96 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -153.68 159.93 42.2 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.218 1.007 . . . . 0.0 109.969 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.29 154.64 46.89 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.566 1.174 . . . . 0.0 111.589 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.81 159.01 26.85 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 124.757 1.17 . . . . 0.0 111.3 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.42 131.75 44.43 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.6 116.56 32.29 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.54 -36.27 0.24 Allowed Glycine 0 N--CA 1.447 -0.573 0 O-C-N 125.158 1.536 . . . . 0.0 111.91 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.08 24.41 0.83 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -178.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.03 70.77 0.61 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.286 1.434 . . . . 0.0 109.623 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.85 144.69 27.09 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 120.805 -1.184 . . . . 0.0 108.52 -178.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.0 m -145.76 166.67 25.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 117.352 -1.309 . . . . 0.0 111.7 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.6 mt -51.99 157.41 1.29 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.531 1.132 . . . . 0.0 110.352 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -170.39 148.27 3.16 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 68.0 m -109.55 121.34 44.99 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.119 1.768 . . . . 0.0 110.56 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.27 178.04 6.88 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.384 1.074 . . . . 0.0 109.57 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -119.85 130.73 55.02 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 102.685 -3.08 . . . . 0.0 102.685 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.73 38.66 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.603 0.761 . . . . 0.0 112.693 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.87 54.78 0.12 Allowed Glycine 0 CA--C 1.503 -0.712 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.0 t0 66.23 13.65 9.27 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.26 141.71 35.13 Favored Pre-proline 0 N--CA 1.448 -0.566 0 C-N-CA 125.61 1.564 . . . . 0.0 110.367 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.54 141.89 22.8 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.607 2.871 . . . . 0.0 113.236 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.8 p -150.42 176.82 10.57 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.506 0.723 . . . . 0.0 110.721 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mt -89.19 150.55 22.62 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.719 0.807 . . . . 0.0 110.845 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -146.01 65.81 1.21 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.935 1.694 . . . . 0.0 109.253 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.43 96.28 9.81 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 126.323 1.849 . . . . 0.0 107.949 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.66 -26.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.996 -177.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -144.44 98.0 3.13 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.487 1.115 . . . . 0.0 109.112 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.52 160.81 0.11 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.256 1.423 . . . . 0.0 110.572 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -142.24 133.16 25.79 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.53 0.732 . . . . 0.0 109.631 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.7 pt -72.27 -44.05 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.688 1.995 . . . . 0.0 111.656 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.21 -26.03 62.33 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.023 0.929 . . . . 0.0 111.395 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -60.64 -52.02 66.93 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.6 mt -61.87 -35.19 77.59 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.717 2.407 . . . . 0.0 110.746 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -80.04 -20.59 44.94 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.195 -1.566 . . . . 0.0 109.769 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -87.27 -37.12 17.49 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.581 -1.324 . . . . 0.0 113.528 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -130.87 162.6 54.33 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 120.09 1.314 . . . . 0.0 109.511 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.03 -172.13 0.39 Allowed 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 122.13 1.887 . . . . 0.0 108.772 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.252 19.8 mm-40 92.09 71.97 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 129.119 2.968 . . . . 0.0 113.934 177.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.456 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 18.3 Cg_endo -61.99 103.54 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.783 2.989 . . . . 0.0 111.573 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.1 t -78.01 98.7 2.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -52.75 -34.82 54.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.002 -1.686 . . . . 0.0 109.665 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.8 m -69.51 11.67 0.23 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.044 1.338 . . . . 0.0 112.564 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -133.85 -21.89 1.89 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.858 1.663 . . . . 0.0 108.683 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.4 mt -84.86 153.33 22.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.806 -1.184 . . . . 0.0 110.374 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -139.4 124.64 19.01 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.198 0.999 . . . . 0.0 110.128 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -72.21 122.42 21.02 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -75.18 141.68 43.6 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.69 178.57 8.05 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -164.62 153.0 12.43 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.83 1.252 . . . . 0.0 111.425 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.7 t -168.2 103.66 0.45 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.582 1.553 . . . . 0.0 113.226 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.47 49.3 5.24 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 126.322 1.915 . . . . 0.0 113.294 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 62.16 26.0 15.6 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -131.83 122.91 26.52 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 117.535 -1.221 . . . . 0.0 109.194 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.65 -177.86 3.37 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.969 1.258 . . . . 0.0 110.604 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.26 169.11 25.49 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 119.885 -1.759 . . . . 0.0 108.512 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -146.43 114.87 6.73 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.611 1.165 . . . . 0.0 111.293 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -108.6 126.6 53.13 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.42 1.488 . . . . 0.0 111.656 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.62 110.91 0.56 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.775 2.03 . . . . 0.0 109.995 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.6 t -60.78 -41.27 87.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 O-C-N 121.394 -0.816 . . . . 0.0 110.644 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.16 -45.34 92.28 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 119.529 -0.868 . . . . 0.0 112.264 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -128.62 86.71 56.92 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.1 156.49 65.6 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.997 1.798 . . . . 0.0 110.731 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.82 -27.12 11.46 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -95.35 140.36 30.34 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -119.07 146.34 45.16 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.575 1.55 . . . . 0.0 109.593 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.9 mm -73.74 121.3 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.294 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.15 143.09 27.26 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 118.719 -1.192 . . . . 0.0 109.91 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.4 m -94.3 -10.46 9.24 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 O-C-N 121.306 -0.871 . . . . 0.0 109.938 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.4 m 57.15 56.84 4.92 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 119.648 -1.907 . . . . 0.0 115.259 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.4 m -99.52 7.07 45.66 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -84.2 -75.03 0.36 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.49 1.116 . . . . 0.0 109.725 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -109.34 -36.51 2.1 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 118.46 60.19 0.28 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 14.0 m -84.86 167.46 26.32 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.44 149.95 87.42 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 N-CA-C 107.028 -1.951 . . . . 0.0 107.028 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.8 mt -66.72 125.11 24.79 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pp -148.42 167.39 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.404 0.682 . . . . 0.0 110.799 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 80.1 mt -81.35 159.63 24.34 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.24 127.81 11.56 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -83.28 -43.23 16.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 124.188 0.93 . . . . 0.0 110.471 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 C--O 1.236 0.342 0 CA-C-O 120.729 0.3 . . . . 0.0 111.035 -177.147 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.18 106.82 14.14 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.433 1.093 . . . . 0.0 108.557 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.07 -34.83 7.83 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.045 0.839 . . . . 0.0 110.633 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -96.52 100.0 11.61 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 127.991 2.516 . . . . 0.0 110.656 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -168.81 173.02 7.39 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.558 1.943 . . . . 0.0 110.277 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.32 -174.07 13.67 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 125.247 1.403 . . . . 0.0 110.425 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.49 169.85 16.92 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.169 0.509 . . . . 0.0 111.865 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 34.3 m -84.38 75.07 10.27 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.84 1.656 . . . . 0.0 109.998 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.74 153.32 35.14 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 68.6 mt -135.02 -165.24 1.64 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 129.852 3.261 . . . . 0.0 109.535 -177.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.5 p90 . . . . . 0 C--O 1.258 1.54 0 C-N-CA 125.721 1.608 . . . . 0.0 114.095 -178.603 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.54 146.97 45.14 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 N-CA-C 105.962 -2.361 . . . . 0.0 105.962 177.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.69 118.02 23.04 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.96 139.86 53.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -168.87 -119.18 0.48 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.8 p -150.19 177.63 9.74 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.202 1.501 . . . . 0.0 114.959 -177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.0 mt -141.79 -9.59 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 128.305 2.642 . . . . 0.0 108.253 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -58.7 -30.13 67.18 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 118.898 -2.376 . . . . 0.0 116.075 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.03 -12.96 9.32 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.44 1.496 . . . . 0.0 113.506 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.6 mt -54.97 -49.86 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 O-C-N 121.112 -0.993 . . . . 0.0 111.628 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -153.41 30.49 0.48 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.699 0.799 . . . . 0.0 109.244 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 64.59 8.0 4.11 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.127 1.771 . . . . 0.0 114.427 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.03 104.7 10.78 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 126.823 2.049 . . . . 0.0 107.022 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.5 t -82.45 175.1 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 178.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -123.07 134.23 54.27 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.788 -1.195 . . . . 0.0 108.264 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.9 t -132.51 133.46 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tp -71.88 112.5 8.03 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -130.76 127.46 38.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 120.457 1.481 . . . . 0.0 109.556 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.9 t0 43.79 56.01 4.82 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.212 1.005 . . . . 0.0 111.568 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.53 ' HB3' ' HE2' ' A' ' 88' ' ' LYS . 91.2 mt-30 57.41 22.28 7.76 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.13 139.7 32.23 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 125.242 1.417 . . . . 0.0 107.366 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.3 mt -79.36 131.31 36.08 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 120.66 -1.275 . . . . 0.0 107.816 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.2 mt -123.97 133.77 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.155 0.889 . . . . 0.0 110.086 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.91 142.57 42.04 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.58 75.16 79.84 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.245 1.418 . . . . 0.0 112.308 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.28 -74.85 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 121.746 1.63 . . . . 0.0 110.736 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -95.44 68.01 2.95 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.5 145.74 51.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -76.34 -62.54 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.54 0.686 . . . . 0.0 110.028 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 -74.27 40.94 0.13 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -75.52 165.71 24.69 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 120.794 -1.191 . . . . 0.0 108.503 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.52 144.22 20.38 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.46 166.37 28.7 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.588 2.192 . . . . 0.0 111.136 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 p -155.75 164.3 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.76 149.9 49.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mm -123.18 118.9 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.943 1.297 . . . . 0.0 110.526 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.6 135.53 37.15 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.772 1.629 . . . . 0.0 108.774 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.3 tt -131.76 135.6 46.92 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.992 1.317 . . . . 0.0 108.029 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.3 mt -141.53 147.11 22.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.35 1.06 . . . . 0.0 108.565 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 p -90.59 128.22 36.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.896 2.479 . . . . 0.0 106.301 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 74.2 m -62.2 144.34 55.6 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.428 0.558 . . . . 0.0 109.627 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -101.21 -34.36 9.7 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.237 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -88.95 41.55 1.03 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.707 1.203 . . . . 0.0 108.737 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -69.84 -13.13 16.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 O-C-N 121.708 -0.62 . . . . 0.0 111.095 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -51.67 -39.32 58.03 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.598 1.559 . . . . 0.0 112.523 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.8 t -89.38 -5.16 57.69 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.753 0.821 . . . . 0.0 112.697 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.3 mt -92.45 -145.52 0.22 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.92 1.288 . . . . 0.0 112.538 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -123.37 160.0 27.71 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 127.815 2.446 . . . . 0.0 109.958 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -137.42 -26.8 0.98 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.61 1.564 . . . . 0.0 111.967 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -61.86 -45.24 94.66 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.79 0.723 . . . . 0.0 110.268 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -58.33 -51.2 70.78 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.726 0.81 . . . . 0.0 108.823 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.3 -179.32 37.69 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 106.422 -2.671 . . . . 0.0 106.422 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -82.46 117.79 69.68 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.052 0.926 . . . . 0.0 109.489 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 108' ' ' TYR . 73.0 Cg_endo -71.93 138.29 31.01 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.981 3.12 . . . . 0.0 111.121 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.4 pt -140.73 -177.39 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.14 0.576 . . . . 0.0 110.215 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -143.21 157.95 44.05 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.976 -0.452 . . . . 0.0 110.55 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 tt -156.84 157.68 35.39 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.757 1.223 . . . . 0.0 109.446 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -164.93 -179.08 38.72 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mt -94.68 160.1 14.77 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -131.95 88.44 2.56 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.9 -40.58 0.02 OUTLIER Glycine 0 CA--C 1.523 0.538 0 CA-C-O 118.93 -0.928 . . . . 0.0 111.463 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.57 23.46 2.3 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.82 0.848 . . . . 0.0 112.731 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.2 m120 59.9 73.07 0.5 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.999 1.72 . . . . 0.0 110.228 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.09 138.55 25.42 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.768 1.227 . . . . 0.0 110.203 -177.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 16.3 m -139.93 177.42 7.98 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.837 0.744 . . . . 0.0 109.604 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 26.8 mt -61.42 151.11 33.4 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.2 ttp -155.04 148.61 25.29 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 9.3 m -124.53 126.46 45.88 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.582 ' CB ' HE21 ' A' ' 86' ' ' GLN . . . -130.47 -178.63 4.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.916 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -132.69 118.98 19.78 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.4 m -75.25 30.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 122.966 0.507 . . . . 0.0 111.276 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.42 -3.86 61.51 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.201 -0.937 . . . . 0.0 112.087 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -127.06 -57.43 1.32 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.799 1.24 . . . . 0.0 112.071 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -145.26 164.06 28.84 Favored Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 125.59 1.556 . . . . 0.0 110.943 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.94 148.96 46.38 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.302 1.334 . . . . 0.0 113.234 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.6 p -146.06 169.83 17.89 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.575 0.75 . . . . 0.0 110.348 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.74 141.76 28.32 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.913 1.285 . . . . 0.0 109.929 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.582 HE21 ' CB ' ' A' ' 77' ' ' ALA . 12.2 mt-30 -140.27 68.28 1.36 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.709 0.766 . . . . 0.0 109.682 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.492 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -85.0 106.57 16.6 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -178.577 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.53 ' HE2' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -163.37 -43.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 O-C-N 124.887 1.367 . . . . 0.0 112.251 -179.328 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -139.97 93.11 2.61 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -167.36 172.44 9.7 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.411 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -146.17 139.31 25.82 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 125.786 1.635 . . . . 0.0 109.356 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.62 -48.14 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.05 0.94 . . . . 0.0 111.057 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -60.82 -28.27 68.67 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 118.984 -0.531 . . . . 0.0 111.098 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -65.99 -51.98 53.51 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.943 0.792 . . . . 0.0 109.702 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.6 mt -63.79 -27.22 69.03 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.021 0.529 . . . . 0.0 111.332 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -82.33 -28.06 31.86 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.531 -0.731 . . . . 0.0 110.231 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -78.14 -37.21 46.61 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.894 1.278 . . . . 0.0 111.406 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -109.12 158.09 35.28 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -77.62 50.29 3.18 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.165 2.577 . . . . 0.0 111.89 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -117.05 74.5 7.18 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 124.892 1.277 . . . . 0.0 111.06 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -78.64 81.1 2.86 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.494 2.13 . . . . 0.0 107.519 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.3 t -70.27 97.95 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -51.43 -30.44 19.44 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.812 0.845 . . . . 0.0 111.76 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -64.43 -5.93 6.26 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 125.751 1.62 . . . . 0.0 112.199 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -123.49 -31.28 3.53 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.244 1.018 . . . . 0.0 109.158 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.1 mt -70.41 162.25 29.01 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.192 1.397 . . . . 0.0 112.489 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -152.2 139.68 19.61 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.152 0.981 . . . . 0.0 109.888 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER -82.98 161.59 21.72 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-N 119.858 1.208 . . . . 0.0 108.926 177.677 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -114.2 126.0 54.56 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 128.32 2.648 . . . . 0.0 112.139 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.5 t -132.35 145.88 51.57 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.29 148.57 47.32 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.185 0.994 . . . . 0.0 109.801 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.5 p -157.67 78.98 0.86 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.32 70.77 1.2 Allowed Glycine 0 N--CA 1.467 0.753 0 C-N-CA 123.958 0.79 . . . . 0.0 112.736 177.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.4 mtm-85 61.61 9.47 2.79 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.473 1.509 . . . . 0.0 112.726 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -119.72 153.4 35.69 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.2 m -139.85 151.55 45.77 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 79.6 p -114.39 174.57 5.89 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.624 0.726 . . . . 0.0 111.286 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -139.82 104.45 4.89 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.927 1.691 . . . . 0.0 106.923 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.55 130.29 56.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.668 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.6 m -53.26 126.21 20.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.107 1.363 . . . . 0.0 112.626 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 99.2 t -71.8 -42.86 69.99 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.889 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.6 91.6 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -128.02 82.04 69.21 Favored Pre-proline 0 C--O 1.234 0.254 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.07 153.38 78.33 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 108.679 -1.316 . . . . 0.0 108.679 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.09 -12.26 44.77 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.511 1.529 . . . . 0.0 110.888 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -113.22 135.48 53.78 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.13 1.772 . . . . 0.0 108.575 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -122.21 150.19 42.62 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.833 1.653 . . . . 0.0 108.463 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 22.3 mt -79.52 134.49 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 123.734 0.814 . . . . 0.0 110.1 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -104.34 124.92 50.05 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 91.7 t -72.9 -19.1 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 127.708 2.403 . . . . 0.0 113.214 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.4 m 54.34 65.58 1.47 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.176 1.39 . . . . 0.0 114.325 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.5 m -88.61 -9.75 51.08 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -58.17 -76.07 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.906 2.188 . . . . 0.0 116.906 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.93 16.11 5.83 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 125.447 1.499 . . . . 0.0 113.278 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.58 56.53 2.77 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -84.33 166.69 31.56 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 117.457 0.628 . . . . 0.0 110.213 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.55 151.32 32.64 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.96 1.773 . . . . 0.0 109.005 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.8 mt -76.51 115.29 16.12 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.499 1.12 . . . . 0.0 108.114 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.06 168.87 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 125.573 1.549 . . . . 0.0 110.713 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 74.4 mt -88.1 165.43 15.14 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.1 t -153.95 137.39 15.86 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -80.23 -41.05 25.87 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.417 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 CA--C 1.504 -0.797 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 -178.066 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.31 88.99 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 129.724 3.21 . . . . 0.0 113.298 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.5 p -111.76 -2.72 15.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.151 -0.968 . . . . 0.0 111.984 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -139.17 109.8 6.64 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.44 -176.99 6.21 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.199 1.8 . . . . 0.0 111.879 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.62 -173.7 25.84 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.537 1.541 . . . . 0.0 110.777 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.66 146.61 52.02 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.621 1.169 . . . . 0.0 109.392 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.0 m -102.8 45.83 0.95 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.331 1.453 . . . . 0.0 107.159 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -67.68 154.18 42.07 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.495 1.118 . . . . 0.0 109.238 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.2 mt -129.11 172.3 11.55 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.006 1.322 . . . . 0.0 109.591 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.8 p90 . . . . . 0 C--O 1.248 0.996 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 179.403 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 119.474 -0.298 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.1 136.05 42.87 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.084 2.523 . . . . 0.0 109.576 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.79 111.11 20.73 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -109.93 145.14 37.39 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.31 -140.17 3.19 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 119.459 1.027 . . . . 0.0 112.54 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.2 p -136.68 -175.95 4.19 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.604 1.702 . . . . 0.0 113.311 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.6 mt -144.31 -6.19 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 126.696 1.999 . . . . 0.0 109.438 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.479 ' C ' ' H ' ' A' ' 18' ' ' ILE . 4.8 pt20 -73.52 -24.32 60.13 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 119.467 -2.02 . . . . 0.0 114.43 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -72.17 36.91 0.07 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.208 3.003 . . . . 0.0 110.732 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 16' ' ' GLN . 45.4 mt -122.14 -71.14 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 128.674 2.79 . . . . 0.0 109.504 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -126.57 25.35 6.49 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 122.548 0.339 . . . . 0.0 111.383 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 64.83 35.82 8.31 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.623 0.725 . . . . 0.0 109.414 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.3 mmt-85 -104.16 81.65 1.86 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 120.838 -1.163 . . . . 0.0 109.809 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.65 134.12 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -89.95 144.66 25.73 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.8 t -144.21 131.52 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.6 tp -71.14 115.01 9.79 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -132.27 123.92 27.86 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.922 1.289 . . . . 0.0 107.731 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.3 t70 46.85 50.4 13.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.728 1.211 . . . . 0.0 112.475 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 65.86 15.76 10.19 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.2 m -137.39 152.11 49.29 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.4 mt -91.07 129.31 37.08 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 119.815 -1.803 . . . . 0.0 107.481 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.2 mm -127.73 138.16 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.407 0.683 . . . . 0.0 110.409 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.18 127.98 33.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.526 1.131 . . . . 0.0 108.73 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -111.26 99.12 42.47 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 124.601 1.16 . . . . 0.0 108.036 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.25 -32.16 8.59 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.287 1.991 . . . . 0.0 112.726 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -92.9 161.99 14.26 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.864 1.266 . . . . 0.0 109.816 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.04 19.44 12.84 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.542 1.137 . . . . 0.0 110.095 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -53.55 -50.82 64.71 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.282 1.401 . . . . 0.0 108.861 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.07 81.79 0.78 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 12.6 ptp -108.8 169.19 8.82 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.9 t -148.28 130.82 7.79 Favored Pre-proline 0 N--CA 1.45 -0.441 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -64.9 148.85 90.06 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.788 1.658 . . . . 0.0 107.86 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.5 m -142.03 171.5 10.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 125.591 1.556 . . . . 0.0 107.365 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.37 157.59 46.51 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mm -118.21 144.0 27.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 127.984 2.513 . . . . 0.0 105.271 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.02 129.92 52.85 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 126.597 1.959 . . . . 0.0 105.793 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.42 132.1 48.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.96 1.255 . . . . 0.0 107.699 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.5 mt -144.93 149.41 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.6 p -81.82 166.03 20.34 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.7 t -88.77 158.43 18.16 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -117.2 -3.8 11.47 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 177.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.532 ' HD1' ' HD3' ' A' ' 101' ' ' PRO . 9.7 t-160 -119.05 57.36 0.88 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.0 m -83.87 -11.97 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.96 0.904 . . . . 0.0 110.837 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -64.72 -6.53 8.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.56 1.944 . . . . 0.0 112.484 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.7 t -121.8 7.89 9.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.157 1.383 . . . . 0.0 110.196 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -108.24 173.05 6.49 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 120.585 -1.322 . . . . 0.0 112.006 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -79.77 154.92 28.17 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -126.44 -40.59 1.94 Allowed 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 116.938 -1.506 . . . . 0.0 110.846 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.28 -38.7 28.08 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.115 1.766 . . . . 0.0 114.177 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -65.63 -33.19 75.33 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 119.602 -0.237 . . . . 0.0 111.349 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.603 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 142.21 -178.14 21.03 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 126.381 1.943 . . . . 0.0 110.584 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -78.2 113.71 36.03 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -81.91 148.22 15.38 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 124.432 3.421 . . . . 0.0 111.592 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -149.84 -171.78 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 126.673 1.989 . . . . 0.0 109.067 178.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -132.86 147.11 52.3 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.928 2.091 . . . . 0.0 112.762 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.1 tt -156.73 134.15 10.69 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 120.474 -1.391 . . . . 0.0 109.645 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -142.02 -167.77 11.43 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mt -100.7 159.52 15.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.89 87.56 2.78 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.61 -38.33 0.03 OUTLIER Glycine 0 C--N 1.336 0.544 0 CA-C-O 117.927 -1.485 . . . . 0.0 116.082 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.78 17.2 2.68 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.852 1.826 . . . . 0.0 111.896 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.15 69.15 0.39 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.62 146.37 29.33 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 124.784 1.233 . . . . 0.0 108.684 -177.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.4 m -145.24 -175.37 4.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.324 1.05 . . . . 0.0 112.232 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.414 ' HA ' HD11 ' A' ' 87' ' ' LEU . 45.4 mt -66.64 160.5 25.34 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.2 ttp -161.69 127.56 3.66 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.3 m -96.51 119.67 35.42 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 118.314 0.506 . . . . 0.0 110.472 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -123.39 175.85 6.49 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -137.25 120.05 16.3 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.9 m -74.18 13.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.17 -23.95 34.25 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -115.32 -39.15 3.65 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -149.64 158.45 37.63 Favored Pre-proline 0 C--O 1.24 0.575 0 C-N-CA 123.785 0.834 . . . . 0.0 111.052 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -71.01 145.31 49.63 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.219 2.613 . . . . 0.0 110.194 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 42.4 p -146.55 156.92 43.6 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.458 0.703 . . . . 0.0 110.075 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mt -83.11 149.11 27.09 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.41 ' OE1' ' HE2' ' A' ' 88' ' ' LYS . 17.0 mm-40 -145.44 67.23 1.22 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.451 1.5 . . . . 0.0 109.437 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.418 HD23 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.12 112.09 19.5 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 127.63 2.372 . . . . 0.0 108.032 -177.715 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.41 ' HE2' ' OE1' ' A' ' 86' ' ' GLN . 0.1 OUTLIER -178.47 -29.28 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 O-C-N 125.21 1.569 . . . . 0.0 113.358 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -146.25 90.07 1.92 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 120.321 1.418 . . . . 0.0 113.21 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -166.9 160.1 14.07 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.564 1.546 . . . . 0.0 107.071 179.417 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.43 146.68 40.42 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.958 1.703 . . . . 0.0 107.688 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mt -96.85 -40.28 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.737 0.815 . . . . 0.0 110.707 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -27.29 68.73 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.399 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.08 -48.28 80.89 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.836 0.827 . . . . 0.0 110.707 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.1 mt -62.71 -27.99 69.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 127.598 2.359 . . . . 0.0 110.368 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -87.32 -20.25 27.05 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -88.27 -25.22 22.94 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 119.339 0.972 . . . . 0.0 112.678 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -137.75 157.43 73.48 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.807 1.243 . . . . 0.0 111.068 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.2 67.64 5.15 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 124.018 3.145 . . . . 0.0 114.124 -178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -118.07 73.27 9.59 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.12 0.968 . . . . 0.0 111.461 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.532 ' HD3' ' HD1' ' A' ' 51' ' ' HIS . 62.3 Cg_endo -80.95 77.42 4.06 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.294 2.663 . . . . 0.0 108.504 179.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.2 t -68.62 103.17 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 126.174 1.789 . . . . 0.0 108.849 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -56.3 -31.62 63.83 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.041 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.0 -9.05 42.53 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.648 1.113 . . . . 0.0 112.284 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -120.82 -18.54 7.61 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.225 0.921 . . . . 0.0 109.169 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 66.6 mt -74.69 149.58 39.84 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 119.774 -1.829 . . . . 0.0 109.724 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -139.7 129.27 24.37 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.988 0.515 . . . . 0.0 110.549 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.603 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -74.68 126.8 31.64 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 177.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -95.49 117.08 29.74 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.023 0.529 . . . . 0.0 111.265 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.1 t -112.33 -176.81 3.01 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 2.1 pt20 -150.93 147.7 27.51 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.177 2.191 . . . . 0.0 110.025 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.1 p -164.63 87.66 0.47 Allowed 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.993 1.433 . . . . 0.0 113.874 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 115' ' ' ASN . . . 78.04 70.46 1.3 Allowed Glycine 0 CA--C 1.504 -0.64 0 C-N-CA 124.899 1.238 . . . . 0.0 112.251 177.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.8 mtm-85 64.22 -2.32 0.61 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.686 1.995 . . . . 0.0 113.075 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' A' ' 113' ' ' GLY . 71.1 m-80 -111.74 165.89 11.65 Favored 'General case' 0 CA--C 1.513 -0.442 0 C-N-CA 124.885 1.274 . . . . 0.0 110.951 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 45.6 m -132.69 162.91 30.18 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.695 1.598 . . . . 0.0 110.471 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.87 170.07 16.43 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.106 0.962 . . . . 0.0 110.222 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -139.67 109.5 6.35 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.443 1.497 . . . . 0.0 108.993 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -100.78 130.02 46.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.491 1.916 . . . . 0.0 110.134 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.4 t -58.1 126.07 25.87 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.548 0.613 . . . . 0.0 109.541 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.34 -47.99 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 O-C-N 120.938 -1.101 . . . . 0.0 110.129 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.42 -37.62 65.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.254 0.479 . . . . 0.0 110.804 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -138.19 91.0 13.18 Favored Pre-proline 0 C--O 1.234 0.269 0 C-N-CA 123.502 0.721 . . . . 0.0 109.137 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.25 174.53 8.94 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.606 2.204 . . . . 0.0 112.264 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.39 -13.76 44.26 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 126.262 1.886 . . . . 0.0 111.341 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -110.2 117.69 34.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.177 0.991 . . . . 0.0 109.553 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -99.27 132.84 44.31 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 127.521 2.328 . . . . 0.0 109.326 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 pt -71.95 120.76 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 121.762 -0.586 . . . . 0.0 109.634 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.27 166.74 16.25 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 118.181 -1.408 . . . . 0.0 111.274 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.5 m -107.28 -16.29 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 C-N-CA 125.099 1.36 . . . . 0.0 112.976 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.1 m 72.63 64.98 0.12 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 122.804 1.288 . . . . 0.0 110.728 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.08 33.09 4.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.532 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -117.05 -47.69 2.67 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.725 0.41 . . . . 0.0 111.749 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -140.46 -60.21 0.04 OUTLIER Glycine 0 C--N 1.333 0.384 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.41 51.94 0.01 OUTLIER Glycine 0 C--N 1.332 0.308 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . 0.451 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 55.9 m -88.18 177.43 2.65 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.921 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 136' ' ' CYS . 42.0 Cg_endo -81.39 169.66 15.43 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.009 2.473 . . . . 0.0 111.025 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 30.3 mt -86.91 112.76 22.09 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 124.159 0.983 . . . . 0.0 110.702 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.25 -175.08 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.034 0.934 . . . . 0.0 110.15 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.09 137.03 45.94 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 15.4 t -131.19 154.36 48.48 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.562 1.545 . . . . 0.0 108.753 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -94.93 -23.36 17.45 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.373 1.469 . . . . 0.0 108.903 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 . . . . . 0 N--CA 1.441 -0.906 0 CA-C-O 123.374 1.559 . . . . 0.0 108.4 -177.757 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 . . . . . 0 C--O 1.237 0.437 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.5 m -82.69 137.34 34.47 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.523 1.929 . . . . 0.0 109.382 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 65.3 p -117.68 -23.65 7.54 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.064 1.302 . . . . 0.0 108.046 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -95.8 110.0 22.23 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.953 1.301 . . . . 0.0 113.654 -177.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -166.52 -175.14 3.08 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.235 1.814 . . . . 0.0 108.78 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -108.85 -178.04 21.61 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.417 ' C ' ' H ' ' A' ' 156' ' ' MET . 0.7 OUTLIER -124.91 131.57 53.41 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 123.739 0.816 . . . . 0.0 109.558 -179.897 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.5 m -79.0 31.85 0.21 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.384 1.474 . . . . 0.0 108.31 177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.417 ' H ' ' C ' ' A' ' 154' ' ' LEU . 4.9 ptt? -63.03 130.14 43.41 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.261 1.824 . . . . 0.0 107.928 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 21.5 mt -100.51 175.83 5.55 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 126.181 1.792 . . . . 0.0 108.753 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 23.9 p90 . . . . . 0 C--O 1.261 1.7 0 CA-C-O 115.615 -2.136 . . . . 0.0 108.924 -179.405 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.538 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.35 152.61 20.77 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.67 2.247 . . . . 0.0 108.328 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.12 124.44 27.53 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 178.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.92 133.81 55.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.82 -131.08 1.29 Allowed Glycine 0 CA--C 1.522 0.478 0 CA-C-O 116.825 -2.097 . . . . 0.0 110.259 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.7 p -154.97 -173.04 4.41 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 122.604 3.202 . . . . 0.0 114.715 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mt -136.36 -2.93 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.763 1.225 . . . . 0.0 108.712 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -56.39 -40.86 75.33 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.099 -1.626 . . . . 0.0 112.114 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -19.98 2.36 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.712 2.005 . . . . 0.0 115.393 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.6 mm -64.91 -58.68 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 123.584 0.753 . . . . 0.0 112.324 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -138.99 24.04 2.58 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.439 0.638 . . . . 0.0 110.816 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.3 t60 62.98 40.18 9.53 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.08 1.752 . . . . 0.0 108.39 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.4 mmt-85 -109.23 85.53 2.12 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.829 -1.169 . . . . 0.0 109.46 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.9 t -78.0 154.63 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 54.1 m0 -105.63 144.81 31.86 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.9 t -141.27 133.4 29.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 tt -74.56 122.61 23.38 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -131.14 119.34 21.77 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 47.0 t0 32.49 67.17 0.17 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.034 1.734 . . . . 0.0 113.876 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 60.5 17.73 7.59 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.5 m -137.97 126.57 23.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.341 1.456 . . . . 0.0 109.813 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.8 mt -77.5 136.2 38.31 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.5 pp -127.05 145.73 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 123.574 0.749 . . . . 0.0 111.861 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.28 127.79 34.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 m -103.69 89.37 2.22 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.65 -55.1 0.3 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.34 1.36 . . . . 0.0 112.731 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -154.73 95.27 1.75 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.484 0.714 . . . . 0.0 111.993 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.43 160.84 39.97 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -69.12 -34.61 75.32 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.846 0.859 . . . . 0.0 112.281 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -82.35 58.64 4.18 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.41 0.684 . . . . 0.0 110.677 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -90.02 157.92 17.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 177.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.1 m -157.98 109.84 1.75 Allowed Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 125.89 1.676 . . . . 0.0 106.517 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.99 148.2 69.5 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 N-CA-C 107.907 -1.613 . . . . 0.0 107.907 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.07 157.58 28.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.05 156.38 19.32 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.3 mm -122.62 113.22 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 128.441 2.696 . . . . 0.0 106.288 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.71 138.56 32.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tt -137.36 130.25 30.39 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.649 1.18 . . . . 0.0 108.671 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -141.09 134.74 31.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.724 1.209 . . . . 0.0 107.975 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.4 p -66.47 158.61 29.07 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.85 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.494 ' HG ' ' C ' ' A' ' 62' ' ' PRO . 5.4 m -68.79 136.99 53.62 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.214 -0.929 . . . . 0.0 112.369 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.28 -30.34 18.54 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 117.234 -1.365 . . . . 0.0 112.865 178.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -122.35 69.98 0.97 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 119.721 1.146 . . . . 0.0 110.809 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.0 m -78.98 -10.76 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 123.043 0.537 . . . . 0.0 110.986 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -55.07 -32.46 61.95 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.54 1.936 . . . . 0.0 114.247 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 t -104.58 9.03 35.5 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.973 0.909 . . . . 0.0 110.463 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.9 mt -111.16 168.24 9.66 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.612 1.165 . . . . 0.0 110.25 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.465 ' HB2' ' HH ' ' A' ' 108' ' ' TYR . 16.6 mm-40 -83.1 159.54 22.08 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.633 1.973 . . . . 0.0 108.165 177.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.4 -24.85 1.77 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.133 1.373 . . . . 0.0 110.872 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.86 -26.76 59.31 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.073 2.149 . . . . 0.0 112.808 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -96.08 -1.2 49.19 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 125.119 1.368 . . . . 0.0 114.17 -178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.07 161.13 11.03 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -79.12 123.29 84.91 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 121.524 -0.986 . . . . 0.0 109.138 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.494 ' C ' ' HG ' ' A' ' 49' ' ' CYS . 83.4 Cg_endo -74.85 151.68 40.64 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.196 2.597 . . . . 0.0 111.228 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.4 pt -146.34 -175.17 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 126.513 1.925 . . . . 0.0 109.706 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -127.29 143.18 51.28 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 129.094 2.957 . . . . 0.0 109.919 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.5 tt -154.83 148.94 25.88 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.434 -1.416 . . . . 0.0 109.221 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.44 -169.0 25.2 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 120.867 -1.146 . . . . 0.0 112.458 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.2 mt -105.51 149.93 25.79 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.92 101.7 8.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.6 -31.45 0.08 OUTLIER Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.462 -1.188 . . . . 0.0 114.006 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.25 20.84 0.75 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.736 1.768 . . . . 0.0 112.936 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.0 m120 65.89 66.64 0.49 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.79 132.35 20.94 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.232 1.013 . . . . 0.0 111.127 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 17.1 m -142.76 174.63 10.48 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 123.735 0.814 . . . . 0.0 110.283 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 45.2 mt -55.14 157.91 3.21 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 125.826 1.651 . . . . 0.0 113.644 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -166.21 150.98 8.06 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 117.519 -1.229 . . . . 0.0 108.73 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.2 m -123.05 112.11 17.37 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.559 1.144 . . . . 0.0 111.139 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.17 143.54 50.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.67 1.123 . . . . 0.0 108.246 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 83' ' ' PRO . 79.1 tttt -92.86 123.29 36.02 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.344 1.458 . . . . 0.0 109.702 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.91 -4.43 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.97 16.92 10.05 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -151.17 -61.05 0.18 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.283 1.833 . . . . 0.0 107.959 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -141.35 161.45 52.76 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.26 1.424 . . . . 0.0 112.03 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 97.8 Cg_endo -74.09 152.53 45.77 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.456 2.77 . . . . 0.0 110.333 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.6 p -146.27 161.94 39.18 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.263 1.825 . . . . 0.0 109.362 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mt -78.9 140.0 38.19 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.784 1.634 . . . . 0.0 110.795 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.35 67.19 1.46 Allowed 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.059 0.845 . . . . 0.0 110.811 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.486 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -92.06 118.6 30.96 Favored 'General case' 0 CA--C 1.493 -1.216 0 C-N-CA 125.183 1.393 . . . . 0.0 109.412 -178.219 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -179.42 -29.34 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 O-C-N 125.013 1.445 . . . . 0.0 113.618 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -146.04 102.25 3.61 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.401 1.48 . . . . 0.0 107.442 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.05 161.65 0.59 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 119.003 0.82 . . . . 0.0 109.041 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.69 153.0 52.19 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.71 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.98 -38.9 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.786 1.234 . . . . 0.0 108.989 178.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.6 tpt -64.6 -33.09 75.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.867 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.07 -40.55 87.07 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.507 1.049 . . . . 0.0 110.647 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.4 mt -65.21 -31.88 73.28 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -78.58 -29.41 46.15 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.085 0.954 . . . . 0.0 110.175 178.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -78.09 -32.73 50.8 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.656 -1.277 . . . . 0.0 113.417 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -126.21 168.66 13.54 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 119.053 0.842 . . . . 0.0 112.017 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -80.34 68.0 8.45 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.319 2.68 . . . . 0.0 109.904 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -121.55 72.8 30.01 Favored Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 121.695 -0.628 . . . . 0.0 110.426 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.24 65.13 8.89 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.853 3.035 . . . . 0.0 108.433 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.4 t -70.98 97.66 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.076 0 C-N-CA 125.142 1.377 . . . . 0.0 107.81 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -48.18 -30.43 4.64 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.202 1.401 . . . . 0.0 112.33 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 t -63.54 -14.93 56.02 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.59 1.556 . . . . 0.0 113.445 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -126.6 -4.08 6.58 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.951 1.7 . . . . 0.0 111.122 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.4 mt -95.18 151.62 19.06 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.363 1.465 . . . . 0.0 110.025 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -139.21 133.02 30.78 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.465 ' HH ' ' HB2' ' A' ' 56' ' ' GLU . 19.5 m-85 -77.94 137.09 38.14 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.652 1.115 . . . . 0.0 108.016 177.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.78 162.47 25.1 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.5 t -161.29 178.06 9.57 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 126.168 1.787 . . . . 0.0 106.346 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 2.0 pp0? -156.47 158.53 37.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.272 1.429 . . . . 0.0 109.431 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.3 p -120.28 2.62 10.85 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.63 -50.13 0.9 Allowed Glycine 0 C--N 1.336 0.531 0 O-C-N 120.532 -1.355 . . . . 0.0 110.544 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.11 -1.81 2.36 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.673 0.789 . . . . 0.0 111.633 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -130.4 168.97 16.11 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.793 1.237 . . . . 0.0 109.115 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 2.6 m -130.16 148.13 51.97 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.552 1.141 . . . . 0.0 111.873 -178.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.79 173.01 7.74 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 127.093 2.157 . . . . 0.0 111.783 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -146.01 128.84 16.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 125' ' ' GLY . 9.4 tt0 -113.52 142.27 46.14 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 126.0 1.72 . . . . 0.0 107.107 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 50.0 m -70.4 124.11 23.38 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.189 2.196 . . . . 0.0 110.985 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.7 t -69.72 -43.87 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 120.812 1.642 . . . . 0.0 112.315 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.19 -24.48 66.64 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -138.76 77.5 32.77 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 126.08 1.752 . . . . 0.0 107.207 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.51 166.21 22.58 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.787 2.325 . . . . 0.0 112.369 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.419 ' H ' ' CD ' ' A' ' 119' ' ' GLU . . . 85.86 -13.7 55.43 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.867 1.222 . . . . 0.0 111.775 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -106.48 119.91 40.53 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.286 1.834 . . . . 0.0 109.802 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -103.04 148.26 25.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.774 0.83 . . . . 0.0 110.243 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 pt -78.38 139.4 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.921 0.391 . . . . 0.0 110.891 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.94 151.75 20.98 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.0 t -106.06 -17.01 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 127.34 2.256 . . . . 0.0 111.047 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.2 m 55.34 82.42 0.1 Allowed 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 126.438 1.895 . . . . 0.0 112.695 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.2 m -111.1 -9.75 14.36 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -54.63 -61.13 2.51 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.639 1.575 . . . . 0.0 111.352 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -139.21 -85.55 0.12 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -165.98 60.82 0.23 Allowed Glycine 0 C--N 1.333 0.378 0 O-C-N 120.694 -1.474 . . . . 0.0 110.201 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.1 m -91.37 163.6 28.08 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.73 161.71 45.1 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.595 1.53 . . . . 0.0 109.779 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 20.4 mt -87.5 113.03 22.83 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.21 167.18 23.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.628 1.571 . . . . 0.0 109.391 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 80.7 mt -83.91 156.15 22.52 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.79 156.13 47.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -99.24 -46.75 5.43 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 N--CA 1.425 -1.683 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 179.441 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.409 HG23 ' CE2' ' A' ' 152' ' ' PHE . 0.2 OUTLIER -142.7 113.15 7.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 -178.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -99.48 -28.99 12.99 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.074 1.75 . . . . 0.0 110.241 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -112.41 123.93 51.36 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 123.657 0.783 . . . . 0.0 109.721 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.409 ' CE2' HG23 ' A' ' 149' ' ' THR . 0.1 OUTLIER -158.82 -170.34 3.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.002 178.38 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.42 176.8 38.79 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.22 111.97 6.46 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 24.3 m -77.16 46.77 0.51 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -73.95 120.38 19.46 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.6 mt -99.07 156.57 16.87 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 123.795 0.838 . . . . 0.0 109.626 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.7 p90 . . . . . 0 C--O 1.246 0.882 0 C-N-CA 125.111 1.364 . . . . 0.0 108.554 179.772 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptm . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -62.89 165.79 6.38 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.689 0.396 . . . . 0.0 111.692 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -78.95 -92.83 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.47 93.24 1.67 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.053 1.341 . . . . 0.0 109.444 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -133.09 174.91 9.86 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 127.82 2.448 . . . . 0.0 110.411 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -130.09 15.14 5.72 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.918 1.287 . . . . 0.0 113.271 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -130.4 26.59 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 125.869 1.668 . . . . 0.0 110.714 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -66.64 -39.02 88.08 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.383 0.673 . . . . 0.0 111.529 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -58.21 141.38 82.31 Favored Pre-proline 0 N--CA 1.45 -0.437 0 O-C-N 123.504 0.503 . . . . 0.0 110.604 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.2 138.53 61.79 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 121.476 1.451 . . . . 0.0 110.229 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.61 109.83 18.32 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.55 133.93 52.85 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.308 1.043 . . . . 0.0 109.969 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.03 -124.38 0.71 Allowed Glycine 0 CA--C 1.523 0.543 0 CA-C-O 117.458 -1.746 . . . . 0.0 109.891 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.2 p -157.96 -165.11 1.66 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 121.517 2.658 . . . . 0.0 113.604 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.9 mt -145.18 -13.8 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.056 1.342 . . . . 0.0 108.277 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -55.17 -31.88 61.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 118.067 -0.968 . . . . 0.0 112.11 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.39 -19.12 3.12 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.584 1.554 . . . . 0.0 112.893 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.4 mt -64.06 -52.5 55.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.174 1.39 . . . . 0.0 113.47 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -148.41 31.54 0.82 Allowed 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 117.931 0.332 . . . . 0.0 110.189 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.0 m80 59.97 25.36 14.54 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.071 0.949 . . . . 0.0 112.054 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.0 mmt-85 -86.71 98.53 11.19 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.382 -1.449 . . . . 0.0 108.178 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.6 t -76.58 145.05 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -105.2 132.43 51.43 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.327 1.451 . . . . 0.0 109.134 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.7 t -137.05 129.69 44.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 119.168 0.895 . . . . 0.0 108.863 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.5 112.97 11.21 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 101.161 -3.644 . . . . 0.0 101.161 176.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -129.55 120.99 26.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.705 2.002 . . . . 0.0 108.153 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.5 t0 45.31 58.23 4.29 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.305 1.442 . . . . 0.0 110.945 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 57.15 20.11 5.35 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.637 1.975 . . . . 0.0 114.913 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.3 m -134.23 143.32 47.75 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.588 0.755 . . . . 0.0 109.329 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.2 mt -90.71 124.68 35.29 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.76 136.78 56.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.685 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.45 136.21 39.41 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -124.32 68.65 49.48 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.34 -6.24 14.47 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.828 2.352 . . . . 0.0 116.304 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.67 78.41 0.7 Allowed 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.597 1.159 . . . . 0.0 109.227 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -151.36 137.29 18.14 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 121.125 -0.984 . . . . 0.0 110.42 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -68.27 -34.6 76.46 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.816 0.846 . . . . 0.0 108.735 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.68 30.3 0.65 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.166 0.987 . . . . 0.0 112.793 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.7 ptp -73.33 167.2 21.72 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.7 t -153.22 121.58 3.12 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.12 151.21 49.24 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 N-CA-C 108.632 -1.334 . . . . 0.0 108.632 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.95 -174.35 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.19 154.87 50.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mm -126.72 111.44 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 C-N-CA 126.901 2.08 . . . . 0.0 108.384 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.74 130.47 41.25 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.509 1.924 . . . . 0.0 107.64 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -126.09 131.62 52.08 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.304 1.842 . . . . 0.0 108.894 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -149.36 145.86 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 124.838 1.255 . . . . 0.0 110.664 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.79 156.38 38.97 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 125.79 1.636 . . . . 0.0 109.001 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 85.4 m -92.78 106.47 18.44 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -67.99 -14.89 63.32 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -98.93 29.88 3.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.988 0.813 . . . . 0.0 111.21 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -62.4 -7.41 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 126.228 1.811 . . . . 0.0 113.251 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -55.75 -35.63 66.41 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.072 0.949 . . . . 0.0 112.614 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -98.56 0.52 45.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.774 1.23 . . . . 0.0 112.491 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -91.0 171.39 9.3 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 123.077 1.418 . . . . 0.0 109.616 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -74.85 157.01 35.83 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.421 -1.718 . . . . 0.0 107.453 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -129.29 -40.32 1.46 Allowed 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.703 -0.665 . . . . 0.0 109.956 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -50.63 -54.3 23.92 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.262 1.425 . . . . 0.0 113.313 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -60.39 -31.23 70.16 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.975 0.91 . . . . 0.0 112.293 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.24 169.45 11.75 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 125.886 1.708 . . . . 0.0 109.828 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -69.76 112.07 11.06 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 127.284 2.234 . . . . 0.0 115.763 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -80.98 131.78 8.12 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.714 2.943 . . . . 0.0 110.302 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 pp -137.82 178.44 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -134.92 153.77 51.94 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.712 1.142 . . . . 0.0 112.15 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.5 tt -145.68 157.03 44.0 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.284 1.434 . . . . 0.0 110.039 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.4 176.01 35.42 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.51 140.86 29.29 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -107.51 118.91 37.96 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 159.67 -75.67 0.2 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.02 19.59 14.86 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 60.94 72.41 0.52 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.952 1.251 . . . . 0.0 109.626 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.59 136.01 22.89 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.034 0.934 . . . . 0.0 110.381 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 17.7 m -144.97 169.67 17.63 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.184 -0.947 . . . . 0.0 110.534 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.5 mt -53.37 148.32 9.1 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.086 0.469 . . . . 0.0 110.39 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.0 ttp -160.71 120.99 2.81 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 93.4 m -82.12 138.15 34.83 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.2 -177.56 4.76 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.202 2.201 . . . . 0.0 106.845 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -143.8 140.5 29.92 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.9 m -90.15 26.64 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.45 5.9 56.59 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.259 0.933 . . . . 0.0 111.648 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -131.48 -57.03 1.01 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.976 1.71 . . . . 0.0 110.624 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -145.14 157.18 54.05 Favored Pre-proline 0 C--O 1.239 0.552 0 C-N-CA 124.416 1.086 . . . . 0.0 110.421 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.06 149.66 88.93 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.897 3.065 . . . . 0.0 113.639 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.1 p -148.61 168.35 23.04 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.908 1.683 . . . . 0.0 110.708 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mt -97.24 149.24 22.26 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.461 1.104 . . . . 0.0 108.856 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -143.83 78.1 1.58 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.43 94.1 9.76 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.69 -48.7 0.19 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.047 0.84 . . . . 0.0 112.6 -177.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -135.28 105.67 6.38 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.713 1.605 . . . . 0.0 107.486 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.06 154.87 0.91 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -127.66 139.98 52.38 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.0 pt -94.83 -41.51 12.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.835 1.654 . . . . 0.0 111.773 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.0 tpt -66.52 -23.14 66.19 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.757 0.708 . . . . 0.0 110.109 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.32 -52.48 18.53 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.525 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.1 mt -60.61 -26.22 66.83 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.175 0.988 . . . . 0.0 112.367 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -75.63 -51.19 13.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -59.67 -46.99 87.37 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.041 1.336 . . . . 0.0 112.67 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -100.74 148.92 35.68 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.706 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -75.4 68.01 6.15 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.036 2.491 . . . . 0.0 109.532 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -128.12 68.19 75.83 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 126.074 1.75 . . . . 0.0 108.556 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -77.55 83.0 2.25 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.608 2.205 . . . . 0.0 106.552 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.4 t -78.17 103.14 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -52.37 -30.56 29.47 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.914 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.05 -15.67 34.99 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.136 0.88 . . . . 0.0 111.982 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -117.72 -15.91 10.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.584 1.154 . . . . 0.0 110.326 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.4 mt -83.59 152.61 24.74 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.27 1.396 . . . . 0.0 111.103 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -139.15 128.42 24.08 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.066 0.947 . . . . 0.0 110.697 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.55 123.73 21.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -94.8 136.21 35.37 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 t -135.88 -177.99 4.93 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.976 1.311 . . . . 0.0 109.596 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -159.65 146.51 16.52 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.734 1.214 . . . . 0.0 109.637 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.17 76.34 1.32 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 124.463 1.102 . . . . 0.0 111.821 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.89 78.84 0.82 Allowed Glycine 0 C--N 1.335 0.509 0 O-C-N 121.152 -0.968 . . . . 0.0 112.065 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 56.51 13.76 1.45 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.359 1.464 . . . . 0.0 112.763 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -121.26 151.82 39.58 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.3 m -125.25 148.45 48.66 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 125.636 1.574 . . . . 0.0 106.957 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.99 157.05 47.04 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -138.83 116.11 11.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.673 1.189 . . . . 0.0 107.833 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -112.24 133.01 54.61 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.881 1.273 . . . . 0.0 110.089 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.9 m -52.31 122.22 8.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.886 2.074 . . . . 0.0 110.458 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.7 t -73.34 -46.09 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 O-C-N 120.105 -1.622 . . . . 0.0 110.869 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.76 -30.83 71.88 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.034 0.834 . . . . 0.0 111.146 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -133.94 81.51 51.76 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 123.747 0.819 . . . . 0.0 110.746 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.16 159.89 44.69 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 N-CA-C 108.421 -1.415 . . . . 0.0 108.421 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.45 -17.78 30.76 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.062 0.839 . . . . 0.0 112.22 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 30.9 m-90 -119.0 141.63 48.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.018 1.727 . . . . 0.0 111.245 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -118.5 142.44 47.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 128.82 2.848 . . . . 0.0 111.414 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.4 mt -69.01 134.18 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.4 114.5 28.72 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.537 0.608 . . . . 0.0 110.112 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.3 m -63.93 -19.15 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.5 m 61.19 63.6 1.21 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.953 1.835 . . . . 0.0 115.953 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 54.5 m -104.43 6.07 34.71 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 125.745 1.618 . . . . 0.0 113.18 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -82.01 -106.64 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.121 1.368 . . . . 0.0 107.563 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.42 -52.13 11.16 Favored Glycine 0 C--N 1.337 0.605 0 O-C-N 120.849 -1.157 . . . . 0.0 112.911 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 141.63 62.77 0.03 OUTLIER Glycine 0 CA--C 1.525 0.69 0 N-CA-C 106.491 -2.644 . . . . 0.0 106.491 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 19.6 m -93.56 166.96 14.86 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 119.105 -0.474 . . . . 0.0 110.701 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.14 157.64 46.16 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.746 2.964 . . . . 0.0 110.352 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.2 mt -76.84 111.59 12.54 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.79 179.77 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 125.861 1.664 . . . . 0.0 110.587 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -110.6 144.74 39.01 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.3 t -134.78 152.7 51.96 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -107.38 -32.73 7.63 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -153.2 136.99 16.13 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.4 pp -132.46 155.11 49.13 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.427 -1.715 . . . . 0.0 107.652 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -114.4 65.4 0.28 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 105.689 -2.964 . . . . 0.0 105.689 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? 41.74 45.02 2.95 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 127.573 2.349 . . . . 0.0 110.746 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -117.13 -11.17 10.74 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.834 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.47 -179.47 5.38 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.98 96.11 4.82 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.605 0.762 . . . . 0.0 110.626 -177.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.5 p -98.52 -32.57 11.39 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.85 96.39 10.37 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.717 1.607 . . . . 0.0 112.374 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.42 175.66 13.43 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.805 -1.184 . . . . 0.0 112.661 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.79 -166.89 29.47 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.5 tp -137.67 161.59 36.09 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.31 34.46 5.21 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -63.38 140.38 58.87 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 18.0 mt -123.18 166.33 15.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 17.7 p90 . . . . . 0 C--O 1.244 0.796 0 CA-C-O 116.482 -1.723 . . . . 0.0 107.469 178.965 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ppp? . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -132.56 165.71 23.77 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.874 1.67 . . . . 0.0 109.363 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -75.52 29.48 0.1 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.717 1.207 . . . . 0.0 113.559 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 52.94 40.47 31.04 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.517 1.927 . . . . 0.0 113.335 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -104.27 -170.25 1.74 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.55 1.54 . . . . 0.0 108.447 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -157.74 -35.18 0.07 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.886 1.274 . . . . 0.0 112.398 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pp -60.55 -36.4 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 128.632 2.773 . . . . 0.0 113.225 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 48.12 26.61 1.06 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.896 2.079 . . . . 0.0 113.876 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -68.59 152.03 96.9 Favored Pre-proline 0 C--O 1.235 0.291 0 O-C-N 120.986 -1.071 . . . . 0.0 109.487 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.04 129.56 15.38 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.84 1.693 . . . . 0.0 108.019 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.55 115.21 29.49 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.61 135.65 53.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.966 0.506 . . . . 0.0 110.823 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.87 -125.82 0.8 Allowed Glycine 0 N--CA 1.46 0.246 0 CA-C-O 117.882 -1.51 . . . . 0.0 109.979 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.6 p -157.03 -173.97 4.7 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 120.276 2.038 . . . . 0.0 112.709 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.4 mt -141.98 -19.07 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.92 1.688 . . . . 0.0 108.437 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.468 HE21 HG23 ' A' ' 22' ' ' VAL . 5.9 pt20 -47.52 -39.99 17.56 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.147 -0.971 . . . . 0.0 113.459 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -51.32 -33.49 29.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.847 2.059 . . . . 0.0 114.866 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.4 mm -41.94 -55.44 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 127.146 2.178 . . . . 0.0 111.047 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.64 26.48 2.11 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.709 -0.619 . . . . 0.0 109.54 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 33.9 m80 60.46 25.05 14.64 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.34 2.256 . . . . 0.0 113.279 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.409 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 20.2 mmt180 -83.58 85.07 7.32 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 126.966 2.106 . . . . 0.0 107.493 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.468 HG23 HE21 ' A' ' 16' ' ' GLN . 93.6 t -69.5 136.7 25.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 120.726 -1.233 . . . . 0.0 108.572 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -95.59 135.01 37.81 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.722 1.209 . . . . 0.0 111.701 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.4 t -141.91 131.28 23.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.74 95.2 3.39 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -106.94 120.02 40.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 119.619 1.099 . . . . 0.0 108.506 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.6 t0 42.06 65.84 0.82 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.267 1.427 . . . . 0.0 111.615 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 57.3 8.7 0.61 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.679 1.591 . . . . 0.0 114.861 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 m -124.81 133.1 53.25 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 125.185 1.394 . . . . 0.0 110.129 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.8 mt -82.88 122.42 28.23 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -125.72 144.39 35.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.19 133.2 34.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -128.14 64.14 65.12 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.665 1.986 . . . . 0.0 111.435 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -58.14 -56.77 1.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.343 1.362 . . . . 0.0 111.693 178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.6 mtp85 -117.73 109.0 16.08 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.558 1.072 . . . . 0.0 109.105 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -167.92 -162.44 0.43 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.668 1.187 . . . . 0.0 109.135 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -122.81 -50.56 1.95 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -66.13 20.66 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.66 1.984 . . . . 0.0 114.977 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.7 ptp -74.59 -178.8 3.74 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 120.49 -1.381 . . . . 0.0 109.434 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 t -174.24 128.34 0.45 Allowed Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.79 146.05 33.09 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 N-CA-C 107.224 -1.875 . . . . 0.0 107.224 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 m -133.45 171.19 18.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.63 163.92 16.65 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.3 mm -131.18 108.42 14.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 127.18 2.192 . . . . 0.0 108.472 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.49 124.75 44.93 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.194 1.398 . . . . 0.0 108.521 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 tt -117.2 138.06 51.94 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.308 1.843 . . . . 0.0 108.744 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 mt -142.2 146.09 22.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 126.498 1.919 . . . . 0.0 108.291 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 p -84.16 145.23 28.5 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.522 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 55.7 m -66.85 107.86 2.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.936 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.75 7.87 9.34 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.577 -1.327 . . . . 0.0 111.564 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.71 29.33 5.03 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.552 2.341 . . . . 0.0 113.624 -177.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.41 -7.83 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 O-C-N 120.078 -1.639 . . . . 0.0 114.312 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -48.41 -51.44 26.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 119.528 1.058 . . . . 0.0 112.594 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 t -82.21 2.7 30.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.713 1.205 . . . . 0.0 112.568 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.6 mt -104.69 176.17 5.25 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 120.356 -1.465 . . . . 0.0 112.017 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -93.02 151.84 19.66 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.599 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -124.03 -25.53 4.19 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.847 1.259 . . . . 0.0 110.018 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -61.81 -20.62 63.83 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.418 0.687 . . . . 0.0 111.05 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -75.99 -20.56 57.77 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.133 0.973 . . . . 0.0 111.143 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.4 -103.41 0.4 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 125.962 1.744 . . . . 0.0 111.574 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -144.76 99.07 4.78 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.581 -0.952 . . . . 0.0 112.885 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.62 131.37 18.55 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.377 2.051 . . . . 0.0 110.682 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pt -143.53 -178.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.802 0.841 . . . . 0.0 109.244 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.407 ' CD1' HD12 ' A' ' 95' ' ' LEU . 4.3 t80 -136.57 134.92 37.97 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.999 0.92 . . . . 0.0 110.076 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 tt -138.43 152.16 48.09 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.994 1.318 . . . . 0.0 109.214 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.56 174.51 33.61 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mt -88.58 139.12 30.8 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -109.46 102.09 10.99 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.87 -26.37 0.09 OUTLIER Glycine 0 CA--C 1.529 0.953 0 CA-C-O 117.945 -1.475 . . . . 0.0 113.335 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.01 19.84 0.58 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.643 1.722 . . . . 0.0 114.421 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.2 m120 62.51 62.1 1.16 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.385 1.474 . . . . 0.0 110.91 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.9 133.72 37.98 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.76 1.224 . . . . 0.0 109.299 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.8 m -136.64 174.65 10.39 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.654 0.661 . . . . 0.0 111.896 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.9 mt -64.6 150.22 47.36 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.782 0.433 . . . . 0.0 111.378 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.441 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 1.4 tmm? -160.85 144.67 13.49 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 117.999 -1.0 . . . . 0.0 108.516 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -110.98 122.38 47.75 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.961 0.788 . . . . 0.0 110.103 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.86 135.16 29.26 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.078 0.951 . . . . 0.0 110.652 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -70.02 117.79 12.03 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.0 p -69.68 -24.21 26.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.813 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.89 -70.34 0.11 Allowed Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 105.357 -3.097 . . . . 0.0 105.357 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -97.36 -23.1 16.26 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -145.4 159.53 48.17 Favored Pre-proline 0 CA--C 1.536 0.405 0 O-C-N 121.374 -0.829 . . . . 0.0 112.891 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.4 148.01 72.67 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.565 2.843 . . . . 0.0 111.681 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.5 p -145.56 170.45 16.4 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.038 1.735 . . . . 0.0 108.668 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.6 mt -83.96 150.88 25.37 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 122.493 0.317 . . . . 0.0 110.687 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -144.91 64.29 1.28 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.109 0.964 . . . . 0.0 110.029 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.06 118.96 25.85 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -171.66 -42.91 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.689 0.677 . . . . 0.0 112.269 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -134.49 101.99 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.852 1.261 . . . . 0.0 109.988 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 75' ' ' MET . 0.2 OUTLIER -163.82 171.36 15.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.696 1.589 . . . . 0.0 109.667 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -142.3 109.85 5.72 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.6 pt -70.77 -36.93 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 121.538 -0.726 . . . . 0.0 111.168 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -29.16 65.66 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.332 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -67.0 -50.0 63.59 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 118.61 0.641 . . . . 0.0 109.808 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.407 HD12 ' CD1' ' A' ' 64' ' ' TYR . 21.3 mt -64.28 -30.52 71.56 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -76.06 -26.85 56.93 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.545 -0.722 . . . . 0.0 109.849 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -86.87 -28.29 22.93 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -129.26 164.82 36.76 Favored Pre-proline 0 N--CA 1.456 -0.168 0 CA-C-N 121.177 1.808 . . . . 0.0 110.736 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.66 -161.65 0.13 Allowed 'Trans proline' 0 N--CA 1.445 -1.357 0 N-CA-C 107.109 -1.92 . . . . 0.0 107.109 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 77.46 70.75 0.2 Allowed Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 127.096 2.158 . . . . 0.0 109.859 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.17 107.45 0.66 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.517 2.145 . . . . 0.0 109.788 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 t -81.1 91.98 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -48.51 -32.32 7.73 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 125.021 1.328 . . . . 0.0 112.965 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.6 m -62.66 -14.33 42.31 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.333 1.053 . . . . 0.0 113.561 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -115.31 -20.87 10.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.319 1.448 . . . . 0.0 110.747 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.8 mt -80.92 154.23 27.13 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.776 0.83 . . . . 0.0 111.286 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -141.69 138.97 32.81 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.281 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -81.46 131.28 35.27 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.43 119.99 32.49 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 125.84 1.656 . . . . 0.0 107.726 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 t -123.1 -172.17 2.45 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -154.15 136.28 14.76 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.28 1.032 . . . . 0.0 108.576 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.98 69.74 1.45 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.78 -177.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' A' ' 115' ' ' ASN . . . 85.31 70.04 1.34 Allowed Glycine 0 C--N 1.338 0.656 0 O-C-N 121.274 -0.892 . . . . 0.0 113.675 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? 67.39 -10.37 0.35 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 128.013 2.525 . . . . 0.0 112.978 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.476 ' H ' ' C ' ' A' ' 113' ' ' GLY . 14.5 m120 -107.39 144.14 34.72 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.181 0.992 . . . . 0.0 108.641 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.55 150.91 22.59 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.519 0.728 . . . . 0.0 110.929 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.61 166.86 12.21 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.518 1.927 . . . . 0.0 110.123 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -139.11 118.47 12.81 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -120.78 131.46 54.49 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.161 0.984 . . . . 0.0 110.248 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.8 t -52.99 116.94 2.62 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.778 1.631 . . . . 0.0 110.842 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.16 -45.82 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 119.227 0.921 . . . . 0.0 110.816 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.03 -26.49 68.58 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.555 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -145.9 87.19 6.86 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 119.202 0.91 . . . . 0.0 111.575 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -58.05 166.35 5.69 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.52 2.813 . . . . 0.0 114.032 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.65 -4.35 86.29 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 117.463 -1.743 . . . . 0.0 114.219 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 42.0 m95 -120.16 131.35 54.98 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.891 1.846 . . . . 0.0 107.843 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -114.9 144.37 43.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 126.037 1.735 . . . . 0.0 111.22 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 13.1 mt -77.11 123.32 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.737 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.74 120.09 32.17 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.38 0.609 . . . . 0.0 110.646 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.72 -23.29 27.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 C-N-CA 128.211 2.604 . . . . 0.0 111.051 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.458 ' HG ' ' CD2' ' A' ' 138' ' ' LEU . 1.4 m 60.9 87.0 0.09 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.911 1.339 . . . . 0.0 109.128 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.409 ' HA ' ' HG3' ' A' ' 21' ' ' ARG 0.271 1.7 m -109.76 4.1 21.48 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.696 -178.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -111.72 160.66 17.07 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 25.6 -87.54 0.01 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 128.043 2.735 . . . . 0.0 114.422 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -177.45 60.71 0.09 OUTLIER Glycine 0 CA--C 1.521 0.415 0 CA-C-O 117.795 -1.559 . . . . 0.0 109.38 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 4.9 m -85.08 161.42 52.53 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 119.455 1.627 . . . . 0.0 112.826 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.22 155.43 37.37 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 N-CA-C 108.553 -1.364 . . . . 0.0 108.553 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.458 ' CD2' ' HG ' ' A' ' 131' ' ' SER . 13.0 mt -82.98 112.22 19.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 pp -138.0 -173.15 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.975 1.71 . . . . 0.0 109.843 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.4 mt -109.14 156.8 19.41 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.609 1.164 . . . . 0.0 108.244 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.37 136.66 21.24 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -81.24 -40.51 23.67 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.895 0.878 . . . . 0.0 110.855 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -161.21 100.75 1.22 Allowed 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.3 pp -81.78 163.69 22.21 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.387 1.075 . . . . 0.0 111.852 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.29 55.11 0.52 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 124.446 1.022 . . . . 0.0 110.825 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.71 33.6 14.29 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.515 1.526 . . . . 0.0 111.545 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -122.61 -22.66 5.34 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.895 0.878 . . . . 0.0 112.889 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -110.72 145.53 37.87 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.43 100.41 10.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.101 0.56 . . . . 0.0 109.588 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.7 p -95.78 -17.77 20.93 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -115.97 131.81 56.83 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.004 1.322 . . . . 0.0 110.013 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . 0.334 0.1 OUTLIER -163.49 -135.75 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 119.066 -0.492 . . . . 0.0 112.153 177.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -146.22 179.33 23.3 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 125.794 1.664 . . . . 0.0 109.363 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.78 122.29 17.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.351 1.075 . . . . 0.0 110.725 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.3 m -79.42 34.72 0.26 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.602 1.561 . . . . 0.0 107.987 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 3.3 ptt? -63.01 131.96 50.39 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 119.865 -1.772 . . . . 0.0 107.665 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 25.5 mt -109.25 165.95 11.23 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.351 1.06 . . . . 0.0 110.841 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 14.7 p90 . . . . . 0 C--O 1.254 1.335 0 C-N-CA 127.099 2.16 . . . . 0.0 107.694 179.894 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 ptm . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -80.46 -172.14 3.41 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.51 0.724 . . . . 0.0 110.351 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -82.69 44.21 0.89 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.718 1.207 . . . . 0.0 113.579 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 40.0 42.57 1.12 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.658 1.583 . . . . 0.0 112.99 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -69.21 -177.92 1.2 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 113.479 -1.691 . . . . 0.0 108.588 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -145.53 1.9 0.94 Allowed 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pp -86.65 -25.79 6.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 124.732 1.213 . . . . 0.0 110.837 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -143.04 110.32 5.7 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 101.396 -3.557 . . . . 0.0 101.396 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.58 149.88 72.11 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 121.874 2.125 . . . . 0.0 111.534 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.39 115.71 3.49 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 124.446 3.431 . . . . 0.0 110.252 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.76 118.59 35.84 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.031 0.933 . . . . 0.0 111.816 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -106.5 133.68 50.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.08 0.552 . . . . 0.0 111.18 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -157.82 -139.06 2.63 Favored Glycine 0 C--O 1.225 -0.429 0 O-C-N 120.825 -1.172 . . . . 0.0 112.921 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -151.87 169.39 22.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.927 0.863 . . . . 0.0 112.055 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 47.3 mt -121.29 -5.59 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 O-C-N 121.236 -0.915 . . . . 0.0 111.001 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -53.1 -34.29 56.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.733 1.213 . . . . 0.0 110.732 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -51.91 -2.8 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 131.339 3.856 . . . . 0.0 115.693 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.5 mm -93.07 -80.46 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.611 1.964 . . . . 0.0 108.888 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -119.29 29.81 7.45 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.818 0.847 . . . . 0.0 112.705 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.7 t60 61.53 25.73 15.6 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.783 2.033 . . . . 0.0 112.428 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -86.36 92.15 8.73 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 120.303 -1.498 . . . . 0.0 110.808 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.4 t -69.43 141.91 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -107.78 144.05 35.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.5 t -141.78 129.31 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 tp -72.33 106.83 4.63 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.405 ' NE2' HH11 ' A' ' 38' ' ' ARG . 0.7 OUTLIER -127.73 127.39 43.56 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.629 0.772 . . . . 0.0 108.956 -178.102 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t70 56.25 27.35 11.63 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 76.28 17.54 2.01 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 129.839 3.256 . . . . 0.0 112.892 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.42 131.41 43.58 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.082 1.353 . . . . 0.0 108.161 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.3 mt -75.42 115.96 15.63 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 120.603 -1.311 . . . . 0.0 107.71 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.01 144.19 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.337 0.655 . . . . 0.0 109.378 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.96 126.4 31.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.81 1.244 . . . . 0.0 109.446 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -126.86 70.13 73.22 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.135 1.774 . . . . 0.0 109.465 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.13 -30.67 37.88 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.843 1.695 . . . . 0.0 114.283 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -148.1 82.5 1.49 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -146.45 158.72 43.93 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 123.473 0.709 . . . . 0.0 109.222 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -76.82 -48.91 17.09 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.699 1.249 . . . . 0.0 108.905 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.405 HH11 ' NE2' ' A' ' 26' ' ' GLN . 14.0 ttm180 -77.4 52.65 0.97 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.608 1.563 . . . . 0.0 112.494 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -108.66 165.05 11.83 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.08 -1.013 . . . . 0.0 111.072 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -156.09 134.17 7.1 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.236 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.45 126.14 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.985 2.456 . . . . 0.0 108.323 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.9 m -121.58 161.09 22.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 125.065 1.346 . . . . 0.0 109.733 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.71 161.19 17.8 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.6 mm -130.2 100.98 5.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 129.282 3.033 . . . . 0.0 109.318 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.48 110.63 21.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.725 2.01 . . . . 0.0 108.163 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tt -107.91 140.53 40.88 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.813 2.045 . . . . 0.0 109.791 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -148.57 153.08 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.943 1.297 . . . . 0.0 109.841 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.4 p -96.88 127.35 42.76 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.184 1.394 . . . . 0.0 110.013 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 55.8 m -54.02 133.03 43.55 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.159 0.984 . . . . 0.0 109.133 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -98.95 -18.12 17.99 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 117.345 -1.312 . . . . 0.0 113.573 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -105.11 41.8 1.3 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.286 1.035 . . . . 0.0 108.772 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.5 m -69.31 -6.98 7.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 O-C-N 120.248 -1.533 . . . . 0.0 114.011 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -56.06 -46.52 78.93 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.172 0.989 . . . . 0.0 111.856 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.0 t -83.46 0.66 45.3 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.7 mt -98.23 174.9 6.28 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.947 -1.096 . . . . 0.0 109.625 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -77.99 155.97 30.44 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.679 -1.6 . . . . 0.0 109.371 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.79 -34.62 2.38 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.869 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.68 -38.52 85.24 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.318 0.963 . . . . 0.0 110.597 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -68.26 -18.52 64.57 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.87 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.473 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 119.18 174.52 15.85 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 126.103 1.811 . . . . 0.0 110.745 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -69.53 114.76 26.62 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.716 0.806 . . . . 0.0 111.829 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -84.16 138.07 7.58 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.423 2.749 . . . . 0.0 110.035 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -140.05 -179.04 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 123.977 0.911 . . . . 0.0 109.681 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -138.22 155.72 48.39 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 122.338 1.066 . . . . 0.0 109.393 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.22 151.86 30.56 Favored 'General case' 0 CA--C 1.507 -0.684 0 O-C-N 120.938 -1.101 . . . . 0.0 108.136 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.17 -179.89 24.5 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.119 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 mt -92.09 169.84 10.31 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -137.3 115.05 11.32 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 120.847 -1.158 . . . . 0.0 109.557 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 155.38 -28.63 0.62 Allowed Glycine 0 CA--C 1.527 0.819 0 CA-C-O 117.992 -1.449 . . . . 0.0 112.756 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.01 30.03 0.88 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.577 1.689 . . . . 0.0 112.123 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.2 m120 51.32 74.92 0.22 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.333 1.853 . . . . 0.0 112.51 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.03 141.82 34.27 Favored 'General case' 0 CA--C 1.517 -0.296 0 O-C-N 121.307 -0.87 . . . . 0.0 109.322 -178.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.7 m -141.76 175.17 9.92 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.421 0.555 . . . . 0.0 111.007 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.433 ' HA ' ' CD2' ' A' ' 87' ' ' LEU . 12.5 mt -63.24 156.71 24.65 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.3 ttp -163.64 134.43 4.53 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.2 m -93.67 132.13 38.3 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.78 131.16 19.7 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.899 0.88 . . . . 0.0 108.98 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -87.45 138.82 31.15 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.152 0.887 . . . . 0.0 109.737 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.9 m -92.37 38.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.46 -51.74 4.25 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -83.13 -54.93 4.66 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -138.08 160.75 63.06 Favored Pre-proline 0 N--CA 1.471 0.617 0 C-N-CA 125.111 1.364 . . . . 0.0 112.649 -176.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.28 151.42 43.33 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.906 2.404 . . . . 0.0 110.707 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 71.1 p -144.84 179.33 7.39 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.876 1.671 . . . . 0.0 108.856 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.15 139.97 38.46 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 127.089 2.156 . . . . 0.0 107.075 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -140.48 72.0 1.38 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.433 ' CD2' ' HA ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -90.28 104.04 16.66 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 127.994 2.518 . . . . 0.0 107.669 -178.168 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.54 -25.58 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -146.72 81.67 1.56 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.838 1.255 . . . . 0.0 111.389 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -162.89 161.1 25.7 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 120.102 -1.624 . . . . 0.0 108.621 179.326 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -137.39 139.9 41.03 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.092 1.757 . . . . 0.0 108.201 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.6 mt -89.45 -42.65 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 126.058 1.743 . . . . 0.0 109.015 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.73 -34.83 63.01 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.468 1.507 . . . . 0.0 111.758 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -62.78 -61.88 2.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.6 1.96 . . . . 0.0 107.976 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 37.7 mt -60.9 -22.37 64.27 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -87.77 -33.57 18.62 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.517 0.727 . . . . 0.0 109.206 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -69.64 -43.65 72.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.202 -0.904 . . . . 0.0 109.145 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.9 152.69 38.21 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 118.713 -0.661 . . . . 0.0 109.813 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.09 38.49 0.54 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.923 3.082 . . . . 0.0 113.936 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -112.55 82.13 4.62 Favored Pre-proline 0 C--O 1.235 0.312 0 O-C-N 120.877 -1.139 . . . . 0.0 112.905 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.43 102.57 1.62 Allowed 'Trans proline' 0 N--CA 1.443 -1.444 0 N-CA-C 106.048 -2.328 . . . . 0.0 106.048 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.4 t -89.29 105.09 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -48.78 -31.26 6.72 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.366 1.466 . . . . 0.0 112.006 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.4 t -62.53 -13.58 32.29 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.6 1.16 . . . . 0.0 112.852 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -121.97 -2.09 9.26 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 119.789 1.177 . . . . 0.0 110.351 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.7 mt -94.91 153.91 17.46 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.605 1.093 . . . . 0.0 110.975 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -138.43 129.41 26.89 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.765 0.826 . . . . 0.0 109.721 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.473 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -71.13 127.26 31.99 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 104.405 -2.442 . . . . 0.0 104.405 177.787 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -103.88 131.87 50.68 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.11 -178.64 5.24 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.924 0.868 . . . . 0.0 109.948 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 0.0 OUTLIER -151.91 138.67 18.86 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.932 2.093 . . . . 0.0 107.808 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.48 70.33 1.17 Allowed 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.193 0.933 . . . . 0.0 112.472 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.46 64.12 0.93 Allowed Glycine 0 CA--C 1.525 0.686 0 O-C-N 121.787 -0.57 . . . . 0.0 114.198 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 67.71 -0.6 1.9 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.722 2.009 . . . . 0.0 113.24 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -120.01 155.11 33.51 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.386 1.474 . . . . 0.0 107.608 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 69.8 m -115.01 166.6 11.62 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.77 2.028 . . . . 0.0 110.559 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.61 164.46 32.58 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.504 1.121 . . . . 0.0 111.095 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -141.75 116.37 9.69 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 125.081 1.352 . . . . 0.0 110.605 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -115.16 122.94 47.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.635 1.574 . . . . 0.0 110.361 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.0 m -49.42 124.13 8.77 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.392 1.477 . . . . 0.0 112.488 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.5 t -70.0 -44.69 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 120.146 -1.596 . . . . 0.0 111.936 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.88 -25.56 67.23 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.398 -0.814 . . . . 0.0 112.971 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -140.39 80.17 19.67 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 125.381 1.472 . . . . 0.0 108.489 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -64.53 151.72 84.49 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.148 1.899 . . . . 0.0 110.123 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.48 -32.88 6.76 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.519 2.009 . . . . 0.0 110.211 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 25.5 m-90 -88.19 106.66 18.34 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 124.626 1.17 . . . . 0.0 111.006 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -91.03 152.8 20.53 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.724 1.21 . . . . 0.0 110.148 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.4 mt -82.25 131.71 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.29 132.85 43.43 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.18 0.446 . . . . 0.0 109.813 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -81.96 -15.38 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 127.06 2.144 . . . . 0.0 111.885 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.7 m 63.29 52.28 2.47 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.914 1.285 . . . . 0.0 113.729 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.3 m -89.31 24.22 2.27 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -96.01 -83.11 0.38 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.105 0.411 . . . . 0.0 110.352 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -103.68 -44.88 1.6 Allowed Glycine 0 C--N 1.336 0.583 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.08 63.52 0.02 OUTLIER Glycine 0 CA--C 1.521 0.433 0 N-CA-C 106.264 -2.734 . . . . 0.0 106.264 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 60.9 m -82.37 170.94 13.11 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.358 1.063 . . . . 0.0 110.113 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.2 153.13 16.32 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.859 1.706 . . . . 0.0 109.127 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 16.6 mt -75.52 106.16 6.93 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.93 171.42 15.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 124.347 1.059 . . . . 0.0 111.338 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 89.6 mt -84.83 156.12 21.46 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.8 t -146.11 136.16 23.6 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -85.56 -35.94 20.75 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.563 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -169.9 62.28 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.671 1.123 . . . . 0.0 113.173 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.493 ' HG ' ' H ' ' A' ' 145' ' ' GLY . 1.2 pp -48.45 -54.27 14.78 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.493 ' H ' ' HG ' ' A' ' 144' ' ' LEU . . . 91.06 -65.59 2.56 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 125.942 1.734 . . . . 0.0 109.505 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.14 1.0 0.73 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.39 0.676 . . . . 0.0 111.867 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.64 -26.71 34.58 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -131.01 -156.62 0.77 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.93 1.696 . . . . 0.0 108.304 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.5 m -146.55 108.48 4.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.2 p -103.32 -15.79 15.84 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.402 1.081 . . . . 0.0 111.08 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -96.67 119.73 35.7 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 128.528 2.731 . . . . 0.0 108.178 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -157.94 -133.37 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.799 0.84 . . . . 0.0 112.893 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 177.14 -161.37 28.92 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 128.737 3.065 . . . . 0.0 108.299 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.73 142.87 23.23 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.083 1.942 . . . . 0.0 112.733 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.0 m -91.39 32.36 1.07 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.835 1.254 . . . . 0.0 107.842 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -60.0 110.71 1.26 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.464 1.906 . . . . 0.0 109.8 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 12.5 mt -89.67 160.01 16.82 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 126.226 1.811 . . . . 0.0 110.583 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 20.9 p90 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 126.023 1.729 . . . . 0.0 110.401 -179.707 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ptt? . . . . . 0 N--CA 1.472 0.64 0 CA-C-O 120.427 0.156 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -112.73 178.43 4.29 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.662 1.585 . . . . 0.0 109.172 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.46 -6.51 14.91 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.755 -1.117 . . . . 0.0 113.64 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.2 -47.49 62.25 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.885 1.674 . . . . 0.0 114.328 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.38 -53.86 48.84 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 pttt 48.74 18.88 0.21 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 131.027 3.731 . . . . 0.0 117.507 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.85 5.88 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -177.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -82.33 14.54 2.91 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.117 -0.99 . . . . 0.0 111.266 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.47 156.88 68.49 Favored Pre-proline 0 N--CA 1.475 0.79 0 O-C-N 119.535 -1.978 . . . . 0.0 111.419 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.14 131.54 18.13 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.329 2.019 . . . . 0.0 107.965 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.19 113.49 24.73 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.312 1.445 . . . . 0.0 109.839 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -109.49 144.94 37.05 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.191 0.996 . . . . 0.0 110.957 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.39 -131.21 1.41 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.135 1.35 . . . . 0.0 110.854 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.1 p -153.66 172.38 17.35 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 120.601 2.2 . . . . 0.0 113.112 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.0 mt -127.39 -12.38 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 125.005 1.322 . . . . 0.0 107.597 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.81 -28.22 69.31 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 120.413 -1.43 . . . . 0.0 112.292 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -57.34 -17.98 15.03 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.395 2.678 . . . . 0.0 115.003 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.1 mt -68.03 -69.71 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.29 1.036 . . . . 0.0 109.745 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.01 29.18 7.18 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.962 0.905 . . . . 0.0 111.102 -178.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 51.48 44.66 28.88 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.303 2.241 . . . . 0.0 110.097 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -100.68 88.15 3.53 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.8 t -70.66 138.46 21.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -101.18 145.47 28.76 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.082 0.953 . . . . 0.0 109.523 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -148.26 134.57 12.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.63 121.0 14.95 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 103.471 -2.788 . . . . 0.0 103.471 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -134.01 117.85 17.15 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . 0.267 1.3 t0 46.72 59.49 3.91 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 124.072 1.892 . . . . 0.0 111.43 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 55.29 17.91 2.29 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 113.406 -1.725 . . . . 0.0 113.783 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.6 m -132.25 137.95 47.71 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.143 1.777 . . . . 0.0 107.812 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.8 mt -80.51 129.8 34.74 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.081 -1.637 . . . . 0.0 108.205 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.7 mm -131.36 140.47 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.653 0.66 . . . . 0.0 111.275 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.57 127.18 31.78 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.379 1.472 . . . . 0.0 109.108 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 m -123.09 62.8 20.51 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.213 1.805 . . . . 0.0 109.493 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.61 6.1 0.48 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.413 3.409 . . . . 0.0 116.641 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.4 ptt85 171.7 88.2 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 130.2 3.4 . . . . 0.0 104.92 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.85 139.13 24.75 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.8 -50.22 73.0 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -85.8 53.93 2.95 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.935 1.294 . . . . 0.0 112.663 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -104.51 155.56 18.71 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -150.97 132.69 7.87 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.94 148.61 64.28 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 N-CA-C 107.952 -1.595 . . . . 0.0 107.952 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.98 165.55 27.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -119.74 157.65 28.13 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.0 mm -115.85 147.45 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.92 130.12 47.96 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 104.659 -2.348 . . . . 0.0 104.659 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 tt -127.28 140.09 52.45 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 mt -146.03 138.07 19.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 125.091 1.356 . . . . 0.0 109.212 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p -79.63 132.96 36.39 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.816 0.846 . . . . 0.0 109.027 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 98.4 m -69.88 113.74 7.4 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 120.891 -1.13 . . . . 0.0 108.602 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -86.01 -9.96 55.89 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 118.68 -0.676 . . . . 0.0 112.443 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -97.45 34.64 1.77 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.768 1.627 . . . . 0.0 110.085 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.85 -10.74 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 127.212 2.205 . . . . 0.0 114.28 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.01 -10.75 4.54 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.202 1.801 . . . . 0.0 114.304 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.7 t -128.51 19.89 6.21 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.357 1.463 . . . . 0.0 110.417 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.3 mt -116.45 169.58 9.21 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.749 0.82 . . . . 0.0 109.659 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -70.88 145.88 49.95 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -116.37 -41.22 3.14 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.29 -37.24 77.2 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.619 1.568 . . . . 0.0 112.383 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -11.01 59.81 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 117.993 -1.003 . . . . 0.0 111.411 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.415 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 119.93 173.42 15.19 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -82.7 118.57 72.26 Favored Pre-proline 0 CA--C 1.542 0.64 0 O-C-N 122.039 -0.683 . . . . 0.0 111.19 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -79.85 146.5 18.6 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.87 3.047 . . . . 0.0 110.739 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 pp -139.53 177.72 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.07 1.748 . . . . 0.0 109.308 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.41 ' CE1' ' HA ' ' A' ' 92' ' ' ILE . 1.1 t80 -131.8 147.67 52.51 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.2 tt -144.87 148.26 33.74 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.6 -179.31 25.34 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.9 mt -98.4 145.74 26.42 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.29 105.99 14.08 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 120.341 1.428 . . . . 0.0 108.549 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.92 -24.16 0.18 Allowed Glycine 0 CA--C 1.525 0.66 0 CA-C-O 117.294 -1.837 . . . . 0.0 116.289 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.8 20.53 1.15 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 119.664 1.732 . . . . 0.0 113.273 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.48 64.35 0.94 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.956 2.102 . . . . 0.0 110.971 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.84 143.19 33.26 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.718 1.207 . . . . 0.0 110.562 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.3 m -144.97 179.47 7.32 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.026 0.531 . . . . 0.0 110.918 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.09 152.47 28.19 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.944 -0.473 . . . . 0.0 110.134 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.3 ttp -159.64 127.65 4.87 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.4 m -85.61 116.76 24.09 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.13 148.71 52.49 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -92.06 123.75 35.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.4 -33.48 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.94 -62.04 0.31 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 105.66 -2.976 . . . . 0.0 105.66 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -82.58 -36.36 26.29 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -145.95 166.32 17.63 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.57 142.12 47.9 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.003 2.469 . . . . 0.0 110.031 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.6 p -146.65 -174.77 4.56 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 125.311 1.444 . . . . 0.0 107.943 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 mt -103.22 145.13 30.4 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.043 1.337 . . . . 0.0 109.471 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -143.89 66.04 1.29 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.62 115.07 19.94 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.7 pttp 179.63 -20.9 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -156.15 87.34 1.05 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.981 1.313 . . . . 0.0 110.41 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -169.2 164.97 11.1 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 120.568 -1.332 . . . . 0.0 108.433 178.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -141.01 125.9 18.14 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.526 1.13 . . . . 0.0 108.78 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.41 ' HA ' ' CE1' ' A' ' 64' ' ' TYR . 27.6 pt -79.51 -37.31 18.52 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 125.935 1.694 . . . . 0.0 111.762 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -36.7 81.64 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 118.476 0.58 . . . . 0.0 111.187 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -56.96 -56.24 24.33 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.5 mt -62.39 -32.87 73.76 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -71.67 -36.36 70.6 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.507 -0.745 . . . . 0.0 110.285 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -75.45 -41.01 56.76 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.527 1.131 . . . . 0.0 113.062 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -112.68 157.0 41.6 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.56 63.53 5.58 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.542 2.828 . . . . 0.0 114.142 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -124.21 63.35 32.66 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.977 1.711 . . . . 0.0 109.308 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.3 77.35 3.86 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.365 2.71 . . . . 0.0 106.289 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.94 104.59 5.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 125.388 1.475 . . . . 0.0 107.996 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -49.9 -30.25 9.76 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.373 0.669 . . . . 0.0 111.952 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.95 -8.58 23.42 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.215 1.006 . . . . 0.0 113.229 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -123.73 -3.06 8.27 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.587 1.155 . . . . 0.0 109.04 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.7 mt -103.03 149.53 24.48 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.894 1.224 . . . . 0.0 111.521 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.402 ' CD2' ' HA ' ' A' ' 120' ' ' SER . 76.3 m-85 -135.32 127.08 29.2 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.172 0.989 . . . . 0.0 110.769 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.415 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -70.52 111.98 6.45 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 178.117 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -94.41 145.2 24.94 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.38 179.48 7.62 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.403 1.481 . . . . 0.0 108.283 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.3 137.11 11.29 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.494 0.718 . . . . 0.0 109.102 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.32 89.37 1.57 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.03 61.04 1.22 Allowed Glycine 0 C--N 1.336 0.545 0 O-C-N 121.37 -0.831 . . . . 0.0 111.351 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 60.09 11.08 2.53 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.306 2.243 . . . . 0.0 113.901 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -125.37 159.45 31.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.977 0.911 . . . . 0.0 108.773 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.6 m -116.49 165.7 12.93 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.095 1.758 . . . . 0.0 110.024 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.81 159.14 42.83 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 126.43 1.892 . . . . 0.0 107.398 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -146.28 119.7 9.03 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.321 1.048 . . . . 0.0 109.045 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -116.82 130.45 56.72 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.943 2.097 . . . . 0.0 110.454 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.402 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 43.5 t -56.84 122.28 11.83 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.586 0.754 . . . . 0.0 109.296 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.5 t -70.27 -38.2 73.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.37 -40.28 93.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.684 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -129.45 79.99 72.87 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 124.482 1.113 . . . . 0.0 110.099 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -61.68 148.32 93.3 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.812 2.341 . . . . 0.0 109.86 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.78 -14.05 26.98 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.163 1.364 . . . . 0.0 112.153 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -110.2 147.11 34.4 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.836 2.054 . . . . 0.0 109.164 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -122.23 147.4 46.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.816 1.646 . . . . 0.0 108.218 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 9.9 mm -73.5 124.18 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.46 133.85 33.69 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.644 1.111 . . . . 0.0 108.834 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.2 t -85.91 -21.16 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.695 1.998 . . . . 0.0 111.907 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m 56.08 67.34 1.02 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 123.425 1.583 . . . . 0.0 112.216 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.1 m -96.26 16.8 17.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.164 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.59 146.48 49.64 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.948 1.699 . . . . 0.0 107.023 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 57.99 -81.98 0.01 OUTLIER Glycine 0 C--N 1.334 0.425 0 C-N-CA 127.005 2.24 . . . . 0.0 111.693 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.03 66.87 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.246 2 N-CA-C 102.566 -4.213 . . . . 0.0 102.566 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 79.0 m -91.48 170.24 9.94 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 118.326 1.063 . . . . 0.0 111.576 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -81.12 154.32 19.21 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.558 2.172 . . . . 0.0 112.075 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 38.4 mt -82.57 107.38 15.17 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.08 175.1 9.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 125.039 1.335 . . . . 0.0 108.325 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.7 mt -88.74 166.56 13.97 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t -160.72 125.41 3.68 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -91.2 -22.22 20.74 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 123.543 0.527 . . . . 0.0 110.104 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -166.66 91.17 0.42 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.001 0.818 . . . . 0.0 110.905 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.434 HD13 ' H ' ' A' ' 146' ' ' LYS . 2.8 pp -88.49 161.11 17.18 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.424 1.09 . . . . 0.0 109.684 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -102.82 48.51 1.03 Allowed Glycine 0 C--O 1.226 -0.372 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.434 ' H ' HD13 ' A' ' 144' ' ' LEU . 0.0 OUTLIER 66.65 2.42 2.54 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.175 2.19 . . . . 0.0 112.871 -178.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.51 -10.27 59.65 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 125.866 1.666 . . . . 0.0 115.4 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -140.22 142.14 35.86 Favored 'General case' 0 CA--C 1.512 -0.517 0 O-C-N 121.17 -0.956 . . . . 0.0 108.58 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.82 132.11 35.46 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.413 0.685 . . . . 0.0 109.225 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 p -124.2 -9.09 7.6 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.175 0.99 . . . . 0.0 108.655 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -127.51 125.96 41.37 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.557 1.543 . . . . 0.0 110.059 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 176.29 178.57 0.21 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.931 2.092 . . . . 0.0 110.504 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.34 -166.61 31.22 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.846 1.212 . . . . 0.0 111.694 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.61 125.71 19.91 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.289 1.436 . . . . 0.0 107.641 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.3 m -81.97 44.13 0.82 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.847 1.659 . . . . 0.0 106.88 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -67.68 147.54 52.54 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.3 mt -124.61 170.73 10.66 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.194 1.798 . . . . 0.0 108.388 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.8 p90 . . . . . 0 C--O 1.243 0.761 0 N-CA-C 104.187 -2.523 . . . . 0.0 104.187 179.422 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ptm . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 120.348 0.118 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -103.24 176.39 5.16 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -116.53 -86.09 0.62 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -151.68 92.83 1.79 Allowed 'General case' 0 C--O 1.237 0.436 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 pp -134.97 6.49 3.39 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -160.03 25.15 0.17 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.464 1.506 . . . . 0.0 108.255 177.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.25 -22.61 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.322 1.049 . . . . 0.0 113.023 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -73.29 -22.79 60.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.234 1.379 . . . . 0.0 110.993 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -56.45 149.24 40.09 Favored Pre-proline 0 CA--C 1.528 0.098 0 CA-C-O 118.421 -0.799 . . . . 0.0 110.42 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.96 132.84 27.42 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.38 1.387 . . . . 0.0 109.534 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.46 117.34 30.1 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -112.86 146.98 37.95 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.846 0.459 . . . . 0.0 109.852 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.86 -125.99 0.97 Allowed Glycine 0 CA--C 1.523 0.535 0 C-N-CA 124.595 1.093 . . . . 0.0 111.883 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.8 p -156.07 -170.1 3.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.975 1.887 . . . . 0.0 112.565 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -146.65 1.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.225 1.01 . . . . 0.0 110.383 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -67.34 -28.92 68.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -54.61 -30.87 56.03 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.19 1.396 . . . . 0.0 111.44 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.5 mm -44.95 -67.61 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.749 2.02 . . . . 0.0 111.625 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.55 26.15 3.73 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.86 -0.525 . . . . 0.0 111.324 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 25.7 m170 60.93 39.56 16.55 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.425 1.49 . . . . 0.0 110.098 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mmt-85 -109.32 97.67 7.22 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.153 0.981 . . . . 0.0 109.932 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 t -82.47 156.46 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -108.75 137.1 47.23 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.772 1.229 . . . . 0.0 107.707 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.97 128.03 52.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.4 100.4 1.75 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -115.62 126.21 53.89 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 126.0 1.72 . . . . 0.0 109.117 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.3 t0 42.53 58.79 2.97 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.535 1.134 . . . . 0.0 112.898 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 58.86 13.44 2.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.942 1.297 . . . . 0.0 114.363 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.7 m -131.78 149.86 52.33 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 120.688 1.586 . . . . 0.0 108.287 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.8 mt -89.96 125.5 35.4 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.5 mm -119.72 140.27 44.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.54 141.67 36.44 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 m -120.3 71.72 18.0 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -63.67 97.35 0.22 Allowed 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.452 2.101 . . . . 0.0 109.958 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 49.55 43.73 24.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.671 1.189 . . . . 0.0 111.165 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -88.67 148.12 24.17 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -65.89 -11.64 48.51 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.259 30.0 ptt180 -117.11 25.15 10.69 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.682 0.793 . . . . 0.0 110.334 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -75.92 148.16 38.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.2 t -145.91 129.98 8.64 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.52 145.29 52.31 Favored 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.045 1.163 . . . . 0.0 112.123 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.4 m -126.31 175.49 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.35 161.72 28.76 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.4 mm -124.82 147.78 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.15 134.5 52.4 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.01 133.88 47.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.833 1.253 . . . . 0.0 107.999 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.67 134.11 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.022 0.529 . . . . 0.0 110.59 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.8 t -72.44 159.77 33.42 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 122.514 1.149 . . . . 0.0 109.427 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.3 m -83.6 100.48 10.84 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.749 1.22 . . . . 0.0 109.653 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 ptt85 -82.94 13.77 3.73 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.54 -1.35 . . . . 0.0 112.428 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -132.48 33.76 3.78 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.723 2.009 . . . . 0.0 111.536 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -73.06 3.81 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 120.326 -1.484 . . . . 0.0 114.641 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -48.75 -33.46 10.33 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -102.6 0.17 32.93 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 120.114 1.325 . . . . 0.0 112.454 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.6 mt -95.48 163.14 13.35 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 120.256 -1.528 . . . . 0.0 111.457 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -70.62 155.36 40.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -120.62 -23.66 5.98 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.26 -13.53 46.46 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.195 0.998 . . . . 0.0 113.507 -178.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.2 mtm-85 -84.29 7.64 18.63 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.452 1.101 . . . . 0.0 112.915 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.0 -173.46 15.57 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -92.62 105.35 14.17 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-O 117.708 -1.139 . . . . 0.0 109.844 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -69.67 128.92 16.81 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.239 2.626 . . . . 0.0 110.319 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.5 pt -139.64 177.71 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.5 1.52 . . . . 0.0 109.218 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -133.01 158.62 42.25 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.6 tt -155.45 155.91 34.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.623 1.569 . . . . 0.0 108.609 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.41 178.46 38.19 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -87.18 177.73 7.09 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -140.62 111.39 6.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.062 -1.024 . . . . 0.0 108.832 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 153.39 -18.57 0.7 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-O 117.962 -1.465 . . . . 0.0 115.403 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.28 24.47 0.62 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.574 1.687 . . . . 0.0 111.969 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 57.24 72.96 0.48 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.324 1.85 . . . . 0.0 109.07 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.42 125.87 10.9 Favored 'General case' 0 N--CA 1.461 0.107 0 O-C-N 121.215 -0.928 . . . . 0.0 111.559 -178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.458 ' HG ' ' CG2' ' A' ' 92' ' ' ILE . 24.3 m -133.05 172.85 12.09 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.106 0.962 . . . . 0.0 110.936 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.9 mt -55.68 150.91 11.72 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.8 ttp -157.18 117.37 3.5 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.3 m -84.5 115.89 22.82 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.598 1.09 . . . . 0.0 110.97 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.86 -170.43 1.83 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -149.35 128.57 12.85 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.1 m -81.84 38.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.59 -7.81 2.61 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 120.914 -1.116 . . . . 0.0 113.253 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -123.85 -50.63 1.83 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 127.653 2.381 . . . . 0.0 113.365 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -144.61 156.51 56.41 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 123.908 0.883 . . . . 0.0 108.965 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.46 160.03 44.83 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.467 1.445 . . . . 0.0 110.974 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.5 p -147.82 160.13 43.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.499 1.119 . . . . 0.0 109.394 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.7 mt -98.64 127.21 44.49 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -123.67 68.09 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.717 0.807 . . . . 0.0 109.838 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.18 102.68 12.78 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.3 -35.56 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.709 1.256 . . . . 0.0 111.342 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -137.3 90.92 2.56 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.61 1.164 . . . . 0.0 109.847 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -173.76 158.24 3.24 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 120.858 -1.151 . . . . 0.0 109.02 178.342 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -138.81 134.03 32.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.104 1.361 . . . . 0.0 107.518 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.458 ' CG2' ' HG ' ' A' ' 73' ' ' CYS . 37.0 pt -90.25 -33.53 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 C-N-CA 123.806 0.843 . . . . 0.0 111.003 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -32.3 73.89 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 118.299 0.5 . . . . 0.0 110.244 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -62.36 -54.31 42.26 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.624 0.647 . . . . 0.0 109.816 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.3 mt -60.22 -40.89 91.75 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -65.11 -31.54 72.79 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.06 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -77.5 -36.07 53.0 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 116.42 -1.752 . . . . 0.0 113.603 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.61 174.43 2.35 Favored Pre-proline 0 N--CA 1.472 0.637 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -175.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.6 -162.93 0.16 Allowed 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.829 2.353 . . . . 0.0 108.228 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 69.3 65.09 0.52 Allowed Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.888 1.675 . . . . 0.0 113.275 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -56.42 116.62 3.32 Favored 'Trans proline' 0 C--O 1.244 0.819 0 C-N-CA 121.903 1.736 . . . . 0.0 110.553 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.96 84.75 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -42.77 -33.77 0.81 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.535 1.934 . . . . 0.0 112.929 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -59.26 -15.25 14.51 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.905 1.682 . . . . 0.0 113.328 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.7 5.9 6.14 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.071 1.348 . . . . 0.0 110.438 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 39.4 mt -101.35 153.71 19.43 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 120.46 1.482 . . . . 0.0 109.208 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -140.73 131.57 25.9 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.259 0.623 . . . . 0.0 110.686 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.402 ' CE1' ' HA ' ' A' ' 121' ' ' VAL . 83.3 m-85 -76.86 123.09 25.74 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.061 0.945 . . . . 0.0 109.346 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -82.4 126.22 31.94 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.9 t -120.95 170.84 9.11 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -142.42 158.77 43.34 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.718 2.007 . . . . 0.0 109.018 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 80.7 p -124.14 -4.58 7.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.854 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.92 -44.17 1.27 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -137.82 10.48 2.87 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.47 1.108 . . . . 0.0 112.965 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -146.84 164.1 33.93 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 106.654 -1.609 . . . . 0.0 106.654 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 m -128.98 153.55 47.45 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.704 0.684 . . . . 0.0 110.527 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.4 170.15 11.13 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -139.19 109.29 6.4 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.916 1.686 . . . . 0.0 109.666 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -106.39 126.18 51.92 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.517 1.127 . . . . 0.0 110.164 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.9 t -50.9 127.58 18.98 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.448 0.699 . . . . 0.0 110.205 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.402 ' HA ' ' CE1' ' A' ' 108' ' ' TYR . 53.6 t -68.37 -48.12 74.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.71 -40.09 91.89 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.269 1.028 . . . . 0.0 112.842 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -127.94 84.74 62.44 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -69.24 160.88 48.12 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 N-CA-C 108.368 -1.436 . . . . 0.0 108.368 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.75 -32.03 7.47 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -95.82 140.28 30.83 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 118.03 0.915 . . . . 0.0 109.442 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -120.33 138.97 53.42 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 127.078 2.151 . . . . 0.0 108.597 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.3 mm -70.24 139.7 19.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -115.18 126.15 54.25 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.943 0.792 . . . . 0.0 111.399 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.8 m -73.74 -5.36 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.816 -1.178 . . . . 0.0 112.697 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.6 m 54.12 35.12 21.61 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 7.8 m -73.18 -1.97 19.75 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.807 1.243 . . . . 0.0 112.749 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -94.91 130.22 41.61 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 101.911 -3.366 . . . . 0.0 101.911 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.32 -84.78 0.05 OUTLIER Glycine 0 CA--C 1.531 1.04 0 C-N-CA 123.554 0.597 . . . . 0.0 111.913 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.33 68.0 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 129.219 3.295 . . . . 0.0 108.361 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 m -91.52 168.45 13.32 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 117.886 0.843 . . . . 0.0 110.523 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 55.7 Cg_endo -67.99 159.82 51.27 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 N-CA-C 107.888 -1.62 . . . . 0.0 107.888 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.9 mt -80.96 137.39 36.1 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -163.14 171.61 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 125.286 1.434 . . . . 0.0 109.354 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.12 171.14 8.92 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.4 t -157.89 145.56 18.5 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.47 -1.394 . . . . 0.0 108.441 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -106.02 -26.23 11.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.559 0.618 . . . . 0.0 109.797 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -159.55 113.62 2.31 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.63 162.84 14.74 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.365 1.866 . . . . 0.0 109.076 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -108.36 55.88 0.49 Allowed Glycine 0 N--CA 1.46 0.283 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 46.13 43.08 10.61 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.326 1.851 . . . . 0.0 109.601 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -120.33 -10.08 9.39 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.682 1.193 . . . . 0.0 112.618 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -126.53 163.82 22.54 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.5 p -108.91 97.36 7.01 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.23 1.012 . . . . 0.0 111.611 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.8 p -93.62 -31.76 14.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.815 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.67 113.42 26.55 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 118.413 -0.803 . . . . 0.0 112.893 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -161.26 178.79 8.89 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.07 1.305 . . . . 0.0 112.168 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.83 173.63 21.01 Favored Glycine 0 C--O 1.24 0.485 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.6 tp -120.98 138.88 53.94 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.3 m -89.99 41.92 1.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.02 167.49 15.83 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.2 mt -136.73 151.59 49.39 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.876 1.27 . . . . 0.0 107.699 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 55.4 p90 . . . . . 0 C--O 1.254 1.339 0 C-N-CA 125.191 1.397 . . . . 0.0 109.014 179.533 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -90.37 174.52 7.52 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.867 0.867 . . . . 0.0 110.872 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -115.66 24.36 11.6 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.462 1.905 . . . . 0.0 111.812 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 51.16 45.0 28.47 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.125 1.77 . . . . 0.0 109.672 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.23 -56.94 15.7 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 117.602 -1.19 . . . . 0.0 109.366 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.3 pttp 45.5 30.23 0.72 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 128.075 2.55 . . . . 0.0 114.255 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 pp -142.9 -42.32 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.367 1.067 . . . . 0.0 111.86 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -87.53 84.12 7.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 104.167 -2.531 . . . . 0.0 104.167 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.9 p -110.72 138.66 21.12 Favored Pre-proline 0 C--N 1.328 -0.334 0 C-N-CA 126.279 1.832 . . . . 0.0 107.469 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.52 122.75 10.5 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.341 2.028 . . . . 0.0 108.982 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.73 138.4 40.41 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -135.19 148.44 49.67 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 119.086 0.857 . . . . 0.0 110.801 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.08 -130.43 1.26 Allowed Glycine 0 C--O 1.227 -0.339 0 CA-C-O 118.668 -1.073 . . . . 0.0 111.534 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.5 p -145.71 -177.7 5.72 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.875 1.338 . . . . 0.0 113.226 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mt -140.54 -11.56 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 126.403 1.881 . . . . 0.0 109.336 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -61.04 -17.98 55.3 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 119.778 -1.826 . . . . 0.0 113.687 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.73 -7.88 5.71 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.757 2.423 . . . . 0.0 113.838 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.6 mm -91.56 -41.51 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.97 23.14 0.86 Allowed 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 121.088 -1.008 . . . . 0.0 111.016 -176.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 62.59 27.83 16.38 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.629 0.728 . . . . 0.0 112.035 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.85 91.09 6.27 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.7 t -85.67 161.51 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -118.79 144.13 46.5 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 119.553 1.069 . . . . 0.0 110.953 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.7 t -142.65 134.45 25.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 tp -68.71 120.73 15.14 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 103.594 -2.743 . . . . 0.0 103.594 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -137.17 123.11 20.17 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.4 t0 47.07 49.41 15.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.001 1.32 . . . . 0.0 112.644 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 67.59 12.05 8.68 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.949 2.1 . . . . 0.0 115.623 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.1 m -132.42 143.54 49.88 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.652 1.115 . . . . 0.0 109.88 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 mt -81.96 121.95 27.17 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.41 -1.431 . . . . 0.0 107.872 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.79 136.76 53.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.54 136.98 40.56 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 124.59 1.182 . . . . 0.0 108.105 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 m -119.5 87.19 35.87 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.54 1.136 . . . . 0.0 108.569 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.66 -44.72 2.81 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.78 2.32 . . . . 0.0 112.927 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -153.22 44.13 0.63 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.49 1.516 . . . . 0.0 109.611 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.0 124.77 32.82 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -55.6 -32.95 63.51 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 123.981 0.801 . . . . 0.0 109.65 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -89.1 31.0 0.9 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.624 1.569 . . . . 0.0 112.513 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -80.2 168.06 19.55 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.068 -1.645 . . . . 0.0 109.97 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.81 147.97 18.26 Favored Pre-proline 0 N--CA 1.448 -0.56 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.39 159.58 46.37 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.286 2.657 . . . . 0.0 108.531 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.85 160.0 9.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 125.77 1.628 . . . . 0.0 108.115 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.04 154.42 27.71 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.964 1.706 . . . . 0.0 108.111 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mm -130.12 104.35 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.193 1.397 . . . . 0.0 108.088 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.97 141.36 28.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.5 tt -132.69 140.2 48.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.57 145.46 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.8 p -75.65 161.9 28.7 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 124.785 1.234 . . . . 0.0 107.824 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.94 176.01 9.61 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.19 -7.52 7.09 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -116.69 37.64 3.72 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.5 m -60.99 -16.29 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 125.253 1.421 . . . . 0.0 113.544 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.46 -18.41 65.3 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.948 0.499 . . . . 0.0 110.094 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.14 -0.82 49.61 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.117 0.967 . . . . 0.0 112.262 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.2 mt -106.69 179.25 4.32 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.262 0.937 . . . . 0.0 110.343 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.614 ' HB2' ' HH ' ' A' ' 108' ' ' TYR . 9.1 mt-10 -92.37 157.63 16.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.909 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.77 -19.46 6.77 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.816 1.247 . . . . 0.0 112.7 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.25 -31.63 72.83 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.506 1.122 . . . . 0.0 113.44 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -86.84 -5.67 59.03 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.536 0.734 . . . . 0.0 112.707 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 127.0 -158.12 20.85 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -102.09 107.77 54.05 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.42 123.5 9.17 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.532 2.821 . . . . 0.0 109.64 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.8 pt -132.91 -171.94 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.445 1.898 . . . . 0.0 108.434 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -134.15 158.62 43.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.588 1.155 . . . . 0.0 108.953 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.1 tt -149.59 150.06 31.63 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.425 1.49 . . . . 0.0 108.534 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.67 177.19 30.52 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 124.211 0.91 . . . . 0.0 111.945 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mt -97.96 132.25 43.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -96.53 35.69 1.46 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.425 1.011 . . . . 0.0 112.581 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -97.7 -96.87 1.96 Allowed Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.488 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 24.3 mt -87.8 13.87 9.82 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.885 1.674 . . . . 0.0 115.018 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 m120 72.37 70.88 0.15 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.437 1.895 . . . . 0.0 109.278 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.454 ' C ' ' HG ' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -141.44 145.89 35.83 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 125.328 1.451 . . . . 0.0 107.976 -177.733 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.454 ' HG ' ' C ' ' A' ' 72' ' ' LEU . 56.9 m -143.72 174.05 11.14 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.202 0.91 . . . . 0.0 109.855 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.1 mt -59.9 150.97 27.08 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.015 0.37 . . . . 0.0 111.185 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.9 ttp -157.89 116.05 3.08 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 95.8 m -89.78 109.7 20.67 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 119.288 0.949 . . . . 0.0 109.46 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.53 -169.23 1.44 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -130.78 118.54 20.97 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.2 p -65.67 -9.97 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.45 -1.29 7.56 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 125.295 1.426 . . . . 0.0 110.981 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -150.09 -44.25 0.13 Allowed 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.072 0.949 . . . . 0.0 111.484 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -135.44 163.06 53.5 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 124.903 1.281 . . . . 0.0 111.504 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -71.95 146.89 48.35 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.396 2.064 . . . . 0.0 112.635 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.1 p -145.75 170.89 15.61 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.4 mt -98.0 132.53 43.48 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -126.15 73.35 1.36 Allowed 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.02 0.928 . . . . 0.0 108.806 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.84 107.82 17.84 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.08 -30.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.127 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -157.35 97.73 1.65 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.183 0.993 . . . . 0.0 110.666 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.84 161.54 4.64 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.509 1.524 . . . . 0.0 107.131 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.1 130.31 42.99 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.424 1.49 . . . . 0.0 112.431 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.1 pt -82.37 -39.67 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 126.233 1.813 . . . . 0.0 111.644 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.2 tpt -64.51 -34.55 78.49 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.297 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.51 -45.88 92.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.879 0.763 . . . . 0.0 109.356 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 10.1 mt -65.82 -33.69 76.44 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.758 0.708 . . . . 0.0 111.278 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -79.77 -16.39 55.63 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.468 0.576 . . . . 0.0 110.403 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -91.73 -36.42 13.59 Favored 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 125.371 1.468 . . . . 0.0 111.486 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.79 159.03 42.25 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 121.141 -0.975 . . . . 0.0 112.049 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -78.86 54.11 4.98 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.435 2.09 . . . . 0.0 112.172 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -116.24 71.85 4.63 Favored Pre-proline 0 N--CA 1.473 0.683 0 O-C-N 120.713 -1.242 . . . . 0.0 110.827 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -79.99 82.1 2.58 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.599 2.199 . . . . 0.0 109.166 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.2 t -74.36 106.01 3.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -50.98 -30.53 15.31 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.423 1.01 . . . . 0.0 111.255 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 m -70.83 -8.82 55.37 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -114.03 -22.6 9.98 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.159 -0.963 . . . . 0.0 109.134 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.3 mt -84.34 154.23 23.02 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.007 0.923 . . . . 0.0 113.024 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -140.28 133.17 29.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.022 0.929 . . . . 0.0 110.079 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.614 ' HH ' ' HB2' ' A' ' 56' ' ' GLU . 62.1 m-85 -77.41 118.45 19.88 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -81.17 141.06 34.58 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.0 m -138.87 174.38 10.58 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.465 1.106 . . . . 0.0 108.175 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -153.14 150.74 29.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.858 0.463 . . . . 0.0 110.142 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.01 107.07 0.35 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.36 56.92 3.28 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 126.121 1.819 . . . . 0.0 111.756 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 11.7 mtm-85 61.87 9.04 2.74 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.6 1.96 . . . . 0.0 109.798 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -117.5 162.35 18.12 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 119.903 1.228 . . . . 0.0 110.882 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.0 m -111.78 158.79 18.94 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.213 2.205 . . . . 0.0 108.632 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.65 162.82 34.55 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.474 1.909 . . . . 0.0 108.747 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -140.83 116.21 10.05 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -108.89 130.14 55.43 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.465 1.506 . . . . 0.0 109.226 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.9 t -56.69 117.69 4.14 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.356 1.462 . . . . 0.0 110.248 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.2 t -62.72 -40.68 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 119.076 0.853 . . . . 0.0 111.022 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.33 -42.02 88.78 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -133.2 86.49 41.7 Favored Pre-proline 0 C--O 1.237 0.414 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.04 168.8 11.59 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.285 2.656 . . . . 0.0 111.535 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.49 -21.67 31.2 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -101.03 118.03 36.19 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 127.444 2.298 . . . . 0.0 107.078 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -108.1 148.32 29.99 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.104 1.361 . . . . 0.0 108.902 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.4 mt -75.61 122.82 30.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.15 140.29 29.81 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.354 0.597 . . . . 0.0 110.494 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.4 m -90.58 -4.75 10.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 C-N-CA 124.548 1.139 . . . . 0.0 112.231 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.1 m 52.97 73.86 0.33 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 123.126 1.441 . . . . 0.0 113.571 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.0 t -93.83 6.12 49.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.676 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -115.36 136.22 53.32 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 53.84 -104.48 0.23 Allowed Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 107.561 -2.216 . . . . 0.0 107.561 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -173.35 66.43 0.11 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 106.394 -2.682 . . . . 0.0 106.394 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 56.5 m -82.0 157.74 68.35 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 117.534 0.667 . . . . 0.0 110.642 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -71.14 165.75 31.39 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 121.973 1.782 . . . . 0.0 108.521 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 22.6 mt -87.82 113.33 23.38 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.642 1.177 . . . . 0.0 112.06 -177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 pp -135.95 178.44 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 125.447 1.499 . . . . 0.0 109.455 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 35.6 mt -96.17 141.58 29.37 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.2 t -129.85 129.8 44.44 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -87.26 -23.47 24.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -160.79 93.78 1.01 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 122.315 1.055 . . . . 0.0 110.88 -177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.53 -57.32 11.84 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.471 1.108 . . . . 0.0 112.285 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 58.79 46.35 93.61 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . 0.25 1.4 tmtp? 63.49 38.87 9.54 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.655 1.982 . . . . 0.0 112.588 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -132.22 -13.42 3.1 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.912 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -140.62 156.39 46.28 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.429 -1.419 . . . . 0.0 108.677 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 55.8 m -109.8 118.51 36.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.7 p -108.07 -11.94 15.21 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.409 1.084 . . . . 0.0 110.099 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.69 126.84 48.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.759 1.223 . . . . 0.0 109.919 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -152.72 -165.08 2.1 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.333 -0.854 . . . . 0.0 109.41 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -148.1 127.59 2.63 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 106.055 -2.818 . . . . 0.0 106.055 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.52 114.47 26.01 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.8 m -78.41 39.59 0.33 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.588 2.355 . . . . 0.0 107.716 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -64.18 148.57 49.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.403 1.881 . . . . 0.0 107.999 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.1 mt -129.51 162.55 27.89 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.244 1.818 . . . . 0.0 108.43 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 22.9 p90 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 115.361 -2.257 . . . . 0.0 109.677 -179.592 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 122.395 1.093 . . . . 0.0 108.619 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 mp0 -75.3 -172.2 1.67 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 128.871 2.869 . . . . 0.0 113.754 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.64 -31.5 3.98 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.349 1.86 . . . . 0.0 112.217 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.73 -41.36 0.06 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 122.609 1.195 . . . . 0.0 113.007 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.14 -172.02 3.86 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 125.809 1.644 . . . . 0.0 109.026 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -131.49 9.2 4.67 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.919 1.288 . . . . 0.0 113.361 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pt -135.55 38.65 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 127.5 2.32 . . . . 0.0 108.679 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.41 -43.04 52.07 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.631 -1.293 . . . . 0.0 112.407 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.15 155.8 91.33 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 123.327 0.651 . . . . 0.0 109.983 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.94 132.15 22.45 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.442 2.094 . . . . 0.0 107.497 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.99 132.81 42.43 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -128.89 145.98 51.07 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.14 -139.19 2.67 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 95.0 p -143.96 -172.62 3.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.036 0.918 . . . . 0.0 112.796 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.3 mt -140.05 -10.6 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 126.443 1.897 . . . . 0.0 109.337 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -24.02 65.31 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 119.544 -1.972 . . . . 0.0 113.268 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -58.86 -16.38 17.06 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.917 2.087 . . . . 0.0 112.706 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.5 mt -74.79 -67.11 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.138 1.375 . . . . 0.0 112.8 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -136.7 32.09 2.75 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.149 0.976 . . . . 0.0 110.535 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 58.62 37.42 25.31 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.924 0.868 . . . . 0.0 110.643 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.1 mmt-85 -105.72 89.67 3.16 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.824 -1.173 . . . . 0.0 109.217 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.3 t -79.11 157.25 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 49.8 m0 -111.47 153.78 25.66 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.988 0.915 . . . . 0.0 108.673 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.5 t -146.62 135.65 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.1 tp -76.25 106.89 8.12 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -132.16 133.51 44.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 119.843 1.201 . . . . 0.0 111.293 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t0 47.83 42.79 16.5 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 123.641 1.686 . . . . 0.0 111.28 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 61.61 26.93 16.51 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 127.223 2.209 . . . . 0.0 115.122 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.1 m -138.71 154.79 48.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.8 mt -92.94 126.45 38.02 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mt -126.97 132.16 70.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 123.141 0.576 . . . . 0.0 110.736 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.34 136.38 46.17 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.951 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.7 m -112.96 81.44 4.57 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.786 1.235 . . . . 0.0 108.117 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.12 -33.36 25.34 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.559 2.172 . . . . 0.0 111.851 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -151.33 12.73 0.65 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -62.86 138.65 58.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 120.585 -1.322 . . . . 0.0 111.059 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -33.13 75.16 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.603 1.961 . . . . 0.0 109.038 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -102.08 71.59 1.27 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.7 ptm -106.7 163.07 13.21 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -157.43 141.12 11.37 Favored Pre-proline 0 N--CA 1.446 -0.652 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -71.91 163.78 37.74 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 N-CA-C 108.502 -1.384 . . . . 0.0 108.502 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.8 p -155.62 154.19 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.437 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 68' ' ' ASN . 0.7 OUTLIER -106.46 150.99 25.53 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 126.827 2.051 . . . . 0.0 110.355 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.3 mm -121.56 122.34 66.85 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.71 145.84 27.96 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.9 tt -140.18 138.01 34.82 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 80.9 mt -146.77 138.0 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 C-N-CA 126.129 1.772 . . . . 0.0 109.856 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.4 p -84.28 130.24 34.82 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 89.9 m -62.68 138.74 58.58 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -94.42 -28.36 15.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.858 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -90.85 40.73 1.03 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.2 m -68.22 -8.81 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 120.44 -1.412 . . . . 0.0 112.783 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -62.6 -7.37 4.61 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.032 2.133 . . . . 0.0 113.583 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 t -122.5 7.23 9.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.897 1.279 . . . . 0.0 111.605 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.6 mt -107.49 167.31 10.03 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.849 -1.157 . . . . 0.0 108.601 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -64.71 153.34 39.98 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.268 -1.333 . . . . 0.0 107.992 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -121.72 -47.01 2.22 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.091 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.16 -26.45 62.75 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 127.909 2.484 . . . . 0.0 113.315 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -85.04 -19.47 31.92 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.789 -0.57 . . . . 0.0 111.601 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.415 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 140.71 -167.44 25.59 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -97.45 102.1 11.9 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.683 0.793 . . . . 0.0 110.676 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.64 138.17 23.6 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 124.298 3.332 . . . . 0.0 112.741 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pp -146.08 -175.35 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 125.738 1.615 . . . . 0.0 110.246 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -134.16 156.46 48.29 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.678 0.791 . . . . 0.0 110.527 178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.8 tt -154.3 151.82 29.55 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.599 1.56 . . . . 0.0 108.428 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.92 -176.67 34.26 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mt -83.47 171.03 13.82 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 176.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.414 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 10.5 t-20 -137.68 47.34 2.06 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.603 -1.311 . . . . 0.0 109.6 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.83 -75.99 0.54 Allowed Glycine 0 C--N 1.337 0.63 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.381 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.21 25.11 11.43 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -178.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 m120 66.88 72.96 0.36 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.662 1.185 . . . . 0.0 109.804 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.46 141.71 25.1 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.963 1.305 . . . . 0.0 110.573 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.3 m -144.04 165.48 27.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.02 0.827 . . . . 0.0 111.385 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.84 156.62 8.63 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.518 1.127 . . . . 0.0 110.174 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.1 tmm? -164.37 140.53 6.17 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.5 m -102.78 119.61 39.14 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.45 -171.75 2.44 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.124 1.37 . . . . 0.0 107.874 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -128.25 127.09 42.18 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.94 -8.04 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 123.437 0.461 . . . . 0.0 110.697 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.73 -82.44 0.1 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -117.17 7.66 13.05 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.968 0.89 . . . . 0.0 112.701 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -141.1 151.01 60.85 Favored Pre-proline 0 C--O 1.241 0.651 0 C-N-CA 124.807 1.243 . . . . 0.0 110.547 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.72 149.13 18.18 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.733 2.289 . . . . 0.0 108.978 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.5 p -144.14 170.61 15.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.957 0.903 . . . . 0.0 110.393 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.5 mt -91.79 151.24 20.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.399 1.08 . . . . 0.0 108.679 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -148.63 80.94 1.45 Allowed 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 125.079 1.351 . . . . 0.0 107.628 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.96 97.39 7.25 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 125.942 1.697 . . . . 0.0 108.858 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.08 -26.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.871 0.732 . . . . 0.0 112.274 -177.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -145.24 103.59 3.86 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.541 1.537 . . . . 0.0 109.482 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER 174.11 159.25 0.16 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.133 1.373 . . . . 0.0 108.915 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -136.35 127.74 28.44 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.181 0.593 . . . . 0.0 110.795 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 tt -68.26 -47.17 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 125.903 1.681 . . . . 0.0 114.25 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.8 tpt -62.95 -29.73 71.03 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.982 -0.532 . . . . 0.0 111.268 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.22 -54.51 32.35 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.034 0.533 . . . . 0.0 109.691 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.2 mt -63.87 -30.04 71.17 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -74.39 -52.42 12.17 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -60.63 -45.08 95.42 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 125.682 1.593 . . . . 0.0 112.685 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -92.99 145.37 29.99 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.64 50.0 2.59 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.439 2.76 . . . . 0.0 112.124 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -118.12 72.73 9.4 Favored Pre-proline 0 CA--C 1.537 0.48 0 O-C-N 120.745 -1.222 . . . . 0.0 109.332 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.94 92.28 1.05 Allowed 'Trans proline' 0 N--CA 1.45 -1.037 0 N-CA-C 105.284 -2.622 . . . . 0.0 105.284 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.5 t -88.35 97.72 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -50.55 -22.23 1.88 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.02 -17.34 64.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.209 0.604 . . . . 0.0 110.858 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -113.61 -22.07 10.46 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 119.164 0.893 . . . . 0.0 110.649 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.8 mt -78.97 164.37 24.46 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.698 1.199 . . . . 0.0 113.64 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.92 140.63 22.65 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 123.772 0.829 . . . . 0.0 111.016 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.415 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.5 OUTLIER -75.3 123.18 24.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 176.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.406 ' CD2' ' HB3' ' A' ' 116' ' ' SER . 3.9 t-160 -97.94 101.35 12.81 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.883 1.273 . . . . 0.0 107.577 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.51 170.9 13.0 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.925 1.29 . . . . 0.0 110.095 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -139.86 147.38 40.58 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.675 1.59 . . . . 0.0 110.044 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.4 p -135.59 15.4 3.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.823 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.5 -79.23 0.31 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -111.47 -1.41 15.9 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.18 0.992 . . . . 0.0 111.985 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -127.03 160.87 29.83 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.206 1.002 . . . . 0.0 108.357 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.406 ' HB3' ' CD2' ' A' ' 109' ' ' HIS . 49.9 m -132.5 151.66 51.83 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.234 1.814 . . . . 0.0 109.024 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.11 165.75 12.79 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -142.8 107.96 4.97 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -111.65 124.72 52.9 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.398 1.879 . . . . 0.0 110.056 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.8 t -53.01 130.23 33.13 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.304 -0.872 . . . . 0.0 110.032 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.2 t -68.87 -51.18 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.909 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.01 78.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -129.19 81.6 70.15 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 124.055 0.942 . . . . 0.0 109.903 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -65.38 161.61 37.2 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.671 2.247 . . . . 0.0 111.113 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.2 0.06 77.69 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.205 -0.775 . . . . 0.0 113.06 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -126.69 131.23 51.43 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.455 1.902 . . . . 0.0 107.753 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.6 149.97 33.77 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.948 1.299 . . . . 0.0 112.493 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 mt -81.51 119.25 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.609 0.764 . . . . 0.0 111.176 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.72 152.31 31.64 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.638 1.108 . . . . 0.0 109.965 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.9 t -103.48 -18.2 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 127.797 2.439 . . . . 0.0 109.754 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.533 ' HB3' ' H ' ' A' ' 136' ' ' CYS . 50.9 m 61.24 39.24 15.91 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.391 1.476 . . . . 0.0 114.295 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.1 m -76.76 -11.38 59.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.61 -66.99 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.77 1.628 . . . . 0.0 111.071 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -122.88 -48.49 0.25 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 124.321 0.963 . . . . 0.0 111.288 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 138.75 60.44 0.05 OUTLIER Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . 0.533 ' H ' ' HB3' ' A' ' 131' ' ' SER . 0.5 OUTLIER -90.45 174.16 4.91 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 123.95 0.9 . . . . 0.0 110.933 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.01 166.43 29.61 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 N-CA-C 108.928 -1.22 . . . . 0.0 108.928 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 21.9 mt -87.28 114.09 23.58 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.9 pp -137.93 172.02 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.078 1.351 . . . . 0.0 110.754 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 66.3 mt -97.72 159.89 14.65 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.37 161.33 41.22 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 125.321 1.448 . . . . 0.0 107.316 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -104.57 -45.66 4.56 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -159.88 126.7 4.45 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.593 ' HG ' ' H ' ' A' ' 145' ' ' GLY . 0.5 OUTLIER -120.3 -63.91 1.31 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.984 1.714 . . . . 0.0 111.209 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.593 ' H ' ' HG ' ' A' ' 144' ' ' LEU . . . 106.68 -70.11 0.22 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 107.118 -2.393 . . . . 0.0 107.118 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.67 -5.65 1.18 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.397 1.079 . . . . 0.0 113.382 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.93 -19.77 65.01 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -138.26 -157.81 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.4 m -146.53 107.9 4.25 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 102.088 -3.301 . . . . 0.0 102.088 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.49 -9.12 14.23 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.389 1.076 . . . . 0.0 110.546 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -123.26 112.32 17.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.94 -176.62 5.0 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.085 0.954 . . . . 0.0 111.165 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.99 -169.04 32.13 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.347 0.975 . . . . 0.0 112.675 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.5 130.33 18.16 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.942 1.697 . . . . 0.0 106.769 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 39.2 m -90.34 51.32 2.0 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -68.73 138.13 54.64 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 40.8 mt -123.03 170.23 10.37 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.159 2.184 . . . . 0.0 107.95 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 1.8 p90 . . . . . 0 C--O 1.255 1.347 0 CA-C-O 117.416 -1.278 . . . . 0.0 108.677 -179.842 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -84.01 -170.34 3.03 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -118.13 26.77 9.41 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.201 -0.937 . . . . 0.0 110.587 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 56.21 62.03 2.5 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 124.571 1.148 . . . . 0.0 110.019 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -110.89 -45.33 3.48 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-O 117.125 -1.417 . . . . 0.0 112.623 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.5 pttt 43.87 37.07 1.53 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.321 2.248 . . . . 0.0 112.994 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -144.02 79.99 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 125.259 1.424 . . . . 0.0 108.684 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.04 100.25 8.07 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.25 154.62 81.69 Favored Pre-proline 0 C--O 1.239 0.55 0 C-N-CA 123.753 0.821 . . . . 0.0 110.613 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.1 146.1 80.97 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.949 1.766 . . . . 0.0 107.833 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -141.23 108.77 5.59 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -111.15 145.18 39.08 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.303 0.641 . . . . 0.0 110.227 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.28 -117.99 0.48 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.0 p -160.45 167.58 26.97 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 119.118 1.459 . . . . 0.0 114.018 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.0 mt -127.19 -2.56 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 123.463 0.705 . . . . 0.0 109.37 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -62.52 -28.65 69.99 Favored 'General case' 0 C--N 1.334 -0.094 0 O-C-N 119.4 -2.062 . . . . 0.0 115.028 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.41 -19.79 16.59 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.205 1.802 . . . . 0.0 112.635 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.7 mm -56.69 -54.48 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 127.458 2.303 . . . . 0.0 115.292 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -151.27 35.17 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.12 16.58 3.02 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.643 1.977 . . . . 0.0 114.29 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -88.22 94.89 9.97 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.596 1.558 . . . . 0.0 109.78 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -75.67 157.73 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 17.5 m0 -108.21 147.9 30.71 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.1 t -142.6 127.93 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 tp -72.31 107.62 5.01 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -124.88 124.82 42.88 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 120.602 1.547 . . . . 0.0 110.37 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 t0 47.81 57.24 6.19 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.443 1.116 . . . . 0.0 111.229 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 51.75 24.9 2.64 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.228 1.011 . . . . 0.0 113.542 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.3 m -142.96 127.05 17.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.9 mt -74.66 144.06 43.99 Favored 'General case' 0 CA--C 1.518 -0.258 0 O-C-N 119.55 -1.969 . . . . 0.0 109.306 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.4 pt -125.14 153.07 32.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 123.895 0.878 . . . . 0.0 108.862 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.36 123.02 44.05 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.3 m -111.25 78.23 1.77 Allowed Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.043 0.937 . . . . 0.0 108.87 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.73 -50.12 2.62 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.57 1.513 . . . . 0.0 110.425 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -141.98 79.73 1.68 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.637 1.175 . . . . 0.0 108.176 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -140.98 132.78 27.42 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.39 -42.56 98.91 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.632 0.582 . . . . 0.0 112.01 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -71.73 22.34 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -73.15 163.73 27.71 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 120.444 -1.41 . . . . 0.0 110.317 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.0 t -156.53 132.43 5.81 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.14 144.99 59.29 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.841 2.361 . . . . 0.0 110.633 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.56 164.51 34.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.523 1.129 . . . . 0.0 108.244 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -115.49 156.2 26.11 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 mm -123.0 136.06 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.24 126.14 46.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 119.926 1.239 . . . . 0.0 107.944 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -118.96 136.86 53.87 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.608 1.163 . . . . 0.0 110.481 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 mt -148.96 142.33 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.941 1.296 . . . . 0.0 109.246 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.7 p -84.83 153.69 22.78 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.2 m -79.53 130.2 35.17 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 120.173 -1.58 . . . . 0.0 108.117 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -79.14 -32.18 44.3 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -97.34 44.8 1.04 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.967 1.307 . . . . 0.0 110.65 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 m -66.22 -7.53 5.48 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 O-C-N 120.412 -1.43 . . . . 0.0 113.636 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -55.5 -28.92 57.5 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.285 0.948 . . . . 0.0 112.662 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.4 t -95.44 -11.13 28.1 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.902 0.774 . . . . 0.0 111.569 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.52 168.24 11.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -82.05 154.44 25.63 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -119.84 -18.31 8.29 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.056 1.343 . . . . 0.0 111.062 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -57.51 -39.59 76.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.107 2.563 . . . . 0.0 114.191 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -85.06 -12.8 52.23 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.178 0.991 . . . . 0.0 111.396 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.06 -162.26 24.99 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -93.94 103.66 11.01 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 126.148 1.779 . . . . 0.0 109.862 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.08 135.73 25.74 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.447 2.098 . . . . 0.0 109.966 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -133.15 178.06 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -137.76 131.4 31.19 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.033 0.533 . . . . 0.0 109.567 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.72 158.7 38.67 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.43 -170.09 22.69 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mt -98.85 166.73 11.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -130.31 94.77 3.74 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.98 -16.23 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 CA-C-O 116.574 -2.236 . . . . 0.0 116.977 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.15 22.95 0.11 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 120.493 2.146 . . . . 0.0 111.914 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 61.45 63.37 1.2 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.786 1.634 . . . . 0.0 108.993 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.49 127.17 27.15 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.219 -178.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 29.1 m -136.84 179.65 6.24 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.9 mt -64.08 153.54 37.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.185 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -161.09 133.57 6.07 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 89.6 m -101.0 125.76 47.63 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.81 -174.7 3.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 81' ' ' ASP . 10.2 tttt -117.48 148.39 41.87 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.7 p -121.67 -6.79 9.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 123.564 0.54 . . . . 0.0 111.458 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.5 72.31 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.421 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 8.4 t0 70.48 5.27 5.3 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.811 2.044 . . . . 0.0 114.34 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.71 143.85 42.13 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.164 1.786 . . . . 0.0 109.356 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -74.91 162.04 37.97 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.989 2.459 . . . . 0.0 113.277 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.1 p -156.8 169.1 25.53 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.342 1.457 . . . . 0.0 109.997 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.18 130.22 37.08 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 127.583 2.353 . . . . 0.0 105.164 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -136.99 70.38 1.4 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 122.118 0.961 . . . . 0.0 109.365 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.516 HD21 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -89.14 113.78 24.99 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 127.458 2.303 . . . . 0.0 109.067 -178.128 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.64 -28.5 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 O-C-N 124.745 1.278 . . . . 0.0 113.529 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -147.65 97.68 2.86 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.361 1.465 . . . . 0.0 109.43 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.95 159.21 2.64 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -135.23 134.03 39.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.5 pt -83.62 -40.38 15.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.7 tpt -63.98 -31.05 72.1 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.237 -0.887 . . . . 0.0 112.424 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.55 -50.18 73.69 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.1 mt -63.44 -35.6 80.96 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.528 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -75.38 -26.41 58.44 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.931 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -78.88 -31.45 45.47 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 120.711 -1.243 . . . . 0.0 113.217 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -112.29 158.07 38.18 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 118.949 0.795 . . . . 0.0 110.829 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -86.74 45.0 1.27 Allowed 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.287 2.658 . . . . 0.0 114.157 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -125.24 58.1 18.87 Favored Pre-proline 0 CA--C 1.553 1.064 0 O-C-N 120.608 -1.308 . . . . 0.0 112.195 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -62.21 117.96 4.83 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.946 3.097 . . . . 0.0 110.82 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.1 t -99.92 107.41 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 123.447 0.699 . . . . 0.0 110.621 -177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.82 -24.28 8.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 118.182 -0.914 . . . . 0.0 112.877 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.1 m -67.69 -11.35 58.12 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.363 0.983 . . . . 0.0 111.362 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -119.62 -16.1 8.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.256 1.422 . . . . 0.0 110.294 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.6 mt -83.74 154.9 23.35 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.08 0.854 . . . . 0.0 111.867 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -136.88 128.14 28.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.483 0.713 . . . . 0.0 110.212 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -71.29 126.46 29.69 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 103.698 -2.704 . . . . 0.0 103.698 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -104.35 145.53 30.12 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.749 0.704 . . . . 0.0 110.25 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.66 -175.22 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.854 -0.529 . . . . 0.0 109.96 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -143.99 151.05 39.22 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.884 1.674 . . . . 0.0 106.959 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.5 p -124.98 -7.11 7.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.89 -35.81 2.39 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -147.68 -5.4 0.48 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.028 1.331 . . . . 0.0 112.082 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -131.57 177.33 7.58 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 125.331 1.452 . . . . 0.0 108.787 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 m -140.64 145.82 37.11 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.552 1.541 . . . . 0.0 110.078 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.65 166.9 10.63 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.926 0.89 . . . . 0.0 108.623 178.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -147.34 114.21 6.11 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.057 1.343 . . . . 0.0 107.773 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -114.83 130.5 56.88 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 127.103 2.161 . . . . 0.0 112.11 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.3 t -53.02 124.01 13.14 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.37 0.668 . . . . 0.0 109.764 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 79.1 t -67.48 -54.11 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 O-C-N 121.08 -1.012 . . . . 0.0 110.137 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.44 -33.52 68.0 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.085 0.954 . . . . 0.0 113.182 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -135.95 80.91 41.0 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 124.647 1.179 . . . . 0.0 109.778 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.44 163.1 37.94 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.005 2.47 . . . . 0.0 109.848 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 96.77 -3.24 62.68 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.582 1.087 . . . . 0.0 110.653 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -125.63 121.82 34.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.731 1.612 . . . . 0.0 108.522 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -106.1 145.87 30.9 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.423 1.489 . . . . 0.0 109.575 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 pt -75.09 121.32 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.08 121.25 27.16 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 68.8 t -78.24 -20.06 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 127.656 2.382 . . . . 0.0 113.385 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m 59.21 66.11 1.09 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.406 1.098 . . . . 0.0 110.438 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.3 m -99.36 36.7 1.69 Allowed 'General case' 0 C--N 1.323 -0.575 0 O-C-N 120.963 -1.085 . . . . 0.0 112.239 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -126.37 -98.96 0.39 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.935 0.494 . . . . 0.0 109.957 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -94.17 23.96 29.13 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-O 117.058 -1.968 . . . . 0.0 117.133 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.38 52.02 6.97 Favored Glycine 0 C--O 1.238 0.376 0 CA-C-N 119.743 1.771 . . . . 0.0 113.306 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.29 164.65 40.03 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.27 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.32 156.87 37.31 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 N-CA-C 107.04 -1.946 . . . . 0.0 107.04 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.7 mt -82.94 118.68 23.64 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.537 1.135 . . . . 0.0 110.862 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.33 167.48 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 123.787 0.835 . . . . 0.0 111.458 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.5 mt -86.14 151.89 23.29 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.1 t -141.36 137.29 32.24 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -83.02 -33.98 26.38 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 122.154 0.978 . . . . 0.0 109.43 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.15 101.51 3.15 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -177.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.88 -160.1 0.34 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.707 -1.588 . . . . 0.0 108.905 178.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 123.74 -5.59 9.13 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 125.542 1.544 . . . . 0.0 112.417 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.18 103.94 1.47 Allowed 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 118.338 1.069 . . . . 0.0 112.279 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 80.72 -2.09 1.85 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 129.656 3.182 . . . . 0.0 114.328 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -121.52 74.95 1.15 Allowed 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.752 2.421 . . . . 0.0 110.276 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.77 106.52 1.53 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 117.317 -1.325 . . . . 0.0 108.898 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.7 p -100.9 -12.99 18.53 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 122.147 2.249 . . . . 0.0 111.108 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -101.69 103.96 14.76 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 130.135 3.374 . . . . 0.0 118.072 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -168.68 177.06 5.31 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.333 -0.854 . . . . 0.0 112.927 177.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.15 178.19 26.69 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.077 1.322 . . . . 0.0 111.675 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.77 144.91 50.81 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.474 1.509 . . . . 0.0 109.534 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.4 m -104.52 48.69 0.83 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.19 158.83 35.74 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.9 mt -129.55 159.49 36.17 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.95 1.3 . . . . 0.0 108.991 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 11.0 p90 . . . . . 0 C--O 1.245 0.834 0 CA-C-O 115.587 -2.149 . . . . 0.0 108.573 -179.858 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.41 169.11 20.92 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.594 1.088 . . . . 0.0 110.06 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -77.62 28.48 0.16 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.335 1.854 . . . . 0.0 112.291 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 56.43 33.58 22.71 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.75 1.22 . . . . 0.0 112.092 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -74.42 168.59 19.4 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 121.665 -0.647 . . . . 0.0 109.58 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -138.31 -22.12 1.03 Allowed 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.84 -39.97 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 O-C-N 123.737 0.648 . . . . 0.0 111.115 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -121.79 114.27 20.84 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.57 162.49 54.48 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 123.977 0.911 . . . . 0.0 108.573 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.63 156.12 58.03 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 N-CA-C 108.301 -1.461 . . . . 0.0 108.301 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.36 116.84 27.02 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 pm0 -113.3 142.47 45.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 122.568 0.347 . . . . 0.0 110.468 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.06 -125.97 0.89 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-O 118.27 -1.295 . . . . 0.0 111.284 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.8 p -154.05 -159.74 1.01 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 120.918 2.359 . . . . 0.0 111.188 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -153.84 -4.5 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 126.329 1.852 . . . . 0.0 109.122 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -62.93 -29.68 70.97 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.74 -16.47 40.3 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.637 1.175 . . . . 0.0 113.487 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mt -61.49 -45.73 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 C-N-CA 125.666 1.586 . . . . 0.0 112.383 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.82 21.84 1.0 Allowed 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.091 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.8 t60 63.95 43.78 5.09 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.414 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 0.1 OUTLIER -113.88 94.1 4.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.794 0.838 . . . . 0.0 109.558 178.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.58 143.67 11.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.407 ' CH2' ' HB2' ' A' ' 21' ' ' ARG . 5.2 m95 -100.53 139.63 35.93 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -135.67 141.07 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 tp -79.98 103.29 9.76 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.7 134.42 50.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.3 t0 39.16 65.76 0.63 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.202 1.401 . . . . 0.0 112.148 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 44.21 31.94 0.62 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.456 1.502 . . . . 0.0 114.597 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.6 m -144.57 162.97 35.28 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.837 1.655 . . . . 0.0 106.77 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.5 mt -103.06 120.29 40.4 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 1.4 mm -119.08 139.66 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 118.03 0.377 . . . . 0.0 110.331 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.62 138.25 39.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 m -122.37 60.66 13.65 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.372 1.069 . . . . 0.0 110.336 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -56.51 -37.64 96.97 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.199 1.933 . . . . 0.0 114.967 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -136.62 13.18 3.2 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.22 128.08 34.71 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.3 1.04 . . . . 0.0 108.369 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.45 6.14 1.51 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.335 1.854 . . . . 0.0 113.094 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -129.02 40.45 3.63 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.363 -1.461 . . . . 0.0 109.881 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.7 ptp -72.58 167.72 20.11 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.836 -0.54 . . . . 0.0 110.217 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.13 128.73 2.19 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.85 157.7 51.25 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.517 2.145 . . . . 0.0 110.474 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.5 m -144.54 166.52 12.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.96 162.73 16.04 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.7 mm -132.05 109.76 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 C-N-CA 126.951 2.1 . . . . 0.0 107.3 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.89 136.54 34.06 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.4 tt -129.38 132.59 47.07 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.7 mt -142.26 141.34 28.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 124.797 1.239 . . . . 0.0 109.323 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.4 t -76.39 164.87 25.59 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.5 m -89.76 146.72 24.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -109.37 -20.92 12.75 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -105.75 39.84 1.69 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 122.475 1.131 . . . . 0.0 109.939 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 m -66.7 -6.03 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.52 1.128 . . . . 0.0 112.653 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -33.77 66.23 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.277 1.031 . . . . 0.0 111.855 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 t -101.79 13.67 34.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.649 1.179 . . . . 0.0 111.885 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.7 mt -107.14 179.58 4.22 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 120.713 -1.242 . . . . 0.0 111.006 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -84.3 153.07 23.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.639 1.176 . . . . 0.0 107.948 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -124.95 -37.78 2.41 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 123.606 0.762 . . . . 0.0 110.491 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -53.98 -44.28 70.67 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.741 1.216 . . . . 0.0 111.84 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -67.54 -27.28 66.83 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.086 -1.435 . . . . 0.0 112.2 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.51 178.84 16.6 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 126.415 1.959 . . . . 0.0 110.512 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.54 120.17 80.39 Favored Pre-proline 0 CA--C 1.541 0.619 0 O-C-N 121.561 -0.964 . . . . 0.0 111.883 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.63 141.79 15.76 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.51 2.807 . . . . 0.0 110.256 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -143.58 -179.47 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.888 2.075 . . . . 0.0 108.083 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -136.83 151.66 49.39 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 tt -145.36 154.87 42.77 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.19 -174.78 28.34 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.43 161.15 13.94 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -130.32 105.4 7.87 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.07 -31.24 0.11 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-O 118.45 -1.195 . . . . 0.0 113.513 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -153.35 37.02 0.47 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.142 1.471 . . . . 0.0 110.402 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 49.83 78.98 0.09 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.233 2.213 . . . . 0.0 111.582 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.75 141.85 31.82 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.233 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 36.5 m -141.16 170.07 16.42 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.323 0.965 . . . . 0.0 112.026 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.3 mt -56.2 149.66 15.72 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.243 1.383 . . . . 0.0 111.435 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.8 mtp -156.64 138.78 14.58 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.3 m -107.57 124.87 50.57 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.29 -178.94 5.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.29 1.436 . . . . 0.0 107.913 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -119.81 146.26 45.86 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 124.159 0.983 . . . . 0.0 109.219 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 p -119.28 6.63 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 O-C-N 123.893 0.746 . . . . 0.0 112.47 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.22 87.0 0.49 Allowed Glycine 0 C--O 1.223 -0.581 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 63.86 17.77 10.74 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.07 143.41 7.17 Favored Pre-proline 0 C--O 1.24 0.575 0 C-N-CA 123.093 0.557 . . . . 0.0 110.906 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.56 164.63 33.43 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.658 2.239 . . . . 0.0 112.604 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.81 160.63 34.05 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.696 1.598 . . . . 0.0 108.905 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 mt -75.87 148.96 37.92 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.28 33.8 2.55 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.96 0.904 . . . . 0.0 110.632 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.29 92.57 0.19 Allowed 'General case' 0 CA--C 1.496 -1.117 0 C-N-CA 129.686 3.195 . . . . 0.0 109.249 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.86 -45.97 0.05 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.691 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -128.78 98.2 4.91 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.463 1.105 . . . . 0.0 111.137 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -176.69 152.62 1.02 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.413 -1.429 . . . . 0.0 108.757 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -114.03 144.2 43.5 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.191 0.996 . . . . 0.0 109.942 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.2 tt -98.85 -44.98 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 125.166 1.386 . . . . 0.0 110.235 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -32.09 71.0 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.729 0.811 . . . . 0.0 110.406 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.3 -54.18 41.16 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.9 mt -59.66 -33.35 71.43 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 122.658 0.383 . . . . 0.0 111.699 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -73.79 -37.96 64.77 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -75.09 -36.73 61.71 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.657 1.583 . . . . 0.0 113.946 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -111.71 149.59 40.97 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 119.84 1.2 . . . . 0.0 111.718 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -76.63 56.68 5.27 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.177 3.251 . . . . 0.0 113.554 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -118.57 80.48 16.94 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.207 1.003 . . . . 0.0 108.441 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.86 74.98 5.02 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.807 3.004 . . . . 0.0 109.012 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -69.72 97.35 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 124.792 1.237 . . . . 0.0 109.314 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -52.45 -26.72 13.56 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.621 1.168 . . . . 0.0 112.9 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.0 -18.24 64.1 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.461 0.573 . . . . 0.0 112.239 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -115.96 -23.81 8.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.479 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.1 mt -72.89 153.8 40.86 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.162 0.892 . . . . 0.0 111.319 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -136.49 138.46 41.43 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.261 1.025 . . . . 0.0 110.516 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.98 123.15 29.68 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 103.528 -2.767 . . . . 0.0 103.528 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -103.39 143.83 32.17 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.258 0.623 . . . . 0.0 109.44 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.85 169.83 20.75 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -140.28 151.76 45.36 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.347 1.459 . . . . 0.0 111.601 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.19 79.18 0.75 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.901 0.858 . . . . 0.0 112.707 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.62 62.95 1.58 Allowed Glycine 0 C--N 1.334 0.46 0 O-C-N 120.954 -1.091 . . . . 0.0 111.639 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.32 4.13 1.58 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.72 1.208 . . . . 0.0 112.861 -178.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.58 163.48 12.44 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.0 m -146.16 152.48 39.32 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.39 159.9 41.18 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -132.18 120.1 21.78 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.407 ' HB2' ' CE2' ' A' ' 127' ' ' PHE . 4.1 tt0 -112.42 131.21 55.67 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.418 1.087 . . . . 0.0 109.116 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.4 121.67 8.8 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.725 1.61 . . . . 0.0 109.705 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.8 t -70.99 -40.61 76.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 O-C-N 120.7 -1.25 . . . . 0.0 111.954 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.62 -38.3 77.73 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.077 0.853 . . . . 0.0 111.918 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -139.2 97.36 8.64 Favored Pre-proline 0 C--O 1.24 0.568 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.02 174.3 10.8 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.366 2.044 . . . . 0.0 109.208 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 91.11 -3.42 80.32 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -125.19 129.74 50.72 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.033 1.333 . . . . 0.0 107.535 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.407 ' CE2' ' HB2' ' A' ' 119' ' ' GLU . 79.3 m-85 -114.92 142.24 46.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.29 1.836 . . . . 0.0 108.322 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 mt -74.02 136.12 25.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 O-C-N 121.999 -0.438 . . . . 0.0 110.511 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.29 141.2 30.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.218 0.532 . . . . 0.0 110.358 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.1 t -93.15 -13.44 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 126.557 1.943 . . . . 0.0 109.254 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.2 m 52.89 37.38 24.15 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.414 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 16.2 m -73.37 -2.01 20.49 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -74.08 -85.01 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 O-C-N 120.331 -1.481 . . . . 0.0 112.049 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -99.06 -22.52 13.04 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.659 1.123 . . . . 0.0 113.935 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 115.59 54.31 0.37 Allowed Glycine 0 CA--C 1.522 0.509 0 CA-C-N 118.543 1.171 . . . . 0.0 111.271 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.7 m -82.04 164.64 47.45 Favored Pre-proline 0 C--O 1.236 0.37 0 CA-C-N 117.715 0.757 . . . . 0.0 109.763 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 58.1 Cg_endo -68.93 171.59 13.29 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 N-CA-C 107.193 -1.887 . . . . 0.0 107.193 176.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.2 mt -96.0 109.12 21.56 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.073 0.949 . . . . 0.0 109.47 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.24 178.21 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.711 1.605 . . . . 0.0 110.678 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.79 169.93 10.3 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.0 t -162.06 149.88 14.53 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.109 1.364 . . . . 0.0 109.221 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -92.6 -40.38 10.8 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.894 0.878 . . . . 0.0 110.059 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -145.89 99.75 3.31 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.04 -166.52 0.16 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.441 -1.254 . . . . 0.0 107.885 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 134.6 -9.23 4.62 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-O 118.641 -1.088 . . . . 0.0 111.056 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.18 77.91 1.6 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 78.39 22.99 0.7 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 127.747 2.419 . . . . 0.0 116.323 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -129.87 74.9 1.62 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 120.578 1.535 . . . . 0.0 110.937 -178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.6 p -61.37 99.22 0.1 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.584 1.554 . . . . 0.0 112.085 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.3 p -88.13 -35.12 17.62 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 121.405 1.911 . . . . 0.0 109.355 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -78.35 101.12 7.05 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 126.102 1.761 . . . . 0.0 111.971 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -167.77 177.57 5.71 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.132 0.878 . . . . 0.0 111.888 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.6 -160.98 30.01 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.8 tp -141.62 153.42 44.74 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.52 29.73 6.29 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.874 1.67 . . . . 0.0 109.355 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -65.9 142.68 57.82 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.5 mt -127.49 158.15 38.18 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.624 1.569 . . . . 0.0 110.345 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 27.8 p90 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 115.767 -2.063 . . . . 0.0 108.612 179.911 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 119.832 -0.127 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -72.65 158.83 34.89 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -84.0 -0.62 52.35 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.102 -0.999 . . . . 0.0 111.371 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 85.27 38.06 0.02 OUTLIER 'General case' 0 C--N 1.341 0.229 0 C-N-CA 129.493 3.117 . . . . 0.0 112.012 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.409 ' H ' HD23 ' A' ' 5' ' ' LEU . 1.3 pt? -101.39 170.43 8.23 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.523 1.129 . . . . 0.0 110.372 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.438 ' HB3' ' HE2' ' A' ' 6' ' ' LYS . 0.6 OUTLIER -141.35 -17.1 0.81 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -178.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.36 -35.81 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 126.732 2.013 . . . . 0.0 109.906 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 49.57 24.25 1.11 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 128.146 2.578 . . . . 0.0 111.848 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.17 151.31 85.85 Favored Pre-proline 0 C--O 1.224 -0.285 0 C-N-CA 126.614 1.966 . . . . 0.0 113.206 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.64 135.63 26.5 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.462 2.108 . . . . 0.0 109.271 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.36 120.49 32.28 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.69 0.796 . . . . 0.0 108.985 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.01 137.0 52.51 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.314 0.646 . . . . 0.0 111.299 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.29 -125.21 0.76 Allowed Glycine 0 C--N 1.335 0.505 0 O-C-N 121.188 -0.945 . . . . 0.0 113.735 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 p -152.0 -170.22 3.58 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.991 1.395 . . . . 0.0 112.59 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.21 6.76 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 125.864 1.666 . . . . 0.0 110.952 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -59.3 -50.55 73.56 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 120.549 -1.344 . . . . 0.0 110.759 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -47.1 -0.17 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 1 C-N-CA 132.139 4.176 . . . . 0.0 118.554 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mt -85.51 -60.56 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 C-N-CA 127.86 2.464 . . . . 0.0 110.492 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.05 23.31 2.05 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.392 0.677 . . . . 0.0 110.138 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 72.26 12.14 5.81 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.46 2.704 . . . . 0.0 113.992 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.76 95.09 7.16 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 127.272 2.229 . . . . 0.0 113.086 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.8 t -79.39 159.49 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -107.44 142.79 36.73 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.0 t -138.14 119.16 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 123.851 0.861 . . . . 0.0 110.374 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 tp -75.47 108.08 8.03 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.559 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 37.6 tt0 -94.96 -175.42 3.54 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.559 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 3.1 t0 -46.11 90.01 0.0 OUTLIER 'General case' 0 C--O 1.234 0.243 0 C-N-CA 129.952 3.301 . . . . 0.0 109.585 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 46.46 32.92 1.74 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.841 1.656 . . . . 0.0 110.502 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.0 m -152.49 135.38 15.53 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mt -96.14 137.74 34.78 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 120.897 -1.127 . . . . 0.0 108.326 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.4 pt -136.49 151.44 28.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.805 0.842 . . . . 0.0 111.616 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.98 139.51 31.26 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.461 0.704 . . . . 0.0 110.225 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.9 m -123.72 108.81 30.64 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.9 -81.03 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.198 1.932 . . . . 0.0 110.871 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.13 6.65 16.41 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.631 1.573 . . . . 0.0 112.46 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -52.04 120.26 5.2 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -58.39 -31.24 67.48 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.089 0.956 . . . . 0.0 111.626 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.86 67.75 6.21 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -118.48 164.54 15.11 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.626 1.17 . . . . 0.0 108.899 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 t -141.63 135.42 14.72 Favored Pre-proline 0 N--CA 1.446 -0.636 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.81 134.78 24.45 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.544 2.829 . . . . 0.0 109.58 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.8 m -128.41 159.83 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 122.696 1.236 . . . . 0.0 108.413 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.15 158.29 23.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 113.139 -1.846 . . . . 0.0 107.64 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.0 mm -123.77 153.02 29.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.61 125.38 23.97 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.6 tt -123.45 141.33 52.11 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.653 1.181 . . . . 0.0 110.264 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.4 mt -149.93 152.9 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 126.253 1.821 . . . . 0.0 108.278 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.4 p -103.37 134.44 46.74 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.667 1.587 . . . . 0.0 109.389 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.9 m -54.53 109.34 0.49 Allowed 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.953 1.701 . . . . 0.0 114.126 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -75.95 -24.82 55.48 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 117.8 -1.095 . . . . 0.0 111.316 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -98.09 49.66 1.01 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-N 119.777 1.171 . . . . 0.0 110.366 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 m -73.79 -1.79 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.099 -1.001 . . . . 0.0 112.115 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -62.99 -0.91 0.77 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.549 1.94 . . . . 0.0 112.842 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 t -132.87 -1.27 3.36 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.859 1.664 . . . . 0.0 110.913 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.28 163.4 13.41 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.745 1.259 . . . . 0.0 109.565 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.506 ' HB2' ' HH ' ' A' ' 108' ' ' TYR . 10.2 mm-40 -82.05 152.4 26.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.654 -1.612 . . . . 0.0 107.641 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -118.83 -29.81 5.24 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.334 1.054 . . . . 0.0 111.095 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -67.85 -38.56 83.3 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.136 1.774 . . . . 0.0 112.312 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -68.1 -25.89 65.54 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.559 1.144 . . . . 0.0 112.84 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.99 -167.65 32.26 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -102.34 97.62 9.06 Favored Pre-proline 0 N--CA 1.466 0.346 0 CA-C-O 117.554 -1.213 . . . . 0.0 109.799 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.71 122.53 9.22 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.204 2.602 . . . . 0.0 109.851 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.13 -177.45 2.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 124.612 1.165 . . . . 0.0 109.821 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -139.78 140.31 36.65 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 122.285 1.041 . . . . 0.0 109.51 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tt -149.01 150.37 32.7 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.716 1.206 . . . . 0.0 110.034 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.78 -171.77 21.89 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.446 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.5 mt -93.74 146.02 24.15 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -110.05 113.45 26.17 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.26 -43.84 0.51 Allowed Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.514 -1.159 . . . . 0.0 113.861 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.33 24.8 4.15 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.572 1.686 . . . . 0.0 114.659 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 m120 60.04 63.87 1.36 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.219 0.918 . . . . 0.0 111.592 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.28 132.65 20.66 Favored 'General case' 0 CA--C 1.51 -0.569 0 O-C-N 120.336 -1.478 . . . . 0.0 110.405 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.441 ' H ' ' HB2' ' A' ' 90' ' ' LYS . 8.5 m -136.93 172.74 12.57 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.463 0.705 . . . . 0.0 112.071 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.464 ' HA ' ' HG ' ' A' ' 87' ' ' LEU . 13.9 mt -62.13 154.29 27.57 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.913 0.885 . . . . 0.0 111.699 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.529 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 3.2 tmm? -164.41 151.12 11.19 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 24.0 m -112.0 122.75 48.63 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.134 0.574 . . . . 0.0 109.608 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.25 151.26 50.43 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.226 1.01 . . . . 0.0 109.522 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.1 tttt -86.88 124.87 33.58 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.4 p -80.24 -17.19 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.48 -63.77 0.33 Allowed Glycine 0 CA--C 1.548 2.094 1 C-N-CA 133.252 5.215 . . . . 0.0 108.407 -177.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -103.34 -27.19 12.6 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 119.722 3.231 . . . . 0.0 119.722 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -133.48 155.91 80.19 Favored Pre-proline 0 CA--C 1.566 1.586 0 C-N-CA 130.001 3.32 . . . . 0.0 115.754 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -74.3 144.37 32.88 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.793 1.662 . . . . 0.0 108.971 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.9 p -140.84 169.62 17.29 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.271 1.428 . . . . 0.0 109.549 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.2 mt -90.71 150.22 21.73 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.27 75.69 1.52 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.765 1.226 . . . . 0.0 110.923 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.464 ' HG ' ' HA ' ' A' ' 74' ' ' LEU . 1.0 OUTLIER -94.65 116.0 28.23 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.13 -13.81 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -158.6 97.51 1.46 Allowed 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 117.67 -1.157 . . . . 0.0 109.607 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.529 ' HE3' ' HB2' ' A' ' 75' ' ' MET . 0.3 OUTLIER -171.21 149.16 2.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 121.393 1.906 . . . . 0.0 109.655 -179.214 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -129.07 114.55 16.51 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.172 0.989 . . . . 0.0 108.847 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.8 pt -62.06 -42.58 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 120.659 -1.275 . . . . 0.0 112.871 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.3 tpt -69.17 -16.28 63.6 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.108 1.363 . . . . 0.0 112.253 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -79.4 -52.04 8.6 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.277 0.944 . . . . 0.0 108.936 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 35.1 mt -65.96 -21.05 66.4 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.62 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -90.81 -34.33 15.35 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -63.41 -36.76 84.79 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.452 1.478 . . . . 0.0 109.423 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.68 156.02 43.07 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.067 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.52 59.54 5.56 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 123.745 2.963 . . . . 0.0 111.197 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -128.14 64.61 66.94 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.846 1.258 . . . . 0.0 112.128 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.4 95.4 0.86 Allowed 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 124.942 3.761 . . . . 0.0 109.849 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 47.1 t -84.78 106.36 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 O-C-N 120.983 -1.073 . . . . 0.0 109.7 -178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -51.52 -29.89 18.39 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.603 1.561 . . . . 0.0 113.269 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.4 m -67.32 -10.67 53.18 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -120.52 -17.86 7.98 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.619 0.768 . . . . 0.0 110.12 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.6 mt -79.68 154.08 28.87 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.428 1.091 . . . . 0.0 110.397 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -140.36 133.82 30.0 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 123.248 0.619 . . . . 0.0 110.851 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.506 ' HH ' ' HB2' ' A' ' 56' ' ' GLU . 63.2 m-85 -76.07 122.6 24.49 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -75.89 103.49 5.99 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.6 t -100.59 178.14 4.81 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.2 156.71 42.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.415 0.686 . . . . 0.0 111.523 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.6 p -132.27 42.13 3.15 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.14 0.976 . . . . 0.0 113.06 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.67 -55.18 2.32 Favored Glycine 0 C--N 1.333 0.396 0 O-C-N 120.215 -1.553 . . . . 0.0 113.435 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -131.19 2.13 4.25 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.644 1.222 . . . . 0.0 112.071 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -134.08 173.49 11.53 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.065 0.546 . . . . 0.0 111.237 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.8 m -116.89 153.87 31.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.846 1.658 . . . . 0.0 109.627 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.01 168.29 19.07 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -138.77 112.56 8.41 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -105.45 117.88 35.14 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 126.901 2.08 . . . . 0.0 109.651 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.9 t -51.16 122.15 7.24 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.293 0.637 . . . . 0.0 111.761 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.1 t -65.1 -45.57 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 O-C-N 121.739 -0.601 . . . . 0.0 110.34 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.23 -38.43 85.22 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.764 -0.585 . . . . 0.0 112.376 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -124.18 80.63 58.44 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.583 0.753 . . . . 0.0 108.992 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -66.94 143.4 66.1 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.55 3.5 . . . . 0.0 110.87 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.81 -22.43 14.62 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 128.449 2.928 . . . . 0.0 113.067 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -99.24 131.96 44.9 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.951 1.7 . . . . 0.0 111.585 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -111.51 142.15 44.16 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.434 1.094 . . . . 0.0 110.597 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.3 mt -73.67 133.87 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -103.23 147.94 26.43 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 6.5 m -91.83 -17.12 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.356 1.462 . . . . 0.0 114.591 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.45 90.56 0.07 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.325 1.85 . . . . 0.0 107.209 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . 0.259 0.0 OUTLIER -107.8 7.87 28.47 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.416 -0.802 . . . . 0.0 111.933 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -135.5 143.41 45.8 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.325 1.05 . . . . 0.0 109.837 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.97 -58.26 0.06 OUTLIER Glycine 0 CA--C 1.531 1.066 0 C-N-CA 127.073 2.273 . . . . 0.0 115.848 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 132.73 45.64 0.13 Allowed Glycine 0 CA--C 1.523 0.555 0 C-N-CA 129.093 3.235 . . . . 0.0 107.352 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 83.4 m -71.91 162.43 73.4 Favored Pre-proline 0 C--O 1.24 0.576 0 CA-C-N 118.064 0.932 . . . . 0.0 110.474 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.26 162.25 28.47 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 120.766 0.977 . . . . 0.0 111.598 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.4 mt -77.88 114.96 17.25 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.701 1.201 . . . . 0.0 109.031 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pp -146.24 176.26 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 123.161 0.584 . . . . 0.0 109.75 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 20.7 mt -101.35 150.01 23.45 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.543 0.737 . . . . 0.0 109.26 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.1 t -144.52 131.68 20.58 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -82.3 -24.73 34.5 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 122.235 -0.291 . . . . 0.0 111.197 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -167.61 94.84 0.43 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.104 1.362 . . . . 0.0 107.345 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.11 175.55 5.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.992 0.901 . . . . 0.0 111.635 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -122.84 51.64 0.79 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 126.15 1.833 . . . . 0.0 109.691 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.4 -0.72 0.48 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 129.286 3.034 . . . . 0.0 114.492 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -93.59 -15.69 25.14 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -128.02 99.51 5.52 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.428 1.013 . . . . 0.0 109.119 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.39 128.54 36.83 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.66 1.184 . . . . 0.0 109.906 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.6 p -114.71 -22.57 9.64 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.168 1.387 . . . . 0.0 112.922 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -118.45 129.06 55.18 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.304 0.641 . . . . 0.0 112.07 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -170.55 -176.47 2.13 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.462 1.905 . . . . 0.0 109.553 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.42 -159.75 31.07 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.7 tp -147.54 166.22 27.98 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.5 m -128.63 49.85 2.16 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.065 1.346 . . . . 0.0 107.921 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -75.21 141.2 43.61 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 22.8 mt -108.53 167.47 10.02 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.512 1.125 . . . . 0.0 108.05 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 31.3 p90 . . . . . 0 C--O 1.251 1.171 0 C-N-CA 126.911 2.084 . . . . 0.0 106.74 -179.564 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptt? . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -123.59 172.84 8.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.534 1.534 . . . . 0.0 107.077 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -127.43 42.67 3.28 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 40.8 69.98 0.29 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.962 1.705 . . . . 0.0 112.47 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.5 pp -147.45 9.0 0.92 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.3 pttt -144.8 -14.16 0.55 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.71 -43.01 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 C-N-CA 125.725 1.61 . . . . 0.0 108.112 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -123.89 116.45 22.94 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.47 153.36 45.72 Favored Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.02 149.01 71.12 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 N-CA-C 107.061 -1.938 . . . . 0.0 107.061 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.47 115.77 19.39 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.77 149.1 27.68 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.08 -137.41 2.9 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 120.045 1.293 . . . . 0.0 109.98 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.7 p -144.84 -168.33 2.89 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 119.15 1.475 . . . . 0.0 111.214 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.7 mt -142.51 -7.03 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 126.903 2.081 . . . . 0.0 107.753 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -45.61 -42.79 11.67 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 127.0 2.12 . . . . 0.0 112.283 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -55.57 -24.13 30.88 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.0 mm -54.65 -68.84 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 123.729 0.811 . . . . 0.0 112.149 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.52 29.64 3.89 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 123.718 0.637 . . . . 0.0 112.366 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.1 m80 61.8 47.86 5.85 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 -122.94 100.28 6.81 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.1 t -85.78 154.53 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -120.23 131.16 54.84 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.39 144.88 35.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 tp -78.14 102.04 7.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -120.48 133.95 55.34 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 t0 45.48 53.41 8.38 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.008 1.323 . . . . 0.0 112.373 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.446 ' HB3' ' HZ2' ' A' ' 88' ' ' LYS . 63.9 mm-40 52.59 29.05 6.72 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.7 m -143.17 159.79 41.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.021 1.728 . . . . 0.0 107.391 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.1 mt -96.49 125.48 41.01 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 119.666 -1.896 . . . . 0.0 106.325 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 1.2 mt -126.84 130.8 71.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 123.604 0.565 . . . . 0.0 110.731 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.98 135.8 49.78 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 m -126.56 74.21 74.42 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 123.839 0.855 . . . . 0.0 110.643 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.23 -43.15 15.48 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.7 2.267 . . . . 0.0 111.387 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -146.51 71.41 1.24 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.544 1.138 . . . . 0.0 108.91 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -120.84 124.22 44.5 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 102.035 -3.32 . . . . 0.0 102.035 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.52 -14.34 19.11 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.95 1.3 . . . . 0.0 113.312 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -113.87 30.43 7.26 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.658 1.183 . . . . 0.0 111.461 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -74.47 161.49 29.74 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.4 t -153.1 142.85 15.05 Favored Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.59 142.38 58.6 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.657 2.238 . . . . 0.0 108.767 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 t -143.61 136.23 24.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 105.915 -1.884 . . . . 0.0 105.915 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.75 162.46 16.22 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.966 0.906 . . . . 0.0 109.845 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.2 mm -130.4 121.99 52.26 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 C-N-CA 127.525 2.33 . . . . 0.0 108.748 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.06 129.98 46.17 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 120.69 1.587 . . . . 0.0 108.461 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.2 tt -122.48 132.24 54.24 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.132 1.773 . . . . 0.0 107.546 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.5 mp -144.09 141.92 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 124.669 1.187 . . . . 0.0 108.826 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 p -79.34 138.59 37.75 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.424 ' HA ' ' CZ ' ' A' ' 64' ' ' TYR . 58.8 m -60.11 124.06 19.08 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.23 -0.08 47.34 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -128.32 49.91 2.13 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.964 1.305 . . . . 0.0 110.272 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.4 m -72.88 6.57 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.684 1.194 . . . . 0.0 113.794 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -49.49 -32.42 12.08 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 128.051 2.54 . . . . 0.0 116.149 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.1 t -125.63 25.44 6.96 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.903 0.881 . . . . 0.0 110.607 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -116.2 155.77 27.71 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 121.183 -0.948 . . . . 0.0 108.917 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.98 152.15 46.31 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 mttm -124.99 -31.22 3.15 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.911 0.485 . . . . 0.0 110.644 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.45 -34.09 76.99 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.182 0.993 . . . . 0.0 112.118 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -64.24 -36.1 82.97 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.429 ' HA3' ' CD1' ' A' ' 108' ' ' TYR . . . 147.47 171.49 16.63 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 127.016 2.246 . . . . 0.0 110.755 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.51 116.38 30.84 Favored Pre-proline 0 C--O 1.238 0.484 0 O-C-N 121.463 -1.022 . . . . 0.0 109.372 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.72 136.15 18.65 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 N-CA-C 106.653 -2.095 . . . . 0.0 106.653 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.258 14.0 pt -137.74 170.69 16.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.424 ' CZ ' ' HA ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -131.41 147.98 52.61 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.769 0.795 . . . . 0.0 111.202 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 tt -148.26 157.14 43.31 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.344 1.058 . . . . 0.0 110.763 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.6 -173.61 30.46 Favored Glycine 0 C--O 1.226 -0.398 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mt -97.67 162.17 13.41 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.357 1.063 . . . . 0.0 110.441 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -132.09 84.08 2.13 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.234 -0.916 . . . . 0.0 108.765 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -158.44 -30.37 0.02 OUTLIER Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.795 -1.003 . . . . 0.0 113.013 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.15 19.45 0.57 Allowed 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.6 m120 68.16 68.41 0.33 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.943 1.697 . . . . 0.0 109.076 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.91 136.03 30.05 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.906 1.282 . . . . 0.0 109.89 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 32.2 m -142.09 175.1 10.0 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.773 0.715 . . . . 0.0 111.044 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.0 mt -58.75 149.95 24.98 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.899 0.772 . . . . 0.0 109.994 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.7 ttp -159.25 123.42 3.91 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 84.0 m -97.2 125.36 41.68 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 120.144 1.338 . . . . 0.0 109.079 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.81 146.29 31.11 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.08 0.952 . . . . 0.0 109.291 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -77.87 131.39 37.5 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 p -80.91 7.0 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.0 0.52 . . . . 0.0 111.508 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.82 10.35 49.96 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -148.03 -57.2 0.23 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.474 1.51 . . . . 0.0 109.772 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -140.3 162.44 49.74 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.065 1.746 . . . . 0.0 110.877 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.89 149.58 72.48 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.862 1.708 . . . . 0.0 110.521 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.9 p -147.3 166.06 28.23 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.91 1.684 . . . . 0.0 107.201 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.3 mt -92.57 148.14 22.32 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -138.97 64.87 1.46 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.446 ' H ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -81.86 102.77 11.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.446 ' HZ2' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -157.18 -39.44 0.07 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.143 0.977 . . . . 0.0 113.022 -178.045 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -145.1 104.69 3.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.755 1.622 . . . . 0.0 109.407 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.437 ' HE2' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -177.22 158.57 1.5 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 178.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.437 ' N ' ' HE2' ' A' ' 90' ' ' LYS . 1.4 m-20 -135.15 131.74 37.18 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.709 1.604 . . . . 0.0 109.687 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 mt -83.11 -37.18 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 118.175 0.443 . . . . 0.0 109.96 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.8 -25.26 66.44 Favored 'General case' 0 CA--C 1.524 -0.034 0 CA-C-O 117.982 -1.009 . . . . 0.0 112.565 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -72.0 -42.77 66.03 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 93.0 mt -62.87 -33.12 74.61 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.512 1.125 . . . . 0.0 108.378 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -75.8 -35.39 60.08 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -65.52 -46.0 81.32 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.202 -0.936 . . . . 0.0 110.767 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -125.31 152.16 70.79 Favored Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.85 83.35 1.39 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 123.621 2.881 . . . . 0.0 110.395 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -132.26 69.09 80.33 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.1 76.5 3.0 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.277 3.318 . . . . 0.0 107.833 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.4 t -83.09 102.14 8.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -177.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -49.99 -28.49 6.98 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.847 0.859 . . . . 0.0 112.023 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.7 m -63.8 -12.51 36.33 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -122.45 1.64 9.58 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.345 1.058 . . . . 0.0 109.98 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.3 mt -100.46 145.77 27.85 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -142.62 123.36 14.23 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.774 0.83 . . . . 0.0 109.454 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.429 ' CD1' ' HA3' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -67.7 124.96 24.73 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 127.765 2.426 . . . . 0.0 106.252 178.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -109.15 147.23 32.82 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.655 0.74 . . . . 0.0 110.052 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 t -138.64 172.14 13.32 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.12 1.768 . . . . 0.0 107.27 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.31 129.0 7.0 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.453 1.501 . . . . 0.0 109.508 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.0 p -141.94 79.54 1.68 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.05 58.85 1.54 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 124.02 0.819 . . . . 0.0 111.585 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 65.66 4.36 2.82 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.797 2.039 . . . . 0.0 112.694 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -112.86 127.92 56.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.4 m -108.68 155.54 20.6 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.197 1.399 . . . . 0.0 109.863 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 p -131.27 165.62 23.0 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.304 1.442 . . . . 0.0 111.661 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -142.65 110.31 5.81 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.607 1.163 . . . . 0.0 111.236 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -108.36 123.07 48.27 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.981 1.312 . . . . 0.0 109.462 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 59.6 m -53.64 125.71 19.2 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.747 1.219 . . . . 0.0 110.228 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.7 t -70.32 -41.3 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 O-C-N 121.175 -0.953 . . . . 0.0 111.623 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.47 -40.64 83.24 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.305 1.042 . . . . 0.0 112.242 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -136.3 90.61 17.63 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -65.9 165.07 24.84 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.025 1.817 . . . . 0.0 109.124 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.3 -18.58 56.62 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -100.85 121.08 41.1 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 118.628 1.214 . . . . 0.0 108.441 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -105.8 144.22 32.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 24.7 mt -71.42 142.47 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.26 113.79 27.53 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.577 0.703 . . . . 0.0 109.781 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.56 -10.71 14.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 C-N-CA 127.617 2.367 . . . . 0.0 112.482 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.5 m 46.02 84.31 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 118.394 2.739 . . . . 0.0 118.394 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 47.8 m -110.6 5.57 21.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -79.75 -93.78 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 O-C-N 121.067 -1.021 . . . . 0.0 112.437 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -99.64 4.78 58.15 Favored Glycine 0 C--N 1.342 0.91 0 C-N-CA 125.652 1.596 . . . . 0.0 116.575 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.31 49.23 2.44 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 18.1 m -80.29 161.99 63.04 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 124.231 1.013 . . . . 0.0 110.472 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 98.5 Cg_endo -73.83 155.33 48.71 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.192 1.261 . . . . 0.0 109.475 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.6 mt -84.72 122.41 29.06 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.241 1.016 . . . . 0.0 109.208 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.0 -168.99 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.32 1.448 . . . . 0.0 110.848 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.5 mt -103.44 153.72 20.2 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.411 1.484 . . . . 0.0 107.181 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.0 t -145.8 120.49 9.84 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.75 1.262 . . . . 0.0 108.796 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -78.76 -30.83 45.92 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.166 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -165.88 83.73 0.32 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 122.028 0.918 . . . . 0.0 112.217 -178.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.506 ' H ' HD23 ' A' ' 144' ' ' LEU . 0.6 OUTLIER -70.66 167.25 19.04 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.06 -1.025 . . . . 0.0 109.164 178.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -141.0 21.8 2.64 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.339 0.971 . . . . 0.0 113.251 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.96 18.73 1.44 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.062 1.345 . . . . 0.0 113.428 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 52.58 42.7 31.53 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.221 1.373 . . . . 0.0 109.576 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -42.97 -35.81 1.34 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.788 1.635 . . . . 0.0 114.65 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . 0.294 75.4 p 113.93 93.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 1 C-N-CA 135.132 5.373 . . . . 0.0 112.643 178.678 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 p -104.6 -29.54 10.56 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.284 1.033 . . . . 0.0 110.686 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -117.72 123.66 46.6 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 127.882 2.473 . . . . 0.0 110.947 -177.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -171.56 -175.62 1.63 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.503 2.321 . . . . 0.0 110.08 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -101.53 -176.89 28.58 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.505 1.05 . . . . 0.0 113.687 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.16 132.03 41.12 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.5 m -88.52 58.38 4.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 18.9 ptp -69.31 162.17 27.78 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.249 0.62 . . . . 0.0 109.518 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.1 mt -142.36 175.25 9.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.102 2.161 . . . . 0.0 106.762 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 53.0 p90 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 124.582 1.153 . . . . 0.0 110.727 179.819 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -78.71 148.79 32.93 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.7 0.762 . . . . 0.0 111.414 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -80.85 18.76 0.94 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 49.85 41.86 23.2 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.063 1.745 . . . . 0.0 109.872 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.5 HD11 ' H ' ' A' ' 7' ' ' ILE . 2.7 pp -66.2 -55.79 14.53 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -177.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 pttt 43.96 31.42 0.51 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 127.608 2.363 . . . . 0.0 114.023 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.5 ' H ' HD11 ' A' ' 5' ' ' LEU . 1.4 pp -138.44 78.15 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 123.152 0.581 . . . . 0.0 112.114 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -81.08 -6.79 59.22 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.425 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.93 159.91 83.98 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.307 1.443 . . . . 0.0 109.726 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.33 127.96 12.39 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.166 2.578 . . . . 0.0 110.093 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.36 111.21 23.56 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 123.782 0.676 . . . . 0.0 111.35 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -104.5 148.01 26.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.779 0.832 . . . . 0.0 110.618 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.46 -139.64 4.18 Favored Glycine 0 C--O 1.226 -0.396 0 O-C-N 121.255 -0.903 . . . . 0.0 111.226 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.2 p -152.33 -174.55 4.93 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 119.029 1.414 . . . . 0.0 113.684 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.67 5.28 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 125.319 1.448 . . . . 0.0 108.371 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -63.17 -38.63 91.93 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 119.923 -1.736 . . . . 0.0 109.293 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -51.5 -19.79 1.59 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 128.085 2.554 . . . . 0.0 114.086 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.2 mt -69.41 -67.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.811 1.644 . . . . 0.0 111.473 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.12 25.71 4.22 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.857 -0.527 . . . . 0.0 111.252 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.252 24.3 t60 57.62 41.09 26.12 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.514 2.726 . . . . 0.0 108.633 -177.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.28 109.86 20.47 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.947 -1.095 . . . . 0.0 110.981 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.4 t -91.86 158.42 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -115.84 106.86 14.31 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.303 1.041 . . . . 0.0 110.325 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.7 t -104.37 122.85 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 120.099 1.318 . . . . 0.0 108.578 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.8 tp -73.33 95.72 2.21 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 124.141 0.9 . . . . 0.0 108.626 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.99 174.79 8.85 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -8.89 -65.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 129.063 2.945 . . . . 0.0 114.935 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -142.05 18.24 2.11 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-O 117.691 -1.147 . . . . 0.0 109.279 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.65 134.71 14.87 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.685 1.129 . . . . 0.0 112.546 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mp -85.64 137.08 33.09 Favored 'General case' 0 CA--C 1.504 -0.795 0 O-C-N 121.514 -0.741 . . . . 0.0 109.27 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mm -131.39 140.51 48.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 O-C-N 124.094 0.871 . . . . 0.0 109.927 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.86 130.27 40.64 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -117.36 82.27 14.72 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 124.339 1.056 . . . . 0.0 108.738 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.25 -33.1 15.35 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.014 1.809 . . . . 0.0 113.778 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.8 ttm-85 -162.02 51.42 0.21 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.12 152.23 19.0 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 124.956 1.302 . . . . 0.0 107.622 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -61.36 1.8 Allowed 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 122.617 0.367 . . . . 0.0 110.473 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.8 ttm-85 -72.8 27.52 0.06 Allowed 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.696 1.198 . . . . 0.0 112.229 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -68.02 149.51 49.61 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.1 t -140.15 138.17 18.98 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -67.64 155.21 71.02 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 N-CA-C 108.055 -1.556 . . . . 0.0 108.055 178.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.7 m -146.38 155.32 12.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.91 158.76 20.68 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -125.69 116.28 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 125.507 1.523 . . . . 0.0 107.756 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.07 127.67 42.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 tt -125.25 145.64 49.9 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.388 1.075 . . . . 0.0 108.649 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.3 mt -148.03 154.22 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.662 1.985 . . . . 0.0 108.828 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.1 p -109.42 115.52 30.11 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.7 m -47.35 143.87 3.2 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.186 1.395 . . . . 0.0 111.915 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -103.99 -26.87 12.46 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 118.096 -0.954 . . . . 0.0 112.992 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -94.68 38.27 1.11 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.2 m -63.46 -17.18 19.45 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 O-C-N 120.597 -1.315 . . . . 0.0 111.293 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -42.8 -44.07 4.27 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 120.704 1.593 . . . . 0.0 114.203 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.7 t -78.5 -14.14 59.5 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.6 mt -88.22 -173.39 4.2 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 120.444 -1.41 . . . . 0.0 109.267 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.43 158.13 16.21 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.822 0.849 . . . . 0.0 109.485 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -124.78 -35.61 2.68 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.034 2.533 . . . . 0.0 111.085 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.81 -42.68 79.97 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.642 1.177 . . . . 0.0 109.35 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -62.6 -36.39 82.6 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.874 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 139.54 -171.09 23.91 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -79.08 114.78 47.38 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.91 135.2 8.69 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.619 2.879 . . . . 0.0 108.557 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.3 pt -138.26 178.28 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 121.372 -0.83 . . . . 0.0 110.616 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -134.44 154.97 51.11 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.198 0.908 . . . . 0.0 112.345 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 tt -156.91 163.48 39.11 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.237 1.015 . . . . 0.0 110.05 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.15 -174.43 36.98 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.825 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.42 135.46 41.82 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 126.105 1.762 . . . . 0.0 106.718 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -114.81 121.41 43.2 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.39 -39.68 0.26 Allowed Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.4 31.35 1.71 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.371 1.069 . . . . 0.0 113.783 -178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.1 m120 58.17 75.15 0.4 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.808 1.243 . . . . 0.0 112.476 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.33 140.78 27.97 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 121.297 -0.877 . . . . 0.0 110.307 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.8 m -147.96 174.49 11.84 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.254 -1.529 . . . . 0.0 111.024 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.42 ' HA ' ' HG ' ' A' ' 87' ' ' LEU . 5.3 mt -57.68 144.3 38.37 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -155.59 124.03 5.92 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 52.1 m -91.88 121.37 33.42 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.826 0.739 . . . . 0.0 110.409 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.37 168.52 19.6 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.252 0.478 . . . . 0.0 110.154 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -98.52 147.11 25.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.3 -2.56 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.556 0.743 . . . . 0.0 111.003 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.4 81.88 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.2 t70 66.56 9.62 6.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.429 1.891 . . . . 0.0 114.49 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.14 143.03 17.61 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.43 156.95 63.84 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 124.171 3.248 . . . . 0.0 113.87 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.3 p -158.47 164.76 35.89 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.017 1.727 . . . . 0.0 108.972 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.8 mt -95.18 138.12 33.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -129.43 67.16 1.44 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.368 1.067 . . . . 0.0 109.995 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.42 ' HG ' ' HA ' ' A' ' 74' ' ' LEU . 2.9 mp -81.97 105.57 13.19 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.59 -39.31 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -136.39 94.18 2.98 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 119.19 0.904 . . . . 0.0 111.653 -177.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -164.61 175.26 9.96 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 121.178 -0.951 . . . . 0.0 110.968 179.592 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.418 ' H ' ' HD3' ' A' ' 90' ' ' LYS . 17.6 m-20 -140.5 143.03 35.24 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.24 1.416 . . . . 0.0 107.469 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.7 tt -104.77 -39.29 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 125.063 1.345 . . . . 0.0 110.863 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -30.94 71.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.884 0.474 . . . . 0.0 110.57 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -66.21 -52.78 44.59 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 32.4 mt -61.87 -29.24 70.06 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 123.776 0.83 . . . . 0.0 111.184 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -79.94 -28.49 39.7 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -78.36 -42.11 31.4 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.322 -0.862 . . . . 0.0 112.01 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -107.03 152.08 40.9 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 123.774 0.829 . . . . 0.0 110.31 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.97 57.89 4.0 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.172 3.248 . . . . 0.0 113.12 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -118.29 73.6 10.47 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.587 1.155 . . . . 0.0 110.507 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.39 86.29 1.71 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.998 2.465 . . . . 0.0 106.179 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 66.7 t -80.74 93.93 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.45 -19.5 1.43 Allowed 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.367 1.067 . . . . 0.0 113.167 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -20.14 65.27 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.471 1.508 . . . . 0.0 110.596 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -115.1 -25.34 8.14 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.639 0.776 . . . . 0.0 110.756 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.6 mt -74.21 159.56 32.35 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.905 1.282 . . . . 0.0 112.093 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -147.65 143.46 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.194 0.998 . . . . 0.0 110.309 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.99 126.4 32.49 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 126.139 1.776 . . . . 0.0 108.644 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -102.13 150.24 23.46 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.6 t -142.02 -157.07 0.74 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -159.53 152.0 21.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.401 1.48 . . . . 0.0 108.112 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.8 p -123.61 6.58 8.86 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.468 1.507 . . . . 0.0 112.538 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.97 -85.13 0.36 Allowed Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 104.896 -3.282 . . . . 0.0 104.896 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.536 ' HG3' HH11 ' A' ' 114' ' ' ARG . 13.8 mtt85 -94.9 -7.8 39.01 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -126.19 172.56 9.95 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 119.119 0.872 . . . . 0.0 109.533 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.6 m -135.99 130.66 33.94 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 126.964 2.106 . . . . 0.0 110.622 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.27 161.13 16.56 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.3 1.04 . . . . 0.0 108.475 178.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -143.95 116.87 8.82 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -125.97 127.1 45.41 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.719 0.637 . . . . 0.0 110.06 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.6 m -51.23 131.67 28.1 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.305 1.042 . . . . 0.0 109.938 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 84.5 t -73.63 -53.6 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 O-C-N 122.225 -0.297 . . . . 0.0 110.915 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.55 74.54 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -124.4 80.71 59.79 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.63 160.01 48.21 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.868 2.378 . . . . 0.0 109.879 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.7 -20.79 48.12 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 126.399 1.952 . . . . 0.0 111.601 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -103.63 116.78 32.97 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 118.823 1.312 . . . . 0.0 110.467 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -90.11 157.02 17.96 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 125.045 1.338 . . . . 0.0 108.825 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 9.7 mm -86.06 129.03 38.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.21 117.01 30.47 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 119.321 0.964 . . . . 0.0 110.209 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.3 m -78.68 -25.66 13.51 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.304 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.2 m 67.39 55.36 0.66 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.537 1.535 . . . . 0.0 113.268 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 75.4 m -95.79 -2.91 46.7 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.334 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -68.06 -66.41 0.57 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.56 1.073 . . . . 0.0 111.353 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -124.17 -55.13 0.18 Allowed Glycine 0 C--N 1.333 0.388 0 CA-C-O 119.302 -0.721 . . . . 0.0 111.796 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.97 54.05 0.01 OUTLIER Glycine 0 CA--C 1.519 0.338 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 68.1 m -87.04 166.93 23.74 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 117.37 0.585 . . . . 0.0 110.697 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.13 168.49 24.67 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 N-CA-C 108.584 -1.352 . . . . 0.0 108.584 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.5 mt -87.0 111.26 20.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -146.33 -177.08 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.812 1.245 . . . . 0.0 110.987 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.7 mt -100.7 161.82 13.34 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -156.3 130.69 8.78 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -90.24 -38.22 13.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 119.603 -0.839 . . . . 0.0 108.764 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -152.64 102.81 2.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.034 1.734 . . . . 0.0 107.971 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 pp -97.41 163.28 12.94 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.615 1.166 . . . . 0.0 112.122 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -109.65 62.09 0.29 Allowed Glycine 0 C--N 1.33 0.247 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm 51.89 16.22 0.49 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.698 2.399 . . . . 0.0 113.431 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.81 -36.04 64.94 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.958 0.903 . . . . 0.0 112.837 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.35 167.86 17.11 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-O 121.106 0.479 . . . . 0.0 109.787 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.5 m -100.24 136.04 40.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.3 p -131.7 7.19 4.42 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.635 1.574 . . . . 0.0 112.267 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -144.4 112.19 6.22 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.98 -175.79 4.55 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.898 1.226 . . . . 0.0 113.146 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.34 -174.26 27.37 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.9 tp -141.04 146.7 37.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.5 m -100.6 48.24 0.91 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.815 1.246 . . . . 0.0 107.658 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.54 159.69 33.86 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.954 1.302 . . . . 0.0 108.493 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 8.9 mt -145.79 153.42 40.9 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.706 2.002 . . . . 0.0 108.496 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.337 0 CA-C-N 119.884 1.22 . . . . 0.0 112.653 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.03 158.76 16.8 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.763 1.625 . . . . 0.0 109.749 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -76.3 -70.12 0.46 Allowed 'General case' 0 C--O 1.238 0.479 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.921 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.06 -55.66 1.96 Allowed 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.949 0.9 . . . . 0.0 111.361 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.529 ' H ' HD23 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -64.67 174.95 1.58 Allowed 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 124.338 1.023 . . . . 0.0 108.669 178.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -116.26 18.82 15.15 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.683 1.193 . . . . 0.0 112.607 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.15 25.59 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 125.584 1.554 . . . . 0.0 110.975 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.15 -17.69 60.35 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.105 0.962 . . . . 0.0 109.789 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 p -60.05 135.23 90.48 Favored Pre-proline 0 C--N 1.344 0.351 0 CA-C-O 117.459 -1.257 . . . . 0.0 109.186 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.26 140.55 24.87 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 N-CA-C 106.973 -1.972 . . . . 0.0 106.973 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.17 149.42 35.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -144.49 132.57 21.59 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.538 -1.351 . . . . 0.0 109.385 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.75 -122.1 0.59 Allowed Glycine 0 CA--C 1.518 0.28 0 CA-C-O 117.844 -1.531 . . . . 0.0 111.225 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.8 p -160.3 -168.78 2.27 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 120.725 2.263 . . . . 0.0 112.566 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.7 mt -145.22 4.52 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.32 1.448 . . . . 0.0 108.97 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.14 -25.13 63.32 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 119.806 -1.809 . . . . 0.0 111.077 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -75.27 46.15 0.32 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.557 1.543 . . . . 0.0 110.897 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mt -130.56 -61.95 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 126.293 1.837 . . . . 0.0 108.688 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.85 27.17 2.02 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.489 0.661 . . . . 0.0 110.646 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.35 11.06 4.29 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 128.88 2.872 . . . . 0.0 114.182 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -70.76 95.38 1.12 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.187 1.795 . . . . 0.0 109.43 -179.641 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.81 158.97 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 102.997 -2.964 . . . . 0.0 102.997 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -118.63 144.84 45.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 120.605 -1.309 . . . . 0.0 108.711 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.7 t -150.53 141.21 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.6 tp -75.77 119.05 19.24 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -133.06 123.2 25.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.7 t70 45.88 58.37 4.41 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.034 1.334 . . . . 0.0 112.845 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 54.23 23.9 4.59 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.021 1.329 . . . . 0.0 112.968 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.5 m -132.94 159.56 39.6 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.589 1.556 . . . . 0.0 107.607 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 mt -108.67 124.34 50.37 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 mm -127.14 141.96 44.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 O-C-N 123.87 0.731 . . . . 0.0 109.766 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.87 137.12 36.17 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.05 66.3 40.33 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.106 0.962 . . . . 0.0 108.439 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.46 -28.66 78.11 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 121.842 1.695 . . . . 0.0 112.193 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -149.54 95.61 2.37 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 125.003 1.321 . . . . 0.0 109.403 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.81 142.31 5.26 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.793 0.837 . . . . 0.0 109.55 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.52 -39.7 77.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 122.367 1.08 . . . . 0.0 108.945 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.8 tpp85 -79.4 62.67 3.8 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.494 1.518 . . . . 0.0 111.706 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.2 ptt? -126.39 168.57 14.0 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.802 1.241 . . . . 0.0 110.999 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 t -158.54 144.99 12.69 Favored Pre-proline 0 N--CA 1.452 -0.375 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.63 154.83 64.03 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 N-CA-C 107.891 -1.619 . . . . 0.0 107.891 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.39 156.95 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.4 m -118.07 161.57 19.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.233 -1.348 . . . . 0.0 108.504 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.3 mm -130.32 110.73 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 C-N-CA 126.157 1.783 . . . . 0.0 111.065 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.87 138.59 31.27 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 176.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 tt -130.53 131.77 45.24 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.5 mt -147.32 143.29 20.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 124.862 2.267 . . . . 0.0 106.933 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.2 p -73.7 162.27 29.36 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.517 -1.674 . . . . 0.0 108.881 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.7 m -91.17 149.58 21.73 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -102.1 -23.73 14.03 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -106.49 56.32 0.66 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.1 m -75.12 -10.73 13.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 120.98 -1.075 . . . . 0.0 111.185 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -69.99 4.09 2.3 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 125.925 1.69 . . . . 0.0 114.596 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 t -129.88 13.6 5.81 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.954 0.902 . . . . 0.0 108.939 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 98.3 mt -119.97 169.3 10.3 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.789 1.236 . . . . 0.0 108.095 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.9 155.35 37.56 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.698 1.199 . . . . 0.0 109.024 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.55 -32.39 2.65 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.226 1.011 . . . . 0.0 111.66 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -64.69 -36.01 82.89 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.535 1.134 . . . . 0.0 110.082 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -65.64 -25.68 67.47 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.463 1.105 . . . . 0.0 112.472 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.516 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 135.52 -173.52 21.7 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -87.13 111.59 41.88 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 123.957 0.903 . . . . 0.0 112.569 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.3 138.44 11.1 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.374 2.049 . . . . 0.0 110.898 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.429 HG13 ' CE1' ' A' ' 107' ' ' PHE . 15.6 pt -145.21 -174.26 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 124.354 1.062 . . . . 0.0 109.402 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.429 ' CD1' HD12 ' A' ' 95' ' ' LEU . 3.7 t80 -139.44 165.37 27.4 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.044 1.338 . . . . 0.0 113.028 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 tt -163.07 159.23 22.99 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.297 1.439 . . . . 0.0 111.148 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.27 176.17 38.67 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.219 0.914 . . . . 0.0 112.1 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mt -94.62 152.55 18.42 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.388 1.075 . . . . 0.0 109.285 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -116.85 120.41 38.4 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.38 -38.82 0.55 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.314 0.483 . . . . 0.0 112.812 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.74 31.5 1.17 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.373 1.087 . . . . 0.0 112.52 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.6 m120 50.24 79.5 0.08 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.573 1.949 . . . . 0.0 111.912 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.67 137.89 25.53 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.651 0.78 . . . . 0.0 110.141 -177.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.0 m -143.85 172.56 12.68 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 118.631 0.65 . . . . 0.0 110.861 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.7 mt -59.05 147.84 33.22 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.115 0.484 . . . . 0.0 111.501 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 mtp -157.6 139.87 14.49 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 92.3 m -115.06 115.47 26.86 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.61 -177.93 3.35 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.396 2.279 . . . . 0.0 107.118 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.4 tttt -122.51 126.8 48.57 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.46 -25.06 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.44 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.58 -49.9 0.2 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -130.04 -11.99 4.19 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.174 -1.192 . . . . 0.0 113.274 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -137.87 153.83 74.05 Favored Pre-proline 0 C--O 1.241 0.657 0 C-N-CA 123.881 0.872 . . . . 0.0 110.749 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -70.04 153.45 67.63 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.424 2.082 . . . . 0.0 108.325 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 p -149.22 158.49 44.22 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mt -80.4 146.18 31.61 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -145.54 63.81 1.26 Allowed 'General case' 0 N--CA 1.461 0.078 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.33 108.51 18.47 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.92 -41.39 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.097 0.559 . . . . 0.0 111.732 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -134.45 101.69 5.07 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 126.111 1.764 . . . . 0.0 109.929 -176.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.25 166.89 4.12 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.1 -1.0 . . . . 0.0 109.345 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.3 135.98 31.12 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 mt -87.68 -43.08 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 125.388 1.475 . . . . 0.0 109.173 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.6 tpt -61.64 -23.4 66.03 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 119.11 -0.471 . . . . 0.0 110.113 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -64.95 -51.2 63.12 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.429 HD12 ' CD1' ' A' ' 64' ' ' TYR . 13.5 mt -60.9 -35.49 76.79 Favored 'General case' 0 N--CA 1.461 0.091 0 O-C-N 121.717 -0.614 . . . . 0.0 110.181 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -78.87 -17.06 56.23 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.392 -0.817 . . . . 0.0 110.638 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -89.73 -42.78 11.13 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 120.504 -1.372 . . . . 0.0 111.181 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -107.01 150.09 39.39 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.433 0.693 . . . . 0.0 111.714 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.6 46.74 1.5 Allowed 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.552 3.502 . . . . 0.0 113.695 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -112.9 75.71 2.03 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.163 0.985 . . . . 0.0 111.134 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.99 71.18 7.16 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.599 3.533 . . . . 0.0 108.932 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 73.8 t -71.01 104.43 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.375 0.67 . . . . 0.0 110.172 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -50.96 -28.67 10.34 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 125.372 1.469 . . . . 0.0 111.029 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m -63.11 -13.63 38.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.327 1.451 . . . . 0.0 112.417 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -121.67 -28.63 4.51 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.769 0.828 . . . . 0.0 109.594 177.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.49 160.89 31.93 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.687 1.195 . . . . 0.0 111.035 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.429 ' CE1' HG13 ' A' ' 63' ' ' ILE . 9.9 p90 -151.16 148.38 28.19 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.57 0.748 . . . . 0.0 111.813 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.516 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -90.1 110.52 21.52 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 128.718 2.807 . . . . 0.0 107.923 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -79.38 141.83 36.55 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.4 t -137.95 -174.3 3.75 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.692 0.797 . . . . 0.0 109.526 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -151.24 163.08 39.68 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.285 1.434 . . . . 0.0 109.533 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.8 p -137.8 14.44 2.91 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.725 1.21 . . . . 0.0 111.825 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.72 -102.46 0.69 Allowed Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 105.452 -3.059 . . . . 0.0 105.452 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.07 -3.9 58.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.136 0.968 . . . . 0.0 113.115 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -117.6 159.47 22.85 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.405 1.002 . . . . 0.0 108.894 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 m -122.36 137.58 54.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.284 1.833 . . . . 0.0 108.963 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.01 166.84 10.72 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.524 1.13 . . . . 0.0 109.372 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -147.13 118.08 7.68 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -115.83 132.18 56.72 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 125.115 1.366 . . . . 0.0 110.554 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 t -59.84 133.93 56.56 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.118 0.967 . . . . 0.0 109.219 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 49.1 t -72.76 -45.95 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 O-C-N 120.649 -1.282 . . . . 0.0 110.191 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.53 70.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.63 -0.669 . . . . 0.0 111.946 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.16 82.92 46.52 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.919 0.888 . . . . 0.0 110.65 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.37 144.18 55.23 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.876 1.717 . . . . 0.0 107.854 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.31 -11.22 43.55 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.705 1.621 . . . . 0.0 109.208 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 25.3 m-90 -113.62 115.53 28.06 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.209 1.404 . . . . 0.0 107.646 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -105.16 156.76 17.79 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 125.024 1.329 . . . . 0.0 110.14 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.4 pt -85.56 127.86 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.932 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.71 119.75 25.61 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.5 t -79.49 -21.04 12.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 127.238 2.215 . . . . 0.0 112.223 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.5 m 54.95 90.93 0.03 OUTLIER 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.966 2.106 . . . . 0.0 110.892 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 m -135.58 43.67 2.59 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 126.174 1.79 . . . . 0.0 108.307 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -110.55 0.27 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.459 2.303 . . . . 0.0 107.036 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.32 7.46 80.64 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 117.744 1.857 . . . . 0.0 117.744 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.45 38.82 8.68 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 119.824 1.812 . . . . 0.0 112.164 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 93.6 m -77.14 163.59 64.03 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.93 1.292 . . . . 0.0 107.857 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.22 169.33 20.93 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.129 1.886 . . . . 0.0 110.5 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.3 mt -85.93 118.83 25.65 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.574 HD13 HD22 ' A' ' 148' ' ' ASN . 0.2 OUTLIER -141.69 172.86 9.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 124.407 1.083 . . . . 0.0 110.586 179.507 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 41.6 mt -91.91 163.6 13.96 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.9 t -149.09 150.14 32.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 177.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -101.79 -31.52 10.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 123.541 1.639 . . . . 0.0 108.09 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -164.25 130.87 3.1 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -124.83 160.33 29.0 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 125.352 1.461 . . . . 0.0 108.982 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -102.49 47.82 1.11 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 107.679 -2.168 . . . . 0.0 107.679 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.44 -9.71 0.5 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.806 2.042 . . . . 0.0 112.228 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.53 -51.09 21.44 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.555 1.542 . . . . 0.0 115.027 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.574 HD22 HD13 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -60.33 -17.56 43.86 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -176.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 55.98 79.45 0.17 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.517 0.599 . . . . 0.0 112.246 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.9 p -105.3 -8.33 18.32 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.058 -1.026 . . . . 0.0 111.612 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -115.52 103.14 10.44 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.091 1.356 . . . . 0.0 112.516 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.19 171.29 17.63 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.185 -1.572 . . . . 0.0 110.918 178.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -83.31 -173.27 49.57 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.96 120.76 11.24 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 14.8 m -78.91 41.94 0.45 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.896 1.679 . . . . 0.0 108.819 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -68.65 140.52 55.48 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.5 mt -115.0 162.07 17.48 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.92 1.688 . . . . 0.0 108.88 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 33.1 p90 . . . . . 0 C--O 1.245 0.849 0 C-N-CA 125.368 1.467 . . . . 0.0 108.108 178.831 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ptm . . . . . 0 CA--C 1.513 -0.45 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.443 ' N ' ' CD ' ' A' ' 2' ' ' GLU . 12.4 mp0 -110.34 -168.36 1.3 Allowed 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 128.235 2.614 . . . . 0.0 109.465 -175.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -130.86 49.14 2.35 Favored 'General case' 0 C--O 1.226 -0.167 0 O-C-N 121.74 -0.6 . . . . 0.0 112.411 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 36.86 81.02 0.02 OUTLIER 'General case' 0 C--O 1.237 0.4 0 C-N-CA 129.305 3.042 . . . . 0.0 112.166 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.74 -169.21 2.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 129.916 3.286 . . . . 0.0 108.633 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.5 pttt -140.96 -8.06 1.05 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.562 1.145 . . . . 0.0 113.716 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -86.2 -19.58 8.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 126.601 1.96 . . . . 0.0 109.575 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 45.42 41.84 6.99 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.048 2.139 . . . . 0.0 111.422 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.5 p -54.35 150.64 15.9 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 118.51 0.595 . . . . 0.0 112.52 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.92 138.29 33.85 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.637 1.558 . . . . 0.0 108.866 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.39 117.47 21.45 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -114.38 143.61 44.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.39 -125.28 0.82 Allowed Glycine 0 C--O 1.226 -0.368 0 CA-C-O 117.988 -1.451 . . . . 0.0 110.356 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.4 p -154.05 -164.99 1.99 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 120.526 2.163 . . . . 0.0 113.628 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.6 mt -140.32 4.36 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.764 1.626 . . . . 0.0 108.033 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.447 ' C ' ' H ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -74.8 -26.85 60.02 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.361 -1.462 . . . . 0.0 111.88 -179.326 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -69.82 19.21 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 128.042 2.537 . . . . 0.0 113.695 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.447 ' H ' ' C ' ' A' ' 16' ' ' GLN . 5.7 mt -110.23 -60.58 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 127.165 2.186 . . . . 0.0 110.827 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -137.72 23.23 2.89 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.711 0.804 . . . . 0.0 110.524 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 61.41 36.81 17.17 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.296 1.038 . . . . 0.0 110.239 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.444 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 26.1 mmt-85 -104.19 86.36 2.54 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.904 -1.122 . . . . 0.0 110.322 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.9 t -73.88 129.36 36.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 32.0 m0 -81.9 137.54 35.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.044 0.938 . . . . 0.0 109.854 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.97 120.69 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-N 119.593 1.088 . . . . 0.0 109.705 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.03 100.31 4.15 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.433 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 4.0 tt0 -89.02 -172.93 3.87 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.433 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -52.59 96.77 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 124.232 1.013 . . . . 0.0 112.306 -178.529 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 52.85 26.12 4.38 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.744 2.017 . . . . 0.0 111.937 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.1 m -154.09 128.67 9.28 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 119.172 0.897 . . . . 0.0 111.23 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mt -84.3 131.96 34.67 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 pt -138.37 133.01 42.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 124.635 1.174 . . . . 0.0 111.134 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.07 146.36 47.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.18 80.78 15.86 Favored Pre-proline 0 N--CA 1.464 0.243 0 C-N-CA 124.031 0.932 . . . . 0.0 109.381 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.4 -31.87 21.24 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.883 1.722 . . . . 0.0 115.079 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 -165.91 84.25 0.32 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.409 1.884 . . . . 0.0 108.73 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -147.77 130.13 15.7 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -60.94 -13.62 17.21 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.308 1.043 . . . . 0.0 113.674 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -96.34 49.09 1.11 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.614 1.552 . . . . 0.0 106.922 177.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.5 mtp -65.25 156.9 30.45 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.554 -1.341 . . . . 0.0 109.402 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.3 t -159.89 87.5 1.97 Allowed Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.634 0.774 . . . . 0.0 109.841 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.42 137.23 46.18 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.015 1.81 . . . . 0.0 111.176 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 m -119.91 -174.18 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.9 m -132.62 155.25 49.06 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.2 mm -127.85 110.67 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 125.971 1.708 . . . . 0.0 108.857 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.7 139.32 30.65 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.168 1.787 . . . . 0.0 109.304 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.7 tt -134.41 129.41 35.3 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.605 1.162 . . . . 0.0 109.19 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.0 mt -144.91 127.93 11.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.932 1.293 . . . . 0.0 111.039 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.0 p -72.68 128.22 34.91 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 90.3 m -61.6 149.48 39.08 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -109.54 -10.09 14.88 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.486 1.114 . . . . 0.0 110.216 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -101.49 26.71 6.97 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.551 1.94 . . . . 0.0 109.918 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.3 m -71.22 -9.79 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 120.497 -1.377 . . . . 0.0 114.567 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.02 -35.92 48.48 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.45 1.1 . . . . 0.0 112.694 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 t -97.97 0.82 47.1 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.565 1.546 . . . . 0.0 111.821 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 72.7 mt -92.13 -179.58 5.3 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.02 -1.05 . . . . 0.0 109.974 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -79.52 162.03 25.65 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.556 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -139.5 -24.19 0.86 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.562 1.545 . . . . 0.0 111.586 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -78.67 9.07 4.42 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.062 1.745 . . . . 0.0 112.703 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -115.18 -50.11 2.76 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.73 -146.47 10.89 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -107.8 104.28 52.58 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.67 131.56 17.46 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.291 3.327 . . . . 0.0 111.267 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.79 177.35 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.36 0.664 . . . . 0.0 111.033 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -125.83 154.55 42.48 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.733 0.778 . . . . 0.0 109.963 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.9 tt -156.07 150.76 26.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.49 178.62 35.53 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mt -88.25 153.75 20.97 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 177.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -119.46 116.05 25.32 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 101.246 -3.613 . . . . 0.0 101.246 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.6 -18.97 0.37 Allowed Glycine 0 C--N 1.342 0.874 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.916 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.19 26.28 0.09 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.823 1.811 . . . . 0.0 112.336 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.0 m120 60.23 62.99 1.48 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.346 1.058 . . . . 0.0 109.322 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.36 137.41 27.09 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.436 -1.415 . . . . 0.0 112.298 -178.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.448 ' H ' ' HB2' ' A' ' 90' ' ' LYS . 5.4 m -143.14 176.23 9.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.145 0.978 . . . . 0.0 111.656 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 18.6 mt -61.3 151.38 32.11 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.322 1.049 . . . . 0.0 111.052 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.491 ' HG3' ' HZ2' ' A' ' 90' ' ' LYS . 4.9 tmm? -158.84 134.28 8.6 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 76.2 m -107.52 120.64 42.76 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 124.482 1.114 . . . . 0.0 109.57 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.21 -168.37 2.12 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -121.59 144.63 48.63 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.8 p -90.93 -24.17 5.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.43 -0.508 . . . . 0.0 109.668 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.24 -45.43 0.47 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -109.74 -40.75 4.72 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -132.97 164.95 40.28 Favored Pre-proline 0 C--O 1.242 0.692 0 C-N-CA 126.158 1.783 . . . . 0.0 112.125 -177.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -71.23 154.34 61.72 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.632 2.222 . . . . 0.0 112.38 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.4 p -151.21 171.9 16.68 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mt -91.86 152.98 19.84 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.425 0.69 . . . . 0.0 111.663 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -145.07 65.83 1.25 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.647 0.779 . . . . 0.0 110.224 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.11 116.71 26.49 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -177.97 -19.27 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.7 94.82 1.49 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.491 ' HZ2' ' HG3' ' A' ' 75' ' ' MET . 0.6 OUTLIER -173.65 162.63 4.15 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 121.503 1.956 . . . . 0.0 109.866 -177.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -142.77 136.79 29.23 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.849 0.459 . . . . 0.0 111.823 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.1 mp -80.91 -36.21 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.972 1.309 . . . . 0.0 110.846 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.8 mmt -59.7 -33.38 71.52 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.868 0.758 . . . . 0.0 109.831 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.8 -54.18 49.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.94 0.896 . . . . 0.0 109.159 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.9 mt -67.19 -29.67 69.41 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -80.7 -25.72 37.96 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.872 0.368 . . . . 0.0 110.698 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -83.69 -44.36 14.57 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.007 1.323 . . . . 0.0 111.524 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.48 154.71 46.53 Favored Pre-proline 0 N--CA 1.457 -0.111 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.059 -177.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.3 65.69 2.77 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 124.132 3.221 . . . . 0.0 113.01 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -119.79 69.78 13.17 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 125.054 1.342 . . . . 0.0 111.388 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.39 75.84 4.46 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.361 2.707 . . . . 0.0 105.95 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 t -88.43 94.34 4.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 O-C-N 120.858 -1.151 . . . . 0.0 109.496 -177.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -45.08 -28.09 0.67 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.242 2.217 . . . . 0.0 114.393 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 m -63.1 -22.28 66.75 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.355 1.462 . . . . 0.0 113.107 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.477 ' CE2' ' HG2' ' A' ' 75' ' ' MET . 20.6 m-85 -109.36 -18.52 13.54 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.658 1.983 . . . . 0.0 109.581 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.1 mt -85.68 155.19 21.19 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 125.717 1.607 . . . . 0.0 113.686 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -138.57 131.72 29.95 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.914 0.886 . . . . 0.0 109.71 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.51 116.35 18.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -90.73 144.23 25.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.402 ' HG ' ' CB ' ' A' ' 117' ' ' THR . 1.0 OUTLIER -128.79 178.24 6.5 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.09 0.956 . . . . 0.0 109.11 178.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -150.63 154.83 38.2 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.597 1.559 . . . . 0.0 110.799 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 57.6 p -132.38 8.9 4.32 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.322 -1.763 . . . . 0.0 113.459 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.79 -47.1 1.08 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.803 1.668 . . . . 0.0 112.159 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -132.82 -2.81 3.27 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -132.83 151.17 52.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.9 m -118.09 159.89 22.46 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.402 ' CB ' ' HG ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -126.2 166.14 17.63 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 177.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -147.87 112.88 5.47 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.02 133.29 55.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.487 1.515 . . . . 0.0 109.555 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.0 t -54.47 120.45 6.65 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.211 1.004 . . . . 0.0 108.652 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.4 t -65.71 -42.36 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.066 -1.021 . . . . 0.0 110.663 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.25 97.49 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -129.31 83.77 64.35 Favored Pre-proline 0 C--O 1.235 0.321 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -68.23 158.34 57.93 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.786 2.324 . . . . 0.0 108.456 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 104.34 -6.97 46.58 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 26.4 m-90 -124.28 142.15 51.49 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 126.157 1.783 . . . . 0.0 109.796 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -126.0 152.23 46.0 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.092 0.957 . . . . 0.0 111.519 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.0 pt -76.04 127.71 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.076 0.465 . . . . 0.0 110.949 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.88 110.0 20.69 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 t -68.21 -15.8 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.844 1.658 . . . . 0.0 113.882 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 m 65.79 33.13 8.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.0 1.32 . . . . 0.0 113.041 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.444 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 5.8 m -65.03 -21.1 66.79 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.353 0.597 . . . . 0.0 111.827 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -84.7 120.3 26.24 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 125.377 1.471 . . . . 0.0 107.787 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 67.57 -72.29 0.24 Allowed Glycine 0 N--CA 1.442 -0.933 0 O-C-N 125.466 1.729 . . . . 0.0 114.311 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.67 71.45 0.02 OUTLIER Glycine 0 CA--C 1.526 0.767 0 N-CA-C 105.837 -2.905 . . . . 0.0 105.837 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 63.9 m -95.0 174.68 3.36 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 124.956 1.302 . . . . 0.0 111.393 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.23 165.21 31.43 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.03 1.82 . . . . 0.0 111.593 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 28.8 mt -91.59 114.01 26.43 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.956 0.903 . . . . 0.0 108.564 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.7 pp -141.21 176.6 4.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 125.255 1.422 . . . . 0.0 107.191 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 20.2 mt -100.63 165.79 11.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.8 t -147.89 162.53 39.09 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -104.63 -42.53 5.38 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -154.2 127.71 8.61 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 122.707 1.241 . . . . 0.0 109.014 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -164.29 155.25 15.39 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.477 2.711 . . . . 0.0 104.96 177.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.428 ' O ' ' HE3' ' A' ' 146' ' ' LYS . . . -160.93 12.22 0.15 Allowed Glycine 0 CA--C 1.53 1.009 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 177.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 146' ' ' LYS . 0.3 OUTLIER -149.09 -41.47 0.15 Allowed 'General case' 0 C--N 1.349 0.546 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -177.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.84 -31.56 72.25 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 -146.04 -161.39 1.3 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 90.9 m -137.29 131.52 32.39 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.3 p -110.37 -13.29 14.31 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.874 1.269 . . . . 0.0 111.689 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -120.63 109.12 14.85 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.767 0.712 . . . . 0.0 111.519 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.68 173.25 14.95 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.168 1.787 . . . . 0.0 111.206 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.38 -166.9 31.21 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.14 140.62 46.69 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 122.076 -0.661 . . . . 0.0 109.233 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.75 28.88 1.24 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.883 1.673 . . . . 0.0 109.837 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -59.45 150.65 26.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.663 1.185 . . . . 0.0 108.523 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 43.1 mt -132.86 160.88 35.69 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.62 1.168 . . . . 0.0 108.333 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 31.2 p90 . . . . . 0 C--O 1.245 0.819 0 CA-C-O 117.198 -1.382 . . . . 0.0 108.29 178.908 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -129.33 178.54 6.37 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -118.18 50.51 1.15 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.75 1.22 . . . . 0.0 111.955 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 34.24 71.76 0.1 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.88 2.472 . . . . 0.0 111.43 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -141.3 -172.34 3.48 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.741 1.217 . . . . 0.0 110.128 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -143.99 14.18 1.68 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.923 1.289 . . . . 0.0 111.678 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 pp -129.68 24.61 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 C-N-CA 124.962 1.305 . . . . 0.0 109.878 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.35 -20.22 48.32 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 p -70.25 160.3 81.41 Favored Pre-proline 0 C--O 1.24 0.595 0 C-N-CA 123.469 0.708 . . . . 0.0 111.103 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.34 147.94 94.09 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 N-CA-C 108.131 -1.527 . . . . 0.0 108.131 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.98 107.16 15.01 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -110.21 134.9 51.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.486 0.66 . . . . 0.0 110.388 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -161.27 -129.05 0.99 Allowed Glycine 0 N--CA 1.451 -0.356 0 O-C-N 121.186 -0.946 . . . . 0.0 111.975 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.2 p -154.23 -172.47 4.22 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.364 1.082 . . . . 0.0 112.11 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -149.81 9.18 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 124.288 1.035 . . . . 0.0 111.575 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.32 -18.03 59.13 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 119.92 -1.738 . . . . 0.0 111.377 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.14 44.85 0.6 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.23 2.612 . . . . 0.0 110.528 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mt -131.71 -64.95 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 126.111 1.764 . . . . 0.0 111.148 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -139.87 27.42 2.21 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.406 1.083 . . . . 0.0 109.855 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 64.59 15.55 9.74 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -79.05 91.03 4.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.6 t -72.24 153.49 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -112.1 132.56 54.78 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 120.513 -1.367 . . . . 0.0 108.798 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.8 t -140.62 126.12 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 119.983 1.265 . . . . 0.0 111.837 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tp -76.41 104.7 7.06 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -88.92 -170.33 2.87 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.86 97.01 0.01 OUTLIER 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.604 1.962 . . . . 0.0 109.925 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 46.51 23.09 0.2 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.893 2.477 . . . . 0.0 112.669 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 m -153.93 128.55 9.32 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 119.412 1.006 . . . . 0.0 111.523 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.7 mt -79.74 149.21 31.21 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.147 -0.971 . . . . 0.0 112.028 179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 16.6 pt -143.15 149.37 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.168 1.387 . . . . 0.0 110.893 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.64 143.97 25.79 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.47 105.32 19.32 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.015 0.926 . . . . 0.0 110.285 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.83 -50.68 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.454 2.769 . . . . 0.0 116.351 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -147.05 57.71 1.15 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.07 130.82 50.33 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.22 -55.24 37.55 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.86 0.725 . . . . 0.0 109.082 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -79.44 60.36 3.18 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.218 1.407 . . . . 0.0 111.692 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -102.64 171.62 7.32 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 176.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t -159.68 133.01 4.79 Favored Pre-proline 0 N--CA 1.452 -0.373 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.69 155.04 59.25 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 N-CA-C 108.088 -1.543 . . . . 0.0 108.088 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m -140.07 -171.03 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 125.244 1.418 . . . . 0.0 107.535 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.92 156.16 48.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.0 mm -127.34 112.55 28.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 126.158 1.783 . . . . 0.0 107.905 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.16 140.74 29.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.8 tt -135.47 139.75 44.3 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.0 mt -150.37 139.72 15.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.287 1.035 . . . . 0.0 108.986 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.7 p -75.14 156.4 35.98 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.468 ' HG ' ' HA ' ' A' ' 63' ' ' ILE . 94.8 m -78.34 140.06 38.79 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 119.873 -1.767 . . . . 0.0 108.681 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -101.16 -21.28 14.99 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.44 -0.788 . . . . 0.0 112.541 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -111.66 67.77 0.65 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.884 1.274 . . . . 0.0 108.255 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.2 m -101.4 2.31 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.61 -18.71 65.16 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.635 1.174 . . . . 0.0 111.526 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 t -105.16 -5.0 21.13 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.764 2.026 . . . . 0.0 113.521 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -80.41 -178.59 6.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.594 -0.691 . . . . 0.0 110.205 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 58' ' ' ASP . 7.1 tt0 -82.37 -38.17 24.56 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.418 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.81 1.55 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.662 1 C-N-CA 132.328 4.251 . . . . 0.0 117.148 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 56' ' ' GLU . 57.6 m-20 -93.53 -14.43 26.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 127.227 2.211 . . . . 0.0 110.399 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.403 HH12 ' HB3' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -98.95 -0.52 42.0 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.928 0.785 . . . . 0.0 111.085 175.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.66 179.86 23.09 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 125.132 1.349 . . . . 0.0 110.389 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -86.62 112.58 47.7 Favored Pre-proline 0 CA--C 1.538 0.506 0 O-C-N 121.552 -0.969 . . . . 0.0 109.051 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -66.73 133.47 31.8 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.449 2.1 . . . . 0.0 114.461 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.468 ' HA ' ' HG ' ' A' ' 49' ' ' CYS . 1.9 pp -142.77 174.02 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 120.04 1.291 . . . . 0.0 109.788 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -131.94 153.4 50.33 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.1 tt -150.76 154.43 37.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.114 1.366 . . . . 0.0 108.23 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -163.65 -173.03 31.85 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.64 159.99 14.72 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -135.02 92.14 2.84 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 120.43 -1.419 . . . . 0.0 110.357 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.37 -7.83 0.02 OUTLIER Glycine 0 CA--C 1.536 1.394 0 CA-C-O 117.518 -1.712 . . . . 0.0 114.872 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -164.86 24.99 0.06 Allowed 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.528 2.164 . . . . 0.0 113.312 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.7 m120 58.7 67.84 0.89 Allowed 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.531 -1.355 . . . . 0.0 109.529 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.25 131.67 23.69 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.441 1.496 . . . . 0.0 109.888 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 61.5 m -140.38 177.99 7.62 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.23 1.812 . . . . 0.0 112.059 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.7 mt -61.71 154.72 24.66 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.284 -1.51 . . . . 0.0 110.772 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.2 ttp -162.46 132.15 4.47 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 93.2 m -103.33 121.96 43.83 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.313 0.96 . . . . 0.0 110.588 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.98 -171.91 2.39 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.926 1.69 . . . . 0.0 107.678 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -146.31 130.48 17.46 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.0 m -78.46 12.08 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 123.576 0.75 . . . . 0.0 112.227 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.02 -10.51 63.94 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.847 2.165 . . . . 0.0 111.687 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -129.08 -50.96 1.21 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.926 1.69 . . . . 0.0 110.857 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -131.48 155.76 81.04 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 125.058 1.343 . . . . 0.0 113.498 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.31 144.09 40.62 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 124.157 3.238 . . . . 0.0 111.769 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.7 p -148.43 147.65 29.42 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.171 0.896 . . . . 0.0 109.5 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.3 mt -71.69 160.08 33.27 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -150.97 64.09 0.91 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.061 0.944 . . . . 0.0 108.673 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.403 HD11 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -85.09 113.01 21.17 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.5 pttp -174.9 -36.16 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.929 1.292 . . . . 0.0 112.283 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -141.64 83.4 1.85 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.841 1.2 . . . . 0.0 113.959 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.47 147.71 6.37 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.36 -1.463 . . . . 0.0 109.014 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.29 140.99 48.16 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.225 1.01 . . . . 0.0 109.958 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.1 tt -87.18 -43.59 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 125.417 1.487 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.3 tpt -62.32 -27.89 69.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.923 -0.56 . . . . 0.0 111.396 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.88 -54.51 37.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.8 mt -60.05 -32.48 70.96 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.427 -0.796 . . . . 0.0 111.248 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -81.83 -15.97 52.35 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.238 -0.914 . . . . 0.0 112.215 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -94.49 -33.16 13.19 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 120.498 -1.376 . . . . 0.0 112.374 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -123.8 167.07 16.14 Favored Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 124.909 1.284 . . . . 0.0 110.799 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.24 -139.14 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 122.81 2.34 . . . . 0.0 109.59 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 56.99 60.77 7.05 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.952 1.701 . . . . 0.0 113.575 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.49 109.37 0.85 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.03 3.153 . . . . 0.0 109.262 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.3 t -88.11 98.7 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -49.53 -29.73 7.29 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.315 1.046 . . . . 0.0 112.286 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.5 m -62.54 -16.07 54.07 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.413 1.085 . . . . 0.0 113.453 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.52 -23.64 8.17 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.141 0.882 . . . . 0.0 111.69 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.5 mt -75.15 156.06 36.34 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.086 0.955 . . . . 0.0 112.801 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -138.93 128.72 24.86 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.644 0.778 . . . . 0.0 112.517 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -77.85 126.23 30.53 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.41 147.37 36.05 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 p -136.72 -177.1 4.59 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.777 1.631 . . . . 0.0 107.52 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -139.52 165.12 28.08 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.833 0.853 . . . . 0.0 109.193 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.5 p -149.84 35.98 0.69 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.753 1.283 . . . . 0.0 112.555 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.91 -56.27 1.85 Allowed Glycine 0 C--N 1.334 0.469 0 O-C-N 120.61 -1.307 . . . . 0.0 112.504 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -131.32 -1.08 4.0 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.508 -0.995 . . . . 0.0 112.669 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -134.05 179.92 5.95 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.752 0.821 . . . . 0.0 110.007 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 p -144.51 133.15 22.23 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.117 0.967 . . . . 0.0 112.435 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.52 170.82 9.08 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.202 1.401 . . . . 0.0 109.572 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -137.6 109.58 7.2 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.294 1.837 . . . . 0.0 106.98 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -98.52 128.08 44.72 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.926 2.09 . . . . 0.0 109.241 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.1 t -61.2 131.89 51.9 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.929 1.24 . . . . 0.0 111.957 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.33 -49.86 72.37 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 O-C-N 121.845 -0.534 . . . . 0.0 110.004 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.73 -27.52 68.97 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -136.29 84.73 28.69 Favored Pre-proline 0 N--CA 1.453 -0.28 0 CA-C-N 118.179 0.445 . . . . 0.0 110.186 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.403 ' HB3' HH12 ' A' ' 59' ' ' ARG . 10.6 Cg_endo -65.36 166.45 19.32 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.113 2.542 . . . . 0.0 111.663 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.19 1.36 90.48 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.443 -0.643 . . . . 0.0 112.546 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -130.56 146.12 52.01 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.092 1.357 . . . . 0.0 107.419 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -130.87 148.95 52.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.121 1.368 . . . . 0.0 110.578 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.4 pt -78.68 129.29 37.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.569 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.86 151.95 22.46 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.2 m -103.48 -17.27 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 125.149 1.38 . . . . 0.0 113.383 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.3 m 67.98 85.39 0.14 Allowed 'General case' 0 CA--C 1.533 0.308 0 O-C-N 124.413 1.07 . . . . 0.0 109.074 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 t -120.2 13.23 11.98 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.28 -1.512 . . . . 0.0 112.228 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -79.1 -52.22 8.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -161.55 -83.39 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.97 49.75 0.56 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 120.196 1.998 . . . . 0.0 113.261 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 32.0 m -78.13 165.85 47.51 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 118.229 1.014 . . . . 0.0 109.335 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 66.0 Cg_endo -78.12 163.92 27.53 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.404 2.07 . . . . 0.0 113.189 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 37.1 mt -85.64 107.9 17.75 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.7 1.2 . . . . 0.0 110.975 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.44 -172.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 124.292 1.037 . . . . 0.0 109.557 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.54 162.86 14.68 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t -148.97 172.92 13.94 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 125.804 1.642 . . . . 0.0 109.004 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -114.89 -44.98 3.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.339 1.856 . . . . 0.0 108.283 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -155.07 130.27 9.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -139.53 -45.29 0.45 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.627 2.371 . . . . 0.0 113.174 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 71.39 -61.78 1.11 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 127.536 2.493 . . . . 0.0 113.653 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.39 -17.01 2.34 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.343 1.857 . . . . 0.0 110.249 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -53.69 -34.91 60.32 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 118.455 0.571 . . . . 0.0 110.219 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.56 -175.75 5.6 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.466 HG22 ' CE2' ' A' ' 152' ' ' PHE 0.289 12.9 m -112.28 140.42 47.01 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 178.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.33 -16.76 2.71 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 128.272 2.629 . . . . 0.0 109.815 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.35 122.56 37.18 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 124.147 0.979 . . . . 0.0 111.775 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.466 ' CE2' HG22 ' A' ' 149' ' ' THR . 0.2 OUTLIER -161.71 -173.71 3.86 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.439 1.096 . . . . 0.0 109.481 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.47 -172.42 33.59 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.3 tp -146.03 127.16 14.7 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.9 m -82.96 40.16 0.68 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.6 ptt? -62.75 138.46 58.52 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 44.1 mt -117.42 -177.12 3.15 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.99 1.716 . . . . 0.0 106.95 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.1 p90 . . . . . 0 C--O 1.239 0.533 0 CA-C-N 119.728 1.149 . . . . 0.0 112.301 -179.206 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.4 ptt? . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -109.93 151.77 26.68 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -89.65 20.74 3.84 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.42 1.488 . . . . 0.0 112.939 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 51.24 68.8 0.73 Allowed 'General case' 0 C--O 1.232 0.133 0 C-N-CA 125.297 1.439 . . . . 0.0 112.413 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.07 160.45 39.75 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.1 pttt 43.94 19.99 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 128.235 2.614 . . . . 0.0 114.205 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 pp -133.13 -28.61 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 124.053 0.941 . . . . 0.0 112.225 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.73 -22.76 61.57 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.999 0.818 . . . . 0.0 111.338 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.95 158.84 50.94 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 126.08 1.752 . . . . 0.0 111.144 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.28 103.34 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.143 2.562 . . . . 0.0 109.123 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.18 113.23 24.9 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -110.62 139.61 45.71 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.001 0.429 . . . . 0.0 110.744 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.93 -126.25 0.88 Allowed Glycine 0 C--O 1.224 -0.516 0 CA-C-O 117.618 -1.657 . . . . 0.0 112.389 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.4 p -161.68 -165.38 1.27 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 121.292 2.546 . . . . 0.0 112.376 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -142.18 0.5 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.176 0.59 . . . . 0.0 109.868 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -66.53 -20.68 66.09 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 120.34 -1.475 . . . . 0.0 111.256 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -60.58 -16.43 38.0 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.893 0.877 . . . . 0.0 112.394 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.0 mt -74.11 -69.02 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.126 0 C-N-CA 125.48 1.512 . . . . 0.0 113.958 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.04 21.27 6.83 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 67.06 30.38 7.45 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.567 1.147 . . . . 0.0 110.792 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.464 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 16.9 mmt-85 -98.3 102.87 14.74 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.068 1.347 . . . . 0.0 108.476 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.0 t -80.25 154.11 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' A' ' 21' ' ' ARG . 5.2 m95 -114.27 143.93 44.05 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.8 t -138.35 121.07 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tp -69.96 106.54 3.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -98.79 -174.19 2.72 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.52 96.29 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.893 1.224 . . . . 0.0 112.303 -178.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 45.45 28.14 0.45 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.583 2.753 . . . . 0.0 111.823 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.2 m -153.5 127.04 8.68 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.092 0.86 . . . . 0.0 110.694 -176.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.3 mt -83.27 127.9 34.04 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 120.93 -1.106 . . . . 0.0 111.164 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.9 mm -128.01 139.25 52.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 122.949 0.499 . . . . 0.0 109.788 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.18 142.81 39.46 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 m -119.9 77.15 22.35 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 124.662 1.185 . . . . 0.0 108.115 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.31 -37.23 10.55 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.837 2.358 . . . . 0.0 113.907 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.45 51.88 1.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.74 134.14 52.34 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -66.41 -41.68 88.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.111 0.482 . . . . 0.0 110.485 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.18 75.15 9.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -123.35 140.71 52.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.797 -1.547 . . . . 0.0 110.075 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.0 t -140.87 141.16 23.38 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.75 160.84 42.99 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 N-CA-C 108.589 -1.35 . . . . 0.0 108.589 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.0 m -143.82 166.91 13.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 126.5 1.92 . . . . 0.0 109.093 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.61 154.77 36.32 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.3 mm -129.95 109.4 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 125.648 1.579 . . . . 0.0 108.053 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.98 133.38 34.84 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.818 1.247 . . . . 0.0 108.537 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.8 tt -129.55 129.78 44.9 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.4 1.48 . . . . 0.0 109.193 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.415 ' HB ' ' CZ ' ' A' ' 64' ' ' TYR . 2.1 mt -142.17 142.71 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.949 0.88 . . . . 0.0 109.62 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.2 p -87.21 146.78 25.85 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 87.3 m -63.98 122.69 17.12 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.589 1.156 . . . . 0.0 110.943 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -81.77 -26.86 34.09 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.049 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -96.96 35.9 1.49 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.842 1.201 . . . . 0.0 111.474 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.7 m -57.06 -15.98 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.583 1.153 . . . . 0.0 112.418 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.18 -13.26 11.36 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.845 2.058 . . . . 0.0 111.227 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.59 -0.89 13.51 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.57 1.548 . . . . 0.0 111.819 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -113.27 164.25 13.79 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.864 1.666 . . . . 0.0 110.25 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -71.15 152.73 43.12 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.816 0.847 . . . . 0.0 109.246 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -112.18 -32.84 6.42 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -52.57 -35.0 53.04 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 128.592 2.757 . . . . 0.0 114.27 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.9 mtt85 -87.08 -1.5 57.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 118.548 -0.739 . . . . 0.0 112.785 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.73 -177.17 18.19 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -82.45 106.14 6.07 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 118.927 1.364 . . . . 0.0 111.699 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.76 134.96 20.85 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.232 2.622 . . . . 0.0 108.934 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.92 -179.16 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.717 1.607 . . . . 0.0 110.565 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.415 ' CZ ' ' HB ' ' A' ' 47' ' ' ILE . 5.1 p90 -133.78 158.68 42.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.578 1.151 . . . . 0.0 110.446 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.2 tt -151.64 143.26 23.61 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.124 1.37 . . . . 0.0 109.162 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.43 -174.85 16.01 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.192 1.377 . . . . 0.0 111.344 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mt -105.5 133.59 50.0 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -95.39 107.36 19.49 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.1 -76.77 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.073 -1.536 . . . . 0.0 111.084 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.19 22.09 16.53 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.266 1.026 . . . . 0.0 111.169 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.11 72.54 0.49 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.033 1.733 . . . . 0.0 110.206 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.13 150.29 39.25 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.775 1.23 . . . . 0.0 108.064 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 3.2 m -147.62 171.64 15.29 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 123.069 0.548 . . . . 0.0 109.937 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 76.7 mt -62.13 166.11 5.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.684 0.794 . . . . 0.0 109.274 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -172.64 137.06 0.78 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.0 m -96.98 128.67 44.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.429 0.633 . . . . 0.0 110.205 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -133.87 -174.9 3.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -131.16 118.01 19.86 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 103.032 -2.951 . . . . 0.0 103.032 178.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 p -72.01 -23.31 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.4 -38.97 0.17 Allowed Glycine 0 N--CA 1.453 -0.227 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -141.8 -17.39 0.77 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.924 0.89 . . . . 0.0 112.488 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -139.47 153.26 70.47 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.836 1.254 . . . . 0.0 113.558 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.93 142.49 88.44 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 124.951 3.767 . . . . 0.0 111.973 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.8 p -147.33 163.52 36.17 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 124.738 1.215 . . . . 0.0 110.218 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 mt -86.12 156.53 20.33 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -147.18 80.08 1.52 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.638 1.975 . . . . 0.0 108.721 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.01 104.63 14.82 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.41 -24.79 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -144.58 87.5 1.87 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.379 1.071 . . . . 0.0 111.72 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -165.86 165.84 18.01 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 119.402 -2.061 . . . . 0.0 108.388 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -137.07 165.41 26.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.9 pt -113.98 -49.66 5.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 124.765 1.226 . . . . 0.0 110.586 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.1 mmt -62.25 -18.84 62.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 117.913 -1.042 . . . . 0.0 109.25 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -71.42 -45.22 63.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.263 1.392 . . . . 0.0 110.299 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 23.4 mt -62.6 -25.94 68.35 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.727 1.211 . . . . 0.0 109.662 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -82.76 -34.89 26.97 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.646 -0.659 . . . . 0.0 109.784 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -65.42 -37.76 87.87 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.621 -1.18 . . . . 0.0 110.859 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -136.12 158.5 73.6 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.87 82.43 2.33 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.926 2.417 . . . . 0.0 111.062 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -135.56 59.91 33.91 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.822 1.649 . . . . 0.0 107.26 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.66 86.84 1.0 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.334 2.023 . . . . 0.0 108.68 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.5 t -73.35 101.74 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -53.08 -29.8 32.42 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 122.998 0.519 . . . . 0.0 111.151 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -65.84 -7.1 14.41 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 178.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -120.92 -33.14 3.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.598 1.09 . . . . 0.0 109.689 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.5 mt -68.32 153.19 44.24 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.239 0.472 . . . . 0.0 111.918 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.95 135.72 24.6 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.126 0.97 . . . . 0.0 111.264 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -74.09 113.75 11.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.716 2.407 . . . . 0.0 105.996 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -88.99 134.06 34.11 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.6 t -132.9 -178.68 5.06 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.77 146.72 20.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.943 0.897 . . . . 0.0 109.891 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.85 88.75 0.98 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.431 1.092 . . . . 0.0 111.843 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 115' ' ' ASN . . . 87.17 61.93 1.54 Allowed Glycine 0 C--N 1.339 0.75 0 C-N-CA 124.335 0.969 . . . . 0.0 112.641 177.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 61.64 0.27 0.47 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.06 2.144 . . . . 0.0 110.437 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 113' ' ' GLY . 89.7 m-20 -115.28 124.9 52.51 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 m -84.72 171.67 12.14 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.096 0.958 . . . . 0.0 109.497 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.14 161.7 41.45 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.053 2.141 . . . . 0.0 108.375 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -141.22 111.93 7.06 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.582 1.153 . . . . 0.0 109.478 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -105.18 128.8 53.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.463 1.905 . . . . 0.0 109.893 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.2 t -52.74 125.58 17.2 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.028 1.731 . . . . 0.0 110.882 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.17 -45.59 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.428 1.013 . . . . 0.0 109.772 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.5 -33.68 74.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.007 -0.997 . . . . 0.0 111.619 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -136.27 83.89 31.17 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.703 1.201 . . . . 0.0 110.269 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.26 157.22 61.09 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.43 1.42 . . . . 0.0 110.342 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 103.73 -34.88 5.42 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.544 1.545 . . . . 0.0 109.5 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 15.7 m-90 -85.95 140.03 30.7 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -123.99 141.45 52.03 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.384 1.074 . . . . 0.0 109.032 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.1 mt -78.73 143.43 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -107.08 158.92 16.69 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.6 t -110.93 1.24 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 126.991 2.117 . . . . 0.0 112.698 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.6 m 49.66 52.93 13.62 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 m -85.1 -15.4 44.06 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.034 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -58.11 -31.52 67.23 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -170.15 -79.72 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.86 57.35 0.22 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 84.3 m -88.37 163.01 38.09 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.73 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.07 164.23 34.67 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 N-CA-C 107.531 -1.757 . . . . 0.0 107.531 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.8 mt -91.29 113.8 26.16 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.2 174.15 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 124.597 1.159 . . . . 0.0 112.445 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.44 150.71 22.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 118.531 -0.747 . . . . 0.0 109.809 177.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.5 t -130.88 173.86 10.55 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.891 1.276 . . . . 0.0 109.307 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -114.64 -32.6 5.8 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.96 1.304 . . . . 0.0 111.028 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -166.1 106.15 0.69 Allowed 'General case' 0 C--O 1.237 0.42 0 CA-C-N 119.14 0.882 . . . . 0.0 109.816 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.5 pp -143.21 164.03 31.29 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.522 1.129 . . . . 0.0 111.221 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.63 23.04 0.22 Allowed Glycine 0 CA--C 1.524 0.601 0 CA-C-O 118.427 -1.207 . . . . 0.0 111.74 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.504 ' CE ' ' HA ' ' A' ' 146' ' ' LYS . 0.3 OUTLIER -175.06 -35.28 0.01 OUTLIER 'General case' 0 C--N 1.347 0.481 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 178.836 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.44 -31.14 71.7 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.7 -169.69 3.14 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.77 105.87 8.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.179 0.445 . . . . 0.0 110.644 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.5 p -97.79 -22.91 16.14 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -103.55 108.07 19.18 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.389 1.876 . . . . 0.0 112.963 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -173.36 -179.29 1.87 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.828 1.251 . . . . 0.0 111.732 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.69 -155.96 27.44 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 124.814 1.197 . . . . 0.0 112.323 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.5 tp -151.48 135.84 16.86 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.6 1.56 . . . . 0.0 107.411 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.5 m -93.74 42.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.317 1.447 . . . . 0.0 110.292 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -64.41 147.82 51.81 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.071 -1.018 . . . . 0.0 108.684 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 26.1 mt -125.0 165.29 18.4 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.612 1.565 . . . . 0.0 110.467 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 36.7 p90 . . . . . 0 C--O 1.252 1.236 0 C-N-CA 126.159 1.784 . . . . 0.0 108.785 179.474 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.472 0.625 0 CA-C-O 119.836 -0.126 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -90.83 -161.73 0.84 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.913 1.285 . . . . 0.0 108.858 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -139.73 -75.08 0.35 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.267 1.827 . . . . 0.0 106.783 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.35 82.87 1.48 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 122.96 0.504 . . . . 0.0 111.2 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -158.35 156.51 30.66 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 125.649 1.58 . . . . 0.0 108.996 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 pttp 47.63 20.37 0.19 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 128.315 2.646 . . . . 0.0 115.753 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 pp -141.03 10.33 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.327 1.451 . . . . 0.0 112.704 -178.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.43 -18.2 28.83 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.909 1.231 . . . . 0.0 110.182 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 p -71.59 156.63 91.12 Favored Pre-proline 0 N--CA 1.445 -0.694 0 C-N-CA 124.483 1.113 . . . . 0.0 109.443 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.19 123.03 9.27 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 N-CA-C 106.965 -1.975 . . . . 0.0 106.965 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -114.75 110.39 19.64 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -90.17 156.63 18.2 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.987 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.8 -154.48 7.96 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.5 p -156.46 138.28 14.3 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.505 1.522 . . . . 0.0 110.048 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -98.28 1.04 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.0 0.92 . . . . 0.0 109.89 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -55.03 -36.45 65.53 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.036 -1.665 . . . . 0.0 111.412 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -4.71 0.24 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.7 mt -72.92 -61.56 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 CA-C-N 118.591 0.632 . . . . 0.0 109.78 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.73 29.92 1.1 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.489 1.116 . . . . 0.0 109.452 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 59.93 34.56 21.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.234 1.814 . . . . 0.0 111.45 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -99.86 107.77 19.87 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.4 t -88.71 160.38 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -113.78 139.57 49.01 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.419 0.554 . . . . 0.0 109.992 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.2 t -138.48 127.59 31.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.36 116.01 12.29 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 101.64 -3.467 . . . . 0.0 101.64 177.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -131.36 124.76 31.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.479 1.512 . . . . 0.0 108.003 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 t0 49.78 42.06 23.22 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 70.84 11.74 7.12 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.331 1.852 . . . . 0.0 113.863 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.5 m -133.05 138.55 46.8 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.602 1.546 . . . . 0.0 109.656 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mt -83.19 125.47 31.58 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 120.688 -1.258 . . . . 0.0 108.703 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.06 147.06 30.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.84 139.6 39.3 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.317 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.32 74.69 80.09 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 123.778 0.831 . . . . 0.0 110.559 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.29 -73.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.65 1.566 . . . . 0.0 112.976 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.27 12.45 32.92 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -72.45 129.03 37.38 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.247 0.619 . . . . 0.0 112.209 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -46.33 79.62 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.515 1.126 . . . . 0.0 108.492 177.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.63 24.37 0.21 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -69.38 177.6 2.77 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.001 0.819 . . . . 0.0 109.644 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.5 t -163.52 135.52 3.87 Favored Pre-proline 0 C--O 1.237 0.408 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.57 151.85 82.0 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.858 1.705 . . . . 0.0 110.434 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.5 p -141.2 156.58 21.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 m -120.82 157.39 29.86 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.05 105.81 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.206 1.002 . . . . 0.0 111.505 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . . . -94.88 120.47 35.15 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.396 1.078 . . . . 0.0 111.085 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.6 tt -106.06 139.39 40.66 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 125.522 1.529 . . . . 0.0 108.754 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.9 mt -137.46 145.48 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 124.778 1.299 . . . . 0.0 108.83 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.1 p -87.37 137.53 32.26 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.7 m -57.29 112.31 1.35 Allowed 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.097 -1.002 . . . . 0.0 109.984 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -94.79 -6.55 42.67 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.456 ' CE1' ' HA ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -117.95 64.48 0.75 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.056 1.742 . . . . 0.0 106.338 179.405 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.3 m -90.95 3.35 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -50.86 -26.69 6.11 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -117.58 18.45 14.23 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.085 1.354 . . . . 0.0 110.651 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -114.43 171.75 7.44 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 120.205 -1.559 . . . . 0.0 108.791 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.81 165.01 16.33 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.9 mttm -136.43 -39.6 0.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.824 1.25 . . . . 0.0 109.683 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -73.8 -17.35 61.09 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 123.554 0.534 . . . . 0.0 111.803 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -44.99 75.78 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.418 -0.801 . . . . 0.0 109.099 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 167.64 169.33 31.04 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 127.433 2.444 . . . . 0.0 107.384 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -73.62 110.16 8.29 Favored Pre-proline 0 CA--C 1.537 0.445 0 O-C-N 120.767 -1.431 . . . . 0.0 112.388 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.68 136.38 25.54 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 CA-C-N 121.862 1.701 . . . . 0.0 109.925 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 37.7 pt -146.06 -178.14 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.965 1.706 . . . . 0.0 108.96 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -153.68 159.93 42.2 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.218 1.007 . . . . 0.0 109.969 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.29 154.64 46.89 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.566 1.174 . . . . 0.0 111.589 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.81 159.01 26.85 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 124.757 1.17 . . . . 0.0 111.3 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.42 131.75 44.43 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.6 116.56 32.29 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.54 -36.27 0.24 Allowed Glycine 0 N--CA 1.447 -0.573 0 O-C-N 125.158 1.536 . . . . 0.0 111.91 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.08 24.41 0.83 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -178.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.03 70.77 0.61 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.286 1.434 . . . . 0.0 109.623 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.85 144.69 27.09 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 120.805 -1.184 . . . . 0.0 108.52 -178.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.0 m -145.76 166.67 25.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 117.352 -1.309 . . . . 0.0 111.7 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.6 mt -51.99 157.41 1.29 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.531 1.132 . . . . 0.0 110.352 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -170.39 148.27 3.16 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 68.0 m -109.55 121.34 44.99 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.119 1.768 . . . . 0.0 110.56 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.27 178.04 6.88 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.384 1.074 . . . . 0.0 109.57 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -119.85 130.73 55.02 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 102.685 -3.08 . . . . 0.0 102.685 178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.73 38.66 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.603 0.761 . . . . 0.0 112.693 -177.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.87 54.78 0.12 Allowed Glycine 0 CA--C 1.503 -0.712 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.0 t0 66.23 13.65 9.27 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.26 141.71 35.13 Favored Pre-proline 0 N--CA 1.448 -0.566 0 C-N-CA 125.61 1.564 . . . . 0.0 110.367 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.54 141.89 22.8 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.607 2.871 . . . . 0.0 113.236 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.8 p -150.42 176.82 10.57 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.506 0.723 . . . . 0.0 110.721 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mt -89.19 150.55 22.62 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.719 0.807 . . . . 0.0 110.845 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -146.01 65.81 1.21 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.935 1.694 . . . . 0.0 109.253 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.43 96.28 9.81 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 126.323 1.849 . . . . 0.0 107.949 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.66 -26.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.996 -177.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -144.44 98.0 3.13 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.487 1.115 . . . . 0.0 109.112 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.52 160.81 0.11 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.256 1.423 . . . . 0.0 110.572 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -142.24 133.16 25.79 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.53 0.732 . . . . 0.0 109.631 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.7 pt -72.27 -44.05 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.688 1.995 . . . . 0.0 111.656 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.21 -26.03 62.33 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.023 0.929 . . . . 0.0 111.395 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -60.64 -52.02 66.93 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 80.6 mt -61.87 -35.19 77.59 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.717 2.407 . . . . 0.0 110.746 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -80.04 -20.59 44.94 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.195 -1.566 . . . . 0.0 109.769 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -87.27 -37.12 17.49 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.581 -1.324 . . . . 0.0 113.528 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -130.87 162.6 54.33 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 120.09 1.314 . . . . 0.0 109.511 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.03 -172.13 0.39 Allowed 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 122.13 1.887 . . . . 0.0 108.772 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.252 19.8 mm-40 92.09 71.97 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 129.119 2.968 . . . . 0.0 113.934 177.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.456 ' HA ' ' CE1' ' A' ' 51' ' ' HIS . 18.3 Cg_endo -61.99 103.54 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.783 2.989 . . . . 0.0 111.573 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.1 t -78.01 98.7 2.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -52.75 -34.82 54.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.002 -1.686 . . . . 0.0 109.665 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.8 m -69.51 11.67 0.23 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.044 1.338 . . . . 0.0 112.564 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -133.85 -21.89 1.89 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.858 1.663 . . . . 0.0 108.683 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.4 mt -84.86 153.33 22.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.806 -1.184 . . . . 0.0 110.374 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -139.4 124.64 19.01 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.198 0.999 . . . . 0.0 110.128 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -72.21 122.42 21.02 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -75.18 141.68 43.6 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.69 178.57 8.05 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -164.62 153.0 12.43 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.83 1.252 . . . . 0.0 111.425 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.7 t -168.2 103.66 0.45 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.582 1.553 . . . . 0.0 113.226 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.47 49.3 5.24 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 126.322 1.915 . . . . 0.0 113.294 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 62.16 26.0 15.6 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -131.83 122.91 26.52 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 117.535 -1.221 . . . . 0.0 109.194 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.65 -177.86 3.37 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.969 1.258 . . . . 0.0 110.604 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.26 169.11 25.49 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 119.885 -1.759 . . . . 0.0 108.512 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -146.43 114.87 6.73 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.611 1.165 . . . . 0.0 111.293 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -108.6 126.6 53.13 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.42 1.488 . . . . 0.0 111.656 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.62 110.91 0.56 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.775 2.03 . . . . 0.0 109.995 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.6 t -60.78 -41.27 87.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 O-C-N 121.394 -0.816 . . . . 0.0 110.644 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.16 -45.34 92.28 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 119.529 -0.868 . . . . 0.0 112.264 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -128.62 86.71 56.92 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.1 156.49 65.6 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.997 1.798 . . . . 0.0 110.731 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.82 -27.12 11.46 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -95.35 140.36 30.34 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -119.07 146.34 45.16 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.575 1.55 . . . . 0.0 109.593 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.9 mm -73.74 121.3 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.294 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.15 143.09 27.26 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 118.719 -1.192 . . . . 0.0 109.91 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.4 m -94.3 -10.46 9.24 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 O-C-N 121.306 -0.871 . . . . 0.0 109.938 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.4 m 57.15 56.84 4.92 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 119.648 -1.907 . . . . 0.0 115.259 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.4 m -99.52 7.07 45.66 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -84.2 -75.03 0.36 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.49 1.116 . . . . 0.0 109.725 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -109.34 -36.51 2.1 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 118.46 60.19 0.28 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 14.0 m -84.86 167.46 26.32 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.44 149.95 87.42 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 N-CA-C 107.028 -1.951 . . . . 0.0 107.028 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.8 mt -66.72 125.11 24.79 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pp -148.42 167.39 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.404 0.682 . . . . 0.0 110.799 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 80.1 mt -81.35 159.63 24.34 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.24 127.81 11.56 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -83.28 -43.23 16.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 124.188 0.93 . . . . 0.0 110.471 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -156.08 83.11 1.0 Allowed 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.729 0.3 . . . . 0.0 111.035 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.2 pp -70.32 154.68 41.63 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.921 0.867 . . . . 0.0 110.922 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -114.14 64.12 0.3 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.89 37.99 11.25 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.874 1.67 . . . . 0.0 110.842 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -118.34 -4.03 10.94 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.616 0.366 . . . . 0.0 110.681 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -142.51 173.24 11.71 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 120.404 -1.435 . . . . 0.0 107.998 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.18 106.82 14.14 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.433 1.093 . . . . 0.0 108.557 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.07 -34.83 7.83 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.045 0.839 . . . . 0.0 110.633 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -96.52 100.0 11.61 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 127.991 2.516 . . . . 0.0 110.656 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -168.81 173.02 7.39 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.558 1.943 . . . . 0.0 110.277 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.32 -174.07 13.67 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 125.247 1.403 . . . . 0.0 110.425 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.49 169.85 16.92 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.169 0.509 . . . . 0.0 111.865 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 34.3 m -84.38 75.07 10.27 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.84 1.656 . . . . 0.0 109.998 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.74 153.32 35.14 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 68.6 mt -135.02 -165.24 1.64 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 129.852 3.261 . . . . 0.0 109.535 -177.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.5 p90 . . . . . 0 C--O 1.258 1.54 0 C-N-CA 125.721 1.608 . . . . 0.0 114.095 -178.603 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 119.507 -0.282 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -91.75 148.63 22.1 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -90.44 -0.19 57.55 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 -177.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 75.54 79.78 0.1 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.812 1.645 . . . . 0.0 108.563 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.6 pp -155.92 7.87 0.23 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.748 1.619 . . . . 0.0 113.397 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -153.95 13.03 0.45 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.395 1.478 . . . . 0.0 110.432 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 pt -144.48 34.62 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 129.411 3.084 . . . . 0.0 107.096 -177.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -85.0 -22.59 29.02 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.037 1.335 . . . . 0.0 110.583 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.25 165.46 38.47 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 177.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.54 146.97 45.14 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 N-CA-C 105.962 -2.361 . . . . 0.0 105.962 177.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.69 118.02 23.04 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.96 139.86 53.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -168.87 -119.18 0.48 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.8 p -150.19 177.63 9.74 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.202 1.501 . . . . 0.0 114.959 -177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.0 mt -141.79 -9.59 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 128.305 2.642 . . . . 0.0 108.253 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -58.7 -30.13 67.18 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 118.898 -2.376 . . . . 0.0 116.075 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.03 -12.96 9.32 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.44 1.496 . . . . 0.0 113.506 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.6 mt -54.97 -49.86 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 O-C-N 121.112 -0.993 . . . . 0.0 111.628 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -153.41 30.49 0.48 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.699 0.799 . . . . 0.0 109.244 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 64.59 8.0 4.11 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.127 1.771 . . . . 0.0 114.427 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.03 104.7 10.78 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 126.823 2.049 . . . . 0.0 107.022 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.5 t -82.45 175.1 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 178.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -123.07 134.23 54.27 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.788 -1.195 . . . . 0.0 108.264 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.9 t -132.51 133.46 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tp -71.88 112.5 8.03 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -130.76 127.46 38.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 120.457 1.481 . . . . 0.0 109.556 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.9 t0 43.79 56.01 4.82 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.212 1.005 . . . . 0.0 111.568 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.53 ' HB3' ' HE2' ' A' ' 88' ' ' LYS . 91.2 mt-30 57.41 22.28 7.76 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.13 139.7 32.23 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 125.242 1.417 . . . . 0.0 107.366 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 17.3 mt -79.36 131.31 36.08 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 120.66 -1.275 . . . . 0.0 107.816 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.2 mt -123.97 133.77 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.155 0.889 . . . . 0.0 110.086 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.91 142.57 42.04 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.58 75.16 79.84 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.245 1.418 . . . . 0.0 112.308 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.28 -74.85 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 121.746 1.63 . . . . 0.0 110.736 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -95.44 68.01 2.95 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.5 145.74 51.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -76.34 -62.54 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.54 0.686 . . . . 0.0 110.028 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 -74.27 40.94 0.13 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -75.52 165.71 24.69 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 120.794 -1.191 . . . . 0.0 108.503 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.52 144.22 20.38 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.46 166.37 28.7 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.588 2.192 . . . . 0.0 111.136 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 p -155.75 164.3 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.76 149.9 49.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mm -123.18 118.9 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.943 1.297 . . . . 0.0 110.526 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.6 135.53 37.15 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.772 1.629 . . . . 0.0 108.774 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.3 tt -131.76 135.6 46.92 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.992 1.317 . . . . 0.0 108.029 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.3 mt -141.53 147.11 22.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.35 1.06 . . . . 0.0 108.565 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 p -90.59 128.22 36.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.896 2.479 . . . . 0.0 106.301 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 74.2 m -62.2 144.34 55.6 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.428 0.558 . . . . 0.0 109.627 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -101.21 -34.36 9.7 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.237 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -88.95 41.55 1.03 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.707 1.203 . . . . 0.0 108.737 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -69.84 -13.13 16.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 O-C-N 121.708 -0.62 . . . . 0.0 111.095 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -51.67 -39.32 58.03 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.598 1.559 . . . . 0.0 112.523 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.8 t -89.38 -5.16 57.69 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.753 0.821 . . . . 0.0 112.697 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.3 mt -92.45 -145.52 0.22 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.92 1.288 . . . . 0.0 112.538 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -123.37 160.0 27.71 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 127.815 2.446 . . . . 0.0 109.958 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -137.42 -26.8 0.98 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.61 1.564 . . . . 0.0 111.967 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -61.86 -45.24 94.66 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.79 0.723 . . . . 0.0 110.268 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -58.33 -51.2 70.78 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.726 0.81 . . . . 0.0 108.823 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.3 -179.32 37.69 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 106.422 -2.671 . . . . 0.0 106.422 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -82.46 117.79 69.68 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.052 0.926 . . . . 0.0 109.489 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 108' ' ' TYR . 73.0 Cg_endo -71.93 138.29 31.01 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.981 3.12 . . . . 0.0 111.121 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.4 pt -140.73 -177.39 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.14 0.576 . . . . 0.0 110.215 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -143.21 157.95 44.05 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.976 -0.452 . . . . 0.0 110.55 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 tt -156.84 157.68 35.39 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.757 1.223 . . . . 0.0 109.446 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -164.93 -179.08 38.72 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mt -94.68 160.1 14.77 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -131.95 88.44 2.56 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.9 -40.58 0.02 OUTLIER Glycine 0 CA--C 1.523 0.538 0 CA-C-O 118.93 -0.928 . . . . 0.0 111.463 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.57 23.46 2.3 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.82 0.848 . . . . 0.0 112.731 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.2 m120 59.9 73.07 0.5 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.999 1.72 . . . . 0.0 110.228 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.09 138.55 25.42 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.768 1.227 . . . . 0.0 110.203 -177.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 16.3 m -139.93 177.42 7.98 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.837 0.744 . . . . 0.0 109.604 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 26.8 mt -61.42 151.11 33.4 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.2 ttp -155.04 148.61 25.29 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 9.3 m -124.53 126.46 45.88 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.582 ' CB ' HE21 ' A' ' 86' ' ' GLN . . . -130.47 -178.63 4.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.916 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -132.69 118.98 19.78 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.4 m -75.25 30.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 122.966 0.507 . . . . 0.0 111.276 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.42 -3.86 61.51 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.201 -0.937 . . . . 0.0 112.087 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -127.06 -57.43 1.32 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.799 1.24 . . . . 0.0 112.071 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -145.26 164.06 28.84 Favored Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 125.59 1.556 . . . . 0.0 110.943 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.94 148.96 46.38 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.302 1.334 . . . . 0.0 113.234 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.6 p -146.06 169.83 17.89 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.575 0.75 . . . . 0.0 110.348 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.74 141.76 28.32 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.913 1.285 . . . . 0.0 109.929 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.582 HE21 ' CB ' ' A' ' 77' ' ' ALA . 12.2 mt-30 -140.27 68.28 1.36 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.709 0.766 . . . . 0.0 109.682 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.492 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -85.0 106.57 16.6 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -178.577 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.53 ' HE2' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -163.37 -43.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 O-C-N 124.887 1.367 . . . . 0.0 112.251 -179.328 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -139.97 93.11 2.61 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -167.36 172.44 9.7 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.411 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -146.17 139.31 25.82 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 125.786 1.635 . . . . 0.0 109.356 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.62 -48.14 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.05 0.94 . . . . 0.0 111.057 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -60.82 -28.27 68.67 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 118.984 -0.531 . . . . 0.0 111.098 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -65.99 -51.98 53.51 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.943 0.792 . . . . 0.0 109.702 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.6 mt -63.79 -27.22 69.03 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.021 0.529 . . . . 0.0 111.332 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -82.33 -28.06 31.86 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.531 -0.731 . . . . 0.0 110.231 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -78.14 -37.21 46.61 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.894 1.278 . . . . 0.0 111.406 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -109.12 158.09 35.28 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -77.62 50.29 3.18 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.165 2.577 . . . . 0.0 111.89 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -117.05 74.5 7.18 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 124.892 1.277 . . . . 0.0 111.06 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -78.64 81.1 2.86 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.494 2.13 . . . . 0.0 107.519 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.3 t -70.27 97.95 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -51.43 -30.44 19.44 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.812 0.845 . . . . 0.0 111.76 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -64.43 -5.93 6.26 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 125.751 1.62 . . . . 0.0 112.199 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -123.49 -31.28 3.53 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.244 1.018 . . . . 0.0 109.158 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.1 mt -70.41 162.25 29.01 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.192 1.397 . . . . 0.0 112.489 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -152.2 139.68 19.61 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.152 0.981 . . . . 0.0 109.888 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER -82.98 161.59 21.72 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-N 119.858 1.208 . . . . 0.0 108.926 177.677 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -114.2 126.0 54.56 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 128.32 2.648 . . . . 0.0 112.139 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.5 t -132.35 145.88 51.57 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.29 148.57 47.32 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.185 0.994 . . . . 0.0 109.801 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.5 p -157.67 78.98 0.86 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.32 70.77 1.2 Allowed Glycine 0 N--CA 1.467 0.753 0 C-N-CA 123.958 0.79 . . . . 0.0 112.736 177.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.4 mtm-85 61.61 9.47 2.79 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.473 1.509 . . . . 0.0 112.726 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -119.72 153.4 35.69 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.2 m -139.85 151.55 45.77 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 79.6 p -114.39 174.57 5.89 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.624 0.726 . . . . 0.0 111.286 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -139.82 104.45 4.89 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.927 1.691 . . . . 0.0 106.923 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.55 130.29 56.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.668 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.6 m -53.26 126.21 20.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.107 1.363 . . . . 0.0 112.626 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 99.2 t -71.8 -42.86 69.99 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.889 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.6 91.6 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -128.02 82.04 69.21 Favored Pre-proline 0 C--O 1.234 0.254 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.07 153.38 78.33 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 108.679 -1.316 . . . . 0.0 108.679 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.09 -12.26 44.77 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.511 1.529 . . . . 0.0 110.888 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -113.22 135.48 53.78 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.13 1.772 . . . . 0.0 108.575 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -122.21 150.19 42.62 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.833 1.653 . . . . 0.0 108.463 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 22.3 mt -79.52 134.49 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 123.734 0.814 . . . . 0.0 110.1 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -104.34 124.92 50.05 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 91.7 t -72.9 -19.1 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 127.708 2.403 . . . . 0.0 113.214 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.4 m 54.34 65.58 1.47 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.176 1.39 . . . . 0.0 114.325 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.5 m -88.61 -9.75 51.08 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -58.17 -76.07 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.906 2.188 . . . . 0.0 116.906 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.93 16.11 5.83 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 125.447 1.499 . . . . 0.0 113.278 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 82.58 56.53 2.77 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -84.33 166.69 31.56 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 117.457 0.628 . . . . 0.0 110.213 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.55 151.32 32.64 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.96 1.773 . . . . 0.0 109.005 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.8 mt -76.51 115.29 16.12 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.499 1.12 . . . . 0.0 108.114 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.06 168.87 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 125.573 1.549 . . . . 0.0 110.713 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 74.4 mt -88.1 165.43 15.14 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.1 t -153.95 137.39 15.86 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -80.23 -41.05 25.87 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.417 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -161.03 102.91 1.28 Allowed 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 -178.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.439 ' H ' HD23 ' A' ' 144' ' ' LEU . 2.0 pt? -64.06 149.58 47.24 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -119.78 -4.06 11.9 Favored Glycine 0 C--N 1.318 -0.45 0 CA-C-O 118.534 -1.148 . . . . 0.0 111.845 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.32 -140.57 0.21 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.155 1.382 . . . . 0.0 108.606 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -107.4 37.71 2.33 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.226 1.81 . . . . 0.0 109.771 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -55.13 -12.77 0.99 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.649 1.58 . . . . 0.0 114.16 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.31 88.99 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 129.724 3.21 . . . . 0.0 113.298 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.5 p -111.76 -2.72 15.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.151 -0.968 . . . . 0.0 111.984 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -139.17 109.8 6.64 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.44 -176.99 6.21 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.199 1.8 . . . . 0.0 111.879 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.62 -173.7 25.84 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.537 1.541 . . . . 0.0 110.777 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.66 146.61 52.02 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.621 1.169 . . . . 0.0 109.392 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.0 m -102.8 45.83 0.95 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.331 1.453 . . . . 0.0 107.159 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -67.68 154.18 42.07 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.495 1.118 . . . . 0.0 109.238 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.2 mt -129.11 172.3 11.55 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.006 1.322 . . . . 0.0 109.591 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.8 p90 . . . . . 0 C--O 1.248 0.996 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 179.403 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 ptm . . . . . 0 N--CA 1.469 0.516 0 CA-C-O 123.247 1.498 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -82.17 177.13 8.97 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 127.475 2.31 . . . . 0.0 108.739 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -98.74 -64.23 1.05 Allowed 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -170.45 111.17 0.4 Allowed 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -152.78 168.51 25.47 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 126.631 1.972 . . . . 0.0 107.524 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -113.29 -23.55 9.85 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.029 0.932 . . . . 0.0 113.213 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pt -68.29 -25.55 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 117.832 -1.08 . . . . 0.0 112.03 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -55.84 -45.86 78.31 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.829 0.74 . . . . 0.0 109.397 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.37 130.1 94.02 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 118.262 0.483 . . . . 0.0 110.879 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.1 136.05 42.87 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.084 2.523 . . . . 0.0 109.576 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.79 111.11 20.73 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -109.93 145.14 37.39 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.31 -140.17 3.19 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 119.459 1.027 . . . . 0.0 112.54 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.2 p -136.68 -175.95 4.19 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.604 1.702 . . . . 0.0 113.311 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.6 mt -144.31 -6.19 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 126.696 1.999 . . . . 0.0 109.438 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.479 ' C ' ' H ' ' A' ' 18' ' ' ILE . 4.8 pt20 -73.52 -24.32 60.13 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 119.467 -2.02 . . . . 0.0 114.43 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -72.17 36.91 0.07 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.208 3.003 . . . . 0.0 110.732 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 16' ' ' GLN . 45.4 mt -122.14 -71.14 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 128.674 2.79 . . . . 0.0 109.504 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -126.57 25.35 6.49 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 122.548 0.339 . . . . 0.0 111.383 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 64.83 35.82 8.31 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.623 0.725 . . . . 0.0 109.414 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.3 mmt-85 -104.16 81.65 1.86 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 120.838 -1.163 . . . . 0.0 109.809 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.65 134.12 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -89.95 144.66 25.73 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.8 t -144.21 131.52 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.6 tp -71.14 115.01 9.79 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -132.27 123.92 27.86 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.922 1.289 . . . . 0.0 107.731 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.3 t70 46.85 50.4 13.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.728 1.211 . . . . 0.0 112.475 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 65.86 15.76 10.19 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.2 m -137.39 152.11 49.29 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.4 mt -91.07 129.31 37.08 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 119.815 -1.803 . . . . 0.0 107.481 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.2 mm -127.73 138.16 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.407 0.683 . . . . 0.0 110.409 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.18 127.98 33.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.526 1.131 . . . . 0.0 108.73 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -111.26 99.12 42.47 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 124.601 1.16 . . . . 0.0 108.036 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.25 -32.16 8.59 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.287 1.991 . . . . 0.0 112.726 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -92.9 161.99 14.26 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.864 1.266 . . . . 0.0 109.816 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.04 19.44 12.84 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.542 1.137 . . . . 0.0 110.095 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -53.55 -50.82 64.71 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.282 1.401 . . . . 0.0 108.861 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.07 81.79 0.78 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 12.6 ptp -108.8 169.19 8.82 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.9 t -148.28 130.82 7.79 Favored Pre-proline 0 N--CA 1.45 -0.441 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -64.9 148.85 90.06 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.788 1.658 . . . . 0.0 107.86 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.5 m -142.03 171.5 10.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 125.591 1.556 . . . . 0.0 107.365 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.37 157.59 46.51 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mm -118.21 144.0 27.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 127.984 2.513 . . . . 0.0 105.271 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.02 129.92 52.85 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 126.597 1.959 . . . . 0.0 105.793 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.42 132.1 48.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.96 1.255 . . . . 0.0 107.699 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.5 mt -144.93 149.41 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.6 p -81.82 166.03 20.34 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.7 t -88.77 158.43 18.16 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -117.2 -3.8 11.47 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 177.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.532 ' HD1' ' HD3' ' A' ' 101' ' ' PRO . 9.7 t-160 -119.05 57.36 0.88 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.0 m -83.87 -11.97 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.96 0.904 . . . . 0.0 110.837 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -64.72 -6.53 8.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.56 1.944 . . . . 0.0 112.484 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.7 t -121.8 7.89 9.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.157 1.383 . . . . 0.0 110.196 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 96.0 mt -108.24 173.05 6.49 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 120.585 -1.322 . . . . 0.0 112.006 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -79.77 154.92 28.17 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -126.44 -40.59 1.94 Allowed 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 116.938 -1.506 . . . . 0.0 110.846 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.28 -38.7 28.08 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.115 1.766 . . . . 0.0 114.177 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -65.63 -33.19 75.33 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 119.602 -0.237 . . . . 0.0 111.349 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.603 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 142.21 -178.14 21.03 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 126.381 1.943 . . . . 0.0 110.584 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -78.2 113.71 36.03 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -81.91 148.22 15.38 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 124.432 3.421 . . . . 0.0 111.592 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -149.84 -171.78 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 126.673 1.989 . . . . 0.0 109.067 178.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -132.86 147.11 52.3 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.928 2.091 . . . . 0.0 112.762 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.1 tt -156.73 134.15 10.69 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 120.474 -1.391 . . . . 0.0 109.645 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -142.02 -167.77 11.43 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mt -100.7 159.52 15.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.89 87.56 2.78 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.61 -38.33 0.03 OUTLIER Glycine 0 C--N 1.336 0.544 0 CA-C-O 117.927 -1.485 . . . . 0.0 116.082 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.78 17.2 2.68 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.852 1.826 . . . . 0.0 111.896 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.15 69.15 0.39 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.62 146.37 29.33 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 124.784 1.233 . . . . 0.0 108.684 -177.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 4.4 m -145.24 -175.37 4.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.324 1.05 . . . . 0.0 112.232 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.414 ' HA ' HD11 ' A' ' 87' ' ' LEU . 45.4 mt -66.64 160.5 25.34 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.2 ttp -161.69 127.56 3.66 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.3 m -96.51 119.67 35.42 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 118.314 0.506 . . . . 0.0 110.472 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -123.39 175.85 6.49 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -137.25 120.05 16.3 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.9 m -74.18 13.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.17 -23.95 34.25 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -115.32 -39.15 3.65 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -149.64 158.45 37.63 Favored Pre-proline 0 C--O 1.24 0.575 0 C-N-CA 123.785 0.834 . . . . 0.0 111.052 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -71.01 145.31 49.63 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.219 2.613 . . . . 0.0 110.194 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 42.4 p -146.55 156.92 43.6 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.458 0.703 . . . . 0.0 110.075 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.9 mt -83.11 149.11 27.09 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.41 ' OE1' ' HE2' ' A' ' 88' ' ' LYS . 17.0 mm-40 -145.44 67.23 1.22 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.451 1.5 . . . . 0.0 109.437 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.418 HD23 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.12 112.09 19.5 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 127.63 2.372 . . . . 0.0 108.032 -177.715 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.41 ' HE2' ' OE1' ' A' ' 86' ' ' GLN . 0.1 OUTLIER -178.47 -29.28 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 O-C-N 125.21 1.569 . . . . 0.0 113.358 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -146.25 90.07 1.92 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 120.321 1.418 . . . . 0.0 113.21 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -166.9 160.1 14.07 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.564 1.546 . . . . 0.0 107.071 179.417 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.43 146.68 40.42 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.958 1.703 . . . . 0.0 107.688 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mt -96.85 -40.28 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.737 0.815 . . . . 0.0 110.707 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -27.29 68.73 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.399 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.08 -48.28 80.89 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.836 0.827 . . . . 0.0 110.707 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.1 mt -62.71 -27.99 69.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 127.598 2.359 . . . . 0.0 110.368 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -87.32 -20.25 27.05 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -88.27 -25.22 22.94 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 119.339 0.972 . . . . 0.0 112.678 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -137.75 157.43 73.48 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.807 1.243 . . . . 0.0 111.068 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.2 67.64 5.15 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 124.018 3.145 . . . . 0.0 114.124 -178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -118.07 73.27 9.59 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.12 0.968 . . . . 0.0 111.461 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.532 ' HD3' ' HD1' ' A' ' 51' ' ' HIS . 62.3 Cg_endo -80.95 77.42 4.06 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.294 2.663 . . . . 0.0 108.504 179.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.2 t -68.62 103.17 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 126.174 1.789 . . . . 0.0 108.849 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -56.3 -31.62 63.83 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.041 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.0 -9.05 42.53 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.648 1.113 . . . . 0.0 112.284 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -120.82 -18.54 7.61 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.225 0.921 . . . . 0.0 109.169 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 66.6 mt -74.69 149.58 39.84 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 119.774 -1.829 . . . . 0.0 109.724 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -139.7 129.27 24.37 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.988 0.515 . . . . 0.0 110.549 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.603 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -74.68 126.8 31.64 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 177.766 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -95.49 117.08 29.74 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.023 0.529 . . . . 0.0 111.265 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.1 t -112.33 -176.81 3.01 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 2.1 pt20 -150.93 147.7 27.51 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.177 2.191 . . . . 0.0 110.025 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.1 p -164.63 87.66 0.47 Allowed 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.993 1.433 . . . . 0.0 113.874 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 115' ' ' ASN . . . 78.04 70.46 1.3 Allowed Glycine 0 CA--C 1.504 -0.64 0 C-N-CA 124.899 1.238 . . . . 0.0 112.251 177.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.8 mtm-85 64.22 -2.32 0.61 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.686 1.995 . . . . 0.0 113.075 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' A' ' 113' ' ' GLY . 71.1 m-80 -111.74 165.89 11.65 Favored 'General case' 0 CA--C 1.513 -0.442 0 C-N-CA 124.885 1.274 . . . . 0.0 110.951 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 45.6 m -132.69 162.91 30.18 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.695 1.598 . . . . 0.0 110.471 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.87 170.07 16.43 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.106 0.962 . . . . 0.0 110.222 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -139.67 109.5 6.35 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.443 1.497 . . . . 0.0 108.993 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -100.78 130.02 46.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.491 1.916 . . . . 0.0 110.134 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.4 t -58.1 126.07 25.87 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.548 0.613 . . . . 0.0 109.541 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.34 -47.99 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 O-C-N 120.938 -1.101 . . . . 0.0 110.129 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.42 -37.62 65.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.254 0.479 . . . . 0.0 110.804 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -138.19 91.0 13.18 Favored Pre-proline 0 C--O 1.234 0.269 0 C-N-CA 123.502 0.721 . . . . 0.0 109.137 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.25 174.53 8.94 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.606 2.204 . . . . 0.0 112.264 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.39 -13.76 44.26 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 126.262 1.886 . . . . 0.0 111.341 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -110.2 117.69 34.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.177 0.991 . . . . 0.0 109.553 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -99.27 132.84 44.31 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 127.521 2.328 . . . . 0.0 109.326 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 pt -71.95 120.76 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 121.762 -0.586 . . . . 0.0 109.634 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.27 166.74 16.25 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 118.181 -1.408 . . . . 0.0 111.274 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.5 m -107.28 -16.29 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 C-N-CA 125.099 1.36 . . . . 0.0 112.976 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.1 m 72.63 64.98 0.12 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 122.804 1.288 . . . . 0.0 110.728 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.08 33.09 4.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.532 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -117.05 -47.69 2.67 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.725 0.41 . . . . 0.0 111.749 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -140.46 -60.21 0.04 OUTLIER Glycine 0 C--N 1.333 0.384 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.41 51.94 0.01 OUTLIER Glycine 0 C--N 1.332 0.308 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . 0.451 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 55.9 m -88.18 177.43 2.65 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.921 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 136' ' ' CYS . 42.0 Cg_endo -81.39 169.66 15.43 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.009 2.473 . . . . 0.0 111.025 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 30.3 mt -86.91 112.76 22.09 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 124.159 0.983 . . . . 0.0 110.702 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.25 -175.08 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.034 0.934 . . . . 0.0 110.15 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.09 137.03 45.94 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 15.4 t -131.19 154.36 48.48 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.562 1.545 . . . . 0.0 108.753 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -94.93 -23.36 17.45 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.373 1.469 . . . . 0.0 108.903 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -131.11 95.0 3.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 123.374 1.559 . . . . 0.0 108.4 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.425 ' C ' ' H ' ' A' ' 146' ' ' LYS . 0.4 OUTLIER -79.47 179.03 7.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.841 -1.527 . . . . 0.0 111.125 178.21 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 61.84 5.37 7.14 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 123.936 0.779 . . . . 0.0 111.758 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.581 ' HE3' ' HA ' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -97.39 -92.1 0.24 Allowed 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 126.436 1.895 . . . . 0.0 108.75 -178.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -90.3 -16.11 29.9 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 117.306 -1.331 . . . . 0.0 109.589 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -158.11 145.91 18.44 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-N 119.95 1.25 . . . . 0.0 109.293 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.5 m -82.69 137.34 34.47 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.523 1.929 . . . . 0.0 109.382 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 65.3 p -117.68 -23.65 7.54 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.064 1.302 . . . . 0.0 108.046 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -95.8 110.0 22.23 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.953 1.301 . . . . 0.0 113.654 -177.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -166.52 -175.14 3.08 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.235 1.814 . . . . 0.0 108.78 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -108.85 -178.04 21.61 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.417 ' C ' ' H ' ' A' ' 156' ' ' MET . 0.7 OUTLIER -124.91 131.57 53.41 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 123.739 0.816 . . . . 0.0 109.558 -179.897 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.5 m -79.0 31.85 0.21 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.384 1.474 . . . . 0.0 108.31 177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.417 ' H ' ' C ' ' A' ' 154' ' ' LEU . 4.9 ptt? -63.03 130.14 43.41 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.261 1.824 . . . . 0.0 107.928 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 21.5 mt -100.51 175.83 5.55 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 126.181 1.792 . . . . 0.0 108.753 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 23.9 p90 . . . . . 0 C--O 1.261 1.7 0 CA-C-O 115.615 -2.136 . . . . 0.0 108.924 -179.405 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -68.06 159.58 30.56 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.055 0.455 . . . . 0.0 111.286 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -85.12 -91.43 0.09 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.33 91.8 2.3 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.839 1.256 . . . . 0.0 110.384 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.96 166.78 31.91 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.984 2.114 . . . . 0.0 108.149 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.6 pttt 45.88 24.6 0.24 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 129.076 2.951 . . . . 0.0 115.04 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 pp -139.1 -43.13 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.618 1.167 . . . . 0.0 111.1 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -87.33 120.44 28.62 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.17 162.23 25.42 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 125.362 1.465 . . . . 0.0 109.318 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.35 152.61 20.77 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.67 2.247 . . . . 0.0 108.328 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.12 124.44 27.53 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 178.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.92 133.81 55.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.82 -131.08 1.29 Allowed Glycine 0 CA--C 1.522 0.478 0 CA-C-O 116.825 -2.097 . . . . 0.0 110.259 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.7 p -154.97 -173.04 4.41 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 122.604 3.202 . . . . 0.0 114.715 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mt -136.36 -2.93 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.763 1.225 . . . . 0.0 108.712 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -56.39 -40.86 75.33 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.099 -1.626 . . . . 0.0 112.114 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -19.98 2.36 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.712 2.005 . . . . 0.0 115.393 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.6 mm -64.91 -58.68 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 123.584 0.753 . . . . 0.0 112.324 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -138.99 24.04 2.58 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.439 0.638 . . . . 0.0 110.816 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.3 t60 62.98 40.18 9.53 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.08 1.752 . . . . 0.0 108.39 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.4 mmt-85 -109.23 85.53 2.12 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.829 -1.169 . . . . 0.0 109.46 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.9 t -78.0 154.63 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 54.1 m0 -105.63 144.81 31.86 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.9 t -141.27 133.4 29.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 tt -74.56 122.61 23.38 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -131.14 119.34 21.77 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 47.0 t0 32.49 67.17 0.17 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.034 1.734 . . . . 0.0 113.876 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 60.5 17.73 7.59 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.5 m -137.97 126.57 23.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.341 1.456 . . . . 0.0 109.813 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.8 mt -77.5 136.2 38.31 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.5 pp -127.05 145.73 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 123.574 0.749 . . . . 0.0 111.861 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.28 127.79 34.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 m -103.69 89.37 2.22 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.65 -55.1 0.3 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.34 1.36 . . . . 0.0 112.731 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -154.73 95.27 1.75 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.484 0.714 . . . . 0.0 111.993 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.43 160.84 39.97 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -69.12 -34.61 75.32 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.846 0.859 . . . . 0.0 112.281 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -82.35 58.64 4.18 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.41 0.684 . . . . 0.0 110.677 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -90.02 157.92 17.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 177.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.1 m -157.98 109.84 1.75 Allowed Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 125.89 1.676 . . . . 0.0 106.517 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.99 148.2 69.5 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 N-CA-C 107.907 -1.613 . . . . 0.0 107.907 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.07 157.58 28.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.05 156.38 19.32 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.3 mm -122.62 113.22 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 128.441 2.696 . . . . 0.0 106.288 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.71 138.56 32.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.4 tt -137.36 130.25 30.39 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.649 1.18 . . . . 0.0 108.671 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -141.09 134.74 31.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.724 1.209 . . . . 0.0 107.975 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.4 p -66.47 158.61 29.07 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.85 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.494 ' HG ' ' C ' ' A' ' 62' ' ' PRO . 5.4 m -68.79 136.99 53.62 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.214 -0.929 . . . . 0.0 112.369 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.28 -30.34 18.54 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 117.234 -1.365 . . . . 0.0 112.865 178.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -122.35 69.98 0.97 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 119.721 1.146 . . . . 0.0 110.809 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.0 m -78.98 -10.76 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 123.043 0.537 . . . . 0.0 110.986 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -55.07 -32.46 61.95 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.54 1.936 . . . . 0.0 114.247 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 t -104.58 9.03 35.5 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.973 0.909 . . . . 0.0 110.463 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.9 mt -111.16 168.24 9.66 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.612 1.165 . . . . 0.0 110.25 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.465 ' HB2' ' HH ' ' A' ' 108' ' ' TYR . 16.6 mm-40 -83.1 159.54 22.08 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.633 1.973 . . . . 0.0 108.165 177.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.4 -24.85 1.77 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.133 1.373 . . . . 0.0 110.872 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.86 -26.76 59.31 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.073 2.149 . . . . 0.0 112.808 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -96.08 -1.2 49.19 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 125.119 1.368 . . . . 0.0 114.17 -178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.07 161.13 11.03 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -79.12 123.29 84.91 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 121.524 -0.986 . . . . 0.0 109.138 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.494 ' C ' ' HG ' ' A' ' 49' ' ' CYS . 83.4 Cg_endo -74.85 151.68 40.64 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.196 2.597 . . . . 0.0 111.228 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.4 pt -146.34 -175.17 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 126.513 1.925 . . . . 0.0 109.706 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -127.29 143.18 51.28 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 129.094 2.957 . . . . 0.0 109.919 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.5 tt -154.83 148.94 25.88 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.434 -1.416 . . . . 0.0 109.221 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.44 -169.0 25.2 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 120.867 -1.146 . . . . 0.0 112.458 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.2 mt -105.51 149.93 25.79 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.92 101.7 8.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.6 -31.45 0.08 OUTLIER Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.462 -1.188 . . . . 0.0 114.006 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.25 20.84 0.75 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.736 1.768 . . . . 0.0 112.936 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.0 m120 65.89 66.64 0.49 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.79 132.35 20.94 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.232 1.013 . . . . 0.0 111.127 -178.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 17.1 m -142.76 174.63 10.48 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 123.735 0.814 . . . . 0.0 110.283 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 45.2 mt -55.14 157.91 3.21 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 125.826 1.651 . . . . 0.0 113.644 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -166.21 150.98 8.06 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 117.519 -1.229 . . . . 0.0 108.73 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.2 m -123.05 112.11 17.37 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.559 1.144 . . . . 0.0 111.139 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.17 143.54 50.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.67 1.123 . . . . 0.0 108.246 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 83' ' ' PRO . 79.1 tttt -92.86 123.29 36.02 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.344 1.458 . . . . 0.0 109.702 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.91 -4.43 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.97 16.92 10.05 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -151.17 -61.05 0.18 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.283 1.833 . . . . 0.0 107.959 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -141.35 161.45 52.76 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.26 1.424 . . . . 0.0 112.03 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 97.8 Cg_endo -74.09 152.53 45.77 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.456 2.77 . . . . 0.0 110.333 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.6 p -146.27 161.94 39.18 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.263 1.825 . . . . 0.0 109.362 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 mt -78.9 140.0 38.19 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.784 1.634 . . . . 0.0 110.795 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.35 67.19 1.46 Allowed 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.059 0.845 . . . . 0.0 110.811 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.486 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -92.06 118.6 30.96 Favored 'General case' 0 CA--C 1.493 -1.216 0 C-N-CA 125.183 1.393 . . . . 0.0 109.412 -178.219 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -179.42 -29.34 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 O-C-N 125.013 1.445 . . . . 0.0 113.618 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -146.04 102.25 3.61 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.401 1.48 . . . . 0.0 107.442 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.05 161.65 0.59 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 119.003 0.82 . . . . 0.0 109.041 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.69 153.0 52.19 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.71 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.98 -38.9 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.786 1.234 . . . . 0.0 108.989 178.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.6 tpt -64.6 -33.09 75.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.867 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.07 -40.55 87.07 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.507 1.049 . . . . 0.0 110.647 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.4 mt -65.21 -31.88 73.28 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -78.58 -29.41 46.15 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.085 0.954 . . . . 0.0 110.175 178.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -78.09 -32.73 50.8 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.656 -1.277 . . . . 0.0 113.417 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -126.21 168.66 13.54 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 119.053 0.842 . . . . 0.0 112.017 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -80.34 68.0 8.45 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.319 2.68 . . . . 0.0 109.904 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -121.55 72.8 30.01 Favored Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 121.695 -0.628 . . . . 0.0 110.426 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.24 65.13 8.89 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.853 3.035 . . . . 0.0 108.433 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.4 t -70.98 97.66 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.076 0 C-N-CA 125.142 1.377 . . . . 0.0 107.81 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -48.18 -30.43 4.64 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.202 1.401 . . . . 0.0 112.33 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 t -63.54 -14.93 56.02 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.59 1.556 . . . . 0.0 113.445 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -126.6 -4.08 6.58 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.951 1.7 . . . . 0.0 111.122 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.4 mt -95.18 151.62 19.06 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.363 1.465 . . . . 0.0 110.025 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -139.21 133.02 30.78 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.465 ' HH ' ' HB2' ' A' ' 56' ' ' GLU . 19.5 m-85 -77.94 137.09 38.14 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.652 1.115 . . . . 0.0 108.016 177.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.78 162.47 25.1 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.5 t -161.29 178.06 9.57 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 126.168 1.787 . . . . 0.0 106.346 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 2.0 pp0? -156.47 158.53 37.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.272 1.429 . . . . 0.0 109.431 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.3 p -120.28 2.62 10.85 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.63 -50.13 0.9 Allowed Glycine 0 C--N 1.336 0.531 0 O-C-N 120.532 -1.355 . . . . 0.0 110.544 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.11 -1.81 2.36 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.673 0.789 . . . . 0.0 111.633 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -130.4 168.97 16.11 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.793 1.237 . . . . 0.0 109.115 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 2.6 m -130.16 148.13 51.97 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.552 1.141 . . . . 0.0 111.873 -178.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.79 173.01 7.74 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 127.093 2.157 . . . . 0.0 111.783 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -146.01 128.84 16.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 125' ' ' GLY . 9.4 tt0 -113.52 142.27 46.14 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 126.0 1.72 . . . . 0.0 107.107 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 50.0 m -70.4 124.11 23.38 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.189 2.196 . . . . 0.0 110.985 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.7 t -69.72 -43.87 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 120.812 1.642 . . . . 0.0 112.315 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.19 -24.48 66.64 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -138.76 77.5 32.77 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 126.08 1.752 . . . . 0.0 107.207 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.51 166.21 22.58 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.787 2.325 . . . . 0.0 112.369 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.419 ' H ' ' CD ' ' A' ' 119' ' ' GLU . . . 85.86 -13.7 55.43 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.867 1.222 . . . . 0.0 111.775 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -106.48 119.91 40.53 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.286 1.834 . . . . 0.0 109.802 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -103.04 148.26 25.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.774 0.83 . . . . 0.0 110.243 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 pt -78.38 139.4 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.921 0.391 . . . . 0.0 110.891 178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.94 151.75 20.98 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.0 t -106.06 -17.01 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 127.34 2.256 . . . . 0.0 111.047 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.2 m 55.34 82.42 0.1 Allowed 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 126.438 1.895 . . . . 0.0 112.695 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.2 m -111.1 -9.75 14.36 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -54.63 -61.13 2.51 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.639 1.575 . . . . 0.0 111.352 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -139.21 -85.55 0.12 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -165.98 60.82 0.23 Allowed Glycine 0 C--N 1.333 0.378 0 O-C-N 120.694 -1.474 . . . . 0.0 110.201 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.1 m -91.37 163.6 28.08 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.73 161.71 45.1 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.595 1.53 . . . . 0.0 109.779 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 20.4 mt -87.5 113.03 22.83 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.21 167.18 23.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.628 1.571 . . . . 0.0 109.391 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 80.7 mt -83.91 156.15 22.52 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.79 156.13 47.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -99.24 -46.75 5.43 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -159.74 142.33 13.67 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -150.18 177.81 9.57 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 129.486 3.114 . . . . 0.0 108.553 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -162.48 -32.48 0.02 OUTLIER Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.863 1.697 . . . . 0.0 109.79 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.3 5.9 1.1 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -91.47 -22.72 20.27 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.445 1.475 . . . . 0.0 114.024 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -160.75 -161.13 0.81 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.409 HG23 ' CE2' ' A' ' 152' ' ' PHE . 0.2 OUTLIER -142.7 113.15 7.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 -178.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -99.48 -28.99 12.99 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.074 1.75 . . . . 0.0 110.241 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -112.41 123.93 51.36 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 123.657 0.783 . . . . 0.0 109.721 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.409 ' CE2' HG23 ' A' ' 149' ' ' THR . 0.1 OUTLIER -158.82 -170.34 3.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.002 178.38 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.42 176.8 38.79 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.22 111.97 6.46 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 24.3 m -77.16 46.77 0.51 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -73.95 120.38 19.46 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.6 mt -99.07 156.57 16.87 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 123.795 0.838 . . . . 0.0 109.626 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.7 p90 . . . . . 0 C--O 1.246 0.882 0 C-N-CA 125.111 1.364 . . . . 0.0 108.554 179.772 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 119.671 -0.204 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.2 138.53 61.79 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 121.476 1.451 . . . . 0.0 110.229 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.61 109.83 18.32 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.55 133.93 52.85 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.308 1.043 . . . . 0.0 109.969 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.03 -124.38 0.71 Allowed Glycine 0 CA--C 1.523 0.543 0 CA-C-O 117.458 -1.746 . . . . 0.0 109.891 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.2 p -157.96 -165.11 1.66 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 121.517 2.658 . . . . 0.0 113.604 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.9 mt -145.18 -13.8 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.056 1.342 . . . . 0.0 108.277 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.406 ' HG3' HG22 ' A' ' 22' ' ' VAL . 2.1 tm0? -55.17 -31.88 61.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 118.067 -0.968 . . . . 0.0 112.11 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.39 -19.12 3.12 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.584 1.554 . . . . 0.0 112.893 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.4 mt -64.06 -52.5 55.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.174 1.39 . . . . 0.0 113.47 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -148.41 31.54 0.82 Allowed 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 117.931 0.332 . . . . 0.0 110.189 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.0 m80 59.97 25.36 14.54 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.071 0.949 . . . . 0.0 112.054 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.45 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 7.0 mmt-85 -86.71 98.53 11.19 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.382 -1.449 . . . . 0.0 108.178 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.406 HG22 ' HG3' ' A' ' 16' ' ' GLN . 72.6 t -76.58 145.05 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -105.2 132.43 51.43 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.327 1.451 . . . . 0.0 109.134 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.7 t -137.05 129.69 44.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 119.168 0.895 . . . . 0.0 108.863 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.666 HD13 ' CD2' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -74.5 112.97 11.21 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 101.161 -3.644 . . . . 0.0 101.161 176.147 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -129.55 120.99 26.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.705 2.002 . . . . 0.0 108.153 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.5 t0 45.31 58.23 4.29 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.305 1.442 . . . . 0.0 110.945 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 57.15 20.11 5.35 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.637 1.975 . . . . 0.0 114.913 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.3 m -134.23 143.32 47.75 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.588 0.755 . . . . 0.0 109.329 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.643 HD12 HD13 ' A' ' 87' ' ' LEU . 19.2 mt -90.71 124.68 35.29 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.76 136.78 56.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.685 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.45 136.21 39.41 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -124.32 68.65 49.48 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.34 -6.24 14.47 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.828 2.352 . . . . 0.0 116.304 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.67 78.41 0.7 Allowed 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.597 1.159 . . . . 0.0 109.227 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -151.36 137.29 18.14 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 121.125 -0.984 . . . . 0.0 110.42 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -68.27 -34.6 76.46 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.816 0.846 . . . . 0.0 108.735 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.68 30.3 0.65 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.166 0.987 . . . . 0.0 112.793 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.7 ptp -73.33 167.2 21.72 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.7 t -153.22 121.58 3.12 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.12 151.21 49.24 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 N-CA-C 108.632 -1.334 . . . . 0.0 108.632 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.95 -174.35 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.19 154.87 50.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mm -126.72 111.44 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 C-N-CA 126.901 2.08 . . . . 0.0 108.384 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.74 130.47 41.25 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.509 1.924 . . . . 0.0 107.64 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -126.09 131.62 52.08 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.304 1.842 . . . . 0.0 108.894 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -149.36 145.86 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 124.838 1.255 . . . . 0.0 110.664 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.79 156.38 38.97 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 125.79 1.636 . . . . 0.0 109.001 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.477 ' O ' HG13 ' A' ' 52' ' ' VAL . 85.4 m -92.78 106.47 18.44 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -67.99 -14.89 63.32 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -98.93 29.88 3.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.988 0.813 . . . . 0.0 111.21 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.604 ' HA ' HD23 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -62.4 -7.41 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 126.228 1.811 . . . . 0.0 113.251 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -55.75 -35.63 66.41 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.072 0.949 . . . . 0.0 112.614 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -98.56 0.52 45.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.774 1.23 . . . . 0.0 112.491 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.642 HD21 ' HB2' ' A' ' 101' ' ' PRO . 3.7 mm? -91.0 171.39 9.3 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 123.077 1.418 . . . . 0.0 109.616 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -74.85 157.01 35.83 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.421 -1.718 . . . . 0.0 107.453 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -129.29 -40.32 1.46 Allowed 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.703 -0.665 . . . . 0.0 109.956 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -50.63 -54.3 23.92 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.262 1.425 . . . . 0.0 113.313 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -60.39 -31.23 70.16 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.975 0.91 . . . . 0.0 112.293 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.24 169.45 11.75 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 125.886 1.708 . . . . 0.0 109.828 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -69.76 112.07 11.06 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 127.284 2.234 . . . . 0.0 115.763 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -80.98 131.78 8.12 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.714 2.943 . . . . 0.0 110.302 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 pp -137.82 178.44 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.669 ' CD1' HG22 ' A' ' 92' ' ' ILE . 5.0 t80 -134.92 153.77 51.94 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.712 1.142 . . . . 0.0 112.15 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.5 tt -145.68 157.03 44.0 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.284 1.434 . . . . 0.0 110.039 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.4 176.01 35.42 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.552 HD11 HD11 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -94.51 140.86 29.29 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 178.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -107.51 118.91 37.96 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 159.67 -75.67 0.2 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.02 19.59 14.86 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.7 t30 60.94 72.41 0.52 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.952 1.251 . . . . 0.0 109.626 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.666 ' CD2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -146.59 136.01 22.89 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.034 0.934 . . . . 0.0 110.381 -177.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.632 ' SG ' HG23 ' A' ' 92' ' ' ILE . 17.7 m -144.97 169.67 17.63 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.184 -0.947 . . . . 0.0 110.534 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.427 HD23 HD21 ' A' ' 87' ' ' LEU . 13.5 mt -53.37 148.32 9.1 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.086 0.469 . . . . 0.0 110.39 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.0 ttp -160.71 120.99 2.81 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 93.4 m -82.12 138.15 34.83 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.2 -177.56 4.76 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.202 2.201 . . . . 0.0 106.845 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -143.8 140.5 29.92 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.9 m -90.15 26.64 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.45 5.9 56.59 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.259 0.933 . . . . 0.0 111.648 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -131.48 -57.03 1.01 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.976 1.71 . . . . 0.0 110.624 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -145.14 157.18 54.05 Favored Pre-proline 0 C--O 1.239 0.552 0 C-N-CA 124.416 1.086 . . . . 0.0 110.421 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.06 149.66 88.93 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.897 3.065 . . . . 0.0 113.639 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.1 p -148.61 168.35 23.04 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.908 1.683 . . . . 0.0 110.708 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mt -97.24 149.24 22.26 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.461 1.104 . . . . 0.0 108.856 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -143.83 78.1 1.58 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.643 HD13 HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -89.43 94.1 9.76 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.69 -48.7 0.19 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.047 0.84 . . . . 0.0 112.6 -177.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -135.28 105.67 6.38 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.713 1.605 . . . . 0.0 107.486 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.06 154.87 0.91 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -127.66 139.98 52.38 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.669 HG22 ' CD1' ' A' ' 64' ' ' TYR . 4.0 pt -94.83 -41.51 12.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.835 1.654 . . . . 0.0 111.773 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.0 tpt -66.52 -23.14 66.19 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.757 0.708 . . . . 0.0 110.109 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.32 -52.48 18.53 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.525 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.523 HD12 ' CE1' ' A' ' 64' ' ' TYR . 18.1 mt -60.61 -26.22 66.83 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.175 0.988 . . . . 0.0 112.367 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -75.63 -51.19 13.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -59.67 -46.99 87.37 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.041 1.336 . . . . 0.0 112.67 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -100.74 148.92 35.68 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.706 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -75.4 68.01 6.15 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.036 2.491 . . . . 0.0 109.532 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -128.12 68.19 75.83 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 126.074 1.75 . . . . 0.0 108.556 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.642 ' HB2' HD21 ' A' ' 55' ' ' LEU . 84.1 Cg_endo -77.55 83.0 2.25 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.608 2.205 . . . . 0.0 106.552 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.4 t -78.17 103.14 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -52.37 -30.56 29.47 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.914 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.05 -15.67 34.99 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.136 0.88 . . . . 0.0 111.982 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -117.72 -15.91 10.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.584 1.154 . . . . 0.0 110.326 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.425 HD22 ' SG ' ' A' ' 49' ' ' CYS . 9.4 mt -83.59 152.61 24.74 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.27 1.396 . . . . 0.0 111.103 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -139.15 128.42 24.08 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.066 0.947 . . . . 0.0 110.697 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.55 123.73 21.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -94.8 136.21 35.37 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 t -135.88 -177.99 4.93 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.976 1.311 . . . . 0.0 109.596 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -159.65 146.51 16.52 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.734 1.214 . . . . 0.0 109.637 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.17 76.34 1.32 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 124.463 1.102 . . . . 0.0 111.821 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.89 78.84 0.82 Allowed Glycine 0 C--N 1.335 0.509 0 O-C-N 121.152 -0.968 . . . . 0.0 112.065 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 56.51 13.76 1.45 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.359 1.464 . . . . 0.0 112.763 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -121.26 151.82 39.58 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.3 m -125.25 148.45 48.66 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 125.636 1.574 . . . . 0.0 106.957 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.99 157.05 47.04 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -138.83 116.11 11.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.673 1.189 . . . . 0.0 107.833 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -112.24 133.01 54.61 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.881 1.273 . . . . 0.0 110.089 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.9 m -52.31 122.22 8.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.886 2.074 . . . . 0.0 110.458 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.7 t -73.34 -46.09 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 O-C-N 120.105 -1.622 . . . . 0.0 110.869 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.76 -30.83 71.88 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.034 0.834 . . . . 0.0 111.146 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -133.94 81.51 51.76 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 123.747 0.819 . . . . 0.0 110.746 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.16 159.89 44.69 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 N-CA-C 108.421 -1.415 . . . . 0.0 108.421 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.45 -17.78 30.76 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.062 0.839 . . . . 0.0 112.22 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 142' ' ' GLN . 30.9 m-90 -119.0 141.63 48.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.018 1.727 . . . . 0.0 111.245 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -118.5 142.44 47.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 128.82 2.848 . . . . 0.0 111.414 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.4 mt -69.01 134.18 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.4 114.5 28.72 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.537 0.608 . . . . 0.0 110.112 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.3 m -63.93 -19.15 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.5 m 61.19 63.6 1.21 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.953 1.835 . . . . 0.0 115.953 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.45 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 54.5 m -104.43 6.07 34.71 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 125.745 1.618 . . . . 0.0 113.18 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -82.01 -106.64 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.121 1.368 . . . . 0.0 107.563 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.42 -52.13 11.16 Favored Glycine 0 C--N 1.337 0.605 0 O-C-N 120.849 -1.157 . . . . 0.0 112.911 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 141.63 62.77 0.03 OUTLIER Glycine 0 CA--C 1.525 0.69 0 N-CA-C 106.491 -2.644 . . . . 0.0 106.491 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' CYS . . . . . 0.421 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 19.6 m -93.56 166.96 14.86 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 119.105 -0.474 . . . . 0.0 110.701 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 136' ' ' CYS . 87.3 Cg_endo -74.14 157.64 46.16 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.746 2.964 . . . . 0.0 110.352 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.557 HD12 HD13 ' A' ' 30' ' ' LEU . 15.2 mt -76.84 111.59 12.54 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.79 179.77 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 125.861 1.664 . . . . 0.0 110.587 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -110.6 144.74 39.01 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.3 t -134.78 152.7 51.96 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 126' ' ' TRP . 3.0 pt20 -107.38 -32.73 7.63 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 N--CA 1.427 -1.585 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 -178.8 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.446 -0.63 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.98 96.11 4.82 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.605 0.762 . . . . 0.0 110.626 -177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.5 p -98.52 -32.57 11.39 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.85 96.39 10.37 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.717 1.607 . . . . 0.0 112.374 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.42 175.66 13.43 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.805 -1.184 . . . . 0.0 112.661 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.79 -166.89 29.47 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.5 tp -137.67 161.59 36.09 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.31 34.46 5.21 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -63.38 140.38 58.87 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 18.0 mt -123.18 166.33 15.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 17.7 p90 . . . . . 0 C--O 1.244 0.796 0 CA-C-O 116.482 -1.723 . . . . 0.0 107.469 178.965 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.235 0.291 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.04 129.56 15.38 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.84 1.693 . . . . 0.0 108.019 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.55 115.21 29.49 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -112.61 135.65 53.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.966 0.506 . . . . 0.0 110.823 -179.434 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.87 -125.82 0.8 Allowed Glycine 0 N--CA 1.46 0.246 0 CA-C-O 117.882 -1.51 . . . . 0.0 109.979 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.475 ' HB2' HE21 ' A' ' 16' ' ' GLN . 26.6 p -157.03 -173.97 4.7 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 120.276 2.038 . . . . 0.0 112.709 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.436 HD11 HD11 ' A' ' 154' ' ' LEU . 8.4 mt -141.98 -19.07 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.92 1.688 . . . . 0.0 108.437 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.475 HE21 ' HB2' ' A' ' 14' ' ' SER . 4.0 pt20 -47.52 -39.99 17.56 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.147 -0.971 . . . . 0.0 113.459 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -51.32 -33.49 29.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.847 2.059 . . . . 0.0 114.866 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.4 mm -41.94 -55.44 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 127.146 2.178 . . . . 0.0 111.047 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.64 26.48 2.11 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.709 -0.619 . . . . 0.0 109.54 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 33.9 m80 60.46 25.05 14.64 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.34 2.256 . . . . 0.0 113.279 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.448 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 20.2 mmt180 -83.58 85.07 7.32 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 126.966 2.106 . . . . 0.0 107.493 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.6 t -69.5 136.7 25.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 120.726 -1.233 . . . . 0.0 108.572 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -95.59 135.01 37.81 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.722 1.209 . . . . 0.0 111.701 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.4 t -141.91 131.28 23.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.484 HD13 HD22 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -75.74 95.2 3.39 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 178.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -106.94 120.02 40.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 119.619 1.099 . . . . 0.0 108.506 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.6 t0 42.06 65.84 0.82 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.267 1.427 . . . . 0.0 111.615 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 57.3 8.7 0.61 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.679 1.591 . . . . 0.0 114.861 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 m -124.81 133.1 53.25 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 125.185 1.394 . . . . 0.0 110.129 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.825 HD12 HD13 ' A' ' 87' ' ' LEU . 8.8 mt -82.88 122.42 28.23 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -125.72 144.39 35.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.19 133.2 34.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -128.14 64.14 65.12 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.665 1.986 . . . . 0.0 111.435 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.429 ' HG3' HH11 ' A' ' 21' ' ' ARG . 11.7 Cg_endo -58.14 -56.77 1.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.343 1.362 . . . . 0.0 111.693 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.6 mtp85 -117.73 109.0 16.08 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.558 1.072 . . . . 0.0 109.105 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -167.92 -162.44 0.43 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.668 1.187 . . . . 0.0 109.135 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -122.81 -50.56 1.95 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -66.13 20.66 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.66 1.984 . . . . 0.0 114.977 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.7 ptp -74.59 -178.8 3.74 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 120.49 -1.381 . . . . 0.0 109.434 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 t -174.24 128.34 0.45 Allowed Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.79 146.05 33.09 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 N-CA-C 107.224 -1.875 . . . . 0.0 107.224 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 m -133.45 171.19 18.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.63 163.92 16.65 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.514 ' CG2' HD11 ' A' ' 65' ' ' LEU . 40.3 mm -131.18 108.42 14.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 127.18 2.192 . . . . 0.0 108.472 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.49 124.75 44.93 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.194 1.398 . . . . 0.0 108.521 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 tt -117.2 138.06 51.94 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.308 1.843 . . . . 0.0 108.744 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 mt -142.2 146.09 22.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 126.498 1.919 . . . . 0.0 108.291 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 p -84.16 145.23 28.5 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.522 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 55.7 m -66.85 107.86 2.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.936 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.75 7.87 9.34 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.577 -1.327 . . . . 0.0 111.564 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.71 29.33 5.03 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.552 2.341 . . . . 0.0 113.624 -177.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.41 -7.83 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 O-C-N 120.078 -1.639 . . . . 0.0 114.312 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -48.41 -51.44 26.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 119.528 1.058 . . . . 0.0 112.594 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 t -82.21 2.7 30.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.713 1.205 . . . . 0.0 112.568 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.6 mt -104.69 176.17 5.25 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 120.356 -1.465 . . . . 0.0 112.017 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -93.02 151.84 19.66 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.599 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -124.03 -25.53 4.19 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.847 1.259 . . . . 0.0 110.018 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -61.81 -20.62 63.83 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.418 0.687 . . . . 0.0 111.05 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -75.99 -20.56 57.77 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.133 0.973 . . . . 0.0 111.143 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.4 -103.41 0.4 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 125.962 1.744 . . . . 0.0 111.574 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -144.76 99.07 4.78 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.581 -0.952 . . . . 0.0 112.885 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.62 131.37 18.55 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.377 2.051 . . . . 0.0 110.682 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pt -143.53 -178.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.802 0.841 . . . . 0.0 109.244 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.57 ' CD1' HD12 ' A' ' 95' ' ' LEU . 4.3 t80 -136.57 134.92 37.97 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.999 0.92 . . . . 0.0 110.076 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.514 HD11 ' CG2' ' A' ' 44' ' ' ILE . 4.2 tt -138.43 152.16 48.09 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.994 1.318 . . . . 0.0 109.214 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.56 174.51 33.61 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.807 HD11 HD11 ' A' ' 30' ' ' LEU . 8.3 mt -88.58 139.12 30.8 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -109.46 102.09 10.99 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.87 -26.37 0.09 OUTLIER Glycine 0 CA--C 1.529 0.953 0 CA-C-O 117.945 -1.475 . . . . 0.0 113.335 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.01 19.84 0.58 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.643 1.722 . . . . 0.0 114.421 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.2 m120 62.51 62.1 1.16 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.385 1.474 . . . . 0.0 110.91 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.484 HD22 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -135.9 133.72 37.98 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.76 1.224 . . . . 0.0 109.299 -178.081 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.569 ' SG ' HG23 ' A' ' 92' ' ' ILE . 6.8 m -136.64 174.65 10.39 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.654 0.661 . . . . 0.0 111.896 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.693 HD23 HD21 ' A' ' 87' ' ' LEU . 17.9 mt -64.6 150.22 47.36 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.782 0.433 . . . . 0.0 111.378 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.453 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 1.4 tmm? -160.85 144.67 13.49 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 117.999 -1.0 . . . . 0.0 108.516 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -110.98 122.38 47.75 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.961 0.788 . . . . 0.0 110.103 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.86 135.16 29.26 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.078 0.951 . . . . 0.0 110.652 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -70.02 117.79 12.03 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.0 p -69.68 -24.21 26.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.813 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.89 -70.34 0.11 Allowed Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 105.357 -3.097 . . . . 0.0 105.357 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -97.36 -23.1 16.26 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -145.4 159.53 48.17 Favored Pre-proline 0 CA--C 1.536 0.405 0 O-C-N 121.374 -0.829 . . . . 0.0 112.891 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.4 148.01 72.67 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.565 2.843 . . . . 0.0 111.681 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.5 p -145.56 170.45 16.4 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.038 1.735 . . . . 0.0 108.668 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.62 HD11 HG23 ' A' ' 128' ' ' ILE . 6.6 mt -83.96 150.88 25.37 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 122.493 0.317 . . . . 0.0 110.687 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -144.91 64.29 1.28 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.109 0.964 . . . . 0.0 110.029 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.825 HD13 HD12 ' A' ' 30' ' ' LEU . 0.6 OUTLIER -86.06 118.96 25.85 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -171.66 -42.91 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.689 0.677 . . . . 0.0 112.269 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -134.49 101.99 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.852 1.261 . . . . 0.0 109.988 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 75' ' ' MET . 0.2 OUTLIER -163.82 171.36 15.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.696 1.589 . . . . 0.0 109.667 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -142.3 109.85 5.72 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.569 HG23 ' SG ' ' A' ' 73' ' ' CYS . 19.6 pt -70.77 -36.93 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 121.538 -0.726 . . . . 0.0 111.168 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -29.16 65.66 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.332 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -67.0 -50.0 63.59 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 118.61 0.641 . . . . 0.0 109.808 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.57 HD12 ' CD1' ' A' ' 64' ' ' TYR . 21.3 mt -64.28 -30.52 71.56 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -76.06 -26.85 56.93 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.545 -0.722 . . . . 0.0 109.849 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -86.87 -28.29 22.93 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -129.26 164.82 36.76 Favored Pre-proline 0 N--CA 1.456 -0.168 0 CA-C-N 121.177 1.808 . . . . 0.0 110.736 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.66 -161.65 0.13 Allowed 'Trans proline' 0 N--CA 1.445 -1.357 0 N-CA-C 107.109 -1.92 . . . . 0.0 107.109 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 77.46 70.75 0.2 Allowed Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 127.096 2.158 . . . . 0.0 109.859 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.17 107.45 0.66 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.517 2.145 . . . . 0.0 109.788 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 t -81.1 91.98 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -48.51 -32.32 7.73 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 125.021 1.328 . . . . 0.0 112.965 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.6 m -62.66 -14.33 42.31 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.333 1.053 . . . . 0.0 113.561 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -115.31 -20.87 10.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.319 1.448 . . . . 0.0 110.747 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.8 mt -80.92 154.23 27.13 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.776 0.83 . . . . 0.0 111.286 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.692 ' CD2' HD11 ' A' ' 128' ' ' ILE . 81.4 m-85 -141.69 138.97 32.81 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.281 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -81.46 131.28 35.27 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.43 119.99 32.49 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 125.84 1.656 . . . . 0.0 107.726 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 t -123.1 -172.17 2.45 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 2.1 pt20 -154.15 136.28 14.76 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.28 1.032 . . . . 0.0 108.576 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.98 69.74 1.45 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.78 -177.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.31 70.04 1.34 Allowed Glycine 0 C--N 1.338 0.656 0 O-C-N 121.274 -0.892 . . . . 0.0 113.675 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? 67.39 -10.37 0.35 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 128.013 2.525 . . . . 0.0 112.978 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -107.39 144.14 34.72 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.181 0.992 . . . . 0.0 108.641 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 0.4 OUTLIER -101.55 150.91 22.59 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.519 0.728 . . . . 0.0 110.929 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.61 166.86 12.21 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.518 1.927 . . . . 0.0 110.123 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -139.11 118.47 12.81 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -120.78 131.46 54.49 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.161 0.984 . . . . 0.0 110.248 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.8 t -52.99 116.94 2.62 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.778 1.631 . . . . 0.0 110.842 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.16 -45.82 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 119.227 0.921 . . . . 0.0 110.816 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.03 -26.49 68.58 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.555 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -145.9 87.19 6.86 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 119.202 0.91 . . . . 0.0 111.575 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -58.05 166.35 5.69 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.52 2.813 . . . . 0.0 114.032 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.65 -4.35 86.29 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 117.463 -1.743 . . . . 0.0 114.219 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 42.0 m95 -120.16 131.35 54.98 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.891 1.846 . . . . 0.0 107.843 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -114.9 144.37 43.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 126.037 1.735 . . . . 0.0 111.22 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.692 HD11 ' CD2' ' A' ' 107' ' ' PHE . 13.1 mt -77.11 123.32 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.737 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.74 120.09 32.17 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.38 0.609 . . . . 0.0 110.646 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.72 -23.29 27.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 C-N-CA 128.211 2.604 . . . . 0.0 111.051 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 m 60.9 87.0 0.09 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.911 1.339 . . . . 0.0 109.128 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.448 ' HA ' ' HG3' ' A' ' 21' ' ' ARG 0.271 1.7 m -109.76 4.1 21.48 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.696 -178.606 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -111.72 160.66 17.07 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 25.6 -87.54 0.01 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 128.043 2.735 . . . . 0.0 114.422 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -177.45 60.71 0.09 OUTLIER Glycine 0 CA--C 1.521 0.415 0 CA-C-O 117.795 -1.559 . . . . 0.0 109.38 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 4.9 m -85.08 161.42 52.53 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 119.455 1.627 . . . . 0.0 112.826 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.22 155.43 37.37 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 N-CA-C 108.553 -1.364 . . . . 0.0 108.553 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.0 mt -82.98 112.22 19.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 pp -138.0 -173.15 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.975 1.71 . . . . 0.0 109.843 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.4 mt -109.14 156.8 19.41 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.609 1.164 . . . . 0.0 108.244 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.37 136.66 21.24 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -81.24 -40.51 23.67 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.895 0.878 . . . . 0.0 110.855 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 C--O 1.239 0.541 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -178.376 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.8 m120 . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.43 100.41 10.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.101 0.56 . . . . 0.0 109.588 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.7 p -95.78 -17.77 20.93 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -115.97 131.81 56.83 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.004 1.322 . . . . 0.0 110.013 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.41 ' HB3' ' H ' ' A' ' 153' ' ' GLY 0.334 0.1 OUTLIER -163.49 -135.75 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 119.066 -0.492 . . . . 0.0 112.153 177.914 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.41 ' H ' ' HB3' ' A' ' 152' ' ' PHE . . . -146.22 179.33 23.3 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 125.794 1.664 . . . . 0.0 109.363 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.599 HD23 ' HB3' ' A' ' 156' ' ' MET . 0.4 OUTLIER -138.78 122.29 17.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.351 1.075 . . . . 0.0 110.725 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.3 m -79.42 34.72 0.26 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.602 1.561 . . . . 0.0 107.987 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.599 ' HB3' HD23 ' A' ' 154' ' ' LEU . 3.3 ptt? -63.01 131.96 50.39 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 119.865 -1.772 . . . . 0.0 107.665 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 25.5 mt -109.25 165.95 11.23 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.351 1.06 . . . . 0.0 110.841 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 14.7 p90 . . . . . 0 C--O 1.254 1.335 0 C-N-CA 127.099 2.16 . . . . 0.0 107.694 179.894 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.64 0 CA-C-O 119.407 -0.33 . . . . 0.0 111.534 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.39 115.71 3.49 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 124.446 3.431 . . . . 0.0 110.252 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.76 118.59 35.84 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.031 0.933 . . . . 0.0 111.816 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -106.5 133.68 50.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.08 0.552 . . . . 0.0 111.18 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -157.82 -139.06 2.63 Favored Glycine 0 C--O 1.225 -0.429 0 O-C-N 120.825 -1.172 . . . . 0.0 112.921 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -151.87 169.39 22.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.927 0.863 . . . . 0.0 112.055 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.541 HD12 ' CH2' ' A' ' 23' ' ' TRP . 47.3 mt -121.29 -5.59 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 O-C-N 121.236 -0.915 . . . . 0.0 111.001 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -53.1 -34.29 56.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.733 1.213 . . . . 0.0 110.732 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -51.91 -2.8 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 131.339 3.856 . . . . 0.0 115.693 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.5 mm -93.07 -80.46 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.611 1.964 . . . . 0.0 108.888 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -119.29 29.81 7.45 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.818 0.847 . . . . 0.0 112.705 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.7 t60 61.53 25.73 15.6 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.783 2.033 . . . . 0.0 112.428 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -86.36 92.15 8.73 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 120.303 -1.498 . . . . 0.0 110.808 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.4 t -69.43 141.91 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.56 ' HB3' HD22 ' A' ' 30' ' ' LEU . 43.7 m0 -107.78 144.05 35.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.412 ' C ' HD23 ' A' ' 30' ' ' LEU . 95.5 t -141.78 129.31 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.531 HD22 ' CD2' ' A' ' 72' ' ' LEU . 4.3 tp -72.33 106.83 4.63 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 178.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.73 127.39 43.56 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.629 0.772 . . . . 0.0 108.956 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t70 56.25 27.35 11.63 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 76.28 17.54 2.01 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 129.839 3.256 . . . . 0.0 112.892 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.42 131.41 43.58 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.082 1.353 . . . . 0.0 108.161 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.753 HD12 HD12 ' A' ' 87' ' ' LEU . 10.3 mt -75.42 115.96 15.63 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 120.603 -1.311 . . . . 0.0 107.71 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.01 144.19 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.337 0.655 . . . . 0.0 109.378 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.96 126.4 31.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.81 1.244 . . . . 0.0 109.446 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -126.86 70.13 73.22 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.135 1.774 . . . . 0.0 109.465 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.13 -30.67 37.88 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.843 1.695 . . . . 0.0 114.283 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -148.1 82.5 1.49 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -146.45 158.72 43.93 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 123.473 0.709 . . . . 0.0 109.222 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -76.82 -48.91 17.09 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.699 1.249 . . . . 0.0 108.905 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -77.4 52.65 0.97 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.608 1.563 . . . . 0.0 112.494 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -108.66 165.05 11.83 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.08 -1.013 . . . . 0.0 111.072 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -156.09 134.17 7.1 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.236 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.45 126.14 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.985 2.456 . . . . 0.0 108.323 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.9 m -121.58 161.09 22.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 125.065 1.346 . . . . 0.0 109.733 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.71 161.19 17.8 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.6 mm -130.2 100.98 5.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 129.282 3.033 . . . . 0.0 109.318 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.48 110.63 21.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.725 2.01 . . . . 0.0 108.163 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tt -107.91 140.53 40.88 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.813 2.045 . . . . 0.0 109.791 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.543 HD12 ' CG2' ' A' ' 92' ' ' ILE . 0.9 OUTLIER -148.57 153.08 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.943 1.297 . . . . 0.0 109.841 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.4 p -96.88 127.35 42.76 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.184 1.394 . . . . 0.0 110.013 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 55.8 m -54.02 133.03 43.55 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.159 0.984 . . . . 0.0 109.133 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -98.95 -18.12 17.99 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 117.345 -1.312 . . . . 0.0 113.573 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -105.11 41.8 1.3 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.286 1.035 . . . . 0.0 108.772 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.5 m -69.31 -6.98 7.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 O-C-N 120.248 -1.533 . . . . 0.0 114.011 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -56.06 -46.52 78.93 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.172 0.989 . . . . 0.0 111.856 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.0 t -83.46 0.66 45.3 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.7 mt -98.23 174.9 6.28 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.947 -1.096 . . . . 0.0 109.625 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -77.99 155.97 30.44 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.679 -1.6 . . . . 0.0 109.371 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.79 -34.62 2.38 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.869 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.68 -38.52 85.24 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.318 0.963 . . . . 0.0 110.597 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -68.26 -18.52 64.57 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.87 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.481 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 119.18 174.52 15.85 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 126.103 1.811 . . . . 0.0 110.745 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -69.53 114.76 26.62 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.716 0.806 . . . . 0.0 111.829 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -84.16 138.07 7.58 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.423 2.749 . . . . 0.0 110.035 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.418 HD12 ' N ' ' A' ' 64' ' ' TYR . 1.6 pp -140.05 -179.04 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 123.977 0.911 . . . . 0.0 109.681 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.547 ' CE1' HD12 ' A' ' 95' ' ' LEU . 1.2 t80 -138.22 155.72 48.39 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 122.338 1.066 . . . . 0.0 109.393 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.22 151.86 30.56 Favored 'General case' 0 CA--C 1.507 -0.684 0 O-C-N 120.938 -1.101 . . . . 0.0 108.136 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.485 ' N ' HD11 ' A' ' 92' ' ' ILE . . . -148.17 -179.89 24.5 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.119 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.436 ' CD1' HD11 ' A' ' 30' ' ' LEU . 3.1 mt -92.09 169.84 10.31 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -137.3 115.05 11.32 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 120.847 -1.158 . . . . 0.0 109.557 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 155.38 -28.63 0.62 Allowed Glycine 0 CA--C 1.527 0.819 0 CA-C-O 117.992 -1.449 . . . . 0.0 112.756 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.01 30.03 0.88 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.577 1.689 . . . . 0.0 112.123 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.2 m120 51.32 74.92 0.22 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.333 1.853 . . . . 0.0 112.51 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.531 ' CD2' HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -141.03 141.82 34.27 Favored 'General case' 0 CA--C 1.517 -0.296 0 O-C-N 121.307 -0.87 . . . . 0.0 109.322 -178.209 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.435 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 13.7 m -141.76 175.17 9.92 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.421 0.555 . . . . 0.0 111.007 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.951 ' HA ' HD22 ' A' ' 87' ' ' LEU . 12.5 mt -63.24 156.71 24.65 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.3 ttp -163.64 134.43 4.53 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.2 m -93.67 132.13 38.3 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.78 131.16 19.7 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.899 0.88 . . . . 0.0 108.98 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -87.45 138.82 31.15 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.152 0.887 . . . . 0.0 109.737 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.9 m -92.37 38.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.46 -51.74 4.25 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -83.13 -54.93 4.66 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -138.08 160.75 63.06 Favored Pre-proline 0 N--CA 1.471 0.617 0 C-N-CA 125.111 1.364 . . . . 0.0 112.649 -176.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.28 151.42 43.33 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.906 2.404 . . . . 0.0 110.707 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 71.1 p -144.84 179.33 7.39 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.876 1.671 . . . . 0.0 108.856 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.596 ' CD2' HD21 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -104.15 139.97 38.46 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 127.089 2.156 . . . . 0.0 107.075 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -140.48 72.0 1.38 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.951 HD22 ' HA ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -90.28 104.04 16.66 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 127.994 2.518 . . . . 0.0 107.669 -178.168 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.54 -25.58 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -146.72 81.67 1.56 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.838 1.255 . . . . 0.0 111.389 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.513 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -162.89 161.1 25.7 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 120.102 -1.624 . . . . 0.0 108.621 179.326 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -137.39 139.9 41.03 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.092 1.757 . . . . 0.0 108.201 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.543 ' CG2' HD12 ' A' ' 47' ' ' ILE . 4.6 mt -89.45 -42.65 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 126.058 1.743 . . . . 0.0 109.015 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.73 -34.83 63.01 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.468 1.507 . . . . 0.0 111.758 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -62.78 -61.88 2.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.6 1.96 . . . . 0.0 107.976 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.547 HD12 ' CE1' ' A' ' 64' ' ' TYR . 37.7 mt -60.9 -22.37 64.27 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -87.77 -33.57 18.62 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.517 0.727 . . . . 0.0 109.206 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -69.64 -43.65 72.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.202 -0.904 . . . . 0.0 109.145 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.9 152.69 38.21 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 118.713 -0.661 . . . . 0.0 109.813 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.09 38.49 0.54 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.923 3.082 . . . . 0.0 113.936 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -112.55 82.13 4.62 Favored Pre-proline 0 C--O 1.235 0.312 0 O-C-N 120.877 -1.139 . . . . 0.0 112.905 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.43 102.57 1.62 Allowed 'Trans proline' 0 N--CA 1.443 -1.444 0 N-CA-C 106.048 -2.328 . . . . 0.0 106.048 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.4 t -89.29 105.09 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -48.78 -31.26 6.72 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.366 1.466 . . . . 0.0 112.006 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.4 t -62.53 -13.58 32.29 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.6 1.16 . . . . 0.0 112.852 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -121.97 -2.09 9.26 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 119.789 1.177 . . . . 0.0 110.351 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.7 mt -94.91 153.91 17.46 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.605 1.093 . . . . 0.0 110.975 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -138.43 129.41 26.89 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.765 0.826 . . . . 0.0 109.721 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.481 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -71.13 127.26 31.99 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 104.405 -2.442 . . . . 0.0 104.405 177.787 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -103.88 131.87 50.68 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.11 -178.64 5.24 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.924 0.868 . . . . 0.0 109.948 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 0.0 OUTLIER -151.91 138.67 18.86 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.932 2.093 . . . . 0.0 107.808 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.48 70.33 1.17 Allowed 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.193 0.933 . . . . 0.0 112.472 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.46 64.12 0.93 Allowed Glycine 0 CA--C 1.525 0.686 0 O-C-N 121.787 -0.57 . . . . 0.0 114.198 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 67.71 -0.6 1.9 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.722 2.009 . . . . 0.0 113.24 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -120.01 155.11 33.51 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.386 1.474 . . . . 0.0 107.608 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 69.8 m -115.01 166.6 11.62 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.77 2.028 . . . . 0.0 110.559 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.61 164.46 32.58 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.504 1.121 . . . . 0.0 111.095 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -141.75 116.37 9.69 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 125.081 1.352 . . . . 0.0 110.605 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -115.16 122.94 47.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.635 1.574 . . . . 0.0 110.361 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.0 m -49.42 124.13 8.77 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.392 1.477 . . . . 0.0 112.488 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.5 t -70.0 -44.69 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 120.146 -1.596 . . . . 0.0 111.936 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.88 -25.56 67.23 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.398 -0.814 . . . . 0.0 112.971 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -140.39 80.17 19.67 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 125.381 1.472 . . . . 0.0 108.489 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -64.53 151.72 84.49 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.148 1.899 . . . . 0.0 110.123 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.48 -32.88 6.76 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.519 2.009 . . . . 0.0 110.211 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 25.5 m-90 -88.19 106.66 18.34 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 124.626 1.17 . . . . 0.0 111.006 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -91.03 152.8 20.53 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.724 1.21 . . . . 0.0 110.148 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.4 mt -82.25 131.71 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.29 132.85 43.43 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.18 0.446 . . . . 0.0 109.813 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -81.96 -15.38 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 127.06 2.144 . . . . 0.0 111.885 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.7 m 63.29 52.28 2.47 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.914 1.285 . . . . 0.0 113.729 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.3 m -89.31 24.22 2.27 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -96.01 -83.11 0.38 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.105 0.411 . . . . 0.0 110.352 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -103.68 -44.88 1.6 Allowed Glycine 0 C--N 1.336 0.583 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.08 63.52 0.02 OUTLIER Glycine 0 CA--C 1.521 0.433 0 N-CA-C 106.264 -2.734 . . . . 0.0 106.264 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 60.9 m -82.37 170.94 13.11 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.358 1.063 . . . . 0.0 110.113 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.2 153.13 16.32 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.859 1.706 . . . . 0.0 109.127 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.475 HD11 ' CD2' ' A' ' 23' ' ' TRP . 16.6 mt -75.52 106.16 6.93 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.93 171.42 15.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 124.347 1.059 . . . . 0.0 111.338 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 89.6 mt -84.83 156.12 21.46 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.8 t -146.11 136.16 23.6 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -85.56 -35.94 20.75 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.563 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 . . . . . 0 N--CA 1.477 0.914 0 CA-C-N 119.671 1.123 . . . . 0.0 113.173 -178.235 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.5 m -146.55 108.48 4.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.2 p -103.32 -15.79 15.84 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.402 1.081 . . . . 0.0 111.08 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -96.67 119.73 35.7 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 128.528 2.731 . . . . 0.0 108.178 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -157.94 -133.37 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.799 0.84 . . . . 0.0 112.893 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 177.14 -161.37 28.92 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 128.737 3.065 . . . . 0.0 108.299 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.73 142.87 23.23 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.083 1.942 . . . . 0.0 112.733 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.0 m -91.39 32.36 1.07 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.835 1.254 . . . . 0.0 107.842 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -60.0 110.71 1.26 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.464 1.906 . . . . 0.0 109.8 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 12.5 mt -89.67 160.01 16.82 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 126.226 1.811 . . . . 0.0 110.583 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 20.9 p90 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 126.023 1.729 . . . . 0.0 110.401 -179.707 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 117.771 -1.109 . . . . 0.0 111.419 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.14 131.54 18.13 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.329 2.019 . . . . 0.0 107.965 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.19 113.49 24.73 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.312 1.445 . . . . 0.0 109.839 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -109.49 144.94 37.05 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.191 0.996 . . . . 0.0 110.957 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.39 -131.21 1.41 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.135 1.35 . . . . 0.0 110.854 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.1 p -153.66 172.38 17.35 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 120.601 2.2 . . . . 0.0 113.112 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.0 mt -127.39 -12.38 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 125.005 1.322 . . . . 0.0 107.597 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.81 -28.22 69.31 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 120.413 -1.43 . . . . 0.0 112.292 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -57.34 -17.98 15.03 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.395 2.678 . . . . 0.0 115.003 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.1 mt -68.03 -69.71 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.29 1.036 . . . . 0.0 109.745 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.01 29.18 7.18 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.962 0.905 . . . . 0.0 111.102 -178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 51.48 44.66 28.88 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.303 2.241 . . . . 0.0 110.097 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.422 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 19.5 mmt180 -100.68 88.15 3.53 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.8 t -70.66 138.46 21.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -101.18 145.47 28.76 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.082 0.953 . . . . 0.0 109.523 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -148.26 134.57 12.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.63 121.0 14.95 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 103.471 -2.788 . . . . 0.0 103.471 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -134.01 117.85 17.15 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . 0.267 1.3 t0 46.72 59.49 3.91 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 124.072 1.892 . . . . 0.0 111.43 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 55.29 17.91 2.29 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 113.406 -1.725 . . . . 0.0 113.783 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.6 m -132.25 137.95 47.71 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.143 1.777 . . . . 0.0 107.812 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.531 HD13 HD12 ' A' ' 138' ' ' LEU . 9.8 mt -80.51 129.8 34.74 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.081 -1.637 . . . . 0.0 108.205 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.7 mm -131.36 140.47 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.653 0.66 . . . . 0.0 111.275 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.57 127.18 31.78 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.379 1.472 . . . . 0.0 109.108 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 m -123.09 62.8 20.51 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.213 1.805 . . . . 0.0 109.493 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.61 6.1 0.48 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.413 3.409 . . . . 0.0 116.641 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.4 ptt85 171.7 88.2 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 130.2 3.4 . . . . 0.0 104.92 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.85 139.13 24.75 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.8 -50.22 73.0 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -85.8 53.93 2.95 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.935 1.294 . . . . 0.0 112.663 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -104.51 155.56 18.71 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -150.97 132.69 7.87 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.94 148.61 64.28 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 N-CA-C 107.952 -1.595 . . . . 0.0 107.952 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.98 165.55 27.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -119.74 157.65 28.13 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.0 mm -115.85 147.45 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.92 130.12 47.96 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 104.659 -2.348 . . . . 0.0 104.659 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 tt -127.28 140.09 52.45 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 mt -146.03 138.07 19.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 125.091 1.356 . . . . 0.0 109.212 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p -79.63 132.96 36.39 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.816 0.846 . . . . 0.0 109.027 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.49 ' SG ' HD22 ' A' ' 106' ' ' LEU . 98.4 m -69.88 113.74 7.4 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 120.891 -1.13 . . . . 0.0 108.602 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -86.01 -9.96 55.89 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 118.68 -0.676 . . . . 0.0 112.443 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -97.45 34.64 1.77 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.768 1.627 . . . . 0.0 110.085 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.85 -10.74 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 127.212 2.205 . . . . 0.0 114.28 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.01 -10.75 4.54 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.202 1.801 . . . . 0.0 114.304 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.7 t -128.51 19.89 6.21 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.357 1.463 . . . . 0.0 110.417 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.3 mt -116.45 169.58 9.21 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.749 0.82 . . . . 0.0 109.659 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -70.88 145.88 49.95 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -116.37 -41.22 3.14 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.29 -37.24 77.2 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.619 1.568 . . . . 0.0 112.383 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -11.01 59.81 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 117.993 -1.003 . . . . 0.0 111.411 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.42 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 119.93 173.42 15.19 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -82.7 118.57 72.26 Favored Pre-proline 0 CA--C 1.542 0.64 0 O-C-N 122.039 -0.683 . . . . 0.0 111.19 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -79.85 146.5 18.6 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.87 3.047 . . . . 0.0 110.739 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 pp -139.53 177.72 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.07 1.748 . . . . 0.0 109.308 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.671 ' CD1' HG22 ' A' ' 92' ' ' ILE . 1.1 t80 -131.8 147.67 52.51 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.2 tt -144.87 148.26 33.74 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.6 -179.31 25.34 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.434 HD11 HD11 ' A' ' 30' ' ' LEU . 1.9 mt -98.4 145.74 26.42 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.29 105.99 14.08 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 120.341 1.428 . . . . 0.0 108.549 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.92 -24.16 0.18 Allowed Glycine 0 CA--C 1.525 0.66 0 CA-C-O 117.294 -1.837 . . . . 0.0 116.289 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.8 20.53 1.15 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 119.664 1.732 . . . . 0.0 113.273 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.48 64.35 0.94 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.956 2.102 . . . . 0.0 110.971 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.84 143.19 33.26 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.718 1.207 . . . . 0.0 110.562 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.726 ' SG ' HG23 ' A' ' 92' ' ' ILE . 15.3 m -144.97 179.47 7.32 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.026 0.531 . . . . 0.0 110.918 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.09 152.47 28.19 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.944 -0.473 . . . . 0.0 110.134 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.3 ttp -159.64 127.65 4.87 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.4 m -85.61 116.76 24.09 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.13 148.71 52.49 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -92.06 123.75 35.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.4 -33.48 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.94 -62.04 0.31 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 105.66 -2.976 . . . . 0.0 105.66 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -82.58 -36.36 26.29 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -145.95 166.32 17.63 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.57 142.12 47.9 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.003 2.469 . . . . 0.0 110.031 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.6 p -146.65 -174.77 4.56 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 125.311 1.444 . . . . 0.0 107.943 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.573 HD11 HG23 ' A' ' 128' ' ' ILE . 4.6 mt -103.22 145.13 30.4 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.043 1.337 . . . . 0.0 109.471 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -143.89 66.04 1.29 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.499 ' H ' HD12 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -80.62 115.07 19.94 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.7 pttp 179.63 -20.9 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -156.15 87.34 1.05 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.981 1.313 . . . . 0.0 110.41 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.498 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -169.2 164.97 11.1 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 120.568 -1.332 . . . . 0.0 108.433 178.362 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -141.01 125.9 18.14 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.526 1.13 . . . . 0.0 108.78 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.726 HG23 ' SG ' ' A' ' 73' ' ' CYS . 27.6 pt -79.51 -37.31 18.52 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 125.935 1.694 . . . . 0.0 111.762 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -36.7 81.64 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 118.476 0.58 . . . . 0.0 111.187 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -56.96 -56.24 24.33 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.47 HD12 ' CD1' ' A' ' 64' ' ' TYR . 13.5 mt -62.39 -32.87 73.76 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -71.67 -36.36 70.6 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.507 -0.745 . . . . 0.0 110.285 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -75.45 -41.01 56.76 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.527 1.131 . . . . 0.0 113.062 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -112.68 157.0 41.6 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.56 63.53 5.58 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.542 2.828 . . . . 0.0 114.142 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -124.21 63.35 32.66 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.977 1.711 . . . . 0.0 109.308 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.3 77.35 3.86 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.365 2.71 . . . . 0.0 106.289 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.94 104.59 5.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 125.388 1.475 . . . . 0.0 107.996 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -49.9 -30.25 9.76 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.373 0.669 . . . . 0.0 111.952 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.95 -8.58 23.42 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.215 1.006 . . . . 0.0 113.229 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -123.73 -3.06 8.27 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.587 1.155 . . . . 0.0 109.04 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.49 HD22 ' SG ' ' A' ' 49' ' ' CYS . 14.7 mt -103.03 149.53 24.48 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.894 1.224 . . . . 0.0 111.521 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.652 ' CD2' HD11 ' A' ' 128' ' ' ILE . 76.3 m-85 -135.32 127.08 29.2 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.172 0.989 . . . . 0.0 110.769 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.42 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -70.52 111.98 6.45 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 178.117 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -94.41 145.2 24.94 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.38 179.48 7.62 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.403 1.481 . . . . 0.0 108.283 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 0.0 OUTLIER -158.3 137.11 11.29 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.494 0.718 . . . . 0.0 109.102 178.479 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.32 89.37 1.57 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.03 61.04 1.22 Allowed Glycine 0 C--N 1.336 0.545 0 O-C-N 121.37 -0.831 . . . . 0.0 111.351 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 60.09 11.08 2.53 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.306 2.243 . . . . 0.0 113.901 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -125.37 159.45 31.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.977 0.911 . . . . 0.0 108.773 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 4.6 m -116.49 165.7 12.93 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.095 1.758 . . . . 0.0 110.024 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.81 159.14 42.83 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 126.43 1.892 . . . . 0.0 107.398 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -146.28 119.7 9.03 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.321 1.048 . . . . 0.0 109.045 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -116.82 130.45 56.72 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.943 2.097 . . . . 0.0 110.454 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.422 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 43.5 t -56.84 122.28 11.83 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.586 0.754 . . . . 0.0 109.296 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.5 t -70.27 -38.2 73.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.37 -40.28 93.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.684 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -129.45 79.99 72.87 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 124.482 1.113 . . . . 0.0 110.099 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -61.68 148.32 93.3 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.812 2.341 . . . . 0.0 109.86 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.78 -14.05 26.98 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.163 1.364 . . . . 0.0 112.153 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -110.2 147.11 34.4 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.836 2.054 . . . . 0.0 109.164 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -122.23 147.4 46.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.816 1.646 . . . . 0.0 108.218 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.652 HD11 ' CD2' ' A' ' 107' ' ' PHE . 9.9 mm -73.5 124.18 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.46 133.85 33.69 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.644 1.111 . . . . 0.0 108.834 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.2 t -85.91 -21.16 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.695 1.998 . . . . 0.0 111.907 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m 56.08 67.34 1.02 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 123.425 1.583 . . . . 0.0 112.216 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.422 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 7.1 m -96.26 16.8 17.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.164 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.59 146.48 49.64 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.948 1.699 . . . . 0.0 107.023 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 57.99 -81.98 0.01 OUTLIER Glycine 0 C--N 1.334 0.425 0 C-N-CA 127.005 2.24 . . . . 0.0 111.693 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.03 66.87 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.246 2 N-CA-C 102.566 -4.213 . . . . 0.0 102.566 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 79.0 m -91.48 170.24 9.94 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 118.326 1.063 . . . . 0.0 111.576 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -81.12 154.32 19.21 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.558 2.172 . . . . 0.0 112.075 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.531 HD12 HD13 ' A' ' 30' ' ' LEU . 38.4 mt -82.57 107.38 15.17 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.08 175.1 9.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 125.039 1.335 . . . . 0.0 108.325 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.7 mt -88.74 166.56 13.97 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t -160.72 125.41 3.68 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -91.2 -22.22 20.74 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 123.543 0.527 . . . . 0.0 110.104 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 CA--C 1.536 0.431 0 CA-C-N 119.001 0.818 . . . . 0.0 110.905 -178.687 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 CA--C 1.512 -0.517 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.82 132.11 35.46 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.413 0.685 . . . . 0.0 109.225 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 p -124.2 -9.09 7.6 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.175 0.99 . . . . 0.0 108.655 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -127.51 125.96 41.37 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.557 1.543 . . . . 0.0 110.059 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 176.29 178.57 0.21 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.931 2.092 . . . . 0.0 110.504 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.34 -166.61 31.22 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.846 1.212 . . . . 0.0 111.694 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.61 125.71 19.91 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.289 1.436 . . . . 0.0 107.641 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.3 m -81.97 44.13 0.82 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.847 1.659 . . . . 0.0 106.88 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -67.68 147.54 52.54 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.3 mt -124.61 170.73 10.66 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.194 1.798 . . . . 0.0 108.388 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.8 p90 . . . . . 0 C--O 1.243 0.761 0 N-CA-C 104.187 -2.523 . . . . 0.0 104.187 179.422 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 118.421 -0.799 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.96 132.84 27.42 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.38 1.387 . . . . 0.0 109.534 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.46 117.34 30.1 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -112.86 146.98 37.95 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.846 0.459 . . . . 0.0 109.852 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.86 -125.99 0.97 Allowed Glycine 0 CA--C 1.523 0.535 0 C-N-CA 124.595 1.093 . . . . 0.0 111.883 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.8 p -156.07 -170.1 3.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.975 1.887 . . . . 0.0 112.565 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -146.65 1.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.225 1.01 . . . . 0.0 110.383 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -67.34 -28.92 68.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -54.61 -30.87 56.03 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.19 1.396 . . . . 0.0 111.44 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.5 mm -44.95 -67.61 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.749 2.02 . . . . 0.0 111.625 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.55 26.15 3.73 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.86 -0.525 . . . . 0.0 111.324 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 25.7 m170 60.93 39.56 16.55 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.425 1.49 . . . . 0.0 110.098 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.406 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 3.0 mmt-85 -109.32 97.67 7.22 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.153 0.981 . . . . 0.0 109.932 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 t -82.47 156.46 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -108.75 137.1 47.23 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.772 1.229 . . . . 0.0 107.707 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.97 128.03 52.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.4 100.4 1.75 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -115.62 126.21 53.89 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 126.0 1.72 . . . . 0.0 109.117 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.3 t0 42.53 58.79 2.97 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.535 1.134 . . . . 0.0 112.898 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 58.86 13.44 2.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.942 1.297 . . . . 0.0 114.363 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.7 m -131.78 149.86 52.33 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 120.688 1.586 . . . . 0.0 108.287 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.768 HD12 HD13 ' A' ' 87' ' ' LEU . 11.8 mt -89.96 125.5 35.4 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 177.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.5 mm -119.72 140.27 44.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.54 141.67 36.44 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 m -120.3 71.72 18.0 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -63.67 97.35 0.22 Allowed 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.452 2.101 . . . . 0.0 109.958 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 49.55 43.73 24.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.671 1.189 . . . . 0.0 111.165 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -88.67 148.12 24.17 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -65.89 -11.64 48.51 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.259 30.0 ptt180 -117.11 25.15 10.69 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.682 0.793 . . . . 0.0 110.334 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -75.92 148.16 38.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.2 t -145.91 129.98 8.64 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.52 145.29 52.31 Favored 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.045 1.163 . . . . 0.0 112.123 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.4 m -126.31 175.49 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -128.35 161.72 28.76 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.4 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.4 mm -124.82 147.78 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.524 ' CB ' HD11 ' A' ' 92' ' ' ILE . . . -125.15 134.5 52.4 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 176.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.01 133.88 47.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.833 1.253 . . . . 0.0 107.999 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.615 HG13 HD12 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -147.67 134.11 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.022 0.529 . . . . 0.0 110.59 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.519 ' HA ' HG22 ' A' ' 63' ' ' ILE . 46.8 t -72.44 159.77 33.42 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 122.514 1.149 . . . . 0.0 109.427 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.3 m -83.6 100.48 10.84 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.749 1.22 . . . . 0.0 109.653 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 ptt85 -82.94 13.77 3.73 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.54 -1.35 . . . . 0.0 112.428 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -132.48 33.76 3.78 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.723 2.009 . . . . 0.0 111.536 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.572 HG12 HD12 ' A' ' 55' ' ' LEU . 15.7 m -73.06 3.81 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 120.326 -1.484 . . . . 0.0 114.641 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -48.75 -33.46 10.33 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -102.6 0.17 32.93 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 120.114 1.325 . . . . 0.0 112.454 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.572 HD12 HG12 ' A' ' 52' ' ' VAL . 95.6 mt -95.48 163.14 13.35 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 120.256 -1.528 . . . . 0.0 111.457 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.425 ' HG3' ' HE ' ' A' ' 59' ' ' ARG . 14.8 mm-40 -70.62 155.36 40.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -120.62 -23.66 5.98 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.26 -13.53 46.46 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.195 0.998 . . . . 0.0 113.507 -178.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.425 ' HE ' ' HG3' ' A' ' 56' ' ' GLU . 3.2 mtm-85 -84.29 7.64 18.63 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.452 1.101 . . . . 0.0 112.915 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.0 -173.46 15.57 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -92.62 105.35 14.17 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-O 117.708 -1.139 . . . . 0.0 109.844 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -69.67 128.92 16.81 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.239 2.626 . . . . 0.0 110.319 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.519 HG22 ' HA ' ' A' ' 48' ' ' SER . 12.5 pt -139.64 177.71 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.5 1.52 . . . . 0.0 109.218 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.681 ' CD1' HG22 ' A' ' 92' ' ' ILE . 1.2 t80 -133.01 158.62 42.25 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.6 tt -155.45 155.91 34.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.623 1.569 . . . . 0.0 108.609 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.411 ' HA3' ' SG ' ' A' ' 73' ' ' CYS . . . -162.41 178.46 38.19 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.678 HD11 HD11 ' A' ' 30' ' ' LEU . 5.4 mt -87.18 177.73 7.09 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.408 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 1.5 t-20 -140.62 111.39 6.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.062 -1.024 . . . . 0.0 108.832 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 153.39 -18.57 0.7 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-O 117.962 -1.465 . . . . 0.0 115.403 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.28 24.47 0.62 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.574 1.687 . . . . 0.0 111.969 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 57.24 72.96 0.48 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.324 1.85 . . . . 0.0 109.07 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.42 125.87 10.9 Favored 'General case' 0 N--CA 1.461 0.107 0 O-C-N 121.215 -0.928 . . . . 0.0 111.559 -178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.731 ' SG ' HG23 ' A' ' 92' ' ' ILE . 24.3 m -133.05 172.85 12.09 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.106 0.962 . . . . 0.0 110.936 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.9 mt -55.68 150.91 11.72 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.8 ttp -157.18 117.37 3.5 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.3 m -84.5 115.89 22.82 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.598 1.09 . . . . 0.0 110.97 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.462 ' HB3' ' OE1' ' A' ' 86' ' ' GLN . . . -116.86 -170.43 1.83 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -149.35 128.57 12.85 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.1 m -81.84 38.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.59 -7.81 2.61 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 120.914 -1.116 . . . . 0.0 113.253 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -123.85 -50.63 1.83 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 127.653 2.381 . . . . 0.0 113.365 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -144.61 156.51 56.41 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 123.908 0.883 . . . . 0.0 108.965 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.46 160.03 44.83 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.467 1.445 . . . . 0.0 110.974 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.5 p -147.82 160.13 43.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.499 1.119 . . . . 0.0 109.394 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.558 HD11 HD12 ' A' ' 128' ' ' ILE . 3.7 mt -98.64 127.21 44.49 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.462 ' OE1' ' HB3' ' A' ' 77' ' ' ALA . 6.8 mp0 -123.67 68.09 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.717 0.807 . . . . 0.0 109.838 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.768 HD13 HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -84.18 102.68 12.78 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.3 -35.56 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.709 1.256 . . . . 0.0 111.342 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -137.3 90.92 2.56 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.61 1.164 . . . . 0.0 109.847 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.565 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -173.76 158.24 3.24 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 120.858 -1.151 . . . . 0.0 109.02 178.342 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -138.81 134.03 32.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.104 1.361 . . . . 0.0 107.518 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.731 HG23 ' SG ' ' A' ' 73' ' ' CYS . 37.0 pt -90.25 -33.53 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 C-N-CA 123.806 0.843 . . . . 0.0 111.003 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -32.3 73.89 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 118.299 0.5 . . . . 0.0 110.244 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -62.36 -54.31 42.26 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.624 0.647 . . . . 0.0 109.816 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.459 HD12 ' CD1' ' A' ' 64' ' ' TYR . 14.3 mt -60.22 -40.89 91.75 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -65.11 -31.54 72.79 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.06 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -77.5 -36.07 53.0 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 116.42 -1.752 . . . . 0.0 113.603 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.61 174.43 2.35 Favored Pre-proline 0 N--CA 1.472 0.637 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -175.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.6 -162.93 0.16 Allowed 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.829 2.353 . . . . 0.0 108.228 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 69.3 65.09 0.52 Allowed Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.888 1.675 . . . . 0.0 113.275 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -56.42 116.62 3.32 Favored 'Trans proline' 0 C--O 1.244 0.819 0 C-N-CA 121.903 1.736 . . . . 0.0 110.553 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.96 84.75 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -42.77 -33.77 0.81 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.535 1.934 . . . . 0.0 112.929 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -59.26 -15.25 14.51 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.905 1.682 . . . . 0.0 113.328 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.7 5.9 6.14 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.071 1.348 . . . . 0.0 110.438 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 39.4 mt -101.35 153.71 19.43 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 120.46 1.482 . . . . 0.0 109.208 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.589 ' CE2' HD11 ' A' ' 128' ' ' ILE . 43.3 m-85 -140.73 131.57 25.9 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.259 0.623 . . . . 0.0 110.686 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.442 ' CE1' ' HA ' ' A' ' 121' ' ' VAL . 83.3 m-85 -76.86 123.09 25.74 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.061 0.945 . . . . 0.0 109.346 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -82.4 126.22 31.94 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.9 t -120.95 170.84 9.11 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -142.42 158.77 43.34 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.718 2.007 . . . . 0.0 109.018 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 80.7 p -124.14 -4.58 7.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.854 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.92 -44.17 1.27 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -137.82 10.48 2.87 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.47 1.108 . . . . 0.0 112.965 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -146.84 164.1 33.93 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 106.654 -1.609 . . . . 0.0 106.654 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 m -128.98 153.55 47.45 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.704 0.684 . . . . 0.0 110.527 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.4 170.15 11.13 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -139.19 109.29 6.4 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.916 1.686 . . . . 0.0 109.666 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -106.39 126.18 51.92 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.517 1.127 . . . . 0.0 110.164 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.9 t -50.9 127.58 18.98 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.448 0.699 . . . . 0.0 110.205 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.442 ' HA ' ' CE1' ' A' ' 108' ' ' TYR . 53.6 t -68.37 -48.12 74.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.71 -40.09 91.89 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.269 1.028 . . . . 0.0 112.842 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -127.94 84.74 62.44 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -69.24 160.88 48.12 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 N-CA-C 108.368 -1.436 . . . . 0.0 108.368 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.75 -32.03 7.47 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -95.82 140.28 30.83 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 118.03 0.915 . . . . 0.0 109.442 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -120.33 138.97 53.42 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 127.078 2.151 . . . . 0.0 108.597 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.589 HD11 ' CE2' ' A' ' 107' ' ' PHE . 28.3 mm -70.24 139.7 19.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -115.18 126.15 54.25 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.943 0.792 . . . . 0.0 111.399 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.8 m -73.74 -5.36 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.816 -1.178 . . . . 0.0 112.697 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.6 m 54.12 35.12 21.61 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.406 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 7.8 m -73.18 -1.97 19.75 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.807 1.243 . . . . 0.0 112.749 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -94.91 130.22 41.61 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 101.911 -3.366 . . . . 0.0 101.911 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.32 -84.78 0.05 OUTLIER Glycine 0 CA--C 1.531 1.04 0 C-N-CA 123.554 0.597 . . . . 0.0 111.913 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.33 68.0 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 129.219 3.295 . . . . 0.0 108.361 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 m -91.52 168.45 13.32 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 117.886 0.843 . . . . 0.0 110.523 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 55.7 Cg_endo -67.99 159.82 51.27 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 N-CA-C 107.888 -1.62 . . . . 0.0 107.888 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.9 mt -80.96 137.39 36.1 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -163.14 171.61 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 125.286 1.434 . . . . 0.0 109.354 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.12 171.14 8.92 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.4 t -157.89 145.56 18.5 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.47 -1.394 . . . . 0.0 108.441 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -106.02 -26.23 11.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.559 0.618 . . . . 0.0 109.797 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 N--CA 1.441 -0.902 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 179.401 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.5 p -108.91 97.36 7.01 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.23 1.012 . . . . 0.0 111.611 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.8 p -93.62 -31.76 14.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.815 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.67 113.42 26.55 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 118.413 -0.803 . . . . 0.0 112.893 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -161.26 178.79 8.89 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.07 1.305 . . . . 0.0 112.168 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.83 173.63 21.01 Favored Glycine 0 C--O 1.24 0.485 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.6 tp -120.98 138.88 53.94 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.3 m -89.99 41.92 1.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.02 167.49 15.83 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.2 mt -136.73 151.59 49.39 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.876 1.27 . . . . 0.0 107.699 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 55.4 p90 . . . . . 0 C--O 1.254 1.339 0 C-N-CA 125.191 1.397 . . . . 0.0 109.014 179.533 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 117.24 -1.362 . . . . 0.0 107.469 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.52 122.75 10.5 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.341 2.028 . . . . 0.0 108.982 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.73 138.4 40.41 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -135.19 148.44 49.67 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 119.086 0.857 . . . . 0.0 110.801 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.08 -130.43 1.26 Allowed Glycine 0 C--O 1.227 -0.339 0 CA-C-O 118.668 -1.073 . . . . 0.0 111.534 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.5 p -145.71 -177.7 5.72 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.875 1.338 . . . . 0.0 113.226 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mt -140.54 -11.56 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 126.403 1.881 . . . . 0.0 109.336 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -61.04 -17.98 55.3 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 119.778 -1.826 . . . . 0.0 113.687 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.73 -7.88 5.71 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.757 2.423 . . . . 0.0 113.838 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.6 mm -91.56 -41.51 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.97 23.14 0.86 Allowed 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 121.088 -1.008 . . . . 0.0 111.016 -176.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 62.59 27.83 16.38 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.629 0.728 . . . . 0.0 112.035 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.85 91.09 6.27 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.7 t -85.67 161.51 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -118.79 144.13 46.5 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 119.553 1.069 . . . . 0.0 110.953 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.7 t -142.65 134.45 25.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 tp -68.71 120.73 15.14 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 103.594 -2.743 . . . . 0.0 103.594 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -137.17 123.11 20.17 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.4 t0 47.07 49.41 15.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.001 1.32 . . . . 0.0 112.644 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 67.59 12.05 8.68 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.949 2.1 . . . . 0.0 115.623 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.1 m -132.42 143.54 49.88 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.652 1.115 . . . . 0.0 109.88 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.441 ' CD1' HD12 ' A' ' 138' ' ' LEU . 7.1 mt -81.96 121.95 27.17 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.41 -1.431 . . . . 0.0 107.872 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.79 136.76 53.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.54 136.98 40.56 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 124.59 1.182 . . . . 0.0 108.105 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 m -119.5 87.19 35.87 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.54 1.136 . . . . 0.0 108.569 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.66 -44.72 2.81 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.78 2.32 . . . . 0.0 112.927 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -153.22 44.13 0.63 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.49 1.516 . . . . 0.0 109.611 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.0 124.77 32.82 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -55.6 -32.95 63.51 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 123.981 0.801 . . . . 0.0 109.65 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -89.1 31.0 0.9 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.624 1.569 . . . . 0.0 112.513 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -80.2 168.06 19.55 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.068 -1.645 . . . . 0.0 109.97 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.81 147.97 18.26 Favored Pre-proline 0 N--CA 1.448 -0.56 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.39 159.58 46.37 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.286 2.657 . . . . 0.0 108.531 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.85 160.0 9.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 125.77 1.628 . . . . 0.0 108.115 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.04 154.42 27.71 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.964 1.706 . . . . 0.0 108.111 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mm -130.12 104.35 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.193 1.397 . . . . 0.0 108.088 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.97 141.36 28.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.5 tt -132.69 140.2 48.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.57 145.46 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.8 p -75.65 161.9 28.7 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 124.785 1.234 . . . . 0.0 107.824 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.94 176.01 9.61 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.474 ' HB2' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -125.19 -7.52 7.09 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -116.69 37.64 3.72 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.5 m -60.99 -16.29 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 125.253 1.421 . . . . 0.0 113.544 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.46 -18.41 65.3 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.948 0.499 . . . . 0.0 110.094 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.14 -0.82 49.61 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.117 0.967 . . . . 0.0 112.262 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.2 mt -106.69 179.25 4.32 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.262 0.937 . . . . 0.0 110.343 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -92.37 157.63 16.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.909 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.77 -19.46 6.77 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.816 1.247 . . . . 0.0 112.7 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.25 -31.63 72.83 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.506 1.122 . . . . 0.0 113.44 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -86.84 -5.67 59.03 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.536 0.734 . . . . 0.0 112.707 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 127.0 -158.12 20.85 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -102.09 107.77 54.05 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.42 123.5 9.17 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.532 2.821 . . . . 0.0 109.64 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.8 pt -132.91 -171.94 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.445 1.898 . . . . 0.0 108.434 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.655 ' CD1' HG22 ' A' ' 92' ' ' ILE . 1.5 t80 -134.15 158.62 43.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.588 1.155 . . . . 0.0 108.953 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.1 tt -149.59 150.06 31.63 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.425 1.49 . . . . 0.0 108.534 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.67 177.19 30.52 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 124.211 0.91 . . . . 0.0 111.945 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mt -97.96 132.25 43.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -96.53 35.69 1.46 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.425 1.011 . . . . 0.0 112.581 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -97.7 -96.87 1.96 Allowed Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.488 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.407 ' H ' HD11 ' A' ' 72' ' ' LEU . 24.3 mt -87.8 13.87 9.82 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.885 1.674 . . . . 0.0 115.018 -177.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 m120 72.37 70.88 0.15 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.437 1.895 . . . . 0.0 109.278 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.407 HD11 ' H ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -141.44 145.89 35.83 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 125.328 1.451 . . . . 0.0 107.976 -177.733 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.526 ' SG ' HG23 ' A' ' 92' ' ' ILE . 56.9 m -143.72 174.05 11.14 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.202 0.91 . . . . 0.0 109.855 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.455 HD23 HD21 ' A' ' 87' ' ' LEU . 15.1 mt -59.9 150.97 27.08 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.015 0.37 . . . . 0.0 111.185 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.9 ttp -157.89 116.05 3.08 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 95.8 m -89.78 109.7 20.67 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 119.288 0.949 . . . . 0.0 109.46 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.53 -169.23 1.44 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -130.78 118.54 20.97 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.2 p -65.67 -9.97 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.45 -1.29 7.56 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 125.295 1.426 . . . . 0.0 110.981 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -150.09 -44.25 0.13 Allowed 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.072 0.949 . . . . 0.0 111.484 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -135.44 163.06 53.5 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 124.903 1.281 . . . . 0.0 111.504 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -71.95 146.89 48.35 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.396 2.064 . . . . 0.0 112.635 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.1 p -145.75 170.89 15.61 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.4 mt -98.0 132.53 43.48 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -126.15 73.35 1.36 Allowed 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.02 0.928 . . . . 0.0 108.806 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.455 HD21 HD23 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -85.84 107.82 17.84 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 178.607 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.08 -30.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.127 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -157.35 97.73 1.65 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.183 0.993 . . . . 0.0 110.666 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.48 ' CE ' ' H ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -172.84 161.54 4.64 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.509 1.524 . . . . 0.0 107.131 178.292 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.48 ' H ' ' CE ' ' A' ' 90' ' ' LYS . 0.9 OUTLIER -131.1 130.31 42.99 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.424 1.49 . . . . 0.0 112.431 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.655 HG22 ' CD1' ' A' ' 64' ' ' TYR . 8.1 pt -82.37 -39.67 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 126.233 1.813 . . . . 0.0 111.644 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.2 tpt -64.51 -34.55 78.49 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.297 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.51 -45.88 92.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.879 0.763 . . . . 0.0 109.356 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.6 HD12 ' CD1' ' A' ' 64' ' ' TYR . 10.1 mt -65.82 -33.69 76.44 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.758 0.708 . . . . 0.0 111.278 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -79.77 -16.39 55.63 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.468 0.576 . . . . 0.0 110.403 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -91.73 -36.42 13.59 Favored 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 125.371 1.468 . . . . 0.0 111.486 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.79 159.03 42.25 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 121.141 -0.975 . . . . 0.0 112.049 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -78.86 54.11 4.98 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.435 2.09 . . . . 0.0 112.172 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -116.24 71.85 4.63 Favored Pre-proline 0 N--CA 1.473 0.683 0 O-C-N 120.713 -1.242 . . . . 0.0 110.827 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -79.99 82.1 2.58 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.599 2.199 . . . . 0.0 109.166 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.2 t -74.36 106.01 3.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -50.98 -30.53 15.31 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.423 1.01 . . . . 0.0 111.255 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 m -70.83 -8.82 55.37 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -114.03 -22.6 9.98 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.159 -0.963 . . . . 0.0 109.134 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.3 mt -84.34 154.23 23.02 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.007 0.923 . . . . 0.0 113.024 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -140.28 133.17 29.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.022 0.929 . . . . 0.0 110.079 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -77.41 118.45 19.88 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -81.17 141.06 34.58 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.0 m -138.87 174.38 10.58 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.465 1.106 . . . . 0.0 108.175 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -153.14 150.74 29.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.858 0.463 . . . . 0.0 110.142 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.01 107.07 0.35 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.36 56.92 3.28 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 126.121 1.819 . . . . 0.0 111.756 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 11.7 mtm-85 61.87 9.04 2.74 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.6 1.96 . . . . 0.0 109.798 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -117.5 162.35 18.12 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 119.903 1.228 . . . . 0.0 110.882 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.0 m -111.78 158.79 18.94 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.213 2.205 . . . . 0.0 108.632 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.65 162.82 34.55 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.474 1.909 . . . . 0.0 108.747 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -140.83 116.21 10.05 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -108.89 130.14 55.43 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.465 1.506 . . . . 0.0 109.226 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.9 t -56.69 117.69 4.14 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.356 1.462 . . . . 0.0 110.248 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.2 t -62.72 -40.68 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 119.076 0.853 . . . . 0.0 111.022 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.33 -42.02 88.78 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -133.2 86.49 41.7 Favored Pre-proline 0 C--O 1.237 0.414 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.04 168.8 11.59 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.285 2.656 . . . . 0.0 111.535 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.49 -21.67 31.2 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -101.03 118.03 36.19 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 127.444 2.298 . . . . 0.0 107.078 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -108.1 148.32 29.99 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.104 1.361 . . . . 0.0 108.902 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.4 mt -75.61 122.82 30.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.15 140.29 29.81 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.354 0.597 . . . . 0.0 110.494 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.4 m -90.58 -4.75 10.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 C-N-CA 124.548 1.139 . . . . 0.0 112.231 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.1 m 52.97 73.86 0.33 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 123.126 1.441 . . . . 0.0 113.571 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.0 t -93.83 6.12 49.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.676 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -115.36 136.22 53.32 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 53.84 -104.48 0.23 Allowed Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 107.561 -2.216 . . . . 0.0 107.561 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -173.35 66.43 0.11 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 106.394 -2.682 . . . . 0.0 106.394 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 56.5 m -82.0 157.74 68.35 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 117.534 0.667 . . . . 0.0 110.642 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -71.14 165.75 31.39 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 121.973 1.782 . . . . 0.0 108.521 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.441 HD12 ' CD1' ' A' ' 30' ' ' LEU . 22.6 mt -87.82 113.33 23.38 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.642 1.177 . . . . 0.0 112.06 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 pp -135.95 178.44 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 125.447 1.499 . . . . 0.0 109.455 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 35.6 mt -96.17 141.58 29.37 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.2 t -129.85 129.8 44.44 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -87.26 -23.47 24.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 122.315 1.055 . . . . 0.0 110.88 -177.977 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 55.8 m -109.8 118.51 36.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.7 p -108.07 -11.94 15.21 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.409 1.084 . . . . 0.0 110.099 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.69 126.84 48.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.759 1.223 . . . . 0.0 109.919 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -152.72 -165.08 2.1 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.333 -0.854 . . . . 0.0 109.41 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -148.1 127.59 2.63 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 106.055 -2.818 . . . . 0.0 106.055 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.52 114.47 26.01 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.8 m -78.41 39.59 0.33 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.588 2.355 . . . . 0.0 107.716 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -64.18 148.57 49.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.403 1.881 . . . . 0.0 107.999 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.1 mt -129.51 162.55 27.89 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.244 1.818 . . . . 0.0 108.43 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 22.9 p90 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 115.361 -2.257 . . . . 0.0 109.677 -179.592 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.46 ' HB3' HD11 ' A' ' 47' ' ' ILE . 60.7 Cg_endo -69.94 132.15 22.45 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.442 2.094 . . . . 0.0 107.497 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.99 132.81 42.43 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.5 mp0 -128.89 145.98 51.07 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.14 -139.19 2.67 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 95.0 p -143.96 -172.62 3.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.036 0.918 . . . . 0.0 112.796 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.3 mt -140.05 -10.6 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 126.443 1.897 . . . . 0.0 109.337 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -24.02 65.31 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 119.544 -1.972 . . . . 0.0 113.268 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -58.86 -16.38 17.06 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.917 2.087 . . . . 0.0 112.706 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.5 mt -74.79 -67.11 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.138 1.375 . . . . 0.0 112.8 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -136.7 32.09 2.75 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.149 0.976 . . . . 0.0 110.535 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 58.62 37.42 25.31 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.924 0.868 . . . . 0.0 110.643 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.1 mmt-85 -105.72 89.67 3.16 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.824 -1.173 . . . . 0.0 109.217 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.3 t -79.11 157.25 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.418 ' CD2' HD11 ' A' ' 138' ' ' LEU . 49.8 m0 -111.47 153.78 25.66 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.988 0.915 . . . . 0.0 108.673 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.5 t -146.62 135.65 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.1 tp -76.25 106.89 8.12 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -132.16 133.51 44.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 119.843 1.201 . . . . 0.0 111.293 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t0 47.83 42.79 16.5 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 123.641 1.686 . . . . 0.0 111.28 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 61.61 26.93 16.51 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 127.223 2.209 . . . . 0.0 115.122 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.1 m -138.71 154.79 48.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.968 HD11 HD21 ' A' ' 67' ' ' LEU . 9.8 mt -92.94 126.45 38.02 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mt -126.97 132.16 70.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 123.141 0.576 . . . . 0.0 110.736 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.34 136.38 46.17 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.951 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.7 m -112.96 81.44 4.57 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.786 1.235 . . . . 0.0 108.117 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.12 -33.36 25.34 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.559 2.172 . . . . 0.0 111.851 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -151.33 12.73 0.65 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -62.86 138.65 58.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 120.585 -1.322 . . . . 0.0 111.059 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -33.13 75.16 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.603 1.961 . . . . 0.0 109.038 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -102.08 71.59 1.27 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.7 ptm -106.7 163.07 13.21 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -157.43 141.12 11.37 Favored Pre-proline 0 N--CA 1.446 -0.652 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -71.91 163.78 37.74 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 N-CA-C 108.502 -1.384 . . . . 0.0 108.502 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.8 p -155.62 154.19 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.437 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.46 150.99 25.53 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 126.827 2.051 . . . . 0.0 110.355 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 12' ' ' GLN . 43.3 mm -121.56 122.34 66.85 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 68' ' ' ASN . . . -100.71 145.84 27.96 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.453 HD12 HD12 ' A' ' 65' ' ' LEU . 3.9 tt -140.18 138.01 34.82 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.473 HD12 HG12 ' A' ' 92' ' ' ILE . 80.9 mt -146.77 138.0 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 C-N-CA 126.129 1.772 . . . . 0.0 109.856 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.4 p -84.28 130.24 34.82 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 89.9 m -62.68 138.74 58.58 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -94.42 -28.36 15.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.858 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -90.85 40.73 1.03 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.2 m -68.22 -8.81 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 120.44 -1.412 . . . . 0.0 112.783 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -62.6 -7.37 4.61 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.032 2.133 . . . . 0.0 113.583 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 t -122.5 7.23 9.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.897 1.279 . . . . 0.0 111.605 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.6 mt -107.49 167.31 10.03 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.849 -1.157 . . . . 0.0 108.601 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -64.71 153.34 39.98 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.268 -1.333 . . . . 0.0 107.992 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -121.72 -47.01 2.22 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.091 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.16 -26.45 62.75 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 127.909 2.484 . . . . 0.0 113.315 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -85.04 -19.47 31.92 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.789 -0.57 . . . . 0.0 111.601 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 140.71 -167.44 25.59 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -97.45 102.1 11.9 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.683 0.793 . . . . 0.0 110.676 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.64 138.17 23.6 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 124.298 3.332 . . . . 0.0 112.741 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pp -146.08 -175.35 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 125.738 1.615 . . . . 0.0 110.246 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.498 ' CE1' HD12 ' A' ' 95' ' ' LEU . 3.2 t80 -134.16 156.46 48.29 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.678 0.791 . . . . 0.0 110.527 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.465 HD11 HD21 ' A' ' 154' ' ' LEU . 6.8 tt -154.3 151.82 29.55 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.599 1.56 . . . . 0.0 108.428 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.92 -176.67 34.26 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.968 HD21 HD11 ' A' ' 30' ' ' LEU . 11.0 mt -83.47 171.03 13.82 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 176.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 10.5 t-20 -137.68 47.34 2.06 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.603 -1.311 . . . . 0.0 109.6 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.83 -75.99 0.54 Allowed Glycine 0 C--N 1.337 0.63 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.381 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.21 25.11 11.43 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 m120 66.88 72.96 0.36 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.662 1.185 . . . . 0.0 109.804 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.46 141.71 25.1 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.963 1.305 . . . . 0.0 110.573 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.3 m -144.04 165.48 27.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.02 0.827 . . . . 0.0 111.385 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.84 156.62 8.63 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.518 1.127 . . . . 0.0 110.174 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.1 tmm? -164.37 140.53 6.17 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.5 m -102.78 119.61 39.14 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.45 -171.75 2.44 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.124 1.37 . . . . 0.0 107.874 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -128.25 127.09 42.18 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.94 -8.04 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 123.437 0.461 . . . . 0.0 110.697 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.73 -82.44 0.1 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -117.17 7.66 13.05 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.968 0.89 . . . . 0.0 112.701 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -141.1 151.01 60.85 Favored Pre-proline 0 C--O 1.241 0.651 0 C-N-CA 124.807 1.243 . . . . 0.0 110.547 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.72 149.13 18.18 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.733 2.289 . . . . 0.0 108.978 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.5 p -144.14 170.61 15.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.957 0.903 . . . . 0.0 110.393 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.66 HD11 HG23 ' A' ' 128' ' ' ILE . 3.5 mt -91.79 151.24 20.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.399 1.08 . . . . 0.0 108.679 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -148.63 80.94 1.45 Allowed 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 125.079 1.351 . . . . 0.0 107.628 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.62 ' HG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -104.96 97.39 7.25 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 125.942 1.697 . . . . 0.0 108.858 -177.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.08 -26.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.871 0.732 . . . . 0.0 112.274 -177.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -145.24 103.59 3.86 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.541 1.537 . . . . 0.0 109.482 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.433 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER 174.11 159.25 0.16 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.133 1.373 . . . . 0.0 108.915 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -136.35 127.74 28.44 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.181 0.593 . . . . 0.0 110.795 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.473 HG12 HD12 ' A' ' 47' ' ' ILE . 1.1 tt -68.26 -47.17 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 125.903 1.681 . . . . 0.0 114.25 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.8 tpt -62.95 -29.73 71.03 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.982 -0.532 . . . . 0.0 111.268 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.22 -54.51 32.35 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.034 0.533 . . . . 0.0 109.691 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.498 HD12 ' CE1' ' A' ' 64' ' ' TYR . 42.2 mt -63.87 -30.04 71.17 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.414 ' CG ' HG21 ' A' ' 47' ' ' ILE . 52.1 t80 -74.39 -52.42 12.17 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -60.63 -45.08 95.42 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 125.682 1.593 . . . . 0.0 112.685 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -92.99 145.37 29.99 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.64 50.0 2.59 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.439 2.76 . . . . 0.0 112.124 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -118.12 72.73 9.4 Favored Pre-proline 0 CA--C 1.537 0.48 0 O-C-N 120.745 -1.222 . . . . 0.0 109.332 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.94 92.28 1.05 Allowed 'Trans proline' 0 N--CA 1.45 -1.037 0 N-CA-C 105.284 -2.622 . . . . 0.0 105.284 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.5 t -88.35 97.72 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -50.55 -22.23 1.88 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.02 -17.34 64.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.209 0.604 . . . . 0.0 110.858 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -113.61 -22.07 10.46 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 119.164 0.893 . . . . 0.0 110.649 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.8 mt -78.97 164.37 24.46 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.698 1.199 . . . . 0.0 113.64 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.92 140.63 22.65 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 123.772 0.829 . . . . 0.0 111.016 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.43 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.5 OUTLIER -75.3 123.18 24.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 176.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.431 ' CD2' ' HB3' ' A' ' 116' ' ' SER . 3.9 t-160 -97.94 101.35 12.81 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.883 1.273 . . . . 0.0 107.577 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.51 170.9 13.0 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.925 1.29 . . . . 0.0 110.095 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -139.86 147.38 40.58 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.675 1.59 . . . . 0.0 110.044 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.4 p -135.59 15.4 3.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.823 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.5 -79.23 0.31 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -111.47 -1.41 15.9 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.18 0.992 . . . . 0.0 111.985 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -127.03 160.87 29.83 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.206 1.002 . . . . 0.0 108.357 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.431 ' HB3' ' CD2' ' A' ' 109' ' ' HIS . 49.9 m -132.5 151.66 51.83 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.234 1.814 . . . . 0.0 109.024 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.11 165.75 12.79 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -142.8 107.96 4.97 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -111.65 124.72 52.9 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.398 1.879 . . . . 0.0 110.056 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.8 t -53.01 130.23 33.13 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.304 -0.872 . . . . 0.0 110.032 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.2 t -68.87 -51.18 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.909 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.01 78.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -129.19 81.6 70.15 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 124.055 0.942 . . . . 0.0 109.903 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -65.38 161.61 37.2 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.671 2.247 . . . . 0.0 111.113 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.2 0.06 77.69 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.205 -0.775 . . . . 0.0 113.06 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -126.69 131.23 51.43 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.455 1.902 . . . . 0.0 107.753 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.6 149.97 33.77 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.948 1.299 . . . . 0.0 112.493 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.66 HG23 HD11 ' A' ' 85' ' ' LEU . 2.1 mt -81.51 119.25 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.609 0.764 . . . . 0.0 111.176 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.72 152.31 31.64 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.638 1.108 . . . . 0.0 109.965 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.9 t -103.48 -18.2 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 127.797 2.439 . . . . 0.0 109.754 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.504 ' HB3' ' H ' ' A' ' 136' ' ' CYS . 50.9 m 61.24 39.24 15.91 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.391 1.476 . . . . 0.0 114.295 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.1 m -76.76 -11.38 59.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.61 -66.99 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.77 1.628 . . . . 0.0 111.071 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -122.88 -48.49 0.25 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 124.321 0.963 . . . . 0.0 111.288 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 138.75 60.44 0.05 OUTLIER Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' CYS . . . . . 0.504 ' H ' ' HB3' ' A' ' 131' ' ' SER . 0.5 OUTLIER -90.45 174.16 4.91 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 123.95 0.9 . . . . 0.0 110.933 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.01 166.43 29.61 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 N-CA-C 108.928 -1.22 . . . . 0.0 108.928 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.418 HD11 ' CD2' ' A' ' 23' ' ' TRP . 21.9 mt -87.28 114.09 23.58 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.9 pp -137.93 172.02 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.078 1.351 . . . . 0.0 110.754 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 66.3 mt -97.72 159.89 14.65 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.37 161.33 41.22 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 125.321 1.448 . . . . 0.0 107.316 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -104.57 -45.66 4.56 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.126 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m120 . . . . . 0 N--CA 1.459 0.019 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.4 m -146.53 107.9 4.25 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 102.088 -3.301 . . . . 0.0 102.088 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.49 -9.12 14.23 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.389 1.076 . . . . 0.0 110.546 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -123.26 112.32 17.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.94 -176.62 5.0 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.085 0.954 . . . . 0.0 111.165 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.99 -169.04 32.13 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.347 0.975 . . . . 0.0 112.675 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.465 HD21 HD11 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -145.5 130.33 18.16 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.942 1.697 . . . . 0.0 106.769 179.164 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 39.2 m -90.34 51.32 2.0 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -68.73 138.13 54.64 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 40.8 mt -123.03 170.23 10.37 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.159 2.184 . . . . 0.0 107.95 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 1.8 p90 . . . . . 0 C--O 1.255 1.347 0 CA-C-O 117.416 -1.278 . . . . 0.0 108.677 -179.842 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.239 0.55 0 CA-C-O 119.581 -0.247 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.1 146.1 80.97 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.949 1.766 . . . . 0.0 107.833 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -141.23 108.77 5.59 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -111.15 145.18 39.08 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.303 0.641 . . . . 0.0 110.227 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.28 -117.99 0.48 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.0 p -160.45 167.58 26.97 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 119.118 1.459 . . . . 0.0 114.018 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.517 HG22 HH12 ' A' ' 21' ' ' ARG . 30.0 mt -127.19 -2.56 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 123.463 0.705 . . . . 0.0 109.37 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -62.52 -28.65 69.99 Favored 'General case' 0 C--N 1.334 -0.094 0 O-C-N 119.4 -2.062 . . . . 0.0 115.028 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.41 -19.79 16.59 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.205 1.802 . . . . 0.0 112.635 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.7 mm -56.69 -54.48 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 127.458 2.303 . . . . 0.0 115.292 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -151.27 35.17 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.12 16.58 3.02 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.643 1.977 . . . . 0.0 114.29 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.517 HH12 HG22 ' A' ' 15' ' ' ILE . 1.1 ptm180 -88.22 94.89 9.97 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.596 1.558 . . . . 0.0 109.78 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -75.67 157.73 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.514 ' CZ3' HD12 ' A' ' 15' ' ' ILE . 17.5 m0 -108.21 147.9 30.71 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.1 t -142.6 127.93 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.427 HD22 ' CD2' ' A' ' 72' ' ' LEU . 3.9 tp -72.31 107.62 5.01 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -124.88 124.82 42.88 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 120.602 1.547 . . . . 0.0 110.37 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 t0 47.81 57.24 6.19 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.443 1.116 . . . . 0.0 111.229 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 51.75 24.9 2.64 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.228 1.011 . . . . 0.0 113.542 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.3 m -142.96 127.05 17.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.463 HD11 HD11 ' A' ' 67' ' ' LEU . 14.9 mt -74.66 144.06 43.99 Favored 'General case' 0 CA--C 1.518 -0.258 0 O-C-N 119.55 -1.969 . . . . 0.0 109.306 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.4 pt -125.14 153.07 32.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 123.895 0.878 . . . . 0.0 108.862 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.36 123.02 44.05 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.3 m -111.25 78.23 1.77 Allowed Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.043 0.937 . . . . 0.0 108.87 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.73 -50.12 2.62 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.57 1.513 . . . . 0.0 110.425 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -141.98 79.73 1.68 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.637 1.175 . . . . 0.0 108.176 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -140.98 132.78 27.42 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.39 -42.56 98.91 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.632 0.582 . . . . 0.0 112.01 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -71.73 22.34 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -73.15 163.73 27.71 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 120.444 -1.41 . . . . 0.0 110.317 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.0 t -156.53 132.43 5.81 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.14 144.99 59.29 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.841 2.361 . . . . 0.0 110.633 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.56 164.51 34.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.523 1.129 . . . . 0.0 108.244 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -115.49 156.2 26.11 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 mm -123.0 136.06 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.24 126.14 46.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 119.926 1.239 . . . . 0.0 107.944 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -118.96 136.86 53.87 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.608 1.163 . . . . 0.0 110.481 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 mt -148.96 142.33 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.941 1.296 . . . . 0.0 109.246 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.7 p -84.83 153.69 22.78 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.2 m -79.53 130.2 35.17 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 120.173 -1.58 . . . . 0.0 108.117 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -79.14 -32.18 44.3 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -97.34 44.8 1.04 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.967 1.307 . . . . 0.0 110.65 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 m -66.22 -7.53 5.48 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 O-C-N 120.412 -1.43 . . . . 0.0 113.636 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -55.5 -28.92 57.5 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.285 0.948 . . . . 0.0 112.662 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.4 t -95.44 -11.13 28.1 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.902 0.774 . . . . 0.0 111.569 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.52 168.24 11.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -82.05 154.44 25.63 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -119.84 -18.31 8.29 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.056 1.343 . . . . 0.0 111.062 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -57.51 -39.59 76.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.107 2.563 . . . . 0.0 114.191 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -85.06 -12.8 52.23 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.178 0.991 . . . . 0.0 111.396 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.06 -162.26 24.99 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -93.94 103.66 11.01 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 126.148 1.779 . . . . 0.0 109.862 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.08 135.73 25.74 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.447 2.098 . . . . 0.0 109.966 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -133.15 178.06 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.633 ' CD1' HG22 ' A' ' 92' ' ' ILE . 2.1 t80 -137.76 131.4 31.19 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.033 0.533 . . . . 0.0 109.567 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.72 158.7 38.67 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.43 -170.09 22.69 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.463 HD11 HD11 ' A' ' 30' ' ' LEU . 4.3 mt -98.85 166.73 11.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -130.31 94.77 3.74 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.98 -16.23 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 CA-C-O 116.574 -2.236 . . . . 0.0 116.977 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.15 22.95 0.11 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 120.493 2.146 . . . . 0.0 111.914 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 61.45 63.37 1.2 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.786 1.634 . . . . 0.0 108.993 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.427 ' CD2' HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -136.49 127.17 27.15 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.219 -178.41 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.579 ' SG ' HG23 ' A' ' 92' ' ' ILE . 29.1 m -136.84 179.65 6.24 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.931 ' HA ' HD12 ' A' ' 87' ' ' LEU . 10.9 mt -64.08 153.54 37.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.185 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -161.09 133.57 6.07 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 89.6 m -101.0 125.76 47.63 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.81 -174.7 3.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 81' ' ' ASP . 10.2 tttt -117.48 148.39 41.87 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.7 p -121.67 -6.79 9.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 123.564 0.54 . . . . 0.0 111.458 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.5 72.31 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.436 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 8.4 t0 70.48 5.27 5.3 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.811 2.044 . . . . 0.0 114.34 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.71 143.85 42.13 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.164 1.786 . . . . 0.0 109.356 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -74.91 162.04 37.97 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.989 2.459 . . . . 0.0 113.277 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.1 p -156.8 169.1 25.53 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.342 1.457 . . . . 0.0 109.997 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.798 HD11 HG22 ' A' ' 128' ' ' ILE . 0.9 OUTLIER -91.18 130.22 37.08 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 127.583 2.353 . . . . 0.0 105.164 178.105 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -136.99 70.38 1.4 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 122.118 0.961 . . . . 0.0 109.365 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.931 HD12 ' HA ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -89.14 113.78 24.99 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 127.458 2.303 . . . . 0.0 109.067 -178.128 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.64 -28.5 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 O-C-N 124.745 1.278 . . . . 0.0 113.529 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -147.65 97.68 2.86 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.361 1.465 . . . . 0.0 109.43 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.95 159.21 2.64 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -135.23 134.03 39.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.633 HG22 ' CD1' ' A' ' 64' ' ' TYR . 6.5 pt -83.62 -40.38 15.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.7 tpt -63.98 -31.05 72.1 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.237 -0.887 . . . . 0.0 112.424 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.55 -50.18 73.69 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.525 HD12 ' CD1' ' A' ' 64' ' ' TYR . 16.1 mt -63.44 -35.6 80.96 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.528 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -75.38 -26.41 58.44 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.931 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -78.88 -31.45 45.47 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 120.711 -1.243 . . . . 0.0 113.217 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -112.29 158.07 38.18 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 118.949 0.795 . . . . 0.0 110.829 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -86.74 45.0 1.27 Allowed 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.287 2.658 . . . . 0.0 114.157 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -125.24 58.1 18.87 Favored Pre-proline 0 CA--C 1.553 1.064 0 O-C-N 120.608 -1.308 . . . . 0.0 112.195 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -62.21 117.96 4.83 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.946 3.097 . . . . 0.0 110.82 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.1 t -99.92 107.41 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 123.447 0.699 . . . . 0.0 110.621 -177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.431 ' HB2' HG12 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -52.82 -24.28 8.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 118.182 -0.914 . . . . 0.0 112.877 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.1 m -67.69 -11.35 58.12 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.363 0.983 . . . . 0.0 111.362 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -119.62 -16.1 8.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.256 1.422 . . . . 0.0 110.294 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.6 mt -83.74 154.9 23.35 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.08 0.854 . . . . 0.0 111.867 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -136.88 128.14 28.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.483 0.713 . . . . 0.0 110.212 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -71.29 126.46 29.69 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 103.698 -2.704 . . . . 0.0 103.698 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -104.35 145.53 30.12 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.749 0.704 . . . . 0.0 110.25 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.66 -175.22 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.854 -0.529 . . . . 0.0 109.96 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -143.99 151.05 39.22 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.884 1.674 . . . . 0.0 106.959 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.5 p -124.98 -7.11 7.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.89 -35.81 2.39 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -147.68 -5.4 0.48 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.028 1.331 . . . . 0.0 112.082 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -131.57 177.33 7.58 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 125.331 1.452 . . . . 0.0 108.787 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 m -140.64 145.82 37.11 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.552 1.541 . . . . 0.0 110.078 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.65 166.9 10.63 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.926 0.89 . . . . 0.0 108.623 178.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -147.34 114.21 6.11 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.057 1.343 . . . . 0.0 107.773 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -114.83 130.5 56.88 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 127.103 2.161 . . . . 0.0 112.11 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.3 t -53.02 124.01 13.14 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.37 0.668 . . . . 0.0 109.764 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.431 HG12 ' HB2' ' A' ' 103' ' ' LYS . 79.1 t -67.48 -54.11 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 O-C-N 121.08 -1.012 . . . . 0.0 110.137 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.44 -33.52 68.0 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.085 0.954 . . . . 0.0 113.182 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -135.95 80.91 41.0 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 124.647 1.179 . . . . 0.0 109.778 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.44 163.1 37.94 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.005 2.47 . . . . 0.0 109.848 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 96.77 -3.24 62.68 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.582 1.087 . . . . 0.0 110.653 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -125.63 121.82 34.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.731 1.612 . . . . 0.0 108.522 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -106.1 145.87 30.9 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.423 1.489 . . . . 0.0 109.575 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.798 HG22 HD11 ' A' ' 85' ' ' LEU . 3.4 pt -75.09 121.32 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.08 121.25 27.16 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 68.8 t -78.24 -20.06 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 127.656 2.382 . . . . 0.0 113.385 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m 59.21 66.11 1.09 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.406 1.098 . . . . 0.0 110.438 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.3 m -99.36 36.7 1.69 Allowed 'General case' 0 C--N 1.323 -0.575 0 O-C-N 120.963 -1.085 . . . . 0.0 112.239 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -126.37 -98.96 0.39 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.935 0.494 . . . . 0.0 109.957 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -94.17 23.96 29.13 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-O 117.058 -1.968 . . . . 0.0 117.133 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.38 52.02 6.97 Favored Glycine 0 C--O 1.238 0.376 0 CA-C-N 119.743 1.771 . . . . 0.0 113.306 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.29 164.65 40.03 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.27 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.32 156.87 37.31 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 N-CA-C 107.04 -1.946 . . . . 0.0 107.04 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.438 HD11 ' CE2' ' A' ' 23' ' ' TRP . 17.7 mt -82.94 118.68 23.64 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.537 1.135 . . . . 0.0 110.862 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.439 ' C ' HD12 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -143.33 167.48 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 123.787 0.835 . . . . 0.0 111.458 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.5 mt -86.14 151.89 23.29 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.1 t -141.36 137.29 32.24 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -83.02 -33.98 26.38 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 122.154 0.978 . . . . 0.0 109.43 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.442 -0.852 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 p30 . . . . . 0 N--CA 1.444 -0.746 0 CA-C-O 121.373 0.606 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.444 HG21 ' CE2' ' A' ' 152' ' ' PHE . 0.3 OUTLIER -65.77 106.52 1.53 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 117.317 -1.325 . . . . 0.0 108.898 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.7 p -100.9 -12.99 18.53 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 122.147 2.249 . . . . 0.0 111.108 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -101.69 103.96 14.76 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 130.135 3.374 . . . . 0.0 118.072 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.444 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.8 OUTLIER -168.68 177.06 5.31 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.333 -0.854 . . . . 0.0 112.927 177.747 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.15 178.19 26.69 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.077 1.322 . . . . 0.0 111.675 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.427 ' HG ' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -126.77 144.91 50.81 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.474 1.509 . . . . 0.0 109.534 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.4 m -104.52 48.69 0.83 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.19 158.83 35.74 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.9 mt -129.55 159.49 36.17 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.95 1.3 . . . . 0.0 108.991 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 11.0 p90 . . . . . 0 C--O 1.245 0.834 0 CA-C-O 115.587 -2.149 . . . . 0.0 108.573 -179.858 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.238 0.499 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HB3' HG12 ' A' ' 47' ' ' ILE . 97.8 Cg_endo -71.63 156.12 58.03 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 N-CA-C 108.301 -1.461 . . . . 0.0 108.301 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.36 116.84 27.02 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 pm0 -113.3 142.47 45.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 122.568 0.347 . . . . 0.0 110.468 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.06 -125.97 0.89 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-O 118.27 -1.295 . . . . 0.0 111.284 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.8 p -154.05 -159.74 1.01 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 120.918 2.359 . . . . 0.0 111.188 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -153.84 -4.5 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 126.329 1.852 . . . . 0.0 109.122 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -62.93 -29.68 70.97 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.74 -16.47 40.3 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.637 1.175 . . . . 0.0 113.487 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mt -61.49 -45.73 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 C-N-CA 125.666 1.586 . . . . 0.0 112.383 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.82 21.84 1.0 Allowed 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.091 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.8 t60 63.95 43.78 5.09 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.45 HH11 ' HB3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -113.88 94.1 4.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.794 0.838 . . . . 0.0 109.558 178.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.58 143.67 11.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -100.53 139.63 35.93 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -135.67 141.07 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 tp -79.98 103.29 9.76 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.7 134.42 50.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.3 t0 39.16 65.76 0.63 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.202 1.401 . . . . 0.0 112.148 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 44.21 31.94 0.62 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.456 1.502 . . . . 0.0 114.597 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.6 m -144.57 162.97 35.28 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.837 1.655 . . . . 0.0 106.77 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.712 HD12 HD22 ' A' ' 87' ' ' LEU . 5.5 mt -103.06 120.29 40.4 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 177.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 1.4 mm -119.08 139.66 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 118.03 0.377 . . . . 0.0 110.331 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.62 138.25 39.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 m -122.37 60.66 13.65 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.372 1.069 . . . . 0.0 110.336 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.45 ' HB3' HH11 ' A' ' 21' ' ' ARG . 19.8 Cg_endo -56.51 -37.64 96.97 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.199 1.933 . . . . 0.0 114.967 -178.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -136.62 13.18 3.2 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.22 128.08 34.71 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.3 1.04 . . . . 0.0 108.369 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.45 6.14 1.51 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.335 1.854 . . . . 0.0 113.094 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -129.02 40.45 3.63 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.363 -1.461 . . . . 0.0 109.881 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.7 ptp -72.58 167.72 20.11 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.836 -0.54 . . . . 0.0 110.217 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.13 128.73 2.19 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.85 157.7 51.25 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.517 2.145 . . . . 0.0 110.474 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.5 m -144.54 166.52 12.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.96 162.73 16.04 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.7 mm -132.05 109.76 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 C-N-CA 126.951 2.1 . . . . 0.0 107.3 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.89 136.54 34.06 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.4 tt -129.38 132.59 47.07 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.424 HG12 ' HB3' ' A' ' 10' ' ' PRO . 1.7 mt -142.26 141.34 28.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 124.797 1.239 . . . . 0.0 109.323 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.4 t -76.39 164.87 25.59 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.5 m -89.76 146.72 24.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -109.37 -20.92 12.75 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -105.75 39.84 1.69 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 122.475 1.131 . . . . 0.0 109.939 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 m -66.7 -6.03 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.52 1.128 . . . . 0.0 112.653 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -33.77 66.23 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.277 1.031 . . . . 0.0 111.855 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 t -101.79 13.67 34.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.649 1.179 . . . . 0.0 111.885 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.7 mt -107.14 179.58 4.22 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 120.713 -1.242 . . . . 0.0 111.006 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -84.3 153.07 23.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.639 1.176 . . . . 0.0 107.948 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -124.95 -37.78 2.41 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 123.606 0.762 . . . . 0.0 110.491 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -53.98 -44.28 70.67 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.741 1.216 . . . . 0.0 111.84 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -67.54 -27.28 66.83 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.086 -1.435 . . . . 0.0 112.2 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.51 178.84 16.6 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 126.415 1.959 . . . . 0.0 110.512 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.54 120.17 80.39 Favored Pre-proline 0 CA--C 1.541 0.619 0 O-C-N 121.561 -0.964 . . . . 0.0 111.883 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.63 141.79 15.76 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.51 2.807 . . . . 0.0 110.256 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -143.58 -179.47 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.888 2.075 . . . . 0.0 108.083 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.509 ' CD1' HD12 ' A' ' 95' ' ' LEU . 2.0 t80 -136.83 151.66 49.39 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 tt -145.36 154.87 42.77 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.19 -174.78 28.34 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.43 161.15 13.94 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -130.32 105.4 7.87 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.07 -31.24 0.11 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-O 118.45 -1.195 . . . . 0.0 113.513 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -153.35 37.02 0.47 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.142 1.471 . . . . 0.0 110.402 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 49.83 78.98 0.09 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.233 2.213 . . . . 0.0 111.582 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -142.75 141.85 31.82 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.233 -177.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 36.5 m -141.16 170.07 16.42 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.323 0.965 . . . . 0.0 112.026 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.3 mt -56.2 149.66 15.72 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.243 1.383 . . . . 0.0 111.435 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.8 mtp -156.64 138.78 14.58 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.3 m -107.57 124.87 50.57 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.29 -178.94 5.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.29 1.436 . . . . 0.0 107.913 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -119.81 146.26 45.86 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 124.159 0.983 . . . . 0.0 109.219 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 p -119.28 6.63 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 O-C-N 123.893 0.746 . . . . 0.0 112.47 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.22 87.0 0.49 Allowed Glycine 0 C--O 1.223 -0.581 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 63.86 17.77 10.74 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.07 143.41 7.17 Favored Pre-proline 0 C--O 1.24 0.575 0 C-N-CA 123.093 0.557 . . . . 0.0 110.906 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.56 164.63 33.43 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.658 2.239 . . . . 0.0 112.604 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.81 160.63 34.05 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.696 1.598 . . . . 0.0 108.905 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.42 HD11 ' CG2' ' A' ' 128' ' ' ILE . 4.2 mt -75.87 148.96 37.92 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.28 33.8 2.55 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.96 0.904 . . . . 0.0 110.632 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.712 HD22 HD12 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -66.29 92.57 0.19 Allowed 'General case' 0 CA--C 1.496 -1.117 0 C-N-CA 129.686 3.195 . . . . 0.0 109.249 -179.565 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.456 ' HA ' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -159.86 -45.97 0.05 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.691 -179.011 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -128.78 98.2 4.91 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.463 1.105 . . . . 0.0 111.137 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.491 ' HZ3' HD21 ' A' ' 95' ' ' LEU . 1.1 mmmt -176.69 152.62 1.02 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.413 -1.429 . . . . 0.0 108.757 178.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -114.03 144.2 43.5 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.191 0.996 . . . . 0.0 109.942 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.2 tt -98.85 -44.98 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 125.166 1.386 . . . . 0.0 110.235 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -32.09 71.0 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.729 0.811 . . . . 0.0 110.406 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.3 -54.18 41.16 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.509 HD12 ' CD1' ' A' ' 64' ' ' TYR . 13.9 mt -59.66 -33.35 71.43 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 122.658 0.383 . . . . 0.0 111.699 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -73.79 -37.96 64.77 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -75.09 -36.73 61.71 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.657 1.583 . . . . 0.0 113.946 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -111.71 149.59 40.97 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 119.84 1.2 . . . . 0.0 111.718 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -76.63 56.68 5.27 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.177 3.251 . . . . 0.0 113.554 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -118.57 80.48 16.94 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.207 1.003 . . . . 0.0 108.441 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.86 74.98 5.02 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.807 3.004 . . . . 0.0 109.012 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -69.72 97.35 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 124.792 1.237 . . . . 0.0 109.314 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -52.45 -26.72 13.56 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.621 1.168 . . . . 0.0 112.9 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.0 -18.24 64.1 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.461 0.573 . . . . 0.0 112.239 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -115.96 -23.81 8.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.479 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.1 mt -72.89 153.8 40.86 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.162 0.892 . . . . 0.0 111.319 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -136.49 138.46 41.43 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.261 1.025 . . . . 0.0 110.516 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.98 123.15 29.68 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 103.528 -2.767 . . . . 0.0 103.528 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -103.39 143.83 32.17 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.258 0.623 . . . . 0.0 109.44 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.85 169.83 20.75 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -140.28 151.76 45.36 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.347 1.459 . . . . 0.0 111.601 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.19 79.18 0.75 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.901 0.858 . . . . 0.0 112.707 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.62 62.95 1.58 Allowed Glycine 0 C--N 1.334 0.46 0 O-C-N 120.954 -1.091 . . . . 0.0 111.639 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.32 4.13 1.58 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.72 1.208 . . . . 0.0 112.861 -178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.58 163.48 12.44 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.0 m -146.16 152.48 39.32 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.39 159.9 41.18 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -132.18 120.1 21.78 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.462 ' HB2' ' CE2' ' A' ' 127' ' ' PHE . 4.1 tt0 -112.42 131.21 55.67 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.418 1.087 . . . . 0.0 109.116 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.4 121.67 8.8 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.725 1.61 . . . . 0.0 109.705 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.8 t -70.99 -40.61 76.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 O-C-N 120.7 -1.25 . . . . 0.0 111.954 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.62 -38.3 77.73 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.077 0.853 . . . . 0.0 111.918 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -139.2 97.36 8.64 Favored Pre-proline 0 C--O 1.24 0.568 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.02 174.3 10.8 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.366 2.044 . . . . 0.0 109.208 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 91.11 -3.42 80.32 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -125.19 129.74 50.72 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.033 1.333 . . . . 0.0 107.535 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 119' ' ' GLU . 79.3 m-85 -114.92 142.24 46.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.29 1.836 . . . . 0.0 108.322 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.42 ' CG2' HD11 ' A' ' 85' ' ' LEU . 3.9 mt -74.02 136.12 25.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 O-C-N 121.999 -0.438 . . . . 0.0 110.511 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.29 141.2 30.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.218 0.532 . . . . 0.0 110.358 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.1 t -93.15 -13.44 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 126.557 1.943 . . . . 0.0 109.254 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.2 m 52.89 37.38 24.15 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.437 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 16.2 m -73.37 -2.01 20.49 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -74.08 -85.01 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 O-C-N 120.331 -1.481 . . . . 0.0 112.049 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -99.06 -22.52 13.04 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.659 1.123 . . . . 0.0 113.935 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 115.59 54.31 0.37 Allowed Glycine 0 CA--C 1.522 0.509 0 CA-C-N 118.543 1.171 . . . . 0.0 111.271 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.7 m -82.04 164.64 47.45 Favored Pre-proline 0 C--O 1.236 0.37 0 CA-C-N 117.715 0.757 . . . . 0.0 109.763 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 58.1 Cg_endo -68.93 171.59 13.29 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 N-CA-C 107.193 -1.887 . . . . 0.0 107.193 176.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.568 HD12 HD13 ' A' ' 30' ' ' LEU . 15.2 mt -96.0 109.12 21.56 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.073 0.949 . . . . 0.0 109.47 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.24 178.21 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.711 1.605 . . . . 0.0 110.678 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.79 169.93 10.3 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.0 t -162.06 149.88 14.53 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.109 1.364 . . . . 0.0 109.221 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -92.6 -40.38 10.8 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.894 0.878 . . . . 0.0 110.059 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 N--CA 1.444 -0.747 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -177.766 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 33.9 m120 . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 119.687 -0.197 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.6 p -61.37 99.22 0.1 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.584 1.554 . . . . 0.0 112.085 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.3 p -88.13 -35.12 17.62 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 121.405 1.911 . . . . 0.0 109.355 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -78.35 101.12 7.05 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 126.102 1.761 . . . . 0.0 111.971 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -167.77 177.57 5.71 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.132 0.878 . . . . 0.0 111.888 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.6 -160.98 30.01 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.8 tp -141.62 153.42 44.74 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.52 29.73 6.29 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.874 1.67 . . . . 0.0 109.355 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -65.9 142.68 57.82 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.5 mt -127.49 158.15 38.18 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.624 1.569 . . . . 0.0 110.345 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 27.8 p90 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 115.767 -2.063 . . . . 0.0 108.612 179.911 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.224 -0.285 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.64 135.63 26.5 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.462 2.108 . . . . 0.0 109.271 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.405 HE21 ' HB3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -124.36 120.49 32.28 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.69 0.796 . . . . 0.0 108.985 178.436 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.01 137.0 52.51 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.314 0.646 . . . . 0.0 111.299 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.29 -125.21 0.76 Allowed Glycine 0 C--N 1.335 0.505 0 O-C-N 121.188 -0.945 . . . . 0.0 113.735 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 p -152.0 -170.22 3.58 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.991 1.395 . . . . 0.0 112.59 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.21 6.76 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 125.864 1.666 . . . . 0.0 110.952 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -59.3 -50.55 73.56 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 120.549 -1.344 . . . . 0.0 110.759 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -47.1 -0.17 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 1 C-N-CA 132.139 4.176 . . . . 0.0 118.554 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mt -85.51 -60.56 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 C-N-CA 127.86 2.464 . . . . 0.0 110.492 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.05 23.31 2.05 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.392 0.677 . . . . 0.0 110.138 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 72.26 12.14 5.81 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.46 2.704 . . . . 0.0 113.992 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.76 95.09 7.16 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 127.272 2.229 . . . . 0.0 113.086 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.8 t -79.39 159.49 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -107.44 142.79 36.73 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.0 t -138.14 119.16 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 123.851 0.861 . . . . 0.0 110.374 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 tp -75.47 108.08 8.03 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.591 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 37.6 tt0 -94.96 -175.42 3.54 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.591 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 3.1 t0 -46.11 90.01 0.0 OUTLIER 'General case' 0 C--O 1.234 0.243 0 C-N-CA 129.952 3.301 . . . . 0.0 109.585 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 46.46 32.92 1.74 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.841 1.656 . . . . 0.0 110.502 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.0 m -152.49 135.38 15.53 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.825 HD11 HD11 ' A' ' 67' ' ' LEU . 1.5 mt -96.14 137.74 34.78 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 120.897 -1.127 . . . . 0.0 108.326 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.4 pt -136.49 151.44 28.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.805 0.842 . . . . 0.0 111.616 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.98 139.51 31.26 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.461 0.704 . . . . 0.0 110.225 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.9 m -123.72 108.81 30.64 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.9 -81.03 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.198 1.932 . . . . 0.0 110.871 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.13 6.65 16.41 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.631 1.573 . . . . 0.0 112.46 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -52.04 120.26 5.2 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -58.39 -31.24 67.48 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.089 0.956 . . . . 0.0 111.626 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.86 67.75 6.21 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -118.48 164.54 15.11 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.626 1.17 . . . . 0.0 108.899 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 t -141.63 135.42 14.72 Favored Pre-proline 0 N--CA 1.446 -0.636 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.81 134.78 24.45 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.544 2.829 . . . . 0.0 109.58 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.8 m -128.41 159.83 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 122.696 1.236 . . . . 0.0 108.413 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.15 158.29 23.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 113.139 -1.846 . . . . 0.0 107.64 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.0 mm -123.77 153.02 29.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.61 125.38 23.97 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.6 tt -123.45 141.33 52.11 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.653 1.181 . . . . 0.0 110.264 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.4 mt -149.93 152.9 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 126.253 1.821 . . . . 0.0 108.278 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.4 p -103.37 134.44 46.74 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.667 1.587 . . . . 0.0 109.389 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.9 m -54.53 109.34 0.49 Allowed 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.953 1.701 . . . . 0.0 114.126 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -75.95 -24.82 55.48 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 117.8 -1.095 . . . . 0.0 111.316 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -98.09 49.66 1.01 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-N 119.777 1.171 . . . . 0.0 110.366 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 m -73.79 -1.79 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.099 -1.001 . . . . 0.0 112.115 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -62.99 -0.91 0.77 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.549 1.94 . . . . 0.0 112.842 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 t -132.87 -1.27 3.36 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.859 1.664 . . . . 0.0 110.913 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.28 163.4 13.41 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.745 1.259 . . . . 0.0 109.565 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -82.05 152.4 26.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.654 -1.612 . . . . 0.0 107.641 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -118.83 -29.81 5.24 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.334 1.054 . . . . 0.0 111.095 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -67.85 -38.56 83.3 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.136 1.774 . . . . 0.0 112.312 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -68.1 -25.89 65.54 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.559 1.144 . . . . 0.0 112.84 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.99 -167.65 32.26 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -102.34 97.62 9.06 Favored Pre-proline 0 N--CA 1.466 0.346 0 CA-C-O 117.554 -1.213 . . . . 0.0 109.799 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.71 122.53 9.22 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.204 2.602 . . . . 0.0 109.851 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.13 -177.45 2.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 124.612 1.165 . . . . 0.0 109.821 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.565 ' CE1' HD12 ' A' ' 95' ' ' LEU . 2.6 t80 -139.78 140.31 36.65 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 122.285 1.041 . . . . 0.0 109.51 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tt -149.01 150.37 32.7 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.716 1.206 . . . . 0.0 110.034 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.78 -171.77 21.89 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.446 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.825 HD11 HD11 ' A' ' 30' ' ' LEU . 18.5 mt -93.74 146.02 24.15 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -110.05 113.45 26.17 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.26 -43.84 0.51 Allowed Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.514 -1.159 . . . . 0.0 113.861 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.33 24.8 4.15 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.572 1.686 . . . . 0.0 114.659 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 m120 60.04 63.87 1.36 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.219 0.918 . . . . 0.0 111.592 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.601 HD13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -145.28 132.65 20.66 Favored 'General case' 0 CA--C 1.51 -0.569 0 O-C-N 120.336 -1.478 . . . . 0.0 110.405 -178.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.562 ' SG ' HG23 ' A' ' 92' ' ' ILE . 8.5 m -136.93 172.74 12.57 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.463 0.705 . . . . 0.0 112.071 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.565 HD23 HD21 ' A' ' 87' ' ' LEU . 13.9 mt -62.13 154.29 27.57 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.913 0.885 . . . . 0.0 111.699 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.556 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 3.2 tmm? -164.41 151.12 11.19 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 24.0 m -112.0 122.75 48.63 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.134 0.574 . . . . 0.0 109.608 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.25 151.26 50.43 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.226 1.01 . . . . 0.0 109.522 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.1 tttt -86.88 124.87 33.58 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.4 p -80.24 -17.19 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.48 -63.77 0.33 Allowed Glycine 0 CA--C 1.548 2.094 1 C-N-CA 133.252 5.215 . . . . 0.0 108.407 -177.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -103.34 -27.19 12.6 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 119.722 3.231 . . . . 0.0 119.722 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -133.48 155.91 80.19 Favored Pre-proline 0 CA--C 1.566 1.586 0 C-N-CA 130.001 3.32 . . . . 0.0 115.754 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -74.3 144.37 32.88 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.793 1.662 . . . . 0.0 108.971 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.9 p -140.84 169.62 17.29 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.271 1.428 . . . . 0.0 109.549 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.895 HD11 HG23 ' A' ' 128' ' ' ILE . 10.2 mt -90.71 150.22 21.73 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.27 75.69 1.52 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.765 1.226 . . . . 0.0 110.923 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.565 HD21 HD23 ' A' ' 74' ' ' LEU . 1.0 OUTLIER -94.65 116.0 28.23 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.13 -13.81 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -158.6 97.51 1.46 Allowed 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 117.67 -1.157 . . . . 0.0 109.607 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.556 ' HE3' ' HB2' ' A' ' 75' ' ' MET . 0.3 OUTLIER -171.21 149.16 2.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 121.393 1.906 . . . . 0.0 109.655 -179.214 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -129.07 114.55 16.51 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.172 0.989 . . . . 0.0 108.847 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.562 HG23 ' SG ' ' A' ' 73' ' ' CYS . 7.8 pt -62.06 -42.58 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 120.659 -1.275 . . . . 0.0 112.871 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.3 tpt -69.17 -16.28 63.6 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.108 1.363 . . . . 0.0 112.253 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -79.4 -52.04 8.6 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.277 0.944 . . . . 0.0 108.936 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.565 HD12 ' CE1' ' A' ' 64' ' ' TYR . 35.1 mt -65.96 -21.05 66.4 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.62 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -90.81 -34.33 15.35 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -63.41 -36.76 84.79 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.452 1.478 . . . . 0.0 109.423 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.68 156.02 43.07 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.067 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.52 59.54 5.56 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 123.745 2.963 . . . . 0.0 111.197 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -128.14 64.61 66.94 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.846 1.258 . . . . 0.0 112.128 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.4 95.4 0.86 Allowed 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 124.942 3.761 . . . . 0.0 109.849 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.435 HG11 ' CZ ' ' A' ' 105' ' ' PHE . 47.1 t -84.78 106.36 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 O-C-N 120.983 -1.073 . . . . 0.0 109.7 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -51.52 -29.89 18.39 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.603 1.561 . . . . 0.0 113.269 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.4 m -67.32 -10.67 53.18 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.435 ' CZ ' HG11 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -120.52 -17.86 7.98 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.619 0.768 . . . . 0.0 110.12 178.59 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.6 mt -79.68 154.08 28.87 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.428 1.091 . . . . 0.0 110.397 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -140.36 133.82 30.0 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 123.248 0.619 . . . . 0.0 110.851 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -76.07 122.6 24.49 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -75.89 103.49 5.99 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.6 t -100.59 178.14 4.81 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.2 156.71 42.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.415 0.686 . . . . 0.0 111.523 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.6 p -132.27 42.13 3.15 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.14 0.976 . . . . 0.0 113.06 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.67 -55.18 2.32 Favored Glycine 0 C--N 1.333 0.396 0 O-C-N 120.215 -1.553 . . . . 0.0 113.435 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -131.19 2.13 4.25 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.644 1.222 . . . . 0.0 112.071 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -134.08 173.49 11.53 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.065 0.546 . . . . 0.0 111.237 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.8 m -116.89 153.87 31.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.846 1.658 . . . . 0.0 109.627 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.01 168.29 19.07 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -138.77 112.56 8.41 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -105.45 117.88 35.14 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 126.901 2.08 . . . . 0.0 109.651 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.9 t -51.16 122.15 7.24 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.293 0.637 . . . . 0.0 111.761 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.1 t -65.1 -45.57 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 O-C-N 121.739 -0.601 . . . . 0.0 110.34 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.23 -38.43 85.22 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.764 -0.585 . . . . 0.0 112.376 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -124.18 80.63 58.44 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.583 0.753 . . . . 0.0 108.992 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -66.94 143.4 66.1 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.55 3.5 . . . . 0.0 110.87 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.81 -22.43 14.62 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 128.449 2.928 . . . . 0.0 113.067 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -99.24 131.96 44.9 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.951 1.7 . . . . 0.0 111.585 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -111.51 142.15 44.16 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.434 1.094 . . . . 0.0 110.597 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.895 HG23 HD11 ' A' ' 85' ' ' LEU . 6.3 mt -73.67 133.87 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -103.23 147.94 26.43 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 6.5 m -91.83 -17.12 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.356 1.462 . . . . 0.0 114.591 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.45 90.56 0.07 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.325 1.85 . . . . 0.0 107.209 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . 0.259 0.0 OUTLIER -107.8 7.87 28.47 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.416 -0.802 . . . . 0.0 111.933 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -135.5 143.41 45.8 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.325 1.05 . . . . 0.0 109.837 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.97 -58.26 0.06 OUTLIER Glycine 0 CA--C 1.531 1.066 0 C-N-CA 127.073 2.273 . . . . 0.0 115.848 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 132.73 45.64 0.13 Allowed Glycine 0 CA--C 1.523 0.555 0 C-N-CA 129.093 3.235 . . . . 0.0 107.352 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 83.4 m -71.91 162.43 73.4 Favored Pre-proline 0 C--O 1.24 0.576 0 CA-C-N 118.064 0.932 . . . . 0.0 110.474 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.26 162.25 28.47 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 120.766 0.977 . . . . 0.0 111.598 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.4 mt -77.88 114.96 17.25 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.701 1.201 . . . . 0.0 109.031 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pp -146.24 176.26 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 123.161 0.584 . . . . 0.0 109.75 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 20.7 mt -101.35 150.01 23.45 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.543 0.737 . . . . 0.0 109.26 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.1 t -144.52 131.68 20.58 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -82.3 -24.73 34.5 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 122.235 -0.291 . . . . 0.0 111.197 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 C--O 1.234 0.237 0 C-N-CA 125.104 1.362 . . . . 0.0 107.345 -178.993 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.0 m120 . . . . . 0 C--O 1.223 -0.311 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.451 HG21 ' CE2' ' A' ' 152' ' ' PHE . 0.8 OUTLIER -61.39 128.54 36.83 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.66 1.184 . . . . 0.0 109.906 -178.744 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.6 p -114.71 -22.57 9.64 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.168 1.387 . . . . 0.0 112.922 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -118.45 129.06 55.18 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.304 0.641 . . . . 0.0 112.07 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.451 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.7 OUTLIER -170.55 -176.47 2.13 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.462 1.905 . . . . 0.0 109.553 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.42 -159.75 31.07 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.7 tp -147.54 166.22 27.98 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.5 m -128.63 49.85 2.16 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.065 1.346 . . . . 0.0 107.921 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -75.21 141.2 43.61 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 22.8 mt -108.53 167.47 10.02 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.512 1.125 . . . . 0.0 108.05 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 31.3 p90 . . . . . 0 C--O 1.251 1.171 0 C-N-CA 126.911 2.084 . . . . 0.0 106.74 -179.564 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.02 149.01 71.12 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 N-CA-C 107.061 -1.938 . . . . 0.0 107.061 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.47 115.77 19.39 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -106.77 149.1 27.68 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.371 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.08 -137.41 2.9 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 120.045 1.293 . . . . 0.0 109.98 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.7 p -144.84 -168.33 2.89 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 119.15 1.475 . . . . 0.0 111.214 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.7 mt -142.51 -7.03 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 126.903 2.081 . . . . 0.0 107.753 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -45.61 -42.79 11.67 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 127.0 2.12 . . . . 0.0 112.283 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -55.57 -24.13 30.88 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.0 mm -54.65 -68.84 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 123.729 0.811 . . . . 0.0 112.149 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.52 29.64 3.89 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 123.718 0.637 . . . . 0.0 112.366 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.1 m80 61.8 47.86 5.85 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 -122.94 100.28 6.81 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.1 t -85.78 154.53 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -120.23 131.16 54.84 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.39 144.88 35.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 tp -78.14 102.04 7.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -120.48 133.95 55.34 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 t0 45.48 53.41 8.38 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.008 1.323 . . . . 0.0 112.373 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 52.59 29.05 6.72 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.7 m -143.17 159.79 41.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.021 1.728 . . . . 0.0 107.391 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.647 HD12 HD22 ' A' ' 87' ' ' LEU . 8.1 mt -96.49 125.48 41.01 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 119.666 -1.896 . . . . 0.0 106.325 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 1.2 mt -126.84 130.8 71.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 123.604 0.565 . . . . 0.0 110.731 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.98 135.8 49.78 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 m -126.56 74.21 74.42 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 123.839 0.855 . . . . 0.0 110.643 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.23 -43.15 15.48 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.7 2.267 . . . . 0.0 111.387 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -146.51 71.41 1.24 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.544 1.138 . . . . 0.0 108.91 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -120.84 124.22 44.5 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 102.035 -3.32 . . . . 0.0 102.035 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.52 -14.34 19.11 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.95 1.3 . . . . 0.0 113.312 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -113.87 30.43 7.26 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.658 1.183 . . . . 0.0 111.461 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -74.47 161.49 29.74 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.4 t -153.1 142.85 15.05 Favored Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.59 142.38 58.6 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.657 2.238 . . . . 0.0 108.767 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 t -143.61 136.23 24.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 105.915 -1.884 . . . . 0.0 105.915 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.75 162.46 16.22 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.966 0.906 . . . . 0.0 109.845 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 12' ' ' GLN . 7.2 mm -130.4 121.99 52.26 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 C-N-CA 127.525 2.33 . . . . 0.0 108.748 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.06 129.98 46.17 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 120.69 1.587 . . . . 0.0 108.461 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.2 tt -122.48 132.24 54.24 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.132 1.773 . . . . 0.0 107.546 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.535 HD13 HG21 ' A' ' 92' ' ' ILE . 3.5 mp -144.09 141.92 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 124.669 1.187 . . . . 0.0 108.826 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 p -79.34 138.59 37.75 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.601 ' SG ' HD22 ' A' ' 106' ' ' LEU . 58.8 m -60.11 124.06 19.08 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.419 ' HD3' ' O ' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -97.23 -0.08 47.34 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -128.32 49.91 2.13 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.964 1.305 . . . . 0.0 110.272 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.659 ' HA ' HD23 ' A' ' 55' ' ' LEU . 27.4 m -72.88 6.57 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.684 1.194 . . . . 0.0 113.794 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -49.49 -32.42 12.08 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 128.051 2.54 . . . . 0.0 116.149 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.1 t -125.63 25.44 6.96 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.903 0.881 . . . . 0.0 110.607 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 101' ' ' PRO . 2.4 mm? -116.2 155.77 27.71 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 121.183 -0.948 . . . . 0.0 108.917 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.98 152.15 46.31 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 mttm -124.99 -31.22 3.15 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.911 0.485 . . . . 0.0 110.644 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.45 -34.09 76.99 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.182 0.993 . . . . 0.0 112.118 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -64.24 -36.1 82.97 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.438 ' HA3' ' CD1' ' A' ' 108' ' ' TYR . . . 147.47 171.49 16.63 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 127.016 2.246 . . . . 0.0 110.755 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.51 116.38 30.84 Favored Pre-proline 0 C--O 1.238 0.484 0 O-C-N 121.463 -1.022 . . . . 0.0 109.372 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.72 136.15 18.65 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 N-CA-C 106.653 -2.095 . . . . 0.0 106.653 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.258 14.0 pt -137.74 170.69 16.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -131.41 147.98 52.61 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.769 0.795 . . . . 0.0 111.202 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 tt -148.26 157.14 43.31 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.344 1.058 . . . . 0.0 110.763 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.6 -173.61 30.46 Favored Glycine 0 C--O 1.226 -0.398 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.584 HD21 HD11 ' A' ' 30' ' ' LEU . 5.4 mt -97.67 162.17 13.41 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.357 1.063 . . . . 0.0 110.441 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -132.09 84.08 2.13 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.234 -0.916 . . . . 0.0 108.765 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -158.44 -30.37 0.02 OUTLIER Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.795 -1.003 . . . . 0.0 113.013 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.15 19.45 0.57 Allowed 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.6 m120 68.16 68.41 0.33 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.943 1.697 . . . . 0.0 109.076 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.91 136.03 30.05 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.906 1.282 . . . . 0.0 109.89 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 32.2 m -142.09 175.1 10.0 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.773 0.715 . . . . 0.0 111.044 177.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.467 HD23 ' CD2' ' A' ' 87' ' ' LEU . 16.0 mt -58.75 149.95 24.98 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.899 0.772 . . . . 0.0 109.994 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.7 ttp -159.25 123.42 3.91 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 84.0 m -97.2 125.36 41.68 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 120.144 1.338 . . . . 0.0 109.079 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.81 146.29 31.11 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.08 0.952 . . . . 0.0 109.291 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -77.87 131.39 37.5 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 p -80.91 7.0 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.0 0.52 . . . . 0.0 111.508 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.82 10.35 49.96 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -148.03 -57.2 0.23 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.474 1.51 . . . . 0.0 109.772 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -140.3 162.44 49.74 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.065 1.746 . . . . 0.0 110.877 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.89 149.58 72.48 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.862 1.708 . . . . 0.0 110.521 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.9 p -147.3 166.06 28.23 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.91 1.684 . . . . 0.0 107.201 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.3 mt -92.57 148.14 22.32 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -138.97 64.87 1.46 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.647 HD22 HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -81.86 102.77 11.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.18 -39.44 0.07 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.143 0.977 . . . . 0.0 113.022 -178.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -145.1 104.69 3.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.755 1.622 . . . . 0.0 109.407 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.45 ' HE2' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -177.22 158.57 1.5 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 178.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.45 ' N ' ' HE2' ' A' ' 90' ' ' LYS . 1.4 m-20 -135.15 131.74 37.18 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.709 1.604 . . . . 0.0 109.687 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.535 HG21 HD13 ' A' ' 47' ' ' ILE . 1.6 mt -83.11 -37.18 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 118.175 0.443 . . . . 0.0 109.96 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.8 -25.26 66.44 Favored 'General case' 0 CA--C 1.524 -0.034 0 CA-C-O 117.982 -1.009 . . . . 0.0 112.565 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -72.0 -42.77 66.03 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 93.0 mt -62.87 -33.12 74.61 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.512 1.125 . . . . 0.0 108.378 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.419 ' O ' ' HD3' ' A' ' 50' ' ' ARG . 1.2 t80 -75.8 -35.39 60.08 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -65.52 -46.0 81.32 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.202 -0.936 . . . . 0.0 110.767 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -125.31 152.16 70.79 Favored Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.85 83.35 1.39 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 123.621 2.881 . . . . 0.0 110.395 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -132.26 69.09 80.33 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.727 ' HB2' HD21 ' A' ' 55' ' ' LEU . 97.9 Cg_endo -74.1 76.5 3.0 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.277 3.318 . . . . 0.0 107.833 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.4 t -83.09 102.14 8.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -177.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -49.99 -28.49 6.98 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.847 0.859 . . . . 0.0 112.023 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.7 m -63.8 -12.51 36.33 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -122.45 1.64 9.58 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.345 1.058 . . . . 0.0 109.98 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.601 HD22 ' SG ' ' A' ' 49' ' ' CYS . 16.3 mt -100.46 145.77 27.85 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -142.62 123.36 14.23 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.774 0.83 . . . . 0.0 109.454 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.438 ' CD1' ' HA3' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -67.7 124.96 24.73 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 127.765 2.426 . . . . 0.0 106.252 178.785 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -109.15 147.23 32.82 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.655 0.74 . . . . 0.0 110.052 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 t -138.64 172.14 13.32 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.12 1.768 . . . . 0.0 107.27 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.31 129.0 7.0 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.453 1.501 . . . . 0.0 109.508 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.0 p -141.94 79.54 1.68 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.05 58.85 1.54 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 124.02 0.819 . . . . 0.0 111.585 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 65.66 4.36 2.82 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.797 2.039 . . . . 0.0 112.694 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -112.86 127.92 56.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.4 m -108.68 155.54 20.6 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.197 1.399 . . . . 0.0 109.863 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 p -131.27 165.62 23.0 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.304 1.442 . . . . 0.0 111.661 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -142.65 110.31 5.81 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.607 1.163 . . . . 0.0 111.236 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -108.36 123.07 48.27 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.981 1.312 . . . . 0.0 109.462 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 59.6 m -53.64 125.71 19.2 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.747 1.219 . . . . 0.0 110.228 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.7 t -70.32 -41.3 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 O-C-N 121.175 -0.953 . . . . 0.0 111.623 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.47 -40.64 83.24 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.305 1.042 . . . . 0.0 112.242 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -136.3 90.61 17.63 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -65.9 165.07 24.84 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.025 1.817 . . . . 0.0 109.124 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.3 -18.58 56.62 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -100.85 121.08 41.1 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 118.628 1.214 . . . . 0.0 108.441 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -105.8 144.22 32.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 24.7 mt -71.42 142.47 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.26 113.79 27.53 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.577 0.703 . . . . 0.0 109.781 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.56 -10.71 14.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 C-N-CA 127.617 2.367 . . . . 0.0 112.482 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.5 m 46.02 84.31 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 118.394 2.739 . . . . 0.0 118.394 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.574 ' HB2' HG21 ' A' ' 149' ' ' THR . 47.8 m -110.6 5.57 21.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -79.75 -93.78 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 O-C-N 121.067 -1.021 . . . . 0.0 112.437 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -99.64 4.78 58.15 Favored Glycine 0 C--N 1.342 0.91 0 C-N-CA 125.652 1.596 . . . . 0.0 116.575 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.31 49.23 2.44 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 18.1 m -80.29 161.99 63.04 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 124.231 1.013 . . . . 0.0 110.472 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 98.5 Cg_endo -73.83 155.33 48.71 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.192 1.261 . . . . 0.0 109.475 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.409 HD12 HD13 ' A' ' 30' ' ' LEU . 12.6 mt -84.72 122.41 29.06 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.241 1.016 . . . . 0.0 109.208 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.0 -168.99 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.32 1.448 . . . . 0.0 110.848 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.5 mt -103.44 153.72 20.2 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.411 1.484 . . . . 0.0 107.181 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.0 t -145.8 120.49 9.84 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.75 1.262 . . . . 0.0 108.796 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -78.76 -30.83 45.92 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.166 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 . . . . . 0 CA--C 1.534 0.327 0 CA-C-O 122.028 0.918 . . . . 0.0 112.217 -178.383 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.574 HG21 ' HB2' ' A' ' 132' ' ' SER 0.294 75.4 p 113.93 93.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 1 C-N-CA 135.132 5.373 . . . . 0.0 112.643 178.678 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 p -104.6 -29.54 10.56 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.284 1.033 . . . . 0.0 110.686 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -117.72 123.66 46.6 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 127.882 2.473 . . . . 0.0 110.947 -177.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -171.56 -175.62 1.63 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.503 2.321 . . . . 0.0 110.08 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -101.53 -176.89 28.58 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.505 1.05 . . . . 0.0 113.687 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.16 132.03 41.12 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.5 m -88.52 58.38 4.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 18.9 ptp -69.31 162.17 27.78 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.249 0.62 . . . . 0.0 109.518 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.1 mt -142.36 175.25 9.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.102 2.161 . . . . 0.0 106.762 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 53.0 p90 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 124.582 1.153 . . . . 0.0 110.727 179.819 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HB3' HD11 ' A' ' 47' ' ' ILE . 86.6 Cg_endo -73.33 127.96 12.39 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.166 2.578 . . . . 0.0 110.093 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.36 111.21 23.56 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 123.782 0.676 . . . . 0.0 111.35 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -104.5 148.01 26.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.779 0.832 . . . . 0.0 110.618 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.46 -139.64 4.18 Favored Glycine 0 C--O 1.226 -0.396 0 O-C-N 121.255 -0.903 . . . . 0.0 111.226 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.2 p -152.33 -174.55 4.93 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 119.029 1.414 . . . . 0.0 113.684 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.67 5.28 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 125.319 1.448 . . . . 0.0 108.371 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -63.17 -38.63 91.93 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 119.923 -1.736 . . . . 0.0 109.293 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -51.5 -19.79 1.59 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 128.085 2.554 . . . . 0.0 114.086 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.2 mt -69.41 -67.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.811 1.644 . . . . 0.0 111.473 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -133.12 25.71 4.22 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.857 -0.527 . . . . 0.0 111.252 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.252 52.4 t-80 57.62 41.09 26.12 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.514 2.726 . . . . 0.0 108.633 -177.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.28 109.86 20.47 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.947 -1.095 . . . . 0.0 110.981 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.4 t -91.86 158.42 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.636 ' O ' HG21 ' A' ' 42' ' ' VAL . 2.7 m95 -115.84 106.86 14.31 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.303 1.041 . . . . 0.0 110.325 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.7 t -104.37 122.85 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 120.099 1.318 . . . . 0.0 108.578 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 30' ' ' LEU . 34.8 tp -73.33 95.72 2.21 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 124.141 0.9 . . . . 0.0 108.626 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.99 174.79 8.85 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -8.89 -65.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 129.063 2.945 . . . . 0.0 114.935 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -142.05 18.24 2.11 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-O 117.691 -1.147 . . . . 0.0 109.279 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.65 134.71 14.87 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.685 1.129 . . . . 0.0 112.546 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.575 HD21 HD11 ' A' ' 67' ' ' LEU . 1.5 mp -85.64 137.08 33.09 Favored 'General case' 0 CA--C 1.504 -0.795 0 O-C-N 121.514 -0.741 . . . . 0.0 109.27 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mm -131.39 140.51 48.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 O-C-N 124.094 0.871 . . . . 0.0 109.927 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.86 130.27 40.64 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -117.36 82.27 14.72 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 124.339 1.056 . . . . 0.0 108.738 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.25 -33.1 15.35 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.014 1.809 . . . . 0.0 113.778 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.8 ttm-85 -162.02 51.42 0.21 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.12 152.23 19.0 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 124.956 1.302 . . . . 0.0 107.622 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -61.36 1.8 Allowed 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 122.617 0.367 . . . . 0.0 110.473 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.8 ttm-85 -72.8 27.52 0.06 Allowed 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.696 1.198 . . . . 0.0 112.229 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -68.02 149.51 49.61 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.1 t -140.15 138.17 18.98 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -67.64 155.21 71.02 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 N-CA-C 108.055 -1.556 . . . . 0.0 108.055 178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.636 HG21 ' O ' ' A' ' 23' ' ' TRP . 4.7 m -146.38 155.32 12.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.91 158.76 20.68 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -125.69 116.28 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 125.507 1.523 . . . . 0.0 107.756 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.07 127.67 42.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.544 HD12 HD12 ' A' ' 65' ' ' LEU . 6.8 tt -125.25 145.64 49.9 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.388 1.075 . . . . 0.0 108.649 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.513 HD12 HG12 ' A' ' 92' ' ' ILE . 39.3 mt -148.03 154.22 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.662 1.985 . . . . 0.0 108.828 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.1 p -109.42 115.52 30.11 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.7 m -47.35 143.87 3.2 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.186 1.395 . . . . 0.0 111.915 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -103.99 -26.87 12.46 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 118.096 -0.954 . . . . 0.0 112.992 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -94.68 38.27 1.11 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.2 m -63.46 -17.18 19.45 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 O-C-N 120.597 -1.315 . . . . 0.0 111.293 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -42.8 -44.07 4.27 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 120.704 1.593 . . . . 0.0 114.203 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.7 t -78.5 -14.14 59.5 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.6 mt -88.22 -173.39 4.2 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 120.444 -1.41 . . . . 0.0 109.267 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.43 158.13 16.21 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.822 0.849 . . . . 0.0 109.485 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -124.78 -35.61 2.68 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.034 2.533 . . . . 0.0 111.085 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.81 -42.68 79.97 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.642 1.177 . . . . 0.0 109.35 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -62.6 -36.39 82.6 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.874 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 139.54 -171.09 23.91 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -79.08 114.78 47.38 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.91 135.2 8.69 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.619 2.879 . . . . 0.0 108.557 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.3 pt -138.26 178.28 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 121.372 -0.83 . . . . 0.0 110.616 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.529 ' CE1' HD12 ' A' ' 95' ' ' LEU . 3.0 t80 -134.44 154.97 51.11 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.198 0.908 . . . . 0.0 112.345 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.544 HD12 HD12 ' A' ' 46' ' ' LEU . 3.7 tt -156.91 163.48 39.11 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.237 1.015 . . . . 0.0 110.05 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.15 -174.43 36.98 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.825 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.737 HD21 HD22 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -100.42 135.46 41.82 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 126.105 1.762 . . . . 0.0 106.718 179.761 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -114.81 121.41 43.2 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.39 -39.68 0.26 Allowed Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.4 31.35 1.71 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.371 1.069 . . . . 0.0 113.783 -178.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.1 m120 58.17 75.15 0.4 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.808 1.243 . . . . 0.0 112.476 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.33 140.78 27.97 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 121.297 -0.877 . . . . 0.0 110.307 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.8 m -147.96 174.49 11.84 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.254 -1.529 . . . . 0.0 111.024 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.421 ' HA ' ' HG ' ' A' ' 87' ' ' LEU . 5.3 mt -57.68 144.3 38.37 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -155.59 124.03 5.92 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 52.1 m -91.88 121.37 33.42 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.826 0.739 . . . . 0.0 110.409 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.37 168.52 19.6 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.252 0.478 . . . . 0.0 110.154 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -98.52 147.11 25.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.3 -2.56 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.556 0.743 . . . . 0.0 111.003 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.4 81.88 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.2 t70 66.56 9.62 6.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.429 1.891 . . . . 0.0 114.49 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.14 143.03 17.61 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.43 156.95 63.84 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 124.171 3.248 . . . . 0.0 113.87 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.3 p -158.47 164.76 35.89 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.017 1.727 . . . . 0.0 108.972 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.533 HD11 HG23 ' A' ' 128' ' ' ILE . 3.8 mt -95.18 138.12 33.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -129.43 67.16 1.44 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.368 1.067 . . . . 0.0 109.995 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.737 HD22 HD21 ' A' ' 67' ' ' LEU . 2.9 mp -81.97 105.57 13.19 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.59 -39.31 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -136.39 94.18 2.98 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 119.19 0.904 . . . . 0.0 111.653 -177.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.599 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -164.61 175.26 9.96 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 121.178 -0.951 . . . . 0.0 110.968 179.592 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.489 ' H ' ' HD3' ' A' ' 90' ' ' LYS . 17.6 m-20 -140.5 143.03 35.24 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.24 1.416 . . . . 0.0 107.469 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.513 HG12 HD12 ' A' ' 47' ' ' ILE . 1.7 tt -104.77 -39.29 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 125.063 1.345 . . . . 0.0 110.863 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -30.94 71.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.884 0.474 . . . . 0.0 110.57 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -66.21 -52.78 44.59 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.529 HD12 ' CE1' ' A' ' 64' ' ' TYR . 32.4 mt -61.87 -29.24 70.06 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 123.776 0.83 . . . . 0.0 111.184 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -79.94 -28.49 39.7 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -78.36 -42.11 31.4 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.322 -0.862 . . . . 0.0 112.01 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -107.03 152.08 40.9 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 123.774 0.829 . . . . 0.0 110.31 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.97 57.89 4.0 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.172 3.248 . . . . 0.0 113.12 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -118.29 73.6 10.47 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.587 1.155 . . . . 0.0 110.507 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.39 86.29 1.71 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.998 2.465 . . . . 0.0 106.179 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 66.7 t -80.74 93.93 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.45 -19.5 1.43 Allowed 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.367 1.067 . . . . 0.0 113.167 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -20.14 65.27 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.471 1.508 . . . . 0.0 110.596 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -115.1 -25.34 8.14 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.639 0.776 . . . . 0.0 110.756 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.6 mt -74.21 159.56 32.35 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.905 1.282 . . . . 0.0 112.093 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.424 ' HA ' HG23 ' A' ' 121' ' ' VAL . 4.4 p90 -147.65 143.46 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.194 0.998 . . . . 0.0 110.309 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.99 126.4 32.49 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 126.139 1.776 . . . . 0.0 108.644 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -102.13 150.24 23.46 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.6 t -142.02 -157.07 0.74 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -159.53 152.0 21.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.401 1.48 . . . . 0.0 108.112 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.8 p -123.61 6.58 8.86 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.468 1.507 . . . . 0.0 112.538 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.97 -85.13 0.36 Allowed Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 104.896 -3.282 . . . . 0.0 104.896 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.481 ' HG3' HH11 ' A' ' 114' ' ' ARG . 13.8 mtt85 -94.9 -7.8 39.01 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -126.19 172.56 9.95 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 119.119 0.872 . . . . 0.0 109.533 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.6 m -135.99 130.66 33.94 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 126.964 2.106 . . . . 0.0 110.622 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.27 161.13 16.56 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.3 1.04 . . . . 0.0 108.475 178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -143.95 116.87 8.82 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -125.97 127.1 45.41 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.719 0.637 . . . . 0.0 110.06 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.6 m -51.23 131.67 28.1 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.305 1.042 . . . . 0.0 109.938 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.424 HG23 ' HA ' ' A' ' 107' ' ' PHE . 84.5 t -73.63 -53.6 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 O-C-N 122.225 -0.297 . . . . 0.0 110.915 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.55 74.54 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -124.4 80.71 59.79 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.63 160.01 48.21 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.868 2.378 . . . . 0.0 109.879 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.7 -20.79 48.12 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 126.399 1.952 . . . . 0.0 111.601 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -103.63 116.78 32.97 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 118.823 1.312 . . . . 0.0 110.467 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -90.11 157.02 17.96 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 125.045 1.338 . . . . 0.0 108.825 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.533 HG23 HD11 ' A' ' 85' ' ' LEU . 9.7 mm -86.06 129.03 38.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.21 117.01 30.47 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 119.321 0.964 . . . . 0.0 110.209 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.3 m -78.68 -25.66 13.51 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.304 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.2 m 67.39 55.36 0.66 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.537 1.535 . . . . 0.0 113.268 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 75.4 m -95.79 -2.91 46.7 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.334 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -68.06 -66.41 0.57 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.56 1.073 . . . . 0.0 111.353 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -124.17 -55.13 0.18 Allowed Glycine 0 C--N 1.333 0.388 0 CA-C-O 119.302 -0.721 . . . . 0.0 111.796 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.97 54.05 0.01 OUTLIER Glycine 0 CA--C 1.519 0.338 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' CYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 68.1 m -87.04 166.93 23.74 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 117.37 0.585 . . . . 0.0 110.697 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 136' ' ' CYS . 83.1 Cg_endo -74.13 168.49 24.67 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 N-CA-C 108.584 -1.352 . . . . 0.0 108.584 178.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' A' ' 23' ' ' TRP . 9.5 mt -87.0 111.26 20.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -146.33 -177.08 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.812 1.245 . . . . 0.0 110.987 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.7 mt -100.7 161.82 13.34 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -156.3 130.69 8.78 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -90.24 -38.22 13.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 119.603 -0.839 . . . . 0.0 108.764 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 . . . . . 0 CA--C 1.532 0.277 0 C-N-CA 126.034 1.734 . . . . 0.0 107.971 -178.724 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.463 0.201 0 CA-C-O 121.106 0.479 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.422 HG21 ' CE2' ' A' ' 152' ' ' PHE . 1.5 m -100.24 136.04 40.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.3 p -131.7 7.19 4.42 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.635 1.574 . . . . 0.0 112.267 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -144.4 112.19 6.22 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.1 OUTLIER -162.98 -175.79 4.55 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.898 1.226 . . . . 0.0 113.146 -179.586 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.34 -174.26 27.37 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.9 tp -141.04 146.7 37.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.5 m -100.6 48.24 0.91 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.815 1.246 . . . . 0.0 107.658 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.54 159.69 33.86 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.954 1.302 . . . . 0.0 108.493 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 8.9 mt -145.79 153.42 40.9 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.706 2.002 . . . . 0.0 108.496 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.337 0 CA-C-N 119.884 1.22 . . . . 0.0 112.653 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 117.459 -1.257 . . . . 0.0 109.186 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.26 140.55 24.87 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 N-CA-C 106.973 -1.972 . . . . 0.0 106.973 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.17 149.42 35.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -144.49 132.57 21.59 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.538 -1.351 . . . . 0.0 109.385 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.75 -122.1 0.59 Allowed Glycine 0 CA--C 1.518 0.28 0 CA-C-O 117.844 -1.531 . . . . 0.0 111.225 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.8 p -160.3 -168.78 2.27 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 120.725 2.263 . . . . 0.0 112.566 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.421 HD12 ' CH2' ' A' ' 23' ' ' TRP . 3.7 mt -145.22 4.52 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.32 1.448 . . . . 0.0 108.97 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.14 -25.13 63.32 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 119.806 -1.809 . . . . 0.0 111.077 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -75.27 46.15 0.32 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.557 1.543 . . . . 0.0 110.897 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mt -130.56 -61.95 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 126.293 1.837 . . . . 0.0 108.688 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.85 27.17 2.02 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.489 0.661 . . . . 0.0 110.646 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.35 11.06 4.29 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 128.88 2.872 . . . . 0.0 114.182 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.459 ' H ' ' HG3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -70.76 95.38 1.12 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.187 1.795 . . . . 0.0 109.43 -179.641 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.81 158.97 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 102.997 -2.964 . . . . 0.0 102.997 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.421 ' CH2' HD12 ' A' ' 15' ' ' ILE . 21.7 m0 -118.63 144.84 45.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 120.605 -1.309 . . . . 0.0 108.711 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.7 t -150.53 141.21 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.6 tp -75.77 119.05 19.24 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -133.06 123.2 25.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.7 t70 45.88 58.37 4.41 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.034 1.334 . . . . 0.0 112.845 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 54.23 23.9 4.59 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.021 1.329 . . . . 0.0 112.968 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.5 m -132.94 159.56 39.6 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.589 1.556 . . . . 0.0 107.607 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.716 HD11 HD11 ' A' ' 67' ' ' LEU . 7.2 mt -108.67 124.34 50.37 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 mm -127.14 141.96 44.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 O-C-N 123.87 0.731 . . . . 0.0 109.766 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.87 137.12 36.17 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.05 66.3 40.33 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.106 0.962 . . . . 0.0 108.439 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.46 -28.66 78.11 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 121.842 1.695 . . . . 0.0 112.193 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -149.54 95.61 2.37 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 125.003 1.321 . . . . 0.0 109.403 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.81 142.31 5.26 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.793 0.837 . . . . 0.0 109.55 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.52 -39.7 77.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 122.367 1.08 . . . . 0.0 108.945 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.8 tpp85 -79.4 62.67 3.8 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.494 1.518 . . . . 0.0 111.706 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.2 ptt? -126.39 168.57 14.0 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.802 1.241 . . . . 0.0 110.999 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 t -158.54 144.99 12.69 Favored Pre-proline 0 N--CA 1.452 -0.375 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.63 154.83 64.03 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 N-CA-C 107.891 -1.619 . . . . 0.0 107.891 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 23' ' ' TRP . 2.5 p -146.39 156.95 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.4 m -118.07 161.57 19.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.233 -1.348 . . . . 0.0 108.504 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.3 mm -130.32 110.73 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 C-N-CA 126.157 1.783 . . . . 0.0 111.065 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.431 ' HB3' HD12 ' A' ' 92' ' ' ILE . . . -88.87 138.59 31.27 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 176.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 tt -130.53 131.77 45.24 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.5 mt -147.32 143.29 20.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 124.862 2.267 . . . . 0.0 106.933 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.2 p -73.7 162.27 29.36 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.517 -1.674 . . . . 0.0 108.881 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.7 m -91.17 149.58 21.73 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -102.1 -23.73 14.03 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -106.49 56.32 0.66 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.1 m -75.12 -10.73 13.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 120.98 -1.075 . . . . 0.0 111.185 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -69.99 4.09 2.3 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 125.925 1.69 . . . . 0.0 114.596 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 t -129.88 13.6 5.81 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.954 0.902 . . . . 0.0 108.939 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 98.3 mt -119.97 169.3 10.3 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.789 1.236 . . . . 0.0 108.095 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.9 155.35 37.56 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.698 1.199 . . . . 0.0 109.024 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.55 -32.39 2.65 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.226 1.011 . . . . 0.0 111.66 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -64.69 -36.01 82.89 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.535 1.134 . . . . 0.0 110.082 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -65.64 -25.68 67.47 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.463 1.105 . . . . 0.0 112.472 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.532 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 135.52 -173.52 21.7 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -87.13 111.59 41.88 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 123.957 0.903 . . . . 0.0 112.569 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.3 138.44 11.1 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.374 2.049 . . . . 0.0 110.898 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.44 HG13 ' CE1' ' A' ' 107' ' ' PHE . 15.6 pt -145.21 -174.26 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 124.354 1.062 . . . . 0.0 109.402 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.642 ' CD1' HG23 ' A' ' 92' ' ' ILE . 3.7 t80 -139.44 165.37 27.4 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.044 1.338 . . . . 0.0 113.028 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.435 HD22 HD11 ' A' ' 74' ' ' LEU . 3.7 tt -163.07 159.23 22.99 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.297 1.439 . . . . 0.0 111.148 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.27 176.17 38.67 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.219 0.914 . . . . 0.0 112.1 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.716 HD11 HD11 ' A' ' 30' ' ' LEU . 4.5 mt -94.62 152.55 18.42 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.388 1.075 . . . . 0.0 109.285 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -116.85 120.41 38.4 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.38 -38.82 0.55 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.314 0.483 . . . . 0.0 112.812 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.74 31.5 1.17 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.373 1.087 . . . . 0.0 112.52 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.6 m120 50.24 79.5 0.08 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.573 1.949 . . . . 0.0 111.912 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.67 137.89 25.53 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.651 0.78 . . . . 0.0 110.141 -177.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 4.0 m -143.85 172.56 12.68 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 118.631 0.65 . . . . 0.0 110.861 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.445 HD23 HD21 ' A' ' 87' ' ' LEU . 17.7 mt -59.05 147.84 33.22 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.115 0.484 . . . . 0.0 111.501 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 mtp -157.6 139.87 14.49 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 92.3 m -115.06 115.47 26.86 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.61 -177.93 3.35 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.396 2.279 . . . . 0.0 107.118 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.4 ' HE3' ' C ' ' A' ' 81' ' ' ASP . 43.4 tttt -122.51 126.8 48.57 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.46 -25.06 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.44 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.58 -49.9 0.2 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.4 ' C ' ' HE3' ' A' ' 78' ' ' LYS . 30.7 t70 -130.04 -11.99 4.19 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.174 -1.192 . . . . 0.0 113.274 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -137.87 153.83 74.05 Favored Pre-proline 0 C--O 1.241 0.657 0 C-N-CA 123.881 0.872 . . . . 0.0 110.749 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -70.04 153.45 67.63 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.424 2.082 . . . . 0.0 108.325 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 p -149.22 158.49 44.22 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.747 HD11 HG22 ' A' ' 128' ' ' ILE . 2.3 mt -80.4 146.18 31.61 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -145.54 63.81 1.26 Allowed 'General case' 0 N--CA 1.461 0.078 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.672 ' H ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -86.33 108.51 18.47 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.64 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.92 -41.39 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.097 0.559 . . . . 0.0 111.732 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -134.45 101.69 5.07 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 126.111 1.764 . . . . 0.0 109.929 -176.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -174.25 166.89 4.12 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.1 -1.0 . . . . 0.0 109.345 179.01 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.404 ' H ' ' HD2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -141.3 135.98 31.12 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 178.495 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.642 HG23 ' CD1' ' A' ' 64' ' ' TYR . 3.7 mt -87.68 -43.08 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 125.388 1.475 . . . . 0.0 109.173 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.6 tpt -61.64 -23.4 66.03 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 119.11 -0.471 . . . . 0.0 110.113 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -64.95 -51.2 63.12 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.637 HD12 ' CD1' ' A' ' 64' ' ' TYR . 13.5 mt -60.9 -35.49 76.79 Favored 'General case' 0 N--CA 1.461 0.091 0 O-C-N 121.717 -0.614 . . . . 0.0 110.181 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -78.87 -17.06 56.23 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.392 -0.817 . . . . 0.0 110.638 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -89.73 -42.78 11.13 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 120.504 -1.372 . . . . 0.0 111.181 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -107.01 150.09 39.39 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.433 0.693 . . . . 0.0 111.714 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.6 46.74 1.5 Allowed 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.552 3.502 . . . . 0.0 113.695 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -112.9 75.71 2.03 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.163 0.985 . . . . 0.0 111.134 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.99 71.18 7.16 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.599 3.533 . . . . 0.0 108.932 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 73.8 t -71.01 104.43 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.375 0.67 . . . . 0.0 110.172 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -50.96 -28.67 10.34 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 125.372 1.469 . . . . 0.0 111.029 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m -63.11 -13.63 38.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.327 1.451 . . . . 0.0 112.417 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -121.67 -28.63 4.51 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.769 0.828 . . . . 0.0 109.594 177.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.49 160.89 31.93 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.687 1.195 . . . . 0.0 111.035 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.481 ' HA ' HG23 ' A' ' 121' ' ' VAL . 9.9 p90 -151.16 148.38 28.19 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.57 0.748 . . . . 0.0 111.813 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.532 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -90.1 110.52 21.52 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 128.718 2.807 . . . . 0.0 107.923 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -79.38 141.83 36.55 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.4 t -137.95 -174.3 3.75 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.692 0.797 . . . . 0.0 109.526 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -151.24 163.08 39.68 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.285 1.434 . . . . 0.0 109.533 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.8 p -137.8 14.44 2.91 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.725 1.21 . . . . 0.0 111.825 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.72 -102.46 0.69 Allowed Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 105.452 -3.059 . . . . 0.0 105.452 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.07 -3.9 58.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.136 0.968 . . . . 0.0 113.115 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -117.6 159.47 22.85 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.405 1.002 . . . . 0.0 108.894 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 m -122.36 137.58 54.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.284 1.833 . . . . 0.0 108.963 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.01 166.84 10.72 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.524 1.13 . . . . 0.0 109.372 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -147.13 118.08 7.68 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -115.83 132.18 56.72 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 125.115 1.366 . . . . 0.0 110.554 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 t -59.84 133.93 56.56 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.118 0.967 . . . . 0.0 109.219 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.481 HG23 ' HA ' ' A' ' 107' ' ' PHE . 49.1 t -72.76 -45.95 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 O-C-N 120.649 -1.282 . . . . 0.0 110.191 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.53 70.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.63 -0.669 . . . . 0.0 111.946 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.16 82.92 46.52 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.919 0.888 . . . . 0.0 110.65 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.37 144.18 55.23 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.876 1.717 . . . . 0.0 107.854 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.31 -11.22 43.55 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.705 1.621 . . . . 0.0 109.208 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 25.3 m-90 -113.62 115.53 28.06 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.209 1.404 . . . . 0.0 107.646 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -105.16 156.76 17.79 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 125.024 1.329 . . . . 0.0 110.14 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.747 HG22 HD11 ' A' ' 85' ' ' LEU . 4.4 pt -85.56 127.86 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.932 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.71 119.75 25.61 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.5 t -79.49 -21.04 12.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 127.238 2.215 . . . . 0.0 112.223 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.5 m 54.95 90.93 0.03 OUTLIER 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.966 2.106 . . . . 0.0 110.892 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.499 ' HB2' HG21 ' A' ' 149' ' ' THR . 1.4 m -135.58 43.67 2.59 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 126.174 1.79 . . . . 0.0 108.307 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -110.55 0.27 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.459 2.303 . . . . 0.0 107.036 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.32 7.46 80.64 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 117.744 1.857 . . . . 0.0 117.744 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.45 38.82 8.68 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 119.824 1.812 . . . . 0.0 112.164 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 93.6 m -77.14 163.59 64.03 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.93 1.292 . . . . 0.0 107.857 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.22 169.33 20.93 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.129 1.886 . . . . 0.0 110.5 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.3 mt -85.93 118.83 25.65 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.69 172.86 9.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 124.407 1.083 . . . . 0.0 110.586 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 41.6 mt -91.91 163.6 13.96 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.9 t -149.09 150.14 32.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 177.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -101.79 -31.52 10.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 123.541 1.639 . . . . 0.0 108.09 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 . . . . . 0 N--CA 1.429 -1.478 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 -178.999 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.467 0.421 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.499 HG21 ' HB2' ' A' ' 132' ' ' SER . 0.0 OUTLIER 55.98 79.45 0.17 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.517 0.599 . . . . 0.0 112.246 179.272 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.9 p -105.3 -8.33 18.32 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.058 -1.026 . . . . 0.0 111.612 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -115.52 103.14 10.44 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.091 1.356 . . . . 0.0 112.516 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.19 171.29 17.63 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.185 -1.572 . . . . 0.0 110.918 178.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -83.31 -173.27 49.57 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.96 120.76 11.24 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 14.8 m -78.91 41.94 0.45 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.896 1.679 . . . . 0.0 108.819 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -68.65 140.52 55.48 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.5 mt -115.0 162.07 17.48 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.92 1.688 . . . . 0.0 108.88 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 33.1 p90 . . . . . 0 C--O 1.245 0.849 0 C-N-CA 125.368 1.467 . . . . 0.0 108.108 178.831 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.5 p . . . . . 0 C--O 1.236 0.382 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.92 138.29 33.85 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.637 1.558 . . . . 0.0 108.866 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.39 117.47 21.45 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -114.38 143.61 44.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.39 -125.28 0.82 Allowed Glycine 0 C--O 1.226 -0.368 0 CA-C-O 117.988 -1.451 . . . . 0.0 110.356 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.4 p -154.05 -164.99 1.99 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 120.526 2.163 . . . . 0.0 113.628 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.6 mt -140.32 4.36 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.764 1.626 . . . . 0.0 108.033 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.8 -26.85 60.02 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.361 -1.462 . . . . 0.0 111.88 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -69.82 19.21 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 128.042 2.537 . . . . 0.0 113.695 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.7 mt -110.23 -60.58 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 127.165 2.186 . . . . 0.0 110.827 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -137.72 23.23 2.89 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.711 0.804 . . . . 0.0 110.524 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 61.41 36.81 17.17 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.296 1.038 . . . . 0.0 110.239 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.502 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 26.1 mmt-85 -104.19 86.36 2.54 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.904 -1.122 . . . . 0.0 110.322 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.9 t -73.88 129.36 36.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.427 ' CD2' HD11 ' A' ' 138' ' ' LEU . 32.0 m0 -81.9 137.54 35.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.044 0.938 . . . . 0.0 109.854 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.97 120.69 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-N 119.593 1.088 . . . . 0.0 109.705 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.479 HD13 HD22 ' A' ' 72' ' ' LEU . 1.0 OUTLIER -75.03 100.31 4.15 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.844 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 4.0 tt0 -89.02 -172.93 3.87 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.408 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -52.59 96.77 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 124.232 1.013 . . . . 0.0 112.306 -178.529 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 52.85 26.12 4.38 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.744 2.017 . . . . 0.0 111.937 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.1 m -154.09 128.67 9.28 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 119.172 0.897 . . . . 0.0 111.23 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.699 HD12 HD13 ' A' ' 87' ' ' LEU . 3.5 mt -84.3 131.96 34.67 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 pt -138.37 133.01 42.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 124.635 1.174 . . . . 0.0 111.134 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.07 146.36 47.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.18 80.78 15.86 Favored Pre-proline 0 N--CA 1.464 0.243 0 C-N-CA 124.031 0.932 . . . . 0.0 109.381 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.4 -31.87 21.24 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.883 1.722 . . . . 0.0 115.079 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 -165.91 84.25 0.32 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.409 1.884 . . . . 0.0 108.73 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -147.77 130.13 15.7 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -60.94 -13.62 17.21 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.308 1.043 . . . . 0.0 113.674 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -96.34 49.09 1.11 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.614 1.552 . . . . 0.0 106.922 177.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.5 mtp -65.25 156.9 30.45 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.554 -1.341 . . . . 0.0 109.402 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.3 t -159.89 87.5 1.97 Allowed Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.634 0.774 . . . . 0.0 109.841 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.42 137.23 46.18 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.015 1.81 . . . . 0.0 111.176 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 m -119.91 -174.18 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.9 m -132.62 155.25 49.06 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.2 mm -127.85 110.67 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 125.971 1.708 . . . . 0.0 108.857 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.7 139.32 30.65 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.168 1.787 . . . . 0.0 109.304 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.7 tt -134.41 129.41 35.3 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.605 1.162 . . . . 0.0 109.19 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.0 mt -144.91 127.93 11.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.932 1.293 . . . . 0.0 111.039 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.0 p -72.68 128.22 34.91 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 90.3 m -61.6 149.48 39.08 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -109.54 -10.09 14.88 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.486 1.114 . . . . 0.0 110.216 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -101.49 26.71 6.97 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.551 1.94 . . . . 0.0 109.918 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.3 m -71.22 -9.79 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 120.497 -1.377 . . . . 0.0 114.567 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.02 -35.92 48.48 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.45 1.1 . . . . 0.0 112.694 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 t -97.97 0.82 47.1 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.565 1.546 . . . . 0.0 111.821 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.484 HD22 ' HG2' ' A' ' 103' ' ' LYS . 72.7 mt -92.13 -179.58 5.3 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.02 -1.05 . . . . 0.0 109.974 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -79.52 162.03 25.65 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.556 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -139.5 -24.19 0.86 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.562 1.545 . . . . 0.0 111.586 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -78.67 9.07 4.42 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.062 1.745 . . . . 0.0 112.703 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -115.18 -50.11 2.76 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.73 -146.47 10.89 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -107.8 104.28 52.58 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.67 131.56 17.46 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.291 3.327 . . . . 0.0 111.267 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.79 177.35 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.36 0.664 . . . . 0.0 111.033 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.548 ' CD1' HD12 ' A' ' 95' ' ' LEU . 1.8 t80 -125.83 154.55 42.48 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.733 0.778 . . . . 0.0 109.963 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.409 HD22 HD11 ' A' ' 74' ' ' LEU . 1.9 tt -156.07 150.76 26.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.49 178.62 35.53 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.665 HD11 HD11 ' A' ' 30' ' ' LEU . 5.6 mt -88.25 153.75 20.97 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -119.46 116.05 25.32 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 101.246 -3.613 . . . . 0.0 101.246 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.6 -18.97 0.37 Allowed Glycine 0 C--N 1.342 0.874 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.916 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.19 26.28 0.09 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.823 1.811 . . . . 0.0 112.336 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.0 m120 60.23 62.99 1.48 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.346 1.058 . . . . 0.0 109.322 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.479 HD22 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.36 137.41 27.09 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.436 -1.415 . . . . 0.0 112.298 -178.66 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.438 ' H ' ' HB2' ' A' ' 90' ' ' LYS . 5.4 m -143.14 176.23 9.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.145 0.978 . . . . 0.0 111.656 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.469 HD23 HD21 ' A' ' 87' ' ' LEU . 18.6 mt -61.3 151.38 32.11 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.322 1.049 . . . . 0.0 111.052 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.478 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 4.9 tmm? -158.84 134.28 8.6 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 76.2 m -107.52 120.64 42.76 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 124.482 1.114 . . . . 0.0 109.57 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.21 -168.37 2.12 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -121.59 144.63 48.63 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.8 p -90.93 -24.17 5.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.43 -0.508 . . . . 0.0 109.668 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.24 -45.43 0.47 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -109.74 -40.75 4.72 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.421 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 2.9 pt20 -132.97 164.95 40.28 Favored Pre-proline 0 C--O 1.242 0.692 0 C-N-CA 126.158 1.783 . . . . 0.0 112.125 -177.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 82' ' ' GLN . 89.2 Cg_endo -71.23 154.34 61.72 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.632 2.222 . . . . 0.0 112.38 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.4 p -151.21 171.9 16.68 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mt -91.86 152.98 19.84 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.425 0.69 . . . . 0.0 111.663 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -145.07 65.83 1.25 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.647 0.779 . . . . 0.0 110.224 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.71 ' H ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -88.11 116.71 26.49 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -177.97 -19.27 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.7 94.82 1.49 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.478 ' HE3' ' HB2' ' A' ' 75' ' ' MET . 0.6 OUTLIER -173.65 162.63 4.15 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 121.503 1.956 . . . . 0.0 109.866 -177.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -142.77 136.79 29.23 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.849 0.459 . . . . 0.0 111.823 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.1 mp -80.91 -36.21 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.972 1.309 . . . . 0.0 110.846 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.8 mmt -59.7 -33.38 71.52 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.868 0.758 . . . . 0.0 109.831 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.8 -54.18 49.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.94 0.896 . . . . 0.0 109.159 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.548 HD12 ' CD1' ' A' ' 64' ' ' TYR . 9.9 mt -67.19 -29.67 69.41 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -80.7 -25.72 37.96 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.872 0.368 . . . . 0.0 110.698 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -83.69 -44.36 14.57 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.007 1.323 . . . . 0.0 111.524 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.48 154.71 46.53 Favored Pre-proline 0 N--CA 1.457 -0.111 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.059 -177.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.3 65.69 2.77 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 124.132 3.221 . . . . 0.0 113.01 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -119.79 69.78 13.17 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 125.054 1.342 . . . . 0.0 111.388 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.464 ' HB2' HD21 ' A' ' 55' ' ' LEU . 58.8 Cg_endo -82.39 75.84 4.46 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.361 2.707 . . . . 0.0 105.95 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 t -88.43 94.34 4.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 O-C-N 120.858 -1.151 . . . . 0.0 109.496 -177.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.484 ' HG2' HD22 ' A' ' 55' ' ' LEU . 30.5 mttt -45.08 -28.09 0.67 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.242 2.217 . . . . 0.0 114.393 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 m -63.1 -22.28 66.75 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.355 1.462 . . . . 0.0 113.107 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.423 ' CE2' ' HG2' ' A' ' 75' ' ' MET . 20.6 m-85 -109.36 -18.52 13.54 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.658 1.983 . . . . 0.0 109.581 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.1 mt -85.68 155.19 21.19 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 125.717 1.607 . . . . 0.0 113.686 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -138.57 131.72 29.95 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.914 0.886 . . . . 0.0 109.71 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.51 116.35 18.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -90.73 144.23 25.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.79 178.24 6.5 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.09 0.956 . . . . 0.0 109.11 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -150.63 154.83 38.2 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.597 1.559 . . . . 0.0 110.799 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 57.6 p -132.38 8.9 4.32 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.322 -1.763 . . . . 0.0 113.459 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.79 -47.1 1.08 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.803 1.668 . . . . 0.0 112.159 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -132.82 -2.81 3.27 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -132.83 151.17 52.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.9 m -118.09 159.89 22.46 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.2 166.14 17.63 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -147.87 112.88 5.47 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.02 133.29 55.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.487 1.515 . . . . 0.0 109.555 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.0 t -54.47 120.45 6.65 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.211 1.004 . . . . 0.0 108.652 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.4 t -65.71 -42.36 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.066 -1.021 . . . . 0.0 110.663 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.25 97.49 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -129.31 83.77 64.35 Favored Pre-proline 0 C--O 1.235 0.321 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -68.23 158.34 57.93 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.786 2.324 . . . . 0.0 108.456 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 104.34 -6.97 46.58 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 26.4 m-90 -124.28 142.15 51.49 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 126.157 1.783 . . . . 0.0 109.796 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -126.0 152.23 46.0 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.092 0.957 . . . . 0.0 111.519 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.0 pt -76.04 127.71 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.076 0.465 . . . . 0.0 110.949 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.88 110.0 20.69 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 t -68.21 -15.8 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.844 1.658 . . . . 0.0 113.882 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 m 65.79 33.13 8.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.0 1.32 . . . . 0.0 113.041 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.502 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 5.8 m -65.03 -21.1 66.79 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.353 0.597 . . . . 0.0 111.827 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -84.7 120.3 26.24 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 125.377 1.471 . . . . 0.0 107.787 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 67.57 -72.29 0.24 Allowed Glycine 0 N--CA 1.442 -0.933 0 O-C-N 125.466 1.729 . . . . 0.0 114.311 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.67 71.45 0.02 OUTLIER Glycine 0 CA--C 1.526 0.767 0 N-CA-C 105.837 -2.905 . . . . 0.0 105.837 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' CYS . . . . . 0.457 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 63.9 m -95.0 174.68 3.36 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 124.956 1.302 . . . . 0.0 111.393 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 136' ' ' CYS . 96.7 Cg_endo -75.23 165.21 31.43 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.03 1.82 . . . . 0.0 111.593 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.583 HD12 HD13 ' A' ' 30' ' ' LEU . 28.8 mt -91.59 114.01 26.43 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.956 0.903 . . . . 0.0 108.564 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.7 pp -141.21 176.6 4.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 125.255 1.422 . . . . 0.0 107.191 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 20.2 mt -100.63 165.79 11.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.8 t -147.89 162.53 39.09 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -104.63 -42.53 5.38 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 . . . . . 0 N--CA 1.441 -0.881 0 CA-C-O 122.707 1.241 . . . . 0.0 109.014 179.312 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.471 HG21 ' CD2' ' A' ' 152' ' ' PHE . 90.9 m -137.29 131.52 32.39 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.3 p -110.37 -13.29 14.31 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.874 1.269 . . . . 0.0 111.689 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -120.63 109.12 14.85 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.767 0.712 . . . . 0.0 111.519 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.471 ' CD2' HG21 ' A' ' 149' ' ' THR . 0.2 OUTLIER -161.68 173.25 14.95 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.168 1.787 . . . . 0.0 111.206 178.836 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.38 -166.9 31.21 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.14 140.62 46.69 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 122.076 -0.661 . . . . 0.0 109.233 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.75 28.88 1.24 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.883 1.673 . . . . 0.0 109.837 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -59.45 150.65 26.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.663 1.185 . . . . 0.0 108.523 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 43.1 mt -132.86 160.88 35.69 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.62 1.168 . . . . 0.0 108.333 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 31.2 p90 . . . . . 0 C--O 1.245 0.819 0 CA-C-O 117.198 -1.382 . . . . 0.0 108.29 178.908 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.24 0.595 0 CA-C-O 119.598 -0.239 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.34 147.94 94.09 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 N-CA-C 108.131 -1.527 . . . . 0.0 108.131 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.98 107.16 15.01 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -110.21 134.9 51.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.486 0.66 . . . . 0.0 110.388 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 156' ' ' MET . . . -161.27 -129.05 0.99 Allowed Glycine 0 N--CA 1.451 -0.356 0 O-C-N 121.186 -0.946 . . . . 0.0 111.975 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.2 p -154.23 -172.47 4.22 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.364 1.082 . . . . 0.0 112.11 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -149.81 9.18 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 124.288 1.035 . . . . 0.0 111.575 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.32 -18.03 59.13 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 119.92 -1.738 . . . . 0.0 111.377 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.14 44.85 0.6 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.23 2.612 . . . . 0.0 110.528 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mt -131.71 -64.95 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 126.111 1.764 . . . . 0.0 111.148 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -139.87 27.42 2.21 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.406 1.083 . . . . 0.0 109.855 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 64.59 15.55 9.74 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -79.05 91.03 4.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.495 ' HB ' HG23 ' A' ' 33' ' ' VAL . 53.6 t -72.24 153.49 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.43 ' HE3' HD11 ' A' ' 138' ' ' LEU . 10.1 m95 -112.1 132.56 54.78 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 120.513 -1.367 . . . . 0.0 108.798 -177.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.472 ' C ' HD23 ' A' ' 30' ' ' LEU . 39.8 t -140.62 126.12 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 119.983 1.265 . . . . 0.0 111.837 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tp -76.41 104.7 7.06 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -88.92 -170.33 2.87 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.86 97.01 0.01 OUTLIER 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.604 1.962 . . . . 0.0 109.925 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 46.51 23.09 0.2 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.893 2.477 . . . . 0.0 112.669 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 m -153.93 128.55 9.32 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 119.412 1.006 . . . . 0.0 111.523 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.545 HD13 HD12 ' A' ' 138' ' ' LEU . 2.7 mt -79.74 149.21 31.21 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.147 -0.971 . . . . 0.0 112.028 179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 16.6 pt -143.15 149.37 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.168 1.387 . . . . 0.0 110.893 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.64 143.97 25.79 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.495 HG23 ' HB ' ' A' ' 22' ' ' VAL . 28.4 m -128.47 105.32 19.32 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.015 0.926 . . . . 0.0 110.285 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.83 -50.68 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.454 2.769 . . . . 0.0 116.351 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -147.05 57.71 1.15 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.07 130.82 50.33 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.22 -55.24 37.55 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.86 0.725 . . . . 0.0 109.082 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -79.44 60.36 3.18 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.218 1.407 . . . . 0.0 111.692 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -102.64 171.62 7.32 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 176.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t -159.68 133.01 4.79 Favored Pre-proline 0 N--CA 1.452 -0.373 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.69 155.04 59.25 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 N-CA-C 108.088 -1.543 . . . . 0.0 108.088 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m -140.07 -171.03 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 125.244 1.418 . . . . 0.0 107.535 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.92 156.16 48.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.0 mm -127.34 112.55 28.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 126.158 1.783 . . . . 0.0 107.905 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.16 140.74 29.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.403 HD12 HD12 ' A' ' 65' ' ' LEU . 4.8 tt -135.47 139.75 44.3 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.0 mt -150.37 139.72 15.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.287 1.035 . . . . 0.0 108.986 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.7 p -75.14 156.4 35.98 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 94.8 m -78.34 140.06 38.79 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 119.873 -1.767 . . . . 0.0 108.681 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -101.16 -21.28 14.99 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.44 -0.788 . . . . 0.0 112.541 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -111.66 67.77 0.65 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.884 1.274 . . . . 0.0 108.255 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.619 ' HA ' HD23 ' A' ' 55' ' ' LEU . 15.2 m -101.4 2.31 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -177.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.61 -18.71 65.16 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.635 1.174 . . . . 0.0 111.526 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 t -105.16 -5.0 21.13 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.764 2.026 . . . . 0.0 113.521 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.619 HD23 ' HA ' ' A' ' 52' ' ' VAL . 3.8 mm? -80.41 -178.59 6.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.594 -0.691 . . . . 0.0 110.205 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -82.37 -38.17 24.56 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.418 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.81 1.55 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.662 1 C-N-CA 132.328 4.251 . . . . 0.0 117.148 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -93.53 -14.43 26.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 127.227 2.211 . . . . 0.0 110.399 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.406 HH12 ' HB3' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -98.95 -0.52 42.0 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.928 0.785 . . . . 0.0 111.085 175.683 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.66 179.86 23.09 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 125.132 1.349 . . . . 0.0 110.389 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -86.62 112.58 47.7 Favored Pre-proline 0 CA--C 1.538 0.506 0 O-C-N 121.552 -0.969 . . . . 0.0 109.051 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -66.73 133.47 31.8 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.449 2.1 . . . . 0.0 114.461 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 pp -142.77 174.02 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 120.04 1.291 . . . . 0.0 109.788 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.664 ' CD1' HD12 ' A' ' 95' ' ' LEU . 2.7 t80 -131.94 153.4 50.33 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.403 HD12 HD12 ' A' ' 46' ' ' LEU . 6.1 tt -150.76 154.43 37.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.114 1.366 . . . . 0.0 108.23 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -163.65 -173.03 31.85 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.449 HD11 HD11 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -95.64 159.99 14.72 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.891 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -135.02 92.14 2.84 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 120.43 -1.419 . . . . 0.0 110.357 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.37 -7.83 0.02 OUTLIER Glycine 0 CA--C 1.536 1.394 0 CA-C-O 117.518 -1.712 . . . . 0.0 114.872 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -164.86 24.99 0.06 Allowed 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.528 2.164 . . . . 0.0 113.312 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.7 m120 58.7 67.84 0.89 Allowed 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.531 -1.355 . . . . 0.0 109.529 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.25 131.67 23.69 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.441 1.496 . . . . 0.0 109.888 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 61.5 m -140.38 177.99 7.62 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.23 1.812 . . . . 0.0 112.059 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.7 mt -61.71 154.72 24.66 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.284 -1.51 . . . . 0.0 110.772 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.2 ttp -162.46 132.15 4.47 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 93.2 m -103.33 121.96 43.83 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.313 0.96 . . . . 0.0 110.588 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.98 -171.91 2.39 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.926 1.69 . . . . 0.0 107.678 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -146.31 130.48 17.46 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.0 m -78.46 12.08 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 123.576 0.75 . . . . 0.0 112.227 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.02 -10.51 63.94 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.847 2.165 . . . . 0.0 111.687 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -129.08 -50.96 1.21 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.926 1.69 . . . . 0.0 110.857 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -131.48 155.76 81.04 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 125.058 1.343 . . . . 0.0 113.498 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.31 144.09 40.62 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 124.157 3.238 . . . . 0.0 111.769 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.7 p -148.43 147.65 29.42 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.171 0.896 . . . . 0.0 109.5 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.3 mt -71.69 160.08 33.27 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -150.97 64.09 0.91 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.061 0.944 . . . . 0.0 108.673 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.79 ' H ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -85.09 113.01 21.17 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.5 pttp -174.9 -36.16 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.929 1.292 . . . . 0.0 112.283 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -141.64 83.4 1.85 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.841 1.2 . . . . 0.0 113.959 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.47 147.71 6.37 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.36 -1.463 . . . . 0.0 109.014 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.29 140.99 48.16 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.225 1.01 . . . . 0.0 109.958 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.1 tt -87.18 -43.59 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 125.417 1.487 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.3 tpt -62.32 -27.89 69.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.923 -0.56 . . . . 0.0 111.396 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.88 -54.51 37.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.664 HD12 ' CD1' ' A' ' 64' ' ' TYR . 18.8 mt -60.05 -32.48 70.96 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.427 -0.796 . . . . 0.0 111.248 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -81.83 -15.97 52.35 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.238 -0.914 . . . . 0.0 112.215 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -94.49 -33.16 13.19 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 120.498 -1.376 . . . . 0.0 112.374 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.422 ' HB2' ' HD2' ' A' ' 99' ' ' PRO . 3.9 pt20 -123.8 167.07 16.14 Favored Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 124.909 1.284 . . . . 0.0 110.799 -178.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 98' ' ' GLN . 58.7 Cg_endo -73.24 -139.14 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 122.81 2.34 . . . . 0.0 109.59 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 56.99 60.77 7.05 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.952 1.701 . . . . 0.0 113.575 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.49 109.37 0.85 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.03 3.153 . . . . 0.0 109.262 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.3 t -88.11 98.7 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -49.53 -29.73 7.29 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.315 1.046 . . . . 0.0 112.286 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.5 m -62.54 -16.07 54.07 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.413 1.085 . . . . 0.0 113.453 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.52 -23.64 8.17 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.141 0.882 . . . . 0.0 111.69 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.5 mt -75.15 156.06 36.34 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.086 0.955 . . . . 0.0 112.801 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -138.93 128.72 24.86 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.644 0.778 . . . . 0.0 112.517 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -77.85 126.23 30.53 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.41 147.37 36.05 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 p -136.72 -177.1 4.59 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.777 1.631 . . . . 0.0 107.52 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -139.52 165.12 28.08 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.833 0.853 . . . . 0.0 109.193 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.5 p -149.84 35.98 0.69 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.753 1.283 . . . . 0.0 112.555 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.91 -56.27 1.85 Allowed Glycine 0 C--N 1.334 0.469 0 O-C-N 120.61 -1.307 . . . . 0.0 112.504 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -131.32 -1.08 4.0 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.508 -0.995 . . . . 0.0 112.669 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -134.05 179.92 5.95 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.752 0.821 . . . . 0.0 110.007 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 p -144.51 133.15 22.23 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.117 0.967 . . . . 0.0 112.435 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.52 170.82 9.08 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.202 1.401 . . . . 0.0 109.572 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -137.6 109.58 7.2 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.294 1.837 . . . . 0.0 106.98 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -98.52 128.08 44.72 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.926 2.09 . . . . 0.0 109.241 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.1 t -61.2 131.89 51.9 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.929 1.24 . . . . 0.0 111.957 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.33 -49.86 72.37 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 O-C-N 121.845 -0.534 . . . . 0.0 110.004 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.73 -27.52 68.97 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -136.29 84.73 28.69 Favored Pre-proline 0 N--CA 1.453 -0.28 0 CA-C-N 118.179 0.445 . . . . 0.0 110.186 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.406 ' HB3' HH12 ' A' ' 59' ' ' ARG . 10.6 Cg_endo -65.36 166.45 19.32 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.113 2.542 . . . . 0.0 111.663 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.19 1.36 90.48 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.443 -0.643 . . . . 0.0 112.546 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -130.56 146.12 52.01 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.092 1.357 . . . . 0.0 107.419 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -130.87 148.95 52.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.121 1.368 . . . . 0.0 110.578 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.4 pt -78.68 129.29 37.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.569 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.86 151.95 22.46 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.2 m -103.48 -17.27 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 125.149 1.38 . . . . 0.0 113.383 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.3 m 67.98 85.39 0.14 Allowed 'General case' 0 CA--C 1.533 0.308 0 O-C-N 124.413 1.07 . . . . 0.0 109.074 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 t -120.2 13.23 11.98 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.28 -1.512 . . . . 0.0 112.228 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -79.1 -52.22 8.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -161.55 -83.39 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.97 49.75 0.56 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 120.196 1.998 . . . . 0.0 113.261 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 32.0 m -78.13 165.85 47.51 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 118.229 1.014 . . . . 0.0 109.335 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 66.0 Cg_endo -78.12 163.92 27.53 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.404 2.07 . . . . 0.0 113.189 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.545 HD12 HD13 ' A' ' 30' ' ' LEU . 37.1 mt -85.64 107.9 17.75 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.7 1.2 . . . . 0.0 110.975 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.44 -172.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 124.292 1.037 . . . . 0.0 109.557 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.54 162.86 14.68 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t -148.97 172.92 13.94 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 125.804 1.642 . . . . 0.0 109.004 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -114.89 -44.98 3.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.339 1.856 . . . . 0.0 108.283 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -178.597 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 C--O 1.24 0.575 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.521 HG21 ' CE2' ' A' ' 152' ' ' PHE 0.289 12.9 m -112.28 140.42 47.01 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 178.238 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.33 -16.76 2.71 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 128.272 2.629 . . . . 0.0 109.815 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.35 122.56 37.18 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 124.147 0.979 . . . . 0.0 111.775 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.2 OUTLIER -161.71 -173.71 3.86 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.439 1.096 . . . . 0.0 109.481 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.47 -172.42 33.59 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.3 tp -146.03 127.16 14.7 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.9 m -82.96 40.16 0.68 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.408 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 5.6 ptt? -62.75 138.46 58.52 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 44.1 mt -117.42 -177.12 3.15 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.99 1.716 . . . . 0.0 106.95 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.1 p90 . . . . . 0 C--O 1.239 0.533 0 CA-C-N 119.728 1.149 . . . . 0.0 112.301 -179.206 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.846 0 CA-C-O 121.498 0.666 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.28 103.34 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.143 2.562 . . . . 0.0 109.123 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.18 113.23 24.9 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -110.62 139.61 45.71 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.001 0.429 . . . . 0.0 110.744 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.93 -126.25 0.88 Allowed Glycine 0 C--O 1.224 -0.516 0 CA-C-O 117.618 -1.657 . . . . 0.0 112.389 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.4 p -161.68 -165.38 1.27 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 121.292 2.546 . . . . 0.0 112.376 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -142.18 0.5 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.176 0.59 . . . . 0.0 109.868 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -66.53 -20.68 66.09 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 120.34 -1.475 . . . . 0.0 111.256 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -60.58 -16.43 38.0 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.893 0.877 . . . . 0.0 112.394 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.0 mt -74.11 -69.02 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.126 0 C-N-CA 125.48 1.512 . . . . 0.0 113.958 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.04 21.27 6.83 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 67.06 30.38 7.45 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.567 1.147 . . . . 0.0 110.792 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.503 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 16.9 mmt-85 -98.3 102.87 14.74 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.068 1.347 . . . . 0.0 108.476 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.431 ' HB ' HG23 ' A' ' 33' ' ' VAL . 71.0 t -80.25 154.11 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 177.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.503 ' CH2' ' HB2' ' A' ' 21' ' ' ARG . 5.2 m95 -114.27 143.93 44.05 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.8 t -138.35 121.07 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tp -69.96 106.54 3.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -98.79 -174.19 2.72 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.52 96.29 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.893 1.224 . . . . 0.0 112.303 -178.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 45.45 28.14 0.45 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.583 2.753 . . . . 0.0 111.823 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.2 m -153.5 127.04 8.68 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.092 0.86 . . . . 0.0 110.694 -176.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.865 HD12 ' HG ' ' A' ' 87' ' ' LEU . 10.3 mt -83.27 127.9 34.04 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 120.93 -1.106 . . . . 0.0 111.164 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.9 mm -128.01 139.25 52.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 122.949 0.499 . . . . 0.0 109.788 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.18 142.81 39.46 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.431 HG23 ' HB ' ' A' ' 22' ' ' VAL . 8.0 m -119.9 77.15 22.35 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 124.662 1.185 . . . . 0.0 108.115 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.31 -37.23 10.55 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.837 2.358 . . . . 0.0 113.907 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.45 51.88 1.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.74 134.14 52.34 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -66.41 -41.68 88.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.111 0.482 . . . . 0.0 110.485 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.18 75.15 9.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -123.35 140.71 52.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.797 -1.547 . . . . 0.0 110.075 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.0 t -140.87 141.16 23.38 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.75 160.84 42.99 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 N-CA-C 108.589 -1.35 . . . . 0.0 108.589 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.0 m -143.82 166.91 13.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 126.5 1.92 . . . . 0.0 109.093 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.61 154.77 36.32 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.3 mm -129.95 109.4 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 125.648 1.579 . . . . 0.0 108.053 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.98 133.38 34.84 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.818 1.247 . . . . 0.0 108.537 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.8 tt -129.55 129.78 44.9 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.4 1.48 . . . . 0.0 109.193 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.1 mt -142.17 142.71 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.949 0.88 . . . . 0.0 109.62 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.2 p -87.21 146.78 25.85 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.42 ' O ' HG13 ' A' ' 52' ' ' VAL . 87.3 m -63.98 122.69 17.12 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.589 1.156 . . . . 0.0 110.943 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -81.77 -26.86 34.09 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.049 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -96.96 35.9 1.49 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.842 1.201 . . . . 0.0 111.474 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 49' ' ' CYS . 3.7 m -57.06 -15.98 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.583 1.153 . . . . 0.0 112.418 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.18 -13.26 11.36 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.845 2.058 . . . . 0.0 111.227 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.59 -0.89 13.51 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.57 1.548 . . . . 0.0 111.819 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 101' ' ' PRO . 3.6 mm? -113.27 164.25 13.79 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.864 1.666 . . . . 0.0 110.25 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -71.15 152.73 43.12 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.816 0.847 . . . . 0.0 109.246 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -112.18 -32.84 6.42 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -52.57 -35.0 53.04 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 128.592 2.757 . . . . 0.0 114.27 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.9 mtt85 -87.08 -1.5 57.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 118.548 -0.739 . . . . 0.0 112.785 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.73 -177.17 18.19 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -82.45 106.14 6.07 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 118.927 1.364 . . . . 0.0 111.699 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.76 134.96 20.85 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.232 2.622 . . . . 0.0 108.934 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.92 -179.16 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.717 1.607 . . . . 0.0 110.565 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -133.78 158.68 42.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.578 1.151 . . . . 0.0 110.446 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.2 tt -151.64 143.26 23.61 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.124 1.37 . . . . 0.0 109.162 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.43 -174.85 16.01 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.192 1.377 . . . . 0.0 111.344 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.854 HD11 HD11 ' A' ' 30' ' ' LEU . 10.0 mt -105.5 133.59 50.0 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -95.39 107.36 19.49 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.1 -76.77 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.073 -1.536 . . . . 0.0 111.084 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.19 22.09 16.53 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.266 1.026 . . . . 0.0 111.169 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.11 72.54 0.49 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.033 1.733 . . . . 0.0 110.206 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.13 150.29 39.25 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.775 1.23 . . . . 0.0 108.064 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.601 ' SG ' HG23 ' A' ' 92' ' ' ILE . 3.2 m -147.62 171.64 15.29 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 123.069 0.548 . . . . 0.0 109.937 178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 76.7 mt -62.13 166.11 5.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.684 0.794 . . . . 0.0 109.274 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -172.64 137.06 0.78 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.0 m -96.98 128.67 44.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.429 0.633 . . . . 0.0 110.205 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -133.87 -174.9 3.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -131.16 118.01 19.86 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 103.032 -2.951 . . . . 0.0 103.032 178.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 p -72.01 -23.31 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.4 -38.97 0.17 Allowed Glycine 0 N--CA 1.453 -0.227 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -141.8 -17.39 0.77 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.924 0.89 . . . . 0.0 112.488 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -139.47 153.26 70.47 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.836 1.254 . . . . 0.0 113.558 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.93 142.49 88.44 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 124.951 3.767 . . . . 0.0 111.973 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.8 p -147.33 163.52 36.17 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 124.738 1.215 . . . . 0.0 110.218 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 mt -86.12 156.53 20.33 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -147.18 80.08 1.52 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.638 1.975 . . . . 0.0 108.721 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.865 ' HG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -103.01 104.63 14.82 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.188 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.41 -24.79 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -144.58 87.5 1.87 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.379 1.071 . . . . 0.0 111.72 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -165.86 165.84 18.01 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 119.402 -2.061 . . . . 0.0 108.388 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -137.07 165.41 26.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.601 HG23 ' SG ' ' A' ' 73' ' ' CYS . 18.9 pt -113.98 -49.66 5.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 124.765 1.226 . . . . 0.0 110.586 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.1 mmt -62.25 -18.84 62.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 117.913 -1.042 . . . . 0.0 109.25 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -71.42 -45.22 63.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.263 1.392 . . . . 0.0 110.299 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 23.4 mt -62.6 -25.94 68.35 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.727 1.211 . . . . 0.0 109.662 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -82.76 -34.89 26.97 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.646 -0.659 . . . . 0.0 109.784 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -65.42 -37.76 87.87 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.621 -1.18 . . . . 0.0 110.859 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -136.12 158.5 73.6 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.87 82.43 2.33 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.926 2.417 . . . . 0.0 111.062 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -135.56 59.91 33.91 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.822 1.649 . . . . 0.0 107.26 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.644 ' HB2' HD21 ' A' ' 55' ' ' LEU . 61.4 Cg_endo -72.66 86.84 1.0 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.334 2.023 . . . . 0.0 108.68 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.5 t -73.35 101.74 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -53.08 -29.8 32.42 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 122.998 0.519 . . . . 0.0 111.151 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -65.84 -7.1 14.41 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 178.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -120.92 -33.14 3.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.598 1.09 . . . . 0.0 109.689 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.5 mt -68.32 153.19 44.24 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.239 0.472 . . . . 0.0 111.918 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.95 135.72 24.6 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.126 0.97 . . . . 0.0 111.264 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -74.09 113.75 11.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.716 2.407 . . . . 0.0 105.996 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -88.99 134.06 34.11 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.6 t -132.9 -178.68 5.06 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.77 146.72 20.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.943 0.897 . . . . 0.0 109.891 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.85 88.75 0.98 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.431 1.092 . . . . 0.0 111.843 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.17 61.93 1.54 Allowed Glycine 0 C--N 1.339 0.75 0 C-N-CA 124.335 0.969 . . . . 0.0 112.641 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 61.64 0.27 0.47 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.06 2.144 . . . . 0.0 110.437 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -115.28 124.9 52.51 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 m -84.72 171.67 12.14 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.096 0.958 . . . . 0.0 109.497 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.14 161.7 41.45 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.053 2.141 . . . . 0.0 108.375 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -141.22 111.93 7.06 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.582 1.153 . . . . 0.0 109.478 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -105.18 128.8 53.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.463 1.905 . . . . 0.0 109.893 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.2 t -52.74 125.58 17.2 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.028 1.731 . . . . 0.0 110.882 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.17 -45.59 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.428 1.013 . . . . 0.0 109.772 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.5 -33.68 74.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.007 -0.997 . . . . 0.0 111.619 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -136.27 83.89 31.17 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.703 1.201 . . . . 0.0 110.269 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.26 157.22 61.09 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.43 1.42 . . . . 0.0 110.342 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 103.73 -34.88 5.42 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.544 1.545 . . . . 0.0 109.5 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 15.7 m-90 -85.95 140.03 30.7 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -123.99 141.45 52.03 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.384 1.074 . . . . 0.0 109.032 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 140' ' ' LEU . 5.1 mt -78.73 143.43 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -107.08 158.92 16.69 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.6 t -110.93 1.24 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 126.991 2.117 . . . . 0.0 112.698 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.6 m 49.66 52.93 13.62 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 m -85.1 -15.4 44.06 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.034 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -58.11 -31.52 67.23 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -170.15 -79.72 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.86 57.35 0.22 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 84.3 m -88.37 163.01 38.09 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.73 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.07 164.23 34.67 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 N-CA-C 107.531 -1.757 . . . . 0.0 107.531 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.8 mt -91.29 113.8 26.16 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.2 174.15 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 124.597 1.159 . . . . 0.0 112.445 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -100.44 150.71 22.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 118.531 -0.747 . . . . 0.0 109.809 177.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.5 t -130.88 173.86 10.55 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.891 1.276 . . . . 0.0 109.307 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -114.64 -32.6 5.8 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.96 1.304 . . . . 0.0 111.028 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 . . . . . 0 C--O 1.237 0.42 0 CA-C-N 119.14 0.882 . . . . 0.0 109.816 -177.918 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.243 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.77 105.87 8.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.179 0.445 . . . . 0.0 110.644 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.5 p -97.79 -22.91 16.14 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -103.55 108.07 19.18 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.389 1.876 . . . . 0.0 112.963 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -173.36 -179.29 1.87 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.828 1.251 . . . . 0.0 111.732 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.69 -155.96 27.44 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 124.814 1.197 . . . . 0.0 112.323 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.5 tp -151.48 135.84 16.86 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.6 1.56 . . . . 0.0 107.411 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.5 m -93.74 42.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.317 1.447 . . . . 0.0 110.292 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -64.41 147.82 51.81 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.071 -1.018 . . . . 0.0 108.684 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 26.1 mt -125.0 165.29 18.4 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.612 1.565 . . . . 0.0 110.467 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 36.7 p90 . . . . . 0 C--O 1.252 1.236 0 C-N-CA 126.159 1.784 . . . . 0.0 108.785 179.474 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.445 -0.694 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.19 123.03 9.27 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 N-CA-C 106.965 -1.975 . . . . 0.0 106.965 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -114.75 110.39 19.64 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -90.17 156.63 18.2 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.987 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.8 -154.48 7.96 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.5 p -156.46 138.28 14.3 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.505 1.522 . . . . 0.0 110.048 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -98.28 1.04 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.0 0.92 . . . . 0.0 109.89 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -55.03 -36.45 65.53 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.036 -1.665 . . . . 0.0 111.412 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -4.71 0.24 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.7 mt -72.92 -61.56 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 CA-C-N 118.591 0.632 . . . . 0.0 109.78 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.73 29.92 1.1 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.489 1.116 . . . . 0.0 109.452 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 59.93 34.56 21.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.234 1.814 . . . . 0.0 111.45 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -99.86 107.77 19.87 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.4 t -88.71 160.38 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.473 ' HB3' HD22 ' A' ' 30' ' ' LEU . 4.7 m95 -113.78 139.57 49.01 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.419 0.554 . . . . 0.0 109.992 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.2 t -138.48 127.59 31.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.36 116.01 12.29 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 101.64 -3.467 . . . . 0.0 101.64 177.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -131.36 124.76 31.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.479 1.512 . . . . 0.0 108.003 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 t0 49.78 42.06 23.22 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 70.84 11.74 7.12 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.331 1.852 . . . . 0.0 113.863 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.5 m -133.05 138.55 46.8 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.602 1.546 . . . . 0.0 109.656 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.803 HD12 HD13 ' A' ' 87' ' ' LEU . 4.0 mt -83.19 125.47 31.58 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 120.688 -1.258 . . . . 0.0 108.703 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.06 147.06 30.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.84 139.6 39.3 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.317 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.32 74.69 80.09 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 123.778 0.831 . . . . 0.0 110.559 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.29 -73.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.65 1.566 . . . . 0.0 112.976 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.27 12.45 32.92 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -72.45 129.03 37.38 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.247 0.619 . . . . 0.0 112.209 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -46.33 79.62 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.515 1.126 . . . . 0.0 108.492 177.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.63 24.37 0.21 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -69.38 177.6 2.77 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.001 0.819 . . . . 0.0 109.644 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.5 t -163.52 135.52 3.87 Favored Pre-proline 0 C--O 1.237 0.408 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.57 151.85 82.0 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.858 1.705 . . . . 0.0 110.434 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.5 p -141.2 156.58 21.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 m -120.82 157.39 29.86 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.806 HG22 HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -132.05 105.81 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.206 1.002 . . . . 0.0 111.505 -178.101 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . . . -94.88 120.47 35.15 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.396 1.078 . . . . 0.0 111.085 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.6 tt -106.06 139.39 40.66 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 125.522 1.529 . . . . 0.0 108.754 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.9 mt -137.46 145.48 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 124.778 1.299 . . . . 0.0 108.83 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.1 p -87.37 137.53 32.26 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.7 m -57.29 112.31 1.35 Allowed 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.097 -1.002 . . . . 0.0 109.984 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -94.79 -6.55 42.67 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.433 ' CE1' ' HA ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -117.95 64.48 0.75 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.056 1.742 . . . . 0.0 106.338 179.405 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.66 ' HA ' HD23 ' A' ' 55' ' ' LEU . 4.3 m -90.95 3.35 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -178.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -50.86 -26.69 6.11 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -117.58 18.45 14.23 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.085 1.354 . . . . 0.0 110.651 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.66 HD23 ' HA ' ' A' ' 52' ' ' VAL . 3.7 mm? -114.43 171.75 7.44 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 120.205 -1.559 . . . . 0.0 108.791 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.81 165.01 16.33 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.419 ' HE2' ' HB ' ' A' ' 52' ' ' VAL . 1.9 mttm -136.43 -39.6 0.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.824 1.25 . . . . 0.0 109.683 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -73.8 -17.35 61.09 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 123.554 0.534 . . . . 0.0 111.803 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -44.99 75.78 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.418 -0.801 . . . . 0.0 109.099 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 167.64 169.33 31.04 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 127.433 2.444 . . . . 0.0 107.384 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -73.62 110.16 8.29 Favored Pre-proline 0 CA--C 1.537 0.445 0 O-C-N 120.767 -1.431 . . . . 0.0 112.388 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.68 136.38 25.54 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 CA-C-N 121.862 1.701 . . . . 0.0 109.925 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 37.7 pt -146.06 -178.14 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.965 1.706 . . . . 0.0 108.96 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -153.68 159.93 42.2 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.218 1.007 . . . . 0.0 109.969 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.806 HD22 HG22 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -140.29 154.64 46.89 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.566 1.174 . . . . 0.0 111.589 -178.808 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.81 159.01 26.85 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 124.757 1.17 . . . . 0.0 111.3 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.539 ' CD1' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -98.42 131.75 44.43 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.6 116.56 32.29 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.54 -36.27 0.24 Allowed Glycine 0 N--CA 1.447 -0.573 0 O-C-N 125.158 1.536 . . . . 0.0 111.91 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.08 24.41 0.83 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -178.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.03 70.77 0.61 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.286 1.434 . . . . 0.0 109.623 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.85 144.69 27.09 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 120.805 -1.184 . . . . 0.0 108.52 -178.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 34.0 m -145.76 166.67 25.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 117.352 -1.309 . . . . 0.0 111.7 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.6 mt -51.99 157.41 1.29 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.531 1.132 . . . . 0.0 110.352 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -170.39 148.27 3.16 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 68.0 m -109.55 121.34 44.99 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.119 1.768 . . . . 0.0 110.56 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.27 178.04 6.88 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.384 1.074 . . . . 0.0 109.57 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.406 ' HE3' ' C ' ' A' ' 81' ' ' ASP . 15.2 tttt -119.85 130.73 55.02 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 102.685 -3.08 . . . . 0.0 102.685 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.443 HG21 HG21 ' A' ' 84' ' ' THR . 27.2 m -128.73 38.66 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.603 0.761 . . . . 0.0 112.693 -177.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.87 54.78 0.12 Allowed Glycine 0 CA--C 1.503 -0.712 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.406 ' C ' ' HE3' ' A' ' 78' ' ' LYS . 23.0 t0 66.23 13.65 9.27 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.26 141.71 35.13 Favored Pre-proline 0 N--CA 1.448 -0.566 0 C-N-CA 125.61 1.564 . . . . 0.0 110.367 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.54 141.89 22.8 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.607 2.871 . . . . 0.0 113.236 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.443 HG21 HG21 ' A' ' 79' ' ' VAL . 72.8 p -150.42 176.82 10.57 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.506 0.723 . . . . 0.0 110.721 178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.468 HD11 HG23 ' A' ' 128' ' ' ILE . 7.9 mt -89.19 150.55 22.62 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.719 0.807 . . . . 0.0 110.845 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -146.01 65.81 1.21 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.935 1.694 . . . . 0.0 109.253 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.803 HD13 HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -93.43 96.28 9.81 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 126.323 1.849 . . . . 0.0 107.949 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.66 -26.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.996 -177.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -144.44 98.0 3.13 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.487 1.115 . . . . 0.0 109.112 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.52 160.81 0.11 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.256 1.423 . . . . 0.0 110.572 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -142.24 133.16 25.79 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.53 0.732 . . . . 0.0 109.631 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.441 HG23 ' SG ' ' A' ' 73' ' ' CYS . 7.7 pt -72.27 -44.05 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.688 1.995 . . . . 0.0 111.656 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.21 -26.03 62.33 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.023 0.929 . . . . 0.0 111.395 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -60.64 -52.02 66.93 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.446 HD11 ' CD2' ' A' ' 105' ' ' PHE . 80.6 mt -61.87 -35.19 77.59 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.717 2.407 . . . . 0.0 110.746 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -80.04 -20.59 44.94 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.195 -1.566 . . . . 0.0 109.769 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -87.27 -37.12 17.49 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.581 -1.324 . . . . 0.0 113.528 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -130.87 162.6 54.33 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 120.09 1.314 . . . . 0.0 109.511 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.03 -172.13 0.39 Allowed 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 122.13 1.887 . . . . 0.0 108.772 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.252 19.8 mm-40 92.09 71.97 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 129.119 2.968 . . . . 0.0 113.934 177.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.594 ' CB ' HD21 ' A' ' 55' ' ' LEU . 18.3 Cg_endo -61.99 103.54 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.783 2.989 . . . . 0.0 111.573 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.1 t -78.01 98.7 2.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -52.75 -34.82 54.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.002 -1.686 . . . . 0.0 109.665 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.8 m -69.51 11.67 0.23 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.044 1.338 . . . . 0.0 112.564 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.446 ' CD2' HD11 ' A' ' 95' ' ' LEU . 44.9 t80 -133.85 -21.89 1.89 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.858 1.663 . . . . 0.0 108.683 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.4 mt -84.86 153.33 22.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.806 -1.184 . . . . 0.0 110.374 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.555 ' CE2' HD11 ' A' ' 128' ' ' ILE . 95.0 m-85 -139.4 124.64 19.01 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.198 0.999 . . . . 0.0 110.128 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -72.21 122.42 21.02 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -75.18 141.68 43.6 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.69 178.57 8.05 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -164.62 153.0 12.43 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.83 1.252 . . . . 0.0 111.425 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.7 t -168.2 103.66 0.45 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.582 1.553 . . . . 0.0 113.226 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.47 49.3 5.24 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 126.322 1.915 . . . . 0.0 113.294 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 62.16 26.0 15.6 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -131.83 122.91 26.52 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 117.535 -1.221 . . . . 0.0 109.194 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.65 -177.86 3.37 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.969 1.258 . . . . 0.0 110.604 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.26 169.11 25.49 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 119.885 -1.759 . . . . 0.0 108.512 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -146.43 114.87 6.73 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.611 1.165 . . . . 0.0 111.293 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -108.6 126.6 53.13 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.42 1.488 . . . . 0.0 111.656 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.62 110.91 0.56 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.775 2.03 . . . . 0.0 109.995 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.6 t -60.78 -41.27 87.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 O-C-N 121.394 -0.816 . . . . 0.0 110.644 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.16 -45.34 92.28 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 119.529 -0.868 . . . . 0.0 112.264 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -128.62 86.71 56.92 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.1 156.49 65.6 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.997 1.798 . . . . 0.0 110.731 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.82 -27.12 11.46 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -95.35 140.36 30.34 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -119.07 146.34 45.16 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.575 1.55 . . . . 0.0 109.593 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.555 HD11 ' CE2' ' A' ' 107' ' ' PHE . 12.9 mm -73.74 121.3 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.294 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.15 143.09 27.26 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 118.719 -1.192 . . . . 0.0 109.91 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.4 m -94.3 -10.46 9.24 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 O-C-N 121.306 -0.871 . . . . 0.0 109.938 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.4 m 57.15 56.84 4.92 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 119.648 -1.907 . . . . 0.0 115.259 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.4 m -99.52 7.07 45.66 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -84.2 -75.03 0.36 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.49 1.116 . . . . 0.0 109.725 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -109.34 -36.51 2.1 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 118.46 60.19 0.28 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 14.0 m -84.86 167.46 26.32 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.44 149.95 87.42 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 N-CA-C 107.028 -1.951 . . . . 0.0 107.028 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.8 mt -66.72 125.11 24.79 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pp -148.42 167.39 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.404 0.682 . . . . 0.0 110.799 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 80.1 mt -81.35 159.63 24.34 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.24 127.81 11.56 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -83.28 -43.23 16.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 124.188 0.93 . . . . 0.0 110.471 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 C--O 1.236 0.342 0 CA-C-O 120.729 0.3 . . . . 0.0 111.035 -177.147 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.18 106.82 14.14 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.433 1.093 . . . . 0.0 108.557 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.07 -34.83 7.83 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.045 0.839 . . . . 0.0 110.633 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -96.52 100.0 11.61 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 127.991 2.516 . . . . 0.0 110.656 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -168.81 173.02 7.39 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.558 1.943 . . . . 0.0 110.277 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.32 -174.07 13.67 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 125.247 1.403 . . . . 0.0 110.425 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.49 169.85 16.92 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.169 0.509 . . . . 0.0 111.865 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 34.3 m -84.38 75.07 10.27 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.84 1.656 . . . . 0.0 109.998 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.74 153.32 35.14 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 68.6 mt -135.02 -165.24 1.64 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 129.852 3.261 . . . . 0.0 109.535 -177.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.5 p90 . . . . . 0 C--O 1.258 1.54 0 C-N-CA 125.721 1.608 . . . . 0.0 114.095 -178.603 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.54 146.97 45.14 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 N-CA-C 105.962 -2.361 . . . . 0.0 105.962 177.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.69 118.02 23.04 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.96 139.86 53.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -168.87 -119.18 0.48 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.8 p -150.19 177.63 9.74 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.202 1.501 . . . . 0.0 114.959 -177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.436 HG21 HD13 ' A' ' 15' ' ' ILE . 84.0 mt -141.79 -9.59 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 128.305 2.642 . . . . 0.0 108.253 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -58.7 -30.13 67.18 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 118.898 -2.376 . . . . 0.0 116.075 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.03 -12.96 9.32 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.44 1.496 . . . . 0.0 113.506 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.6 mt -54.97 -49.86 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 O-C-N 121.112 -0.993 . . . . 0.0 111.628 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -153.41 30.49 0.48 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.699 0.799 . . . . 0.0 109.244 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 64.59 8.0 4.11 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.127 1.771 . . . . 0.0 114.427 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.03 104.7 10.78 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 126.823 2.049 . . . . 0.0 107.022 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.5 t -82.45 175.1 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 178.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.407 ' CE2' HD11 ' A' ' 138' ' ' LEU . 40.4 m0 -123.07 134.23 54.27 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.788 -1.195 . . . . 0.0 108.264 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.9 t -132.51 133.46 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tp -71.88 112.5 8.03 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -130.76 127.46 38.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 120.457 1.481 . . . . 0.0 109.556 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.9 t0 43.79 56.01 4.82 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.212 1.005 . . . . 0.0 111.568 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.554 ' HB3' ' HE2' ' A' ' 88' ' ' LYS . 91.2 mt-30 57.41 22.28 7.76 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.13 139.7 32.23 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 125.242 1.417 . . . . 0.0 107.366 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.809 HD21 HD11 ' A' ' 67' ' ' LEU . 17.3 mt -79.36 131.31 36.08 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 120.66 -1.275 . . . . 0.0 107.816 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.2 mt -123.97 133.77 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.155 0.889 . . . . 0.0 110.086 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.519 ' HB3' ' HA2' ' A' ' 135' ' ' GLY . . . -75.91 142.57 42.04 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.58 75.16 79.84 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.245 1.418 . . . . 0.0 112.308 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.28 -74.85 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 121.746 1.63 . . . . 0.0 110.736 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -95.44 68.01 2.95 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.5 145.74 51.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -76.34 -62.54 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.54 0.686 . . . . 0.0 110.028 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 -74.27 40.94 0.13 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -75.52 165.71 24.69 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 120.794 -1.191 . . . . 0.0 108.503 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.52 144.22 20.38 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.46 166.37 28.7 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.588 2.192 . . . . 0.0 111.136 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 p -155.75 164.3 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.76 149.9 49.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mm -123.18 118.9 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.943 1.297 . . . . 0.0 110.526 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.6 135.53 37.15 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.772 1.629 . . . . 0.0 108.774 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.3 tt -131.76 135.6 46.92 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.992 1.317 . . . . 0.0 108.029 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.3 mt -141.53 147.11 22.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.35 1.06 . . . . 0.0 108.565 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 p -90.59 128.22 36.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.896 2.479 . . . . 0.0 106.301 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 74.2 m -62.2 144.34 55.6 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.428 0.558 . . . . 0.0 109.627 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -101.21 -34.36 9.7 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.237 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -88.95 41.55 1.03 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.707 1.203 . . . . 0.0 108.737 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -69.84 -13.13 16.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 O-C-N 121.708 -0.62 . . . . 0.0 111.095 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -51.67 -39.32 58.03 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.598 1.559 . . . . 0.0 112.523 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.8 t -89.38 -5.16 57.69 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.753 0.821 . . . . 0.0 112.697 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.3 mt -92.45 -145.52 0.22 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.92 1.288 . . . . 0.0 112.538 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -123.37 160.0 27.71 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 127.815 2.446 . . . . 0.0 109.958 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -137.42 -26.8 0.98 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.61 1.564 . . . . 0.0 111.967 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -61.86 -45.24 94.66 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.79 0.723 . . . . 0.0 110.268 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -58.33 -51.2 70.78 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.726 0.81 . . . . 0.0 108.823 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.3 -179.32 37.69 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 106.422 -2.671 . . . . 0.0 106.422 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -82.46 117.79 69.68 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.052 0.926 . . . . 0.0 109.489 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 108' ' ' TYR . 73.0 Cg_endo -71.93 138.29 31.01 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.981 3.12 . . . . 0.0 111.121 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.4 pt -140.73 -177.39 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.14 0.576 . . . . 0.0 110.215 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.5 ' CD1' HG23 ' A' ' 92' ' ' ILE . 3.7 t80 -143.21 157.95 44.05 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.976 -0.452 . . . . 0.0 110.55 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 tt -156.84 157.68 35.39 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.757 1.223 . . . . 0.0 109.446 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -164.93 -179.08 38.72 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.809 HD11 HD21 ' A' ' 30' ' ' LEU . 9.5 mt -94.68 160.1 14.77 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -131.95 88.44 2.56 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.9 -40.58 0.02 OUTLIER Glycine 0 CA--C 1.523 0.538 0 CA-C-O 118.93 -0.928 . . . . 0.0 111.463 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.57 23.46 2.3 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.82 0.848 . . . . 0.0 112.731 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.2 m120 59.9 73.07 0.5 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.999 1.72 . . . . 0.0 110.228 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.09 138.55 25.42 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.768 1.227 . . . . 0.0 110.203 -177.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 16.3 m -139.93 177.42 7.98 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.837 0.744 . . . . 0.0 109.604 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.889 ' HA ' HD12 ' A' ' 87' ' ' LEU . 26.8 mt -61.42 151.11 33.4 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.2 ttp -155.04 148.61 25.29 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 9.3 m -124.53 126.46 45.88 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.47 -178.63 4.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.916 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -132.69 118.98 19.78 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.4 m -75.25 30.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 122.966 0.507 . . . . 0.0 111.276 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.42 -3.86 61.51 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.201 -0.937 . . . . 0.0 112.087 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -127.06 -57.43 1.32 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.799 1.24 . . . . 0.0 112.071 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -145.26 164.06 28.84 Favored Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 125.59 1.556 . . . . 0.0 110.943 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.94 148.96 46.38 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.302 1.334 . . . . 0.0 113.234 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.6 p -146.06 169.83 17.89 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.575 0.75 . . . . 0.0 110.348 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.559 ' CD2' HD11 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -89.74 141.76 28.32 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.913 1.285 . . . . 0.0 109.929 179.326 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.63 HE21 ' HE3' ' A' ' 88' ' ' LYS . 7.6 mt-30 -140.27 68.28 1.36 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.709 0.766 . . . . 0.0 109.682 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.889 HD12 ' HA ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -85.0 106.57 16.6 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -178.577 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.63 ' HE3' HE21 ' A' ' 86' ' ' GLN . 0.0 OUTLIER -163.37 -43.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 O-C-N 124.887 1.367 . . . . 0.0 112.251 -179.328 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -139.97 93.11 2.61 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -167.36 172.44 9.7 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.411 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.463 ' H ' ' HD3' ' A' ' 90' ' ' LYS . 14.9 m-20 -146.17 139.31 25.82 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 125.786 1.635 . . . . 0.0 109.356 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.5 HG23 ' CD1' ' A' ' 64' ' ' TYR . 1.8 mp -87.62 -48.14 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.05 0.94 . . . . 0.0 111.057 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -60.82 -28.27 68.67 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 118.984 -0.531 . . . . 0.0 111.098 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -65.99 -51.98 53.51 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.943 0.792 . . . . 0.0 109.702 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.443 HD12 ' CE1' ' A' ' 64' ' ' TYR . 52.6 mt -63.79 -27.22 69.03 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.021 0.529 . . . . 0.0 111.332 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -82.33 -28.06 31.86 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.531 -0.731 . . . . 0.0 110.231 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -78.14 -37.21 46.61 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.894 1.278 . . . . 0.0 111.406 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -109.12 158.09 35.28 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -77.62 50.29 3.18 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.165 2.577 . . . . 0.0 111.89 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -117.05 74.5 7.18 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 124.892 1.277 . . . . 0.0 111.06 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -78.64 81.1 2.86 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.494 2.13 . . . . 0.0 107.519 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.3 t -70.27 97.95 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -51.43 -30.44 19.44 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.812 0.845 . . . . 0.0 111.76 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -64.43 -5.93 6.26 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 125.751 1.62 . . . . 0.0 112.199 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -123.49 -31.28 3.53 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.244 1.018 . . . . 0.0 109.158 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.1 mt -70.41 162.25 29.01 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.192 1.397 . . . . 0.0 112.489 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -152.2 139.68 19.61 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.152 0.981 . . . . 0.0 109.888 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER -82.98 161.59 21.72 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-N 119.858 1.208 . . . . 0.0 108.926 177.677 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -114.2 126.0 54.56 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 128.32 2.648 . . . . 0.0 112.139 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.5 t -132.35 145.88 51.57 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.29 148.57 47.32 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.185 0.994 . . . . 0.0 109.801 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.5 p -157.67 78.98 0.86 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.32 70.77 1.2 Allowed Glycine 0 N--CA 1.467 0.753 0 C-N-CA 123.958 0.79 . . . . 0.0 112.736 177.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.4 mtm-85 61.61 9.47 2.79 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.473 1.509 . . . . 0.0 112.726 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -119.72 153.4 35.69 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.2 m -139.85 151.55 45.77 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 79.6 p -114.39 174.57 5.89 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.624 0.726 . . . . 0.0 111.286 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -139.82 104.45 4.89 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.927 1.691 . . . . 0.0 106.923 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.444 ' HB2' ' CD2' ' A' ' 127' ' ' PHE . 0.3 OUTLIER -117.55 130.29 56.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.668 178.628 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.6 m -53.26 126.21 20.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.107 1.363 . . . . 0.0 112.626 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 99.2 t -71.8 -42.86 69.99 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.889 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.6 91.6 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -128.02 82.04 69.21 Favored Pre-proline 0 C--O 1.234 0.254 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.07 153.38 78.33 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 108.679 -1.316 . . . . 0.0 108.679 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.09 -12.26 44.77 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.511 1.529 . . . . 0.0 110.888 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -113.22 135.48 53.78 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.13 1.772 . . . . 0.0 108.575 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.444 ' CD2' ' HB2' ' A' ' 119' ' ' GLU . 37.7 m-85 -122.21 150.19 42.62 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.833 1.653 . . . . 0.0 108.463 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 22.3 mt -79.52 134.49 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 123.734 0.814 . . . . 0.0 110.1 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -104.34 124.92 50.05 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 91.7 t -72.9 -19.1 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 127.708 2.403 . . . . 0.0 113.214 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.4 m 54.34 65.58 1.47 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.176 1.39 . . . . 0.0 114.325 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.5 m -88.61 -9.75 51.08 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -58.17 -76.07 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.906 2.188 . . . . 0.0 116.906 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.93 16.11 5.83 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 125.447 1.499 . . . . 0.0 113.278 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.519 ' HA2' ' HB3' ' A' ' 32' ' ' ALA . . . 82.58 56.53 2.77 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -84.33 166.69 31.56 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 117.457 0.628 . . . . 0.0 110.213 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.55 151.32 32.64 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.96 1.773 . . . . 0.0 109.005 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.407 HD11 ' CE2' ' A' ' 23' ' ' TRP . 12.8 mt -76.51 115.29 16.12 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.499 1.12 . . . . 0.0 108.114 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.06 168.87 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 125.573 1.549 . . . . 0.0 110.713 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 74.4 mt -88.1 165.43 15.14 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.1 t -153.95 137.39 15.86 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -80.23 -41.05 25.87 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.417 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 CA--C 1.504 -0.797 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 -178.066 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.31 88.99 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 129.724 3.21 . . . . 0.0 113.298 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.5 p -111.76 -2.72 15.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.151 -0.968 . . . . 0.0 111.984 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -139.17 109.8 6.64 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.44 -176.99 6.21 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.199 1.8 . . . . 0.0 111.879 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.62 -173.7 25.84 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.537 1.541 . . . . 0.0 110.777 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.41 HD11 HD11 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -132.66 146.61 52.02 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.621 1.169 . . . . 0.0 109.392 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.0 m -102.8 45.83 0.95 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.331 1.453 . . . . 0.0 107.159 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -67.68 154.18 42.07 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.495 1.118 . . . . 0.0 109.238 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.2 mt -129.11 172.3 11.55 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.006 1.322 . . . . 0.0 109.591 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.8 p90 . . . . . 0 C--O 1.248 0.996 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 179.403 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 119.474 -0.298 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.1 136.05 42.87 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.084 2.523 . . . . 0.0 109.576 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.79 111.11 20.73 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -109.93 145.14 37.39 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.31 -140.17 3.19 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 119.459 1.027 . . . . 0.0 112.54 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.2 p -136.68 -175.95 4.19 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.604 1.702 . . . . 0.0 113.311 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.6 mt -144.31 -6.19 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 126.696 1.999 . . . . 0.0 109.438 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.413 ' C ' ' H ' ' A' ' 18' ' ' ILE . 4.8 pt20 -73.52 -24.32 60.13 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 119.467 -2.02 . . . . 0.0 114.43 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -72.17 36.91 0.07 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.208 3.003 . . . . 0.0 110.732 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.413 ' H ' ' C ' ' A' ' 16' ' ' GLN . 45.4 mt -122.14 -71.14 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 128.674 2.79 . . . . 0.0 109.504 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -126.57 25.35 6.49 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 122.548 0.339 . . . . 0.0 111.383 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 t60 64.83 35.82 8.31 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.623 0.725 . . . . 0.0 109.414 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.3 mmt-85 -104.16 81.65 1.86 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 120.838 -1.163 . . . . 0.0 109.809 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.65 134.12 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.566 ' CD2' HD11 ' A' ' 138' ' ' LEU . 45.8 m0 -89.95 144.66 25.73 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.8 t -144.21 131.52 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.6 tp -71.14 115.01 9.79 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -132.27 123.92 27.86 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.922 1.289 . . . . 0.0 107.731 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.3 t70 46.85 50.4 13.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.728 1.211 . . . . 0.0 112.475 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 65.86 15.76 10.19 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.2 m -137.39 152.11 49.29 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.592 HD11 HD11 ' A' ' 67' ' ' LEU . 31.4 mt -91.07 129.31 37.08 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 119.815 -1.803 . . . . 0.0 107.481 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.2 mm -127.73 138.16 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.407 0.683 . . . . 0.0 110.409 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.18 127.98 33.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.526 1.131 . . . . 0.0 108.73 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -111.26 99.12 42.47 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 124.601 1.16 . . . . 0.0 108.036 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.25 -32.16 8.59 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.287 1.991 . . . . 0.0 112.726 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -92.9 161.99 14.26 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.864 1.266 . . . . 0.0 109.816 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.04 19.44 12.84 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.542 1.137 . . . . 0.0 110.095 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -53.55 -50.82 64.71 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.282 1.401 . . . . 0.0 108.861 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.07 81.79 0.78 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 12.6 ptp -108.8 169.19 8.82 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.9 t -148.28 130.82 7.79 Favored Pre-proline 0 N--CA 1.45 -0.441 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -64.9 148.85 90.06 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.788 1.658 . . . . 0.0 107.86 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.5 m -142.03 171.5 10.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 125.591 1.556 . . . . 0.0 107.365 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.37 157.59 46.51 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mm -118.21 144.0 27.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 127.984 2.513 . . . . 0.0 105.271 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.02 129.92 52.85 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 126.597 1.959 . . . . 0.0 105.793 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.42 132.1 48.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.96 1.255 . . . . 0.0 107.699 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.5 mt -144.93 149.41 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.6 p -81.82 166.03 20.34 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.7 t -88.77 158.43 18.16 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -117.2 -3.8 11.47 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 177.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -119.05 57.36 0.88 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.417 ' HA ' HD12 ' A' ' 55' ' ' LEU . 24.0 m -83.87 -11.97 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.96 0.904 . . . . 0.0 110.837 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -64.72 -6.53 8.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.56 1.944 . . . . 0.0 112.484 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.7 t -121.8 7.89 9.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.157 1.383 . . . . 0.0 110.196 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 52' ' ' VAL . 96.0 mt -108.24 173.05 6.49 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 120.585 -1.322 . . . . 0.0 112.006 -178.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -79.77 154.92 28.17 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -126.44 -40.59 1.94 Allowed 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 116.938 -1.506 . . . . 0.0 110.846 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.28 -38.7 28.08 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.115 1.766 . . . . 0.0 114.177 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -65.63 -33.19 75.33 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 119.602 -0.237 . . . . 0.0 111.349 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.633 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 142.21 -178.14 21.03 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 126.381 1.943 . . . . 0.0 110.584 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -78.2 113.71 36.03 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -81.91 148.22 15.38 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 124.432 3.421 . . . . 0.0 111.592 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -149.84 -171.78 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 126.673 1.989 . . . . 0.0 109.067 178.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.456 ' CZ ' HD13 ' A' ' 95' ' ' LEU . 8.2 m-85 -132.86 147.11 52.3 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.928 2.091 . . . . 0.0 112.762 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.404 HD22 HD11 ' A' ' 74' ' ' LEU . 5.1 tt -156.73 134.15 10.69 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 120.474 -1.391 . . . . 0.0 109.645 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -142.02 -167.77 11.43 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.592 HD11 HD11 ' A' ' 30' ' ' LEU . 2.5 mt -100.7 159.52 15.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -120.89 87.56 2.78 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.61 -38.33 0.03 OUTLIER Glycine 0 C--N 1.336 0.544 0 CA-C-O 117.927 -1.485 . . . . 0.0 116.082 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.78 17.2 2.68 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.852 1.826 . . . . 0.0 111.896 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.15 69.15 0.39 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.62 146.37 29.33 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 124.784 1.233 . . . . 0.0 108.684 -177.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.401 ' SG ' HG13 ' A' ' 92' ' ' ILE . 4.4 m -145.24 -175.37 4.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.324 1.05 . . . . 0.0 112.232 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.886 ' HA ' HD12 ' A' ' 87' ' ' LEU . 45.4 mt -66.64 160.5 25.34 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.2 ttp -161.69 127.56 3.66 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.3 m -96.51 119.67 35.42 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 118.314 0.506 . . . . 0.0 110.472 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -123.39 175.85 6.49 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -137.25 120.05 16.3 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.9 m -74.18 13.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.17 -23.95 34.25 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -115.32 -39.15 3.65 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -149.64 158.45 37.63 Favored Pre-proline 0 C--O 1.24 0.575 0 C-N-CA 123.785 0.834 . . . . 0.0 111.052 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -71.01 145.31 49.63 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.219 2.613 . . . . 0.0 110.194 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 42.4 p -146.55 156.92 43.6 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.458 0.703 . . . . 0.0 110.075 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.452 ' HB3' HD11 ' A' ' 87' ' ' LEU . 7.9 mt -83.11 149.11 27.09 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -145.44 67.23 1.22 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.451 1.5 . . . . 0.0 109.437 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.886 HD12 ' HA ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -83.12 112.09 19.5 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 127.63 2.372 . . . . 0.0 108.032 -177.715 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.47 -29.28 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 O-C-N 125.21 1.569 . . . . 0.0 113.358 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -146.25 90.07 1.92 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 120.321 1.418 . . . . 0.0 113.21 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -166.9 160.1 14.07 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.564 1.546 . . . . 0.0 107.071 179.417 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.43 146.68 40.42 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.958 1.703 . . . . 0.0 107.688 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.464 ' HA ' HD12 ' A' ' 95' ' ' LEU . 3.0 mt -96.85 -40.28 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.737 0.815 . . . . 0.0 110.707 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -27.29 68.73 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.399 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.08 -48.28 80.89 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.836 0.827 . . . . 0.0 110.707 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 92' ' ' ILE . 13.1 mt -62.71 -27.99 69.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 127.598 2.359 . . . . 0.0 110.368 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -87.32 -20.25 27.05 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -88.27 -25.22 22.94 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 119.339 0.972 . . . . 0.0 112.678 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -137.75 157.43 73.48 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.807 1.243 . . . . 0.0 111.068 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.2 67.64 5.15 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 124.018 3.145 . . . . 0.0 114.124 -178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -118.07 73.27 9.59 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.12 0.968 . . . . 0.0 111.461 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -80.95 77.42 4.06 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.294 2.663 . . . . 0.0 108.504 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.2 t -68.62 103.17 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 126.174 1.789 . . . . 0.0 108.849 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.409 ' HA ' HD12 ' A' ' 106' ' ' LEU . 44.4 mtpt -56.3 -31.62 63.83 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.041 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.0 -9.05 42.53 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.648 1.113 . . . . 0.0 112.284 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -120.82 -18.54 7.61 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.225 0.921 . . . . 0.0 109.169 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 103' ' ' LYS . 66.6 mt -74.69 149.58 39.84 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 119.774 -1.829 . . . . 0.0 109.724 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -139.7 129.27 24.37 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.988 0.515 . . . . 0.0 110.549 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.633 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -74.68 126.8 31.64 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 177.766 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -95.49 117.08 29.74 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.023 0.529 . . . . 0.0 111.265 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.1 t -112.33 -176.81 3.01 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 2.1 pt20 -150.93 147.7 27.51 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.177 2.191 . . . . 0.0 110.025 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.1 p -164.63 87.66 0.47 Allowed 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.993 1.433 . . . . 0.0 113.874 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.04 70.46 1.3 Allowed Glycine 0 CA--C 1.504 -0.64 0 C-N-CA 124.899 1.238 . . . . 0.0 112.251 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.8 mtm-85 64.22 -2.32 0.61 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.686 1.995 . . . . 0.0 113.075 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -111.74 165.89 11.65 Favored 'General case' 0 CA--C 1.513 -0.442 0 C-N-CA 124.885 1.274 . . . . 0.0 110.951 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 45.6 m -132.69 162.91 30.18 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.695 1.598 . . . . 0.0 110.471 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.87 170.07 16.43 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.106 0.962 . . . . 0.0 110.222 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -139.67 109.5 6.35 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.443 1.497 . . . . 0.0 108.993 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -100.78 130.02 46.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.491 1.916 . . . . 0.0 110.134 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.4 t -58.1 126.07 25.87 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.548 0.613 . . . . 0.0 109.541 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.34 -47.99 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 O-C-N 120.938 -1.101 . . . . 0.0 110.129 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.42 -37.62 65.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.254 0.479 . . . . 0.0 110.804 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -138.19 91.0 13.18 Favored Pre-proline 0 C--O 1.234 0.269 0 C-N-CA 123.502 0.721 . . . . 0.0 109.137 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.25 174.53 8.94 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.606 2.204 . . . . 0.0 112.264 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.39 -13.76 44.26 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 126.262 1.886 . . . . 0.0 111.341 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -110.2 117.69 34.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.177 0.991 . . . . 0.0 109.553 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -99.27 132.84 44.31 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 127.521 2.328 . . . . 0.0 109.326 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 pt -71.95 120.76 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 121.762 -0.586 . . . . 0.0 109.634 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.27 166.74 16.25 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 118.181 -1.408 . . . . 0.0 111.274 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.5 m -107.28 -16.29 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 C-N-CA 125.099 1.36 . . . . 0.0 112.976 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.1 m 72.63 64.98 0.12 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 122.804 1.288 . . . . 0.0 110.728 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.08 33.09 4.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.532 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -117.05 -47.69 2.67 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.725 0.41 . . . . 0.0 111.749 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -140.46 -60.21 0.04 OUTLIER Glycine 0 C--N 1.333 0.384 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.41 51.94 0.01 OUTLIER Glycine 0 C--N 1.332 0.308 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' CYS . . . . . 0.524 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 55.9 m -88.18 177.43 2.65 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.921 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 136' ' ' CYS . 42.0 Cg_endo -81.39 169.66 15.43 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.009 2.473 . . . . 0.0 111.025 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 23' ' ' TRP . 30.3 mt -86.91 112.76 22.09 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 124.159 0.983 . . . . 0.0 110.702 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.25 -175.08 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.034 0.934 . . . . 0.0 110.15 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.09 137.03 45.94 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 15.4 t -131.19 154.36 48.48 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.562 1.545 . . . . 0.0 108.753 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -94.93 -23.36 17.45 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.373 1.469 . . . . 0.0 108.903 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 . . . . . 0 N--CA 1.441 -0.906 0 CA-C-O 123.374 1.559 . . . . 0.0 108.4 -177.757 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 . . . . . 0 C--O 1.237 0.437 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.533 HG21 ' CE2' ' A' ' 152' ' ' PHE . 3.5 m -82.69 137.34 34.47 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.523 1.929 . . . . 0.0 109.382 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 65.3 p -117.68 -23.65 7.54 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.064 1.302 . . . . 0.0 108.046 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -95.8 110.0 22.23 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.953 1.301 . . . . 0.0 113.654 -177.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.533 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.6 OUTLIER -166.52 -175.14 3.08 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.235 1.814 . . . . 0.0 108.78 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -108.85 -178.04 21.61 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.91 131.57 53.41 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 123.739 0.816 . . . . 0.0 109.558 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.5 m -79.0 31.85 0.21 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.384 1.474 . . . . 0.0 108.31 177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.9 ptt? -63.03 130.14 43.41 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.261 1.824 . . . . 0.0 107.928 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 21.5 mt -100.51 175.83 5.55 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 126.181 1.792 . . . . 0.0 108.753 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 23.9 p90 . . . . . 0 C--O 1.261 1.7 0 CA-C-O 115.615 -2.136 . . . . 0.0 108.924 -179.405 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.538 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.35 152.61 20.77 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.67 2.247 . . . . 0.0 108.328 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.12 124.44 27.53 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 178.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.92 133.81 55.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.82 -131.08 1.29 Allowed Glycine 0 CA--C 1.522 0.478 0 CA-C-O 116.825 -2.097 . . . . 0.0 110.259 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.7 p -154.97 -173.04 4.41 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 122.604 3.202 . . . . 0.0 114.715 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mt -136.36 -2.93 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.763 1.225 . . . . 0.0 108.712 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.508 ' CB ' HG22 ' A' ' 22' ' ' VAL . 4.7 pt20 -56.39 -40.86 75.33 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.099 -1.626 . . . . 0.0 112.114 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -19.98 2.36 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.712 2.005 . . . . 0.0 115.393 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.6 mm -64.91 -58.68 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 123.584 0.753 . . . . 0.0 112.324 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -138.99 24.04 2.58 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.439 0.638 . . . . 0.0 110.816 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.3 t60 62.98 40.18 9.53 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.08 1.752 . . . . 0.0 108.39 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.4 mmt-85 -109.23 85.53 2.12 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.829 -1.169 . . . . 0.0 109.46 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.508 HG22 ' CB ' ' A' ' 16' ' ' GLN . 90.9 t -78.0 154.63 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.514 ' CD2' HD11 ' A' ' 138' ' ' LEU . 54.1 m0 -105.63 144.81 31.86 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.9 t -141.27 133.4 29.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.448 HD13 ' CD2' ' A' ' 72' ' ' LEU . 4.0 tt -74.56 122.61 23.38 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -131.14 119.34 21.77 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 47.0 t0 32.49 67.17 0.17 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.034 1.734 . . . . 0.0 113.876 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 60.5 17.73 7.59 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.5 m -137.97 126.57 23.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.341 1.456 . . . . 0.0 109.813 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.537 HD12 ' HG ' ' A' ' 87' ' ' LEU . 11.8 mt -77.5 136.2 38.31 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.5 pp -127.05 145.73 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 123.574 0.749 . . . . 0.0 111.861 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.28 127.79 34.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 m -103.69 89.37 2.22 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.65 -55.1 0.3 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.34 1.36 . . . . 0.0 112.731 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -154.73 95.27 1.75 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.484 0.714 . . . . 0.0 111.993 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.43 160.84 39.97 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -69.12 -34.61 75.32 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.846 0.859 . . . . 0.0 112.281 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -82.35 58.64 4.18 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.41 0.684 . . . . 0.0 110.677 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -90.02 157.92 17.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 177.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.1 m -157.98 109.84 1.75 Allowed Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 125.89 1.676 . . . . 0.0 106.517 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.99 148.2 69.5 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 N-CA-C 107.907 -1.613 . . . . 0.0 107.907 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.07 157.58 28.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.05 156.38 19.32 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.3 mm -122.62 113.22 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 128.441 2.696 . . . . 0.0 106.288 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.71 138.56 32.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 65' ' ' LEU . 5.4 tt -137.36 130.25 30.39 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.649 1.18 . . . . 0.0 108.671 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -141.09 134.74 31.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.724 1.209 . . . . 0.0 107.975 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.4 p -66.47 158.61 29.07 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.85 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.4 m -68.79 136.99 53.62 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.214 -0.929 . . . . 0.0 112.369 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -89.28 -30.34 18.54 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 117.234 -1.365 . . . . 0.0 112.865 178.483 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -122.35 69.98 0.97 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 119.721 1.146 . . . . 0.0 110.809 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.0 m -78.98 -10.76 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 123.043 0.537 . . . . 0.0 110.986 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -55.07 -32.46 61.95 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.54 1.936 . . . . 0.0 114.247 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 t -104.58 9.03 35.5 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.973 0.909 . . . . 0.0 110.463 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.9 mt -111.16 168.24 9.66 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.612 1.165 . . . . 0.0 110.25 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -83.1 159.54 22.08 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.633 1.973 . . . . 0.0 108.165 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.4 -24.85 1.77 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.133 1.373 . . . . 0.0 110.872 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.86 -26.76 59.31 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.073 2.149 . . . . 0.0 112.808 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -96.08 -1.2 49.19 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 125.119 1.368 . . . . 0.0 114.17 -178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.07 161.13 11.03 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -79.12 123.29 84.91 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 121.524 -0.986 . . . . 0.0 109.138 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 108' ' ' TYR . 83.4 Cg_endo -74.85 151.68 40.64 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.196 2.597 . . . . 0.0 111.228 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.459 HD11 ' CE1' ' A' ' 118' ' ' PHE . 1.4 pt -146.34 -175.17 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 126.513 1.925 . . . . 0.0 109.706 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -127.29 143.18 51.28 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 129.094 2.957 . . . . 0.0 109.919 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 46' ' ' LEU . 8.5 tt -154.83 148.94 25.88 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.434 -1.416 . . . . 0.0 109.221 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.403 ' HA3' ' SG ' ' A' ' 73' ' ' CYS . . . -162.44 -169.0 25.2 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 120.867 -1.146 . . . . 0.0 112.458 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.444 HD11 HD21 ' A' ' 30' ' ' LEU . 14.2 mt -105.51 149.93 25.79 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.92 101.7 8.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.6 -31.45 0.08 OUTLIER Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.462 -1.188 . . . . 0.0 114.006 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.25 20.84 0.75 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.736 1.768 . . . . 0.0 112.936 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.0 m120 65.89 66.64 0.49 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.448 ' CD2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.79 132.35 20.94 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.232 1.013 . . . . 0.0 111.127 -178.051 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.403 ' SG ' ' HA3' ' A' ' 66' ' ' GLY . 17.1 m -142.76 174.63 10.48 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 123.735 0.814 . . . . 0.0 110.283 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.82 ' HA ' HD12 ' A' ' 87' ' ' LEU . 45.2 mt -55.14 157.91 3.21 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 125.826 1.651 . . . . 0.0 113.644 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -166.21 150.98 8.06 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 117.519 -1.229 . . . . 0.0 108.73 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.2 m -123.05 112.11 17.37 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.559 1.144 . . . . 0.0 111.139 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.17 143.54 50.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.67 1.123 . . . . 0.0 108.246 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -92.86 123.29 36.02 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.344 1.458 . . . . 0.0 109.702 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.91 -4.43 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.97 16.92 10.05 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -151.17 -61.05 0.18 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.283 1.833 . . . . 0.0 107.959 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -141.35 161.45 52.76 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.26 1.424 . . . . 0.0 112.03 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.09 152.53 45.77 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.456 2.77 . . . . 0.0 110.333 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.6 p -146.27 161.94 39.18 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.263 1.825 . . . . 0.0 109.362 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.83 HD22 HD11 ' A' ' 87' ' ' LEU . 4.5 mt -78.9 140.0 38.19 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.784 1.634 . . . . 0.0 110.795 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.35 67.19 1.46 Allowed 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.059 0.845 . . . . 0.0 110.811 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.83 HD11 HD22 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -92.06 118.6 30.96 Favored 'General case' 0 CA--C 1.493 -1.216 0 C-N-CA 125.183 1.393 . . . . 0.0 109.412 -178.219 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -179.42 -29.34 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 O-C-N 125.013 1.445 . . . . 0.0 113.618 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -146.04 102.25 3.61 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.401 1.48 . . . . 0.0 107.442 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.05 161.65 0.59 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 119.003 0.82 . . . . 0.0 109.041 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.69 153.0 52.19 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.71 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.98 -38.9 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.786 1.234 . . . . 0.0 108.989 178.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.6 tpt -64.6 -33.09 75.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.867 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.07 -40.55 87.07 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.507 1.049 . . . . 0.0 110.647 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.4 mt -65.21 -31.88 73.28 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.416 ' CZ ' ' HG3' ' A' ' 50' ' ' ARG . 36.3 t80 -78.58 -29.41 46.15 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.085 0.954 . . . . 0.0 110.175 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -78.09 -32.73 50.8 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.656 -1.277 . . . . 0.0 113.417 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -126.21 168.66 13.54 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 119.053 0.842 . . . . 0.0 112.017 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -80.34 68.0 8.45 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.319 2.68 . . . . 0.0 109.904 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -121.55 72.8 30.01 Favored Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 121.695 -0.628 . . . . 0.0 110.426 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.24 65.13 8.89 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.853 3.035 . . . . 0.0 108.433 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.4 t -70.98 97.66 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.076 0 C-N-CA 125.142 1.377 . . . . 0.0 107.81 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -48.18 -30.43 4.64 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.202 1.401 . . . . 0.0 112.33 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 t -63.54 -14.93 56.02 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.59 1.556 . . . . 0.0 113.445 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -126.6 -4.08 6.58 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.951 1.7 . . . . 0.0 111.122 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.4 mt -95.18 151.62 19.06 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.363 1.465 . . . . 0.0 110.025 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -139.21 133.02 30.78 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 19.5 m-85 -77.94 137.09 38.14 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.652 1.115 . . . . 0.0 108.016 177.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.78 162.47 25.1 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.5 t -161.29 178.06 9.57 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 126.168 1.787 . . . . 0.0 106.346 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 2.0 pp0? -156.47 158.53 37.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.272 1.429 . . . . 0.0 109.431 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.3 p -120.28 2.62 10.85 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.63 -50.13 0.9 Allowed Glycine 0 C--N 1.336 0.531 0 O-C-N 120.532 -1.355 . . . . 0.0 110.544 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.11 -1.81 2.36 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.673 0.789 . . . . 0.0 111.633 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -130.4 168.97 16.11 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.793 1.237 . . . . 0.0 109.115 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 2.6 m -130.16 148.13 51.97 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.552 1.141 . . . . 0.0 111.873 -178.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.79 173.01 7.74 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 127.093 2.157 . . . . 0.0 111.783 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.459 ' CE1' HD11 ' A' ' 63' ' ' ILE . 31.6 m-85 -146.01 128.84 16.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 125' ' ' GLY . 9.4 tt0 -113.52 142.27 46.14 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 126.0 1.72 . . . . 0.0 107.107 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 50.0 m -70.4 124.11 23.38 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.189 2.196 . . . . 0.0 110.985 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.7 t -69.72 -43.87 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 120.812 1.642 . . . . 0.0 112.315 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.19 -24.48 66.64 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -138.76 77.5 32.77 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 126.08 1.752 . . . . 0.0 107.207 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.51 166.21 22.58 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.787 2.325 . . . . 0.0 112.369 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.407 ' H ' ' CD ' ' A' ' 119' ' ' GLU . . . 85.86 -13.7 55.43 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.867 1.222 . . . . 0.0 111.775 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -106.48 119.91 40.53 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.286 1.834 . . . . 0.0 109.802 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -103.04 148.26 25.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.774 0.83 . . . . 0.0 110.243 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.514 HG22 HD11 ' A' ' 85' ' ' LEU . 3.4 pt -78.38 139.4 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.921 0.391 . . . . 0.0 110.891 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.94 151.75 20.98 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.404 HG13 ' HZ2' ' A' ' 23' ' ' TRP . 45.0 t -106.06 -17.01 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 127.34 2.256 . . . . 0.0 111.047 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.2 m 55.34 82.42 0.1 Allowed 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 126.438 1.895 . . . . 0.0 112.695 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.2 m -111.1 -9.75 14.36 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -54.63 -61.13 2.51 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.639 1.575 . . . . 0.0 111.352 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -139.21 -85.55 0.12 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -165.98 60.82 0.23 Allowed Glycine 0 C--N 1.333 0.378 0 O-C-N 120.694 -1.474 . . . . 0.0 110.201 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.1 m -91.37 163.6 28.08 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.73 161.71 45.1 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.595 1.53 . . . . 0.0 109.779 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.514 HD11 ' CD2' ' A' ' 23' ' ' TRP . 20.4 mt -87.5 113.03 22.83 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.21 167.18 23.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.628 1.571 . . . . 0.0 109.391 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 80.7 mt -83.91 156.15 22.52 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.79 156.13 47.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -99.24 -46.75 5.43 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 N--CA 1.425 -1.683 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 179.441 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.582 HG21 ' CE2' ' A' ' 152' ' ' PHE . 0.2 OUTLIER -142.7 113.15 7.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 -178.946 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -99.48 -28.99 12.99 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.074 1.75 . . . . 0.0 110.241 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -112.41 123.93 51.36 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 123.657 0.783 . . . . 0.0 109.721 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.582 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.1 OUTLIER -158.82 -170.34 3.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.002 178.38 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.42 176.8 38.79 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.22 111.97 6.46 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 24.3 m -77.16 46.77 0.51 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -73.95 120.38 19.46 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.6 mt -99.07 156.57 16.87 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 123.795 0.838 . . . . 0.0 109.626 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.7 p90 . . . . . 0 C--O 1.246 0.882 0 C-N-CA 125.111 1.364 . . . . 0.0 108.554 179.772 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptm . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -62.89 165.79 6.38 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.689 0.396 . . . . 0.0 111.692 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -78.95 -92.83 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.47 93.24 1.67 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.053 1.341 . . . . 0.0 109.444 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.582 ' H ' HD23 ' A' ' 5' ' ' LEU . 1.9 pt? -133.09 174.91 9.86 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 127.82 2.448 . . . . 0.0 110.411 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -130.09 15.14 5.72 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.918 1.287 . . . . 0.0 113.271 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -130.4 26.59 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 125.869 1.668 . . . . 0.0 110.714 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -66.64 -39.02 88.08 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.383 0.673 . . . . 0.0 111.529 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -58.21 141.38 82.31 Favored Pre-proline 0 N--CA 1.45 -0.437 0 O-C-N 123.504 0.503 . . . . 0.0 110.604 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.2 138.53 61.79 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 121.476 1.451 . . . . 0.0 110.229 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.61 109.83 18.32 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.55 133.93 52.85 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.308 1.043 . . . . 0.0 109.969 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.03 -124.38 0.71 Allowed Glycine 0 CA--C 1.523 0.543 0 CA-C-O 117.458 -1.746 . . . . 0.0 109.891 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.2 p -157.96 -165.11 1.66 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 121.517 2.658 . . . . 0.0 113.604 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.9 mt -145.18 -13.8 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.056 1.342 . . . . 0.0 108.277 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.406 ' HG3' HG22 ' A' ' 22' ' ' VAL . 2.1 tm0? -55.17 -31.88 61.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 118.067 -0.968 . . . . 0.0 112.11 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.39 -19.12 3.12 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.584 1.554 . . . . 0.0 112.893 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.4 mt -64.06 -52.5 55.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.174 1.39 . . . . 0.0 113.47 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -148.41 31.54 0.82 Allowed 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 117.931 0.332 . . . . 0.0 110.189 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.0 m80 59.97 25.36 14.54 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.071 0.949 . . . . 0.0 112.054 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.45 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 7.0 mmt-85 -86.71 98.53 11.19 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.382 -1.449 . . . . 0.0 108.178 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.406 HG22 ' HG3' ' A' ' 16' ' ' GLN . 72.6 t -76.58 145.05 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -105.2 132.43 51.43 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.327 1.451 . . . . 0.0 109.134 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.7 t -137.05 129.69 44.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 119.168 0.895 . . . . 0.0 108.863 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.666 HD13 ' CD2' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -74.5 112.97 11.21 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 101.161 -3.644 . . . . 0.0 101.161 176.147 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -129.55 120.99 26.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.705 2.002 . . . . 0.0 108.153 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.5 t0 45.31 58.23 4.29 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.305 1.442 . . . . 0.0 110.945 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 57.15 20.11 5.35 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.637 1.975 . . . . 0.0 114.913 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.3 m -134.23 143.32 47.75 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.588 0.755 . . . . 0.0 109.329 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.643 HD12 HD13 ' A' ' 87' ' ' LEU . 19.2 mt -90.71 124.68 35.29 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.76 136.78 56.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.685 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.45 136.21 39.41 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -124.32 68.65 49.48 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.34 -6.24 14.47 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.828 2.352 . . . . 0.0 116.304 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.67 78.41 0.7 Allowed 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.597 1.159 . . . . 0.0 109.227 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -151.36 137.29 18.14 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 121.125 -0.984 . . . . 0.0 110.42 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -68.27 -34.6 76.46 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.816 0.846 . . . . 0.0 108.735 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.68 30.3 0.65 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.166 0.987 . . . . 0.0 112.793 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.7 ptp -73.33 167.2 21.72 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.7 t -153.22 121.58 3.12 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.12 151.21 49.24 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 N-CA-C 108.632 -1.334 . . . . 0.0 108.632 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.95 -174.35 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.19 154.87 50.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mm -126.72 111.44 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 C-N-CA 126.901 2.08 . . . . 0.0 108.384 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.74 130.47 41.25 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.509 1.924 . . . . 0.0 107.64 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -126.09 131.62 52.08 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.304 1.842 . . . . 0.0 108.894 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -149.36 145.86 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 124.838 1.255 . . . . 0.0 110.664 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.79 156.38 38.97 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 125.79 1.636 . . . . 0.0 109.001 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.477 ' O ' HG13 ' A' ' 52' ' ' VAL . 85.4 m -92.78 106.47 18.44 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -67.99 -14.89 63.32 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -98.93 29.88 3.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.988 0.813 . . . . 0.0 111.21 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.604 ' HA ' HD23 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -62.4 -7.41 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 126.228 1.811 . . . . 0.0 113.251 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -55.75 -35.63 66.41 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.072 0.949 . . . . 0.0 112.614 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -98.56 0.52 45.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.774 1.23 . . . . 0.0 112.491 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.642 HD21 ' HB2' ' A' ' 101' ' ' PRO . 3.7 mm? -91.0 171.39 9.3 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 123.077 1.418 . . . . 0.0 109.616 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -74.85 157.01 35.83 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.421 -1.718 . . . . 0.0 107.453 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -129.29 -40.32 1.46 Allowed 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.703 -0.665 . . . . 0.0 109.956 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -50.63 -54.3 23.92 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.262 1.425 . . . . 0.0 113.313 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -60.39 -31.23 70.16 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.975 0.91 . . . . 0.0 112.293 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.24 169.45 11.75 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 125.886 1.708 . . . . 0.0 109.828 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -69.76 112.07 11.06 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 127.284 2.234 . . . . 0.0 115.763 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -80.98 131.78 8.12 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.714 2.943 . . . . 0.0 110.302 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 pp -137.82 178.44 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.669 ' CD1' HG22 ' A' ' 92' ' ' ILE . 5.0 t80 -134.92 153.77 51.94 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.712 1.142 . . . . 0.0 112.15 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.5 tt -145.68 157.03 44.0 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.284 1.434 . . . . 0.0 110.039 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.4 176.01 35.42 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.552 HD11 HD11 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -94.51 140.86 29.29 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 178.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -107.51 118.91 37.96 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 159.67 -75.67 0.2 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.02 19.59 14.86 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 41.7 t30 60.94 72.41 0.52 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.952 1.251 . . . . 0.0 109.626 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.666 ' CD2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -146.59 136.01 22.89 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.034 0.934 . . . . 0.0 110.381 -177.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.632 ' SG ' HG23 ' A' ' 92' ' ' ILE . 17.7 m -144.97 169.67 17.63 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.184 -0.947 . . . . 0.0 110.534 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.427 HD23 HD21 ' A' ' 87' ' ' LEU . 13.5 mt -53.37 148.32 9.1 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.086 0.469 . . . . 0.0 110.39 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.0 ttp -160.71 120.99 2.81 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 93.4 m -82.12 138.15 34.83 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.2 -177.56 4.76 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.202 2.201 . . . . 0.0 106.845 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -143.8 140.5 29.92 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.9 m -90.15 26.64 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.45 5.9 56.59 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.259 0.933 . . . . 0.0 111.648 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -131.48 -57.03 1.01 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.976 1.71 . . . . 0.0 110.624 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -145.14 157.18 54.05 Favored Pre-proline 0 C--O 1.239 0.552 0 C-N-CA 124.416 1.086 . . . . 0.0 110.421 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.06 149.66 88.93 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.897 3.065 . . . . 0.0 113.639 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.1 p -148.61 168.35 23.04 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.908 1.683 . . . . 0.0 110.708 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mt -97.24 149.24 22.26 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.461 1.104 . . . . 0.0 108.856 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -143.83 78.1 1.58 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.643 HD13 HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -89.43 94.1 9.76 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.69 -48.7 0.19 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.047 0.84 . . . . 0.0 112.6 -177.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -135.28 105.67 6.38 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.713 1.605 . . . . 0.0 107.486 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.06 154.87 0.91 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -127.66 139.98 52.38 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.669 HG22 ' CD1' ' A' ' 64' ' ' TYR . 4.0 pt -94.83 -41.51 12.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.835 1.654 . . . . 0.0 111.773 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.0 tpt -66.52 -23.14 66.19 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.757 0.708 . . . . 0.0 110.109 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.32 -52.48 18.53 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.525 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.523 HD12 ' CE1' ' A' ' 64' ' ' TYR . 18.1 mt -60.61 -26.22 66.83 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.175 0.988 . . . . 0.0 112.367 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -75.63 -51.19 13.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -59.67 -46.99 87.37 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.041 1.336 . . . . 0.0 112.67 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -100.74 148.92 35.68 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.706 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -75.4 68.01 6.15 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.036 2.491 . . . . 0.0 109.532 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -128.12 68.19 75.83 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 126.074 1.75 . . . . 0.0 108.556 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.642 ' HB2' HD21 ' A' ' 55' ' ' LEU . 84.1 Cg_endo -77.55 83.0 2.25 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.608 2.205 . . . . 0.0 106.552 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.4 t -78.17 103.14 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -52.37 -30.56 29.47 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.914 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.05 -15.67 34.99 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.136 0.88 . . . . 0.0 111.982 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -117.72 -15.91 10.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.584 1.154 . . . . 0.0 110.326 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.425 HD22 ' SG ' ' A' ' 49' ' ' CYS . 9.4 mt -83.59 152.61 24.74 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.27 1.396 . . . . 0.0 111.103 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -139.15 128.42 24.08 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.066 0.947 . . . . 0.0 110.697 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.55 123.73 21.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -94.8 136.21 35.37 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 t -135.88 -177.99 4.93 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.976 1.311 . . . . 0.0 109.596 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -159.65 146.51 16.52 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.734 1.214 . . . . 0.0 109.637 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.17 76.34 1.32 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 124.463 1.102 . . . . 0.0 111.821 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.89 78.84 0.82 Allowed Glycine 0 C--N 1.335 0.509 0 O-C-N 121.152 -0.968 . . . . 0.0 112.065 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 56.51 13.76 1.45 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.359 1.464 . . . . 0.0 112.763 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -121.26 151.82 39.58 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.3 m -125.25 148.45 48.66 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 125.636 1.574 . . . . 0.0 106.957 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.99 157.05 47.04 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -138.83 116.11 11.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.673 1.189 . . . . 0.0 107.833 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -112.24 133.01 54.61 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.881 1.273 . . . . 0.0 110.089 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.9 m -52.31 122.22 8.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.886 2.074 . . . . 0.0 110.458 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.7 t -73.34 -46.09 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 O-C-N 120.105 -1.622 . . . . 0.0 110.869 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.76 -30.83 71.88 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.034 0.834 . . . . 0.0 111.146 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -133.94 81.51 51.76 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 123.747 0.819 . . . . 0.0 110.746 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.16 159.89 44.69 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 N-CA-C 108.421 -1.415 . . . . 0.0 108.421 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.45 -17.78 30.76 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.062 0.839 . . . . 0.0 112.22 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 142' ' ' GLN . 30.9 m-90 -119.0 141.63 48.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.018 1.727 . . . . 0.0 111.245 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -118.5 142.44 47.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 128.82 2.848 . . . . 0.0 111.414 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.4 mt -69.01 134.18 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.4 114.5 28.72 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.537 0.608 . . . . 0.0 110.112 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.3 m -63.93 -19.15 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.5 m 61.19 63.6 1.21 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.953 1.835 . . . . 0.0 115.953 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.45 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 54.5 m -104.43 6.07 34.71 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 125.745 1.618 . . . . 0.0 113.18 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -82.01 -106.64 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.121 1.368 . . . . 0.0 107.563 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.42 -52.13 11.16 Favored Glycine 0 C--N 1.337 0.605 0 O-C-N 120.849 -1.157 . . . . 0.0 112.911 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 141.63 62.77 0.03 OUTLIER Glycine 0 CA--C 1.525 0.69 0 N-CA-C 106.491 -2.644 . . . . 0.0 106.491 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' CYS . . . . . 0.421 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 19.6 m -93.56 166.96 14.86 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 119.105 -0.474 . . . . 0.0 110.701 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 136' ' ' CYS . 87.3 Cg_endo -74.14 157.64 46.16 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.746 2.964 . . . . 0.0 110.352 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.557 HD12 HD13 ' A' ' 30' ' ' LEU . 15.2 mt -76.84 111.59 12.54 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.79 179.77 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 125.861 1.664 . . . . 0.0 110.587 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -110.6 144.74 39.01 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.3 t -134.78 152.7 51.96 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 126' ' ' TRP . 3.0 pt20 -107.38 -32.73 7.63 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -153.2 136.99 16.13 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.4 pp -132.46 155.11 49.13 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.427 -1.715 . . . . 0.0 107.652 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -114.4 65.4 0.28 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 105.689 -2.964 . . . . 0.0 105.689 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? 41.74 45.02 2.95 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 127.573 2.349 . . . . 0.0 110.746 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -117.13 -11.17 10.74 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.834 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.47 -179.47 5.38 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.98 96.11 4.82 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.605 0.762 . . . . 0.0 110.626 -177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.5 p -98.52 -32.57 11.39 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.85 96.39 10.37 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.717 1.607 . . . . 0.0 112.374 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.42 175.66 13.43 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.805 -1.184 . . . . 0.0 112.661 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.79 -166.89 29.47 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.5 tp -137.67 161.59 36.09 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.31 34.46 5.21 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -63.38 140.38 58.87 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 18.0 mt -123.18 166.33 15.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 17.7 p90 . . . . . 0 C--O 1.244 0.796 0 CA-C-O 116.482 -1.723 . . . . 0.0 107.469 178.965 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ppp? . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -132.56 165.71 23.77 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.874 1.67 . . . . 0.0 109.363 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -75.52 29.48 0.1 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.717 1.207 . . . . 0.0 113.559 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 52.94 40.47 31.04 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.517 1.927 . . . . 0.0 113.335 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.403 ' H ' HD23 ' A' ' 5' ' ' LEU . 1.7 pt? -104.27 -170.25 1.74 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.55 1.54 . . . . 0.0 108.447 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -157.74 -35.18 0.07 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.886 1.274 . . . . 0.0 112.398 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pp -60.55 -36.4 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 128.632 2.773 . . . . 0.0 113.225 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 48.12 26.61 1.06 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.896 2.079 . . . . 0.0 113.876 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -68.59 152.03 96.9 Favored Pre-proline 0 C--O 1.235 0.291 0 O-C-N 120.986 -1.071 . . . . 0.0 109.487 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.04 129.56 15.38 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.84 1.693 . . . . 0.0 108.019 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.55 115.21 29.49 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -112.61 135.65 53.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.966 0.506 . . . . 0.0 110.823 -179.434 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.87 -125.82 0.8 Allowed Glycine 0 N--CA 1.46 0.246 0 CA-C-O 117.882 -1.51 . . . . 0.0 109.979 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.475 ' HB2' HE21 ' A' ' 16' ' ' GLN . 26.6 p -157.03 -173.97 4.7 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 120.276 2.038 . . . . 0.0 112.709 -178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.436 HD11 HD11 ' A' ' 154' ' ' LEU . 8.4 mt -141.98 -19.07 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.92 1.688 . . . . 0.0 108.437 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.475 HE21 ' HB2' ' A' ' 14' ' ' SER . 4.0 pt20 -47.52 -39.99 17.56 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.147 -0.971 . . . . 0.0 113.459 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -51.32 -33.49 29.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.847 2.059 . . . . 0.0 114.866 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.4 mm -41.94 -55.44 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 127.146 2.178 . . . . 0.0 111.047 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.64 26.48 2.11 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.709 -0.619 . . . . 0.0 109.54 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 33.9 m80 60.46 25.05 14.64 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.34 2.256 . . . . 0.0 113.279 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.448 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 20.2 mmt180 -83.58 85.07 7.32 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 126.966 2.106 . . . . 0.0 107.493 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.6 t -69.5 136.7 25.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 120.726 -1.233 . . . . 0.0 108.572 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -95.59 135.01 37.81 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.722 1.209 . . . . 0.0 111.701 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.4 t -141.91 131.28 23.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.484 HD13 HD22 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -75.74 95.2 3.39 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 178.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -106.94 120.02 40.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 119.619 1.099 . . . . 0.0 108.506 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.6 t0 42.06 65.84 0.82 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.267 1.427 . . . . 0.0 111.615 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 57.3 8.7 0.61 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.679 1.591 . . . . 0.0 114.861 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 m -124.81 133.1 53.25 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 125.185 1.394 . . . . 0.0 110.129 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.825 HD12 HD13 ' A' ' 87' ' ' LEU . 8.8 mt -82.88 122.42 28.23 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -125.72 144.39 35.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.19 133.2 34.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -128.14 64.14 65.12 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.665 1.986 . . . . 0.0 111.435 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.429 ' HG3' HH11 ' A' ' 21' ' ' ARG . 11.7 Cg_endo -58.14 -56.77 1.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.343 1.362 . . . . 0.0 111.693 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.6 mtp85 -117.73 109.0 16.08 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.558 1.072 . . . . 0.0 109.105 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -167.92 -162.44 0.43 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.668 1.187 . . . . 0.0 109.135 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -122.81 -50.56 1.95 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -66.13 20.66 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.66 1.984 . . . . 0.0 114.977 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.7 ptp -74.59 -178.8 3.74 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 120.49 -1.381 . . . . 0.0 109.434 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 t -174.24 128.34 0.45 Allowed Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.79 146.05 33.09 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 N-CA-C 107.224 -1.875 . . . . 0.0 107.224 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 m -133.45 171.19 18.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.63 163.92 16.65 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.514 ' CG2' HD11 ' A' ' 65' ' ' LEU . 40.3 mm -131.18 108.42 14.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 127.18 2.192 . . . . 0.0 108.472 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.49 124.75 44.93 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.194 1.398 . . . . 0.0 108.521 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 tt -117.2 138.06 51.94 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.308 1.843 . . . . 0.0 108.744 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 mt -142.2 146.09 22.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 126.498 1.919 . . . . 0.0 108.291 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 p -84.16 145.23 28.5 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.522 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 55.7 m -66.85 107.86 2.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.936 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.75 7.87 9.34 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.577 -1.327 . . . . 0.0 111.564 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.71 29.33 5.03 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.552 2.341 . . . . 0.0 113.624 -177.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.41 -7.83 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 O-C-N 120.078 -1.639 . . . . 0.0 114.312 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -48.41 -51.44 26.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 119.528 1.058 . . . . 0.0 112.594 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 t -82.21 2.7 30.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.713 1.205 . . . . 0.0 112.568 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.6 mt -104.69 176.17 5.25 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 120.356 -1.465 . . . . 0.0 112.017 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -93.02 151.84 19.66 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.599 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -124.03 -25.53 4.19 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.847 1.259 . . . . 0.0 110.018 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -61.81 -20.62 63.83 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.418 0.687 . . . . 0.0 111.05 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -75.99 -20.56 57.77 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.133 0.973 . . . . 0.0 111.143 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.4 -103.41 0.4 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 125.962 1.744 . . . . 0.0 111.574 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -144.76 99.07 4.78 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.581 -0.952 . . . . 0.0 112.885 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.62 131.37 18.55 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.377 2.051 . . . . 0.0 110.682 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pt -143.53 -178.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.802 0.841 . . . . 0.0 109.244 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.57 ' CD1' HD12 ' A' ' 95' ' ' LEU . 4.3 t80 -136.57 134.92 37.97 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.999 0.92 . . . . 0.0 110.076 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.514 HD11 ' CG2' ' A' ' 44' ' ' ILE . 4.2 tt -138.43 152.16 48.09 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.994 1.318 . . . . 0.0 109.214 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.56 174.51 33.61 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.807 HD11 HD11 ' A' ' 30' ' ' LEU . 8.3 mt -88.58 139.12 30.8 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -109.46 102.09 10.99 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.87 -26.37 0.09 OUTLIER Glycine 0 CA--C 1.529 0.953 0 CA-C-O 117.945 -1.475 . . . . 0.0 113.335 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.01 19.84 0.58 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.643 1.722 . . . . 0.0 114.421 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.2 m120 62.51 62.1 1.16 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.385 1.474 . . . . 0.0 110.91 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.484 HD22 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -135.9 133.72 37.98 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.76 1.224 . . . . 0.0 109.299 -178.081 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.569 ' SG ' HG23 ' A' ' 92' ' ' ILE . 6.8 m -136.64 174.65 10.39 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.654 0.661 . . . . 0.0 111.896 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.693 HD23 HD21 ' A' ' 87' ' ' LEU . 17.9 mt -64.6 150.22 47.36 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.782 0.433 . . . . 0.0 111.378 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.453 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 1.4 tmm? -160.85 144.67 13.49 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 117.999 -1.0 . . . . 0.0 108.516 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -110.98 122.38 47.75 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.961 0.788 . . . . 0.0 110.103 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.86 135.16 29.26 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.078 0.951 . . . . 0.0 110.652 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -70.02 117.79 12.03 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.0 p -69.68 -24.21 26.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.813 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.89 -70.34 0.11 Allowed Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 105.357 -3.097 . . . . 0.0 105.357 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -97.36 -23.1 16.26 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -145.4 159.53 48.17 Favored Pre-proline 0 CA--C 1.536 0.405 0 O-C-N 121.374 -0.829 . . . . 0.0 112.891 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.4 148.01 72.67 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.565 2.843 . . . . 0.0 111.681 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.5 p -145.56 170.45 16.4 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.038 1.735 . . . . 0.0 108.668 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.62 HD11 HG23 ' A' ' 128' ' ' ILE . 6.6 mt -83.96 150.88 25.37 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 122.493 0.317 . . . . 0.0 110.687 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -144.91 64.29 1.28 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.109 0.964 . . . . 0.0 110.029 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.825 HD13 HD12 ' A' ' 30' ' ' LEU . 0.6 OUTLIER -86.06 118.96 25.85 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -171.66 -42.91 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.689 0.677 . . . . 0.0 112.269 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -134.49 101.99 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.852 1.261 . . . . 0.0 109.988 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 75' ' ' MET . 0.2 OUTLIER -163.82 171.36 15.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.696 1.589 . . . . 0.0 109.667 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -142.3 109.85 5.72 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.569 HG23 ' SG ' ' A' ' 73' ' ' CYS . 19.6 pt -70.77 -36.93 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 121.538 -0.726 . . . . 0.0 111.168 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -29.16 65.66 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.332 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -67.0 -50.0 63.59 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 118.61 0.641 . . . . 0.0 109.808 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.57 HD12 ' CD1' ' A' ' 64' ' ' TYR . 21.3 mt -64.28 -30.52 71.56 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -76.06 -26.85 56.93 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.545 -0.722 . . . . 0.0 109.849 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -86.87 -28.29 22.93 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -129.26 164.82 36.76 Favored Pre-proline 0 N--CA 1.456 -0.168 0 CA-C-N 121.177 1.808 . . . . 0.0 110.736 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.66 -161.65 0.13 Allowed 'Trans proline' 0 N--CA 1.445 -1.357 0 N-CA-C 107.109 -1.92 . . . . 0.0 107.109 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 77.46 70.75 0.2 Allowed Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 127.096 2.158 . . . . 0.0 109.859 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.17 107.45 0.66 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.517 2.145 . . . . 0.0 109.788 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 t -81.1 91.98 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -48.51 -32.32 7.73 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 125.021 1.328 . . . . 0.0 112.965 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.6 m -62.66 -14.33 42.31 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.333 1.053 . . . . 0.0 113.561 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -115.31 -20.87 10.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.319 1.448 . . . . 0.0 110.747 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.8 mt -80.92 154.23 27.13 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.776 0.83 . . . . 0.0 111.286 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.692 ' CD2' HD11 ' A' ' 128' ' ' ILE . 81.4 m-85 -141.69 138.97 32.81 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.281 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -81.46 131.28 35.27 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.43 119.99 32.49 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 125.84 1.656 . . . . 0.0 107.726 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 t -123.1 -172.17 2.45 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 2.1 pt20 -154.15 136.28 14.76 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.28 1.032 . . . . 0.0 108.576 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.98 69.74 1.45 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.78 -177.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.31 70.04 1.34 Allowed Glycine 0 C--N 1.338 0.656 0 O-C-N 121.274 -0.892 . . . . 0.0 113.675 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? 67.39 -10.37 0.35 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 128.013 2.525 . . . . 0.0 112.978 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -107.39 144.14 34.72 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.181 0.992 . . . . 0.0 108.641 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 0.4 OUTLIER -101.55 150.91 22.59 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.519 0.728 . . . . 0.0 110.929 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.61 166.86 12.21 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.518 1.927 . . . . 0.0 110.123 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -139.11 118.47 12.81 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -120.78 131.46 54.49 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.161 0.984 . . . . 0.0 110.248 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.8 t -52.99 116.94 2.62 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.778 1.631 . . . . 0.0 110.842 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.16 -45.82 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 119.227 0.921 . . . . 0.0 110.816 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.03 -26.49 68.58 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.555 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -145.9 87.19 6.86 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 119.202 0.91 . . . . 0.0 111.575 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -58.05 166.35 5.69 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.52 2.813 . . . . 0.0 114.032 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.65 -4.35 86.29 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 117.463 -1.743 . . . . 0.0 114.219 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 42.0 m95 -120.16 131.35 54.98 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.891 1.846 . . . . 0.0 107.843 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -114.9 144.37 43.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 126.037 1.735 . . . . 0.0 111.22 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.692 HD11 ' CD2' ' A' ' 107' ' ' PHE . 13.1 mt -77.11 123.32 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.737 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.74 120.09 32.17 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.38 0.609 . . . . 0.0 110.646 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.72 -23.29 27.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 C-N-CA 128.211 2.604 . . . . 0.0 111.051 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 m 60.9 87.0 0.09 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.911 1.339 . . . . 0.0 109.128 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.448 ' HA ' ' HG3' ' A' ' 21' ' ' ARG 0.271 1.7 m -109.76 4.1 21.48 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.696 -178.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -111.72 160.66 17.07 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 25.6 -87.54 0.01 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 128.043 2.735 . . . . 0.0 114.422 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -177.45 60.71 0.09 OUTLIER Glycine 0 CA--C 1.521 0.415 0 CA-C-O 117.795 -1.559 . . . . 0.0 109.38 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 4.9 m -85.08 161.42 52.53 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 119.455 1.627 . . . . 0.0 112.826 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.22 155.43 37.37 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 N-CA-C 108.553 -1.364 . . . . 0.0 108.553 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.0 mt -82.98 112.22 19.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 pp -138.0 -173.15 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.975 1.71 . . . . 0.0 109.843 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.4 mt -109.14 156.8 19.41 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.609 1.164 . . . . 0.0 108.244 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.37 136.66 21.24 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -81.24 -40.51 23.67 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.895 0.878 . . . . 0.0 110.855 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -161.21 100.75 1.22 Allowed 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.537 HD12 ' H ' ' A' ' 146' ' ' LYS . 2.3 pp -81.78 163.69 22.21 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.387 1.075 . . . . 0.0 111.852 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.29 55.11 0.52 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 124.446 1.022 . . . . 0.0 110.825 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.537 ' H ' HD12 ' A' ' 144' ' ' LEU . 0.0 OUTLIER 52.71 33.6 14.29 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.515 1.526 . . . . 0.0 111.545 179.472 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -122.61 -22.66 5.34 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.895 0.878 . . . . 0.0 112.889 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -110.72 145.53 37.87 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.43 100.41 10.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.101 0.56 . . . . 0.0 109.588 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.7 p -95.78 -17.77 20.93 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -115.97 131.81 56.83 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.004 1.322 . . . . 0.0 110.013 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.41 ' HB3' ' H ' ' A' ' 153' ' ' GLY 0.334 0.1 OUTLIER -163.49 -135.75 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 119.066 -0.492 . . . . 0.0 112.153 177.914 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.41 ' H ' ' HB3' ' A' ' 152' ' ' PHE . . . -146.22 179.33 23.3 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 125.794 1.664 . . . . 0.0 109.363 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.599 HD23 ' HB3' ' A' ' 156' ' ' MET . 0.4 OUTLIER -138.78 122.29 17.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.351 1.075 . . . . 0.0 110.725 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.3 m -79.42 34.72 0.26 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.602 1.561 . . . . 0.0 107.987 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.599 ' HB3' HD23 ' A' ' 154' ' ' LEU . 3.3 ptt? -63.01 131.96 50.39 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 119.865 -1.772 . . . . 0.0 107.665 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 25.5 mt -109.25 165.95 11.23 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.351 1.06 . . . . 0.0 110.841 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 14.7 p90 . . . . . 0 C--O 1.254 1.335 0 C-N-CA 127.099 2.16 . . . . 0.0 107.694 179.894 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 ptm . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -80.46 -172.14 3.41 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.51 0.724 . . . . 0.0 110.351 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -82.69 44.21 0.89 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.718 1.207 . . . . 0.0 113.579 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 40.0 42.57 1.12 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.658 1.583 . . . . 0.0 112.99 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -69.21 -177.92 1.2 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 113.479 -1.691 . . . . 0.0 108.588 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 6' ' ' LYS . 11.5 ptmt -145.53 1.9 0.94 Allowed 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 7' ' ' ILE . 1.1 pp -86.65 -25.79 6.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 124.732 1.213 . . . . 0.0 110.837 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -143.04 110.32 5.7 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 101.396 -3.557 . . . . 0.0 101.396 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.58 149.88 72.11 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 121.874 2.125 . . . . 0.0 111.534 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.39 115.71 3.49 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 124.446 3.431 . . . . 0.0 110.252 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.76 118.59 35.84 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.031 0.933 . . . . 0.0 111.816 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -106.5 133.68 50.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.08 0.552 . . . . 0.0 111.18 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -157.82 -139.06 2.63 Favored Glycine 0 C--O 1.225 -0.429 0 O-C-N 120.825 -1.172 . . . . 0.0 112.921 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -151.87 169.39 22.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.927 0.863 . . . . 0.0 112.055 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.541 HD12 ' CH2' ' A' ' 23' ' ' TRP . 47.3 mt -121.29 -5.59 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 O-C-N 121.236 -0.915 . . . . 0.0 111.001 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -53.1 -34.29 56.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.733 1.213 . . . . 0.0 110.732 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -51.91 -2.8 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 131.339 3.856 . . . . 0.0 115.693 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.5 mm -93.07 -80.46 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.611 1.964 . . . . 0.0 108.888 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -119.29 29.81 7.45 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.818 0.847 . . . . 0.0 112.705 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.7 t60 61.53 25.73 15.6 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.783 2.033 . . . . 0.0 112.428 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -86.36 92.15 8.73 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 120.303 -1.498 . . . . 0.0 110.808 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.4 t -69.43 141.91 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.56 ' HB3' HD22 ' A' ' 30' ' ' LEU . 43.7 m0 -107.78 144.05 35.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.412 ' C ' HD23 ' A' ' 30' ' ' LEU . 95.5 t -141.78 129.31 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.531 HD22 ' CD2' ' A' ' 72' ' ' LEU . 4.3 tp -72.33 106.83 4.63 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 178.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.73 127.39 43.56 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.629 0.772 . . . . 0.0 108.956 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t70 56.25 27.35 11.63 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 76.28 17.54 2.01 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 129.839 3.256 . . . . 0.0 112.892 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.42 131.41 43.58 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.082 1.353 . . . . 0.0 108.161 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.753 HD12 HD12 ' A' ' 87' ' ' LEU . 10.3 mt -75.42 115.96 15.63 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 120.603 -1.311 . . . . 0.0 107.71 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.01 144.19 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.337 0.655 . . . . 0.0 109.378 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.96 126.4 31.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.81 1.244 . . . . 0.0 109.446 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -126.86 70.13 73.22 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.135 1.774 . . . . 0.0 109.465 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.13 -30.67 37.88 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.843 1.695 . . . . 0.0 114.283 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -148.1 82.5 1.49 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -146.45 158.72 43.93 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 123.473 0.709 . . . . 0.0 109.222 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -76.82 -48.91 17.09 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.699 1.249 . . . . 0.0 108.905 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -77.4 52.65 0.97 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.608 1.563 . . . . 0.0 112.494 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -108.66 165.05 11.83 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.08 -1.013 . . . . 0.0 111.072 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -156.09 134.17 7.1 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.236 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.45 126.14 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.985 2.456 . . . . 0.0 108.323 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.9 m -121.58 161.09 22.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 125.065 1.346 . . . . 0.0 109.733 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.71 161.19 17.8 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.6 mm -130.2 100.98 5.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 129.282 3.033 . . . . 0.0 109.318 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.48 110.63 21.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.725 2.01 . . . . 0.0 108.163 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tt -107.91 140.53 40.88 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.813 2.045 . . . . 0.0 109.791 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.543 HD12 ' CG2' ' A' ' 92' ' ' ILE . 0.9 OUTLIER -148.57 153.08 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.943 1.297 . . . . 0.0 109.841 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.4 p -96.88 127.35 42.76 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.184 1.394 . . . . 0.0 110.013 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 55.8 m -54.02 133.03 43.55 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.159 0.984 . . . . 0.0 109.133 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -98.95 -18.12 17.99 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 117.345 -1.312 . . . . 0.0 113.573 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -105.11 41.8 1.3 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.286 1.035 . . . . 0.0 108.772 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.5 m -69.31 -6.98 7.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 O-C-N 120.248 -1.533 . . . . 0.0 114.011 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -56.06 -46.52 78.93 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.172 0.989 . . . . 0.0 111.856 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.0 t -83.46 0.66 45.3 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.7 mt -98.23 174.9 6.28 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.947 -1.096 . . . . 0.0 109.625 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -77.99 155.97 30.44 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.679 -1.6 . . . . 0.0 109.371 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.79 -34.62 2.38 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.869 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.68 -38.52 85.24 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.318 0.963 . . . . 0.0 110.597 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -68.26 -18.52 64.57 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.87 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.481 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 119.18 174.52 15.85 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 126.103 1.811 . . . . 0.0 110.745 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -69.53 114.76 26.62 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.716 0.806 . . . . 0.0 111.829 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -84.16 138.07 7.58 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.423 2.749 . . . . 0.0 110.035 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.418 HD12 ' N ' ' A' ' 64' ' ' TYR . 1.6 pp -140.05 -179.04 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 123.977 0.911 . . . . 0.0 109.681 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.547 ' CE1' HD12 ' A' ' 95' ' ' LEU . 1.2 t80 -138.22 155.72 48.39 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 122.338 1.066 . . . . 0.0 109.393 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.22 151.86 30.56 Favored 'General case' 0 CA--C 1.507 -0.684 0 O-C-N 120.938 -1.101 . . . . 0.0 108.136 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.485 ' N ' HD11 ' A' ' 92' ' ' ILE . . . -148.17 -179.89 24.5 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.119 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.436 ' CD1' HD11 ' A' ' 30' ' ' LEU . 3.1 mt -92.09 169.84 10.31 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -137.3 115.05 11.32 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 120.847 -1.158 . . . . 0.0 109.557 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 155.38 -28.63 0.62 Allowed Glycine 0 CA--C 1.527 0.819 0 CA-C-O 117.992 -1.449 . . . . 0.0 112.756 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.01 30.03 0.88 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.577 1.689 . . . . 0.0 112.123 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.2 m120 51.32 74.92 0.22 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.333 1.853 . . . . 0.0 112.51 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.531 ' CD2' HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -141.03 141.82 34.27 Favored 'General case' 0 CA--C 1.517 -0.296 0 O-C-N 121.307 -0.87 . . . . 0.0 109.322 -178.209 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.435 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 13.7 m -141.76 175.17 9.92 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.421 0.555 . . . . 0.0 111.007 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.951 ' HA ' HD22 ' A' ' 87' ' ' LEU . 12.5 mt -63.24 156.71 24.65 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.3 ttp -163.64 134.43 4.53 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.2 m -93.67 132.13 38.3 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.78 131.16 19.7 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.899 0.88 . . . . 0.0 108.98 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -87.45 138.82 31.15 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.152 0.887 . . . . 0.0 109.737 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.9 m -92.37 38.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.46 -51.74 4.25 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -83.13 -54.93 4.66 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -138.08 160.75 63.06 Favored Pre-proline 0 N--CA 1.471 0.617 0 C-N-CA 125.111 1.364 . . . . 0.0 112.649 -176.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.28 151.42 43.33 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.906 2.404 . . . . 0.0 110.707 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 71.1 p -144.84 179.33 7.39 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.876 1.671 . . . . 0.0 108.856 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.596 ' CD2' HD21 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -104.15 139.97 38.46 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 127.089 2.156 . . . . 0.0 107.075 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -140.48 72.0 1.38 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.951 HD22 ' HA ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -90.28 104.04 16.66 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 127.994 2.518 . . . . 0.0 107.669 -178.168 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.54 -25.58 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -146.72 81.67 1.56 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.838 1.255 . . . . 0.0 111.389 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.513 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -162.89 161.1 25.7 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 120.102 -1.624 . . . . 0.0 108.621 179.326 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -137.39 139.9 41.03 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.092 1.757 . . . . 0.0 108.201 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.543 ' CG2' HD12 ' A' ' 47' ' ' ILE . 4.6 mt -89.45 -42.65 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 126.058 1.743 . . . . 0.0 109.015 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.73 -34.83 63.01 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.468 1.507 . . . . 0.0 111.758 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -62.78 -61.88 2.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.6 1.96 . . . . 0.0 107.976 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.547 HD12 ' CE1' ' A' ' 64' ' ' TYR . 37.7 mt -60.9 -22.37 64.27 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -87.77 -33.57 18.62 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.517 0.727 . . . . 0.0 109.206 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -69.64 -43.65 72.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.202 -0.904 . . . . 0.0 109.145 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.9 152.69 38.21 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 118.713 -0.661 . . . . 0.0 109.813 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.09 38.49 0.54 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.923 3.082 . . . . 0.0 113.936 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -112.55 82.13 4.62 Favored Pre-proline 0 C--O 1.235 0.312 0 O-C-N 120.877 -1.139 . . . . 0.0 112.905 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.43 102.57 1.62 Allowed 'Trans proline' 0 N--CA 1.443 -1.444 0 N-CA-C 106.048 -2.328 . . . . 0.0 106.048 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.4 t -89.29 105.09 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -48.78 -31.26 6.72 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.366 1.466 . . . . 0.0 112.006 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.4 t -62.53 -13.58 32.29 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.6 1.16 . . . . 0.0 112.852 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -121.97 -2.09 9.26 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 119.789 1.177 . . . . 0.0 110.351 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.7 mt -94.91 153.91 17.46 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.605 1.093 . . . . 0.0 110.975 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -138.43 129.41 26.89 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.765 0.826 . . . . 0.0 109.721 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.481 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -71.13 127.26 31.99 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 104.405 -2.442 . . . . 0.0 104.405 177.787 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -103.88 131.87 50.68 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.11 -178.64 5.24 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.924 0.868 . . . . 0.0 109.948 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 0.0 OUTLIER -151.91 138.67 18.86 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.932 2.093 . . . . 0.0 107.808 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.48 70.33 1.17 Allowed 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.193 0.933 . . . . 0.0 112.472 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.46 64.12 0.93 Allowed Glycine 0 CA--C 1.525 0.686 0 O-C-N 121.787 -0.57 . . . . 0.0 114.198 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 67.71 -0.6 1.9 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.722 2.009 . . . . 0.0 113.24 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -120.01 155.11 33.51 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.386 1.474 . . . . 0.0 107.608 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 69.8 m -115.01 166.6 11.62 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.77 2.028 . . . . 0.0 110.559 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.61 164.46 32.58 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.504 1.121 . . . . 0.0 111.095 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -141.75 116.37 9.69 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 125.081 1.352 . . . . 0.0 110.605 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -115.16 122.94 47.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.635 1.574 . . . . 0.0 110.361 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.0 m -49.42 124.13 8.77 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.392 1.477 . . . . 0.0 112.488 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.5 t -70.0 -44.69 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 120.146 -1.596 . . . . 0.0 111.936 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.88 -25.56 67.23 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.398 -0.814 . . . . 0.0 112.971 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -140.39 80.17 19.67 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 125.381 1.472 . . . . 0.0 108.489 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -64.53 151.72 84.49 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.148 1.899 . . . . 0.0 110.123 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.48 -32.88 6.76 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.519 2.009 . . . . 0.0 110.211 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 25.5 m-90 -88.19 106.66 18.34 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 124.626 1.17 . . . . 0.0 111.006 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -91.03 152.8 20.53 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.724 1.21 . . . . 0.0 110.148 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.4 mt -82.25 131.71 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.29 132.85 43.43 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.18 0.446 . . . . 0.0 109.813 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -81.96 -15.38 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 127.06 2.144 . . . . 0.0 111.885 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.7 m 63.29 52.28 2.47 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.914 1.285 . . . . 0.0 113.729 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.3 m -89.31 24.22 2.27 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -96.01 -83.11 0.38 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.105 0.411 . . . . 0.0 110.352 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -103.68 -44.88 1.6 Allowed Glycine 0 C--N 1.336 0.583 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.08 63.52 0.02 OUTLIER Glycine 0 CA--C 1.521 0.433 0 N-CA-C 106.264 -2.734 . . . . 0.0 106.264 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 60.9 m -82.37 170.94 13.11 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.358 1.063 . . . . 0.0 110.113 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.2 153.13 16.32 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.859 1.706 . . . . 0.0 109.127 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.475 HD11 ' CD2' ' A' ' 23' ' ' TRP . 16.6 mt -75.52 106.16 6.93 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.93 171.42 15.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 124.347 1.059 . . . . 0.0 111.338 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 89.6 mt -84.83 156.12 21.46 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.8 t -146.11 136.16 23.6 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -85.56 -35.94 20.75 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.563 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -169.9 62.28 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.671 1.123 . . . . 0.0 113.173 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.622 HD13 ' H ' ' A' ' 148' ' ' ASN . 1.2 pp -48.45 -54.27 14.78 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.47 ' H ' ' HG ' ' A' ' 144' ' ' LEU . . . 91.06 -65.59 2.56 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 125.942 1.734 . . . . 0.0 109.505 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.14 1.0 0.73 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.39 0.676 . . . . 0.0 111.867 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.64 -26.71 34.58 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.622 ' H ' HD13 ' A' ' 144' ' ' LEU . 8.1 m120 -131.01 -156.62 0.77 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.93 1.696 . . . . 0.0 108.304 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.5 m -146.55 108.48 4.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.2 p -103.32 -15.79 15.84 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.402 1.081 . . . . 0.0 111.08 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -96.67 119.73 35.7 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 128.528 2.731 . . . . 0.0 108.178 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -157.94 -133.37 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.799 0.84 . . . . 0.0 112.893 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 177.14 -161.37 28.92 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 128.737 3.065 . . . . 0.0 108.299 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.73 142.87 23.23 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.083 1.942 . . . . 0.0 112.733 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.0 m -91.39 32.36 1.07 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.835 1.254 . . . . 0.0 107.842 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -60.0 110.71 1.26 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.464 1.906 . . . . 0.0 109.8 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 12.5 mt -89.67 160.01 16.82 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 126.226 1.811 . . . . 0.0 110.583 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 20.9 p90 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 126.023 1.729 . . . . 0.0 110.401 -179.707 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ptt? . . . . . 0 N--CA 1.472 0.64 0 CA-C-O 120.427 0.156 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -112.73 178.43 4.29 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.662 1.585 . . . . 0.0 109.172 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.46 -6.51 14.91 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.755 -1.117 . . . . 0.0 113.64 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.2 -47.49 62.25 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.885 1.674 . . . . 0.0 114.328 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.38 -53.86 48.84 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 pttt 48.74 18.88 0.21 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 131.027 3.731 . . . . 0.0 117.507 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.85 5.88 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -177.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -82.33 14.54 2.91 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.117 -0.99 . . . . 0.0 111.266 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.47 156.88 68.49 Favored Pre-proline 0 N--CA 1.475 0.79 0 O-C-N 119.535 -1.978 . . . . 0.0 111.419 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.14 131.54 18.13 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.329 2.019 . . . . 0.0 107.965 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.19 113.49 24.73 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.312 1.445 . . . . 0.0 109.839 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -109.49 144.94 37.05 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.191 0.996 . . . . 0.0 110.957 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.39 -131.21 1.41 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.135 1.35 . . . . 0.0 110.854 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.1 p -153.66 172.38 17.35 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 120.601 2.2 . . . . 0.0 113.112 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.0 mt -127.39 -12.38 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 125.005 1.322 . . . . 0.0 107.597 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.81 -28.22 69.31 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 120.413 -1.43 . . . . 0.0 112.292 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -57.34 -17.98 15.03 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.395 2.678 . . . . 0.0 115.003 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.1 mt -68.03 -69.71 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.29 1.036 . . . . 0.0 109.745 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.01 29.18 7.18 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.962 0.905 . . . . 0.0 111.102 -178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 51.48 44.66 28.88 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.303 2.241 . . . . 0.0 110.097 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.422 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 19.5 mmt180 -100.68 88.15 3.53 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.8 t -70.66 138.46 21.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -101.18 145.47 28.76 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.082 0.953 . . . . 0.0 109.523 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -148.26 134.57 12.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.63 121.0 14.95 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 103.471 -2.788 . . . . 0.0 103.471 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -134.01 117.85 17.15 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . 0.267 1.3 t0 46.72 59.49 3.91 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 124.072 1.892 . . . . 0.0 111.43 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 55.29 17.91 2.29 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 113.406 -1.725 . . . . 0.0 113.783 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.6 m -132.25 137.95 47.71 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.143 1.777 . . . . 0.0 107.812 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.531 HD13 HD12 ' A' ' 138' ' ' LEU . 9.8 mt -80.51 129.8 34.74 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.081 -1.637 . . . . 0.0 108.205 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.7 mm -131.36 140.47 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.653 0.66 . . . . 0.0 111.275 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.57 127.18 31.78 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.379 1.472 . . . . 0.0 109.108 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 m -123.09 62.8 20.51 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.213 1.805 . . . . 0.0 109.493 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.61 6.1 0.48 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.413 3.409 . . . . 0.0 116.641 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.4 ptt85 171.7 88.2 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 130.2 3.4 . . . . 0.0 104.92 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.85 139.13 24.75 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.8 -50.22 73.0 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -85.8 53.93 2.95 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.935 1.294 . . . . 0.0 112.663 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -104.51 155.56 18.71 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -150.97 132.69 7.87 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.94 148.61 64.28 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 N-CA-C 107.952 -1.595 . . . . 0.0 107.952 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.98 165.55 27.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -119.74 157.65 28.13 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.0 mm -115.85 147.45 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.92 130.12 47.96 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 104.659 -2.348 . . . . 0.0 104.659 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 tt -127.28 140.09 52.45 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 mt -146.03 138.07 19.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 125.091 1.356 . . . . 0.0 109.212 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p -79.63 132.96 36.39 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.816 0.846 . . . . 0.0 109.027 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.49 ' SG ' HD22 ' A' ' 106' ' ' LEU . 98.4 m -69.88 113.74 7.4 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 120.891 -1.13 . . . . 0.0 108.602 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -86.01 -9.96 55.89 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 118.68 -0.676 . . . . 0.0 112.443 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -97.45 34.64 1.77 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.768 1.627 . . . . 0.0 110.085 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.85 -10.74 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 127.212 2.205 . . . . 0.0 114.28 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.01 -10.75 4.54 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.202 1.801 . . . . 0.0 114.304 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.7 t -128.51 19.89 6.21 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.357 1.463 . . . . 0.0 110.417 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.3 mt -116.45 169.58 9.21 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.749 0.82 . . . . 0.0 109.659 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -70.88 145.88 49.95 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -116.37 -41.22 3.14 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.29 -37.24 77.2 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.619 1.568 . . . . 0.0 112.383 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -11.01 59.81 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 117.993 -1.003 . . . . 0.0 111.411 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.42 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 119.93 173.42 15.19 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -82.7 118.57 72.26 Favored Pre-proline 0 CA--C 1.542 0.64 0 O-C-N 122.039 -0.683 . . . . 0.0 111.19 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -79.85 146.5 18.6 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.87 3.047 . . . . 0.0 110.739 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 pp -139.53 177.72 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.07 1.748 . . . . 0.0 109.308 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.671 ' CD1' HG22 ' A' ' 92' ' ' ILE . 1.1 t80 -131.8 147.67 52.51 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.2 tt -144.87 148.26 33.74 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.6 -179.31 25.34 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.434 HD11 HD11 ' A' ' 30' ' ' LEU . 1.9 mt -98.4 145.74 26.42 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.29 105.99 14.08 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 120.341 1.428 . . . . 0.0 108.549 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.92 -24.16 0.18 Allowed Glycine 0 CA--C 1.525 0.66 0 CA-C-O 117.294 -1.837 . . . . 0.0 116.289 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.8 20.53 1.15 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 119.664 1.732 . . . . 0.0 113.273 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.48 64.35 0.94 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.956 2.102 . . . . 0.0 110.971 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.84 143.19 33.26 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.718 1.207 . . . . 0.0 110.562 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.726 ' SG ' HG23 ' A' ' 92' ' ' ILE . 15.3 m -144.97 179.47 7.32 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.026 0.531 . . . . 0.0 110.918 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.09 152.47 28.19 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.944 -0.473 . . . . 0.0 110.134 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.3 ttp -159.64 127.65 4.87 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.4 m -85.61 116.76 24.09 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.13 148.71 52.49 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -92.06 123.75 35.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.4 -33.48 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.94 -62.04 0.31 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 105.66 -2.976 . . . . 0.0 105.66 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -82.58 -36.36 26.29 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -145.95 166.32 17.63 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.57 142.12 47.9 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.003 2.469 . . . . 0.0 110.031 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.6 p -146.65 -174.77 4.56 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 125.311 1.444 . . . . 0.0 107.943 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.573 HD11 HG23 ' A' ' 128' ' ' ILE . 4.6 mt -103.22 145.13 30.4 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.043 1.337 . . . . 0.0 109.471 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -143.89 66.04 1.29 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.499 ' H ' HD12 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -80.62 115.07 19.94 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.7 pttp 179.63 -20.9 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -156.15 87.34 1.05 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.981 1.313 . . . . 0.0 110.41 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.498 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -169.2 164.97 11.1 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 120.568 -1.332 . . . . 0.0 108.433 178.362 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -141.01 125.9 18.14 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.526 1.13 . . . . 0.0 108.78 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.726 HG23 ' SG ' ' A' ' 73' ' ' CYS . 27.6 pt -79.51 -37.31 18.52 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 125.935 1.694 . . . . 0.0 111.762 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -36.7 81.64 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 118.476 0.58 . . . . 0.0 111.187 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -56.96 -56.24 24.33 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.47 HD12 ' CD1' ' A' ' 64' ' ' TYR . 13.5 mt -62.39 -32.87 73.76 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -71.67 -36.36 70.6 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.507 -0.745 . . . . 0.0 110.285 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -75.45 -41.01 56.76 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.527 1.131 . . . . 0.0 113.062 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -112.68 157.0 41.6 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.56 63.53 5.58 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.542 2.828 . . . . 0.0 114.142 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -124.21 63.35 32.66 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.977 1.711 . . . . 0.0 109.308 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.3 77.35 3.86 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.365 2.71 . . . . 0.0 106.289 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.94 104.59 5.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 125.388 1.475 . . . . 0.0 107.996 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -49.9 -30.25 9.76 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.373 0.669 . . . . 0.0 111.952 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.95 -8.58 23.42 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.215 1.006 . . . . 0.0 113.229 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -123.73 -3.06 8.27 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.587 1.155 . . . . 0.0 109.04 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.49 HD22 ' SG ' ' A' ' 49' ' ' CYS . 14.7 mt -103.03 149.53 24.48 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.894 1.224 . . . . 0.0 111.521 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.652 ' CD2' HD11 ' A' ' 128' ' ' ILE . 76.3 m-85 -135.32 127.08 29.2 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.172 0.989 . . . . 0.0 110.769 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.42 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -70.52 111.98 6.45 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 178.117 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -94.41 145.2 24.94 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.38 179.48 7.62 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.403 1.481 . . . . 0.0 108.283 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 0.0 OUTLIER -158.3 137.11 11.29 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.494 0.718 . . . . 0.0 109.102 178.479 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.32 89.37 1.57 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.03 61.04 1.22 Allowed Glycine 0 C--N 1.336 0.545 0 O-C-N 121.37 -0.831 . . . . 0.0 111.351 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 60.09 11.08 2.53 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.306 2.243 . . . . 0.0 113.901 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -125.37 159.45 31.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.977 0.911 . . . . 0.0 108.773 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 4.6 m -116.49 165.7 12.93 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.095 1.758 . . . . 0.0 110.024 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.81 159.14 42.83 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 126.43 1.892 . . . . 0.0 107.398 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -146.28 119.7 9.03 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.321 1.048 . . . . 0.0 109.045 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -116.82 130.45 56.72 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.943 2.097 . . . . 0.0 110.454 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.422 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 43.5 t -56.84 122.28 11.83 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.586 0.754 . . . . 0.0 109.296 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.5 t -70.27 -38.2 73.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.37 -40.28 93.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.684 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -129.45 79.99 72.87 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 124.482 1.113 . . . . 0.0 110.099 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -61.68 148.32 93.3 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.812 2.341 . . . . 0.0 109.86 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.78 -14.05 26.98 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.163 1.364 . . . . 0.0 112.153 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -110.2 147.11 34.4 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.836 2.054 . . . . 0.0 109.164 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -122.23 147.4 46.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.816 1.646 . . . . 0.0 108.218 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.652 HD11 ' CD2' ' A' ' 107' ' ' PHE . 9.9 mm -73.5 124.18 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.46 133.85 33.69 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.644 1.111 . . . . 0.0 108.834 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.2 t -85.91 -21.16 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.695 1.998 . . . . 0.0 111.907 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m 56.08 67.34 1.02 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 123.425 1.583 . . . . 0.0 112.216 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.422 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 7.1 m -96.26 16.8 17.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.164 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.59 146.48 49.64 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.948 1.699 . . . . 0.0 107.023 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 57.99 -81.98 0.01 OUTLIER Glycine 0 C--N 1.334 0.425 0 C-N-CA 127.005 2.24 . . . . 0.0 111.693 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.03 66.87 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.246 2 N-CA-C 102.566 -4.213 . . . . 0.0 102.566 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 79.0 m -91.48 170.24 9.94 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 118.326 1.063 . . . . 0.0 111.576 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -81.12 154.32 19.21 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.558 2.172 . . . . 0.0 112.075 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.531 HD12 HD13 ' A' ' 30' ' ' LEU . 38.4 mt -82.57 107.38 15.17 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.08 175.1 9.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 125.039 1.335 . . . . 0.0 108.325 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.7 mt -88.74 166.56 13.97 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t -160.72 125.41 3.68 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -91.2 -22.22 20.74 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 123.543 0.527 . . . . 0.0 110.104 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -166.66 91.17 0.42 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.001 0.818 . . . . 0.0 110.905 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.776 HD12 ' H ' ' A' ' 146' ' ' LYS . 2.8 pp -88.49 161.11 17.18 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.424 1.09 . . . . 0.0 109.684 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -102.82 48.51 1.03 Allowed Glycine 0 C--O 1.226 -0.372 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.776 ' H ' HD12 ' A' ' 144' ' ' LEU . 0.0 OUTLIER 66.65 2.42 2.54 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.175 2.19 . . . . 0.0 112.871 -178.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.51 -10.27 59.65 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 125.866 1.666 . . . . 0.0 115.4 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -140.22 142.14 35.86 Favored 'General case' 0 CA--C 1.512 -0.517 0 O-C-N 121.17 -0.956 . . . . 0.0 108.58 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.82 132.11 35.46 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.413 0.685 . . . . 0.0 109.225 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 p -124.2 -9.09 7.6 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.175 0.99 . . . . 0.0 108.655 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -127.51 125.96 41.37 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.557 1.543 . . . . 0.0 110.059 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 176.29 178.57 0.21 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.931 2.092 . . . . 0.0 110.504 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.34 -166.61 31.22 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.846 1.212 . . . . 0.0 111.694 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.61 125.71 19.91 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.289 1.436 . . . . 0.0 107.641 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.3 m -81.97 44.13 0.82 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.847 1.659 . . . . 0.0 106.88 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -67.68 147.54 52.54 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.3 mt -124.61 170.73 10.66 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.194 1.798 . . . . 0.0 108.388 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.8 p90 . . . . . 0 C--O 1.243 0.761 0 N-CA-C 104.187 -2.523 . . . . 0.0 104.187 179.422 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ptm . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 120.348 0.118 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -103.24 176.39 5.16 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -116.53 -86.09 0.62 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -151.68 92.83 1.79 Allowed 'General case' 0 C--O 1.237 0.436 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 pp -134.97 6.49 3.39 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -160.03 25.15 0.17 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.464 1.506 . . . . 0.0 108.255 177.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.25 -22.61 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.322 1.049 . . . . 0.0 113.023 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -73.29 -22.79 60.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.234 1.379 . . . . 0.0 110.993 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -56.45 149.24 40.09 Favored Pre-proline 0 CA--C 1.528 0.098 0 CA-C-O 118.421 -0.799 . . . . 0.0 110.42 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.96 132.84 27.42 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.38 1.387 . . . . 0.0 109.534 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.46 117.34 30.1 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -112.86 146.98 37.95 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.846 0.459 . . . . 0.0 109.852 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.86 -125.99 0.97 Allowed Glycine 0 CA--C 1.523 0.535 0 C-N-CA 124.595 1.093 . . . . 0.0 111.883 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.8 p -156.07 -170.1 3.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.975 1.887 . . . . 0.0 112.565 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -146.65 1.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.225 1.01 . . . . 0.0 110.383 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -67.34 -28.92 68.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -54.61 -30.87 56.03 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.19 1.396 . . . . 0.0 111.44 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.5 mm -44.95 -67.61 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.749 2.02 . . . . 0.0 111.625 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.55 26.15 3.73 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.86 -0.525 . . . . 0.0 111.324 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 25.7 m170 60.93 39.56 16.55 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.425 1.49 . . . . 0.0 110.098 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.406 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 3.0 mmt-85 -109.32 97.67 7.22 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.153 0.981 . . . . 0.0 109.932 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 t -82.47 156.46 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -108.75 137.1 47.23 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.772 1.229 . . . . 0.0 107.707 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.97 128.03 52.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.4 100.4 1.75 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -115.62 126.21 53.89 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 126.0 1.72 . . . . 0.0 109.117 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.3 t0 42.53 58.79 2.97 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.535 1.134 . . . . 0.0 112.898 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 58.86 13.44 2.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.942 1.297 . . . . 0.0 114.363 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.7 m -131.78 149.86 52.33 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 120.688 1.586 . . . . 0.0 108.287 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.768 HD12 HD13 ' A' ' 87' ' ' LEU . 11.8 mt -89.96 125.5 35.4 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 177.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.5 mm -119.72 140.27 44.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.54 141.67 36.44 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 m -120.3 71.72 18.0 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -63.67 97.35 0.22 Allowed 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.452 2.101 . . . . 0.0 109.958 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 49.55 43.73 24.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.671 1.189 . . . . 0.0 111.165 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -88.67 148.12 24.17 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -65.89 -11.64 48.51 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.259 30.0 ptt180 -117.11 25.15 10.69 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.682 0.793 . . . . 0.0 110.334 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -75.92 148.16 38.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.2 t -145.91 129.98 8.64 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.52 145.29 52.31 Favored 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.045 1.163 . . . . 0.0 112.123 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.4 m -126.31 175.49 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -128.35 161.72 28.76 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.4 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.4 mm -124.82 147.78 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.524 ' CB ' HD11 ' A' ' 92' ' ' ILE . . . -125.15 134.5 52.4 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 176.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.01 133.88 47.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.833 1.253 . . . . 0.0 107.999 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.615 HG13 HD12 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -147.67 134.11 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.022 0.529 . . . . 0.0 110.59 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.519 ' HA ' HG22 ' A' ' 63' ' ' ILE . 46.8 t -72.44 159.77 33.42 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 122.514 1.149 . . . . 0.0 109.427 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.3 m -83.6 100.48 10.84 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.749 1.22 . . . . 0.0 109.653 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 ptt85 -82.94 13.77 3.73 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.54 -1.35 . . . . 0.0 112.428 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -132.48 33.76 3.78 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.723 2.009 . . . . 0.0 111.536 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.572 HG12 HD12 ' A' ' 55' ' ' LEU . 15.7 m -73.06 3.81 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 120.326 -1.484 . . . . 0.0 114.641 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -48.75 -33.46 10.33 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -102.6 0.17 32.93 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 120.114 1.325 . . . . 0.0 112.454 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.572 HD12 HG12 ' A' ' 52' ' ' VAL . 95.6 mt -95.48 163.14 13.35 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 120.256 -1.528 . . . . 0.0 111.457 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.425 ' HG3' ' HE ' ' A' ' 59' ' ' ARG . 14.8 mm-40 -70.62 155.36 40.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -120.62 -23.66 5.98 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.26 -13.53 46.46 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.195 0.998 . . . . 0.0 113.507 -178.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.425 ' HE ' ' HG3' ' A' ' 56' ' ' GLU . 3.2 mtm-85 -84.29 7.64 18.63 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.452 1.101 . . . . 0.0 112.915 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.0 -173.46 15.57 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -92.62 105.35 14.17 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-O 117.708 -1.139 . . . . 0.0 109.844 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -69.67 128.92 16.81 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.239 2.626 . . . . 0.0 110.319 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.519 HG22 ' HA ' ' A' ' 48' ' ' SER . 12.5 pt -139.64 177.71 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.5 1.52 . . . . 0.0 109.218 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.681 ' CD1' HG22 ' A' ' 92' ' ' ILE . 1.2 t80 -133.01 158.62 42.25 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.6 tt -155.45 155.91 34.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.623 1.569 . . . . 0.0 108.609 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.411 ' HA3' ' SG ' ' A' ' 73' ' ' CYS . . . -162.41 178.46 38.19 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.678 HD11 HD11 ' A' ' 30' ' ' LEU . 5.4 mt -87.18 177.73 7.09 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.408 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 1.5 t-20 -140.62 111.39 6.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.062 -1.024 . . . . 0.0 108.832 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 153.39 -18.57 0.7 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-O 117.962 -1.465 . . . . 0.0 115.403 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.28 24.47 0.62 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.574 1.687 . . . . 0.0 111.969 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 57.24 72.96 0.48 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.324 1.85 . . . . 0.0 109.07 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.42 125.87 10.9 Favored 'General case' 0 N--CA 1.461 0.107 0 O-C-N 121.215 -0.928 . . . . 0.0 111.559 -178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.731 ' SG ' HG23 ' A' ' 92' ' ' ILE . 24.3 m -133.05 172.85 12.09 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.106 0.962 . . . . 0.0 110.936 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.9 mt -55.68 150.91 11.72 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.8 ttp -157.18 117.37 3.5 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.3 m -84.5 115.89 22.82 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.598 1.09 . . . . 0.0 110.97 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.462 ' HB3' ' OE1' ' A' ' 86' ' ' GLN . . . -116.86 -170.43 1.83 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -149.35 128.57 12.85 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.1 m -81.84 38.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.59 -7.81 2.61 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 120.914 -1.116 . . . . 0.0 113.253 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -123.85 -50.63 1.83 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 127.653 2.381 . . . . 0.0 113.365 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -144.61 156.51 56.41 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 123.908 0.883 . . . . 0.0 108.965 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.46 160.03 44.83 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.467 1.445 . . . . 0.0 110.974 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.5 p -147.82 160.13 43.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.499 1.119 . . . . 0.0 109.394 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.558 HD11 HD12 ' A' ' 128' ' ' ILE . 3.7 mt -98.64 127.21 44.49 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.462 ' OE1' ' HB3' ' A' ' 77' ' ' ALA . 6.8 mp0 -123.67 68.09 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.717 0.807 . . . . 0.0 109.838 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.768 HD13 HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -84.18 102.68 12.78 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.3 -35.56 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.709 1.256 . . . . 0.0 111.342 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -137.3 90.92 2.56 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.61 1.164 . . . . 0.0 109.847 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.565 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -173.76 158.24 3.24 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 120.858 -1.151 . . . . 0.0 109.02 178.342 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -138.81 134.03 32.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.104 1.361 . . . . 0.0 107.518 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.731 HG23 ' SG ' ' A' ' 73' ' ' CYS . 37.0 pt -90.25 -33.53 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 C-N-CA 123.806 0.843 . . . . 0.0 111.003 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -32.3 73.89 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 118.299 0.5 . . . . 0.0 110.244 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -62.36 -54.31 42.26 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.624 0.647 . . . . 0.0 109.816 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.459 HD12 ' CD1' ' A' ' 64' ' ' TYR . 14.3 mt -60.22 -40.89 91.75 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -65.11 -31.54 72.79 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.06 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -77.5 -36.07 53.0 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 116.42 -1.752 . . . . 0.0 113.603 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.61 174.43 2.35 Favored Pre-proline 0 N--CA 1.472 0.637 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -175.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.6 -162.93 0.16 Allowed 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.829 2.353 . . . . 0.0 108.228 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 69.3 65.09 0.52 Allowed Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.888 1.675 . . . . 0.0 113.275 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -56.42 116.62 3.32 Favored 'Trans proline' 0 C--O 1.244 0.819 0 C-N-CA 121.903 1.736 . . . . 0.0 110.553 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.96 84.75 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -42.77 -33.77 0.81 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.535 1.934 . . . . 0.0 112.929 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -59.26 -15.25 14.51 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.905 1.682 . . . . 0.0 113.328 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.7 5.9 6.14 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.071 1.348 . . . . 0.0 110.438 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 39.4 mt -101.35 153.71 19.43 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 120.46 1.482 . . . . 0.0 109.208 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.589 ' CE2' HD11 ' A' ' 128' ' ' ILE . 43.3 m-85 -140.73 131.57 25.9 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.259 0.623 . . . . 0.0 110.686 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.442 ' CE1' ' HA ' ' A' ' 121' ' ' VAL . 83.3 m-85 -76.86 123.09 25.74 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.061 0.945 . . . . 0.0 109.346 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -82.4 126.22 31.94 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.9 t -120.95 170.84 9.11 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -142.42 158.77 43.34 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.718 2.007 . . . . 0.0 109.018 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 80.7 p -124.14 -4.58 7.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.854 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.92 -44.17 1.27 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -137.82 10.48 2.87 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.47 1.108 . . . . 0.0 112.965 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -146.84 164.1 33.93 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 106.654 -1.609 . . . . 0.0 106.654 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 m -128.98 153.55 47.45 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.704 0.684 . . . . 0.0 110.527 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.4 170.15 11.13 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -139.19 109.29 6.4 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.916 1.686 . . . . 0.0 109.666 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -106.39 126.18 51.92 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.517 1.127 . . . . 0.0 110.164 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.9 t -50.9 127.58 18.98 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.448 0.699 . . . . 0.0 110.205 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.442 ' HA ' ' CE1' ' A' ' 108' ' ' TYR . 53.6 t -68.37 -48.12 74.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.71 -40.09 91.89 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.269 1.028 . . . . 0.0 112.842 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -127.94 84.74 62.44 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -69.24 160.88 48.12 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 N-CA-C 108.368 -1.436 . . . . 0.0 108.368 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.75 -32.03 7.47 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -95.82 140.28 30.83 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 118.03 0.915 . . . . 0.0 109.442 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -120.33 138.97 53.42 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 127.078 2.151 . . . . 0.0 108.597 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.589 HD11 ' CE2' ' A' ' 107' ' ' PHE . 28.3 mm -70.24 139.7 19.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -115.18 126.15 54.25 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.943 0.792 . . . . 0.0 111.399 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.8 m -73.74 -5.36 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.816 -1.178 . . . . 0.0 112.697 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.6 m 54.12 35.12 21.61 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.406 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 7.8 m -73.18 -1.97 19.75 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.807 1.243 . . . . 0.0 112.749 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -94.91 130.22 41.61 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 101.911 -3.366 . . . . 0.0 101.911 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.32 -84.78 0.05 OUTLIER Glycine 0 CA--C 1.531 1.04 0 C-N-CA 123.554 0.597 . . . . 0.0 111.913 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.33 68.0 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 129.219 3.295 . . . . 0.0 108.361 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 m -91.52 168.45 13.32 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 117.886 0.843 . . . . 0.0 110.523 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 55.7 Cg_endo -67.99 159.82 51.27 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 N-CA-C 107.888 -1.62 . . . . 0.0 107.888 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.9 mt -80.96 137.39 36.1 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -163.14 171.61 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 125.286 1.434 . . . . 0.0 109.354 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.12 171.14 8.92 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.4 t -157.89 145.56 18.5 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.47 -1.394 . . . . 0.0 108.441 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -106.02 -26.23 11.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.559 0.618 . . . . 0.0 109.797 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -159.55 113.62 2.31 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.63 162.84 14.74 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.365 1.866 . . . . 0.0 109.076 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -108.36 55.88 0.49 Allowed Glycine 0 N--CA 1.46 0.283 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 46.13 43.08 10.61 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.326 1.851 . . . . 0.0 109.601 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -120.33 -10.08 9.39 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.682 1.193 . . . . 0.0 112.618 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -126.53 163.82 22.54 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.5 p -108.91 97.36 7.01 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.23 1.012 . . . . 0.0 111.611 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.8 p -93.62 -31.76 14.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.815 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.67 113.42 26.55 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 118.413 -0.803 . . . . 0.0 112.893 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -161.26 178.79 8.89 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.07 1.305 . . . . 0.0 112.168 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.83 173.63 21.01 Favored Glycine 0 C--O 1.24 0.485 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.6 tp -120.98 138.88 53.94 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.3 m -89.99 41.92 1.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.02 167.49 15.83 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.2 mt -136.73 151.59 49.39 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.876 1.27 . . . . 0.0 107.699 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 55.4 p90 . . . . . 0 C--O 1.254 1.339 0 C-N-CA 125.191 1.397 . . . . 0.0 109.014 179.533 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -90.37 174.52 7.52 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.867 0.867 . . . . 0.0 110.872 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -115.66 24.36 11.6 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.462 1.905 . . . . 0.0 111.812 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 51.16 45.0 28.47 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.125 1.77 . . . . 0.0 109.672 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.23 -56.94 15.7 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 117.602 -1.19 . . . . 0.0 109.366 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.3 pttp 45.5 30.23 0.72 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 128.075 2.55 . . . . 0.0 114.255 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 pp -142.9 -42.32 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.367 1.067 . . . . 0.0 111.86 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -87.53 84.12 7.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 104.167 -2.531 . . . . 0.0 104.167 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.9 p -110.72 138.66 21.12 Favored Pre-proline 0 C--N 1.328 -0.334 0 C-N-CA 126.279 1.832 . . . . 0.0 107.469 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.52 122.75 10.5 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.341 2.028 . . . . 0.0 108.982 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.73 138.4 40.41 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -135.19 148.44 49.67 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 119.086 0.857 . . . . 0.0 110.801 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.08 -130.43 1.26 Allowed Glycine 0 C--O 1.227 -0.339 0 CA-C-O 118.668 -1.073 . . . . 0.0 111.534 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.5 p -145.71 -177.7 5.72 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.875 1.338 . . . . 0.0 113.226 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mt -140.54 -11.56 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 126.403 1.881 . . . . 0.0 109.336 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -61.04 -17.98 55.3 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 119.778 -1.826 . . . . 0.0 113.687 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.73 -7.88 5.71 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.757 2.423 . . . . 0.0 113.838 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.6 mm -91.56 -41.51 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.97 23.14 0.86 Allowed 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 121.088 -1.008 . . . . 0.0 111.016 -176.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 62.59 27.83 16.38 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.629 0.728 . . . . 0.0 112.035 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.85 91.09 6.27 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.7 t -85.67 161.51 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -118.79 144.13 46.5 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 119.553 1.069 . . . . 0.0 110.953 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.7 t -142.65 134.45 25.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 tp -68.71 120.73 15.14 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 103.594 -2.743 . . . . 0.0 103.594 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -137.17 123.11 20.17 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.4 t0 47.07 49.41 15.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.001 1.32 . . . . 0.0 112.644 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 67.59 12.05 8.68 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.949 2.1 . . . . 0.0 115.623 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.1 m -132.42 143.54 49.88 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.652 1.115 . . . . 0.0 109.88 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.441 ' CD1' HD12 ' A' ' 138' ' ' LEU . 7.1 mt -81.96 121.95 27.17 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.41 -1.431 . . . . 0.0 107.872 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.79 136.76 53.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.54 136.98 40.56 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 124.59 1.182 . . . . 0.0 108.105 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 m -119.5 87.19 35.87 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.54 1.136 . . . . 0.0 108.569 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.66 -44.72 2.81 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.78 2.32 . . . . 0.0 112.927 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -153.22 44.13 0.63 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.49 1.516 . . . . 0.0 109.611 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.0 124.77 32.82 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -55.6 -32.95 63.51 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 123.981 0.801 . . . . 0.0 109.65 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -89.1 31.0 0.9 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.624 1.569 . . . . 0.0 112.513 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -80.2 168.06 19.55 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.068 -1.645 . . . . 0.0 109.97 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.81 147.97 18.26 Favored Pre-proline 0 N--CA 1.448 -0.56 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.39 159.58 46.37 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.286 2.657 . . . . 0.0 108.531 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.85 160.0 9.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 125.77 1.628 . . . . 0.0 108.115 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.04 154.42 27.71 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.964 1.706 . . . . 0.0 108.111 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mm -130.12 104.35 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.193 1.397 . . . . 0.0 108.088 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.97 141.36 28.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.5 tt -132.69 140.2 48.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.57 145.46 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.8 p -75.65 161.9 28.7 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 124.785 1.234 . . . . 0.0 107.824 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.94 176.01 9.61 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.474 ' HB2' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -125.19 -7.52 7.09 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -116.69 37.64 3.72 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.5 m -60.99 -16.29 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 125.253 1.421 . . . . 0.0 113.544 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.46 -18.41 65.3 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.948 0.499 . . . . 0.0 110.094 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.14 -0.82 49.61 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.117 0.967 . . . . 0.0 112.262 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.2 mt -106.69 179.25 4.32 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.262 0.937 . . . . 0.0 110.343 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -92.37 157.63 16.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.909 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.77 -19.46 6.77 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.816 1.247 . . . . 0.0 112.7 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.25 -31.63 72.83 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.506 1.122 . . . . 0.0 113.44 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -86.84 -5.67 59.03 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.536 0.734 . . . . 0.0 112.707 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 127.0 -158.12 20.85 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -102.09 107.77 54.05 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.42 123.5 9.17 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.532 2.821 . . . . 0.0 109.64 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.8 pt -132.91 -171.94 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.445 1.898 . . . . 0.0 108.434 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.655 ' CD1' HG22 ' A' ' 92' ' ' ILE . 1.5 t80 -134.15 158.62 43.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.588 1.155 . . . . 0.0 108.953 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.1 tt -149.59 150.06 31.63 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.425 1.49 . . . . 0.0 108.534 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.67 177.19 30.52 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 124.211 0.91 . . . . 0.0 111.945 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mt -97.96 132.25 43.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -96.53 35.69 1.46 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.425 1.011 . . . . 0.0 112.581 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -97.7 -96.87 1.96 Allowed Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.488 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.407 ' H ' HD11 ' A' ' 72' ' ' LEU . 24.3 mt -87.8 13.87 9.82 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.885 1.674 . . . . 0.0 115.018 -177.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 m120 72.37 70.88 0.15 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.437 1.895 . . . . 0.0 109.278 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.407 HD11 ' H ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -141.44 145.89 35.83 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 125.328 1.451 . . . . 0.0 107.976 -177.733 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.526 ' SG ' HG23 ' A' ' 92' ' ' ILE . 56.9 m -143.72 174.05 11.14 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.202 0.91 . . . . 0.0 109.855 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.455 HD23 HD21 ' A' ' 87' ' ' LEU . 15.1 mt -59.9 150.97 27.08 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.015 0.37 . . . . 0.0 111.185 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.9 ttp -157.89 116.05 3.08 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 95.8 m -89.78 109.7 20.67 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 119.288 0.949 . . . . 0.0 109.46 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.53 -169.23 1.44 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -130.78 118.54 20.97 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.2 p -65.67 -9.97 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.45 -1.29 7.56 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 125.295 1.426 . . . . 0.0 110.981 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -150.09 -44.25 0.13 Allowed 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.072 0.949 . . . . 0.0 111.484 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -135.44 163.06 53.5 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 124.903 1.281 . . . . 0.0 111.504 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -71.95 146.89 48.35 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.396 2.064 . . . . 0.0 112.635 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.1 p -145.75 170.89 15.61 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.4 mt -98.0 132.53 43.48 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -126.15 73.35 1.36 Allowed 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.02 0.928 . . . . 0.0 108.806 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.455 HD21 HD23 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -85.84 107.82 17.84 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 178.607 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.08 -30.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.127 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -157.35 97.73 1.65 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.183 0.993 . . . . 0.0 110.666 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.48 ' CE ' ' H ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -172.84 161.54 4.64 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.509 1.524 . . . . 0.0 107.131 178.292 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.48 ' H ' ' CE ' ' A' ' 90' ' ' LYS . 0.9 OUTLIER -131.1 130.31 42.99 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.424 1.49 . . . . 0.0 112.431 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.655 HG22 ' CD1' ' A' ' 64' ' ' TYR . 8.1 pt -82.37 -39.67 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 126.233 1.813 . . . . 0.0 111.644 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.2 tpt -64.51 -34.55 78.49 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.297 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.51 -45.88 92.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.879 0.763 . . . . 0.0 109.356 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.6 HD12 ' CD1' ' A' ' 64' ' ' TYR . 10.1 mt -65.82 -33.69 76.44 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.758 0.708 . . . . 0.0 111.278 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -79.77 -16.39 55.63 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.468 0.576 . . . . 0.0 110.403 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -91.73 -36.42 13.59 Favored 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 125.371 1.468 . . . . 0.0 111.486 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.79 159.03 42.25 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 121.141 -0.975 . . . . 0.0 112.049 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -78.86 54.11 4.98 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.435 2.09 . . . . 0.0 112.172 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -116.24 71.85 4.63 Favored Pre-proline 0 N--CA 1.473 0.683 0 O-C-N 120.713 -1.242 . . . . 0.0 110.827 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -79.99 82.1 2.58 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.599 2.199 . . . . 0.0 109.166 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.2 t -74.36 106.01 3.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -50.98 -30.53 15.31 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.423 1.01 . . . . 0.0 111.255 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 m -70.83 -8.82 55.37 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -114.03 -22.6 9.98 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.159 -0.963 . . . . 0.0 109.134 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.3 mt -84.34 154.23 23.02 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.007 0.923 . . . . 0.0 113.024 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -140.28 133.17 29.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.022 0.929 . . . . 0.0 110.079 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -77.41 118.45 19.88 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -81.17 141.06 34.58 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.0 m -138.87 174.38 10.58 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.465 1.106 . . . . 0.0 108.175 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -153.14 150.74 29.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.858 0.463 . . . . 0.0 110.142 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.01 107.07 0.35 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.36 56.92 3.28 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 126.121 1.819 . . . . 0.0 111.756 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 11.7 mtm-85 61.87 9.04 2.74 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.6 1.96 . . . . 0.0 109.798 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -117.5 162.35 18.12 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 119.903 1.228 . . . . 0.0 110.882 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.0 m -111.78 158.79 18.94 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.213 2.205 . . . . 0.0 108.632 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.65 162.82 34.55 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.474 1.909 . . . . 0.0 108.747 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -140.83 116.21 10.05 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -108.89 130.14 55.43 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.465 1.506 . . . . 0.0 109.226 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.9 t -56.69 117.69 4.14 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.356 1.462 . . . . 0.0 110.248 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.2 t -62.72 -40.68 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 119.076 0.853 . . . . 0.0 111.022 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.33 -42.02 88.78 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -133.2 86.49 41.7 Favored Pre-proline 0 C--O 1.237 0.414 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.04 168.8 11.59 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.285 2.656 . . . . 0.0 111.535 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.49 -21.67 31.2 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -101.03 118.03 36.19 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 127.444 2.298 . . . . 0.0 107.078 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -108.1 148.32 29.99 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.104 1.361 . . . . 0.0 108.902 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.4 mt -75.61 122.82 30.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.15 140.29 29.81 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.354 0.597 . . . . 0.0 110.494 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.4 m -90.58 -4.75 10.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 C-N-CA 124.548 1.139 . . . . 0.0 112.231 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.1 m 52.97 73.86 0.33 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 123.126 1.441 . . . . 0.0 113.571 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.0 t -93.83 6.12 49.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.676 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -115.36 136.22 53.32 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 53.84 -104.48 0.23 Allowed Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 107.561 -2.216 . . . . 0.0 107.561 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -173.35 66.43 0.11 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 106.394 -2.682 . . . . 0.0 106.394 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 56.5 m -82.0 157.74 68.35 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 117.534 0.667 . . . . 0.0 110.642 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -71.14 165.75 31.39 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 121.973 1.782 . . . . 0.0 108.521 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.441 HD12 ' CD1' ' A' ' 30' ' ' LEU . 22.6 mt -87.82 113.33 23.38 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.642 1.177 . . . . 0.0 112.06 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 pp -135.95 178.44 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 125.447 1.499 . . . . 0.0 109.455 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 35.6 mt -96.17 141.58 29.37 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.2 t -129.85 129.8 44.44 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -87.26 -23.47 24.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -160.79 93.78 1.01 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 122.315 1.055 . . . . 0.0 110.88 -177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.53 -57.32 11.84 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.471 1.108 . . . . 0.0 112.285 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 58.79 46.35 93.61 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . 0.25 1.4 tmtp? 63.49 38.87 9.54 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.655 1.982 . . . . 0.0 112.588 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -132.22 -13.42 3.1 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.912 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -140.62 156.39 46.28 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.429 -1.419 . . . . 0.0 108.677 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 55.8 m -109.8 118.51 36.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.7 p -108.07 -11.94 15.21 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.409 1.084 . . . . 0.0 110.099 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.69 126.84 48.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.759 1.223 . . . . 0.0 109.919 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -152.72 -165.08 2.1 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.333 -0.854 . . . . 0.0 109.41 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -148.1 127.59 2.63 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 106.055 -2.818 . . . . 0.0 106.055 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.52 114.47 26.01 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.8 m -78.41 39.59 0.33 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.588 2.355 . . . . 0.0 107.716 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -64.18 148.57 49.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.403 1.881 . . . . 0.0 107.999 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.1 mt -129.51 162.55 27.89 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.244 1.818 . . . . 0.0 108.43 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 22.9 p90 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 115.361 -2.257 . . . . 0.0 109.677 -179.592 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 122.395 1.093 . . . . 0.0 108.619 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 mp0 -75.3 -172.2 1.67 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 128.871 2.869 . . . . 0.0 113.754 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.64 -31.5 3.98 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.349 1.86 . . . . 0.0 112.217 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.73 -41.36 0.06 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 122.609 1.195 . . . . 0.0 113.007 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.502 ' H ' HD23 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -86.14 -172.02 3.86 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 125.809 1.644 . . . . 0.0 109.026 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -131.49 9.2 4.67 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.919 1.288 . . . . 0.0 113.361 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pt -135.55 38.65 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 127.5 2.32 . . . . 0.0 108.679 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.41 -43.04 52.07 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.631 -1.293 . . . . 0.0 112.407 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.15 155.8 91.33 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 123.327 0.651 . . . . 0.0 109.983 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.46 ' HB3' HD11 ' A' ' 47' ' ' ILE . 60.7 Cg_endo -69.94 132.15 22.45 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.442 2.094 . . . . 0.0 107.497 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.99 132.81 42.43 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.5 mp0 -128.89 145.98 51.07 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.14 -139.19 2.67 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 95.0 p -143.96 -172.62 3.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.036 0.918 . . . . 0.0 112.796 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.3 mt -140.05 -10.6 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 126.443 1.897 . . . . 0.0 109.337 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -24.02 65.31 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 119.544 -1.972 . . . . 0.0 113.268 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -58.86 -16.38 17.06 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.917 2.087 . . . . 0.0 112.706 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.5 mt -74.79 -67.11 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.138 1.375 . . . . 0.0 112.8 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -136.7 32.09 2.75 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.149 0.976 . . . . 0.0 110.535 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 58.62 37.42 25.31 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.924 0.868 . . . . 0.0 110.643 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.1 mmt-85 -105.72 89.67 3.16 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.824 -1.173 . . . . 0.0 109.217 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.3 t -79.11 157.25 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.418 ' CD2' HD11 ' A' ' 138' ' ' LEU . 49.8 m0 -111.47 153.78 25.66 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.988 0.915 . . . . 0.0 108.673 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.5 t -146.62 135.65 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.1 tp -76.25 106.89 8.12 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -132.16 133.51 44.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 119.843 1.201 . . . . 0.0 111.293 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t0 47.83 42.79 16.5 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 123.641 1.686 . . . . 0.0 111.28 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 61.61 26.93 16.51 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 127.223 2.209 . . . . 0.0 115.122 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.1 m -138.71 154.79 48.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.968 HD11 HD21 ' A' ' 67' ' ' LEU . 9.8 mt -92.94 126.45 38.02 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mt -126.97 132.16 70.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 123.141 0.576 . . . . 0.0 110.736 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.34 136.38 46.17 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.951 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.7 m -112.96 81.44 4.57 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.786 1.235 . . . . 0.0 108.117 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.12 -33.36 25.34 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.559 2.172 . . . . 0.0 111.851 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -151.33 12.73 0.65 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -62.86 138.65 58.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 120.585 -1.322 . . . . 0.0 111.059 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -33.13 75.16 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.603 1.961 . . . . 0.0 109.038 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -102.08 71.59 1.27 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.7 ptm -106.7 163.07 13.21 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -157.43 141.12 11.37 Favored Pre-proline 0 N--CA 1.446 -0.652 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -71.91 163.78 37.74 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 N-CA-C 108.502 -1.384 . . . . 0.0 108.502 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.8 p -155.62 154.19 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.437 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.46 150.99 25.53 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 126.827 2.051 . . . . 0.0 110.355 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 12' ' ' GLN . 43.3 mm -121.56 122.34 66.85 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 68' ' ' ASN . . . -100.71 145.84 27.96 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.453 HD12 HD12 ' A' ' 65' ' ' LEU . 3.9 tt -140.18 138.01 34.82 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.473 HD12 HG12 ' A' ' 92' ' ' ILE . 80.9 mt -146.77 138.0 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 C-N-CA 126.129 1.772 . . . . 0.0 109.856 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.4 p -84.28 130.24 34.82 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 89.9 m -62.68 138.74 58.58 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -94.42 -28.36 15.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.858 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -90.85 40.73 1.03 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.2 m -68.22 -8.81 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 120.44 -1.412 . . . . 0.0 112.783 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -62.6 -7.37 4.61 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.032 2.133 . . . . 0.0 113.583 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 t -122.5 7.23 9.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.897 1.279 . . . . 0.0 111.605 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.6 mt -107.49 167.31 10.03 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.849 -1.157 . . . . 0.0 108.601 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -64.71 153.34 39.98 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.268 -1.333 . . . . 0.0 107.992 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -121.72 -47.01 2.22 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.091 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.16 -26.45 62.75 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 127.909 2.484 . . . . 0.0 113.315 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -85.04 -19.47 31.92 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.789 -0.57 . . . . 0.0 111.601 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 140.71 -167.44 25.59 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -97.45 102.1 11.9 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.683 0.793 . . . . 0.0 110.676 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.64 138.17 23.6 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 124.298 3.332 . . . . 0.0 112.741 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pp -146.08 -175.35 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 125.738 1.615 . . . . 0.0 110.246 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.498 ' CE1' HD12 ' A' ' 95' ' ' LEU . 3.2 t80 -134.16 156.46 48.29 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.678 0.791 . . . . 0.0 110.527 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.465 HD11 HD21 ' A' ' 154' ' ' LEU . 6.8 tt -154.3 151.82 29.55 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.599 1.56 . . . . 0.0 108.428 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.92 -176.67 34.26 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.968 HD21 HD11 ' A' ' 30' ' ' LEU . 11.0 mt -83.47 171.03 13.82 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 176.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 10.5 t-20 -137.68 47.34 2.06 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.603 -1.311 . . . . 0.0 109.6 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.83 -75.99 0.54 Allowed Glycine 0 C--N 1.337 0.63 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.381 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.21 25.11 11.43 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 m120 66.88 72.96 0.36 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.662 1.185 . . . . 0.0 109.804 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.46 141.71 25.1 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.963 1.305 . . . . 0.0 110.573 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.3 m -144.04 165.48 27.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.02 0.827 . . . . 0.0 111.385 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.84 156.62 8.63 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.518 1.127 . . . . 0.0 110.174 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.1 tmm? -164.37 140.53 6.17 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.5 m -102.78 119.61 39.14 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.45 -171.75 2.44 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.124 1.37 . . . . 0.0 107.874 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -128.25 127.09 42.18 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.94 -8.04 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 123.437 0.461 . . . . 0.0 110.697 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.73 -82.44 0.1 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -117.17 7.66 13.05 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.968 0.89 . . . . 0.0 112.701 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -141.1 151.01 60.85 Favored Pre-proline 0 C--O 1.241 0.651 0 C-N-CA 124.807 1.243 . . . . 0.0 110.547 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.72 149.13 18.18 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.733 2.289 . . . . 0.0 108.978 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.5 p -144.14 170.61 15.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.957 0.903 . . . . 0.0 110.393 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.66 HD11 HG23 ' A' ' 128' ' ' ILE . 3.5 mt -91.79 151.24 20.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.399 1.08 . . . . 0.0 108.679 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -148.63 80.94 1.45 Allowed 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 125.079 1.351 . . . . 0.0 107.628 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.62 ' HG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -104.96 97.39 7.25 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 125.942 1.697 . . . . 0.0 108.858 -177.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.08 -26.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.871 0.732 . . . . 0.0 112.274 -177.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -145.24 103.59 3.86 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.541 1.537 . . . . 0.0 109.482 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.433 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER 174.11 159.25 0.16 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.133 1.373 . . . . 0.0 108.915 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -136.35 127.74 28.44 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.181 0.593 . . . . 0.0 110.795 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.473 HG12 HD12 ' A' ' 47' ' ' ILE . 1.1 tt -68.26 -47.17 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 125.903 1.681 . . . . 0.0 114.25 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.8 tpt -62.95 -29.73 71.03 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.982 -0.532 . . . . 0.0 111.268 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.22 -54.51 32.35 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.034 0.533 . . . . 0.0 109.691 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.498 HD12 ' CE1' ' A' ' 64' ' ' TYR . 42.2 mt -63.87 -30.04 71.17 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.414 ' CG ' HG21 ' A' ' 47' ' ' ILE . 52.1 t80 -74.39 -52.42 12.17 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -60.63 -45.08 95.42 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 125.682 1.593 . . . . 0.0 112.685 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -92.99 145.37 29.99 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.64 50.0 2.59 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.439 2.76 . . . . 0.0 112.124 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -118.12 72.73 9.4 Favored Pre-proline 0 CA--C 1.537 0.48 0 O-C-N 120.745 -1.222 . . . . 0.0 109.332 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.94 92.28 1.05 Allowed 'Trans proline' 0 N--CA 1.45 -1.037 0 N-CA-C 105.284 -2.622 . . . . 0.0 105.284 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.5 t -88.35 97.72 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -50.55 -22.23 1.88 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.02 -17.34 64.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.209 0.604 . . . . 0.0 110.858 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -113.61 -22.07 10.46 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 119.164 0.893 . . . . 0.0 110.649 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.8 mt -78.97 164.37 24.46 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.698 1.199 . . . . 0.0 113.64 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.92 140.63 22.65 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 123.772 0.829 . . . . 0.0 111.016 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.43 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.5 OUTLIER -75.3 123.18 24.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 176.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.431 ' CD2' ' HB3' ' A' ' 116' ' ' SER . 3.9 t-160 -97.94 101.35 12.81 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.883 1.273 . . . . 0.0 107.577 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.51 170.9 13.0 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.925 1.29 . . . . 0.0 110.095 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -139.86 147.38 40.58 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.675 1.59 . . . . 0.0 110.044 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.4 p -135.59 15.4 3.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.823 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.5 -79.23 0.31 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -111.47 -1.41 15.9 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.18 0.992 . . . . 0.0 111.985 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -127.03 160.87 29.83 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.206 1.002 . . . . 0.0 108.357 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.431 ' HB3' ' CD2' ' A' ' 109' ' ' HIS . 49.9 m -132.5 151.66 51.83 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.234 1.814 . . . . 0.0 109.024 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.11 165.75 12.79 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -142.8 107.96 4.97 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -111.65 124.72 52.9 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.398 1.879 . . . . 0.0 110.056 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.8 t -53.01 130.23 33.13 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.304 -0.872 . . . . 0.0 110.032 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.2 t -68.87 -51.18 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.909 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.01 78.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -129.19 81.6 70.15 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 124.055 0.942 . . . . 0.0 109.903 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -65.38 161.61 37.2 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.671 2.247 . . . . 0.0 111.113 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.2 0.06 77.69 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.205 -0.775 . . . . 0.0 113.06 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -126.69 131.23 51.43 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.455 1.902 . . . . 0.0 107.753 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.6 149.97 33.77 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.948 1.299 . . . . 0.0 112.493 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.66 HG23 HD11 ' A' ' 85' ' ' LEU . 2.1 mt -81.51 119.25 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.609 0.764 . . . . 0.0 111.176 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.72 152.31 31.64 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.638 1.108 . . . . 0.0 109.965 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.9 t -103.48 -18.2 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 127.797 2.439 . . . . 0.0 109.754 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.504 ' HB3' ' H ' ' A' ' 136' ' ' CYS . 50.9 m 61.24 39.24 15.91 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.391 1.476 . . . . 0.0 114.295 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.1 m -76.76 -11.38 59.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.61 -66.99 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.77 1.628 . . . . 0.0 111.071 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -122.88 -48.49 0.25 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 124.321 0.963 . . . . 0.0 111.288 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 138.75 60.44 0.05 OUTLIER Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' CYS . . . . . 0.504 ' H ' ' HB3' ' A' ' 131' ' ' SER . 0.5 OUTLIER -90.45 174.16 4.91 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 123.95 0.9 . . . . 0.0 110.933 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.01 166.43 29.61 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 N-CA-C 108.928 -1.22 . . . . 0.0 108.928 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.418 HD11 ' CD2' ' A' ' 23' ' ' TRP . 21.9 mt -87.28 114.09 23.58 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.9 pp -137.93 172.02 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.078 1.351 . . . . 0.0 110.754 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 66.3 mt -97.72 159.89 14.65 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.37 161.33 41.22 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 125.321 1.448 . . . . 0.0 107.316 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -104.57 -45.66 4.56 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -159.88 126.7 4.45 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.667 ' HG ' ' H ' ' A' ' 145' ' ' GLY . 0.5 OUTLIER -120.3 -63.91 1.31 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.984 1.714 . . . . 0.0 111.209 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.667 ' H ' ' HG ' ' A' ' 144' ' ' LEU . . . 106.68 -70.11 0.22 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 107.118 -2.393 . . . . 0.0 107.118 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.67 -5.65 1.18 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.397 1.079 . . . . 0.0 113.382 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.93 -19.77 65.01 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -138.26 -157.81 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.4 m -146.53 107.9 4.25 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 102.088 -3.301 . . . . 0.0 102.088 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.49 -9.12 14.23 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.389 1.076 . . . . 0.0 110.546 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -123.26 112.32 17.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.94 -176.62 5.0 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.085 0.954 . . . . 0.0 111.165 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.99 -169.04 32.13 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.347 0.975 . . . . 0.0 112.675 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.465 HD21 HD11 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -145.5 130.33 18.16 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.942 1.697 . . . . 0.0 106.769 179.164 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 39.2 m -90.34 51.32 2.0 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -68.73 138.13 54.64 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 40.8 mt -123.03 170.23 10.37 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.159 2.184 . . . . 0.0 107.95 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 1.8 p90 . . . . . 0 C--O 1.255 1.347 0 CA-C-O 117.416 -1.278 . . . . 0.0 108.677 -179.842 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -84.01 -170.34 3.03 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -118.13 26.77 9.41 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.201 -0.937 . . . . 0.0 110.587 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 56.21 62.03 2.5 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 124.571 1.148 . . . . 0.0 110.019 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -110.89 -45.33 3.48 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-O 117.125 -1.417 . . . . 0.0 112.623 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.5 pttt 43.87 37.07 1.53 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.321 2.248 . . . . 0.0 112.994 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -144.02 79.99 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 125.259 1.424 . . . . 0.0 108.684 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.04 100.25 8.07 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.25 154.62 81.69 Favored Pre-proline 0 C--O 1.239 0.55 0 C-N-CA 123.753 0.821 . . . . 0.0 110.613 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.1 146.1 80.97 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.949 1.766 . . . . 0.0 107.833 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -141.23 108.77 5.59 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -111.15 145.18 39.08 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.303 0.641 . . . . 0.0 110.227 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.28 -117.99 0.48 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.0 p -160.45 167.58 26.97 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 119.118 1.459 . . . . 0.0 114.018 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.517 HG22 HH12 ' A' ' 21' ' ' ARG . 30.0 mt -127.19 -2.56 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 123.463 0.705 . . . . 0.0 109.37 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -62.52 -28.65 69.99 Favored 'General case' 0 C--N 1.334 -0.094 0 O-C-N 119.4 -2.062 . . . . 0.0 115.028 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.41 -19.79 16.59 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.205 1.802 . . . . 0.0 112.635 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.7 mm -56.69 -54.48 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 127.458 2.303 . . . . 0.0 115.292 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -151.27 35.17 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.12 16.58 3.02 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.643 1.977 . . . . 0.0 114.29 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.517 HH12 HG22 ' A' ' 15' ' ' ILE . 1.1 ptm180 -88.22 94.89 9.97 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.596 1.558 . . . . 0.0 109.78 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -75.67 157.73 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.514 ' CZ3' HD12 ' A' ' 15' ' ' ILE . 17.5 m0 -108.21 147.9 30.71 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.1 t -142.6 127.93 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.427 HD22 ' CD2' ' A' ' 72' ' ' LEU . 3.9 tp -72.31 107.62 5.01 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -124.88 124.82 42.88 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 120.602 1.547 . . . . 0.0 110.37 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 t0 47.81 57.24 6.19 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.443 1.116 . . . . 0.0 111.229 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 51.75 24.9 2.64 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.228 1.011 . . . . 0.0 113.542 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.3 m -142.96 127.05 17.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.463 HD11 HD11 ' A' ' 67' ' ' LEU . 14.9 mt -74.66 144.06 43.99 Favored 'General case' 0 CA--C 1.518 -0.258 0 O-C-N 119.55 -1.969 . . . . 0.0 109.306 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.4 pt -125.14 153.07 32.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 123.895 0.878 . . . . 0.0 108.862 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.36 123.02 44.05 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.3 m -111.25 78.23 1.77 Allowed Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.043 0.937 . . . . 0.0 108.87 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.73 -50.12 2.62 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.57 1.513 . . . . 0.0 110.425 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -141.98 79.73 1.68 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.637 1.175 . . . . 0.0 108.176 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -140.98 132.78 27.42 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.39 -42.56 98.91 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.632 0.582 . . . . 0.0 112.01 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -71.73 22.34 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -73.15 163.73 27.71 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 120.444 -1.41 . . . . 0.0 110.317 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.0 t -156.53 132.43 5.81 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.14 144.99 59.29 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.841 2.361 . . . . 0.0 110.633 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.56 164.51 34.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.523 1.129 . . . . 0.0 108.244 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -115.49 156.2 26.11 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 mm -123.0 136.06 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.24 126.14 46.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 119.926 1.239 . . . . 0.0 107.944 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -118.96 136.86 53.87 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.608 1.163 . . . . 0.0 110.481 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 mt -148.96 142.33 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.941 1.296 . . . . 0.0 109.246 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.7 p -84.83 153.69 22.78 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.2 m -79.53 130.2 35.17 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 120.173 -1.58 . . . . 0.0 108.117 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -79.14 -32.18 44.3 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -97.34 44.8 1.04 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.967 1.307 . . . . 0.0 110.65 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 m -66.22 -7.53 5.48 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 O-C-N 120.412 -1.43 . . . . 0.0 113.636 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -55.5 -28.92 57.5 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.285 0.948 . . . . 0.0 112.662 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.4 t -95.44 -11.13 28.1 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.902 0.774 . . . . 0.0 111.569 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.52 168.24 11.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -82.05 154.44 25.63 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -119.84 -18.31 8.29 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.056 1.343 . . . . 0.0 111.062 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -57.51 -39.59 76.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.107 2.563 . . . . 0.0 114.191 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -85.06 -12.8 52.23 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.178 0.991 . . . . 0.0 111.396 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.06 -162.26 24.99 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -93.94 103.66 11.01 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 126.148 1.779 . . . . 0.0 109.862 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.08 135.73 25.74 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.447 2.098 . . . . 0.0 109.966 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -133.15 178.06 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.633 ' CD1' HG22 ' A' ' 92' ' ' ILE . 2.1 t80 -137.76 131.4 31.19 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.033 0.533 . . . . 0.0 109.567 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.72 158.7 38.67 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.43 -170.09 22.69 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.463 HD11 HD11 ' A' ' 30' ' ' LEU . 4.3 mt -98.85 166.73 11.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -130.31 94.77 3.74 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.98 -16.23 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 CA-C-O 116.574 -2.236 . . . . 0.0 116.977 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.15 22.95 0.11 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 120.493 2.146 . . . . 0.0 111.914 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 61.45 63.37 1.2 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.786 1.634 . . . . 0.0 108.993 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.427 ' CD2' HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -136.49 127.17 27.15 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.219 -178.41 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.579 ' SG ' HG23 ' A' ' 92' ' ' ILE . 29.1 m -136.84 179.65 6.24 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.931 ' HA ' HD12 ' A' ' 87' ' ' LEU . 10.9 mt -64.08 153.54 37.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.185 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -161.09 133.57 6.07 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 89.6 m -101.0 125.76 47.63 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.81 -174.7 3.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 81' ' ' ASP . 10.2 tttt -117.48 148.39 41.87 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.7 p -121.67 -6.79 9.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 123.564 0.54 . . . . 0.0 111.458 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.5 72.31 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.436 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 8.4 t0 70.48 5.27 5.3 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.811 2.044 . . . . 0.0 114.34 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.71 143.85 42.13 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.164 1.786 . . . . 0.0 109.356 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -74.91 162.04 37.97 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.989 2.459 . . . . 0.0 113.277 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.1 p -156.8 169.1 25.53 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.342 1.457 . . . . 0.0 109.997 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.798 HD11 HG22 ' A' ' 128' ' ' ILE . 0.9 OUTLIER -91.18 130.22 37.08 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 127.583 2.353 . . . . 0.0 105.164 178.105 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -136.99 70.38 1.4 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 122.118 0.961 . . . . 0.0 109.365 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.931 HD12 ' HA ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -89.14 113.78 24.99 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 127.458 2.303 . . . . 0.0 109.067 -178.128 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.64 -28.5 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 O-C-N 124.745 1.278 . . . . 0.0 113.529 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -147.65 97.68 2.86 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.361 1.465 . . . . 0.0 109.43 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.95 159.21 2.64 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -135.23 134.03 39.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.633 HG22 ' CD1' ' A' ' 64' ' ' TYR . 6.5 pt -83.62 -40.38 15.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.7 tpt -63.98 -31.05 72.1 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.237 -0.887 . . . . 0.0 112.424 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.55 -50.18 73.69 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.525 HD12 ' CD1' ' A' ' 64' ' ' TYR . 16.1 mt -63.44 -35.6 80.96 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.528 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -75.38 -26.41 58.44 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.931 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -78.88 -31.45 45.47 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 120.711 -1.243 . . . . 0.0 113.217 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -112.29 158.07 38.18 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 118.949 0.795 . . . . 0.0 110.829 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -86.74 45.0 1.27 Allowed 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.287 2.658 . . . . 0.0 114.157 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -125.24 58.1 18.87 Favored Pre-proline 0 CA--C 1.553 1.064 0 O-C-N 120.608 -1.308 . . . . 0.0 112.195 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -62.21 117.96 4.83 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.946 3.097 . . . . 0.0 110.82 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.1 t -99.92 107.41 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 123.447 0.699 . . . . 0.0 110.621 -177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.431 ' HB2' HG12 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -52.82 -24.28 8.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 118.182 -0.914 . . . . 0.0 112.877 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.1 m -67.69 -11.35 58.12 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.363 0.983 . . . . 0.0 111.362 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -119.62 -16.1 8.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.256 1.422 . . . . 0.0 110.294 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.6 mt -83.74 154.9 23.35 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.08 0.854 . . . . 0.0 111.867 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -136.88 128.14 28.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.483 0.713 . . . . 0.0 110.212 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -71.29 126.46 29.69 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 103.698 -2.704 . . . . 0.0 103.698 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -104.35 145.53 30.12 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.749 0.704 . . . . 0.0 110.25 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.66 -175.22 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.854 -0.529 . . . . 0.0 109.96 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -143.99 151.05 39.22 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.884 1.674 . . . . 0.0 106.959 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.5 p -124.98 -7.11 7.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.89 -35.81 2.39 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -147.68 -5.4 0.48 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.028 1.331 . . . . 0.0 112.082 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -131.57 177.33 7.58 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 125.331 1.452 . . . . 0.0 108.787 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 m -140.64 145.82 37.11 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.552 1.541 . . . . 0.0 110.078 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.65 166.9 10.63 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.926 0.89 . . . . 0.0 108.623 178.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -147.34 114.21 6.11 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.057 1.343 . . . . 0.0 107.773 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -114.83 130.5 56.88 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 127.103 2.161 . . . . 0.0 112.11 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.3 t -53.02 124.01 13.14 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.37 0.668 . . . . 0.0 109.764 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.431 HG12 ' HB2' ' A' ' 103' ' ' LYS . 79.1 t -67.48 -54.11 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 O-C-N 121.08 -1.012 . . . . 0.0 110.137 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.44 -33.52 68.0 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.085 0.954 . . . . 0.0 113.182 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -135.95 80.91 41.0 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 124.647 1.179 . . . . 0.0 109.778 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.44 163.1 37.94 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.005 2.47 . . . . 0.0 109.848 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 96.77 -3.24 62.68 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.582 1.087 . . . . 0.0 110.653 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -125.63 121.82 34.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.731 1.612 . . . . 0.0 108.522 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -106.1 145.87 30.9 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.423 1.489 . . . . 0.0 109.575 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.798 HG22 HD11 ' A' ' 85' ' ' LEU . 3.4 pt -75.09 121.32 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.08 121.25 27.16 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 68.8 t -78.24 -20.06 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 127.656 2.382 . . . . 0.0 113.385 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m 59.21 66.11 1.09 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.406 1.098 . . . . 0.0 110.438 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.3 m -99.36 36.7 1.69 Allowed 'General case' 0 C--N 1.323 -0.575 0 O-C-N 120.963 -1.085 . . . . 0.0 112.239 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -126.37 -98.96 0.39 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.935 0.494 . . . . 0.0 109.957 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -94.17 23.96 29.13 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-O 117.058 -1.968 . . . . 0.0 117.133 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.38 52.02 6.97 Favored Glycine 0 C--O 1.238 0.376 0 CA-C-N 119.743 1.771 . . . . 0.0 113.306 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.29 164.65 40.03 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.27 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.32 156.87 37.31 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 N-CA-C 107.04 -1.946 . . . . 0.0 107.04 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.438 HD11 ' CE2' ' A' ' 23' ' ' TRP . 17.7 mt -82.94 118.68 23.64 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.537 1.135 . . . . 0.0 110.862 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.439 ' C ' HD12 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -143.33 167.48 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 123.787 0.835 . . . . 0.0 111.458 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.5 mt -86.14 151.89 23.29 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.1 t -141.36 137.29 32.24 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -83.02 -33.98 26.38 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 122.154 0.978 . . . . 0.0 109.43 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.15 101.51 3.15 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -177.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.499 ' H ' HD23 ' A' ' 144' ' ' LEU . 0.7 OUTLIER -81.88 -160.1 0.34 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.707 -1.588 . . . . 0.0 108.905 178.458 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 123.74 -5.59 9.13 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 125.542 1.544 . . . . 0.0 112.417 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.18 103.94 1.47 Allowed 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 118.338 1.069 . . . . 0.0 112.279 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 80.72 -2.09 1.85 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 129.656 3.182 . . . . 0.0 114.328 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -121.52 74.95 1.15 Allowed 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.752 2.421 . . . . 0.0 110.276 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.444 HG21 ' CE2' ' A' ' 152' ' ' PHE . 0.3 OUTLIER -65.77 106.52 1.53 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 117.317 -1.325 . . . . 0.0 108.898 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.7 p -100.9 -12.99 18.53 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 122.147 2.249 . . . . 0.0 111.108 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -101.69 103.96 14.76 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 130.135 3.374 . . . . 0.0 118.072 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.444 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.8 OUTLIER -168.68 177.06 5.31 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.333 -0.854 . . . . 0.0 112.927 177.747 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.15 178.19 26.69 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.077 1.322 . . . . 0.0 111.675 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.427 ' HG ' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -126.77 144.91 50.81 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.474 1.509 . . . . 0.0 109.534 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.4 m -104.52 48.69 0.83 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.19 158.83 35.74 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.9 mt -129.55 159.49 36.17 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.95 1.3 . . . . 0.0 108.991 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 11.0 p90 . . . . . 0 C--O 1.245 0.834 0 CA-C-O 115.587 -2.149 . . . . 0.0 108.573 -179.858 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.41 169.11 20.92 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.594 1.088 . . . . 0.0 110.06 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -77.62 28.48 0.16 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.335 1.854 . . . . 0.0 112.291 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 56.43 33.58 22.71 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.75 1.22 . . . . 0.0 112.092 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.432 ' H ' HD23 ' A' ' 5' ' ' LEU . 2.2 pt? -74.42 168.59 19.4 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 121.665 -0.647 . . . . 0.0 109.58 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -138.31 -22.12 1.03 Allowed 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.84 -39.97 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 O-C-N 123.737 0.648 . . . . 0.0 111.115 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -121.79 114.27 20.84 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.57 162.49 54.48 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 123.977 0.911 . . . . 0.0 108.573 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HB3' HG12 ' A' ' 47' ' ' ILE . 97.8 Cg_endo -71.63 156.12 58.03 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 N-CA-C 108.301 -1.461 . . . . 0.0 108.301 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.36 116.84 27.02 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 pm0 -113.3 142.47 45.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 122.568 0.347 . . . . 0.0 110.468 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.06 -125.97 0.89 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-O 118.27 -1.295 . . . . 0.0 111.284 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.8 p -154.05 -159.74 1.01 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 120.918 2.359 . . . . 0.0 111.188 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -153.84 -4.5 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 126.329 1.852 . . . . 0.0 109.122 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -62.93 -29.68 70.97 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.74 -16.47 40.3 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.637 1.175 . . . . 0.0 113.487 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mt -61.49 -45.73 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 C-N-CA 125.666 1.586 . . . . 0.0 112.383 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.82 21.84 1.0 Allowed 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.091 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.8 t60 63.95 43.78 5.09 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.45 HH11 ' HB3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -113.88 94.1 4.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.794 0.838 . . . . 0.0 109.558 178.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.58 143.67 11.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -100.53 139.63 35.93 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -135.67 141.07 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 tp -79.98 103.29 9.76 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.7 134.42 50.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.3 t0 39.16 65.76 0.63 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.202 1.401 . . . . 0.0 112.148 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 44.21 31.94 0.62 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.456 1.502 . . . . 0.0 114.597 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.6 m -144.57 162.97 35.28 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.837 1.655 . . . . 0.0 106.77 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.712 HD12 HD22 ' A' ' 87' ' ' LEU . 5.5 mt -103.06 120.29 40.4 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 177.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 1.4 mm -119.08 139.66 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 118.03 0.377 . . . . 0.0 110.331 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.62 138.25 39.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 m -122.37 60.66 13.65 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.372 1.069 . . . . 0.0 110.336 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.45 ' HB3' HH11 ' A' ' 21' ' ' ARG . 19.8 Cg_endo -56.51 -37.64 96.97 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.199 1.933 . . . . 0.0 114.967 -178.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -136.62 13.18 3.2 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.22 128.08 34.71 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.3 1.04 . . . . 0.0 108.369 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.45 6.14 1.51 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.335 1.854 . . . . 0.0 113.094 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -129.02 40.45 3.63 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.363 -1.461 . . . . 0.0 109.881 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.7 ptp -72.58 167.72 20.11 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.836 -0.54 . . . . 0.0 110.217 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.13 128.73 2.19 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.85 157.7 51.25 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.517 2.145 . . . . 0.0 110.474 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.5 m -144.54 166.52 12.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.96 162.73 16.04 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.7 mm -132.05 109.76 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 C-N-CA 126.951 2.1 . . . . 0.0 107.3 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.89 136.54 34.06 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.4 tt -129.38 132.59 47.07 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.424 HG12 ' HB3' ' A' ' 10' ' ' PRO . 1.7 mt -142.26 141.34 28.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 124.797 1.239 . . . . 0.0 109.323 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.4 t -76.39 164.87 25.59 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.5 m -89.76 146.72 24.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -109.37 -20.92 12.75 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -105.75 39.84 1.69 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 122.475 1.131 . . . . 0.0 109.939 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 m -66.7 -6.03 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.52 1.128 . . . . 0.0 112.653 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -33.77 66.23 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.277 1.031 . . . . 0.0 111.855 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 t -101.79 13.67 34.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.649 1.179 . . . . 0.0 111.885 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.7 mt -107.14 179.58 4.22 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 120.713 -1.242 . . . . 0.0 111.006 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -84.3 153.07 23.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.639 1.176 . . . . 0.0 107.948 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -124.95 -37.78 2.41 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 123.606 0.762 . . . . 0.0 110.491 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -53.98 -44.28 70.67 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.741 1.216 . . . . 0.0 111.84 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -67.54 -27.28 66.83 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.086 -1.435 . . . . 0.0 112.2 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.51 178.84 16.6 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 126.415 1.959 . . . . 0.0 110.512 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.54 120.17 80.39 Favored Pre-proline 0 CA--C 1.541 0.619 0 O-C-N 121.561 -0.964 . . . . 0.0 111.883 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.63 141.79 15.76 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.51 2.807 . . . . 0.0 110.256 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -143.58 -179.47 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.888 2.075 . . . . 0.0 108.083 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.509 ' CD1' HD12 ' A' ' 95' ' ' LEU . 2.0 t80 -136.83 151.66 49.39 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 tt -145.36 154.87 42.77 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.19 -174.78 28.34 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.43 161.15 13.94 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -130.32 105.4 7.87 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.07 -31.24 0.11 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-O 118.45 -1.195 . . . . 0.0 113.513 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -153.35 37.02 0.47 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.142 1.471 . . . . 0.0 110.402 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 49.83 78.98 0.09 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.233 2.213 . . . . 0.0 111.582 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -142.75 141.85 31.82 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.233 -177.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 36.5 m -141.16 170.07 16.42 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.323 0.965 . . . . 0.0 112.026 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.3 mt -56.2 149.66 15.72 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.243 1.383 . . . . 0.0 111.435 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.8 mtp -156.64 138.78 14.58 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.3 m -107.57 124.87 50.57 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.29 -178.94 5.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.29 1.436 . . . . 0.0 107.913 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -119.81 146.26 45.86 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 124.159 0.983 . . . . 0.0 109.219 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 p -119.28 6.63 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 O-C-N 123.893 0.746 . . . . 0.0 112.47 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.22 87.0 0.49 Allowed Glycine 0 C--O 1.223 -0.581 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 63.86 17.77 10.74 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.07 143.41 7.17 Favored Pre-proline 0 C--O 1.24 0.575 0 C-N-CA 123.093 0.557 . . . . 0.0 110.906 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.56 164.63 33.43 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.658 2.239 . . . . 0.0 112.604 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.81 160.63 34.05 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.696 1.598 . . . . 0.0 108.905 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.42 HD11 ' CG2' ' A' ' 128' ' ' ILE . 4.2 mt -75.87 148.96 37.92 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.28 33.8 2.55 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.96 0.904 . . . . 0.0 110.632 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.712 HD22 HD12 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -66.29 92.57 0.19 Allowed 'General case' 0 CA--C 1.496 -1.117 0 C-N-CA 129.686 3.195 . . . . 0.0 109.249 -179.565 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.456 ' HA ' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -159.86 -45.97 0.05 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.691 -179.011 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -128.78 98.2 4.91 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.463 1.105 . . . . 0.0 111.137 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.491 ' HZ3' HD21 ' A' ' 95' ' ' LEU . 1.1 mmmt -176.69 152.62 1.02 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.413 -1.429 . . . . 0.0 108.757 178.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -114.03 144.2 43.5 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.191 0.996 . . . . 0.0 109.942 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.2 tt -98.85 -44.98 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 125.166 1.386 . . . . 0.0 110.235 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -32.09 71.0 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.729 0.811 . . . . 0.0 110.406 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.3 -54.18 41.16 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.509 HD12 ' CD1' ' A' ' 64' ' ' TYR . 13.9 mt -59.66 -33.35 71.43 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 122.658 0.383 . . . . 0.0 111.699 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -73.79 -37.96 64.77 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -75.09 -36.73 61.71 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.657 1.583 . . . . 0.0 113.946 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -111.71 149.59 40.97 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 119.84 1.2 . . . . 0.0 111.718 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -76.63 56.68 5.27 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.177 3.251 . . . . 0.0 113.554 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -118.57 80.48 16.94 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.207 1.003 . . . . 0.0 108.441 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.86 74.98 5.02 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.807 3.004 . . . . 0.0 109.012 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -69.72 97.35 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 124.792 1.237 . . . . 0.0 109.314 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -52.45 -26.72 13.56 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.621 1.168 . . . . 0.0 112.9 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.0 -18.24 64.1 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.461 0.573 . . . . 0.0 112.239 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -115.96 -23.81 8.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.479 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.1 mt -72.89 153.8 40.86 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.162 0.892 . . . . 0.0 111.319 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -136.49 138.46 41.43 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.261 1.025 . . . . 0.0 110.516 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.98 123.15 29.68 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 103.528 -2.767 . . . . 0.0 103.528 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -103.39 143.83 32.17 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.258 0.623 . . . . 0.0 109.44 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.85 169.83 20.75 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -140.28 151.76 45.36 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.347 1.459 . . . . 0.0 111.601 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.19 79.18 0.75 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.901 0.858 . . . . 0.0 112.707 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.62 62.95 1.58 Allowed Glycine 0 C--N 1.334 0.46 0 O-C-N 120.954 -1.091 . . . . 0.0 111.639 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.32 4.13 1.58 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.72 1.208 . . . . 0.0 112.861 -178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.58 163.48 12.44 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.0 m -146.16 152.48 39.32 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.39 159.9 41.18 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -132.18 120.1 21.78 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.462 ' HB2' ' CE2' ' A' ' 127' ' ' PHE . 4.1 tt0 -112.42 131.21 55.67 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.418 1.087 . . . . 0.0 109.116 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.4 121.67 8.8 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.725 1.61 . . . . 0.0 109.705 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.8 t -70.99 -40.61 76.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 O-C-N 120.7 -1.25 . . . . 0.0 111.954 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.62 -38.3 77.73 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.077 0.853 . . . . 0.0 111.918 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -139.2 97.36 8.64 Favored Pre-proline 0 C--O 1.24 0.568 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.02 174.3 10.8 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.366 2.044 . . . . 0.0 109.208 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 91.11 -3.42 80.32 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -125.19 129.74 50.72 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.033 1.333 . . . . 0.0 107.535 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 119' ' ' GLU . 79.3 m-85 -114.92 142.24 46.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.29 1.836 . . . . 0.0 108.322 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.42 ' CG2' HD11 ' A' ' 85' ' ' LEU . 3.9 mt -74.02 136.12 25.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 O-C-N 121.999 -0.438 . . . . 0.0 110.511 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.29 141.2 30.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.218 0.532 . . . . 0.0 110.358 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.1 t -93.15 -13.44 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 126.557 1.943 . . . . 0.0 109.254 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.2 m 52.89 37.38 24.15 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.437 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 16.2 m -73.37 -2.01 20.49 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -74.08 -85.01 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 O-C-N 120.331 -1.481 . . . . 0.0 112.049 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -99.06 -22.52 13.04 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.659 1.123 . . . . 0.0 113.935 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 115.59 54.31 0.37 Allowed Glycine 0 CA--C 1.522 0.509 0 CA-C-N 118.543 1.171 . . . . 0.0 111.271 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.7 m -82.04 164.64 47.45 Favored Pre-proline 0 C--O 1.236 0.37 0 CA-C-N 117.715 0.757 . . . . 0.0 109.763 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 58.1 Cg_endo -68.93 171.59 13.29 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 N-CA-C 107.193 -1.887 . . . . 0.0 107.193 176.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.568 HD12 HD13 ' A' ' 30' ' ' LEU . 15.2 mt -96.0 109.12 21.56 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.073 0.949 . . . . 0.0 109.47 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.24 178.21 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.711 1.605 . . . . 0.0 110.678 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.79 169.93 10.3 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.0 t -162.06 149.88 14.53 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.109 1.364 . . . . 0.0 109.221 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -92.6 -40.38 10.8 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.894 0.878 . . . . 0.0 110.059 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -145.89 99.75 3.31 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.04 -166.52 0.16 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.441 -1.254 . . . . 0.0 107.885 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 134.6 -9.23 4.62 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-O 118.641 -1.088 . . . . 0.0 111.056 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.18 77.91 1.6 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 78.39 22.99 0.7 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 127.747 2.419 . . . . 0.0 116.323 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -129.87 74.9 1.62 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 120.578 1.535 . . . . 0.0 110.937 -178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.6 p -61.37 99.22 0.1 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.584 1.554 . . . . 0.0 112.085 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.3 p -88.13 -35.12 17.62 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 121.405 1.911 . . . . 0.0 109.355 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -78.35 101.12 7.05 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 126.102 1.761 . . . . 0.0 111.971 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -167.77 177.57 5.71 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.132 0.878 . . . . 0.0 111.888 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.6 -160.98 30.01 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.8 tp -141.62 153.42 44.74 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.52 29.73 6.29 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.874 1.67 . . . . 0.0 109.355 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -65.9 142.68 57.82 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.5 mt -127.49 158.15 38.18 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.624 1.569 . . . . 0.0 110.345 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 27.8 p90 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 115.767 -2.063 . . . . 0.0 108.612 179.911 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 119.832 -0.127 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -72.65 158.83 34.89 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -84.0 -0.62 52.35 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.102 -0.999 . . . . 0.0 111.371 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 85.27 38.06 0.02 OUTLIER 'General case' 0 C--N 1.341 0.229 0 C-N-CA 129.493 3.117 . . . . 0.0 112.012 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 5' ' ' LEU . 1.3 pt? -101.39 170.43 8.23 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.523 1.129 . . . . 0.0 110.372 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.35 -17.1 0.81 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.36 -35.81 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 126.732 2.013 . . . . 0.0 109.906 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 49.57 24.25 1.11 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 128.146 2.578 . . . . 0.0 111.848 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.17 151.31 85.85 Favored Pre-proline 0 C--O 1.224 -0.285 0 C-N-CA 126.614 1.966 . . . . 0.0 113.206 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.64 135.63 26.5 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.462 2.108 . . . . 0.0 109.271 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.405 HE21 ' HB3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -124.36 120.49 32.28 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.69 0.796 . . . . 0.0 108.985 178.436 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.01 137.0 52.51 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.314 0.646 . . . . 0.0 111.299 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.29 -125.21 0.76 Allowed Glycine 0 C--N 1.335 0.505 0 O-C-N 121.188 -0.945 . . . . 0.0 113.735 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 p -152.0 -170.22 3.58 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.991 1.395 . . . . 0.0 112.59 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.21 6.76 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 125.864 1.666 . . . . 0.0 110.952 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -59.3 -50.55 73.56 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 120.549 -1.344 . . . . 0.0 110.759 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -47.1 -0.17 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 1 C-N-CA 132.139 4.176 . . . . 0.0 118.554 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mt -85.51 -60.56 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 C-N-CA 127.86 2.464 . . . . 0.0 110.492 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.05 23.31 2.05 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.392 0.677 . . . . 0.0 110.138 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 72.26 12.14 5.81 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.46 2.704 . . . . 0.0 113.992 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.76 95.09 7.16 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 127.272 2.229 . . . . 0.0 113.086 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.8 t -79.39 159.49 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -107.44 142.79 36.73 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.0 t -138.14 119.16 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 123.851 0.861 . . . . 0.0 110.374 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 tp -75.47 108.08 8.03 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.591 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 37.6 tt0 -94.96 -175.42 3.54 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.591 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 3.1 t0 -46.11 90.01 0.0 OUTLIER 'General case' 0 C--O 1.234 0.243 0 C-N-CA 129.952 3.301 . . . . 0.0 109.585 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 46.46 32.92 1.74 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.841 1.656 . . . . 0.0 110.502 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.0 m -152.49 135.38 15.53 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.825 HD11 HD11 ' A' ' 67' ' ' LEU . 1.5 mt -96.14 137.74 34.78 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 120.897 -1.127 . . . . 0.0 108.326 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.4 pt -136.49 151.44 28.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.805 0.842 . . . . 0.0 111.616 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.98 139.51 31.26 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.461 0.704 . . . . 0.0 110.225 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.9 m -123.72 108.81 30.64 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.9 -81.03 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.198 1.932 . . . . 0.0 110.871 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.13 6.65 16.41 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.631 1.573 . . . . 0.0 112.46 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -52.04 120.26 5.2 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -58.39 -31.24 67.48 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.089 0.956 . . . . 0.0 111.626 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.86 67.75 6.21 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -118.48 164.54 15.11 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.626 1.17 . . . . 0.0 108.899 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 t -141.63 135.42 14.72 Favored Pre-proline 0 N--CA 1.446 -0.636 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.81 134.78 24.45 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.544 2.829 . . . . 0.0 109.58 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.8 m -128.41 159.83 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 122.696 1.236 . . . . 0.0 108.413 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.15 158.29 23.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 113.139 -1.846 . . . . 0.0 107.64 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.0 mm -123.77 153.02 29.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.61 125.38 23.97 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.6 tt -123.45 141.33 52.11 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.653 1.181 . . . . 0.0 110.264 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.4 mt -149.93 152.9 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 126.253 1.821 . . . . 0.0 108.278 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.4 p -103.37 134.44 46.74 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.667 1.587 . . . . 0.0 109.389 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.9 m -54.53 109.34 0.49 Allowed 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.953 1.701 . . . . 0.0 114.126 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -75.95 -24.82 55.48 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 117.8 -1.095 . . . . 0.0 111.316 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -98.09 49.66 1.01 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-N 119.777 1.171 . . . . 0.0 110.366 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 m -73.79 -1.79 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.099 -1.001 . . . . 0.0 112.115 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -62.99 -0.91 0.77 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.549 1.94 . . . . 0.0 112.842 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 t -132.87 -1.27 3.36 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.859 1.664 . . . . 0.0 110.913 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.28 163.4 13.41 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.745 1.259 . . . . 0.0 109.565 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -82.05 152.4 26.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.654 -1.612 . . . . 0.0 107.641 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -118.83 -29.81 5.24 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.334 1.054 . . . . 0.0 111.095 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -67.85 -38.56 83.3 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.136 1.774 . . . . 0.0 112.312 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -68.1 -25.89 65.54 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.559 1.144 . . . . 0.0 112.84 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.99 -167.65 32.26 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -102.34 97.62 9.06 Favored Pre-proline 0 N--CA 1.466 0.346 0 CA-C-O 117.554 -1.213 . . . . 0.0 109.799 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.71 122.53 9.22 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.204 2.602 . . . . 0.0 109.851 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.13 -177.45 2.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 124.612 1.165 . . . . 0.0 109.821 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.565 ' CE1' HD12 ' A' ' 95' ' ' LEU . 2.6 t80 -139.78 140.31 36.65 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 122.285 1.041 . . . . 0.0 109.51 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tt -149.01 150.37 32.7 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.716 1.206 . . . . 0.0 110.034 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.78 -171.77 21.89 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.446 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.825 HD11 HD11 ' A' ' 30' ' ' LEU . 18.5 mt -93.74 146.02 24.15 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -110.05 113.45 26.17 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.26 -43.84 0.51 Allowed Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.514 -1.159 . . . . 0.0 113.861 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.33 24.8 4.15 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.572 1.686 . . . . 0.0 114.659 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 m120 60.04 63.87 1.36 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.219 0.918 . . . . 0.0 111.592 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.601 HD13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -145.28 132.65 20.66 Favored 'General case' 0 CA--C 1.51 -0.569 0 O-C-N 120.336 -1.478 . . . . 0.0 110.405 -178.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.562 ' SG ' HG23 ' A' ' 92' ' ' ILE . 8.5 m -136.93 172.74 12.57 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.463 0.705 . . . . 0.0 112.071 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.565 HD23 HD21 ' A' ' 87' ' ' LEU . 13.9 mt -62.13 154.29 27.57 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.913 0.885 . . . . 0.0 111.699 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.556 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 3.2 tmm? -164.41 151.12 11.19 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 24.0 m -112.0 122.75 48.63 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.134 0.574 . . . . 0.0 109.608 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.25 151.26 50.43 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.226 1.01 . . . . 0.0 109.522 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.1 tttt -86.88 124.87 33.58 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.4 p -80.24 -17.19 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.48 -63.77 0.33 Allowed Glycine 0 CA--C 1.548 2.094 1 C-N-CA 133.252 5.215 . . . . 0.0 108.407 -177.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -103.34 -27.19 12.6 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 119.722 3.231 . . . . 0.0 119.722 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -133.48 155.91 80.19 Favored Pre-proline 0 CA--C 1.566 1.586 0 C-N-CA 130.001 3.32 . . . . 0.0 115.754 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -74.3 144.37 32.88 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.793 1.662 . . . . 0.0 108.971 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.9 p -140.84 169.62 17.29 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.271 1.428 . . . . 0.0 109.549 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.895 HD11 HG23 ' A' ' 128' ' ' ILE . 10.2 mt -90.71 150.22 21.73 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.27 75.69 1.52 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.765 1.226 . . . . 0.0 110.923 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.565 HD21 HD23 ' A' ' 74' ' ' LEU . 1.0 OUTLIER -94.65 116.0 28.23 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.13 -13.81 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -158.6 97.51 1.46 Allowed 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 117.67 -1.157 . . . . 0.0 109.607 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.556 ' HE3' ' HB2' ' A' ' 75' ' ' MET . 0.3 OUTLIER -171.21 149.16 2.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 121.393 1.906 . . . . 0.0 109.655 -179.214 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -129.07 114.55 16.51 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.172 0.989 . . . . 0.0 108.847 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.562 HG23 ' SG ' ' A' ' 73' ' ' CYS . 7.8 pt -62.06 -42.58 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 120.659 -1.275 . . . . 0.0 112.871 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.3 tpt -69.17 -16.28 63.6 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.108 1.363 . . . . 0.0 112.253 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -79.4 -52.04 8.6 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.277 0.944 . . . . 0.0 108.936 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.565 HD12 ' CE1' ' A' ' 64' ' ' TYR . 35.1 mt -65.96 -21.05 66.4 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.62 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -90.81 -34.33 15.35 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -63.41 -36.76 84.79 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.452 1.478 . . . . 0.0 109.423 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.68 156.02 43.07 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.067 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.52 59.54 5.56 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 123.745 2.963 . . . . 0.0 111.197 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -128.14 64.61 66.94 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.846 1.258 . . . . 0.0 112.128 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.4 95.4 0.86 Allowed 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 124.942 3.761 . . . . 0.0 109.849 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.435 HG11 ' CZ ' ' A' ' 105' ' ' PHE . 47.1 t -84.78 106.36 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 O-C-N 120.983 -1.073 . . . . 0.0 109.7 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -51.52 -29.89 18.39 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.603 1.561 . . . . 0.0 113.269 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.4 m -67.32 -10.67 53.18 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.435 ' CZ ' HG11 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -120.52 -17.86 7.98 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.619 0.768 . . . . 0.0 110.12 178.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.6 mt -79.68 154.08 28.87 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.428 1.091 . . . . 0.0 110.397 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -140.36 133.82 30.0 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 123.248 0.619 . . . . 0.0 110.851 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -76.07 122.6 24.49 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -75.89 103.49 5.99 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.6 t -100.59 178.14 4.81 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.2 156.71 42.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.415 0.686 . . . . 0.0 111.523 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.6 p -132.27 42.13 3.15 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.14 0.976 . . . . 0.0 113.06 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.67 -55.18 2.32 Favored Glycine 0 C--N 1.333 0.396 0 O-C-N 120.215 -1.553 . . . . 0.0 113.435 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -131.19 2.13 4.25 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.644 1.222 . . . . 0.0 112.071 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -134.08 173.49 11.53 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.065 0.546 . . . . 0.0 111.237 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.8 m -116.89 153.87 31.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.846 1.658 . . . . 0.0 109.627 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.01 168.29 19.07 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -138.77 112.56 8.41 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -105.45 117.88 35.14 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 126.901 2.08 . . . . 0.0 109.651 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.9 t -51.16 122.15 7.24 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.293 0.637 . . . . 0.0 111.761 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.1 t -65.1 -45.57 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 O-C-N 121.739 -0.601 . . . . 0.0 110.34 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.23 -38.43 85.22 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.764 -0.585 . . . . 0.0 112.376 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -124.18 80.63 58.44 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.583 0.753 . . . . 0.0 108.992 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -66.94 143.4 66.1 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.55 3.5 . . . . 0.0 110.87 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.81 -22.43 14.62 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 128.449 2.928 . . . . 0.0 113.067 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -99.24 131.96 44.9 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.951 1.7 . . . . 0.0 111.585 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -111.51 142.15 44.16 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.434 1.094 . . . . 0.0 110.597 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.895 HG23 HD11 ' A' ' 85' ' ' LEU . 6.3 mt -73.67 133.87 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -103.23 147.94 26.43 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 6.5 m -91.83 -17.12 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.356 1.462 . . . . 0.0 114.591 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.45 90.56 0.07 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.325 1.85 . . . . 0.0 107.209 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . 0.259 0.0 OUTLIER -107.8 7.87 28.47 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.416 -0.802 . . . . 0.0 111.933 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -135.5 143.41 45.8 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.325 1.05 . . . . 0.0 109.837 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.97 -58.26 0.06 OUTLIER Glycine 0 CA--C 1.531 1.066 0 C-N-CA 127.073 2.273 . . . . 0.0 115.848 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 132.73 45.64 0.13 Allowed Glycine 0 CA--C 1.523 0.555 0 C-N-CA 129.093 3.235 . . . . 0.0 107.352 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 83.4 m -71.91 162.43 73.4 Favored Pre-proline 0 C--O 1.24 0.576 0 CA-C-N 118.064 0.932 . . . . 0.0 110.474 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.26 162.25 28.47 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 120.766 0.977 . . . . 0.0 111.598 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.4 mt -77.88 114.96 17.25 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.701 1.201 . . . . 0.0 109.031 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pp -146.24 176.26 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 123.161 0.584 . . . . 0.0 109.75 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 20.7 mt -101.35 150.01 23.45 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.543 0.737 . . . . 0.0 109.26 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.1 t -144.52 131.68 20.58 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -82.3 -24.73 34.5 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 122.235 -0.291 . . . . 0.0 111.197 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -167.61 94.84 0.43 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.104 1.362 . . . . 0.0 107.345 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.419 HD12 ' H ' ' A' ' 146' ' ' LYS . 0.6 OUTLIER -72.11 175.55 5.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.992 0.901 . . . . 0.0 111.635 178.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -122.84 51.64 0.79 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 126.15 1.833 . . . . 0.0 109.691 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.419 ' H ' HD12 ' A' ' 144' ' ' LEU . 0.1 OUTLIER 62.4 -0.72 0.48 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 129.286 3.034 . . . . 0.0 114.492 179.213 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -93.59 -15.69 25.14 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -128.02 99.51 5.52 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.428 1.013 . . . . 0.0 109.119 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.451 HG21 ' CE2' ' A' ' 152' ' ' PHE . 0.8 OUTLIER -61.39 128.54 36.83 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.66 1.184 . . . . 0.0 109.906 -178.744 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.6 p -114.71 -22.57 9.64 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.168 1.387 . . . . 0.0 112.922 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -118.45 129.06 55.18 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.304 0.641 . . . . 0.0 112.07 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.451 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.7 OUTLIER -170.55 -176.47 2.13 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.462 1.905 . . . . 0.0 109.553 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.42 -159.75 31.07 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.7 tp -147.54 166.22 27.98 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.5 m -128.63 49.85 2.16 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.065 1.346 . . . . 0.0 107.921 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -75.21 141.2 43.61 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 22.8 mt -108.53 167.47 10.02 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.512 1.125 . . . . 0.0 108.05 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 31.3 p90 . . . . . 0 C--O 1.251 1.171 0 C-N-CA 126.911 2.084 . . . . 0.0 106.74 -179.564 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptt? . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.419 ' HG2' ' HE3' ' A' ' 6' ' ' LYS . 2.7 mp0 -123.59 172.84 8.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.534 1.534 . . . . 0.0 107.077 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -127.43 42.67 3.28 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 40.8 69.98 0.29 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.962 1.705 . . . . 0.0 112.47 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.5 pp -147.45 9.0 0.92 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.419 ' HE3' ' HG2' ' A' ' 2' ' ' GLU . 13.3 pttt -144.8 -14.16 0.55 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.71 -43.01 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 C-N-CA 125.725 1.61 . . . . 0.0 108.112 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -123.89 116.45 22.94 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.47 153.36 45.72 Favored Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.02 149.01 71.12 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 N-CA-C 107.061 -1.938 . . . . 0.0 107.061 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.47 115.77 19.39 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -106.77 149.1 27.68 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.371 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.08 -137.41 2.9 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 120.045 1.293 . . . . 0.0 109.98 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.7 p -144.84 -168.33 2.89 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 119.15 1.475 . . . . 0.0 111.214 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.7 mt -142.51 -7.03 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 126.903 2.081 . . . . 0.0 107.753 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -45.61 -42.79 11.67 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 127.0 2.12 . . . . 0.0 112.283 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -55.57 -24.13 30.88 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.0 mm -54.65 -68.84 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 123.729 0.811 . . . . 0.0 112.149 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.52 29.64 3.89 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 123.718 0.637 . . . . 0.0 112.366 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.1 m80 61.8 47.86 5.85 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 -122.94 100.28 6.81 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.1 t -85.78 154.53 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -120.23 131.16 54.84 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.39 144.88 35.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 tp -78.14 102.04 7.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -120.48 133.95 55.34 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 t0 45.48 53.41 8.38 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.008 1.323 . . . . 0.0 112.373 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 52.59 29.05 6.72 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.7 m -143.17 159.79 41.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.021 1.728 . . . . 0.0 107.391 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.647 HD12 HD22 ' A' ' 87' ' ' LEU . 8.1 mt -96.49 125.48 41.01 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 119.666 -1.896 . . . . 0.0 106.325 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 1.2 mt -126.84 130.8 71.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 123.604 0.565 . . . . 0.0 110.731 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.98 135.8 49.78 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 m -126.56 74.21 74.42 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 123.839 0.855 . . . . 0.0 110.643 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.23 -43.15 15.48 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.7 2.267 . . . . 0.0 111.387 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -146.51 71.41 1.24 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.544 1.138 . . . . 0.0 108.91 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -120.84 124.22 44.5 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 102.035 -3.32 . . . . 0.0 102.035 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.52 -14.34 19.11 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.95 1.3 . . . . 0.0 113.312 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -113.87 30.43 7.26 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.658 1.183 . . . . 0.0 111.461 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -74.47 161.49 29.74 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.4 t -153.1 142.85 15.05 Favored Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.59 142.38 58.6 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.657 2.238 . . . . 0.0 108.767 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 t -143.61 136.23 24.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 105.915 -1.884 . . . . 0.0 105.915 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.75 162.46 16.22 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.966 0.906 . . . . 0.0 109.845 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 12' ' ' GLN . 7.2 mm -130.4 121.99 52.26 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 C-N-CA 127.525 2.33 . . . . 0.0 108.748 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.06 129.98 46.17 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 120.69 1.587 . . . . 0.0 108.461 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.2 tt -122.48 132.24 54.24 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.132 1.773 . . . . 0.0 107.546 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.535 HD13 HG21 ' A' ' 92' ' ' ILE . 3.5 mp -144.09 141.92 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 124.669 1.187 . . . . 0.0 108.826 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 p -79.34 138.59 37.75 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.601 ' SG ' HD22 ' A' ' 106' ' ' LEU . 58.8 m -60.11 124.06 19.08 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.419 ' HD3' ' O ' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -97.23 -0.08 47.34 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -128.32 49.91 2.13 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.964 1.305 . . . . 0.0 110.272 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.659 ' HA ' HD23 ' A' ' 55' ' ' LEU . 27.4 m -72.88 6.57 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.684 1.194 . . . . 0.0 113.794 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -49.49 -32.42 12.08 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 128.051 2.54 . . . . 0.0 116.149 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.1 t -125.63 25.44 6.96 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.903 0.881 . . . . 0.0 110.607 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 101' ' ' PRO . 2.4 mm? -116.2 155.77 27.71 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 121.183 -0.948 . . . . 0.0 108.917 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.98 152.15 46.31 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 mttm -124.99 -31.22 3.15 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.911 0.485 . . . . 0.0 110.644 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.45 -34.09 76.99 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.182 0.993 . . . . 0.0 112.118 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -64.24 -36.1 82.97 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.438 ' HA3' ' CD1' ' A' ' 108' ' ' TYR . . . 147.47 171.49 16.63 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 127.016 2.246 . . . . 0.0 110.755 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.51 116.38 30.84 Favored Pre-proline 0 C--O 1.238 0.484 0 O-C-N 121.463 -1.022 . . . . 0.0 109.372 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.72 136.15 18.65 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 N-CA-C 106.653 -2.095 . . . . 0.0 106.653 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.258 14.0 pt -137.74 170.69 16.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -131.41 147.98 52.61 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.769 0.795 . . . . 0.0 111.202 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 tt -148.26 157.14 43.31 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.344 1.058 . . . . 0.0 110.763 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.6 -173.61 30.46 Favored Glycine 0 C--O 1.226 -0.398 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.584 HD21 HD11 ' A' ' 30' ' ' LEU . 5.4 mt -97.67 162.17 13.41 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.357 1.063 . . . . 0.0 110.441 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -132.09 84.08 2.13 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.234 -0.916 . . . . 0.0 108.765 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -158.44 -30.37 0.02 OUTLIER Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.795 -1.003 . . . . 0.0 113.013 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.15 19.45 0.57 Allowed 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.6 m120 68.16 68.41 0.33 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.943 1.697 . . . . 0.0 109.076 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.91 136.03 30.05 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.906 1.282 . . . . 0.0 109.89 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 32.2 m -142.09 175.1 10.0 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.773 0.715 . . . . 0.0 111.044 177.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.467 HD23 ' CD2' ' A' ' 87' ' ' LEU . 16.0 mt -58.75 149.95 24.98 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.899 0.772 . . . . 0.0 109.994 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.7 ttp -159.25 123.42 3.91 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 84.0 m -97.2 125.36 41.68 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 120.144 1.338 . . . . 0.0 109.079 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.81 146.29 31.11 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.08 0.952 . . . . 0.0 109.291 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -77.87 131.39 37.5 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 p -80.91 7.0 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.0 0.52 . . . . 0.0 111.508 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.82 10.35 49.96 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -148.03 -57.2 0.23 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.474 1.51 . . . . 0.0 109.772 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -140.3 162.44 49.74 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.065 1.746 . . . . 0.0 110.877 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.89 149.58 72.48 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.862 1.708 . . . . 0.0 110.521 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.9 p -147.3 166.06 28.23 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.91 1.684 . . . . 0.0 107.201 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.3 mt -92.57 148.14 22.32 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -138.97 64.87 1.46 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.647 HD22 HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -81.86 102.77 11.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.18 -39.44 0.07 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.143 0.977 . . . . 0.0 113.022 -178.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -145.1 104.69 3.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.755 1.622 . . . . 0.0 109.407 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.45 ' HE2' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -177.22 158.57 1.5 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 178.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.45 ' N ' ' HE2' ' A' ' 90' ' ' LYS . 1.4 m-20 -135.15 131.74 37.18 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.709 1.604 . . . . 0.0 109.687 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.535 HG21 HD13 ' A' ' 47' ' ' ILE . 1.6 mt -83.11 -37.18 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 118.175 0.443 . . . . 0.0 109.96 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.8 -25.26 66.44 Favored 'General case' 0 CA--C 1.524 -0.034 0 CA-C-O 117.982 -1.009 . . . . 0.0 112.565 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -72.0 -42.77 66.03 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 93.0 mt -62.87 -33.12 74.61 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.512 1.125 . . . . 0.0 108.378 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.419 ' O ' ' HD3' ' A' ' 50' ' ' ARG . 1.2 t80 -75.8 -35.39 60.08 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -65.52 -46.0 81.32 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.202 -0.936 . . . . 0.0 110.767 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -125.31 152.16 70.79 Favored Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.85 83.35 1.39 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 123.621 2.881 . . . . 0.0 110.395 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -132.26 69.09 80.33 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.727 ' HB2' HD21 ' A' ' 55' ' ' LEU . 97.9 Cg_endo -74.1 76.5 3.0 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.277 3.318 . . . . 0.0 107.833 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.4 t -83.09 102.14 8.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -177.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -49.99 -28.49 6.98 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.847 0.859 . . . . 0.0 112.023 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.7 m -63.8 -12.51 36.33 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -122.45 1.64 9.58 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.345 1.058 . . . . 0.0 109.98 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.601 HD22 ' SG ' ' A' ' 49' ' ' CYS . 16.3 mt -100.46 145.77 27.85 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -142.62 123.36 14.23 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.774 0.83 . . . . 0.0 109.454 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.438 ' CD1' ' HA3' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -67.7 124.96 24.73 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 127.765 2.426 . . . . 0.0 106.252 178.785 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -109.15 147.23 32.82 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.655 0.74 . . . . 0.0 110.052 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 t -138.64 172.14 13.32 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.12 1.768 . . . . 0.0 107.27 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.31 129.0 7.0 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.453 1.501 . . . . 0.0 109.508 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.0 p -141.94 79.54 1.68 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.05 58.85 1.54 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 124.02 0.819 . . . . 0.0 111.585 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 65.66 4.36 2.82 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.797 2.039 . . . . 0.0 112.694 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -112.86 127.92 56.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.4 m -108.68 155.54 20.6 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.197 1.399 . . . . 0.0 109.863 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 p -131.27 165.62 23.0 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.304 1.442 . . . . 0.0 111.661 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -142.65 110.31 5.81 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.607 1.163 . . . . 0.0 111.236 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -108.36 123.07 48.27 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.981 1.312 . . . . 0.0 109.462 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 59.6 m -53.64 125.71 19.2 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.747 1.219 . . . . 0.0 110.228 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.7 t -70.32 -41.3 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 O-C-N 121.175 -0.953 . . . . 0.0 111.623 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.47 -40.64 83.24 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.305 1.042 . . . . 0.0 112.242 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -136.3 90.61 17.63 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -65.9 165.07 24.84 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.025 1.817 . . . . 0.0 109.124 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.3 -18.58 56.62 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -100.85 121.08 41.1 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 118.628 1.214 . . . . 0.0 108.441 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -105.8 144.22 32.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 24.7 mt -71.42 142.47 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.26 113.79 27.53 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.577 0.703 . . . . 0.0 109.781 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.56 -10.71 14.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 C-N-CA 127.617 2.367 . . . . 0.0 112.482 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.5 m 46.02 84.31 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 118.394 2.739 . . . . 0.0 118.394 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.574 ' HB2' HG21 ' A' ' 149' ' ' THR . 47.8 m -110.6 5.57 21.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -79.75 -93.78 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 O-C-N 121.067 -1.021 . . . . 0.0 112.437 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -99.64 4.78 58.15 Favored Glycine 0 C--N 1.342 0.91 0 C-N-CA 125.652 1.596 . . . . 0.0 116.575 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.31 49.23 2.44 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 18.1 m -80.29 161.99 63.04 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 124.231 1.013 . . . . 0.0 110.472 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 98.5 Cg_endo -73.83 155.33 48.71 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.192 1.261 . . . . 0.0 109.475 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.409 HD12 HD13 ' A' ' 30' ' ' LEU . 12.6 mt -84.72 122.41 29.06 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.241 1.016 . . . . 0.0 109.208 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.0 -168.99 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.32 1.448 . . . . 0.0 110.848 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.5 mt -103.44 153.72 20.2 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.411 1.484 . . . . 0.0 107.181 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.0 t -145.8 120.49 9.84 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.75 1.262 . . . . 0.0 108.796 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -78.76 -30.83 45.92 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.166 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -165.88 83.73 0.32 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 122.028 0.918 . . . . 0.0 112.217 -178.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.605 ' H ' HD23 ' A' ' 144' ' ' LEU . 0.6 OUTLIER -70.66 167.25 19.04 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.06 -1.025 . . . . 0.0 109.164 178.33 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -141.0 21.8 2.64 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.339 0.971 . . . . 0.0 113.251 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.96 18.73 1.44 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.062 1.345 . . . . 0.0 113.428 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 52.58 42.7 31.53 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.221 1.373 . . . . 0.0 109.576 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -42.97 -35.81 1.34 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.788 1.635 . . . . 0.0 114.65 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.574 HG21 ' HB2' ' A' ' 132' ' ' SER 0.294 75.4 p 113.93 93.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 1 C-N-CA 135.132 5.373 . . . . 0.0 112.643 178.678 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 p -104.6 -29.54 10.56 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.284 1.033 . . . . 0.0 110.686 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -117.72 123.66 46.6 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 127.882 2.473 . . . . 0.0 110.947 -177.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -171.56 -175.62 1.63 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.503 2.321 . . . . 0.0 110.08 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -101.53 -176.89 28.58 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.505 1.05 . . . . 0.0 113.687 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.16 132.03 41.12 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.5 m -88.52 58.38 4.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 18.9 ptp -69.31 162.17 27.78 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.249 0.62 . . . . 0.0 109.518 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.1 mt -142.36 175.25 9.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.102 2.161 . . . . 0.0 106.762 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 53.0 p90 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 124.582 1.153 . . . . 0.0 110.727 179.819 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -78.71 148.79 32.93 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.7 0.762 . . . . 0.0 111.414 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -80.85 18.76 0.94 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 49.85 41.86 23.2 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.063 1.745 . . . . 0.0 109.872 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.473 HD12 ' H ' ' A' ' 7' ' ' ILE . 2.7 pp -66.2 -55.79 14.53 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -177.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 pttt 43.96 31.42 0.51 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 127.608 2.363 . . . . 0.0 114.023 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 5' ' ' LEU . 1.4 pp -138.44 78.15 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 123.152 0.581 . . . . 0.0 112.114 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -81.08 -6.79 59.22 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.425 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.93 159.91 83.98 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.307 1.443 . . . . 0.0 109.726 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HB3' HD11 ' A' ' 47' ' ' ILE . 86.6 Cg_endo -73.33 127.96 12.39 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.166 2.578 . . . . 0.0 110.093 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.36 111.21 23.56 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 123.782 0.676 . . . . 0.0 111.35 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -104.5 148.01 26.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.779 0.832 . . . . 0.0 110.618 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.46 -139.64 4.18 Favored Glycine 0 C--O 1.226 -0.396 0 O-C-N 121.255 -0.903 . . . . 0.0 111.226 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.2 p -152.33 -174.55 4.93 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 119.029 1.414 . . . . 0.0 113.684 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.67 5.28 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 125.319 1.448 . . . . 0.0 108.371 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -63.17 -38.63 91.93 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 119.923 -1.736 . . . . 0.0 109.293 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -51.5 -19.79 1.59 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 128.085 2.554 . . . . 0.0 114.086 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.2 mt -69.41 -67.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.811 1.644 . . . . 0.0 111.473 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -133.12 25.71 4.22 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.857 -0.527 . . . . 0.0 111.252 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.252 52.4 t-80 57.62 41.09 26.12 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.514 2.726 . . . . 0.0 108.633 -177.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.28 109.86 20.47 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.947 -1.095 . . . . 0.0 110.981 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.4 t -91.86 158.42 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.636 ' O ' HG21 ' A' ' 42' ' ' VAL . 2.7 m95 -115.84 106.86 14.31 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.303 1.041 . . . . 0.0 110.325 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.7 t -104.37 122.85 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 120.099 1.318 . . . . 0.0 108.578 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 30' ' ' LEU . 34.8 tp -73.33 95.72 2.21 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 124.141 0.9 . . . . 0.0 108.626 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.99 174.79 8.85 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -8.89 -65.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 129.063 2.945 . . . . 0.0 114.935 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -142.05 18.24 2.11 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-O 117.691 -1.147 . . . . 0.0 109.279 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.65 134.71 14.87 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.685 1.129 . . . . 0.0 112.546 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.575 HD21 HD11 ' A' ' 67' ' ' LEU . 1.5 mp -85.64 137.08 33.09 Favored 'General case' 0 CA--C 1.504 -0.795 0 O-C-N 121.514 -0.741 . . . . 0.0 109.27 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mm -131.39 140.51 48.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 O-C-N 124.094 0.871 . . . . 0.0 109.927 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.86 130.27 40.64 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -117.36 82.27 14.72 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 124.339 1.056 . . . . 0.0 108.738 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.25 -33.1 15.35 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.014 1.809 . . . . 0.0 113.778 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.8 ttm-85 -162.02 51.42 0.21 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.12 152.23 19.0 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 124.956 1.302 . . . . 0.0 107.622 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -61.36 1.8 Allowed 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 122.617 0.367 . . . . 0.0 110.473 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.8 ttm-85 -72.8 27.52 0.06 Allowed 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.696 1.198 . . . . 0.0 112.229 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -68.02 149.51 49.61 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.1 t -140.15 138.17 18.98 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -67.64 155.21 71.02 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 N-CA-C 108.055 -1.556 . . . . 0.0 108.055 178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.636 HG21 ' O ' ' A' ' 23' ' ' TRP . 4.7 m -146.38 155.32 12.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.91 158.76 20.68 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -125.69 116.28 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 125.507 1.523 . . . . 0.0 107.756 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.07 127.67 42.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.544 HD12 HD12 ' A' ' 65' ' ' LEU . 6.8 tt -125.25 145.64 49.9 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.388 1.075 . . . . 0.0 108.649 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.513 HD12 HG12 ' A' ' 92' ' ' ILE . 39.3 mt -148.03 154.22 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.662 1.985 . . . . 0.0 108.828 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.1 p -109.42 115.52 30.11 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.7 m -47.35 143.87 3.2 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.186 1.395 . . . . 0.0 111.915 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -103.99 -26.87 12.46 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 118.096 -0.954 . . . . 0.0 112.992 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -94.68 38.27 1.11 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.2 m -63.46 -17.18 19.45 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 O-C-N 120.597 -1.315 . . . . 0.0 111.293 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -42.8 -44.07 4.27 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 120.704 1.593 . . . . 0.0 114.203 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.7 t -78.5 -14.14 59.5 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.6 mt -88.22 -173.39 4.2 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 120.444 -1.41 . . . . 0.0 109.267 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.43 158.13 16.21 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.822 0.849 . . . . 0.0 109.485 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -124.78 -35.61 2.68 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.034 2.533 . . . . 0.0 111.085 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.81 -42.68 79.97 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.642 1.177 . . . . 0.0 109.35 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -62.6 -36.39 82.6 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.874 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 139.54 -171.09 23.91 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -79.08 114.78 47.38 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.91 135.2 8.69 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.619 2.879 . . . . 0.0 108.557 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.3 pt -138.26 178.28 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 121.372 -0.83 . . . . 0.0 110.616 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.529 ' CE1' HD12 ' A' ' 95' ' ' LEU . 3.0 t80 -134.44 154.97 51.11 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.198 0.908 . . . . 0.0 112.345 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.544 HD12 HD12 ' A' ' 46' ' ' LEU . 3.7 tt -156.91 163.48 39.11 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.237 1.015 . . . . 0.0 110.05 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.15 -174.43 36.98 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.825 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.737 HD21 HD22 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -100.42 135.46 41.82 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 126.105 1.762 . . . . 0.0 106.718 179.761 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -114.81 121.41 43.2 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.39 -39.68 0.26 Allowed Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.4 31.35 1.71 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.371 1.069 . . . . 0.0 113.783 -178.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.1 m120 58.17 75.15 0.4 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.808 1.243 . . . . 0.0 112.476 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.33 140.78 27.97 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 121.297 -0.877 . . . . 0.0 110.307 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.8 m -147.96 174.49 11.84 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.254 -1.529 . . . . 0.0 111.024 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.421 ' HA ' ' HG ' ' A' ' 87' ' ' LEU . 5.3 mt -57.68 144.3 38.37 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -155.59 124.03 5.92 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 52.1 m -91.88 121.37 33.42 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.826 0.739 . . . . 0.0 110.409 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.37 168.52 19.6 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.252 0.478 . . . . 0.0 110.154 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -98.52 147.11 25.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.3 -2.56 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.556 0.743 . . . . 0.0 111.003 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.4 81.88 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.2 t70 66.56 9.62 6.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.429 1.891 . . . . 0.0 114.49 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.14 143.03 17.61 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.43 156.95 63.84 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 124.171 3.248 . . . . 0.0 113.87 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.3 p -158.47 164.76 35.89 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.017 1.727 . . . . 0.0 108.972 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.533 HD11 HG23 ' A' ' 128' ' ' ILE . 3.8 mt -95.18 138.12 33.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -129.43 67.16 1.44 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.368 1.067 . . . . 0.0 109.995 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.737 HD22 HD21 ' A' ' 67' ' ' LEU . 2.9 mp -81.97 105.57 13.19 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.59 -39.31 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -136.39 94.18 2.98 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 119.19 0.904 . . . . 0.0 111.653 -177.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.599 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -164.61 175.26 9.96 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 121.178 -0.951 . . . . 0.0 110.968 179.592 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.489 ' H ' ' HD3' ' A' ' 90' ' ' LYS . 17.6 m-20 -140.5 143.03 35.24 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.24 1.416 . . . . 0.0 107.469 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.513 HG12 HD12 ' A' ' 47' ' ' ILE . 1.7 tt -104.77 -39.29 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 125.063 1.345 . . . . 0.0 110.863 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -30.94 71.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.884 0.474 . . . . 0.0 110.57 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -66.21 -52.78 44.59 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.529 HD12 ' CE1' ' A' ' 64' ' ' TYR . 32.4 mt -61.87 -29.24 70.06 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 123.776 0.83 . . . . 0.0 111.184 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -79.94 -28.49 39.7 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -78.36 -42.11 31.4 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.322 -0.862 . . . . 0.0 112.01 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -107.03 152.08 40.9 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 123.774 0.829 . . . . 0.0 110.31 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.97 57.89 4.0 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.172 3.248 . . . . 0.0 113.12 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -118.29 73.6 10.47 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.587 1.155 . . . . 0.0 110.507 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.39 86.29 1.71 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.998 2.465 . . . . 0.0 106.179 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 66.7 t -80.74 93.93 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.45 -19.5 1.43 Allowed 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.367 1.067 . . . . 0.0 113.167 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -20.14 65.27 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.471 1.508 . . . . 0.0 110.596 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -115.1 -25.34 8.14 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.639 0.776 . . . . 0.0 110.756 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.6 mt -74.21 159.56 32.35 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.905 1.282 . . . . 0.0 112.093 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.424 ' HA ' HG23 ' A' ' 121' ' ' VAL . 4.4 p90 -147.65 143.46 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.194 0.998 . . . . 0.0 110.309 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.99 126.4 32.49 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 126.139 1.776 . . . . 0.0 108.644 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -102.13 150.24 23.46 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.6 t -142.02 -157.07 0.74 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -159.53 152.0 21.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.401 1.48 . . . . 0.0 108.112 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.8 p -123.61 6.58 8.86 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.468 1.507 . . . . 0.0 112.538 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.97 -85.13 0.36 Allowed Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 104.896 -3.282 . . . . 0.0 104.896 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.481 ' HG3' HH11 ' A' ' 114' ' ' ARG . 13.8 mtt85 -94.9 -7.8 39.01 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -126.19 172.56 9.95 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 119.119 0.872 . . . . 0.0 109.533 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.6 m -135.99 130.66 33.94 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 126.964 2.106 . . . . 0.0 110.622 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.27 161.13 16.56 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.3 1.04 . . . . 0.0 108.475 178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -143.95 116.87 8.82 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -125.97 127.1 45.41 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.719 0.637 . . . . 0.0 110.06 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.6 m -51.23 131.67 28.1 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.305 1.042 . . . . 0.0 109.938 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.424 HG23 ' HA ' ' A' ' 107' ' ' PHE . 84.5 t -73.63 -53.6 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 O-C-N 122.225 -0.297 . . . . 0.0 110.915 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.55 74.54 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -124.4 80.71 59.79 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.63 160.01 48.21 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.868 2.378 . . . . 0.0 109.879 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.7 -20.79 48.12 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 126.399 1.952 . . . . 0.0 111.601 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -103.63 116.78 32.97 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 118.823 1.312 . . . . 0.0 110.467 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -90.11 157.02 17.96 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 125.045 1.338 . . . . 0.0 108.825 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.533 HG23 HD11 ' A' ' 85' ' ' LEU . 9.7 mm -86.06 129.03 38.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.21 117.01 30.47 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 119.321 0.964 . . . . 0.0 110.209 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.3 m -78.68 -25.66 13.51 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.304 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.2 m 67.39 55.36 0.66 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.537 1.535 . . . . 0.0 113.268 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 75.4 m -95.79 -2.91 46.7 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.334 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -68.06 -66.41 0.57 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.56 1.073 . . . . 0.0 111.353 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -124.17 -55.13 0.18 Allowed Glycine 0 C--N 1.333 0.388 0 CA-C-O 119.302 -0.721 . . . . 0.0 111.796 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.97 54.05 0.01 OUTLIER Glycine 0 CA--C 1.519 0.338 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' CYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 68.1 m -87.04 166.93 23.74 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 117.37 0.585 . . . . 0.0 110.697 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 136' ' ' CYS . 83.1 Cg_endo -74.13 168.49 24.67 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 N-CA-C 108.584 -1.352 . . . . 0.0 108.584 178.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' A' ' 23' ' ' TRP . 9.5 mt -87.0 111.26 20.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -146.33 -177.08 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.812 1.245 . . . . 0.0 110.987 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.7 mt -100.7 161.82 13.34 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -156.3 130.69 8.78 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -90.24 -38.22 13.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 119.603 -0.839 . . . . 0.0 108.764 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -152.64 102.81 2.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.034 1.734 . . . . 0.0 107.971 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.436 HD12 ' H ' ' A' ' 146' ' ' LYS . 4.6 pp -97.41 163.28 12.94 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.615 1.166 . . . . 0.0 112.122 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -109.65 62.09 0.29 Allowed Glycine 0 C--N 1.33 0.247 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.436 ' H ' HD12 ' A' ' 144' ' ' LEU . 14.1 mmmm 51.89 16.22 0.49 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.698 2.399 . . . . 0.0 113.431 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.81 -36.04 64.94 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.958 0.903 . . . . 0.0 112.837 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.35 167.86 17.11 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-O 121.106 0.479 . . . . 0.0 109.787 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.422 HG21 ' CE2' ' A' ' 152' ' ' PHE . 1.5 m -100.24 136.04 40.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.3 p -131.7 7.19 4.42 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.635 1.574 . . . . 0.0 112.267 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -144.4 112.19 6.22 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.1 OUTLIER -162.98 -175.79 4.55 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.898 1.226 . . . . 0.0 113.146 -179.586 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.34 -174.26 27.37 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.9 tp -141.04 146.7 37.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.5 m -100.6 48.24 0.91 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.815 1.246 . . . . 0.0 107.658 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.54 159.69 33.86 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.954 1.302 . . . . 0.0 108.493 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 8.9 mt -145.79 153.42 40.9 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.706 2.002 . . . . 0.0 108.496 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.337 0 CA-C-N 119.884 1.22 . . . . 0.0 112.653 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.03 158.76 16.8 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.763 1.625 . . . . 0.0 109.749 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -76.3 -70.12 0.46 Allowed 'General case' 0 C--O 1.238 0.479 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.921 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.06 -55.66 1.96 Allowed 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.949 0.9 . . . . 0.0 111.361 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.682 ' H ' HD23 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -64.67 174.95 1.58 Allowed 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 124.338 1.023 . . . . 0.0 108.669 178.596 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -116.26 18.82 15.15 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.683 1.193 . . . . 0.0 112.607 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.15 25.59 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 125.584 1.554 . . . . 0.0 110.975 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.15 -17.69 60.35 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.105 0.962 . . . . 0.0 109.789 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 p -60.05 135.23 90.48 Favored Pre-proline 0 C--N 1.344 0.351 0 CA-C-O 117.459 -1.257 . . . . 0.0 109.186 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.26 140.55 24.87 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 N-CA-C 106.973 -1.972 . . . . 0.0 106.973 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.17 149.42 35.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -144.49 132.57 21.59 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.538 -1.351 . . . . 0.0 109.385 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.75 -122.1 0.59 Allowed Glycine 0 CA--C 1.518 0.28 0 CA-C-O 117.844 -1.531 . . . . 0.0 111.225 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.8 p -160.3 -168.78 2.27 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 120.725 2.263 . . . . 0.0 112.566 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.421 HD12 ' CH2' ' A' ' 23' ' ' TRP . 3.7 mt -145.22 4.52 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.32 1.448 . . . . 0.0 108.97 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.14 -25.13 63.32 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 119.806 -1.809 . . . . 0.0 111.077 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -75.27 46.15 0.32 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.557 1.543 . . . . 0.0 110.897 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mt -130.56 -61.95 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 126.293 1.837 . . . . 0.0 108.688 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.85 27.17 2.02 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.489 0.661 . . . . 0.0 110.646 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.35 11.06 4.29 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 128.88 2.872 . . . . 0.0 114.182 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.459 ' H ' ' HG3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -70.76 95.38 1.12 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.187 1.795 . . . . 0.0 109.43 -179.641 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.81 158.97 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 102.997 -2.964 . . . . 0.0 102.997 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.421 ' CH2' HD12 ' A' ' 15' ' ' ILE . 21.7 m0 -118.63 144.84 45.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 120.605 -1.309 . . . . 0.0 108.711 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.7 t -150.53 141.21 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.6 tp -75.77 119.05 19.24 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -133.06 123.2 25.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.7 t70 45.88 58.37 4.41 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.034 1.334 . . . . 0.0 112.845 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 54.23 23.9 4.59 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.021 1.329 . . . . 0.0 112.968 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.5 m -132.94 159.56 39.6 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.589 1.556 . . . . 0.0 107.607 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.716 HD11 HD11 ' A' ' 67' ' ' LEU . 7.2 mt -108.67 124.34 50.37 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 mm -127.14 141.96 44.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 O-C-N 123.87 0.731 . . . . 0.0 109.766 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.87 137.12 36.17 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.05 66.3 40.33 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.106 0.962 . . . . 0.0 108.439 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.46 -28.66 78.11 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 121.842 1.695 . . . . 0.0 112.193 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -149.54 95.61 2.37 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 125.003 1.321 . . . . 0.0 109.403 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.81 142.31 5.26 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.793 0.837 . . . . 0.0 109.55 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.52 -39.7 77.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 122.367 1.08 . . . . 0.0 108.945 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.8 tpp85 -79.4 62.67 3.8 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.494 1.518 . . . . 0.0 111.706 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.2 ptt? -126.39 168.57 14.0 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.802 1.241 . . . . 0.0 110.999 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 t -158.54 144.99 12.69 Favored Pre-proline 0 N--CA 1.452 -0.375 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.63 154.83 64.03 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 N-CA-C 107.891 -1.619 . . . . 0.0 107.891 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 23' ' ' TRP . 2.5 p -146.39 156.95 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.4 m -118.07 161.57 19.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.233 -1.348 . . . . 0.0 108.504 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.3 mm -130.32 110.73 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 C-N-CA 126.157 1.783 . . . . 0.0 111.065 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.431 ' HB3' HD12 ' A' ' 92' ' ' ILE . . . -88.87 138.59 31.27 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 176.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 tt -130.53 131.77 45.24 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.5 mt -147.32 143.29 20.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 124.862 2.267 . . . . 0.0 106.933 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.2 p -73.7 162.27 29.36 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.517 -1.674 . . . . 0.0 108.881 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.7 m -91.17 149.58 21.73 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -102.1 -23.73 14.03 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -106.49 56.32 0.66 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.1 m -75.12 -10.73 13.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 120.98 -1.075 . . . . 0.0 111.185 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -69.99 4.09 2.3 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 125.925 1.69 . . . . 0.0 114.596 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 t -129.88 13.6 5.81 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.954 0.902 . . . . 0.0 108.939 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 98.3 mt -119.97 169.3 10.3 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.789 1.236 . . . . 0.0 108.095 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.9 155.35 37.56 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.698 1.199 . . . . 0.0 109.024 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.55 -32.39 2.65 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.226 1.011 . . . . 0.0 111.66 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -64.69 -36.01 82.89 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.535 1.134 . . . . 0.0 110.082 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -65.64 -25.68 67.47 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.463 1.105 . . . . 0.0 112.472 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.532 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 135.52 -173.52 21.7 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -87.13 111.59 41.88 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 123.957 0.903 . . . . 0.0 112.569 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.3 138.44 11.1 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.374 2.049 . . . . 0.0 110.898 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.44 HG13 ' CE1' ' A' ' 107' ' ' PHE . 15.6 pt -145.21 -174.26 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 124.354 1.062 . . . . 0.0 109.402 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.642 ' CD1' HG23 ' A' ' 92' ' ' ILE . 3.7 t80 -139.44 165.37 27.4 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.044 1.338 . . . . 0.0 113.028 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.435 HD22 HD11 ' A' ' 74' ' ' LEU . 3.7 tt -163.07 159.23 22.99 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.297 1.439 . . . . 0.0 111.148 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.27 176.17 38.67 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.219 0.914 . . . . 0.0 112.1 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.716 HD11 HD11 ' A' ' 30' ' ' LEU . 4.5 mt -94.62 152.55 18.42 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.388 1.075 . . . . 0.0 109.285 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -116.85 120.41 38.4 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.38 -38.82 0.55 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.314 0.483 . . . . 0.0 112.812 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.74 31.5 1.17 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.373 1.087 . . . . 0.0 112.52 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.6 m120 50.24 79.5 0.08 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.573 1.949 . . . . 0.0 111.912 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.67 137.89 25.53 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.651 0.78 . . . . 0.0 110.141 -177.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 4.0 m -143.85 172.56 12.68 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 118.631 0.65 . . . . 0.0 110.861 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.445 HD23 HD21 ' A' ' 87' ' ' LEU . 17.7 mt -59.05 147.84 33.22 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.115 0.484 . . . . 0.0 111.501 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 mtp -157.6 139.87 14.49 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 92.3 m -115.06 115.47 26.86 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.61 -177.93 3.35 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.396 2.279 . . . . 0.0 107.118 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.4 ' HE3' ' C ' ' A' ' 81' ' ' ASP . 43.4 tttt -122.51 126.8 48.57 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.46 -25.06 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.44 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.58 -49.9 0.2 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.4 ' C ' ' HE3' ' A' ' 78' ' ' LYS . 30.7 t70 -130.04 -11.99 4.19 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.174 -1.192 . . . . 0.0 113.274 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -137.87 153.83 74.05 Favored Pre-proline 0 C--O 1.241 0.657 0 C-N-CA 123.881 0.872 . . . . 0.0 110.749 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -70.04 153.45 67.63 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.424 2.082 . . . . 0.0 108.325 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 p -149.22 158.49 44.22 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.747 HD11 HG22 ' A' ' 128' ' ' ILE . 2.3 mt -80.4 146.18 31.61 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -145.54 63.81 1.26 Allowed 'General case' 0 N--CA 1.461 0.078 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.672 ' H ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -86.33 108.51 18.47 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.64 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.92 -41.39 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.097 0.559 . . . . 0.0 111.732 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -134.45 101.69 5.07 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 126.111 1.764 . . . . 0.0 109.929 -176.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -174.25 166.89 4.12 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.1 -1.0 . . . . 0.0 109.345 179.01 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.404 ' H ' ' HD2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -141.3 135.98 31.12 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 178.495 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.642 HG23 ' CD1' ' A' ' 64' ' ' TYR . 3.7 mt -87.68 -43.08 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 125.388 1.475 . . . . 0.0 109.173 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.6 tpt -61.64 -23.4 66.03 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 119.11 -0.471 . . . . 0.0 110.113 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -64.95 -51.2 63.12 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.637 HD12 ' CD1' ' A' ' 64' ' ' TYR . 13.5 mt -60.9 -35.49 76.79 Favored 'General case' 0 N--CA 1.461 0.091 0 O-C-N 121.717 -0.614 . . . . 0.0 110.181 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -78.87 -17.06 56.23 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.392 -0.817 . . . . 0.0 110.638 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -89.73 -42.78 11.13 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 120.504 -1.372 . . . . 0.0 111.181 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -107.01 150.09 39.39 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.433 0.693 . . . . 0.0 111.714 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.6 46.74 1.5 Allowed 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.552 3.502 . . . . 0.0 113.695 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -112.9 75.71 2.03 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.163 0.985 . . . . 0.0 111.134 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.99 71.18 7.16 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.599 3.533 . . . . 0.0 108.932 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 73.8 t -71.01 104.43 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.375 0.67 . . . . 0.0 110.172 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -50.96 -28.67 10.34 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 125.372 1.469 . . . . 0.0 111.029 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m -63.11 -13.63 38.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.327 1.451 . . . . 0.0 112.417 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -121.67 -28.63 4.51 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.769 0.828 . . . . 0.0 109.594 177.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.49 160.89 31.93 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.687 1.195 . . . . 0.0 111.035 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.481 ' HA ' HG23 ' A' ' 121' ' ' VAL . 9.9 p90 -151.16 148.38 28.19 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.57 0.748 . . . . 0.0 111.813 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.532 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -90.1 110.52 21.52 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 128.718 2.807 . . . . 0.0 107.923 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -79.38 141.83 36.55 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.4 t -137.95 -174.3 3.75 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.692 0.797 . . . . 0.0 109.526 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -151.24 163.08 39.68 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.285 1.434 . . . . 0.0 109.533 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.8 p -137.8 14.44 2.91 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.725 1.21 . . . . 0.0 111.825 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.72 -102.46 0.69 Allowed Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 105.452 -3.059 . . . . 0.0 105.452 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.07 -3.9 58.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.136 0.968 . . . . 0.0 113.115 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -117.6 159.47 22.85 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.405 1.002 . . . . 0.0 108.894 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 m -122.36 137.58 54.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.284 1.833 . . . . 0.0 108.963 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.01 166.84 10.72 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.524 1.13 . . . . 0.0 109.372 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -147.13 118.08 7.68 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -115.83 132.18 56.72 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 125.115 1.366 . . . . 0.0 110.554 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 t -59.84 133.93 56.56 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.118 0.967 . . . . 0.0 109.219 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.481 HG23 ' HA ' ' A' ' 107' ' ' PHE . 49.1 t -72.76 -45.95 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 O-C-N 120.649 -1.282 . . . . 0.0 110.191 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.53 70.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.63 -0.669 . . . . 0.0 111.946 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.16 82.92 46.52 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.919 0.888 . . . . 0.0 110.65 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.37 144.18 55.23 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.876 1.717 . . . . 0.0 107.854 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.31 -11.22 43.55 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.705 1.621 . . . . 0.0 109.208 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 25.3 m-90 -113.62 115.53 28.06 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.209 1.404 . . . . 0.0 107.646 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -105.16 156.76 17.79 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 125.024 1.329 . . . . 0.0 110.14 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.747 HG22 HD11 ' A' ' 85' ' ' LEU . 4.4 pt -85.56 127.86 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.932 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.71 119.75 25.61 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.5 t -79.49 -21.04 12.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 127.238 2.215 . . . . 0.0 112.223 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.5 m 54.95 90.93 0.03 OUTLIER 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.966 2.106 . . . . 0.0 110.892 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.499 ' HB2' HG21 ' A' ' 149' ' ' THR . 1.4 m -135.58 43.67 2.59 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 126.174 1.79 . . . . 0.0 108.307 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -110.55 0.27 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.459 2.303 . . . . 0.0 107.036 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.32 7.46 80.64 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 117.744 1.857 . . . . 0.0 117.744 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.45 38.82 8.68 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 119.824 1.812 . . . . 0.0 112.164 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 93.6 m -77.14 163.59 64.03 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.93 1.292 . . . . 0.0 107.857 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.22 169.33 20.93 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.129 1.886 . . . . 0.0 110.5 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.3 mt -85.93 118.83 25.65 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.69 172.86 9.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 124.407 1.083 . . . . 0.0 110.586 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 41.6 mt -91.91 163.6 13.96 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.9 t -149.09 150.14 32.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 177.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -101.79 -31.52 10.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 123.541 1.639 . . . . 0.0 108.09 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -164.25 130.87 3.1 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -124.83 160.33 29.0 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 125.352 1.461 . . . . 0.0 108.982 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -102.49 47.82 1.11 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 107.679 -2.168 . . . . 0.0 107.679 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.44 -9.71 0.5 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.806 2.042 . . . . 0.0 112.228 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.53 -51.09 21.44 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.555 1.542 . . . . 0.0 115.027 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -60.33 -17.56 43.86 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.499 HG21 ' HB2' ' A' ' 132' ' ' SER . 0.0 OUTLIER 55.98 79.45 0.17 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.517 0.599 . . . . 0.0 112.246 179.272 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.9 p -105.3 -8.33 18.32 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.058 -1.026 . . . . 0.0 111.612 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -115.52 103.14 10.44 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.091 1.356 . . . . 0.0 112.516 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.19 171.29 17.63 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.185 -1.572 . . . . 0.0 110.918 178.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -83.31 -173.27 49.57 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.96 120.76 11.24 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 14.8 m -78.91 41.94 0.45 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.896 1.679 . . . . 0.0 108.819 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -68.65 140.52 55.48 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.5 mt -115.0 162.07 17.48 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.92 1.688 . . . . 0.0 108.88 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 33.1 p90 . . . . . 0 C--O 1.245 0.849 0 C-N-CA 125.368 1.467 . . . . 0.0 108.108 178.831 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ptm . . . . . 0 CA--C 1.513 -0.45 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.443 ' N ' ' CD ' ' A' ' 2' ' ' GLU . 12.4 mp0 -110.34 -168.36 1.3 Allowed 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 128.235 2.614 . . . . 0.0 109.465 -175.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -130.86 49.14 2.35 Favored 'General case' 0 C--O 1.226 -0.167 0 O-C-N 121.74 -0.6 . . . . 0.0 112.411 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 36.86 81.02 0.02 OUTLIER 'General case' 0 C--O 1.237 0.4 0 C-N-CA 129.305 3.042 . . . . 0.0 112.166 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 5' ' ' LEU . 1.1 pt? -134.74 -169.21 2.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 129.916 3.286 . . . . 0.0 108.633 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.5 pttt -140.96 -8.06 1.05 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.562 1.145 . . . . 0.0 113.716 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -86.2 -19.58 8.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 126.601 1.96 . . . . 0.0 109.575 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 45.42 41.84 6.99 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.048 2.139 . . . . 0.0 111.422 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.5 p -54.35 150.64 15.9 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 118.51 0.595 . . . . 0.0 112.52 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.92 138.29 33.85 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.637 1.558 . . . . 0.0 108.866 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.39 117.47 21.45 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -114.38 143.61 44.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.39 -125.28 0.82 Allowed Glycine 0 C--O 1.226 -0.368 0 CA-C-O 117.988 -1.451 . . . . 0.0 110.356 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.4 p -154.05 -164.99 1.99 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 120.526 2.163 . . . . 0.0 113.628 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.6 mt -140.32 4.36 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.764 1.626 . . . . 0.0 108.033 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.8 -26.85 60.02 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.361 -1.462 . . . . 0.0 111.88 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -69.82 19.21 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 128.042 2.537 . . . . 0.0 113.695 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.7 mt -110.23 -60.58 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 127.165 2.186 . . . . 0.0 110.827 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -137.72 23.23 2.89 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.711 0.804 . . . . 0.0 110.524 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 61.41 36.81 17.17 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.296 1.038 . . . . 0.0 110.239 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.502 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 26.1 mmt-85 -104.19 86.36 2.54 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.904 -1.122 . . . . 0.0 110.322 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.9 t -73.88 129.36 36.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.427 ' CD2' HD11 ' A' ' 138' ' ' LEU . 32.0 m0 -81.9 137.54 35.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.044 0.938 . . . . 0.0 109.854 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.97 120.69 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-N 119.593 1.088 . . . . 0.0 109.705 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.479 HD13 HD22 ' A' ' 72' ' ' LEU . 1.0 OUTLIER -75.03 100.31 4.15 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.844 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 4.0 tt0 -89.02 -172.93 3.87 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.408 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -52.59 96.77 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 124.232 1.013 . . . . 0.0 112.306 -178.529 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 52.85 26.12 4.38 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.744 2.017 . . . . 0.0 111.937 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.1 m -154.09 128.67 9.28 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 119.172 0.897 . . . . 0.0 111.23 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.699 HD12 HD13 ' A' ' 87' ' ' LEU . 3.5 mt -84.3 131.96 34.67 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 pt -138.37 133.01 42.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 124.635 1.174 . . . . 0.0 111.134 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.07 146.36 47.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.18 80.78 15.86 Favored Pre-proline 0 N--CA 1.464 0.243 0 C-N-CA 124.031 0.932 . . . . 0.0 109.381 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.4 -31.87 21.24 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.883 1.722 . . . . 0.0 115.079 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 -165.91 84.25 0.32 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.409 1.884 . . . . 0.0 108.73 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -147.77 130.13 15.7 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -60.94 -13.62 17.21 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.308 1.043 . . . . 0.0 113.674 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -96.34 49.09 1.11 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.614 1.552 . . . . 0.0 106.922 177.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.5 mtp -65.25 156.9 30.45 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.554 -1.341 . . . . 0.0 109.402 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.3 t -159.89 87.5 1.97 Allowed Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.634 0.774 . . . . 0.0 109.841 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.42 137.23 46.18 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.015 1.81 . . . . 0.0 111.176 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 m -119.91 -174.18 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.9 m -132.62 155.25 49.06 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.2 mm -127.85 110.67 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 125.971 1.708 . . . . 0.0 108.857 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.7 139.32 30.65 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.168 1.787 . . . . 0.0 109.304 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.7 tt -134.41 129.41 35.3 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.605 1.162 . . . . 0.0 109.19 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.0 mt -144.91 127.93 11.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.932 1.293 . . . . 0.0 111.039 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.0 p -72.68 128.22 34.91 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 90.3 m -61.6 149.48 39.08 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -109.54 -10.09 14.88 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.486 1.114 . . . . 0.0 110.216 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -101.49 26.71 6.97 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.551 1.94 . . . . 0.0 109.918 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.3 m -71.22 -9.79 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 120.497 -1.377 . . . . 0.0 114.567 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.02 -35.92 48.48 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.45 1.1 . . . . 0.0 112.694 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 t -97.97 0.82 47.1 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.565 1.546 . . . . 0.0 111.821 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.484 HD22 ' HG2' ' A' ' 103' ' ' LYS . 72.7 mt -92.13 -179.58 5.3 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.02 -1.05 . . . . 0.0 109.974 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -79.52 162.03 25.65 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.556 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -139.5 -24.19 0.86 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.562 1.545 . . . . 0.0 111.586 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -78.67 9.07 4.42 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.062 1.745 . . . . 0.0 112.703 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -115.18 -50.11 2.76 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.73 -146.47 10.89 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -107.8 104.28 52.58 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.67 131.56 17.46 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.291 3.327 . . . . 0.0 111.267 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.79 177.35 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.36 0.664 . . . . 0.0 111.033 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.548 ' CD1' HD12 ' A' ' 95' ' ' LEU . 1.8 t80 -125.83 154.55 42.48 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.733 0.778 . . . . 0.0 109.963 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.409 HD22 HD11 ' A' ' 74' ' ' LEU . 1.9 tt -156.07 150.76 26.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.49 178.62 35.53 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.665 HD11 HD11 ' A' ' 30' ' ' LEU . 5.6 mt -88.25 153.75 20.97 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -119.46 116.05 25.32 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 101.246 -3.613 . . . . 0.0 101.246 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.6 -18.97 0.37 Allowed Glycine 0 C--N 1.342 0.874 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.916 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.19 26.28 0.09 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.823 1.811 . . . . 0.0 112.336 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.0 m120 60.23 62.99 1.48 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.346 1.058 . . . . 0.0 109.322 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.479 HD22 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.36 137.41 27.09 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.436 -1.415 . . . . 0.0 112.298 -178.66 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.438 ' H ' ' HB2' ' A' ' 90' ' ' LYS . 5.4 m -143.14 176.23 9.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.145 0.978 . . . . 0.0 111.656 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.469 HD23 HD21 ' A' ' 87' ' ' LEU . 18.6 mt -61.3 151.38 32.11 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.322 1.049 . . . . 0.0 111.052 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.478 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 4.9 tmm? -158.84 134.28 8.6 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 76.2 m -107.52 120.64 42.76 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 124.482 1.114 . . . . 0.0 109.57 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.21 -168.37 2.12 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -121.59 144.63 48.63 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.8 p -90.93 -24.17 5.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.43 -0.508 . . . . 0.0 109.668 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.24 -45.43 0.47 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -109.74 -40.75 4.72 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.421 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 2.9 pt20 -132.97 164.95 40.28 Favored Pre-proline 0 C--O 1.242 0.692 0 C-N-CA 126.158 1.783 . . . . 0.0 112.125 -177.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 82' ' ' GLN . 89.2 Cg_endo -71.23 154.34 61.72 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.632 2.222 . . . . 0.0 112.38 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.4 p -151.21 171.9 16.68 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mt -91.86 152.98 19.84 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.425 0.69 . . . . 0.0 111.663 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -145.07 65.83 1.25 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.647 0.779 . . . . 0.0 110.224 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.71 ' H ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -88.11 116.71 26.49 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -177.97 -19.27 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.7 94.82 1.49 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.478 ' HE3' ' HB2' ' A' ' 75' ' ' MET . 0.6 OUTLIER -173.65 162.63 4.15 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 121.503 1.956 . . . . 0.0 109.866 -177.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -142.77 136.79 29.23 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.849 0.459 . . . . 0.0 111.823 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.1 mp -80.91 -36.21 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.972 1.309 . . . . 0.0 110.846 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.8 mmt -59.7 -33.38 71.52 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.868 0.758 . . . . 0.0 109.831 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.8 -54.18 49.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.94 0.896 . . . . 0.0 109.159 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.548 HD12 ' CD1' ' A' ' 64' ' ' TYR . 9.9 mt -67.19 -29.67 69.41 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -80.7 -25.72 37.96 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.872 0.368 . . . . 0.0 110.698 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -83.69 -44.36 14.57 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.007 1.323 . . . . 0.0 111.524 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.48 154.71 46.53 Favored Pre-proline 0 N--CA 1.457 -0.111 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.059 -177.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.3 65.69 2.77 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 124.132 3.221 . . . . 0.0 113.01 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -119.79 69.78 13.17 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 125.054 1.342 . . . . 0.0 111.388 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.464 ' HB2' HD21 ' A' ' 55' ' ' LEU . 58.8 Cg_endo -82.39 75.84 4.46 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.361 2.707 . . . . 0.0 105.95 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 t -88.43 94.34 4.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 O-C-N 120.858 -1.151 . . . . 0.0 109.496 -177.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.484 ' HG2' HD22 ' A' ' 55' ' ' LEU . 30.5 mttt -45.08 -28.09 0.67 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.242 2.217 . . . . 0.0 114.393 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 m -63.1 -22.28 66.75 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.355 1.462 . . . . 0.0 113.107 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.423 ' CE2' ' HG2' ' A' ' 75' ' ' MET . 20.6 m-85 -109.36 -18.52 13.54 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.658 1.983 . . . . 0.0 109.581 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.1 mt -85.68 155.19 21.19 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 125.717 1.607 . . . . 0.0 113.686 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -138.57 131.72 29.95 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.914 0.886 . . . . 0.0 109.71 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.51 116.35 18.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -90.73 144.23 25.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.79 178.24 6.5 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.09 0.956 . . . . 0.0 109.11 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -150.63 154.83 38.2 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.597 1.559 . . . . 0.0 110.799 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 57.6 p -132.38 8.9 4.32 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.322 -1.763 . . . . 0.0 113.459 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.79 -47.1 1.08 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.803 1.668 . . . . 0.0 112.159 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -132.82 -2.81 3.27 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -132.83 151.17 52.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.9 m -118.09 159.89 22.46 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.2 166.14 17.63 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -147.87 112.88 5.47 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.02 133.29 55.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.487 1.515 . . . . 0.0 109.555 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.0 t -54.47 120.45 6.65 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.211 1.004 . . . . 0.0 108.652 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.4 t -65.71 -42.36 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.066 -1.021 . . . . 0.0 110.663 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.25 97.49 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -129.31 83.77 64.35 Favored Pre-proline 0 C--O 1.235 0.321 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -68.23 158.34 57.93 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.786 2.324 . . . . 0.0 108.456 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 104.34 -6.97 46.58 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 26.4 m-90 -124.28 142.15 51.49 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 126.157 1.783 . . . . 0.0 109.796 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -126.0 152.23 46.0 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.092 0.957 . . . . 0.0 111.519 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.0 pt -76.04 127.71 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.076 0.465 . . . . 0.0 110.949 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.88 110.0 20.69 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 t -68.21 -15.8 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.844 1.658 . . . . 0.0 113.882 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 m 65.79 33.13 8.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.0 1.32 . . . . 0.0 113.041 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.502 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 5.8 m -65.03 -21.1 66.79 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.353 0.597 . . . . 0.0 111.827 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -84.7 120.3 26.24 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 125.377 1.471 . . . . 0.0 107.787 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 67.57 -72.29 0.24 Allowed Glycine 0 N--CA 1.442 -0.933 0 O-C-N 125.466 1.729 . . . . 0.0 114.311 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.67 71.45 0.02 OUTLIER Glycine 0 CA--C 1.526 0.767 0 N-CA-C 105.837 -2.905 . . . . 0.0 105.837 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' CYS . . . . . 0.457 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 63.9 m -95.0 174.68 3.36 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 124.956 1.302 . . . . 0.0 111.393 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 136' ' ' CYS . 96.7 Cg_endo -75.23 165.21 31.43 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.03 1.82 . . . . 0.0 111.593 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.583 HD12 HD13 ' A' ' 30' ' ' LEU . 28.8 mt -91.59 114.01 26.43 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.956 0.903 . . . . 0.0 108.564 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.7 pp -141.21 176.6 4.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 125.255 1.422 . . . . 0.0 107.191 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 20.2 mt -100.63 165.79 11.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.536 HG21 HD23 ' A' ' 144' ' ' LEU . 8.8 t -147.89 162.53 39.09 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -104.63 -42.53 5.38 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -154.2 127.71 8.61 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 122.707 1.241 . . . . 0.0 109.014 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.536 HD23 HG21 ' A' ' 141' ' ' THR . 0.8 OUTLIER -164.29 155.25 15.39 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.477 2.711 . . . . 0.0 104.96 177.064 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.428 ' O ' ' HE3' ' A' ' 146' ' ' LYS . . . -160.93 12.22 0.15 Allowed Glycine 0 CA--C 1.53 1.009 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 177.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 145' ' ' GLY . 0.3 OUTLIER -149.09 -41.47 0.15 Allowed 'General case' 0 C--N 1.349 0.546 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -177.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.84 -31.56 72.25 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.526 ' H ' HD13 ' A' ' 144' ' ' LEU . 20.4 m-80 -146.04 -161.39 1.3 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.471 HG21 ' CD2' ' A' ' 152' ' ' PHE . 90.9 m -137.29 131.52 32.39 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.3 p -110.37 -13.29 14.31 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.874 1.269 . . . . 0.0 111.689 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -120.63 109.12 14.85 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.767 0.712 . . . . 0.0 111.519 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.471 ' CD2' HG21 ' A' ' 149' ' ' THR . 0.2 OUTLIER -161.68 173.25 14.95 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.168 1.787 . . . . 0.0 111.206 178.836 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.38 -166.9 31.21 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.14 140.62 46.69 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 122.076 -0.661 . . . . 0.0 109.233 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.75 28.88 1.24 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.883 1.673 . . . . 0.0 109.837 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -59.45 150.65 26.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.663 1.185 . . . . 0.0 108.523 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 43.1 mt -132.86 160.88 35.69 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.62 1.168 . . . . 0.0 108.333 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 31.2 p90 . . . . . 0 C--O 1.245 0.819 0 CA-C-O 117.198 -1.382 . . . . 0.0 108.29 178.908 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -129.33 178.54 6.37 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -118.18 50.51 1.15 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.75 1.22 . . . . 0.0 111.955 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 34.24 71.76 0.1 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.88 2.472 . . . . 0.0 111.43 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -141.3 -172.34 3.48 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.741 1.217 . . . . 0.0 110.128 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -143.99 14.18 1.68 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.923 1.289 . . . . 0.0 111.678 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 pp -129.68 24.61 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 C-N-CA 124.962 1.305 . . . . 0.0 109.878 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.35 -20.22 48.32 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 p -70.25 160.3 81.41 Favored Pre-proline 0 C--O 1.24 0.595 0 C-N-CA 123.469 0.708 . . . . 0.0 111.103 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.34 147.94 94.09 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 N-CA-C 108.131 -1.527 . . . . 0.0 108.131 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.98 107.16 15.01 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -110.21 134.9 51.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.486 0.66 . . . . 0.0 110.388 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 156' ' ' MET . . . -161.27 -129.05 0.99 Allowed Glycine 0 N--CA 1.451 -0.356 0 O-C-N 121.186 -0.946 . . . . 0.0 111.975 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.2 p -154.23 -172.47 4.22 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.364 1.082 . . . . 0.0 112.11 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -149.81 9.18 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 124.288 1.035 . . . . 0.0 111.575 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.32 -18.03 59.13 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 119.92 -1.738 . . . . 0.0 111.377 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.14 44.85 0.6 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.23 2.612 . . . . 0.0 110.528 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mt -131.71 -64.95 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 126.111 1.764 . . . . 0.0 111.148 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -139.87 27.42 2.21 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.406 1.083 . . . . 0.0 109.855 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 64.59 15.55 9.74 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -79.05 91.03 4.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.495 ' HB ' HG23 ' A' ' 33' ' ' VAL . 53.6 t -72.24 153.49 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.43 ' HE3' HD11 ' A' ' 138' ' ' LEU . 10.1 m95 -112.1 132.56 54.78 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 120.513 -1.367 . . . . 0.0 108.798 -177.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.472 ' C ' HD23 ' A' ' 30' ' ' LEU . 39.8 t -140.62 126.12 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 119.983 1.265 . . . . 0.0 111.837 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tp -76.41 104.7 7.06 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -88.92 -170.33 2.87 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.86 97.01 0.01 OUTLIER 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.604 1.962 . . . . 0.0 109.925 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 46.51 23.09 0.2 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.893 2.477 . . . . 0.0 112.669 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 m -153.93 128.55 9.32 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 119.412 1.006 . . . . 0.0 111.523 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.545 HD13 HD12 ' A' ' 138' ' ' LEU . 2.7 mt -79.74 149.21 31.21 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.147 -0.971 . . . . 0.0 112.028 179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 16.6 pt -143.15 149.37 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.168 1.387 . . . . 0.0 110.893 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.64 143.97 25.79 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.495 HG23 ' HB ' ' A' ' 22' ' ' VAL . 28.4 m -128.47 105.32 19.32 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.015 0.926 . . . . 0.0 110.285 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.83 -50.68 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.454 2.769 . . . . 0.0 116.351 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -147.05 57.71 1.15 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.07 130.82 50.33 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.22 -55.24 37.55 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.86 0.725 . . . . 0.0 109.082 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -79.44 60.36 3.18 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.218 1.407 . . . . 0.0 111.692 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -102.64 171.62 7.32 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 176.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t -159.68 133.01 4.79 Favored Pre-proline 0 N--CA 1.452 -0.373 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.69 155.04 59.25 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 N-CA-C 108.088 -1.543 . . . . 0.0 108.088 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m -140.07 -171.03 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 125.244 1.418 . . . . 0.0 107.535 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.92 156.16 48.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.0 mm -127.34 112.55 28.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 126.158 1.783 . . . . 0.0 107.905 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.16 140.74 29.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.403 HD12 HD12 ' A' ' 65' ' ' LEU . 4.8 tt -135.47 139.75 44.3 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.0 mt -150.37 139.72 15.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.287 1.035 . . . . 0.0 108.986 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.7 p -75.14 156.4 35.98 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 94.8 m -78.34 140.06 38.79 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 119.873 -1.767 . . . . 0.0 108.681 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -101.16 -21.28 14.99 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.44 -0.788 . . . . 0.0 112.541 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -111.66 67.77 0.65 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.884 1.274 . . . . 0.0 108.255 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.619 ' HA ' HD23 ' A' ' 55' ' ' LEU . 15.2 m -101.4 2.31 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -177.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.61 -18.71 65.16 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.635 1.174 . . . . 0.0 111.526 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 t -105.16 -5.0 21.13 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.764 2.026 . . . . 0.0 113.521 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.619 HD23 ' HA ' ' A' ' 52' ' ' VAL . 3.8 mm? -80.41 -178.59 6.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.594 -0.691 . . . . 0.0 110.205 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -82.37 -38.17 24.56 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.418 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.81 1.55 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.662 1 C-N-CA 132.328 4.251 . . . . 0.0 117.148 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -93.53 -14.43 26.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 127.227 2.211 . . . . 0.0 110.399 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.406 HH12 ' HB3' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -98.95 -0.52 42.0 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.928 0.785 . . . . 0.0 111.085 175.683 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.66 179.86 23.09 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 125.132 1.349 . . . . 0.0 110.389 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -86.62 112.58 47.7 Favored Pre-proline 0 CA--C 1.538 0.506 0 O-C-N 121.552 -0.969 . . . . 0.0 109.051 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -66.73 133.47 31.8 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.449 2.1 . . . . 0.0 114.461 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 pp -142.77 174.02 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 120.04 1.291 . . . . 0.0 109.788 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.664 ' CD1' HD12 ' A' ' 95' ' ' LEU . 2.7 t80 -131.94 153.4 50.33 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.403 HD12 HD12 ' A' ' 46' ' ' LEU . 6.1 tt -150.76 154.43 37.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.114 1.366 . . . . 0.0 108.23 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -163.65 -173.03 31.85 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.449 HD11 HD11 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -95.64 159.99 14.72 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -135.02 92.14 2.84 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 120.43 -1.419 . . . . 0.0 110.357 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.37 -7.83 0.02 OUTLIER Glycine 0 CA--C 1.536 1.394 0 CA-C-O 117.518 -1.712 . . . . 0.0 114.872 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -164.86 24.99 0.06 Allowed 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.528 2.164 . . . . 0.0 113.312 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.7 m120 58.7 67.84 0.89 Allowed 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.531 -1.355 . . . . 0.0 109.529 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.25 131.67 23.69 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.441 1.496 . . . . 0.0 109.888 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 61.5 m -140.38 177.99 7.62 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.23 1.812 . . . . 0.0 112.059 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.7 mt -61.71 154.72 24.66 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.284 -1.51 . . . . 0.0 110.772 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.2 ttp -162.46 132.15 4.47 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 93.2 m -103.33 121.96 43.83 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.313 0.96 . . . . 0.0 110.588 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.98 -171.91 2.39 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.926 1.69 . . . . 0.0 107.678 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -146.31 130.48 17.46 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.0 m -78.46 12.08 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 123.576 0.75 . . . . 0.0 112.227 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.02 -10.51 63.94 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.847 2.165 . . . . 0.0 111.687 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -129.08 -50.96 1.21 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.926 1.69 . . . . 0.0 110.857 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -131.48 155.76 81.04 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 125.058 1.343 . . . . 0.0 113.498 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.31 144.09 40.62 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 124.157 3.238 . . . . 0.0 111.769 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.7 p -148.43 147.65 29.42 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.171 0.896 . . . . 0.0 109.5 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.3 mt -71.69 160.08 33.27 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -150.97 64.09 0.91 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.061 0.944 . . . . 0.0 108.673 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.79 ' H ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -85.09 113.01 21.17 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.5 pttp -174.9 -36.16 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.929 1.292 . . . . 0.0 112.283 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -141.64 83.4 1.85 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.841 1.2 . . . . 0.0 113.959 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.47 147.71 6.37 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.36 -1.463 . . . . 0.0 109.014 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.29 140.99 48.16 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.225 1.01 . . . . 0.0 109.958 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.1 tt -87.18 -43.59 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 125.417 1.487 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.3 tpt -62.32 -27.89 69.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.923 -0.56 . . . . 0.0 111.396 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.88 -54.51 37.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.664 HD12 ' CD1' ' A' ' 64' ' ' TYR . 18.8 mt -60.05 -32.48 70.96 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.427 -0.796 . . . . 0.0 111.248 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -81.83 -15.97 52.35 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.238 -0.914 . . . . 0.0 112.215 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -94.49 -33.16 13.19 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 120.498 -1.376 . . . . 0.0 112.374 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.422 ' HB2' ' HD2' ' A' ' 99' ' ' PRO . 3.9 pt20 -123.8 167.07 16.14 Favored Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 124.909 1.284 . . . . 0.0 110.799 -178.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 98' ' ' GLN . 58.7 Cg_endo -73.24 -139.14 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 122.81 2.34 . . . . 0.0 109.59 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 56.99 60.77 7.05 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.952 1.701 . . . . 0.0 113.575 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.49 109.37 0.85 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.03 3.153 . . . . 0.0 109.262 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.3 t -88.11 98.7 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -49.53 -29.73 7.29 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.315 1.046 . . . . 0.0 112.286 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.5 m -62.54 -16.07 54.07 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.413 1.085 . . . . 0.0 113.453 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.52 -23.64 8.17 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.141 0.882 . . . . 0.0 111.69 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.5 mt -75.15 156.06 36.34 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.086 0.955 . . . . 0.0 112.801 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -138.93 128.72 24.86 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.644 0.778 . . . . 0.0 112.517 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -77.85 126.23 30.53 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.41 147.37 36.05 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 p -136.72 -177.1 4.59 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.777 1.631 . . . . 0.0 107.52 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -139.52 165.12 28.08 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.833 0.853 . . . . 0.0 109.193 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.5 p -149.84 35.98 0.69 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.753 1.283 . . . . 0.0 112.555 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.91 -56.27 1.85 Allowed Glycine 0 C--N 1.334 0.469 0 O-C-N 120.61 -1.307 . . . . 0.0 112.504 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -131.32 -1.08 4.0 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.508 -0.995 . . . . 0.0 112.669 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -134.05 179.92 5.95 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.752 0.821 . . . . 0.0 110.007 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 p -144.51 133.15 22.23 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.117 0.967 . . . . 0.0 112.435 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.52 170.82 9.08 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.202 1.401 . . . . 0.0 109.572 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -137.6 109.58 7.2 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.294 1.837 . . . . 0.0 106.98 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -98.52 128.08 44.72 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.926 2.09 . . . . 0.0 109.241 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.1 t -61.2 131.89 51.9 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.929 1.24 . . . . 0.0 111.957 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.33 -49.86 72.37 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 O-C-N 121.845 -0.534 . . . . 0.0 110.004 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.73 -27.52 68.97 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -136.29 84.73 28.69 Favored Pre-proline 0 N--CA 1.453 -0.28 0 CA-C-N 118.179 0.445 . . . . 0.0 110.186 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.406 ' HB3' HH12 ' A' ' 59' ' ' ARG . 10.6 Cg_endo -65.36 166.45 19.32 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.113 2.542 . . . . 0.0 111.663 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.19 1.36 90.48 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.443 -0.643 . . . . 0.0 112.546 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -130.56 146.12 52.01 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.092 1.357 . . . . 0.0 107.419 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -130.87 148.95 52.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.121 1.368 . . . . 0.0 110.578 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.4 pt -78.68 129.29 37.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.569 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.86 151.95 22.46 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.2 m -103.48 -17.27 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 125.149 1.38 . . . . 0.0 113.383 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.3 m 67.98 85.39 0.14 Allowed 'General case' 0 CA--C 1.533 0.308 0 O-C-N 124.413 1.07 . . . . 0.0 109.074 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 t -120.2 13.23 11.98 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.28 -1.512 . . . . 0.0 112.228 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -79.1 -52.22 8.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -161.55 -83.39 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.97 49.75 0.56 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 120.196 1.998 . . . . 0.0 113.261 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 32.0 m -78.13 165.85 47.51 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 118.229 1.014 . . . . 0.0 109.335 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 66.0 Cg_endo -78.12 163.92 27.53 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.404 2.07 . . . . 0.0 113.189 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.545 HD12 HD13 ' A' ' 30' ' ' LEU . 37.1 mt -85.64 107.9 17.75 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.7 1.2 . . . . 0.0 110.975 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.44 -172.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 124.292 1.037 . . . . 0.0 109.557 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.54 162.86 14.68 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t -148.97 172.92 13.94 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 125.804 1.642 . . . . 0.0 109.004 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -114.89 -44.98 3.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.339 1.856 . . . . 0.0 108.283 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -155.07 130.27 9.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.411 ' H ' HD23 ' A' ' 144' ' ' LEU . 1.6 pt? -139.53 -45.29 0.45 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.627 2.371 . . . . 0.0 113.174 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 71.39 -61.78 1.11 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 127.536 2.493 . . . . 0.0 113.653 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.39 -17.01 2.34 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.343 1.857 . . . . 0.0 110.249 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -53.69 -34.91 60.32 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 118.455 0.571 . . . . 0.0 110.219 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -156.56 -175.75 5.6 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.521 HG21 ' CE2' ' A' ' 152' ' ' PHE 0.289 12.9 m -112.28 140.42 47.01 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 178.238 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.33 -16.76 2.71 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 128.272 2.629 . . . . 0.0 109.815 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.35 122.56 37.18 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 124.147 0.979 . . . . 0.0 111.775 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.2 OUTLIER -161.71 -173.71 3.86 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.439 1.096 . . . . 0.0 109.481 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.47 -172.42 33.59 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.3 tp -146.03 127.16 14.7 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.9 m -82.96 40.16 0.68 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.408 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 5.6 ptt? -62.75 138.46 58.52 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 44.1 mt -117.42 -177.12 3.15 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.99 1.716 . . . . 0.0 106.95 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.1 p90 . . . . . 0 C--O 1.239 0.533 0 CA-C-N 119.728 1.149 . . . . 0.0 112.301 -179.206 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.4 ptt? . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -109.93 151.77 26.68 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -89.65 20.74 3.84 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.42 1.488 . . . . 0.0 112.939 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 51.24 68.8 0.73 Allowed 'General case' 0 C--O 1.232 0.133 0 C-N-CA 125.297 1.439 . . . . 0.0 112.413 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.07 160.45 39.75 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.1 pttt 43.94 19.99 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 128.235 2.614 . . . . 0.0 114.205 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 pp -133.13 -28.61 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 124.053 0.941 . . . . 0.0 112.225 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.73 -22.76 61.57 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.999 0.818 . . . . 0.0 111.338 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.95 158.84 50.94 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 126.08 1.752 . . . . 0.0 111.144 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.28 103.34 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.143 2.562 . . . . 0.0 109.123 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.18 113.23 24.9 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -110.62 139.61 45.71 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.001 0.429 . . . . 0.0 110.744 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.93 -126.25 0.88 Allowed Glycine 0 C--O 1.224 -0.516 0 CA-C-O 117.618 -1.657 . . . . 0.0 112.389 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.4 p -161.68 -165.38 1.27 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 121.292 2.546 . . . . 0.0 112.376 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -142.18 0.5 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.176 0.59 . . . . 0.0 109.868 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -66.53 -20.68 66.09 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 120.34 -1.475 . . . . 0.0 111.256 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -60.58 -16.43 38.0 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.893 0.877 . . . . 0.0 112.394 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.0 mt -74.11 -69.02 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.126 0 C-N-CA 125.48 1.512 . . . . 0.0 113.958 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.04 21.27 6.83 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 67.06 30.38 7.45 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.567 1.147 . . . . 0.0 110.792 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.503 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 16.9 mmt-85 -98.3 102.87 14.74 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.068 1.347 . . . . 0.0 108.476 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.431 ' HB ' HG23 ' A' ' 33' ' ' VAL . 71.0 t -80.25 154.11 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 177.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.503 ' CH2' ' HB2' ' A' ' 21' ' ' ARG . 5.2 m95 -114.27 143.93 44.05 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.8 t -138.35 121.07 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tp -69.96 106.54 3.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -98.79 -174.19 2.72 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.52 96.29 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.893 1.224 . . . . 0.0 112.303 -178.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 45.45 28.14 0.45 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.583 2.753 . . . . 0.0 111.823 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.2 m -153.5 127.04 8.68 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.092 0.86 . . . . 0.0 110.694 -176.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.865 HD12 ' HG ' ' A' ' 87' ' ' LEU . 10.3 mt -83.27 127.9 34.04 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 120.93 -1.106 . . . . 0.0 111.164 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.9 mm -128.01 139.25 52.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 122.949 0.499 . . . . 0.0 109.788 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.18 142.81 39.46 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.431 HG23 ' HB ' ' A' ' 22' ' ' VAL . 8.0 m -119.9 77.15 22.35 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 124.662 1.185 . . . . 0.0 108.115 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.31 -37.23 10.55 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.837 2.358 . . . . 0.0 113.907 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.45 51.88 1.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.74 134.14 52.34 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -66.41 -41.68 88.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.111 0.482 . . . . 0.0 110.485 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.18 75.15 9.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -123.35 140.71 52.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.797 -1.547 . . . . 0.0 110.075 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.0 t -140.87 141.16 23.38 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.75 160.84 42.99 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 N-CA-C 108.589 -1.35 . . . . 0.0 108.589 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.0 m -143.82 166.91 13.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 126.5 1.92 . . . . 0.0 109.093 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.61 154.77 36.32 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.3 mm -129.95 109.4 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 125.648 1.579 . . . . 0.0 108.053 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.98 133.38 34.84 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.818 1.247 . . . . 0.0 108.537 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.8 tt -129.55 129.78 44.9 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.4 1.48 . . . . 0.0 109.193 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.1 mt -142.17 142.71 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.949 0.88 . . . . 0.0 109.62 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.2 p -87.21 146.78 25.85 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.42 ' O ' HG13 ' A' ' 52' ' ' VAL . 87.3 m -63.98 122.69 17.12 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.589 1.156 . . . . 0.0 110.943 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -81.77 -26.86 34.09 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.049 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -96.96 35.9 1.49 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.842 1.201 . . . . 0.0 111.474 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 49' ' ' CYS . 3.7 m -57.06 -15.98 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.583 1.153 . . . . 0.0 112.418 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.18 -13.26 11.36 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.845 2.058 . . . . 0.0 111.227 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.59 -0.89 13.51 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.57 1.548 . . . . 0.0 111.819 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 101' ' ' PRO . 3.6 mm? -113.27 164.25 13.79 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.864 1.666 . . . . 0.0 110.25 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -71.15 152.73 43.12 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.816 0.847 . . . . 0.0 109.246 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -112.18 -32.84 6.42 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -52.57 -35.0 53.04 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 128.592 2.757 . . . . 0.0 114.27 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.9 mtt85 -87.08 -1.5 57.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 118.548 -0.739 . . . . 0.0 112.785 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.73 -177.17 18.19 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -82.45 106.14 6.07 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 118.927 1.364 . . . . 0.0 111.699 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.76 134.96 20.85 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.232 2.622 . . . . 0.0 108.934 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.92 -179.16 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.717 1.607 . . . . 0.0 110.565 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -133.78 158.68 42.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.578 1.151 . . . . 0.0 110.446 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.2 tt -151.64 143.26 23.61 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.124 1.37 . . . . 0.0 109.162 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.43 -174.85 16.01 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.192 1.377 . . . . 0.0 111.344 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.854 HD11 HD11 ' A' ' 30' ' ' LEU . 10.0 mt -105.5 133.59 50.0 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -95.39 107.36 19.49 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.1 -76.77 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.073 -1.536 . . . . 0.0 111.084 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.19 22.09 16.53 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.266 1.026 . . . . 0.0 111.169 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.11 72.54 0.49 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.033 1.733 . . . . 0.0 110.206 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.13 150.29 39.25 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.775 1.23 . . . . 0.0 108.064 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.601 ' SG ' HG23 ' A' ' 92' ' ' ILE . 3.2 m -147.62 171.64 15.29 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 123.069 0.548 . . . . 0.0 109.937 178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 76.7 mt -62.13 166.11 5.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.684 0.794 . . . . 0.0 109.274 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -172.64 137.06 0.78 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.0 m -96.98 128.67 44.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.429 0.633 . . . . 0.0 110.205 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -133.87 -174.9 3.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -131.16 118.01 19.86 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 103.032 -2.951 . . . . 0.0 103.032 178.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 p -72.01 -23.31 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.4 -38.97 0.17 Allowed Glycine 0 N--CA 1.453 -0.227 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -141.8 -17.39 0.77 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.924 0.89 . . . . 0.0 112.488 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -139.47 153.26 70.47 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.836 1.254 . . . . 0.0 113.558 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.93 142.49 88.44 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 124.951 3.767 . . . . 0.0 111.973 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.8 p -147.33 163.52 36.17 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 124.738 1.215 . . . . 0.0 110.218 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 mt -86.12 156.53 20.33 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -147.18 80.08 1.52 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.638 1.975 . . . . 0.0 108.721 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.865 ' HG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -103.01 104.63 14.82 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.188 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.41 -24.79 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -144.58 87.5 1.87 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.379 1.071 . . . . 0.0 111.72 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -165.86 165.84 18.01 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 119.402 -2.061 . . . . 0.0 108.388 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -137.07 165.41 26.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.601 HG23 ' SG ' ' A' ' 73' ' ' CYS . 18.9 pt -113.98 -49.66 5.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 124.765 1.226 . . . . 0.0 110.586 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.1 mmt -62.25 -18.84 62.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 117.913 -1.042 . . . . 0.0 109.25 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -71.42 -45.22 63.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.263 1.392 . . . . 0.0 110.299 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 23.4 mt -62.6 -25.94 68.35 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.727 1.211 . . . . 0.0 109.662 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -82.76 -34.89 26.97 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.646 -0.659 . . . . 0.0 109.784 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -65.42 -37.76 87.87 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.621 -1.18 . . . . 0.0 110.859 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -136.12 158.5 73.6 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.87 82.43 2.33 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.926 2.417 . . . . 0.0 111.062 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -135.56 59.91 33.91 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.822 1.649 . . . . 0.0 107.26 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.644 ' HB2' HD21 ' A' ' 55' ' ' LEU . 61.4 Cg_endo -72.66 86.84 1.0 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.334 2.023 . . . . 0.0 108.68 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.5 t -73.35 101.74 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -53.08 -29.8 32.42 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 122.998 0.519 . . . . 0.0 111.151 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -65.84 -7.1 14.41 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 178.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -120.92 -33.14 3.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.598 1.09 . . . . 0.0 109.689 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.5 mt -68.32 153.19 44.24 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.239 0.472 . . . . 0.0 111.918 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.95 135.72 24.6 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.126 0.97 . . . . 0.0 111.264 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -74.09 113.75 11.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.716 2.407 . . . . 0.0 105.996 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -88.99 134.06 34.11 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.6 t -132.9 -178.68 5.06 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.77 146.72 20.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.943 0.897 . . . . 0.0 109.891 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.85 88.75 0.98 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.431 1.092 . . . . 0.0 111.843 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.17 61.93 1.54 Allowed Glycine 0 C--N 1.339 0.75 0 C-N-CA 124.335 0.969 . . . . 0.0 112.641 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 61.64 0.27 0.47 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.06 2.144 . . . . 0.0 110.437 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -115.28 124.9 52.51 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 m -84.72 171.67 12.14 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.096 0.958 . . . . 0.0 109.497 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.14 161.7 41.45 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.053 2.141 . . . . 0.0 108.375 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -141.22 111.93 7.06 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.582 1.153 . . . . 0.0 109.478 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -105.18 128.8 53.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.463 1.905 . . . . 0.0 109.893 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.2 t -52.74 125.58 17.2 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.028 1.731 . . . . 0.0 110.882 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.17 -45.59 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.428 1.013 . . . . 0.0 109.772 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.5 -33.68 74.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.007 -0.997 . . . . 0.0 111.619 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -136.27 83.89 31.17 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.703 1.201 . . . . 0.0 110.269 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.26 157.22 61.09 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.43 1.42 . . . . 0.0 110.342 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 103.73 -34.88 5.42 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.544 1.545 . . . . 0.0 109.5 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 15.7 m-90 -85.95 140.03 30.7 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -123.99 141.45 52.03 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.384 1.074 . . . . 0.0 109.032 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 140' ' ' LEU . 5.1 mt -78.73 143.43 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -107.08 158.92 16.69 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.6 t -110.93 1.24 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 126.991 2.117 . . . . 0.0 112.698 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.6 m 49.66 52.93 13.62 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 m -85.1 -15.4 44.06 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.034 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -58.11 -31.52 67.23 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -170.15 -79.72 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.86 57.35 0.22 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 84.3 m -88.37 163.01 38.09 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.73 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.07 164.23 34.67 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 N-CA-C 107.531 -1.757 . . . . 0.0 107.531 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.8 mt -91.29 113.8 26.16 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.2 174.15 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 124.597 1.159 . . . . 0.0 112.445 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -100.44 150.71 22.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 118.531 -0.747 . . . . 0.0 109.809 177.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.615 HG21 HD23 ' A' ' 144' ' ' LEU . 11.5 t -130.88 173.86 10.55 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.891 1.276 . . . . 0.0 109.307 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -114.64 -32.6 5.8 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.96 1.304 . . . . 0.0 111.028 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -166.1 106.15 0.69 Allowed 'General case' 0 C--O 1.237 0.42 0 CA-C-N 119.14 0.882 . . . . 0.0 109.816 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.615 HD23 HG21 ' A' ' 141' ' ' THR . 1.5 pp -143.21 164.03 31.29 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.522 1.129 . . . . 0.0 111.221 178.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.63 23.04 0.22 Allowed Glycine 0 CA--C 1.524 0.601 0 CA-C-O 118.427 -1.207 . . . . 0.0 111.74 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.557 ' CE ' ' HA ' ' A' ' 146' ' ' LYS . 0.3 OUTLIER -175.06 -35.28 0.01 OUTLIER 'General case' 0 C--N 1.347 0.481 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 178.836 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.44 -31.14 71.7 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.7 -169.69 3.14 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.77 105.87 8.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.179 0.445 . . . . 0.0 110.644 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.5 p -97.79 -22.91 16.14 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -103.55 108.07 19.18 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.389 1.876 . . . . 0.0 112.963 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -173.36 -179.29 1.87 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.828 1.251 . . . . 0.0 111.732 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.69 -155.96 27.44 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 124.814 1.197 . . . . 0.0 112.323 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.5 tp -151.48 135.84 16.86 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.6 1.56 . . . . 0.0 107.411 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.5 m -93.74 42.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.317 1.447 . . . . 0.0 110.292 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -64.41 147.82 51.81 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.071 -1.018 . . . . 0.0 108.684 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 26.1 mt -125.0 165.29 18.4 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.612 1.565 . . . . 0.0 110.467 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 36.7 p90 . . . . . 0 C--O 1.252 1.236 0 C-N-CA 126.159 1.784 . . . . 0.0 108.785 179.474 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.472 0.625 0 CA-C-O 119.836 -0.126 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -90.83 -161.73 0.84 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.913 1.285 . . . . 0.0 108.858 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -139.73 -75.08 0.35 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.267 1.827 . . . . 0.0 106.783 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.35 82.87 1.48 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 122.96 0.504 . . . . 0.0 111.2 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -158.35 156.51 30.66 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 125.649 1.58 . . . . 0.0 108.996 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 pttp 47.63 20.37 0.19 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 128.315 2.646 . . . . 0.0 115.753 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 pp -141.03 10.33 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.327 1.451 . . . . 0.0 112.704 -178.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.43 -18.2 28.83 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.909 1.231 . . . . 0.0 110.182 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 p -71.59 156.63 91.12 Favored Pre-proline 0 N--CA 1.445 -0.694 0 C-N-CA 124.483 1.113 . . . . 0.0 109.443 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.19 123.03 9.27 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 N-CA-C 106.965 -1.975 . . . . 0.0 106.965 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -114.75 110.39 19.64 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -90.17 156.63 18.2 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.987 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.8 -154.48 7.96 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.5 p -156.46 138.28 14.3 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.505 1.522 . . . . 0.0 110.048 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -98.28 1.04 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.0 0.92 . . . . 0.0 109.89 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -55.03 -36.45 65.53 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.036 -1.665 . . . . 0.0 111.412 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -4.71 0.24 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.7 mt -72.92 -61.56 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 CA-C-N 118.591 0.632 . . . . 0.0 109.78 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.73 29.92 1.1 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.489 1.116 . . . . 0.0 109.452 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 59.93 34.56 21.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.234 1.814 . . . . 0.0 111.45 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -99.86 107.77 19.87 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.4 t -88.71 160.38 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.473 ' HB3' HD22 ' A' ' 30' ' ' LEU . 4.7 m95 -113.78 139.57 49.01 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.419 0.554 . . . . 0.0 109.992 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.2 t -138.48 127.59 31.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.36 116.01 12.29 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 101.64 -3.467 . . . . 0.0 101.64 177.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -131.36 124.76 31.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.479 1.512 . . . . 0.0 108.003 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 t0 49.78 42.06 23.22 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 70.84 11.74 7.12 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.331 1.852 . . . . 0.0 113.863 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.5 m -133.05 138.55 46.8 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.602 1.546 . . . . 0.0 109.656 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.803 HD12 HD13 ' A' ' 87' ' ' LEU . 4.0 mt -83.19 125.47 31.58 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 120.688 -1.258 . . . . 0.0 108.703 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.06 147.06 30.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.84 139.6 39.3 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.317 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.32 74.69 80.09 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 123.778 0.831 . . . . 0.0 110.559 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.29 -73.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.65 1.566 . . . . 0.0 112.976 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.27 12.45 32.92 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -72.45 129.03 37.38 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.247 0.619 . . . . 0.0 112.209 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -46.33 79.62 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.515 1.126 . . . . 0.0 108.492 177.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.63 24.37 0.21 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -69.38 177.6 2.77 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.001 0.819 . . . . 0.0 109.644 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.5 t -163.52 135.52 3.87 Favored Pre-proline 0 C--O 1.237 0.408 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.57 151.85 82.0 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.858 1.705 . . . . 0.0 110.434 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.5 p -141.2 156.58 21.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 m -120.82 157.39 29.86 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.806 HG22 HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -132.05 105.81 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.206 1.002 . . . . 0.0 111.505 -178.101 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . . . -94.88 120.47 35.15 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.396 1.078 . . . . 0.0 111.085 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.6 tt -106.06 139.39 40.66 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 125.522 1.529 . . . . 0.0 108.754 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.9 mt -137.46 145.48 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 124.778 1.299 . . . . 0.0 108.83 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.1 p -87.37 137.53 32.26 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.7 m -57.29 112.31 1.35 Allowed 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.097 -1.002 . . . . 0.0 109.984 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -94.79 -6.55 42.67 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.433 ' CE1' ' HA ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -117.95 64.48 0.75 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.056 1.742 . . . . 0.0 106.338 179.405 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.66 ' HA ' HD23 ' A' ' 55' ' ' LEU . 4.3 m -90.95 3.35 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -178.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -50.86 -26.69 6.11 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -117.58 18.45 14.23 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.085 1.354 . . . . 0.0 110.651 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.66 HD23 ' HA ' ' A' ' 52' ' ' VAL . 3.7 mm? -114.43 171.75 7.44 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 120.205 -1.559 . . . . 0.0 108.791 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.81 165.01 16.33 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.419 ' HE2' ' HB ' ' A' ' 52' ' ' VAL . 1.9 mttm -136.43 -39.6 0.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.824 1.25 . . . . 0.0 109.683 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -73.8 -17.35 61.09 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 123.554 0.534 . . . . 0.0 111.803 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -44.99 75.78 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.418 -0.801 . . . . 0.0 109.099 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 167.64 169.33 31.04 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 127.433 2.444 . . . . 0.0 107.384 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -73.62 110.16 8.29 Favored Pre-proline 0 CA--C 1.537 0.445 0 O-C-N 120.767 -1.431 . . . . 0.0 112.388 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.68 136.38 25.54 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 CA-C-N 121.862 1.701 . . . . 0.0 109.925 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 37.7 pt -146.06 -178.14 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.965 1.706 . . . . 0.0 108.96 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -153.68 159.93 42.2 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.218 1.007 . . . . 0.0 109.969 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.806 HD22 HG22 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -140.29 154.64 46.89 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.566 1.174 . . . . 0.0 111.589 -178.808 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.81 159.01 26.85 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 124.757 1.17 . . . . 0.0 111.3 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.539 ' CD1' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -98.42 131.75 44.43 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.6 116.56 32.29 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.54 -36.27 0.24 Allowed Glycine 0 N--CA 1.447 -0.573 0 O-C-N 125.158 1.536 . . . . 0.0 111.91 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.08 24.41 0.83 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -178.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.03 70.77 0.61 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.286 1.434 . . . . 0.0 109.623 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.85 144.69 27.09 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 120.805 -1.184 . . . . 0.0 108.52 -178.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 34.0 m -145.76 166.67 25.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 117.352 -1.309 . . . . 0.0 111.7 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.6 mt -51.99 157.41 1.29 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.531 1.132 . . . . 0.0 110.352 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -170.39 148.27 3.16 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 68.0 m -109.55 121.34 44.99 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.119 1.768 . . . . 0.0 110.56 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.27 178.04 6.88 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.384 1.074 . . . . 0.0 109.57 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.406 ' HE3' ' C ' ' A' ' 81' ' ' ASP . 15.2 tttt -119.85 130.73 55.02 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 102.685 -3.08 . . . . 0.0 102.685 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.443 HG21 HG21 ' A' ' 84' ' ' THR . 27.2 m -128.73 38.66 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.603 0.761 . . . . 0.0 112.693 -177.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.87 54.78 0.12 Allowed Glycine 0 CA--C 1.503 -0.712 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.406 ' C ' ' HE3' ' A' ' 78' ' ' LYS . 23.0 t0 66.23 13.65 9.27 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.26 141.71 35.13 Favored Pre-proline 0 N--CA 1.448 -0.566 0 C-N-CA 125.61 1.564 . . . . 0.0 110.367 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.54 141.89 22.8 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.607 2.871 . . . . 0.0 113.236 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.443 HG21 HG21 ' A' ' 79' ' ' VAL . 72.8 p -150.42 176.82 10.57 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.506 0.723 . . . . 0.0 110.721 178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.468 HD11 HG23 ' A' ' 128' ' ' ILE . 7.9 mt -89.19 150.55 22.62 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.719 0.807 . . . . 0.0 110.845 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -146.01 65.81 1.21 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.935 1.694 . . . . 0.0 109.253 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.803 HD13 HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -93.43 96.28 9.81 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 126.323 1.849 . . . . 0.0 107.949 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.66 -26.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.996 -177.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -144.44 98.0 3.13 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.487 1.115 . . . . 0.0 109.112 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.52 160.81 0.11 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.256 1.423 . . . . 0.0 110.572 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -142.24 133.16 25.79 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.53 0.732 . . . . 0.0 109.631 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.441 HG23 ' SG ' ' A' ' 73' ' ' CYS . 7.7 pt -72.27 -44.05 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.688 1.995 . . . . 0.0 111.656 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.21 -26.03 62.33 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.023 0.929 . . . . 0.0 111.395 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -60.64 -52.02 66.93 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.446 HD11 ' CD2' ' A' ' 105' ' ' PHE . 80.6 mt -61.87 -35.19 77.59 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.717 2.407 . . . . 0.0 110.746 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -80.04 -20.59 44.94 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.195 -1.566 . . . . 0.0 109.769 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -87.27 -37.12 17.49 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.581 -1.324 . . . . 0.0 113.528 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -130.87 162.6 54.33 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 120.09 1.314 . . . . 0.0 109.511 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.03 -172.13 0.39 Allowed 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 122.13 1.887 . . . . 0.0 108.772 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.252 19.8 mm-40 92.09 71.97 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 129.119 2.968 . . . . 0.0 113.934 177.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.594 ' CB ' HD21 ' A' ' 55' ' ' LEU . 18.3 Cg_endo -61.99 103.54 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.783 2.989 . . . . 0.0 111.573 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.1 t -78.01 98.7 2.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -52.75 -34.82 54.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.002 -1.686 . . . . 0.0 109.665 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.8 m -69.51 11.67 0.23 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.044 1.338 . . . . 0.0 112.564 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.446 ' CD2' HD11 ' A' ' 95' ' ' LEU . 44.9 t80 -133.85 -21.89 1.89 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.858 1.663 . . . . 0.0 108.683 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.4 mt -84.86 153.33 22.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.806 -1.184 . . . . 0.0 110.374 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.555 ' CE2' HD11 ' A' ' 128' ' ' ILE . 95.0 m-85 -139.4 124.64 19.01 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.198 0.999 . . . . 0.0 110.128 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -72.21 122.42 21.02 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -75.18 141.68 43.6 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.69 178.57 8.05 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -164.62 153.0 12.43 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.83 1.252 . . . . 0.0 111.425 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.7 t -168.2 103.66 0.45 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.582 1.553 . . . . 0.0 113.226 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.47 49.3 5.24 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 126.322 1.915 . . . . 0.0 113.294 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 62.16 26.0 15.6 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -131.83 122.91 26.52 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 117.535 -1.221 . . . . 0.0 109.194 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.65 -177.86 3.37 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.969 1.258 . . . . 0.0 110.604 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.26 169.11 25.49 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 119.885 -1.759 . . . . 0.0 108.512 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -146.43 114.87 6.73 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.611 1.165 . . . . 0.0 111.293 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -108.6 126.6 53.13 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.42 1.488 . . . . 0.0 111.656 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.62 110.91 0.56 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.775 2.03 . . . . 0.0 109.995 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.6 t -60.78 -41.27 87.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 O-C-N 121.394 -0.816 . . . . 0.0 110.644 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.16 -45.34 92.28 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 119.529 -0.868 . . . . 0.0 112.264 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -128.62 86.71 56.92 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.1 156.49 65.6 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.997 1.798 . . . . 0.0 110.731 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.82 -27.12 11.46 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -95.35 140.36 30.34 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -119.07 146.34 45.16 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.575 1.55 . . . . 0.0 109.593 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.555 HD11 ' CE2' ' A' ' 107' ' ' PHE . 12.9 mm -73.74 121.3 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.294 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.15 143.09 27.26 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 118.719 -1.192 . . . . 0.0 109.91 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.4 m -94.3 -10.46 9.24 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 O-C-N 121.306 -0.871 . . . . 0.0 109.938 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.4 m 57.15 56.84 4.92 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 119.648 -1.907 . . . . 0.0 115.259 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.4 m -99.52 7.07 45.66 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -84.2 -75.03 0.36 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.49 1.116 . . . . 0.0 109.725 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -109.34 -36.51 2.1 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 118.46 60.19 0.28 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 14.0 m -84.86 167.46 26.32 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.44 149.95 87.42 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 N-CA-C 107.028 -1.951 . . . . 0.0 107.028 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.8 mt -66.72 125.11 24.79 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pp -148.42 167.39 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.404 0.682 . . . . 0.0 110.799 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 80.1 mt -81.35 159.63 24.34 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.24 127.81 11.56 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -83.28 -43.23 16.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 124.188 0.93 . . . . 0.0 110.471 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -156.08 83.11 1.0 Allowed 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.729 0.3 . . . . 0.0 111.035 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.406 HD12 ' H ' ' A' ' 146' ' ' LYS . 4.2 pp -70.32 154.68 41.63 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.921 0.867 . . . . 0.0 110.922 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -114.14 64.12 0.3 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.406 ' H ' HD12 ' A' ' 144' ' ' LEU . 0.0 OUTLIER 48.89 37.99 11.25 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.874 1.67 . . . . 0.0 110.842 -179.385 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -118.34 -4.03 10.94 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.616 0.366 . . . . 0.0 110.681 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -142.51 173.24 11.71 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 120.404 -1.435 . . . . 0.0 107.998 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.18 106.82 14.14 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.433 1.093 . . . . 0.0 108.557 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.07 -34.83 7.83 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.045 0.839 . . . . 0.0 110.633 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -96.52 100.0 11.61 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 127.991 2.516 . . . . 0.0 110.656 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -168.81 173.02 7.39 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.558 1.943 . . . . 0.0 110.277 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.32 -174.07 13.67 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 125.247 1.403 . . . . 0.0 110.425 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.49 169.85 16.92 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.169 0.509 . . . . 0.0 111.865 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 34.3 m -84.38 75.07 10.27 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.84 1.656 . . . . 0.0 109.998 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.74 153.32 35.14 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 68.6 mt -135.02 -165.24 1.64 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 129.852 3.261 . . . . 0.0 109.535 -177.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.5 p90 . . . . . 0 C--O 1.258 1.54 0 C-N-CA 125.721 1.608 . . . . 0.0 114.095 -178.603 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 119.507 -0.282 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -91.75 148.63 22.1 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -90.44 -0.19 57.55 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 -177.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 75.54 79.78 0.1 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.812 1.645 . . . . 0.0 108.563 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.6 pp -155.92 7.87 0.23 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.748 1.619 . . . . 0.0 113.397 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -153.95 13.03 0.45 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.395 1.478 . . . . 0.0 110.432 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 pt -144.48 34.62 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 129.411 3.084 . . . . 0.0 107.096 -177.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -85.0 -22.59 29.02 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.037 1.335 . . . . 0.0 110.583 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.25 165.46 38.47 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 177.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.54 146.97 45.14 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 N-CA-C 105.962 -2.361 . . . . 0.0 105.962 177.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.69 118.02 23.04 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.96 139.86 53.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -168.87 -119.18 0.48 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.8 p -150.19 177.63 9.74 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.202 1.501 . . . . 0.0 114.959 -177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.436 HG21 HD13 ' A' ' 15' ' ' ILE . 84.0 mt -141.79 -9.59 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 128.305 2.642 . . . . 0.0 108.253 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -58.7 -30.13 67.18 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 118.898 -2.376 . . . . 0.0 116.075 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.03 -12.96 9.32 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.44 1.496 . . . . 0.0 113.506 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.6 mt -54.97 -49.86 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 O-C-N 121.112 -0.993 . . . . 0.0 111.628 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -153.41 30.49 0.48 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.699 0.799 . . . . 0.0 109.244 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 64.59 8.0 4.11 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.127 1.771 . . . . 0.0 114.427 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.03 104.7 10.78 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 126.823 2.049 . . . . 0.0 107.022 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.5 t -82.45 175.1 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 178.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.407 ' CE2' HD11 ' A' ' 138' ' ' LEU . 40.4 m0 -123.07 134.23 54.27 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.788 -1.195 . . . . 0.0 108.264 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.9 t -132.51 133.46 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tp -71.88 112.5 8.03 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -130.76 127.46 38.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 120.457 1.481 . . . . 0.0 109.556 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.9 t0 43.79 56.01 4.82 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.212 1.005 . . . . 0.0 111.568 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.554 ' HB3' ' HE2' ' A' ' 88' ' ' LYS . 91.2 mt-30 57.41 22.28 7.76 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.13 139.7 32.23 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 125.242 1.417 . . . . 0.0 107.366 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.809 HD21 HD11 ' A' ' 67' ' ' LEU . 17.3 mt -79.36 131.31 36.08 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 120.66 -1.275 . . . . 0.0 107.816 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.2 mt -123.97 133.77 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.155 0.889 . . . . 0.0 110.086 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.519 ' HB3' ' HA2' ' A' ' 135' ' ' GLY . . . -75.91 142.57 42.04 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.58 75.16 79.84 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.245 1.418 . . . . 0.0 112.308 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.28 -74.85 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 121.746 1.63 . . . . 0.0 110.736 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -95.44 68.01 2.95 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.5 145.74 51.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -76.34 -62.54 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.54 0.686 . . . . 0.0 110.028 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 -74.27 40.94 0.13 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -75.52 165.71 24.69 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 120.794 -1.191 . . . . 0.0 108.503 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.52 144.22 20.38 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.46 166.37 28.7 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.588 2.192 . . . . 0.0 111.136 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 p -155.75 164.3 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.76 149.9 49.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mm -123.18 118.9 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.943 1.297 . . . . 0.0 110.526 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.6 135.53 37.15 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.772 1.629 . . . . 0.0 108.774 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.3 tt -131.76 135.6 46.92 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.992 1.317 . . . . 0.0 108.029 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.3 mt -141.53 147.11 22.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.35 1.06 . . . . 0.0 108.565 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 p -90.59 128.22 36.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.896 2.479 . . . . 0.0 106.301 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 74.2 m -62.2 144.34 55.6 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.428 0.558 . . . . 0.0 109.627 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -101.21 -34.36 9.7 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.237 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -88.95 41.55 1.03 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.707 1.203 . . . . 0.0 108.737 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -69.84 -13.13 16.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 O-C-N 121.708 -0.62 . . . . 0.0 111.095 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -51.67 -39.32 58.03 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.598 1.559 . . . . 0.0 112.523 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.8 t -89.38 -5.16 57.69 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.753 0.821 . . . . 0.0 112.697 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.3 mt -92.45 -145.52 0.22 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.92 1.288 . . . . 0.0 112.538 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -123.37 160.0 27.71 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 127.815 2.446 . . . . 0.0 109.958 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -137.42 -26.8 0.98 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.61 1.564 . . . . 0.0 111.967 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -61.86 -45.24 94.66 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.79 0.723 . . . . 0.0 110.268 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -58.33 -51.2 70.78 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.726 0.81 . . . . 0.0 108.823 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.3 -179.32 37.69 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 106.422 -2.671 . . . . 0.0 106.422 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -82.46 117.79 69.68 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.052 0.926 . . . . 0.0 109.489 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 108' ' ' TYR . 73.0 Cg_endo -71.93 138.29 31.01 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.981 3.12 . . . . 0.0 111.121 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.4 pt -140.73 -177.39 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.14 0.576 . . . . 0.0 110.215 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.5 ' CD1' HG23 ' A' ' 92' ' ' ILE . 3.7 t80 -143.21 157.95 44.05 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.976 -0.452 . . . . 0.0 110.55 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 tt -156.84 157.68 35.39 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.757 1.223 . . . . 0.0 109.446 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -164.93 -179.08 38.72 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.809 HD11 HD21 ' A' ' 30' ' ' LEU . 9.5 mt -94.68 160.1 14.77 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -131.95 88.44 2.56 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.9 -40.58 0.02 OUTLIER Glycine 0 CA--C 1.523 0.538 0 CA-C-O 118.93 -0.928 . . . . 0.0 111.463 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.57 23.46 2.3 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.82 0.848 . . . . 0.0 112.731 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.2 m120 59.9 73.07 0.5 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.999 1.72 . . . . 0.0 110.228 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.09 138.55 25.42 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.768 1.227 . . . . 0.0 110.203 -177.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 16.3 m -139.93 177.42 7.98 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.837 0.744 . . . . 0.0 109.604 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.889 ' HA ' HD12 ' A' ' 87' ' ' LEU . 26.8 mt -61.42 151.11 33.4 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.2 ttp -155.04 148.61 25.29 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 9.3 m -124.53 126.46 45.88 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.47 -178.63 4.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.916 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -132.69 118.98 19.78 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.4 m -75.25 30.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 122.966 0.507 . . . . 0.0 111.276 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.42 -3.86 61.51 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.201 -0.937 . . . . 0.0 112.087 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -127.06 -57.43 1.32 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.799 1.24 . . . . 0.0 112.071 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -145.26 164.06 28.84 Favored Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 125.59 1.556 . . . . 0.0 110.943 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.94 148.96 46.38 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.302 1.334 . . . . 0.0 113.234 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.6 p -146.06 169.83 17.89 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.575 0.75 . . . . 0.0 110.348 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.559 ' CD2' HD11 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -89.74 141.76 28.32 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.913 1.285 . . . . 0.0 109.929 179.326 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.63 HE21 ' HE3' ' A' ' 88' ' ' LYS . 7.6 mt-30 -140.27 68.28 1.36 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.709 0.766 . . . . 0.0 109.682 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.889 HD12 ' HA ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -85.0 106.57 16.6 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -178.577 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.63 ' HE3' HE21 ' A' ' 86' ' ' GLN . 0.0 OUTLIER -163.37 -43.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 O-C-N 124.887 1.367 . . . . 0.0 112.251 -179.328 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -139.97 93.11 2.61 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -167.36 172.44 9.7 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.411 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.463 ' H ' ' HD3' ' A' ' 90' ' ' LYS . 14.9 m-20 -146.17 139.31 25.82 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 125.786 1.635 . . . . 0.0 109.356 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.5 HG23 ' CD1' ' A' ' 64' ' ' TYR . 1.8 mp -87.62 -48.14 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.05 0.94 . . . . 0.0 111.057 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -60.82 -28.27 68.67 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 118.984 -0.531 . . . . 0.0 111.098 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -65.99 -51.98 53.51 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.943 0.792 . . . . 0.0 109.702 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.443 HD12 ' CE1' ' A' ' 64' ' ' TYR . 52.6 mt -63.79 -27.22 69.03 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.021 0.529 . . . . 0.0 111.332 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -82.33 -28.06 31.86 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.531 -0.731 . . . . 0.0 110.231 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -78.14 -37.21 46.61 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.894 1.278 . . . . 0.0 111.406 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -109.12 158.09 35.28 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -77.62 50.29 3.18 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.165 2.577 . . . . 0.0 111.89 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -117.05 74.5 7.18 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 124.892 1.277 . . . . 0.0 111.06 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -78.64 81.1 2.86 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.494 2.13 . . . . 0.0 107.519 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.3 t -70.27 97.95 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -51.43 -30.44 19.44 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.812 0.845 . . . . 0.0 111.76 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -64.43 -5.93 6.26 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 125.751 1.62 . . . . 0.0 112.199 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -123.49 -31.28 3.53 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.244 1.018 . . . . 0.0 109.158 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.1 mt -70.41 162.25 29.01 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.192 1.397 . . . . 0.0 112.489 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -152.2 139.68 19.61 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.152 0.981 . . . . 0.0 109.888 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER -82.98 161.59 21.72 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-N 119.858 1.208 . . . . 0.0 108.926 177.677 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -114.2 126.0 54.56 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 128.32 2.648 . . . . 0.0 112.139 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.5 t -132.35 145.88 51.57 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.29 148.57 47.32 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.185 0.994 . . . . 0.0 109.801 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.5 p -157.67 78.98 0.86 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.32 70.77 1.2 Allowed Glycine 0 N--CA 1.467 0.753 0 C-N-CA 123.958 0.79 . . . . 0.0 112.736 177.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.4 mtm-85 61.61 9.47 2.79 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.473 1.509 . . . . 0.0 112.726 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -119.72 153.4 35.69 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.2 m -139.85 151.55 45.77 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 79.6 p -114.39 174.57 5.89 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.624 0.726 . . . . 0.0 111.286 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -139.82 104.45 4.89 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.927 1.691 . . . . 0.0 106.923 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.444 ' HB2' ' CD2' ' A' ' 127' ' ' PHE . 0.3 OUTLIER -117.55 130.29 56.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.668 178.628 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.6 m -53.26 126.21 20.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.107 1.363 . . . . 0.0 112.626 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 99.2 t -71.8 -42.86 69.99 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.889 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.6 91.6 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -128.02 82.04 69.21 Favored Pre-proline 0 C--O 1.234 0.254 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.07 153.38 78.33 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 108.679 -1.316 . . . . 0.0 108.679 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.09 -12.26 44.77 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.511 1.529 . . . . 0.0 110.888 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -113.22 135.48 53.78 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.13 1.772 . . . . 0.0 108.575 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.444 ' CD2' ' HB2' ' A' ' 119' ' ' GLU . 37.7 m-85 -122.21 150.19 42.62 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.833 1.653 . . . . 0.0 108.463 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 22.3 mt -79.52 134.49 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 123.734 0.814 . . . . 0.0 110.1 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -104.34 124.92 50.05 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 91.7 t -72.9 -19.1 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 127.708 2.403 . . . . 0.0 113.214 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.4 m 54.34 65.58 1.47 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.176 1.39 . . . . 0.0 114.325 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.5 m -88.61 -9.75 51.08 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -58.17 -76.07 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.906 2.188 . . . . 0.0 116.906 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.93 16.11 5.83 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 125.447 1.499 . . . . 0.0 113.278 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.519 ' HA2' ' HB3' ' A' ' 32' ' ' ALA . . . 82.58 56.53 2.77 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -84.33 166.69 31.56 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 117.457 0.628 . . . . 0.0 110.213 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.55 151.32 32.64 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.96 1.773 . . . . 0.0 109.005 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.407 HD11 ' CE2' ' A' ' 23' ' ' TRP . 12.8 mt -76.51 115.29 16.12 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.499 1.12 . . . . 0.0 108.114 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.06 168.87 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 125.573 1.549 . . . . 0.0 110.713 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 74.4 mt -88.1 165.43 15.14 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.1 t -153.95 137.39 15.86 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -80.23 -41.05 25.87 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.417 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -161.03 102.91 1.28 Allowed 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 -178.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.635 ' H ' HD23 ' A' ' 144' ' ' LEU . 2.0 pt? -64.06 149.58 47.24 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -119.78 -4.06 11.9 Favored Glycine 0 C--N 1.318 -0.45 0 CA-C-O 118.534 -1.148 . . . . 0.0 111.845 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.32 -140.57 0.21 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.155 1.382 . . . . 0.0 108.606 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -107.4 37.71 2.33 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.226 1.81 . . . . 0.0 109.771 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -55.13 -12.77 0.99 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.649 1.58 . . . . 0.0 114.16 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.31 88.99 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 129.724 3.21 . . . . 0.0 113.298 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.5 p -111.76 -2.72 15.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.151 -0.968 . . . . 0.0 111.984 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -139.17 109.8 6.64 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.44 -176.99 6.21 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.199 1.8 . . . . 0.0 111.879 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.62 -173.7 25.84 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.537 1.541 . . . . 0.0 110.777 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.41 HD11 HD11 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -132.66 146.61 52.02 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.621 1.169 . . . . 0.0 109.392 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.0 m -102.8 45.83 0.95 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.331 1.453 . . . . 0.0 107.159 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -67.68 154.18 42.07 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.495 1.118 . . . . 0.0 109.238 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.2 mt -129.11 172.3 11.55 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.006 1.322 . . . . 0.0 109.591 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.8 p90 . . . . . 0 C--O 1.248 0.996 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 179.403 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 ptm . . . . . 0 N--CA 1.469 0.516 0 CA-C-O 123.247 1.498 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -82.17 177.13 8.97 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 127.475 2.31 . . . . 0.0 108.739 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -98.74 -64.23 1.05 Allowed 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -170.45 111.17 0.4 Allowed 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -152.78 168.51 25.47 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 126.631 1.972 . . . . 0.0 107.524 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -113.29 -23.55 9.85 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.029 0.932 . . . . 0.0 113.213 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pt -68.29 -25.55 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 117.832 -1.08 . . . . 0.0 112.03 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -55.84 -45.86 78.31 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.829 0.74 . . . . 0.0 109.397 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.37 130.1 94.02 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 118.262 0.483 . . . . 0.0 110.879 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.1 136.05 42.87 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.084 2.523 . . . . 0.0 109.576 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.79 111.11 20.73 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -109.93 145.14 37.39 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.31 -140.17 3.19 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 119.459 1.027 . . . . 0.0 112.54 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.2 p -136.68 -175.95 4.19 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.604 1.702 . . . . 0.0 113.311 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.6 mt -144.31 -6.19 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 126.696 1.999 . . . . 0.0 109.438 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.413 ' C ' ' H ' ' A' ' 18' ' ' ILE . 4.8 pt20 -73.52 -24.32 60.13 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 119.467 -2.02 . . . . 0.0 114.43 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -72.17 36.91 0.07 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.208 3.003 . . . . 0.0 110.732 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.413 ' H ' ' C ' ' A' ' 16' ' ' GLN . 45.4 mt -122.14 -71.14 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 128.674 2.79 . . . . 0.0 109.504 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -126.57 25.35 6.49 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 122.548 0.339 . . . . 0.0 111.383 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.0 t60 64.83 35.82 8.31 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.623 0.725 . . . . 0.0 109.414 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.3 mmt-85 -104.16 81.65 1.86 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 120.838 -1.163 . . . . 0.0 109.809 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.65 134.12 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.566 ' CD2' HD11 ' A' ' 138' ' ' LEU . 45.8 m0 -89.95 144.66 25.73 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.8 t -144.21 131.52 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.6 tp -71.14 115.01 9.79 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -132.27 123.92 27.86 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.922 1.289 . . . . 0.0 107.731 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.3 t70 46.85 50.4 13.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.728 1.211 . . . . 0.0 112.475 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 65.86 15.76 10.19 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.2 m -137.39 152.11 49.29 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.592 HD11 HD11 ' A' ' 67' ' ' LEU . 31.4 mt -91.07 129.31 37.08 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 119.815 -1.803 . . . . 0.0 107.481 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.2 mm -127.73 138.16 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.407 0.683 . . . . 0.0 110.409 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.18 127.98 33.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.526 1.131 . . . . 0.0 108.73 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -111.26 99.12 42.47 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 124.601 1.16 . . . . 0.0 108.036 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.25 -32.16 8.59 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.287 1.991 . . . . 0.0 112.726 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -92.9 161.99 14.26 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.864 1.266 . . . . 0.0 109.816 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.04 19.44 12.84 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.542 1.137 . . . . 0.0 110.095 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -53.55 -50.82 64.71 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.282 1.401 . . . . 0.0 108.861 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.07 81.79 0.78 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 12.6 ptp -108.8 169.19 8.82 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.9 t -148.28 130.82 7.79 Favored Pre-proline 0 N--CA 1.45 -0.441 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -64.9 148.85 90.06 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.788 1.658 . . . . 0.0 107.86 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.5 m -142.03 171.5 10.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 125.591 1.556 . . . . 0.0 107.365 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.37 157.59 46.51 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mm -118.21 144.0 27.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 127.984 2.513 . . . . 0.0 105.271 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.02 129.92 52.85 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 126.597 1.959 . . . . 0.0 105.793 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.42 132.1 48.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.96 1.255 . . . . 0.0 107.699 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.5 mt -144.93 149.41 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.6 p -81.82 166.03 20.34 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.7 t -88.77 158.43 18.16 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -117.2 -3.8 11.47 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 177.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -119.05 57.36 0.88 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.417 ' HA ' HD12 ' A' ' 55' ' ' LEU . 24.0 m -83.87 -11.97 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.96 0.904 . . . . 0.0 110.837 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -64.72 -6.53 8.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.56 1.944 . . . . 0.0 112.484 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.7 t -121.8 7.89 9.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.157 1.383 . . . . 0.0 110.196 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 52' ' ' VAL . 96.0 mt -108.24 173.05 6.49 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 120.585 -1.322 . . . . 0.0 112.006 -178.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -79.77 154.92 28.17 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -126.44 -40.59 1.94 Allowed 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 116.938 -1.506 . . . . 0.0 110.846 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.28 -38.7 28.08 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.115 1.766 . . . . 0.0 114.177 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -65.63 -33.19 75.33 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 119.602 -0.237 . . . . 0.0 111.349 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.633 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 142.21 -178.14 21.03 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 126.381 1.943 . . . . 0.0 110.584 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -78.2 113.71 36.03 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -81.91 148.22 15.38 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 124.432 3.421 . . . . 0.0 111.592 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -149.84 -171.78 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 126.673 1.989 . . . . 0.0 109.067 178.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.456 ' CZ ' HD13 ' A' ' 95' ' ' LEU . 8.2 m-85 -132.86 147.11 52.3 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.928 2.091 . . . . 0.0 112.762 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.404 HD22 HD11 ' A' ' 74' ' ' LEU . 5.1 tt -156.73 134.15 10.69 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 120.474 -1.391 . . . . 0.0 109.645 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -142.02 -167.77 11.43 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.592 HD11 HD11 ' A' ' 30' ' ' LEU . 2.5 mt -100.7 159.52 15.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -120.89 87.56 2.78 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.61 -38.33 0.03 OUTLIER Glycine 0 C--N 1.336 0.544 0 CA-C-O 117.927 -1.485 . . . . 0.0 116.082 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.78 17.2 2.68 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.852 1.826 . . . . 0.0 111.896 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.15 69.15 0.39 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.62 146.37 29.33 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 124.784 1.233 . . . . 0.0 108.684 -177.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.401 ' SG ' HG13 ' A' ' 92' ' ' ILE . 4.4 m -145.24 -175.37 4.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.324 1.05 . . . . 0.0 112.232 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.886 ' HA ' HD12 ' A' ' 87' ' ' LEU . 45.4 mt -66.64 160.5 25.34 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.2 ttp -161.69 127.56 3.66 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.3 m -96.51 119.67 35.42 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 118.314 0.506 . . . . 0.0 110.472 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -123.39 175.85 6.49 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -137.25 120.05 16.3 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.9 m -74.18 13.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.17 -23.95 34.25 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -115.32 -39.15 3.65 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -149.64 158.45 37.63 Favored Pre-proline 0 C--O 1.24 0.575 0 C-N-CA 123.785 0.834 . . . . 0.0 111.052 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -71.01 145.31 49.63 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.219 2.613 . . . . 0.0 110.194 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 42.4 p -146.55 156.92 43.6 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.458 0.703 . . . . 0.0 110.075 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.452 ' HB3' HD11 ' A' ' 87' ' ' LEU . 7.9 mt -83.11 149.11 27.09 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -145.44 67.23 1.22 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.451 1.5 . . . . 0.0 109.437 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.886 HD12 ' HA ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -83.12 112.09 19.5 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 127.63 2.372 . . . . 0.0 108.032 -177.715 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.47 -29.28 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 O-C-N 125.21 1.569 . . . . 0.0 113.358 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -146.25 90.07 1.92 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 120.321 1.418 . . . . 0.0 113.21 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -166.9 160.1 14.07 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.564 1.546 . . . . 0.0 107.071 179.417 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.43 146.68 40.42 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.958 1.703 . . . . 0.0 107.688 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.464 ' HA ' HD12 ' A' ' 95' ' ' LEU . 3.0 mt -96.85 -40.28 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.737 0.815 . . . . 0.0 110.707 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -27.29 68.73 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.399 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.08 -48.28 80.89 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.836 0.827 . . . . 0.0 110.707 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 92' ' ' ILE . 13.1 mt -62.71 -27.99 69.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 127.598 2.359 . . . . 0.0 110.368 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -87.32 -20.25 27.05 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -88.27 -25.22 22.94 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 119.339 0.972 . . . . 0.0 112.678 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -137.75 157.43 73.48 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.807 1.243 . . . . 0.0 111.068 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.2 67.64 5.15 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 124.018 3.145 . . . . 0.0 114.124 -178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -118.07 73.27 9.59 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.12 0.968 . . . . 0.0 111.461 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -80.95 77.42 4.06 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.294 2.663 . . . . 0.0 108.504 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.2 t -68.62 103.17 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 126.174 1.789 . . . . 0.0 108.849 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.409 ' HA ' HD12 ' A' ' 106' ' ' LEU . 44.4 mtpt -56.3 -31.62 63.83 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.041 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.0 -9.05 42.53 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.648 1.113 . . . . 0.0 112.284 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -120.82 -18.54 7.61 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.225 0.921 . . . . 0.0 109.169 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 103' ' ' LYS . 66.6 mt -74.69 149.58 39.84 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 119.774 -1.829 . . . . 0.0 109.724 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -139.7 129.27 24.37 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.988 0.515 . . . . 0.0 110.549 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.633 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -74.68 126.8 31.64 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 177.766 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -95.49 117.08 29.74 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.023 0.529 . . . . 0.0 111.265 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.1 t -112.33 -176.81 3.01 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 2.1 pt20 -150.93 147.7 27.51 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.177 2.191 . . . . 0.0 110.025 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.1 p -164.63 87.66 0.47 Allowed 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.993 1.433 . . . . 0.0 113.874 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.04 70.46 1.3 Allowed Glycine 0 CA--C 1.504 -0.64 0 C-N-CA 124.899 1.238 . . . . 0.0 112.251 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.8 mtm-85 64.22 -2.32 0.61 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.686 1.995 . . . . 0.0 113.075 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -111.74 165.89 11.65 Favored 'General case' 0 CA--C 1.513 -0.442 0 C-N-CA 124.885 1.274 . . . . 0.0 110.951 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 45.6 m -132.69 162.91 30.18 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.695 1.598 . . . . 0.0 110.471 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.87 170.07 16.43 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.106 0.962 . . . . 0.0 110.222 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -139.67 109.5 6.35 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.443 1.497 . . . . 0.0 108.993 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -100.78 130.02 46.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.491 1.916 . . . . 0.0 110.134 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.4 t -58.1 126.07 25.87 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.548 0.613 . . . . 0.0 109.541 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.34 -47.99 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 O-C-N 120.938 -1.101 . . . . 0.0 110.129 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.42 -37.62 65.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.254 0.479 . . . . 0.0 110.804 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -138.19 91.0 13.18 Favored Pre-proline 0 C--O 1.234 0.269 0 C-N-CA 123.502 0.721 . . . . 0.0 109.137 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.25 174.53 8.94 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.606 2.204 . . . . 0.0 112.264 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.39 -13.76 44.26 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 126.262 1.886 . . . . 0.0 111.341 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -110.2 117.69 34.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.177 0.991 . . . . 0.0 109.553 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -99.27 132.84 44.31 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 127.521 2.328 . . . . 0.0 109.326 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 pt -71.95 120.76 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 121.762 -0.586 . . . . 0.0 109.634 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.27 166.74 16.25 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 118.181 -1.408 . . . . 0.0 111.274 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.5 m -107.28 -16.29 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 C-N-CA 125.099 1.36 . . . . 0.0 112.976 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.1 m 72.63 64.98 0.12 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 122.804 1.288 . . . . 0.0 110.728 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.08 33.09 4.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.532 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -117.05 -47.69 2.67 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.725 0.41 . . . . 0.0 111.749 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -140.46 -60.21 0.04 OUTLIER Glycine 0 C--N 1.333 0.384 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.41 51.94 0.01 OUTLIER Glycine 0 C--N 1.332 0.308 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' CYS . . . . . 0.524 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 55.9 m -88.18 177.43 2.65 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.921 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 136' ' ' CYS . 42.0 Cg_endo -81.39 169.66 15.43 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.009 2.473 . . . . 0.0 111.025 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 23' ' ' TRP . 30.3 mt -86.91 112.76 22.09 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 124.159 0.983 . . . . 0.0 110.702 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.25 -175.08 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.034 0.934 . . . . 0.0 110.15 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.09 137.03 45.94 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 15.4 t -131.19 154.36 48.48 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.562 1.545 . . . . 0.0 108.753 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -94.93 -23.36 17.45 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.373 1.469 . . . . 0.0 108.903 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -131.11 95.0 3.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 123.374 1.559 . . . . 0.0 108.4 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.47 179.03 7.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.841 -1.527 . . . . 0.0 111.125 178.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 61.84 5.37 7.14 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 123.936 0.779 . . . . 0.0 111.758 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.778 ' HE3' ' HA ' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -97.39 -92.1 0.24 Allowed 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 126.436 1.895 . . . . 0.0 108.75 -178.344 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -90.3 -16.11 29.9 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 117.306 -1.331 . . . . 0.0 109.589 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -158.11 145.91 18.44 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-N 119.95 1.25 . . . . 0.0 109.293 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.533 HG21 ' CE2' ' A' ' 152' ' ' PHE . 3.5 m -82.69 137.34 34.47 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.523 1.929 . . . . 0.0 109.382 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 65.3 p -117.68 -23.65 7.54 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.064 1.302 . . . . 0.0 108.046 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -95.8 110.0 22.23 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.953 1.301 . . . . 0.0 113.654 -177.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.533 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.6 OUTLIER -166.52 -175.14 3.08 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.235 1.814 . . . . 0.0 108.78 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -108.85 -178.04 21.61 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.91 131.57 53.41 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 123.739 0.816 . . . . 0.0 109.558 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.5 m -79.0 31.85 0.21 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.384 1.474 . . . . 0.0 108.31 177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.9 ptt? -63.03 130.14 43.41 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.261 1.824 . . . . 0.0 107.928 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 21.5 mt -100.51 175.83 5.55 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 126.181 1.792 . . . . 0.0 108.753 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 23.9 p90 . . . . . 0 C--O 1.261 1.7 0 CA-C-O 115.615 -2.136 . . . . 0.0 108.924 -179.405 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -68.06 159.58 30.56 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.055 0.455 . . . . 0.0 111.286 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -85.12 -91.43 0.09 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.33 91.8 2.3 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.839 1.256 . . . . 0.0 110.384 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.96 166.78 31.91 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.984 2.114 . . . . 0.0 108.149 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.6 pttt 45.88 24.6 0.24 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 129.076 2.951 . . . . 0.0 115.04 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 pp -139.1 -43.13 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.618 1.167 . . . . 0.0 111.1 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -87.33 120.44 28.62 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.17 162.23 25.42 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 125.362 1.465 . . . . 0.0 109.318 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.35 152.61 20.77 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.67 2.247 . . . . 0.0 108.328 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.12 124.44 27.53 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 178.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.92 133.81 55.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.82 -131.08 1.29 Allowed Glycine 0 CA--C 1.522 0.478 0 CA-C-O 116.825 -2.097 . . . . 0.0 110.259 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.7 p -154.97 -173.04 4.41 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 122.604 3.202 . . . . 0.0 114.715 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mt -136.36 -2.93 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.763 1.225 . . . . 0.0 108.712 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.508 ' CB ' HG22 ' A' ' 22' ' ' VAL . 4.7 pt20 -56.39 -40.86 75.33 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.099 -1.626 . . . . 0.0 112.114 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -19.98 2.36 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.712 2.005 . . . . 0.0 115.393 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.6 mm -64.91 -58.68 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 123.584 0.753 . . . . 0.0 112.324 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -138.99 24.04 2.58 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.439 0.638 . . . . 0.0 110.816 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.3 t60 62.98 40.18 9.53 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.08 1.752 . . . . 0.0 108.39 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.4 mmt-85 -109.23 85.53 2.12 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.829 -1.169 . . . . 0.0 109.46 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.508 HG22 ' CB ' ' A' ' 16' ' ' GLN . 90.9 t -78.0 154.63 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.514 ' CD2' HD11 ' A' ' 138' ' ' LEU . 54.1 m0 -105.63 144.81 31.86 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.9 t -141.27 133.4 29.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.448 HD13 ' CD2' ' A' ' 72' ' ' LEU . 4.0 tt -74.56 122.61 23.38 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -131.14 119.34 21.77 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 47.0 t0 32.49 67.17 0.17 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.034 1.734 . . . . 0.0 113.876 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 60.5 17.73 7.59 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.5 m -137.97 126.57 23.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.341 1.456 . . . . 0.0 109.813 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.537 HD12 ' HG ' ' A' ' 87' ' ' LEU . 11.8 mt -77.5 136.2 38.31 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.5 pp -127.05 145.73 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 123.574 0.749 . . . . 0.0 111.861 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.28 127.79 34.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 m -103.69 89.37 2.22 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.65 -55.1 0.3 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.34 1.36 . . . . 0.0 112.731 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -154.73 95.27 1.75 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.484 0.714 . . . . 0.0 111.993 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.43 160.84 39.97 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -69.12 -34.61 75.32 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.846 0.859 . . . . 0.0 112.281 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -82.35 58.64 4.18 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.41 0.684 . . . . 0.0 110.677 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -90.02 157.92 17.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 177.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.1 m -157.98 109.84 1.75 Allowed Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 125.89 1.676 . . . . 0.0 106.517 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.99 148.2 69.5 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 N-CA-C 107.907 -1.613 . . . . 0.0 107.907 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.07 157.58 28.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.05 156.38 19.32 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.3 mm -122.62 113.22 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 128.441 2.696 . . . . 0.0 106.288 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.71 138.56 32.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 65' ' ' LEU . 5.4 tt -137.36 130.25 30.39 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.649 1.18 . . . . 0.0 108.671 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -141.09 134.74 31.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.724 1.209 . . . . 0.0 107.975 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.4 p -66.47 158.61 29.07 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.85 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.4 m -68.79 136.99 53.62 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.214 -0.929 . . . . 0.0 112.369 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -89.28 -30.34 18.54 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 117.234 -1.365 . . . . 0.0 112.865 178.483 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -122.35 69.98 0.97 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 119.721 1.146 . . . . 0.0 110.809 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.0 m -78.98 -10.76 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 123.043 0.537 . . . . 0.0 110.986 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -55.07 -32.46 61.95 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.54 1.936 . . . . 0.0 114.247 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 t -104.58 9.03 35.5 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.973 0.909 . . . . 0.0 110.463 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.9 mt -111.16 168.24 9.66 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.612 1.165 . . . . 0.0 110.25 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -83.1 159.54 22.08 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.633 1.973 . . . . 0.0 108.165 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.4 -24.85 1.77 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.133 1.373 . . . . 0.0 110.872 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.86 -26.76 59.31 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.073 2.149 . . . . 0.0 112.808 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -96.08 -1.2 49.19 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 125.119 1.368 . . . . 0.0 114.17 -178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.07 161.13 11.03 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -79.12 123.29 84.91 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 121.524 -0.986 . . . . 0.0 109.138 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 108' ' ' TYR . 83.4 Cg_endo -74.85 151.68 40.64 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.196 2.597 . . . . 0.0 111.228 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.459 HD11 ' CE1' ' A' ' 118' ' ' PHE . 1.4 pt -146.34 -175.17 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 126.513 1.925 . . . . 0.0 109.706 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -127.29 143.18 51.28 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 129.094 2.957 . . . . 0.0 109.919 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 46' ' ' LEU . 8.5 tt -154.83 148.94 25.88 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.434 -1.416 . . . . 0.0 109.221 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.403 ' HA3' ' SG ' ' A' ' 73' ' ' CYS . . . -162.44 -169.0 25.2 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 120.867 -1.146 . . . . 0.0 112.458 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.444 HD11 HD21 ' A' ' 30' ' ' LEU . 14.2 mt -105.51 149.93 25.79 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.92 101.7 8.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.6 -31.45 0.08 OUTLIER Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.462 -1.188 . . . . 0.0 114.006 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.25 20.84 0.75 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.736 1.768 . . . . 0.0 112.936 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.0 m120 65.89 66.64 0.49 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.448 ' CD2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.79 132.35 20.94 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.232 1.013 . . . . 0.0 111.127 -178.051 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.403 ' SG ' ' HA3' ' A' ' 66' ' ' GLY . 17.1 m -142.76 174.63 10.48 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 123.735 0.814 . . . . 0.0 110.283 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.82 ' HA ' HD12 ' A' ' 87' ' ' LEU . 45.2 mt -55.14 157.91 3.21 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 125.826 1.651 . . . . 0.0 113.644 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -166.21 150.98 8.06 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 117.519 -1.229 . . . . 0.0 108.73 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.2 m -123.05 112.11 17.37 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.559 1.144 . . . . 0.0 111.139 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.17 143.54 50.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.67 1.123 . . . . 0.0 108.246 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -92.86 123.29 36.02 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.344 1.458 . . . . 0.0 109.702 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.91 -4.43 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.97 16.92 10.05 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -151.17 -61.05 0.18 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.283 1.833 . . . . 0.0 107.959 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -141.35 161.45 52.76 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.26 1.424 . . . . 0.0 112.03 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.09 152.53 45.77 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.456 2.77 . . . . 0.0 110.333 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.6 p -146.27 161.94 39.18 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.263 1.825 . . . . 0.0 109.362 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.83 HD22 HD11 ' A' ' 87' ' ' LEU . 4.5 mt -78.9 140.0 38.19 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.784 1.634 . . . . 0.0 110.795 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.35 67.19 1.46 Allowed 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.059 0.845 . . . . 0.0 110.811 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.83 HD11 HD22 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -92.06 118.6 30.96 Favored 'General case' 0 CA--C 1.493 -1.216 0 C-N-CA 125.183 1.393 . . . . 0.0 109.412 -178.219 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -179.42 -29.34 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 O-C-N 125.013 1.445 . . . . 0.0 113.618 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -146.04 102.25 3.61 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.401 1.48 . . . . 0.0 107.442 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.05 161.65 0.59 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 119.003 0.82 . . . . 0.0 109.041 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.69 153.0 52.19 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.71 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.98 -38.9 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.786 1.234 . . . . 0.0 108.989 178.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.6 tpt -64.6 -33.09 75.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.867 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.07 -40.55 87.07 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.507 1.049 . . . . 0.0 110.647 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.4 mt -65.21 -31.88 73.28 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.416 ' CZ ' ' HG3' ' A' ' 50' ' ' ARG . 36.3 t80 -78.58 -29.41 46.15 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.085 0.954 . . . . 0.0 110.175 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -78.09 -32.73 50.8 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.656 -1.277 . . . . 0.0 113.417 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -126.21 168.66 13.54 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 119.053 0.842 . . . . 0.0 112.017 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -80.34 68.0 8.45 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.319 2.68 . . . . 0.0 109.904 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -121.55 72.8 30.01 Favored Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 121.695 -0.628 . . . . 0.0 110.426 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.24 65.13 8.89 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.853 3.035 . . . . 0.0 108.433 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.4 t -70.98 97.66 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.076 0 C-N-CA 125.142 1.377 . . . . 0.0 107.81 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -48.18 -30.43 4.64 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.202 1.401 . . . . 0.0 112.33 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 t -63.54 -14.93 56.02 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.59 1.556 . . . . 0.0 113.445 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -126.6 -4.08 6.58 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.951 1.7 . . . . 0.0 111.122 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.4 mt -95.18 151.62 19.06 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.363 1.465 . . . . 0.0 110.025 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -139.21 133.02 30.78 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 19.5 m-85 -77.94 137.09 38.14 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.652 1.115 . . . . 0.0 108.016 177.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.78 162.47 25.1 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.5 t -161.29 178.06 9.57 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 126.168 1.787 . . . . 0.0 106.346 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 2.0 pp0? -156.47 158.53 37.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.272 1.429 . . . . 0.0 109.431 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.3 p -120.28 2.62 10.85 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.63 -50.13 0.9 Allowed Glycine 0 C--N 1.336 0.531 0 O-C-N 120.532 -1.355 . . . . 0.0 110.544 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.11 -1.81 2.36 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.673 0.789 . . . . 0.0 111.633 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -130.4 168.97 16.11 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.793 1.237 . . . . 0.0 109.115 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 2.6 m -130.16 148.13 51.97 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.552 1.141 . . . . 0.0 111.873 -178.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.79 173.01 7.74 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 127.093 2.157 . . . . 0.0 111.783 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.459 ' CE1' HD11 ' A' ' 63' ' ' ILE . 31.6 m-85 -146.01 128.84 16.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 125' ' ' GLY . 9.4 tt0 -113.52 142.27 46.14 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 126.0 1.72 . . . . 0.0 107.107 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 50.0 m -70.4 124.11 23.38 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.189 2.196 . . . . 0.0 110.985 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.7 t -69.72 -43.87 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 120.812 1.642 . . . . 0.0 112.315 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.19 -24.48 66.64 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -138.76 77.5 32.77 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 126.08 1.752 . . . . 0.0 107.207 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.51 166.21 22.58 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.787 2.325 . . . . 0.0 112.369 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.407 ' H ' ' CD ' ' A' ' 119' ' ' GLU . . . 85.86 -13.7 55.43 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.867 1.222 . . . . 0.0 111.775 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -106.48 119.91 40.53 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.286 1.834 . . . . 0.0 109.802 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -103.04 148.26 25.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.774 0.83 . . . . 0.0 110.243 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.514 HG22 HD11 ' A' ' 85' ' ' LEU . 3.4 pt -78.38 139.4 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.921 0.391 . . . . 0.0 110.891 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.94 151.75 20.98 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.404 HG13 ' HZ2' ' A' ' 23' ' ' TRP . 45.0 t -106.06 -17.01 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 127.34 2.256 . . . . 0.0 111.047 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.2 m 55.34 82.42 0.1 Allowed 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 126.438 1.895 . . . . 0.0 112.695 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.2 m -111.1 -9.75 14.36 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -54.63 -61.13 2.51 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.639 1.575 . . . . 0.0 111.352 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -139.21 -85.55 0.12 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -165.98 60.82 0.23 Allowed Glycine 0 C--N 1.333 0.378 0 O-C-N 120.694 -1.474 . . . . 0.0 110.201 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.1 m -91.37 163.6 28.08 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.73 161.71 45.1 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.595 1.53 . . . . 0.0 109.779 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.514 HD11 ' CD2' ' A' ' 23' ' ' TRP . 20.4 mt -87.5 113.03 22.83 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.21 167.18 23.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.628 1.571 . . . . 0.0 109.391 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 80.7 mt -83.91 156.15 22.52 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.79 156.13 47.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -99.24 -46.75 5.43 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -159.74 142.33 13.67 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -150.18 177.81 9.57 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 129.486 3.114 . . . . 0.0 108.553 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -162.48 -32.48 0.02 OUTLIER Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.863 1.697 . . . . 0.0 109.79 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.3 5.9 1.1 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -91.47 -22.72 20.27 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.445 1.475 . . . . 0.0 114.024 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -160.75 -161.13 0.81 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.582 HG21 ' CE2' ' A' ' 152' ' ' PHE . 0.2 OUTLIER -142.7 113.15 7.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 -178.946 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -99.48 -28.99 12.99 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.074 1.75 . . . . 0.0 110.241 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -112.41 123.93 51.36 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 123.657 0.783 . . . . 0.0 109.721 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.582 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.1 OUTLIER -158.82 -170.34 3.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.002 178.38 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.42 176.8 38.79 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.22 111.97 6.46 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 24.3 m -77.16 46.77 0.51 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -73.95 120.38 19.46 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.6 mt -99.07 156.57 16.87 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 123.795 0.838 . . . . 0.0 109.626 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.7 p90 . . . . . 0 C--O 1.246 0.882 0 C-N-CA 125.111 1.364 . . . . 0.0 108.554 179.772 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 119.671 -0.204 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.2 138.53 61.79 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 121.476 1.451 . . . . 0.0 110.229 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.61 109.83 18.32 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.55 133.93 52.85 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.308 1.043 . . . . 0.0 109.969 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.03 -124.38 0.71 Allowed Glycine 0 CA--C 1.523 0.543 0 CA-C-O 117.458 -1.746 . . . . 0.0 109.891 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.2 p -157.96 -165.11 1.66 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 121.517 2.658 . . . . 0.0 113.604 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.9 mt -145.18 -13.8 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.056 1.342 . . . . 0.0 108.277 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.406 ' HG3' HG22 ' A' ' 22' ' ' VAL . 2.1 tm0? -55.17 -31.88 61.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 118.067 -0.968 . . . . 0.0 112.11 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.39 -19.12 3.12 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.584 1.554 . . . . 0.0 112.893 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.4 mt -64.06 -52.5 55.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.174 1.39 . . . . 0.0 113.47 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -148.41 31.54 0.82 Allowed 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 117.931 0.332 . . . . 0.0 110.189 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.0 m80 59.97 25.36 14.54 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.071 0.949 . . . . 0.0 112.054 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.45 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 7.0 mmt-85 -86.71 98.53 11.19 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.382 -1.449 . . . . 0.0 108.178 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.406 HG22 ' HG3' ' A' ' 16' ' ' GLN . 72.6 t -76.58 145.05 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -105.2 132.43 51.43 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.327 1.451 . . . . 0.0 109.134 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.7 t -137.05 129.69 44.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 119.168 0.895 . . . . 0.0 108.863 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.666 HD13 ' CD2' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -74.5 112.97 11.21 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 101.161 -3.644 . . . . 0.0 101.161 176.147 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -129.55 120.99 26.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.705 2.002 . . . . 0.0 108.153 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.5 t0 45.31 58.23 4.29 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.305 1.442 . . . . 0.0 110.945 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 57.15 20.11 5.35 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.637 1.975 . . . . 0.0 114.913 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.3 m -134.23 143.32 47.75 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.588 0.755 . . . . 0.0 109.329 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.643 HD12 HD13 ' A' ' 87' ' ' LEU . 19.2 mt -90.71 124.68 35.29 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.76 136.78 56.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.685 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.45 136.21 39.41 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -124.32 68.65 49.48 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.34 -6.24 14.47 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.828 2.352 . . . . 0.0 116.304 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.67 78.41 0.7 Allowed 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.597 1.159 . . . . 0.0 109.227 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -151.36 137.29 18.14 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 121.125 -0.984 . . . . 0.0 110.42 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -68.27 -34.6 76.46 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.816 0.846 . . . . 0.0 108.735 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.68 30.3 0.65 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.166 0.987 . . . . 0.0 112.793 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.7 ptp -73.33 167.2 21.72 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.7 t -153.22 121.58 3.12 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.12 151.21 49.24 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 N-CA-C 108.632 -1.334 . . . . 0.0 108.632 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.95 -174.35 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.19 154.87 50.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mm -126.72 111.44 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 C-N-CA 126.901 2.08 . . . . 0.0 108.384 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.74 130.47 41.25 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.509 1.924 . . . . 0.0 107.64 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -126.09 131.62 52.08 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.304 1.842 . . . . 0.0 108.894 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -149.36 145.86 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 124.838 1.255 . . . . 0.0 110.664 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.79 156.38 38.97 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 125.79 1.636 . . . . 0.0 109.001 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.477 ' O ' HG13 ' A' ' 52' ' ' VAL . 85.4 m -92.78 106.47 18.44 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -67.99 -14.89 63.32 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -98.93 29.88 3.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.988 0.813 . . . . 0.0 111.21 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.604 ' HA ' HD23 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -62.4 -7.41 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 126.228 1.811 . . . . 0.0 113.251 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -55.75 -35.63 66.41 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.072 0.949 . . . . 0.0 112.614 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -98.56 0.52 45.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.774 1.23 . . . . 0.0 112.491 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.642 HD21 ' HB2' ' A' ' 101' ' ' PRO . 3.7 mm? -91.0 171.39 9.3 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 123.077 1.418 . . . . 0.0 109.616 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -74.85 157.01 35.83 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.421 -1.718 . . . . 0.0 107.453 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -129.29 -40.32 1.46 Allowed 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.703 -0.665 . . . . 0.0 109.956 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -50.63 -54.3 23.92 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.262 1.425 . . . . 0.0 113.313 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -60.39 -31.23 70.16 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.975 0.91 . . . . 0.0 112.293 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.24 169.45 11.75 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 125.886 1.708 . . . . 0.0 109.828 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -69.76 112.07 11.06 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 127.284 2.234 . . . . 0.0 115.763 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -80.98 131.78 8.12 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.714 2.943 . . . . 0.0 110.302 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 pp -137.82 178.44 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.669 ' CD1' HG22 ' A' ' 92' ' ' ILE . 5.0 t80 -134.92 153.77 51.94 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.712 1.142 . . . . 0.0 112.15 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.5 tt -145.68 157.03 44.0 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.284 1.434 . . . . 0.0 110.039 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.4 176.01 35.42 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.552 HD11 HD11 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -94.51 140.86 29.29 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 178.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -107.51 118.91 37.96 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 159.67 -75.67 0.2 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.02 19.59 14.86 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 60.94 72.41 0.52 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.952 1.251 . . . . 0.0 109.626 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.666 ' CD2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -146.59 136.01 22.89 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.034 0.934 . . . . 0.0 110.381 -177.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.632 ' SG ' HG23 ' A' ' 92' ' ' ILE . 17.7 m -144.97 169.67 17.63 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.184 -0.947 . . . . 0.0 110.534 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.427 HD23 HD21 ' A' ' 87' ' ' LEU . 13.5 mt -53.37 148.32 9.1 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.086 0.469 . . . . 0.0 110.39 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.0 ttp -160.71 120.99 2.81 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 93.4 m -82.12 138.15 34.83 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.2 -177.56 4.76 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.202 2.201 . . . . 0.0 106.845 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -143.8 140.5 29.92 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.9 m -90.15 26.64 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.45 5.9 56.59 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.259 0.933 . . . . 0.0 111.648 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -131.48 -57.03 1.01 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.976 1.71 . . . . 0.0 110.624 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -145.14 157.18 54.05 Favored Pre-proline 0 C--O 1.239 0.552 0 C-N-CA 124.416 1.086 . . . . 0.0 110.421 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.06 149.66 88.93 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.897 3.065 . . . . 0.0 113.639 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.1 p -148.61 168.35 23.04 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.908 1.683 . . . . 0.0 110.708 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mt -97.24 149.24 22.26 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.461 1.104 . . . . 0.0 108.856 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -143.83 78.1 1.58 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.643 HD13 HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -89.43 94.1 9.76 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.69 -48.7 0.19 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.047 0.84 . . . . 0.0 112.6 -177.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -135.28 105.67 6.38 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.713 1.605 . . . . 0.0 107.486 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.06 154.87 0.91 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -127.66 139.98 52.38 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.669 HG22 ' CD1' ' A' ' 64' ' ' TYR . 4.0 pt -94.83 -41.51 12.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.835 1.654 . . . . 0.0 111.773 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.0 tpt -66.52 -23.14 66.19 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.757 0.708 . . . . 0.0 110.109 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.32 -52.48 18.53 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.525 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.523 HD12 ' CE1' ' A' ' 64' ' ' TYR . 18.1 mt -60.61 -26.22 66.83 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.175 0.988 . . . . 0.0 112.367 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -75.63 -51.19 13.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -59.67 -46.99 87.37 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.041 1.336 . . . . 0.0 112.67 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -100.74 148.92 35.68 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.706 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -75.4 68.01 6.15 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.036 2.491 . . . . 0.0 109.532 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -128.12 68.19 75.83 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 126.074 1.75 . . . . 0.0 108.556 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.642 ' HB2' HD21 ' A' ' 55' ' ' LEU . 84.1 Cg_endo -77.55 83.0 2.25 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.608 2.205 . . . . 0.0 106.552 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.4 t -78.17 103.14 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -52.37 -30.56 29.47 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.914 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.05 -15.67 34.99 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.136 0.88 . . . . 0.0 111.982 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -117.72 -15.91 10.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.584 1.154 . . . . 0.0 110.326 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.425 HD22 ' SG ' ' A' ' 49' ' ' CYS . 9.4 mt -83.59 152.61 24.74 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.27 1.396 . . . . 0.0 111.103 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -139.15 128.42 24.08 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.066 0.947 . . . . 0.0 110.697 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.55 123.73 21.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -94.8 136.21 35.37 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 t -135.88 -177.99 4.93 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.976 1.311 . . . . 0.0 109.596 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -159.65 146.51 16.52 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.734 1.214 . . . . 0.0 109.637 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.17 76.34 1.32 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 124.463 1.102 . . . . 0.0 111.821 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.89 78.84 0.82 Allowed Glycine 0 C--N 1.335 0.509 0 O-C-N 121.152 -0.968 . . . . 0.0 112.065 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 56.51 13.76 1.45 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.359 1.464 . . . . 0.0 112.763 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -121.26 151.82 39.58 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.3 m -125.25 148.45 48.66 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 125.636 1.574 . . . . 0.0 106.957 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.99 157.05 47.04 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -138.83 116.11 11.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.673 1.189 . . . . 0.0 107.833 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -112.24 133.01 54.61 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.881 1.273 . . . . 0.0 110.089 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.9 m -52.31 122.22 8.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.886 2.074 . . . . 0.0 110.458 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.7 t -73.34 -46.09 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 O-C-N 120.105 -1.622 . . . . 0.0 110.869 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.76 -30.83 71.88 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.034 0.834 . . . . 0.0 111.146 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -133.94 81.51 51.76 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 123.747 0.819 . . . . 0.0 110.746 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.16 159.89 44.69 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 N-CA-C 108.421 -1.415 . . . . 0.0 108.421 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.45 -17.78 30.76 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.062 0.839 . . . . 0.0 112.22 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 142' ' ' GLN . 30.9 m-90 -119.0 141.63 48.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.018 1.727 . . . . 0.0 111.245 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -118.5 142.44 47.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 128.82 2.848 . . . . 0.0 111.414 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.4 mt -69.01 134.18 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.4 114.5 28.72 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.537 0.608 . . . . 0.0 110.112 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.3 m -63.93 -19.15 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.5 m 61.19 63.6 1.21 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.953 1.835 . . . . 0.0 115.953 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.45 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 54.5 m -104.43 6.07 34.71 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 125.745 1.618 . . . . 0.0 113.18 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -82.01 -106.64 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.121 1.368 . . . . 0.0 107.563 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.42 -52.13 11.16 Favored Glycine 0 C--N 1.337 0.605 0 O-C-N 120.849 -1.157 . . . . 0.0 112.911 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 141.63 62.77 0.03 OUTLIER Glycine 0 CA--C 1.525 0.69 0 N-CA-C 106.491 -2.644 . . . . 0.0 106.491 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . 0.421 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 19.6 m -93.56 166.96 14.86 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 119.105 -0.474 . . . . 0.0 110.701 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 136' ' ' CYS . 87.3 Cg_endo -74.14 157.64 46.16 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.746 2.964 . . . . 0.0 110.352 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.557 HD12 HD13 ' A' ' 30' ' ' LEU . 15.2 mt -76.84 111.59 12.54 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.79 179.77 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 125.861 1.664 . . . . 0.0 110.587 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -110.6 144.74 39.01 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.3 t -134.78 152.7 51.96 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 126' ' ' TRP . 3.0 pt20 -107.38 -32.73 7.63 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 N--CA 1.427 -1.585 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 -178.8 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.446 -0.63 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.98 96.11 4.82 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.605 0.762 . . . . 0.0 110.626 -177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.5 p -98.52 -32.57 11.39 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.85 96.39 10.37 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.717 1.607 . . . . 0.0 112.374 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.42 175.66 13.43 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.805 -1.184 . . . . 0.0 112.661 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.79 -166.89 29.47 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.5 tp -137.67 161.59 36.09 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.31 34.46 5.21 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -63.38 140.38 58.87 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 18.0 mt -123.18 166.33 15.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 17.7 p90 . . . . . 0 C--O 1.244 0.796 0 CA-C-O 116.482 -1.723 . . . . 0.0 107.469 178.965 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 C--O 1.235 0.291 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.04 129.56 15.38 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.84 1.693 . . . . 0.0 108.019 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.55 115.21 29.49 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -112.61 135.65 53.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.966 0.506 . . . . 0.0 110.823 -179.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.87 -125.82 0.8 Allowed Glycine 0 N--CA 1.46 0.246 0 CA-C-O 117.882 -1.51 . . . . 0.0 109.979 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.6 p -157.03 -173.97 4.7 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 120.276 2.038 . . . . 0.0 112.709 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.436 HD11 HD11 ' A' ' 154' ' ' LEU . 8.4 mt -141.98 -19.07 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.92 1.688 . . . . 0.0 108.437 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.716 HE21 HG22 ' A' ' 22' ' ' VAL . 5.9 pt20 -47.52 -39.99 17.56 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.147 -0.971 . . . . 0.0 113.459 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -51.32 -33.49 29.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.847 2.059 . . . . 0.0 114.866 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.4 mm -41.94 -55.44 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 127.146 2.178 . . . . 0.0 111.047 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.64 26.48 2.11 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.709 -0.619 . . . . 0.0 109.54 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 33.9 m80 60.46 25.05 14.64 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.34 2.256 . . . . 0.0 113.279 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.448 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 20.2 mmt180 -83.58 85.07 7.32 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 126.966 2.106 . . . . 0.0 107.493 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.716 HG22 HE21 ' A' ' 16' ' ' GLN . 93.6 t -69.5 136.7 25.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 120.726 -1.233 . . . . 0.0 108.572 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -95.59 135.01 37.81 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.722 1.209 . . . . 0.0 111.701 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.4 t -141.91 131.28 23.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.484 HD13 HD22 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -75.74 95.2 3.39 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 178.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -106.94 120.02 40.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 119.619 1.099 . . . . 0.0 108.506 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.6 t0 42.06 65.84 0.82 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.267 1.427 . . . . 0.0 111.615 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 57.3 8.7 0.61 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.679 1.591 . . . . 0.0 114.861 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 m -124.81 133.1 53.25 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 125.185 1.394 . . . . 0.0 110.129 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.825 HD12 HD13 ' A' ' 87' ' ' LEU . 8.8 mt -82.88 122.42 28.23 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -125.72 144.39 35.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.19 133.2 34.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -128.14 64.14 65.12 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.665 1.986 . . . . 0.0 111.435 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.429 ' HG3' HH11 ' A' ' 21' ' ' ARG . 11.7 Cg_endo -58.14 -56.77 1.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.343 1.362 . . . . 0.0 111.693 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.6 mtp85 -117.73 109.0 16.08 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.558 1.072 . . . . 0.0 109.105 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -167.92 -162.44 0.43 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.668 1.187 . . . . 0.0 109.135 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -122.81 -50.56 1.95 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -66.13 20.66 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.66 1.984 . . . . 0.0 114.977 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.7 ptp -74.59 -178.8 3.74 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 120.49 -1.381 . . . . 0.0 109.434 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 t -174.24 128.34 0.45 Allowed Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.79 146.05 33.09 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 N-CA-C 107.224 -1.875 . . . . 0.0 107.224 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 m -133.45 171.19 18.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.63 163.92 16.65 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.514 ' CG2' HD11 ' A' ' 65' ' ' LEU . 40.3 mm -131.18 108.42 14.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 127.18 2.192 . . . . 0.0 108.472 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.49 124.75 44.93 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.194 1.398 . . . . 0.0 108.521 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 tt -117.2 138.06 51.94 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.308 1.843 . . . . 0.0 108.744 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 mt -142.2 146.09 22.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 126.498 1.919 . . . . 0.0 108.291 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 p -84.16 145.23 28.5 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.522 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 55.7 m -66.85 107.86 2.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.936 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.75 7.87 9.34 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.577 -1.327 . . . . 0.0 111.564 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.71 29.33 5.03 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.552 2.341 . . . . 0.0 113.624 -177.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.41 -7.83 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 O-C-N 120.078 -1.639 . . . . 0.0 114.312 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -48.41 -51.44 26.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 119.528 1.058 . . . . 0.0 112.594 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 t -82.21 2.7 30.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.713 1.205 . . . . 0.0 112.568 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.6 mt -104.69 176.17 5.25 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 120.356 -1.465 . . . . 0.0 112.017 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -93.02 151.84 19.66 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.599 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -124.03 -25.53 4.19 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.847 1.259 . . . . 0.0 110.018 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -61.81 -20.62 63.83 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.418 0.687 . . . . 0.0 111.05 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -75.99 -20.56 57.77 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.133 0.973 . . . . 0.0 111.143 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.4 -103.41 0.4 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 125.962 1.744 . . . . 0.0 111.574 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -144.76 99.07 4.78 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.581 -0.952 . . . . 0.0 112.885 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.62 131.37 18.55 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.377 2.051 . . . . 0.0 110.682 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pt -143.53 -178.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.802 0.841 . . . . 0.0 109.244 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.57 ' CD1' HD12 ' A' ' 95' ' ' LEU . 4.3 t80 -136.57 134.92 37.97 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.999 0.92 . . . . 0.0 110.076 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.514 HD11 ' CG2' ' A' ' 44' ' ' ILE . 4.2 tt -138.43 152.16 48.09 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.994 1.318 . . . . 0.0 109.214 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.56 174.51 33.61 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.807 HD11 HD11 ' A' ' 30' ' ' LEU . 8.3 mt -88.58 139.12 30.8 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -109.46 102.09 10.99 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.87 -26.37 0.09 OUTLIER Glycine 0 CA--C 1.529 0.953 0 CA-C-O 117.945 -1.475 . . . . 0.0 113.335 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.01 19.84 0.58 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.643 1.722 . . . . 0.0 114.421 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.2 m120 62.51 62.1 1.16 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.385 1.474 . . . . 0.0 110.91 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.484 HD22 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -135.9 133.72 37.98 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.76 1.224 . . . . 0.0 109.299 -178.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.569 ' SG ' HG23 ' A' ' 92' ' ' ILE . 6.8 m -136.64 174.65 10.39 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.654 0.661 . . . . 0.0 111.896 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.693 HD23 HD21 ' A' ' 87' ' ' LEU . 17.9 mt -64.6 150.22 47.36 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.782 0.433 . . . . 0.0 111.378 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.453 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 1.4 tmm? -160.85 144.67 13.49 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 117.999 -1.0 . . . . 0.0 108.516 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -110.98 122.38 47.75 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.961 0.788 . . . . 0.0 110.103 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.86 135.16 29.26 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.078 0.951 . . . . 0.0 110.652 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -70.02 117.79 12.03 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.0 p -69.68 -24.21 26.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.813 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.89 -70.34 0.11 Allowed Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 105.357 -3.097 . . . . 0.0 105.357 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -97.36 -23.1 16.26 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -145.4 159.53 48.17 Favored Pre-proline 0 CA--C 1.536 0.405 0 O-C-N 121.374 -0.829 . . . . 0.0 112.891 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.4 148.01 72.67 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.565 2.843 . . . . 0.0 111.681 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.5 p -145.56 170.45 16.4 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.038 1.735 . . . . 0.0 108.668 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.62 HD11 HG23 ' A' ' 128' ' ' ILE . 6.6 mt -83.96 150.88 25.37 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 122.493 0.317 . . . . 0.0 110.687 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -144.91 64.29 1.28 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.109 0.964 . . . . 0.0 110.029 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.825 HD13 HD12 ' A' ' 30' ' ' LEU . 0.6 OUTLIER -86.06 118.96 25.85 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -171.66 -42.91 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.689 0.677 . . . . 0.0 112.269 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -134.49 101.99 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.852 1.261 . . . . 0.0 109.988 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 75' ' ' MET . 0.2 OUTLIER -163.82 171.36 15.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.696 1.589 . . . . 0.0 109.667 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -142.3 109.85 5.72 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.569 HG23 ' SG ' ' A' ' 73' ' ' CYS . 19.6 pt -70.77 -36.93 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 121.538 -0.726 . . . . 0.0 111.168 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -29.16 65.66 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.332 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -67.0 -50.0 63.59 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 118.61 0.641 . . . . 0.0 109.808 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.57 HD12 ' CD1' ' A' ' 64' ' ' TYR . 21.3 mt -64.28 -30.52 71.56 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -76.06 -26.85 56.93 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.545 -0.722 . . . . 0.0 109.849 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -86.87 -28.29 22.93 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -129.26 164.82 36.76 Favored Pre-proline 0 N--CA 1.456 -0.168 0 CA-C-N 121.177 1.808 . . . . 0.0 110.736 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.66 -161.65 0.13 Allowed 'Trans proline' 0 N--CA 1.445 -1.357 0 N-CA-C 107.109 -1.92 . . . . 0.0 107.109 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 77.46 70.75 0.2 Allowed Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 127.096 2.158 . . . . 0.0 109.859 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.17 107.45 0.66 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.517 2.145 . . . . 0.0 109.788 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 t -81.1 91.98 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -48.51 -32.32 7.73 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 125.021 1.328 . . . . 0.0 112.965 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.6 m -62.66 -14.33 42.31 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.333 1.053 . . . . 0.0 113.561 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -115.31 -20.87 10.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.319 1.448 . . . . 0.0 110.747 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.8 mt -80.92 154.23 27.13 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.776 0.83 . . . . 0.0 111.286 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.692 ' CD2' HD11 ' A' ' 128' ' ' ILE . 81.4 m-85 -141.69 138.97 32.81 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.281 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -81.46 131.28 35.27 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.43 119.99 32.49 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 125.84 1.656 . . . . 0.0 107.726 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 t -123.1 -172.17 2.45 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 2.1 pt20 -154.15 136.28 14.76 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.28 1.032 . . . . 0.0 108.576 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.98 69.74 1.45 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.78 -177.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.31 70.04 1.34 Allowed Glycine 0 C--N 1.338 0.656 0 O-C-N 121.274 -0.892 . . . . 0.0 113.675 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? 67.39 -10.37 0.35 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 128.013 2.525 . . . . 0.0 112.978 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -107.39 144.14 34.72 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.181 0.992 . . . . 0.0 108.641 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 0.4 OUTLIER -101.55 150.91 22.59 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.519 0.728 . . . . 0.0 110.929 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.61 166.86 12.21 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.518 1.927 . . . . 0.0 110.123 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -139.11 118.47 12.81 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -120.78 131.46 54.49 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.161 0.984 . . . . 0.0 110.248 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.8 t -52.99 116.94 2.62 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.778 1.631 . . . . 0.0 110.842 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.16 -45.82 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 119.227 0.921 . . . . 0.0 110.816 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.03 -26.49 68.58 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.555 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -145.9 87.19 6.86 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 119.202 0.91 . . . . 0.0 111.575 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -58.05 166.35 5.69 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.52 2.813 . . . . 0.0 114.032 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.65 -4.35 86.29 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 117.463 -1.743 . . . . 0.0 114.219 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 42.0 m95 -120.16 131.35 54.98 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.891 1.846 . . . . 0.0 107.843 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -114.9 144.37 43.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 126.037 1.735 . . . . 0.0 111.22 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.692 HD11 ' CD2' ' A' ' 107' ' ' PHE . 13.1 mt -77.11 123.32 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.737 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.74 120.09 32.17 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.38 0.609 . . . . 0.0 110.646 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.72 -23.29 27.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 C-N-CA 128.211 2.604 . . . . 0.0 111.051 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 m 60.9 87.0 0.09 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.911 1.339 . . . . 0.0 109.128 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.448 ' HA ' ' HG3' ' A' ' 21' ' ' ARG 0.271 1.7 m -109.76 4.1 21.48 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.696 -178.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -111.72 160.66 17.07 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 25.6 -87.54 0.01 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 128.043 2.735 . . . . 0.0 114.422 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -177.45 60.71 0.09 OUTLIER Glycine 0 CA--C 1.521 0.415 0 CA-C-O 117.795 -1.559 . . . . 0.0 109.38 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 4.9 m -85.08 161.42 52.53 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 119.455 1.627 . . . . 0.0 112.826 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.22 155.43 37.37 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 N-CA-C 108.553 -1.364 . . . . 0.0 108.553 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.0 mt -82.98 112.22 19.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 pp -138.0 -173.15 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.975 1.71 . . . . 0.0 109.843 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.4 mt -109.14 156.8 19.41 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.609 1.164 . . . . 0.0 108.244 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.37 136.66 21.24 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -81.24 -40.51 23.67 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.895 0.878 . . . . 0.0 110.855 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 C--O 1.239 0.541 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -178.376 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.8 m120 . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.43 100.41 10.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.101 0.56 . . . . 0.0 109.588 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.7 p -95.78 -17.77 20.93 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -115.97 131.81 56.83 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.004 1.322 . . . . 0.0 110.013 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.41 ' HB3' ' H ' ' A' ' 153' ' ' GLY 0.334 0.1 OUTLIER -163.49 -135.75 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 119.066 -0.492 . . . . 0.0 112.153 177.914 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.41 ' H ' ' HB3' ' A' ' 152' ' ' PHE . . . -146.22 179.33 23.3 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 125.794 1.664 . . . . 0.0 109.363 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.599 HD23 ' HB3' ' A' ' 156' ' ' MET . 0.4 OUTLIER -138.78 122.29 17.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.351 1.075 . . . . 0.0 110.725 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.3 m -79.42 34.72 0.26 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.602 1.561 . . . . 0.0 107.987 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.599 ' HB3' HD23 ' A' ' 154' ' ' LEU . 3.3 ptt? -63.01 131.96 50.39 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 119.865 -1.772 . . . . 0.0 107.665 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 25.5 mt -109.25 165.95 11.23 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.351 1.06 . . . . 0.0 110.841 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 14.7 p90 . . . . . 0 C--O 1.254 1.335 0 C-N-CA 127.099 2.16 . . . . 0.0 107.694 179.894 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.64 0 CA-C-O 119.407 -0.33 . . . . 0.0 111.534 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.39 115.71 3.49 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 124.446 3.431 . . . . 0.0 110.252 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.76 118.59 35.84 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.031 0.933 . . . . 0.0 111.816 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -106.5 133.68 50.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.08 0.552 . . . . 0.0 111.18 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -157.82 -139.06 2.63 Favored Glycine 0 C--O 1.225 -0.429 0 O-C-N 120.825 -1.172 . . . . 0.0 112.921 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -151.87 169.39 22.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.927 0.863 . . . . 0.0 112.055 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.541 HD12 ' CH2' ' A' ' 23' ' ' TRP . 47.3 mt -121.29 -5.59 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 O-C-N 121.236 -0.915 . . . . 0.0 111.001 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -53.1 -34.29 56.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.733 1.213 . . . . 0.0 110.732 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -51.91 -2.8 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 131.339 3.856 . . . . 0.0 115.693 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.5 mm -93.07 -80.46 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.611 1.964 . . . . 0.0 108.888 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -119.29 29.81 7.45 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.818 0.847 . . . . 0.0 112.705 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.7 t60 61.53 25.73 15.6 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.783 2.033 . . . . 0.0 112.428 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -86.36 92.15 8.73 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 120.303 -1.498 . . . . 0.0 110.808 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.4 t -69.43 141.91 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.56 ' HB3' HD22 ' A' ' 30' ' ' LEU . 43.7 m0 -107.78 144.05 35.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.412 ' C ' HD23 ' A' ' 30' ' ' LEU . 95.5 t -141.78 129.31 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.531 HD22 ' CD2' ' A' ' 72' ' ' LEU . 4.3 tp -72.33 106.83 4.63 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 178.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.407 ' NE2' HH11 ' A' ' 38' ' ' ARG . 0.7 OUTLIER -127.73 127.39 43.56 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.629 0.772 . . . . 0.0 108.956 -178.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t70 56.25 27.35 11.63 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 76.28 17.54 2.01 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 129.839 3.256 . . . . 0.0 112.892 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.42 131.41 43.58 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.082 1.353 . . . . 0.0 108.161 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.753 HD12 HD12 ' A' ' 87' ' ' LEU . 10.3 mt -75.42 115.96 15.63 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 120.603 -1.311 . . . . 0.0 107.71 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.01 144.19 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.337 0.655 . . . . 0.0 109.378 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.96 126.4 31.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.81 1.244 . . . . 0.0 109.446 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -126.86 70.13 73.22 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.135 1.774 . . . . 0.0 109.465 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.13 -30.67 37.88 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.843 1.695 . . . . 0.0 114.283 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -148.1 82.5 1.49 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -146.45 158.72 43.93 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 123.473 0.709 . . . . 0.0 109.222 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -76.82 -48.91 17.09 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.699 1.249 . . . . 0.0 108.905 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.407 HH11 ' NE2' ' A' ' 26' ' ' GLN . 14.0 ttm180 -77.4 52.65 0.97 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.608 1.563 . . . . 0.0 112.494 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -108.66 165.05 11.83 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.08 -1.013 . . . . 0.0 111.072 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -156.09 134.17 7.1 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.236 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.45 126.14 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.985 2.456 . . . . 0.0 108.323 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.9 m -121.58 161.09 22.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 125.065 1.346 . . . . 0.0 109.733 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.71 161.19 17.8 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.6 mm -130.2 100.98 5.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 129.282 3.033 . . . . 0.0 109.318 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.48 110.63 21.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.725 2.01 . . . . 0.0 108.163 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tt -107.91 140.53 40.88 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.813 2.045 . . . . 0.0 109.791 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.543 HD12 ' CG2' ' A' ' 92' ' ' ILE . 0.9 OUTLIER -148.57 153.08 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.943 1.297 . . . . 0.0 109.841 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.4 p -96.88 127.35 42.76 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.184 1.394 . . . . 0.0 110.013 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 55.8 m -54.02 133.03 43.55 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.159 0.984 . . . . 0.0 109.133 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -98.95 -18.12 17.99 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 117.345 -1.312 . . . . 0.0 113.573 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -105.11 41.8 1.3 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.286 1.035 . . . . 0.0 108.772 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.5 m -69.31 -6.98 7.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 O-C-N 120.248 -1.533 . . . . 0.0 114.011 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -56.06 -46.52 78.93 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.172 0.989 . . . . 0.0 111.856 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.0 t -83.46 0.66 45.3 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.7 mt -98.23 174.9 6.28 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.947 -1.096 . . . . 0.0 109.625 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -77.99 155.97 30.44 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.679 -1.6 . . . . 0.0 109.371 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.79 -34.62 2.38 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.869 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.68 -38.52 85.24 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.318 0.963 . . . . 0.0 110.597 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -68.26 -18.52 64.57 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.87 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.481 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 119.18 174.52 15.85 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 126.103 1.811 . . . . 0.0 110.745 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -69.53 114.76 26.62 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.716 0.806 . . . . 0.0 111.829 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -84.16 138.07 7.58 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.423 2.749 . . . . 0.0 110.035 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.418 HD12 ' N ' ' A' ' 64' ' ' TYR . 1.6 pp -140.05 -179.04 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 123.977 0.911 . . . . 0.0 109.681 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.547 ' CE1' HD12 ' A' ' 95' ' ' LEU . 1.2 t80 -138.22 155.72 48.39 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 122.338 1.066 . . . . 0.0 109.393 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.22 151.86 30.56 Favored 'General case' 0 CA--C 1.507 -0.684 0 O-C-N 120.938 -1.101 . . . . 0.0 108.136 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.485 ' N ' HD11 ' A' ' 92' ' ' ILE . . . -148.17 -179.89 24.5 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.119 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.436 ' CD1' HD11 ' A' ' 30' ' ' LEU . 3.1 mt -92.09 169.84 10.31 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -137.3 115.05 11.32 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 120.847 -1.158 . . . . 0.0 109.557 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 155.38 -28.63 0.62 Allowed Glycine 0 CA--C 1.527 0.819 0 CA-C-O 117.992 -1.449 . . . . 0.0 112.756 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.01 30.03 0.88 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.577 1.689 . . . . 0.0 112.123 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.2 m120 51.32 74.92 0.22 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.333 1.853 . . . . 0.0 112.51 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.531 ' CD2' HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -141.03 141.82 34.27 Favored 'General case' 0 CA--C 1.517 -0.296 0 O-C-N 121.307 -0.87 . . . . 0.0 109.322 -178.209 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.435 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 13.7 m -141.76 175.17 9.92 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.421 0.555 . . . . 0.0 111.007 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.951 ' HA ' HD22 ' A' ' 87' ' ' LEU . 12.5 mt -63.24 156.71 24.65 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.3 ttp -163.64 134.43 4.53 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.2 m -93.67 132.13 38.3 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.78 131.16 19.7 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.899 0.88 . . . . 0.0 108.98 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -87.45 138.82 31.15 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.152 0.887 . . . . 0.0 109.737 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.9 m -92.37 38.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.46 -51.74 4.25 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -83.13 -54.93 4.66 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -138.08 160.75 63.06 Favored Pre-proline 0 N--CA 1.471 0.617 0 C-N-CA 125.111 1.364 . . . . 0.0 112.649 -176.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.28 151.42 43.33 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.906 2.404 . . . . 0.0 110.707 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 71.1 p -144.84 179.33 7.39 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.876 1.671 . . . . 0.0 108.856 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.596 ' CD2' HD21 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -104.15 139.97 38.46 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 127.089 2.156 . . . . 0.0 107.075 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -140.48 72.0 1.38 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.951 HD22 ' HA ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -90.28 104.04 16.66 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 127.994 2.518 . . . . 0.0 107.669 -178.168 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.54 -25.58 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -146.72 81.67 1.56 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.838 1.255 . . . . 0.0 111.389 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.513 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -162.89 161.1 25.7 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 120.102 -1.624 . . . . 0.0 108.621 179.326 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -137.39 139.9 41.03 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.092 1.757 . . . . 0.0 108.201 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.543 ' CG2' HD12 ' A' ' 47' ' ' ILE . 4.6 mt -89.45 -42.65 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 126.058 1.743 . . . . 0.0 109.015 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.73 -34.83 63.01 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.468 1.507 . . . . 0.0 111.758 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -62.78 -61.88 2.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.6 1.96 . . . . 0.0 107.976 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.547 HD12 ' CE1' ' A' ' 64' ' ' TYR . 37.7 mt -60.9 -22.37 64.27 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -87.77 -33.57 18.62 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.517 0.727 . . . . 0.0 109.206 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -69.64 -43.65 72.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.202 -0.904 . . . . 0.0 109.145 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.9 152.69 38.21 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 118.713 -0.661 . . . . 0.0 109.813 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.09 38.49 0.54 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.923 3.082 . . . . 0.0 113.936 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -112.55 82.13 4.62 Favored Pre-proline 0 C--O 1.235 0.312 0 O-C-N 120.877 -1.139 . . . . 0.0 112.905 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.43 102.57 1.62 Allowed 'Trans proline' 0 N--CA 1.443 -1.444 0 N-CA-C 106.048 -2.328 . . . . 0.0 106.048 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.4 t -89.29 105.09 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -48.78 -31.26 6.72 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.366 1.466 . . . . 0.0 112.006 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.4 t -62.53 -13.58 32.29 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.6 1.16 . . . . 0.0 112.852 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -121.97 -2.09 9.26 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 119.789 1.177 . . . . 0.0 110.351 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.7 mt -94.91 153.91 17.46 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.605 1.093 . . . . 0.0 110.975 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -138.43 129.41 26.89 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.765 0.826 . . . . 0.0 109.721 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.481 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -71.13 127.26 31.99 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 104.405 -2.442 . . . . 0.0 104.405 177.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -103.88 131.87 50.68 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.11 -178.64 5.24 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.924 0.868 . . . . 0.0 109.948 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 0.0 OUTLIER -151.91 138.67 18.86 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.932 2.093 . . . . 0.0 107.808 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.48 70.33 1.17 Allowed 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.193 0.933 . . . . 0.0 112.472 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.46 64.12 0.93 Allowed Glycine 0 CA--C 1.525 0.686 0 O-C-N 121.787 -0.57 . . . . 0.0 114.198 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 67.71 -0.6 1.9 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.722 2.009 . . . . 0.0 113.24 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -120.01 155.11 33.51 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.386 1.474 . . . . 0.0 107.608 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 69.8 m -115.01 166.6 11.62 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.77 2.028 . . . . 0.0 110.559 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.61 164.46 32.58 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.504 1.121 . . . . 0.0 111.095 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -141.75 116.37 9.69 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 125.081 1.352 . . . . 0.0 110.605 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -115.16 122.94 47.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.635 1.574 . . . . 0.0 110.361 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.0 m -49.42 124.13 8.77 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.392 1.477 . . . . 0.0 112.488 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.5 t -70.0 -44.69 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 120.146 -1.596 . . . . 0.0 111.936 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.88 -25.56 67.23 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.398 -0.814 . . . . 0.0 112.971 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -140.39 80.17 19.67 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 125.381 1.472 . . . . 0.0 108.489 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -64.53 151.72 84.49 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.148 1.899 . . . . 0.0 110.123 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.48 -32.88 6.76 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.519 2.009 . . . . 0.0 110.211 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 25.5 m-90 -88.19 106.66 18.34 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 124.626 1.17 . . . . 0.0 111.006 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -91.03 152.8 20.53 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.724 1.21 . . . . 0.0 110.148 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.4 mt -82.25 131.71 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.29 132.85 43.43 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.18 0.446 . . . . 0.0 109.813 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -81.96 -15.38 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 127.06 2.144 . . . . 0.0 111.885 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.7 m 63.29 52.28 2.47 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.914 1.285 . . . . 0.0 113.729 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.3 m -89.31 24.22 2.27 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -96.01 -83.11 0.38 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.105 0.411 . . . . 0.0 110.352 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -103.68 -44.88 1.6 Allowed Glycine 0 C--N 1.336 0.583 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.08 63.52 0.02 OUTLIER Glycine 0 CA--C 1.521 0.433 0 N-CA-C 106.264 -2.734 . . . . 0.0 106.264 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 60.9 m -82.37 170.94 13.11 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.358 1.063 . . . . 0.0 110.113 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.2 153.13 16.32 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.859 1.706 . . . . 0.0 109.127 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.475 HD11 ' CD2' ' A' ' 23' ' ' TRP . 16.6 mt -75.52 106.16 6.93 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.93 171.42 15.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 124.347 1.059 . . . . 0.0 111.338 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 89.6 mt -84.83 156.12 21.46 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.8 t -146.11 136.16 23.6 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -85.56 -35.94 20.75 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.563 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 . . . . . 0 N--CA 1.477 0.914 0 CA-C-N 119.671 1.123 . . . . 0.0 113.173 -178.235 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.5 m -146.55 108.48 4.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.2 p -103.32 -15.79 15.84 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.402 1.081 . . . . 0.0 111.08 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -96.67 119.73 35.7 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 128.528 2.731 . . . . 0.0 108.178 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -157.94 -133.37 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.799 0.84 . . . . 0.0 112.893 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 177.14 -161.37 28.92 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 128.737 3.065 . . . . 0.0 108.299 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.73 142.87 23.23 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.083 1.942 . . . . 0.0 112.733 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.0 m -91.39 32.36 1.07 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.835 1.254 . . . . 0.0 107.842 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -60.0 110.71 1.26 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.464 1.906 . . . . 0.0 109.8 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 12.5 mt -89.67 160.01 16.82 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 126.226 1.811 . . . . 0.0 110.583 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 20.9 p90 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 126.023 1.729 . . . . 0.0 110.401 -179.707 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 117.771 -1.109 . . . . 0.0 111.419 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.14 131.54 18.13 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.329 2.019 . . . . 0.0 107.965 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.19 113.49 24.73 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.312 1.445 . . . . 0.0 109.839 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -109.49 144.94 37.05 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.191 0.996 . . . . 0.0 110.957 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.39 -131.21 1.41 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.135 1.35 . . . . 0.0 110.854 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.1 p -153.66 172.38 17.35 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 120.601 2.2 . . . . 0.0 113.112 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.0 mt -127.39 -12.38 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 125.005 1.322 . . . . 0.0 107.597 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.81 -28.22 69.31 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 120.413 -1.43 . . . . 0.0 112.292 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -57.34 -17.98 15.03 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.395 2.678 . . . . 0.0 115.003 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.1 mt -68.03 -69.71 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.29 1.036 . . . . 0.0 109.745 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.01 29.18 7.18 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.962 0.905 . . . . 0.0 111.102 -178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 51.48 44.66 28.88 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.303 2.241 . . . . 0.0 110.097 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.422 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 19.5 mmt180 -100.68 88.15 3.53 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.8 t -70.66 138.46 21.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -101.18 145.47 28.76 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.082 0.953 . . . . 0.0 109.523 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -148.26 134.57 12.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.63 121.0 14.95 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 103.471 -2.788 . . . . 0.0 103.471 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -134.01 117.85 17.15 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . 0.267 1.3 t0 46.72 59.49 3.91 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 124.072 1.892 . . . . 0.0 111.43 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 55.29 17.91 2.29 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 113.406 -1.725 . . . . 0.0 113.783 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.6 m -132.25 137.95 47.71 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.143 1.777 . . . . 0.0 107.812 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.531 HD13 HD12 ' A' ' 138' ' ' LEU . 9.8 mt -80.51 129.8 34.74 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.081 -1.637 . . . . 0.0 108.205 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.7 mm -131.36 140.47 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.653 0.66 . . . . 0.0 111.275 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.57 127.18 31.78 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.379 1.472 . . . . 0.0 109.108 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 m -123.09 62.8 20.51 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.213 1.805 . . . . 0.0 109.493 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.61 6.1 0.48 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.413 3.409 . . . . 0.0 116.641 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.4 ptt85 171.7 88.2 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 130.2 3.4 . . . . 0.0 104.92 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.85 139.13 24.75 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.8 -50.22 73.0 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -85.8 53.93 2.95 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.935 1.294 . . . . 0.0 112.663 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -104.51 155.56 18.71 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -150.97 132.69 7.87 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.94 148.61 64.28 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 N-CA-C 107.952 -1.595 . . . . 0.0 107.952 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.98 165.55 27.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -119.74 157.65 28.13 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.0 mm -115.85 147.45 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.92 130.12 47.96 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 104.659 -2.348 . . . . 0.0 104.659 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 tt -127.28 140.09 52.45 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 mt -146.03 138.07 19.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 125.091 1.356 . . . . 0.0 109.212 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p -79.63 132.96 36.39 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.816 0.846 . . . . 0.0 109.027 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.49 ' SG ' HD22 ' A' ' 106' ' ' LEU . 98.4 m -69.88 113.74 7.4 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 120.891 -1.13 . . . . 0.0 108.602 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -86.01 -9.96 55.89 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 118.68 -0.676 . . . . 0.0 112.443 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -97.45 34.64 1.77 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.768 1.627 . . . . 0.0 110.085 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.85 -10.74 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 127.212 2.205 . . . . 0.0 114.28 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.01 -10.75 4.54 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.202 1.801 . . . . 0.0 114.304 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.7 t -128.51 19.89 6.21 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.357 1.463 . . . . 0.0 110.417 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.3 mt -116.45 169.58 9.21 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.749 0.82 . . . . 0.0 109.659 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -70.88 145.88 49.95 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -116.37 -41.22 3.14 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.29 -37.24 77.2 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.619 1.568 . . . . 0.0 112.383 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -11.01 59.81 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 117.993 -1.003 . . . . 0.0 111.411 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.42 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 119.93 173.42 15.19 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -82.7 118.57 72.26 Favored Pre-proline 0 CA--C 1.542 0.64 0 O-C-N 122.039 -0.683 . . . . 0.0 111.19 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -79.85 146.5 18.6 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.87 3.047 . . . . 0.0 110.739 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 pp -139.53 177.72 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.07 1.748 . . . . 0.0 109.308 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.671 ' CD1' HG22 ' A' ' 92' ' ' ILE . 1.1 t80 -131.8 147.67 52.51 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.2 tt -144.87 148.26 33.74 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.6 -179.31 25.34 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.434 HD11 HD11 ' A' ' 30' ' ' LEU . 1.9 mt -98.4 145.74 26.42 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.29 105.99 14.08 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 120.341 1.428 . . . . 0.0 108.549 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.92 -24.16 0.18 Allowed Glycine 0 CA--C 1.525 0.66 0 CA-C-O 117.294 -1.837 . . . . 0.0 116.289 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.8 20.53 1.15 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 119.664 1.732 . . . . 0.0 113.273 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.48 64.35 0.94 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.956 2.102 . . . . 0.0 110.971 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.84 143.19 33.26 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.718 1.207 . . . . 0.0 110.562 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.726 ' SG ' HG23 ' A' ' 92' ' ' ILE . 15.3 m -144.97 179.47 7.32 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.026 0.531 . . . . 0.0 110.918 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.09 152.47 28.19 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.944 -0.473 . . . . 0.0 110.134 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.3 ttp -159.64 127.65 4.87 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.4 m -85.61 116.76 24.09 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.13 148.71 52.49 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -92.06 123.75 35.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.4 -33.48 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.94 -62.04 0.31 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 105.66 -2.976 . . . . 0.0 105.66 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -82.58 -36.36 26.29 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -145.95 166.32 17.63 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.57 142.12 47.9 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.003 2.469 . . . . 0.0 110.031 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.6 p -146.65 -174.77 4.56 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 125.311 1.444 . . . . 0.0 107.943 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.573 HD11 HG23 ' A' ' 128' ' ' ILE . 4.6 mt -103.22 145.13 30.4 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.043 1.337 . . . . 0.0 109.471 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -143.89 66.04 1.29 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.499 ' H ' HD12 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -80.62 115.07 19.94 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.7 pttp 179.63 -20.9 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -156.15 87.34 1.05 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.981 1.313 . . . . 0.0 110.41 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.498 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -169.2 164.97 11.1 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 120.568 -1.332 . . . . 0.0 108.433 178.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -141.01 125.9 18.14 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.526 1.13 . . . . 0.0 108.78 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.726 HG23 ' SG ' ' A' ' 73' ' ' CYS . 27.6 pt -79.51 -37.31 18.52 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 125.935 1.694 . . . . 0.0 111.762 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -36.7 81.64 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 118.476 0.58 . . . . 0.0 111.187 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -56.96 -56.24 24.33 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.47 HD12 ' CD1' ' A' ' 64' ' ' TYR . 13.5 mt -62.39 -32.87 73.76 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -71.67 -36.36 70.6 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.507 -0.745 . . . . 0.0 110.285 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -75.45 -41.01 56.76 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.527 1.131 . . . . 0.0 113.062 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -112.68 157.0 41.6 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.56 63.53 5.58 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.542 2.828 . . . . 0.0 114.142 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -124.21 63.35 32.66 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.977 1.711 . . . . 0.0 109.308 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.3 77.35 3.86 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.365 2.71 . . . . 0.0 106.289 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.94 104.59 5.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 125.388 1.475 . . . . 0.0 107.996 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -49.9 -30.25 9.76 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.373 0.669 . . . . 0.0 111.952 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.95 -8.58 23.42 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.215 1.006 . . . . 0.0 113.229 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -123.73 -3.06 8.27 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.587 1.155 . . . . 0.0 109.04 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.49 HD22 ' SG ' ' A' ' 49' ' ' CYS . 14.7 mt -103.03 149.53 24.48 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.894 1.224 . . . . 0.0 111.521 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.652 ' CD2' HD11 ' A' ' 128' ' ' ILE . 76.3 m-85 -135.32 127.08 29.2 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.172 0.989 . . . . 0.0 110.769 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.42 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -70.52 111.98 6.45 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 178.117 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -94.41 145.2 24.94 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.38 179.48 7.62 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.403 1.481 . . . . 0.0 108.283 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 0.0 OUTLIER -158.3 137.11 11.29 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.494 0.718 . . . . 0.0 109.102 178.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.32 89.37 1.57 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.03 61.04 1.22 Allowed Glycine 0 C--N 1.336 0.545 0 O-C-N 121.37 -0.831 . . . . 0.0 111.351 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 60.09 11.08 2.53 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.306 2.243 . . . . 0.0 113.901 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -125.37 159.45 31.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.977 0.911 . . . . 0.0 108.773 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 4.6 m -116.49 165.7 12.93 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.095 1.758 . . . . 0.0 110.024 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.81 159.14 42.83 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 126.43 1.892 . . . . 0.0 107.398 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -146.28 119.7 9.03 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.321 1.048 . . . . 0.0 109.045 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -116.82 130.45 56.72 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.943 2.097 . . . . 0.0 110.454 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.422 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 43.5 t -56.84 122.28 11.83 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.586 0.754 . . . . 0.0 109.296 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.5 t -70.27 -38.2 73.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.37 -40.28 93.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.684 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -129.45 79.99 72.87 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 124.482 1.113 . . . . 0.0 110.099 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -61.68 148.32 93.3 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.812 2.341 . . . . 0.0 109.86 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.78 -14.05 26.98 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.163 1.364 . . . . 0.0 112.153 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -110.2 147.11 34.4 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.836 2.054 . . . . 0.0 109.164 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -122.23 147.4 46.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.816 1.646 . . . . 0.0 108.218 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.652 HD11 ' CD2' ' A' ' 107' ' ' PHE . 9.9 mm -73.5 124.18 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.46 133.85 33.69 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.644 1.111 . . . . 0.0 108.834 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.2 t -85.91 -21.16 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.695 1.998 . . . . 0.0 111.907 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m 56.08 67.34 1.02 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 123.425 1.583 . . . . 0.0 112.216 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.422 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 7.1 m -96.26 16.8 17.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.164 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.59 146.48 49.64 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.948 1.699 . . . . 0.0 107.023 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 57.99 -81.98 0.01 OUTLIER Glycine 0 C--N 1.334 0.425 0 C-N-CA 127.005 2.24 . . . . 0.0 111.693 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.03 66.87 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.246 2 N-CA-C 102.566 -4.213 . . . . 0.0 102.566 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 79.0 m -91.48 170.24 9.94 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 118.326 1.063 . . . . 0.0 111.576 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -81.12 154.32 19.21 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.558 2.172 . . . . 0.0 112.075 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.531 HD12 HD13 ' A' ' 30' ' ' LEU . 38.4 mt -82.57 107.38 15.17 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.08 175.1 9.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 125.039 1.335 . . . . 0.0 108.325 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.7 mt -88.74 166.56 13.97 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t -160.72 125.41 3.68 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -91.2 -22.22 20.74 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 123.543 0.527 . . . . 0.0 110.104 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 CA--C 1.536 0.431 0 CA-C-N 119.001 0.818 . . . . 0.0 110.905 -178.687 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 CA--C 1.512 -0.517 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.82 132.11 35.46 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.413 0.685 . . . . 0.0 109.225 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 p -124.2 -9.09 7.6 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.175 0.99 . . . . 0.0 108.655 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -127.51 125.96 41.37 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.557 1.543 . . . . 0.0 110.059 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 176.29 178.57 0.21 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.931 2.092 . . . . 0.0 110.504 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.34 -166.61 31.22 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.846 1.212 . . . . 0.0 111.694 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.61 125.71 19.91 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.289 1.436 . . . . 0.0 107.641 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.3 m -81.97 44.13 0.82 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.847 1.659 . . . . 0.0 106.88 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -67.68 147.54 52.54 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.3 mt -124.61 170.73 10.66 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.194 1.798 . . . . 0.0 108.388 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.8 p90 . . . . . 0 C--O 1.243 0.761 0 N-CA-C 104.187 -2.523 . . . . 0.0 104.187 179.422 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 118.421 -0.799 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.96 132.84 27.42 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.38 1.387 . . . . 0.0 109.534 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.46 117.34 30.1 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -112.86 146.98 37.95 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.846 0.459 . . . . 0.0 109.852 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.86 -125.99 0.97 Allowed Glycine 0 CA--C 1.523 0.535 0 C-N-CA 124.595 1.093 . . . . 0.0 111.883 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.8 p -156.07 -170.1 3.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.975 1.887 . . . . 0.0 112.565 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -146.65 1.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.225 1.01 . . . . 0.0 110.383 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -67.34 -28.92 68.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -54.61 -30.87 56.03 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.19 1.396 . . . . 0.0 111.44 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.5 mm -44.95 -67.61 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.749 2.02 . . . . 0.0 111.625 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.55 26.15 3.73 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.86 -0.525 . . . . 0.0 111.324 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 25.7 m170 60.93 39.56 16.55 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.425 1.49 . . . . 0.0 110.098 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.406 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 3.0 mmt-85 -109.32 97.67 7.22 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.153 0.981 . . . . 0.0 109.932 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 t -82.47 156.46 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -108.75 137.1 47.23 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.772 1.229 . . . . 0.0 107.707 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.97 128.03 52.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.4 100.4 1.75 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -115.62 126.21 53.89 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 126.0 1.72 . . . . 0.0 109.117 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.3 t0 42.53 58.79 2.97 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.535 1.134 . . . . 0.0 112.898 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 58.86 13.44 2.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.942 1.297 . . . . 0.0 114.363 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.7 m -131.78 149.86 52.33 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 120.688 1.586 . . . . 0.0 108.287 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.768 HD12 HD13 ' A' ' 87' ' ' LEU . 11.8 mt -89.96 125.5 35.4 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 177.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.5 mm -119.72 140.27 44.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.54 141.67 36.44 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 m -120.3 71.72 18.0 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -63.67 97.35 0.22 Allowed 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.452 2.101 . . . . 0.0 109.958 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 49.55 43.73 24.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.671 1.189 . . . . 0.0 111.165 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -88.67 148.12 24.17 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -65.89 -11.64 48.51 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.259 30.0 ptt180 -117.11 25.15 10.69 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.682 0.793 . . . . 0.0 110.334 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -75.92 148.16 38.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.2 t -145.91 129.98 8.64 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.52 145.29 52.31 Favored 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.045 1.163 . . . . 0.0 112.123 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.4 m -126.31 175.49 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -128.35 161.72 28.76 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.4 mm -124.82 147.78 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.524 ' CB ' HD11 ' A' ' 92' ' ' ILE . . . -125.15 134.5 52.4 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 176.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.01 133.88 47.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.833 1.253 . . . . 0.0 107.999 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.615 HG13 HD12 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -147.67 134.11 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.022 0.529 . . . . 0.0 110.59 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.519 ' HA ' HG22 ' A' ' 63' ' ' ILE . 46.8 t -72.44 159.77 33.42 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 122.514 1.149 . . . . 0.0 109.427 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.3 m -83.6 100.48 10.84 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.749 1.22 . . . . 0.0 109.653 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 ptt85 -82.94 13.77 3.73 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.54 -1.35 . . . . 0.0 112.428 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -132.48 33.76 3.78 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.723 2.009 . . . . 0.0 111.536 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.572 HG12 HD12 ' A' ' 55' ' ' LEU . 15.7 m -73.06 3.81 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 120.326 -1.484 . . . . 0.0 114.641 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -48.75 -33.46 10.33 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -102.6 0.17 32.93 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 120.114 1.325 . . . . 0.0 112.454 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.572 HD12 HG12 ' A' ' 52' ' ' VAL . 95.6 mt -95.48 163.14 13.35 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 120.256 -1.528 . . . . 0.0 111.457 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.425 ' HG3' ' HE ' ' A' ' 59' ' ' ARG . 14.8 mm-40 -70.62 155.36 40.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -120.62 -23.66 5.98 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.26 -13.53 46.46 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.195 0.998 . . . . 0.0 113.507 -178.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.425 ' HE ' ' HG3' ' A' ' 56' ' ' GLU . 3.2 mtm-85 -84.29 7.64 18.63 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.452 1.101 . . . . 0.0 112.915 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.0 -173.46 15.57 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -92.62 105.35 14.17 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-O 117.708 -1.139 . . . . 0.0 109.844 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -69.67 128.92 16.81 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.239 2.626 . . . . 0.0 110.319 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.519 HG22 ' HA ' ' A' ' 48' ' ' SER . 12.5 pt -139.64 177.71 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.5 1.52 . . . . 0.0 109.218 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.681 ' CD1' HG22 ' A' ' 92' ' ' ILE . 1.2 t80 -133.01 158.62 42.25 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.6 tt -155.45 155.91 34.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.623 1.569 . . . . 0.0 108.609 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.411 ' HA3' ' SG ' ' A' ' 73' ' ' CYS . . . -162.41 178.46 38.19 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.678 HD11 HD11 ' A' ' 30' ' ' LEU . 5.4 mt -87.18 177.73 7.09 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.408 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 1.5 t-20 -140.62 111.39 6.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.062 -1.024 . . . . 0.0 108.832 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 153.39 -18.57 0.7 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-O 117.962 -1.465 . . . . 0.0 115.403 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.28 24.47 0.62 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.574 1.687 . . . . 0.0 111.969 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 57.24 72.96 0.48 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.324 1.85 . . . . 0.0 109.07 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.42 125.87 10.9 Favored 'General case' 0 N--CA 1.461 0.107 0 O-C-N 121.215 -0.928 . . . . 0.0 111.559 -178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.731 ' SG ' HG23 ' A' ' 92' ' ' ILE . 24.3 m -133.05 172.85 12.09 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.106 0.962 . . . . 0.0 110.936 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.9 mt -55.68 150.91 11.72 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.8 ttp -157.18 117.37 3.5 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.3 m -84.5 115.89 22.82 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.598 1.09 . . . . 0.0 110.97 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.462 ' HB3' ' OE1' ' A' ' 86' ' ' GLN . . . -116.86 -170.43 1.83 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -149.35 128.57 12.85 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.1 m -81.84 38.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.59 -7.81 2.61 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 120.914 -1.116 . . . . 0.0 113.253 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -123.85 -50.63 1.83 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 127.653 2.381 . . . . 0.0 113.365 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -144.61 156.51 56.41 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 123.908 0.883 . . . . 0.0 108.965 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.46 160.03 44.83 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.467 1.445 . . . . 0.0 110.974 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.5 p -147.82 160.13 43.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.499 1.119 . . . . 0.0 109.394 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.558 HD11 HD12 ' A' ' 128' ' ' ILE . 3.7 mt -98.64 127.21 44.49 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.462 ' OE1' ' HB3' ' A' ' 77' ' ' ALA . 6.8 mp0 -123.67 68.09 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.717 0.807 . . . . 0.0 109.838 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.768 HD13 HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -84.18 102.68 12.78 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.3 -35.56 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.709 1.256 . . . . 0.0 111.342 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -137.3 90.92 2.56 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.61 1.164 . . . . 0.0 109.847 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.565 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -173.76 158.24 3.24 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 120.858 -1.151 . . . . 0.0 109.02 178.342 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -138.81 134.03 32.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.104 1.361 . . . . 0.0 107.518 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.731 HG23 ' SG ' ' A' ' 73' ' ' CYS . 37.0 pt -90.25 -33.53 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 C-N-CA 123.806 0.843 . . . . 0.0 111.003 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -32.3 73.89 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 118.299 0.5 . . . . 0.0 110.244 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -62.36 -54.31 42.26 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.624 0.647 . . . . 0.0 109.816 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.459 HD12 ' CD1' ' A' ' 64' ' ' TYR . 14.3 mt -60.22 -40.89 91.75 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -65.11 -31.54 72.79 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.06 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -77.5 -36.07 53.0 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 116.42 -1.752 . . . . 0.0 113.603 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.61 174.43 2.35 Favored Pre-proline 0 N--CA 1.472 0.637 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -175.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.6 -162.93 0.16 Allowed 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.829 2.353 . . . . 0.0 108.228 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 69.3 65.09 0.52 Allowed Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.888 1.675 . . . . 0.0 113.275 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -56.42 116.62 3.32 Favored 'Trans proline' 0 C--O 1.244 0.819 0 C-N-CA 121.903 1.736 . . . . 0.0 110.553 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.96 84.75 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -42.77 -33.77 0.81 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.535 1.934 . . . . 0.0 112.929 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -59.26 -15.25 14.51 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.905 1.682 . . . . 0.0 113.328 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.7 5.9 6.14 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.071 1.348 . . . . 0.0 110.438 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 39.4 mt -101.35 153.71 19.43 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 120.46 1.482 . . . . 0.0 109.208 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.589 ' CE2' HD11 ' A' ' 128' ' ' ILE . 43.3 m-85 -140.73 131.57 25.9 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.259 0.623 . . . . 0.0 110.686 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.442 ' CE1' ' HA ' ' A' ' 121' ' ' VAL . 83.3 m-85 -76.86 123.09 25.74 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.061 0.945 . . . . 0.0 109.346 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -82.4 126.22 31.94 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.9 t -120.95 170.84 9.11 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -142.42 158.77 43.34 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.718 2.007 . . . . 0.0 109.018 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 80.7 p -124.14 -4.58 7.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.854 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.92 -44.17 1.27 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -137.82 10.48 2.87 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.47 1.108 . . . . 0.0 112.965 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -146.84 164.1 33.93 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 106.654 -1.609 . . . . 0.0 106.654 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 m -128.98 153.55 47.45 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.704 0.684 . . . . 0.0 110.527 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.4 170.15 11.13 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -139.19 109.29 6.4 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.916 1.686 . . . . 0.0 109.666 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -106.39 126.18 51.92 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.517 1.127 . . . . 0.0 110.164 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.9 t -50.9 127.58 18.98 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.448 0.699 . . . . 0.0 110.205 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.442 ' HA ' ' CE1' ' A' ' 108' ' ' TYR . 53.6 t -68.37 -48.12 74.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.71 -40.09 91.89 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.269 1.028 . . . . 0.0 112.842 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -127.94 84.74 62.44 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -69.24 160.88 48.12 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 N-CA-C 108.368 -1.436 . . . . 0.0 108.368 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.75 -32.03 7.47 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -95.82 140.28 30.83 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 118.03 0.915 . . . . 0.0 109.442 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -120.33 138.97 53.42 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 127.078 2.151 . . . . 0.0 108.597 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.589 HD11 ' CE2' ' A' ' 107' ' ' PHE . 28.3 mm -70.24 139.7 19.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -115.18 126.15 54.25 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.943 0.792 . . . . 0.0 111.399 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.8 m -73.74 -5.36 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.816 -1.178 . . . . 0.0 112.697 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.6 m 54.12 35.12 21.61 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.406 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 7.8 m -73.18 -1.97 19.75 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.807 1.243 . . . . 0.0 112.749 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -94.91 130.22 41.61 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 101.911 -3.366 . . . . 0.0 101.911 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.32 -84.78 0.05 OUTLIER Glycine 0 CA--C 1.531 1.04 0 C-N-CA 123.554 0.597 . . . . 0.0 111.913 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.33 68.0 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 129.219 3.295 . . . . 0.0 108.361 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 m -91.52 168.45 13.32 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 117.886 0.843 . . . . 0.0 110.523 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 55.7 Cg_endo -67.99 159.82 51.27 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 N-CA-C 107.888 -1.62 . . . . 0.0 107.888 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.9 mt -80.96 137.39 36.1 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -163.14 171.61 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 125.286 1.434 . . . . 0.0 109.354 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.12 171.14 8.92 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.4 t -157.89 145.56 18.5 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.47 -1.394 . . . . 0.0 108.441 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -106.02 -26.23 11.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.559 0.618 . . . . 0.0 109.797 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 N--CA 1.441 -0.902 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 179.401 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.5 p -108.91 97.36 7.01 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.23 1.012 . . . . 0.0 111.611 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.8 p -93.62 -31.76 14.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.815 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.67 113.42 26.55 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 118.413 -0.803 . . . . 0.0 112.893 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -161.26 178.79 8.89 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.07 1.305 . . . . 0.0 112.168 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.83 173.63 21.01 Favored Glycine 0 C--O 1.24 0.485 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.6 tp -120.98 138.88 53.94 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.3 m -89.99 41.92 1.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.02 167.49 15.83 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.2 mt -136.73 151.59 49.39 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.876 1.27 . . . . 0.0 107.699 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 55.4 p90 . . . . . 0 C--O 1.254 1.339 0 C-N-CA 125.191 1.397 . . . . 0.0 109.014 179.533 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 117.24 -1.362 . . . . 0.0 107.469 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.52 122.75 10.5 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.341 2.028 . . . . 0.0 108.982 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.73 138.4 40.41 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -135.19 148.44 49.67 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 119.086 0.857 . . . . 0.0 110.801 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.08 -130.43 1.26 Allowed Glycine 0 C--O 1.227 -0.339 0 CA-C-O 118.668 -1.073 . . . . 0.0 111.534 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.5 p -145.71 -177.7 5.72 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.875 1.338 . . . . 0.0 113.226 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mt -140.54 -11.56 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 126.403 1.881 . . . . 0.0 109.336 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -61.04 -17.98 55.3 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 119.778 -1.826 . . . . 0.0 113.687 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.73 -7.88 5.71 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.757 2.423 . . . . 0.0 113.838 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.6 mm -91.56 -41.51 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.97 23.14 0.86 Allowed 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 121.088 -1.008 . . . . 0.0 111.016 -176.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 62.59 27.83 16.38 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.629 0.728 . . . . 0.0 112.035 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.85 91.09 6.27 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.7 t -85.67 161.51 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -118.79 144.13 46.5 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 119.553 1.069 . . . . 0.0 110.953 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.7 t -142.65 134.45 25.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 tp -68.71 120.73 15.14 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 103.594 -2.743 . . . . 0.0 103.594 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -137.17 123.11 20.17 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.4 t0 47.07 49.41 15.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.001 1.32 . . . . 0.0 112.644 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 67.59 12.05 8.68 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.949 2.1 . . . . 0.0 115.623 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.1 m -132.42 143.54 49.88 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.652 1.115 . . . . 0.0 109.88 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.441 ' CD1' HD12 ' A' ' 138' ' ' LEU . 7.1 mt -81.96 121.95 27.17 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.41 -1.431 . . . . 0.0 107.872 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.79 136.76 53.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.54 136.98 40.56 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 124.59 1.182 . . . . 0.0 108.105 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 m -119.5 87.19 35.87 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.54 1.136 . . . . 0.0 108.569 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.66 -44.72 2.81 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.78 2.32 . . . . 0.0 112.927 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -153.22 44.13 0.63 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.49 1.516 . . . . 0.0 109.611 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.0 124.77 32.82 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -55.6 -32.95 63.51 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 123.981 0.801 . . . . 0.0 109.65 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -89.1 31.0 0.9 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.624 1.569 . . . . 0.0 112.513 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -80.2 168.06 19.55 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.068 -1.645 . . . . 0.0 109.97 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.81 147.97 18.26 Favored Pre-proline 0 N--CA 1.448 -0.56 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.39 159.58 46.37 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.286 2.657 . . . . 0.0 108.531 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.85 160.0 9.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 125.77 1.628 . . . . 0.0 108.115 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.04 154.42 27.71 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.964 1.706 . . . . 0.0 108.111 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mm -130.12 104.35 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.193 1.397 . . . . 0.0 108.088 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.97 141.36 28.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.5 tt -132.69 140.2 48.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.57 145.46 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.8 p -75.65 161.9 28.7 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 124.785 1.234 . . . . 0.0 107.824 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.94 176.01 9.61 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.474 ' HB2' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -125.19 -7.52 7.09 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -116.69 37.64 3.72 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.5 m -60.99 -16.29 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 125.253 1.421 . . . . 0.0 113.544 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.46 -18.41 65.3 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.948 0.499 . . . . 0.0 110.094 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.14 -0.82 49.61 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.117 0.967 . . . . 0.0 112.262 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.2 mt -106.69 179.25 4.32 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.262 0.937 . . . . 0.0 110.343 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -92.37 157.63 16.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.909 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.77 -19.46 6.77 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.816 1.247 . . . . 0.0 112.7 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.25 -31.63 72.83 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.506 1.122 . . . . 0.0 113.44 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -86.84 -5.67 59.03 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.536 0.734 . . . . 0.0 112.707 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 127.0 -158.12 20.85 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -102.09 107.77 54.05 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.42 123.5 9.17 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.532 2.821 . . . . 0.0 109.64 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.8 pt -132.91 -171.94 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.445 1.898 . . . . 0.0 108.434 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.655 ' CD1' HG22 ' A' ' 92' ' ' ILE . 1.5 t80 -134.15 158.62 43.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.588 1.155 . . . . 0.0 108.953 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.1 tt -149.59 150.06 31.63 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.425 1.49 . . . . 0.0 108.534 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.67 177.19 30.52 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 124.211 0.91 . . . . 0.0 111.945 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mt -97.96 132.25 43.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -96.53 35.69 1.46 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.425 1.011 . . . . 0.0 112.581 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -97.7 -96.87 1.96 Allowed Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.488 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.407 ' H ' HD11 ' A' ' 72' ' ' LEU . 24.3 mt -87.8 13.87 9.82 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.885 1.674 . . . . 0.0 115.018 -177.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 m120 72.37 70.88 0.15 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.437 1.895 . . . . 0.0 109.278 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.407 HD11 ' H ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -141.44 145.89 35.83 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 125.328 1.451 . . . . 0.0 107.976 -177.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.526 ' SG ' HG23 ' A' ' 92' ' ' ILE . 56.9 m -143.72 174.05 11.14 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.202 0.91 . . . . 0.0 109.855 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.455 HD23 HD21 ' A' ' 87' ' ' LEU . 15.1 mt -59.9 150.97 27.08 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.015 0.37 . . . . 0.0 111.185 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.9 ttp -157.89 116.05 3.08 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 95.8 m -89.78 109.7 20.67 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 119.288 0.949 . . . . 0.0 109.46 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.53 -169.23 1.44 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -130.78 118.54 20.97 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.2 p -65.67 -9.97 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.45 -1.29 7.56 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 125.295 1.426 . . . . 0.0 110.981 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -150.09 -44.25 0.13 Allowed 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.072 0.949 . . . . 0.0 111.484 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -135.44 163.06 53.5 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 124.903 1.281 . . . . 0.0 111.504 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -71.95 146.89 48.35 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.396 2.064 . . . . 0.0 112.635 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.1 p -145.75 170.89 15.61 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.4 mt -98.0 132.53 43.48 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -126.15 73.35 1.36 Allowed 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.02 0.928 . . . . 0.0 108.806 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.455 HD21 HD23 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -85.84 107.82 17.84 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 178.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.08 -30.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.127 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -157.35 97.73 1.65 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.183 0.993 . . . . 0.0 110.666 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.48 ' CE ' ' H ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -172.84 161.54 4.64 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.509 1.524 . . . . 0.0 107.131 178.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.48 ' H ' ' CE ' ' A' ' 90' ' ' LYS . 0.9 OUTLIER -131.1 130.31 42.99 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.424 1.49 . . . . 0.0 112.431 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.655 HG22 ' CD1' ' A' ' 64' ' ' TYR . 8.1 pt -82.37 -39.67 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 126.233 1.813 . . . . 0.0 111.644 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.2 tpt -64.51 -34.55 78.49 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.297 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.51 -45.88 92.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.879 0.763 . . . . 0.0 109.356 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.6 HD12 ' CD1' ' A' ' 64' ' ' TYR . 10.1 mt -65.82 -33.69 76.44 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.758 0.708 . . . . 0.0 111.278 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -79.77 -16.39 55.63 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.468 0.576 . . . . 0.0 110.403 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -91.73 -36.42 13.59 Favored 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 125.371 1.468 . . . . 0.0 111.486 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.79 159.03 42.25 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 121.141 -0.975 . . . . 0.0 112.049 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -78.86 54.11 4.98 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.435 2.09 . . . . 0.0 112.172 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -116.24 71.85 4.63 Favored Pre-proline 0 N--CA 1.473 0.683 0 O-C-N 120.713 -1.242 . . . . 0.0 110.827 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -79.99 82.1 2.58 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.599 2.199 . . . . 0.0 109.166 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.2 t -74.36 106.01 3.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -50.98 -30.53 15.31 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.423 1.01 . . . . 0.0 111.255 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 m -70.83 -8.82 55.37 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -114.03 -22.6 9.98 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.159 -0.963 . . . . 0.0 109.134 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.3 mt -84.34 154.23 23.02 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.007 0.923 . . . . 0.0 113.024 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -140.28 133.17 29.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.022 0.929 . . . . 0.0 110.079 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -77.41 118.45 19.88 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -81.17 141.06 34.58 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.0 m -138.87 174.38 10.58 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.465 1.106 . . . . 0.0 108.175 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -153.14 150.74 29.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.858 0.463 . . . . 0.0 110.142 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.01 107.07 0.35 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.36 56.92 3.28 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 126.121 1.819 . . . . 0.0 111.756 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 11.7 mtm-85 61.87 9.04 2.74 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.6 1.96 . . . . 0.0 109.798 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -117.5 162.35 18.12 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 119.903 1.228 . . . . 0.0 110.882 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.0 m -111.78 158.79 18.94 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.213 2.205 . . . . 0.0 108.632 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.65 162.82 34.55 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.474 1.909 . . . . 0.0 108.747 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -140.83 116.21 10.05 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -108.89 130.14 55.43 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.465 1.506 . . . . 0.0 109.226 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.9 t -56.69 117.69 4.14 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.356 1.462 . . . . 0.0 110.248 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.2 t -62.72 -40.68 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 119.076 0.853 . . . . 0.0 111.022 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.33 -42.02 88.78 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -133.2 86.49 41.7 Favored Pre-proline 0 C--O 1.237 0.414 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.04 168.8 11.59 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.285 2.656 . . . . 0.0 111.535 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.49 -21.67 31.2 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -101.03 118.03 36.19 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 127.444 2.298 . . . . 0.0 107.078 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -108.1 148.32 29.99 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.104 1.361 . . . . 0.0 108.902 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.4 mt -75.61 122.82 30.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.15 140.29 29.81 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.354 0.597 . . . . 0.0 110.494 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.4 m -90.58 -4.75 10.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 C-N-CA 124.548 1.139 . . . . 0.0 112.231 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.1 m 52.97 73.86 0.33 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 123.126 1.441 . . . . 0.0 113.571 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.0 t -93.83 6.12 49.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.676 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -115.36 136.22 53.32 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 53.84 -104.48 0.23 Allowed Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 107.561 -2.216 . . . . 0.0 107.561 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -173.35 66.43 0.11 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 106.394 -2.682 . . . . 0.0 106.394 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 56.5 m -82.0 157.74 68.35 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 117.534 0.667 . . . . 0.0 110.642 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -71.14 165.75 31.39 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 121.973 1.782 . . . . 0.0 108.521 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.441 HD12 ' CD1' ' A' ' 30' ' ' LEU . 22.6 mt -87.82 113.33 23.38 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.642 1.177 . . . . 0.0 112.06 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 pp -135.95 178.44 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 125.447 1.499 . . . . 0.0 109.455 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 35.6 mt -96.17 141.58 29.37 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.2 t -129.85 129.8 44.44 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -87.26 -23.47 24.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 122.315 1.055 . . . . 0.0 110.88 -177.977 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 55.8 m -109.8 118.51 36.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.7 p -108.07 -11.94 15.21 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.409 1.084 . . . . 0.0 110.099 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.69 126.84 48.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.759 1.223 . . . . 0.0 109.919 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -152.72 -165.08 2.1 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.333 -0.854 . . . . 0.0 109.41 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -148.1 127.59 2.63 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 106.055 -2.818 . . . . 0.0 106.055 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.52 114.47 26.01 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.8 m -78.41 39.59 0.33 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.588 2.355 . . . . 0.0 107.716 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -64.18 148.57 49.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.403 1.881 . . . . 0.0 107.999 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.1 mt -129.51 162.55 27.89 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.244 1.818 . . . . 0.0 108.43 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 22.9 p90 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 115.361 -2.257 . . . . 0.0 109.677 -179.592 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.54 0.582 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.46 ' HB3' HD11 ' A' ' 47' ' ' ILE . 60.7 Cg_endo -69.94 132.15 22.45 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.442 2.094 . . . . 0.0 107.497 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.99 132.81 42.43 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.5 mp0 -128.89 145.98 51.07 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.14 -139.19 2.67 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 95.0 p -143.96 -172.62 3.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.036 0.918 . . . . 0.0 112.796 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.3 mt -140.05 -10.6 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 126.443 1.897 . . . . 0.0 109.337 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -24.02 65.31 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 119.544 -1.972 . . . . 0.0 113.268 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -58.86 -16.38 17.06 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.917 2.087 . . . . 0.0 112.706 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.5 mt -74.79 -67.11 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.138 1.375 . . . . 0.0 112.8 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -136.7 32.09 2.75 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.149 0.976 . . . . 0.0 110.535 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 58.62 37.42 25.31 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.924 0.868 . . . . 0.0 110.643 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.1 mmt-85 -105.72 89.67 3.16 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.824 -1.173 . . . . 0.0 109.217 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.3 t -79.11 157.25 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.418 ' CD2' HD11 ' A' ' 138' ' ' LEU . 49.8 m0 -111.47 153.78 25.66 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.988 0.915 . . . . 0.0 108.673 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.5 t -146.62 135.65 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.1 tp -76.25 106.89 8.12 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -132.16 133.51 44.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 119.843 1.201 . . . . 0.0 111.293 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t0 47.83 42.79 16.5 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 123.641 1.686 . . . . 0.0 111.28 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 61.61 26.93 16.51 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 127.223 2.209 . . . . 0.0 115.122 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.1 m -138.71 154.79 48.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.968 HD11 HD21 ' A' ' 67' ' ' LEU . 9.8 mt -92.94 126.45 38.02 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mt -126.97 132.16 70.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 123.141 0.576 . . . . 0.0 110.736 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.34 136.38 46.17 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.951 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.7 m -112.96 81.44 4.57 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.786 1.235 . . . . 0.0 108.117 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.12 -33.36 25.34 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.559 2.172 . . . . 0.0 111.851 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -151.33 12.73 0.65 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -62.86 138.65 58.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 120.585 -1.322 . . . . 0.0 111.059 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -33.13 75.16 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.603 1.961 . . . . 0.0 109.038 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -102.08 71.59 1.27 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.7 ptm -106.7 163.07 13.21 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -157.43 141.12 11.37 Favored Pre-proline 0 N--CA 1.446 -0.652 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -71.91 163.78 37.74 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 N-CA-C 108.502 -1.384 . . . . 0.0 108.502 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.8 p -155.62 154.19 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.437 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.46 150.99 25.53 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 126.827 2.051 . . . . 0.0 110.355 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 12' ' ' GLN . 43.3 mm -121.56 122.34 66.85 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 68' ' ' ASN . . . -100.71 145.84 27.96 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.453 HD12 HD12 ' A' ' 65' ' ' LEU . 3.9 tt -140.18 138.01 34.82 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.473 HD12 HG12 ' A' ' 92' ' ' ILE . 80.9 mt -146.77 138.0 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 C-N-CA 126.129 1.772 . . . . 0.0 109.856 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.4 p -84.28 130.24 34.82 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 89.9 m -62.68 138.74 58.58 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -94.42 -28.36 15.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.858 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -90.85 40.73 1.03 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.2 m -68.22 -8.81 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 120.44 -1.412 . . . . 0.0 112.783 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -62.6 -7.37 4.61 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.032 2.133 . . . . 0.0 113.583 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 t -122.5 7.23 9.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.897 1.279 . . . . 0.0 111.605 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.6 mt -107.49 167.31 10.03 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.849 -1.157 . . . . 0.0 108.601 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -64.71 153.34 39.98 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.268 -1.333 . . . . 0.0 107.992 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -121.72 -47.01 2.22 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.091 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.16 -26.45 62.75 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 127.909 2.484 . . . . 0.0 113.315 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -85.04 -19.47 31.92 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.789 -0.57 . . . . 0.0 111.601 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 140.71 -167.44 25.59 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -97.45 102.1 11.9 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.683 0.793 . . . . 0.0 110.676 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.64 138.17 23.6 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 124.298 3.332 . . . . 0.0 112.741 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pp -146.08 -175.35 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 125.738 1.615 . . . . 0.0 110.246 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.498 ' CE1' HD12 ' A' ' 95' ' ' LEU . 3.2 t80 -134.16 156.46 48.29 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.678 0.791 . . . . 0.0 110.527 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.465 HD11 HD21 ' A' ' 154' ' ' LEU . 6.8 tt -154.3 151.82 29.55 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.599 1.56 . . . . 0.0 108.428 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.92 -176.67 34.26 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.968 HD21 HD11 ' A' ' 30' ' ' LEU . 11.0 mt -83.47 171.03 13.82 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 176.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 10.5 t-20 -137.68 47.34 2.06 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.603 -1.311 . . . . 0.0 109.6 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.83 -75.99 0.54 Allowed Glycine 0 C--N 1.337 0.63 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.381 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.21 25.11 11.43 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -178.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 m120 66.88 72.96 0.36 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.662 1.185 . . . . 0.0 109.804 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.46 141.71 25.1 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.963 1.305 . . . . 0.0 110.573 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.3 m -144.04 165.48 27.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.02 0.827 . . . . 0.0 111.385 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.84 156.62 8.63 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.518 1.127 . . . . 0.0 110.174 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.1 tmm? -164.37 140.53 6.17 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.5 m -102.78 119.61 39.14 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.45 -171.75 2.44 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.124 1.37 . . . . 0.0 107.874 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -128.25 127.09 42.18 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.94 -8.04 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 123.437 0.461 . . . . 0.0 110.697 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.73 -82.44 0.1 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -117.17 7.66 13.05 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.968 0.89 . . . . 0.0 112.701 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -141.1 151.01 60.85 Favored Pre-proline 0 C--O 1.241 0.651 0 C-N-CA 124.807 1.243 . . . . 0.0 110.547 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.72 149.13 18.18 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.733 2.289 . . . . 0.0 108.978 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.5 p -144.14 170.61 15.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.957 0.903 . . . . 0.0 110.393 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.66 HD11 HG23 ' A' ' 128' ' ' ILE . 3.5 mt -91.79 151.24 20.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.399 1.08 . . . . 0.0 108.679 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -148.63 80.94 1.45 Allowed 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 125.079 1.351 . . . . 0.0 107.628 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.62 ' HG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -104.96 97.39 7.25 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 125.942 1.697 . . . . 0.0 108.858 -177.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.08 -26.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.871 0.732 . . . . 0.0 112.274 -177.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -145.24 103.59 3.86 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.541 1.537 . . . . 0.0 109.482 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.433 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER 174.11 159.25 0.16 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.133 1.373 . . . . 0.0 108.915 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -136.35 127.74 28.44 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.181 0.593 . . . . 0.0 110.795 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.473 HG12 HD12 ' A' ' 47' ' ' ILE . 1.1 tt -68.26 -47.17 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 125.903 1.681 . . . . 0.0 114.25 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.8 tpt -62.95 -29.73 71.03 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.982 -0.532 . . . . 0.0 111.268 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.22 -54.51 32.35 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.034 0.533 . . . . 0.0 109.691 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.498 HD12 ' CE1' ' A' ' 64' ' ' TYR . 42.2 mt -63.87 -30.04 71.17 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.414 ' CG ' HG21 ' A' ' 47' ' ' ILE . 52.1 t80 -74.39 -52.42 12.17 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -60.63 -45.08 95.42 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 125.682 1.593 . . . . 0.0 112.685 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -92.99 145.37 29.99 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.64 50.0 2.59 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.439 2.76 . . . . 0.0 112.124 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -118.12 72.73 9.4 Favored Pre-proline 0 CA--C 1.537 0.48 0 O-C-N 120.745 -1.222 . . . . 0.0 109.332 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.94 92.28 1.05 Allowed 'Trans proline' 0 N--CA 1.45 -1.037 0 N-CA-C 105.284 -2.622 . . . . 0.0 105.284 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.5 t -88.35 97.72 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -50.55 -22.23 1.88 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.02 -17.34 64.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.209 0.604 . . . . 0.0 110.858 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -113.61 -22.07 10.46 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 119.164 0.893 . . . . 0.0 110.649 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.8 mt -78.97 164.37 24.46 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.698 1.199 . . . . 0.0 113.64 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.92 140.63 22.65 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 123.772 0.829 . . . . 0.0 111.016 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.43 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.5 OUTLIER -75.3 123.18 24.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 176.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.431 ' CD2' ' HB3' ' A' ' 116' ' ' SER . 3.9 t-160 -97.94 101.35 12.81 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.883 1.273 . . . . 0.0 107.577 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.51 170.9 13.0 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.925 1.29 . . . . 0.0 110.095 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -139.86 147.38 40.58 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.675 1.59 . . . . 0.0 110.044 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.4 p -135.59 15.4 3.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.823 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.5 -79.23 0.31 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -111.47 -1.41 15.9 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.18 0.992 . . . . 0.0 111.985 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -127.03 160.87 29.83 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.206 1.002 . . . . 0.0 108.357 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.431 ' HB3' ' CD2' ' A' ' 109' ' ' HIS . 49.9 m -132.5 151.66 51.83 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.234 1.814 . . . . 0.0 109.024 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.11 165.75 12.79 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -142.8 107.96 4.97 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -111.65 124.72 52.9 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.398 1.879 . . . . 0.0 110.056 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.8 t -53.01 130.23 33.13 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.304 -0.872 . . . . 0.0 110.032 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.2 t -68.87 -51.18 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.909 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.01 78.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -129.19 81.6 70.15 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 124.055 0.942 . . . . 0.0 109.903 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -65.38 161.61 37.2 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.671 2.247 . . . . 0.0 111.113 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.2 0.06 77.69 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.205 -0.775 . . . . 0.0 113.06 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -126.69 131.23 51.43 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.455 1.902 . . . . 0.0 107.753 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.6 149.97 33.77 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.948 1.299 . . . . 0.0 112.493 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.66 HG23 HD11 ' A' ' 85' ' ' LEU . 2.1 mt -81.51 119.25 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.609 0.764 . . . . 0.0 111.176 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.72 152.31 31.64 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.638 1.108 . . . . 0.0 109.965 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.9 t -103.48 -18.2 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 127.797 2.439 . . . . 0.0 109.754 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.504 ' HB3' ' H ' ' A' ' 136' ' ' CYS . 50.9 m 61.24 39.24 15.91 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.391 1.476 . . . . 0.0 114.295 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.1 m -76.76 -11.38 59.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.61 -66.99 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.77 1.628 . . . . 0.0 111.071 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -122.88 -48.49 0.25 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 124.321 0.963 . . . . 0.0 111.288 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 138.75 60.44 0.05 OUTLIER Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . 0.504 ' H ' ' HB3' ' A' ' 131' ' ' SER . 0.5 OUTLIER -90.45 174.16 4.91 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 123.95 0.9 . . . . 0.0 110.933 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.01 166.43 29.61 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 N-CA-C 108.928 -1.22 . . . . 0.0 108.928 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.418 HD11 ' CD2' ' A' ' 23' ' ' TRP . 21.9 mt -87.28 114.09 23.58 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.9 pp -137.93 172.02 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.078 1.351 . . . . 0.0 110.754 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 66.3 mt -97.72 159.89 14.65 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.37 161.33 41.22 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 125.321 1.448 . . . . 0.0 107.316 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -104.57 -45.66 4.56 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.126 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m120 . . . . . 0 N--CA 1.459 0.019 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.4 m -146.53 107.9 4.25 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 102.088 -3.301 . . . . 0.0 102.088 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.49 -9.12 14.23 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.389 1.076 . . . . 0.0 110.546 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -123.26 112.32 17.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.94 -176.62 5.0 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.085 0.954 . . . . 0.0 111.165 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.99 -169.04 32.13 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.347 0.975 . . . . 0.0 112.675 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.465 HD21 HD11 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -145.5 130.33 18.16 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.942 1.697 . . . . 0.0 106.769 179.164 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 39.2 m -90.34 51.32 2.0 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -68.73 138.13 54.64 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 40.8 mt -123.03 170.23 10.37 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.159 2.184 . . . . 0.0 107.95 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 1.8 p90 . . . . . 0 C--O 1.255 1.347 0 CA-C-O 117.416 -1.278 . . . . 0.0 108.677 -179.842 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.239 0.55 0 CA-C-O 119.581 -0.247 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.1 146.1 80.97 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.949 1.766 . . . . 0.0 107.833 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -141.23 108.77 5.59 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -111.15 145.18 39.08 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.303 0.641 . . . . 0.0 110.227 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.28 -117.99 0.48 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.0 p -160.45 167.58 26.97 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 119.118 1.459 . . . . 0.0 114.018 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.517 HG22 HH12 ' A' ' 21' ' ' ARG . 30.0 mt -127.19 -2.56 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 123.463 0.705 . . . . 0.0 109.37 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -62.52 -28.65 69.99 Favored 'General case' 0 C--N 1.334 -0.094 0 O-C-N 119.4 -2.062 . . . . 0.0 115.028 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.41 -19.79 16.59 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.205 1.802 . . . . 0.0 112.635 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.7 mm -56.69 -54.48 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 127.458 2.303 . . . . 0.0 115.292 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -151.27 35.17 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.12 16.58 3.02 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.643 1.977 . . . . 0.0 114.29 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.517 HH12 HG22 ' A' ' 15' ' ' ILE . 1.1 ptm180 -88.22 94.89 9.97 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.596 1.558 . . . . 0.0 109.78 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -75.67 157.73 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.514 ' CZ3' HD12 ' A' ' 15' ' ' ILE . 17.5 m0 -108.21 147.9 30.71 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.1 t -142.6 127.93 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.427 HD22 ' CD2' ' A' ' 72' ' ' LEU . 3.9 tp -72.31 107.62 5.01 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -124.88 124.82 42.88 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 120.602 1.547 . . . . 0.0 110.37 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 t0 47.81 57.24 6.19 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.443 1.116 . . . . 0.0 111.229 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 51.75 24.9 2.64 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.228 1.011 . . . . 0.0 113.542 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.3 m -142.96 127.05 17.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.463 HD11 HD11 ' A' ' 67' ' ' LEU . 14.9 mt -74.66 144.06 43.99 Favored 'General case' 0 CA--C 1.518 -0.258 0 O-C-N 119.55 -1.969 . . . . 0.0 109.306 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.4 pt -125.14 153.07 32.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 123.895 0.878 . . . . 0.0 108.862 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.36 123.02 44.05 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.3 m -111.25 78.23 1.77 Allowed Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.043 0.937 . . . . 0.0 108.87 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.73 -50.12 2.62 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.57 1.513 . . . . 0.0 110.425 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -141.98 79.73 1.68 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.637 1.175 . . . . 0.0 108.176 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -140.98 132.78 27.42 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.39 -42.56 98.91 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.632 0.582 . . . . 0.0 112.01 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -71.73 22.34 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -73.15 163.73 27.71 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 120.444 -1.41 . . . . 0.0 110.317 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.0 t -156.53 132.43 5.81 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.14 144.99 59.29 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.841 2.361 . . . . 0.0 110.633 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.56 164.51 34.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.523 1.129 . . . . 0.0 108.244 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -115.49 156.2 26.11 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 mm -123.0 136.06 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.24 126.14 46.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 119.926 1.239 . . . . 0.0 107.944 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -118.96 136.86 53.87 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.608 1.163 . . . . 0.0 110.481 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 mt -148.96 142.33 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.941 1.296 . . . . 0.0 109.246 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.7 p -84.83 153.69 22.78 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.2 m -79.53 130.2 35.17 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 120.173 -1.58 . . . . 0.0 108.117 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -79.14 -32.18 44.3 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -97.34 44.8 1.04 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.967 1.307 . . . . 0.0 110.65 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 m -66.22 -7.53 5.48 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 O-C-N 120.412 -1.43 . . . . 0.0 113.636 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -55.5 -28.92 57.5 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.285 0.948 . . . . 0.0 112.662 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.4 t -95.44 -11.13 28.1 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.902 0.774 . . . . 0.0 111.569 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.52 168.24 11.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -82.05 154.44 25.63 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -119.84 -18.31 8.29 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.056 1.343 . . . . 0.0 111.062 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -57.51 -39.59 76.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.107 2.563 . . . . 0.0 114.191 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -85.06 -12.8 52.23 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.178 0.991 . . . . 0.0 111.396 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.06 -162.26 24.99 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -93.94 103.66 11.01 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 126.148 1.779 . . . . 0.0 109.862 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.08 135.73 25.74 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.447 2.098 . . . . 0.0 109.966 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -133.15 178.06 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.633 ' CD1' HG22 ' A' ' 92' ' ' ILE . 2.1 t80 -137.76 131.4 31.19 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.033 0.533 . . . . 0.0 109.567 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.72 158.7 38.67 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.43 -170.09 22.69 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.463 HD11 HD11 ' A' ' 30' ' ' LEU . 4.3 mt -98.85 166.73 11.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -130.31 94.77 3.74 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.98 -16.23 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 CA-C-O 116.574 -2.236 . . . . 0.0 116.977 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.15 22.95 0.11 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 120.493 2.146 . . . . 0.0 111.914 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 61.45 63.37 1.2 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.786 1.634 . . . . 0.0 108.993 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.427 ' CD2' HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -136.49 127.17 27.15 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.219 -178.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.579 ' SG ' HG23 ' A' ' 92' ' ' ILE . 29.1 m -136.84 179.65 6.24 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.931 ' HA ' HD12 ' A' ' 87' ' ' LEU . 10.9 mt -64.08 153.54 37.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.185 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -161.09 133.57 6.07 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 89.6 m -101.0 125.76 47.63 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.81 -174.7 3.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 81' ' ' ASP . 10.2 tttt -117.48 148.39 41.87 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.7 p -121.67 -6.79 9.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 123.564 0.54 . . . . 0.0 111.458 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.5 72.31 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.436 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 8.4 t0 70.48 5.27 5.3 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.811 2.044 . . . . 0.0 114.34 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.71 143.85 42.13 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.164 1.786 . . . . 0.0 109.356 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -74.91 162.04 37.97 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.989 2.459 . . . . 0.0 113.277 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.1 p -156.8 169.1 25.53 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.342 1.457 . . . . 0.0 109.997 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.798 HD11 HG22 ' A' ' 128' ' ' ILE . 0.9 OUTLIER -91.18 130.22 37.08 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 127.583 2.353 . . . . 0.0 105.164 178.105 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -136.99 70.38 1.4 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 122.118 0.961 . . . . 0.0 109.365 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.931 HD12 ' HA ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -89.14 113.78 24.99 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 127.458 2.303 . . . . 0.0 109.067 -178.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.64 -28.5 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 O-C-N 124.745 1.278 . . . . 0.0 113.529 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -147.65 97.68 2.86 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.361 1.465 . . . . 0.0 109.43 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.95 159.21 2.64 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -135.23 134.03 39.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.633 HG22 ' CD1' ' A' ' 64' ' ' TYR . 6.5 pt -83.62 -40.38 15.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.7 tpt -63.98 -31.05 72.1 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.237 -0.887 . . . . 0.0 112.424 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.55 -50.18 73.69 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.525 HD12 ' CD1' ' A' ' 64' ' ' TYR . 16.1 mt -63.44 -35.6 80.96 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.528 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -75.38 -26.41 58.44 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.931 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -78.88 -31.45 45.47 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 120.711 -1.243 . . . . 0.0 113.217 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -112.29 158.07 38.18 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 118.949 0.795 . . . . 0.0 110.829 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -86.74 45.0 1.27 Allowed 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.287 2.658 . . . . 0.0 114.157 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -125.24 58.1 18.87 Favored Pre-proline 0 CA--C 1.553 1.064 0 O-C-N 120.608 -1.308 . . . . 0.0 112.195 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -62.21 117.96 4.83 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.946 3.097 . . . . 0.0 110.82 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.1 t -99.92 107.41 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 123.447 0.699 . . . . 0.0 110.621 -177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.431 ' HB2' HG12 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -52.82 -24.28 8.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 118.182 -0.914 . . . . 0.0 112.877 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.1 m -67.69 -11.35 58.12 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.363 0.983 . . . . 0.0 111.362 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -119.62 -16.1 8.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.256 1.422 . . . . 0.0 110.294 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.6 mt -83.74 154.9 23.35 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.08 0.854 . . . . 0.0 111.867 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -136.88 128.14 28.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.483 0.713 . . . . 0.0 110.212 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -71.29 126.46 29.69 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 103.698 -2.704 . . . . 0.0 103.698 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -104.35 145.53 30.12 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.749 0.704 . . . . 0.0 110.25 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.66 -175.22 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.854 -0.529 . . . . 0.0 109.96 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -143.99 151.05 39.22 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.884 1.674 . . . . 0.0 106.959 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.5 p -124.98 -7.11 7.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.89 -35.81 2.39 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -147.68 -5.4 0.48 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.028 1.331 . . . . 0.0 112.082 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -131.57 177.33 7.58 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 125.331 1.452 . . . . 0.0 108.787 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 m -140.64 145.82 37.11 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.552 1.541 . . . . 0.0 110.078 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.65 166.9 10.63 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.926 0.89 . . . . 0.0 108.623 178.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -147.34 114.21 6.11 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.057 1.343 . . . . 0.0 107.773 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -114.83 130.5 56.88 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 127.103 2.161 . . . . 0.0 112.11 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.3 t -53.02 124.01 13.14 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.37 0.668 . . . . 0.0 109.764 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.431 HG12 ' HB2' ' A' ' 103' ' ' LYS . 79.1 t -67.48 -54.11 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 O-C-N 121.08 -1.012 . . . . 0.0 110.137 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.44 -33.52 68.0 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.085 0.954 . . . . 0.0 113.182 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -135.95 80.91 41.0 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 124.647 1.179 . . . . 0.0 109.778 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.44 163.1 37.94 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.005 2.47 . . . . 0.0 109.848 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 96.77 -3.24 62.68 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.582 1.087 . . . . 0.0 110.653 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -125.63 121.82 34.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.731 1.612 . . . . 0.0 108.522 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -106.1 145.87 30.9 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.423 1.489 . . . . 0.0 109.575 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.798 HG22 HD11 ' A' ' 85' ' ' LEU . 3.4 pt -75.09 121.32 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.08 121.25 27.16 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 68.8 t -78.24 -20.06 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 127.656 2.382 . . . . 0.0 113.385 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m 59.21 66.11 1.09 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.406 1.098 . . . . 0.0 110.438 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.3 m -99.36 36.7 1.69 Allowed 'General case' 0 C--N 1.323 -0.575 0 O-C-N 120.963 -1.085 . . . . 0.0 112.239 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -126.37 -98.96 0.39 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.935 0.494 . . . . 0.0 109.957 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -94.17 23.96 29.13 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-O 117.058 -1.968 . . . . 0.0 117.133 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.38 52.02 6.97 Favored Glycine 0 C--O 1.238 0.376 0 CA-C-N 119.743 1.771 . . . . 0.0 113.306 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.29 164.65 40.03 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.27 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.32 156.87 37.31 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 N-CA-C 107.04 -1.946 . . . . 0.0 107.04 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.438 HD11 ' CE2' ' A' ' 23' ' ' TRP . 17.7 mt -82.94 118.68 23.64 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.537 1.135 . . . . 0.0 110.862 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.439 ' C ' HD12 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -143.33 167.48 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 123.787 0.835 . . . . 0.0 111.458 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.5 mt -86.14 151.89 23.29 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.1 t -141.36 137.29 32.24 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -83.02 -33.98 26.38 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 122.154 0.978 . . . . 0.0 109.43 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.442 -0.852 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 p30 . . . . . 0 N--CA 1.444 -0.746 0 CA-C-O 121.373 0.606 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.444 HG21 ' CE2' ' A' ' 152' ' ' PHE . 0.3 OUTLIER -65.77 106.52 1.53 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 117.317 -1.325 . . . . 0.0 108.898 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.7 p -100.9 -12.99 18.53 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 122.147 2.249 . . . . 0.0 111.108 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -101.69 103.96 14.76 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 130.135 3.374 . . . . 0.0 118.072 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.444 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.8 OUTLIER -168.68 177.06 5.31 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.333 -0.854 . . . . 0.0 112.927 177.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.15 178.19 26.69 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.077 1.322 . . . . 0.0 111.675 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.427 ' HG ' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -126.77 144.91 50.81 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.474 1.509 . . . . 0.0 109.534 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.4 m -104.52 48.69 0.83 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.19 158.83 35.74 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.9 mt -129.55 159.49 36.17 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.95 1.3 . . . . 0.0 108.991 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 11.0 p90 . . . . . 0 C--O 1.245 0.834 0 CA-C-O 115.587 -2.149 . . . . 0.0 108.573 -179.858 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.238 0.499 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HB3' HG12 ' A' ' 47' ' ' ILE . 97.8 Cg_endo -71.63 156.12 58.03 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 N-CA-C 108.301 -1.461 . . . . 0.0 108.301 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.36 116.84 27.02 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 pm0 -113.3 142.47 45.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 122.568 0.347 . . . . 0.0 110.468 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.06 -125.97 0.89 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-O 118.27 -1.295 . . . . 0.0 111.284 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.8 p -154.05 -159.74 1.01 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 120.918 2.359 . . . . 0.0 111.188 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -153.84 -4.5 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 126.329 1.852 . . . . 0.0 109.122 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -62.93 -29.68 70.97 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.74 -16.47 40.3 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.637 1.175 . . . . 0.0 113.487 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mt -61.49 -45.73 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 C-N-CA 125.666 1.586 . . . . 0.0 112.383 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.82 21.84 1.0 Allowed 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.091 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.8 t60 63.95 43.78 5.09 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.45 HH11 ' HB3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -113.88 94.1 4.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.794 0.838 . . . . 0.0 109.558 178.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.58 143.67 11.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -100.53 139.63 35.93 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -135.67 141.07 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 tp -79.98 103.29 9.76 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.7 134.42 50.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.3 t0 39.16 65.76 0.63 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.202 1.401 . . . . 0.0 112.148 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 44.21 31.94 0.62 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.456 1.502 . . . . 0.0 114.597 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.6 m -144.57 162.97 35.28 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.837 1.655 . . . . 0.0 106.77 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.712 HD12 HD22 ' A' ' 87' ' ' LEU . 5.5 mt -103.06 120.29 40.4 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 177.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 1.4 mm -119.08 139.66 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 118.03 0.377 . . . . 0.0 110.331 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.62 138.25 39.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 m -122.37 60.66 13.65 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.372 1.069 . . . . 0.0 110.336 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.45 ' HB3' HH11 ' A' ' 21' ' ' ARG . 19.8 Cg_endo -56.51 -37.64 96.97 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.199 1.933 . . . . 0.0 114.967 -178.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -136.62 13.18 3.2 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.22 128.08 34.71 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.3 1.04 . . . . 0.0 108.369 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.45 6.14 1.51 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.335 1.854 . . . . 0.0 113.094 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -129.02 40.45 3.63 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.363 -1.461 . . . . 0.0 109.881 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.7 ptp -72.58 167.72 20.11 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.836 -0.54 . . . . 0.0 110.217 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.13 128.73 2.19 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.85 157.7 51.25 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.517 2.145 . . . . 0.0 110.474 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.5 m -144.54 166.52 12.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.96 162.73 16.04 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.7 mm -132.05 109.76 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 C-N-CA 126.951 2.1 . . . . 0.0 107.3 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.89 136.54 34.06 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.4 tt -129.38 132.59 47.07 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.424 HG12 ' HB3' ' A' ' 10' ' ' PRO . 1.7 mt -142.26 141.34 28.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 124.797 1.239 . . . . 0.0 109.323 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.4 t -76.39 164.87 25.59 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.5 m -89.76 146.72 24.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -109.37 -20.92 12.75 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -105.75 39.84 1.69 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 122.475 1.131 . . . . 0.0 109.939 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 m -66.7 -6.03 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.52 1.128 . . . . 0.0 112.653 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -33.77 66.23 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.277 1.031 . . . . 0.0 111.855 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 t -101.79 13.67 34.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.649 1.179 . . . . 0.0 111.885 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.7 mt -107.14 179.58 4.22 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 120.713 -1.242 . . . . 0.0 111.006 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -84.3 153.07 23.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.639 1.176 . . . . 0.0 107.948 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -124.95 -37.78 2.41 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 123.606 0.762 . . . . 0.0 110.491 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -53.98 -44.28 70.67 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.741 1.216 . . . . 0.0 111.84 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -67.54 -27.28 66.83 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.086 -1.435 . . . . 0.0 112.2 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.51 178.84 16.6 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 126.415 1.959 . . . . 0.0 110.512 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.54 120.17 80.39 Favored Pre-proline 0 CA--C 1.541 0.619 0 O-C-N 121.561 -0.964 . . . . 0.0 111.883 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.63 141.79 15.76 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.51 2.807 . . . . 0.0 110.256 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -143.58 -179.47 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.888 2.075 . . . . 0.0 108.083 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.509 ' CD1' HD12 ' A' ' 95' ' ' LEU . 2.0 t80 -136.83 151.66 49.39 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 tt -145.36 154.87 42.77 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.19 -174.78 28.34 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.43 161.15 13.94 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -130.32 105.4 7.87 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.07 -31.24 0.11 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-O 118.45 -1.195 . . . . 0.0 113.513 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -153.35 37.02 0.47 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.142 1.471 . . . . 0.0 110.402 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 49.83 78.98 0.09 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.233 2.213 . . . . 0.0 111.582 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -142.75 141.85 31.82 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.233 -177.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 36.5 m -141.16 170.07 16.42 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.323 0.965 . . . . 0.0 112.026 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.3 mt -56.2 149.66 15.72 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.243 1.383 . . . . 0.0 111.435 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.8 mtp -156.64 138.78 14.58 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.3 m -107.57 124.87 50.57 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.29 -178.94 5.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.29 1.436 . . . . 0.0 107.913 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -119.81 146.26 45.86 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 124.159 0.983 . . . . 0.0 109.219 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 p -119.28 6.63 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 O-C-N 123.893 0.746 . . . . 0.0 112.47 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.22 87.0 0.49 Allowed Glycine 0 C--O 1.223 -0.581 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 63.86 17.77 10.74 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.07 143.41 7.17 Favored Pre-proline 0 C--O 1.24 0.575 0 C-N-CA 123.093 0.557 . . . . 0.0 110.906 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.56 164.63 33.43 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.658 2.239 . . . . 0.0 112.604 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.81 160.63 34.05 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.696 1.598 . . . . 0.0 108.905 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.42 HD11 ' CG2' ' A' ' 128' ' ' ILE . 4.2 mt -75.87 148.96 37.92 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.28 33.8 2.55 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.96 0.904 . . . . 0.0 110.632 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.712 HD22 HD12 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -66.29 92.57 0.19 Allowed 'General case' 0 CA--C 1.496 -1.117 0 C-N-CA 129.686 3.195 . . . . 0.0 109.249 -179.565 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.456 ' HA ' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -159.86 -45.97 0.05 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.691 -179.011 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -128.78 98.2 4.91 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.463 1.105 . . . . 0.0 111.137 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.491 ' HZ3' HD21 ' A' ' 95' ' ' LEU . 1.1 mmmt -176.69 152.62 1.02 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.413 -1.429 . . . . 0.0 108.757 178.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -114.03 144.2 43.5 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.191 0.996 . . . . 0.0 109.942 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.2 tt -98.85 -44.98 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 125.166 1.386 . . . . 0.0 110.235 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -32.09 71.0 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.729 0.811 . . . . 0.0 110.406 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.3 -54.18 41.16 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.509 HD12 ' CD1' ' A' ' 64' ' ' TYR . 13.9 mt -59.66 -33.35 71.43 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 122.658 0.383 . . . . 0.0 111.699 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -73.79 -37.96 64.77 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -75.09 -36.73 61.71 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.657 1.583 . . . . 0.0 113.946 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -111.71 149.59 40.97 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 119.84 1.2 . . . . 0.0 111.718 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -76.63 56.68 5.27 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.177 3.251 . . . . 0.0 113.554 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -118.57 80.48 16.94 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.207 1.003 . . . . 0.0 108.441 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.86 74.98 5.02 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.807 3.004 . . . . 0.0 109.012 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -69.72 97.35 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 124.792 1.237 . . . . 0.0 109.314 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -52.45 -26.72 13.56 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.621 1.168 . . . . 0.0 112.9 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.0 -18.24 64.1 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.461 0.573 . . . . 0.0 112.239 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -115.96 -23.81 8.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.479 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.1 mt -72.89 153.8 40.86 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.162 0.892 . . . . 0.0 111.319 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -136.49 138.46 41.43 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.261 1.025 . . . . 0.0 110.516 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.98 123.15 29.68 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 103.528 -2.767 . . . . 0.0 103.528 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -103.39 143.83 32.17 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.258 0.623 . . . . 0.0 109.44 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.85 169.83 20.75 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -140.28 151.76 45.36 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.347 1.459 . . . . 0.0 111.601 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.19 79.18 0.75 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.901 0.858 . . . . 0.0 112.707 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.62 62.95 1.58 Allowed Glycine 0 C--N 1.334 0.46 0 O-C-N 120.954 -1.091 . . . . 0.0 111.639 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.32 4.13 1.58 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.72 1.208 . . . . 0.0 112.861 -178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.58 163.48 12.44 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.0 m -146.16 152.48 39.32 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.39 159.9 41.18 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -132.18 120.1 21.78 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.462 ' HB2' ' CE2' ' A' ' 127' ' ' PHE . 4.1 tt0 -112.42 131.21 55.67 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.418 1.087 . . . . 0.0 109.116 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.4 121.67 8.8 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.725 1.61 . . . . 0.0 109.705 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.8 t -70.99 -40.61 76.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 O-C-N 120.7 -1.25 . . . . 0.0 111.954 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.62 -38.3 77.73 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.077 0.853 . . . . 0.0 111.918 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -139.2 97.36 8.64 Favored Pre-proline 0 C--O 1.24 0.568 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.02 174.3 10.8 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.366 2.044 . . . . 0.0 109.208 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 91.11 -3.42 80.32 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -125.19 129.74 50.72 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.033 1.333 . . . . 0.0 107.535 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 119' ' ' GLU . 79.3 m-85 -114.92 142.24 46.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.29 1.836 . . . . 0.0 108.322 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.42 ' CG2' HD11 ' A' ' 85' ' ' LEU . 3.9 mt -74.02 136.12 25.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 O-C-N 121.999 -0.438 . . . . 0.0 110.511 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.29 141.2 30.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.218 0.532 . . . . 0.0 110.358 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.1 t -93.15 -13.44 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 126.557 1.943 . . . . 0.0 109.254 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.2 m 52.89 37.38 24.15 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.437 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 16.2 m -73.37 -2.01 20.49 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -74.08 -85.01 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 O-C-N 120.331 -1.481 . . . . 0.0 112.049 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -99.06 -22.52 13.04 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.659 1.123 . . . . 0.0 113.935 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 115.59 54.31 0.37 Allowed Glycine 0 CA--C 1.522 0.509 0 CA-C-N 118.543 1.171 . . . . 0.0 111.271 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.7 m -82.04 164.64 47.45 Favored Pre-proline 0 C--O 1.236 0.37 0 CA-C-N 117.715 0.757 . . . . 0.0 109.763 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 58.1 Cg_endo -68.93 171.59 13.29 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 N-CA-C 107.193 -1.887 . . . . 0.0 107.193 176.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.568 HD12 HD13 ' A' ' 30' ' ' LEU . 15.2 mt -96.0 109.12 21.56 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.073 0.949 . . . . 0.0 109.47 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.24 178.21 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.711 1.605 . . . . 0.0 110.678 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.79 169.93 10.3 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.0 t -162.06 149.88 14.53 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.109 1.364 . . . . 0.0 109.221 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -92.6 -40.38 10.8 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.894 0.878 . . . . 0.0 110.059 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 . . . . . 0 N--CA 1.444 -0.747 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -177.766 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 33.9 m120 . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 119.687 -0.197 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.6 p -61.37 99.22 0.1 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.584 1.554 . . . . 0.0 112.085 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.3 p -88.13 -35.12 17.62 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 121.405 1.911 . . . . 0.0 109.355 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -78.35 101.12 7.05 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 126.102 1.761 . . . . 0.0 111.971 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -167.77 177.57 5.71 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.132 0.878 . . . . 0.0 111.888 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.6 -160.98 30.01 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.8 tp -141.62 153.42 44.74 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.52 29.73 6.29 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.874 1.67 . . . . 0.0 109.355 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -65.9 142.68 57.82 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.5 mt -127.49 158.15 38.18 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.624 1.569 . . . . 0.0 110.345 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 27.8 p90 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 115.767 -2.063 . . . . 0.0 108.612 179.911 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.224 -0.285 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.64 135.63 26.5 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.462 2.108 . . . . 0.0 109.271 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.405 HE21 ' HB3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -124.36 120.49 32.28 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.69 0.796 . . . . 0.0 108.985 178.436 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.01 137.0 52.51 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.314 0.646 . . . . 0.0 111.299 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.29 -125.21 0.76 Allowed Glycine 0 C--N 1.335 0.505 0 O-C-N 121.188 -0.945 . . . . 0.0 113.735 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 p -152.0 -170.22 3.58 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.991 1.395 . . . . 0.0 112.59 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.21 6.76 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 125.864 1.666 . . . . 0.0 110.952 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -59.3 -50.55 73.56 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 120.549 -1.344 . . . . 0.0 110.759 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -47.1 -0.17 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 1 C-N-CA 132.139 4.176 . . . . 0.0 118.554 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mt -85.51 -60.56 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 C-N-CA 127.86 2.464 . . . . 0.0 110.492 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.05 23.31 2.05 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.392 0.677 . . . . 0.0 110.138 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 72.26 12.14 5.81 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.46 2.704 . . . . 0.0 113.992 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.76 95.09 7.16 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 127.272 2.229 . . . . 0.0 113.086 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.8 t -79.39 159.49 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -107.44 142.79 36.73 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.0 t -138.14 119.16 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 123.851 0.861 . . . . 0.0 110.374 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 tp -75.47 108.08 8.03 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.591 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 37.6 tt0 -94.96 -175.42 3.54 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.591 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 3.1 t0 -46.11 90.01 0.0 OUTLIER 'General case' 0 C--O 1.234 0.243 0 C-N-CA 129.952 3.301 . . . . 0.0 109.585 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 46.46 32.92 1.74 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.841 1.656 . . . . 0.0 110.502 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.0 m -152.49 135.38 15.53 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.825 HD11 HD11 ' A' ' 67' ' ' LEU . 1.5 mt -96.14 137.74 34.78 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 120.897 -1.127 . . . . 0.0 108.326 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.4 pt -136.49 151.44 28.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.805 0.842 . . . . 0.0 111.616 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.98 139.51 31.26 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.461 0.704 . . . . 0.0 110.225 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.9 m -123.72 108.81 30.64 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.9 -81.03 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.198 1.932 . . . . 0.0 110.871 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.13 6.65 16.41 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.631 1.573 . . . . 0.0 112.46 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -52.04 120.26 5.2 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -58.39 -31.24 67.48 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.089 0.956 . . . . 0.0 111.626 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.86 67.75 6.21 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -118.48 164.54 15.11 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.626 1.17 . . . . 0.0 108.899 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 t -141.63 135.42 14.72 Favored Pre-proline 0 N--CA 1.446 -0.636 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.81 134.78 24.45 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.544 2.829 . . . . 0.0 109.58 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.8 m -128.41 159.83 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 122.696 1.236 . . . . 0.0 108.413 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.15 158.29 23.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 113.139 -1.846 . . . . 0.0 107.64 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.0 mm -123.77 153.02 29.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.61 125.38 23.97 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.6 tt -123.45 141.33 52.11 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.653 1.181 . . . . 0.0 110.264 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.4 mt -149.93 152.9 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 126.253 1.821 . . . . 0.0 108.278 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.4 p -103.37 134.44 46.74 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.667 1.587 . . . . 0.0 109.389 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.9 m -54.53 109.34 0.49 Allowed 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.953 1.701 . . . . 0.0 114.126 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -75.95 -24.82 55.48 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 117.8 -1.095 . . . . 0.0 111.316 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -98.09 49.66 1.01 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-N 119.777 1.171 . . . . 0.0 110.366 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 m -73.79 -1.79 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.099 -1.001 . . . . 0.0 112.115 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -62.99 -0.91 0.77 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.549 1.94 . . . . 0.0 112.842 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 t -132.87 -1.27 3.36 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.859 1.664 . . . . 0.0 110.913 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.28 163.4 13.41 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.745 1.259 . . . . 0.0 109.565 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -82.05 152.4 26.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.654 -1.612 . . . . 0.0 107.641 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -118.83 -29.81 5.24 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.334 1.054 . . . . 0.0 111.095 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -67.85 -38.56 83.3 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.136 1.774 . . . . 0.0 112.312 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -68.1 -25.89 65.54 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.559 1.144 . . . . 0.0 112.84 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.99 -167.65 32.26 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -102.34 97.62 9.06 Favored Pre-proline 0 N--CA 1.466 0.346 0 CA-C-O 117.554 -1.213 . . . . 0.0 109.799 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.71 122.53 9.22 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.204 2.602 . . . . 0.0 109.851 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.13 -177.45 2.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 124.612 1.165 . . . . 0.0 109.821 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.565 ' CE1' HD12 ' A' ' 95' ' ' LEU . 2.6 t80 -139.78 140.31 36.65 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 122.285 1.041 . . . . 0.0 109.51 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tt -149.01 150.37 32.7 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.716 1.206 . . . . 0.0 110.034 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.78 -171.77 21.89 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.446 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.825 HD11 HD11 ' A' ' 30' ' ' LEU . 18.5 mt -93.74 146.02 24.15 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -110.05 113.45 26.17 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.26 -43.84 0.51 Allowed Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.514 -1.159 . . . . 0.0 113.861 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.33 24.8 4.15 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.572 1.686 . . . . 0.0 114.659 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 m120 60.04 63.87 1.36 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.219 0.918 . . . . 0.0 111.592 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.601 HD13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -145.28 132.65 20.66 Favored 'General case' 0 CA--C 1.51 -0.569 0 O-C-N 120.336 -1.478 . . . . 0.0 110.405 -178.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.562 ' SG ' HG23 ' A' ' 92' ' ' ILE . 8.5 m -136.93 172.74 12.57 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.463 0.705 . . . . 0.0 112.071 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.565 HD23 HD21 ' A' ' 87' ' ' LEU . 13.9 mt -62.13 154.29 27.57 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.913 0.885 . . . . 0.0 111.699 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.556 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 3.2 tmm? -164.41 151.12 11.19 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 24.0 m -112.0 122.75 48.63 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.134 0.574 . . . . 0.0 109.608 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.25 151.26 50.43 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.226 1.01 . . . . 0.0 109.522 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.1 tttt -86.88 124.87 33.58 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.4 p -80.24 -17.19 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.48 -63.77 0.33 Allowed Glycine 0 CA--C 1.548 2.094 1 C-N-CA 133.252 5.215 . . . . 0.0 108.407 -177.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -103.34 -27.19 12.6 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 119.722 3.231 . . . . 0.0 119.722 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -133.48 155.91 80.19 Favored Pre-proline 0 CA--C 1.566 1.586 0 C-N-CA 130.001 3.32 . . . . 0.0 115.754 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -74.3 144.37 32.88 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.793 1.662 . . . . 0.0 108.971 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.9 p -140.84 169.62 17.29 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.271 1.428 . . . . 0.0 109.549 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.895 HD11 HG23 ' A' ' 128' ' ' ILE . 10.2 mt -90.71 150.22 21.73 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.27 75.69 1.52 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.765 1.226 . . . . 0.0 110.923 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.565 HD21 HD23 ' A' ' 74' ' ' LEU . 1.0 OUTLIER -94.65 116.0 28.23 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.13 -13.81 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -158.6 97.51 1.46 Allowed 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 117.67 -1.157 . . . . 0.0 109.607 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.556 ' HE3' ' HB2' ' A' ' 75' ' ' MET . 0.3 OUTLIER -171.21 149.16 2.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 121.393 1.906 . . . . 0.0 109.655 -179.214 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -129.07 114.55 16.51 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.172 0.989 . . . . 0.0 108.847 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.562 HG23 ' SG ' ' A' ' 73' ' ' CYS . 7.8 pt -62.06 -42.58 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 120.659 -1.275 . . . . 0.0 112.871 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.3 tpt -69.17 -16.28 63.6 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.108 1.363 . . . . 0.0 112.253 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -79.4 -52.04 8.6 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.277 0.944 . . . . 0.0 108.936 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.565 HD12 ' CE1' ' A' ' 64' ' ' TYR . 35.1 mt -65.96 -21.05 66.4 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.62 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -90.81 -34.33 15.35 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -63.41 -36.76 84.79 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.452 1.478 . . . . 0.0 109.423 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.68 156.02 43.07 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.067 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.52 59.54 5.56 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 123.745 2.963 . . . . 0.0 111.197 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -128.14 64.61 66.94 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.846 1.258 . . . . 0.0 112.128 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.4 95.4 0.86 Allowed 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 124.942 3.761 . . . . 0.0 109.849 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.435 HG11 ' CZ ' ' A' ' 105' ' ' PHE . 47.1 t -84.78 106.36 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 O-C-N 120.983 -1.073 . . . . 0.0 109.7 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -51.52 -29.89 18.39 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.603 1.561 . . . . 0.0 113.269 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.4 m -67.32 -10.67 53.18 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.435 ' CZ ' HG11 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -120.52 -17.86 7.98 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.619 0.768 . . . . 0.0 110.12 178.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.6 mt -79.68 154.08 28.87 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.428 1.091 . . . . 0.0 110.397 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -140.36 133.82 30.0 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 123.248 0.619 . . . . 0.0 110.851 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -76.07 122.6 24.49 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -75.89 103.49 5.99 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.6 t -100.59 178.14 4.81 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.2 156.71 42.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.415 0.686 . . . . 0.0 111.523 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.6 p -132.27 42.13 3.15 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.14 0.976 . . . . 0.0 113.06 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.67 -55.18 2.32 Favored Glycine 0 C--N 1.333 0.396 0 O-C-N 120.215 -1.553 . . . . 0.0 113.435 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -131.19 2.13 4.25 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.644 1.222 . . . . 0.0 112.071 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -134.08 173.49 11.53 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.065 0.546 . . . . 0.0 111.237 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.8 m -116.89 153.87 31.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.846 1.658 . . . . 0.0 109.627 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.01 168.29 19.07 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -138.77 112.56 8.41 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -105.45 117.88 35.14 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 126.901 2.08 . . . . 0.0 109.651 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.9 t -51.16 122.15 7.24 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.293 0.637 . . . . 0.0 111.761 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.1 t -65.1 -45.57 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 O-C-N 121.739 -0.601 . . . . 0.0 110.34 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.23 -38.43 85.22 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.764 -0.585 . . . . 0.0 112.376 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -124.18 80.63 58.44 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.583 0.753 . . . . 0.0 108.992 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -66.94 143.4 66.1 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.55 3.5 . . . . 0.0 110.87 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.81 -22.43 14.62 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 128.449 2.928 . . . . 0.0 113.067 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -99.24 131.96 44.9 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.951 1.7 . . . . 0.0 111.585 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -111.51 142.15 44.16 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.434 1.094 . . . . 0.0 110.597 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.895 HG23 HD11 ' A' ' 85' ' ' LEU . 6.3 mt -73.67 133.87 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -103.23 147.94 26.43 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 6.5 m -91.83 -17.12 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.356 1.462 . . . . 0.0 114.591 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.45 90.56 0.07 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.325 1.85 . . . . 0.0 107.209 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . 0.259 0.0 OUTLIER -107.8 7.87 28.47 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.416 -0.802 . . . . 0.0 111.933 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -135.5 143.41 45.8 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.325 1.05 . . . . 0.0 109.837 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.97 -58.26 0.06 OUTLIER Glycine 0 CA--C 1.531 1.066 0 C-N-CA 127.073 2.273 . . . . 0.0 115.848 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 132.73 45.64 0.13 Allowed Glycine 0 CA--C 1.523 0.555 0 C-N-CA 129.093 3.235 . . . . 0.0 107.352 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 83.4 m -71.91 162.43 73.4 Favored Pre-proline 0 C--O 1.24 0.576 0 CA-C-N 118.064 0.932 . . . . 0.0 110.474 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.26 162.25 28.47 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 120.766 0.977 . . . . 0.0 111.598 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.4 mt -77.88 114.96 17.25 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.701 1.201 . . . . 0.0 109.031 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pp -146.24 176.26 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 123.161 0.584 . . . . 0.0 109.75 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 20.7 mt -101.35 150.01 23.45 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.543 0.737 . . . . 0.0 109.26 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.1 t -144.52 131.68 20.58 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -82.3 -24.73 34.5 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 122.235 -0.291 . . . . 0.0 111.197 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 . . . . . 0 C--O 1.234 0.237 0 C-N-CA 125.104 1.362 . . . . 0.0 107.345 -178.993 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.0 m120 . . . . . 0 C--O 1.223 -0.311 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.451 HG21 ' CE2' ' A' ' 152' ' ' PHE . 0.8 OUTLIER -61.39 128.54 36.83 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.66 1.184 . . . . 0.0 109.906 -178.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.6 p -114.71 -22.57 9.64 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.168 1.387 . . . . 0.0 112.922 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -118.45 129.06 55.18 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.304 0.641 . . . . 0.0 112.07 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.451 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.7 OUTLIER -170.55 -176.47 2.13 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.462 1.905 . . . . 0.0 109.553 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.42 -159.75 31.07 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.7 tp -147.54 166.22 27.98 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.5 m -128.63 49.85 2.16 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.065 1.346 . . . . 0.0 107.921 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -75.21 141.2 43.61 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 22.8 mt -108.53 167.47 10.02 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.512 1.125 . . . . 0.0 108.05 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 31.3 p90 . . . . . 0 C--O 1.251 1.171 0 C-N-CA 126.911 2.084 . . . . 0.0 106.74 -179.564 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.02 149.01 71.12 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 N-CA-C 107.061 -1.938 . . . . 0.0 107.061 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.47 115.77 19.39 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -106.77 149.1 27.68 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.371 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.08 -137.41 2.9 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 120.045 1.293 . . . . 0.0 109.98 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.7 p -144.84 -168.33 2.89 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 119.15 1.475 . . . . 0.0 111.214 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.7 mt -142.51 -7.03 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 126.903 2.081 . . . . 0.0 107.753 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -45.61 -42.79 11.67 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 127.0 2.12 . . . . 0.0 112.283 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -55.57 -24.13 30.88 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.0 mm -54.65 -68.84 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 123.729 0.811 . . . . 0.0 112.149 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.52 29.64 3.89 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 123.718 0.637 . . . . 0.0 112.366 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.1 m80 61.8 47.86 5.85 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 -122.94 100.28 6.81 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.1 t -85.78 154.53 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -120.23 131.16 54.84 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.39 144.88 35.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 tp -78.14 102.04 7.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -120.48 133.95 55.34 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 t0 45.48 53.41 8.38 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.008 1.323 . . . . 0.0 112.373 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 52.59 29.05 6.72 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.7 m -143.17 159.79 41.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.021 1.728 . . . . 0.0 107.391 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.647 HD12 HD22 ' A' ' 87' ' ' LEU . 8.1 mt -96.49 125.48 41.01 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 119.666 -1.896 . . . . 0.0 106.325 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 1.2 mt -126.84 130.8 71.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 123.604 0.565 . . . . 0.0 110.731 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.98 135.8 49.78 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 m -126.56 74.21 74.42 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 123.839 0.855 . . . . 0.0 110.643 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.23 -43.15 15.48 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.7 2.267 . . . . 0.0 111.387 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -146.51 71.41 1.24 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.544 1.138 . . . . 0.0 108.91 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -120.84 124.22 44.5 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 102.035 -3.32 . . . . 0.0 102.035 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.52 -14.34 19.11 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.95 1.3 . . . . 0.0 113.312 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -113.87 30.43 7.26 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.658 1.183 . . . . 0.0 111.461 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -74.47 161.49 29.74 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.4 t -153.1 142.85 15.05 Favored Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.59 142.38 58.6 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.657 2.238 . . . . 0.0 108.767 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 t -143.61 136.23 24.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 105.915 -1.884 . . . . 0.0 105.915 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.75 162.46 16.22 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.966 0.906 . . . . 0.0 109.845 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 12' ' ' GLN . 7.2 mm -130.4 121.99 52.26 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 C-N-CA 127.525 2.33 . . . . 0.0 108.748 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.06 129.98 46.17 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 120.69 1.587 . . . . 0.0 108.461 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.2 tt -122.48 132.24 54.24 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.132 1.773 . . . . 0.0 107.546 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.535 HD13 HG21 ' A' ' 92' ' ' ILE . 3.5 mp -144.09 141.92 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 124.669 1.187 . . . . 0.0 108.826 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 p -79.34 138.59 37.75 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.601 ' SG ' HD22 ' A' ' 106' ' ' LEU . 58.8 m -60.11 124.06 19.08 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.419 ' HD3' ' O ' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -97.23 -0.08 47.34 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -128.32 49.91 2.13 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.964 1.305 . . . . 0.0 110.272 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.659 ' HA ' HD23 ' A' ' 55' ' ' LEU . 27.4 m -72.88 6.57 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.684 1.194 . . . . 0.0 113.794 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -49.49 -32.42 12.08 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 128.051 2.54 . . . . 0.0 116.149 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.1 t -125.63 25.44 6.96 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.903 0.881 . . . . 0.0 110.607 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 101' ' ' PRO . 2.4 mm? -116.2 155.77 27.71 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 121.183 -0.948 . . . . 0.0 108.917 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.98 152.15 46.31 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 mttm -124.99 -31.22 3.15 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.911 0.485 . . . . 0.0 110.644 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.45 -34.09 76.99 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.182 0.993 . . . . 0.0 112.118 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -64.24 -36.1 82.97 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.438 ' HA3' ' CD1' ' A' ' 108' ' ' TYR . . . 147.47 171.49 16.63 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 127.016 2.246 . . . . 0.0 110.755 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.51 116.38 30.84 Favored Pre-proline 0 C--O 1.238 0.484 0 O-C-N 121.463 -1.022 . . . . 0.0 109.372 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.72 136.15 18.65 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 N-CA-C 106.653 -2.095 . . . . 0.0 106.653 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.258 14.0 pt -137.74 170.69 16.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -131.41 147.98 52.61 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.769 0.795 . . . . 0.0 111.202 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 tt -148.26 157.14 43.31 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.344 1.058 . . . . 0.0 110.763 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.6 -173.61 30.46 Favored Glycine 0 C--O 1.226 -0.398 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.584 HD21 HD11 ' A' ' 30' ' ' LEU . 5.4 mt -97.67 162.17 13.41 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.357 1.063 . . . . 0.0 110.441 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -132.09 84.08 2.13 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.234 -0.916 . . . . 0.0 108.765 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -158.44 -30.37 0.02 OUTLIER Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.795 -1.003 . . . . 0.0 113.013 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.15 19.45 0.57 Allowed 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.6 m120 68.16 68.41 0.33 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.943 1.697 . . . . 0.0 109.076 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.91 136.03 30.05 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.906 1.282 . . . . 0.0 109.89 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 32.2 m -142.09 175.1 10.0 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.773 0.715 . . . . 0.0 111.044 177.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.467 HD23 ' CD2' ' A' ' 87' ' ' LEU . 16.0 mt -58.75 149.95 24.98 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.899 0.772 . . . . 0.0 109.994 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.7 ttp -159.25 123.42 3.91 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 84.0 m -97.2 125.36 41.68 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 120.144 1.338 . . . . 0.0 109.079 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.81 146.29 31.11 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.08 0.952 . . . . 0.0 109.291 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -77.87 131.39 37.5 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 p -80.91 7.0 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.0 0.52 . . . . 0.0 111.508 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.82 10.35 49.96 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -148.03 -57.2 0.23 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.474 1.51 . . . . 0.0 109.772 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -140.3 162.44 49.74 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.065 1.746 . . . . 0.0 110.877 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.89 149.58 72.48 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.862 1.708 . . . . 0.0 110.521 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.9 p -147.3 166.06 28.23 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.91 1.684 . . . . 0.0 107.201 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.3 mt -92.57 148.14 22.32 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -138.97 64.87 1.46 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.647 HD22 HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -81.86 102.77 11.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.18 -39.44 0.07 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.143 0.977 . . . . 0.0 113.022 -178.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -145.1 104.69 3.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.755 1.622 . . . . 0.0 109.407 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.45 ' HE2' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -177.22 158.57 1.5 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 178.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.45 ' N ' ' HE2' ' A' ' 90' ' ' LYS . 1.4 m-20 -135.15 131.74 37.18 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.709 1.604 . . . . 0.0 109.687 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.535 HG21 HD13 ' A' ' 47' ' ' ILE . 1.6 mt -83.11 -37.18 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 118.175 0.443 . . . . 0.0 109.96 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.8 -25.26 66.44 Favored 'General case' 0 CA--C 1.524 -0.034 0 CA-C-O 117.982 -1.009 . . . . 0.0 112.565 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -72.0 -42.77 66.03 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 93.0 mt -62.87 -33.12 74.61 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.512 1.125 . . . . 0.0 108.378 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.419 ' O ' ' HD3' ' A' ' 50' ' ' ARG . 1.2 t80 -75.8 -35.39 60.08 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -65.52 -46.0 81.32 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.202 -0.936 . . . . 0.0 110.767 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -125.31 152.16 70.79 Favored Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.85 83.35 1.39 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 123.621 2.881 . . . . 0.0 110.395 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -132.26 69.09 80.33 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.727 ' HB2' HD21 ' A' ' 55' ' ' LEU . 97.9 Cg_endo -74.1 76.5 3.0 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.277 3.318 . . . . 0.0 107.833 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.4 t -83.09 102.14 8.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -177.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -49.99 -28.49 6.98 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.847 0.859 . . . . 0.0 112.023 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.7 m -63.8 -12.51 36.33 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -122.45 1.64 9.58 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.345 1.058 . . . . 0.0 109.98 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.601 HD22 ' SG ' ' A' ' 49' ' ' CYS . 16.3 mt -100.46 145.77 27.85 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -142.62 123.36 14.23 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.774 0.83 . . . . 0.0 109.454 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.438 ' CD1' ' HA3' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -67.7 124.96 24.73 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 127.765 2.426 . . . . 0.0 106.252 178.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -109.15 147.23 32.82 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.655 0.74 . . . . 0.0 110.052 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 t -138.64 172.14 13.32 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.12 1.768 . . . . 0.0 107.27 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.31 129.0 7.0 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.453 1.501 . . . . 0.0 109.508 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.0 p -141.94 79.54 1.68 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.05 58.85 1.54 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 124.02 0.819 . . . . 0.0 111.585 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 65.66 4.36 2.82 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.797 2.039 . . . . 0.0 112.694 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -112.86 127.92 56.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.4 m -108.68 155.54 20.6 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.197 1.399 . . . . 0.0 109.863 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 p -131.27 165.62 23.0 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.304 1.442 . . . . 0.0 111.661 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -142.65 110.31 5.81 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.607 1.163 . . . . 0.0 111.236 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -108.36 123.07 48.27 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.981 1.312 . . . . 0.0 109.462 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 59.6 m -53.64 125.71 19.2 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.747 1.219 . . . . 0.0 110.228 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.7 t -70.32 -41.3 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 O-C-N 121.175 -0.953 . . . . 0.0 111.623 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.47 -40.64 83.24 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.305 1.042 . . . . 0.0 112.242 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -136.3 90.61 17.63 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -65.9 165.07 24.84 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.025 1.817 . . . . 0.0 109.124 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.3 -18.58 56.62 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -100.85 121.08 41.1 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 118.628 1.214 . . . . 0.0 108.441 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -105.8 144.22 32.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 24.7 mt -71.42 142.47 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.26 113.79 27.53 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.577 0.703 . . . . 0.0 109.781 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.56 -10.71 14.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 C-N-CA 127.617 2.367 . . . . 0.0 112.482 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.5 m 46.02 84.31 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 118.394 2.739 . . . . 0.0 118.394 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.574 ' HB2' HG21 ' A' ' 149' ' ' THR . 47.8 m -110.6 5.57 21.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -79.75 -93.78 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 O-C-N 121.067 -1.021 . . . . 0.0 112.437 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -99.64 4.78 58.15 Favored Glycine 0 C--N 1.342 0.91 0 C-N-CA 125.652 1.596 . . . . 0.0 116.575 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.31 49.23 2.44 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 18.1 m -80.29 161.99 63.04 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 124.231 1.013 . . . . 0.0 110.472 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 98.5 Cg_endo -73.83 155.33 48.71 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.192 1.261 . . . . 0.0 109.475 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.409 HD12 HD13 ' A' ' 30' ' ' LEU . 12.6 mt -84.72 122.41 29.06 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.241 1.016 . . . . 0.0 109.208 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.0 -168.99 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.32 1.448 . . . . 0.0 110.848 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.5 mt -103.44 153.72 20.2 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.411 1.484 . . . . 0.0 107.181 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.0 t -145.8 120.49 9.84 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.75 1.262 . . . . 0.0 108.796 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -78.76 -30.83 45.92 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.166 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 . . . . . 0 CA--C 1.534 0.327 0 CA-C-O 122.028 0.918 . . . . 0.0 112.217 -178.383 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.574 HG21 ' HB2' ' A' ' 132' ' ' SER 0.294 75.4 p 113.93 93.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 1 C-N-CA 135.132 5.373 . . . . 0.0 112.643 178.678 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 p -104.6 -29.54 10.56 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.284 1.033 . . . . 0.0 110.686 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -117.72 123.66 46.6 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 127.882 2.473 . . . . 0.0 110.947 -177.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -171.56 -175.62 1.63 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.503 2.321 . . . . 0.0 110.08 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -101.53 -176.89 28.58 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.505 1.05 . . . . 0.0 113.687 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.16 132.03 41.12 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.5 m -88.52 58.38 4.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 18.9 ptp -69.31 162.17 27.78 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.249 0.62 . . . . 0.0 109.518 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.1 mt -142.36 175.25 9.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.102 2.161 . . . . 0.0 106.762 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 53.0 p90 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 124.582 1.153 . . . . 0.0 110.727 179.819 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HB3' HD11 ' A' ' 47' ' ' ILE . 86.6 Cg_endo -73.33 127.96 12.39 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.166 2.578 . . . . 0.0 110.093 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.36 111.21 23.56 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 123.782 0.676 . . . . 0.0 111.35 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -104.5 148.01 26.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.779 0.832 . . . . 0.0 110.618 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.46 -139.64 4.18 Favored Glycine 0 C--O 1.226 -0.396 0 O-C-N 121.255 -0.903 . . . . 0.0 111.226 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.2 p -152.33 -174.55 4.93 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 119.029 1.414 . . . . 0.0 113.684 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.67 5.28 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 125.319 1.448 . . . . 0.0 108.371 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -63.17 -38.63 91.93 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 119.923 -1.736 . . . . 0.0 109.293 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -51.5 -19.79 1.59 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 128.085 2.554 . . . . 0.0 114.086 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.2 mt -69.41 -67.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.811 1.644 . . . . 0.0 111.473 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.12 25.71 4.22 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.857 -0.527 . . . . 0.0 111.252 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.252 24.3 t60 57.62 41.09 26.12 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.514 2.726 . . . . 0.0 108.633 -177.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.28 109.86 20.47 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.947 -1.095 . . . . 0.0 110.981 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.4 t -91.86 158.42 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.636 ' O ' HG21 ' A' ' 42' ' ' VAL . 2.7 m95 -115.84 106.86 14.31 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.303 1.041 . . . . 0.0 110.325 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.7 t -104.37 122.85 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 120.099 1.318 . . . . 0.0 108.578 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 30' ' ' LEU . 34.8 tp -73.33 95.72 2.21 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 124.141 0.9 . . . . 0.0 108.626 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.99 174.79 8.85 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -8.89 -65.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 129.063 2.945 . . . . 0.0 114.935 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -142.05 18.24 2.11 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-O 117.691 -1.147 . . . . 0.0 109.279 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.65 134.71 14.87 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.685 1.129 . . . . 0.0 112.546 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.575 HD21 HD11 ' A' ' 67' ' ' LEU . 1.5 mp -85.64 137.08 33.09 Favored 'General case' 0 CA--C 1.504 -0.795 0 O-C-N 121.514 -0.741 . . . . 0.0 109.27 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mm -131.39 140.51 48.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 O-C-N 124.094 0.871 . . . . 0.0 109.927 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.86 130.27 40.64 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -117.36 82.27 14.72 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 124.339 1.056 . . . . 0.0 108.738 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.25 -33.1 15.35 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.014 1.809 . . . . 0.0 113.778 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.8 ttm-85 -162.02 51.42 0.21 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.12 152.23 19.0 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 124.956 1.302 . . . . 0.0 107.622 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -61.36 1.8 Allowed 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 122.617 0.367 . . . . 0.0 110.473 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.8 ttm-85 -72.8 27.52 0.06 Allowed 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.696 1.198 . . . . 0.0 112.229 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -68.02 149.51 49.61 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.1 t -140.15 138.17 18.98 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -67.64 155.21 71.02 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 N-CA-C 108.055 -1.556 . . . . 0.0 108.055 178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.636 HG21 ' O ' ' A' ' 23' ' ' TRP . 4.7 m -146.38 155.32 12.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.91 158.76 20.68 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -125.69 116.28 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 125.507 1.523 . . . . 0.0 107.756 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.07 127.67 42.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.544 HD12 HD12 ' A' ' 65' ' ' LEU . 6.8 tt -125.25 145.64 49.9 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.388 1.075 . . . . 0.0 108.649 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.513 HD12 HG12 ' A' ' 92' ' ' ILE . 39.3 mt -148.03 154.22 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.662 1.985 . . . . 0.0 108.828 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.1 p -109.42 115.52 30.11 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.7 m -47.35 143.87 3.2 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.186 1.395 . . . . 0.0 111.915 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -103.99 -26.87 12.46 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 118.096 -0.954 . . . . 0.0 112.992 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -94.68 38.27 1.11 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.2 m -63.46 -17.18 19.45 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 O-C-N 120.597 -1.315 . . . . 0.0 111.293 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -42.8 -44.07 4.27 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 120.704 1.593 . . . . 0.0 114.203 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.7 t -78.5 -14.14 59.5 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.6 mt -88.22 -173.39 4.2 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 120.444 -1.41 . . . . 0.0 109.267 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.43 158.13 16.21 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.822 0.849 . . . . 0.0 109.485 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -124.78 -35.61 2.68 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.034 2.533 . . . . 0.0 111.085 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.81 -42.68 79.97 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.642 1.177 . . . . 0.0 109.35 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -62.6 -36.39 82.6 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.874 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 139.54 -171.09 23.91 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -79.08 114.78 47.38 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.91 135.2 8.69 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.619 2.879 . . . . 0.0 108.557 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.3 pt -138.26 178.28 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 121.372 -0.83 . . . . 0.0 110.616 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.529 ' CE1' HD12 ' A' ' 95' ' ' LEU . 3.0 t80 -134.44 154.97 51.11 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.198 0.908 . . . . 0.0 112.345 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.544 HD12 HD12 ' A' ' 46' ' ' LEU . 3.7 tt -156.91 163.48 39.11 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.237 1.015 . . . . 0.0 110.05 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.15 -174.43 36.98 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.825 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.737 HD21 HD22 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -100.42 135.46 41.82 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 126.105 1.762 . . . . 0.0 106.718 179.761 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -114.81 121.41 43.2 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.39 -39.68 0.26 Allowed Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.4 31.35 1.71 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.371 1.069 . . . . 0.0 113.783 -178.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.1 m120 58.17 75.15 0.4 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.808 1.243 . . . . 0.0 112.476 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.33 140.78 27.97 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 121.297 -0.877 . . . . 0.0 110.307 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.8 m -147.96 174.49 11.84 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.254 -1.529 . . . . 0.0 111.024 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.421 ' HA ' ' HG ' ' A' ' 87' ' ' LEU . 5.3 mt -57.68 144.3 38.37 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -155.59 124.03 5.92 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 52.1 m -91.88 121.37 33.42 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.826 0.739 . . . . 0.0 110.409 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.37 168.52 19.6 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.252 0.478 . . . . 0.0 110.154 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -98.52 147.11 25.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.3 -2.56 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.556 0.743 . . . . 0.0 111.003 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.4 81.88 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.2 t70 66.56 9.62 6.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.429 1.891 . . . . 0.0 114.49 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.14 143.03 17.61 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.43 156.95 63.84 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 124.171 3.248 . . . . 0.0 113.87 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.3 p -158.47 164.76 35.89 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.017 1.727 . . . . 0.0 108.972 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.533 HD11 HG23 ' A' ' 128' ' ' ILE . 3.8 mt -95.18 138.12 33.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -129.43 67.16 1.44 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.368 1.067 . . . . 0.0 109.995 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.737 HD22 HD21 ' A' ' 67' ' ' LEU . 2.9 mp -81.97 105.57 13.19 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.59 -39.31 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -136.39 94.18 2.98 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 119.19 0.904 . . . . 0.0 111.653 -177.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.599 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -164.61 175.26 9.96 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 121.178 -0.951 . . . . 0.0 110.968 179.592 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.489 ' H ' ' HD3' ' A' ' 90' ' ' LYS . 17.6 m-20 -140.5 143.03 35.24 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.24 1.416 . . . . 0.0 107.469 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.513 HG12 HD12 ' A' ' 47' ' ' ILE . 1.7 tt -104.77 -39.29 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 125.063 1.345 . . . . 0.0 110.863 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -30.94 71.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.884 0.474 . . . . 0.0 110.57 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -66.21 -52.78 44.59 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.529 HD12 ' CE1' ' A' ' 64' ' ' TYR . 32.4 mt -61.87 -29.24 70.06 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 123.776 0.83 . . . . 0.0 111.184 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -79.94 -28.49 39.7 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -78.36 -42.11 31.4 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.322 -0.862 . . . . 0.0 112.01 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -107.03 152.08 40.9 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 123.774 0.829 . . . . 0.0 110.31 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.97 57.89 4.0 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.172 3.248 . . . . 0.0 113.12 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -118.29 73.6 10.47 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.587 1.155 . . . . 0.0 110.507 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.39 86.29 1.71 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.998 2.465 . . . . 0.0 106.179 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 66.7 t -80.74 93.93 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.45 -19.5 1.43 Allowed 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.367 1.067 . . . . 0.0 113.167 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -20.14 65.27 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.471 1.508 . . . . 0.0 110.596 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -115.1 -25.34 8.14 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.639 0.776 . . . . 0.0 110.756 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.6 mt -74.21 159.56 32.35 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.905 1.282 . . . . 0.0 112.093 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.424 ' HA ' HG23 ' A' ' 121' ' ' VAL . 4.4 p90 -147.65 143.46 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.194 0.998 . . . . 0.0 110.309 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.99 126.4 32.49 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 126.139 1.776 . . . . 0.0 108.644 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -102.13 150.24 23.46 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.6 t -142.02 -157.07 0.74 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -159.53 152.0 21.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.401 1.48 . . . . 0.0 108.112 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.8 p -123.61 6.58 8.86 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.468 1.507 . . . . 0.0 112.538 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.97 -85.13 0.36 Allowed Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 104.896 -3.282 . . . . 0.0 104.896 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.481 ' HG3' HH11 ' A' ' 114' ' ' ARG . 13.8 mtt85 -94.9 -7.8 39.01 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -126.19 172.56 9.95 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 119.119 0.872 . . . . 0.0 109.533 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.6 m -135.99 130.66 33.94 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 126.964 2.106 . . . . 0.0 110.622 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.27 161.13 16.56 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.3 1.04 . . . . 0.0 108.475 178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -143.95 116.87 8.82 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -125.97 127.1 45.41 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.719 0.637 . . . . 0.0 110.06 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.6 m -51.23 131.67 28.1 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.305 1.042 . . . . 0.0 109.938 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.424 HG23 ' HA ' ' A' ' 107' ' ' PHE . 84.5 t -73.63 -53.6 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 O-C-N 122.225 -0.297 . . . . 0.0 110.915 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.55 74.54 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -124.4 80.71 59.79 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.63 160.01 48.21 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.868 2.378 . . . . 0.0 109.879 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.7 -20.79 48.12 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 126.399 1.952 . . . . 0.0 111.601 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -103.63 116.78 32.97 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 118.823 1.312 . . . . 0.0 110.467 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -90.11 157.02 17.96 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 125.045 1.338 . . . . 0.0 108.825 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.533 HG23 HD11 ' A' ' 85' ' ' LEU . 9.7 mm -86.06 129.03 38.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.21 117.01 30.47 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 119.321 0.964 . . . . 0.0 110.209 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.3 m -78.68 -25.66 13.51 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.304 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.2 m 67.39 55.36 0.66 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.537 1.535 . . . . 0.0 113.268 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 75.4 m -95.79 -2.91 46.7 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.334 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -68.06 -66.41 0.57 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.56 1.073 . . . . 0.0 111.353 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -124.17 -55.13 0.18 Allowed Glycine 0 C--N 1.333 0.388 0 CA-C-O 119.302 -0.721 . . . . 0.0 111.796 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.97 54.05 0.01 OUTLIER Glycine 0 CA--C 1.519 0.338 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 68.1 m -87.04 166.93 23.74 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 117.37 0.585 . . . . 0.0 110.697 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 136' ' ' CYS . 83.1 Cg_endo -74.13 168.49 24.67 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 N-CA-C 108.584 -1.352 . . . . 0.0 108.584 178.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' A' ' 23' ' ' TRP . 9.5 mt -87.0 111.26 20.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -146.33 -177.08 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.812 1.245 . . . . 0.0 110.987 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.7 mt -100.7 161.82 13.34 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -156.3 130.69 8.78 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -90.24 -38.22 13.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 119.603 -0.839 . . . . 0.0 108.764 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 . . . . . 0 CA--C 1.532 0.277 0 C-N-CA 126.034 1.734 . . . . 0.0 107.971 -178.724 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.463 0.201 0 CA-C-O 121.106 0.479 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.422 HG21 ' CE2' ' A' ' 152' ' ' PHE . 1.5 m -100.24 136.04 40.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.3 p -131.7 7.19 4.42 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.635 1.574 . . . . 0.0 112.267 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -144.4 112.19 6.22 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.1 OUTLIER -162.98 -175.79 4.55 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.898 1.226 . . . . 0.0 113.146 -179.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.34 -174.26 27.37 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.9 tp -141.04 146.7 37.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.5 m -100.6 48.24 0.91 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.815 1.246 . . . . 0.0 107.658 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.54 159.69 33.86 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.954 1.302 . . . . 0.0 108.493 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 8.9 mt -145.79 153.42 40.9 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.706 2.002 . . . . 0.0 108.496 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.337 0 CA-C-N 119.884 1.22 . . . . 0.0 112.653 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 117.459 -1.257 . . . . 0.0 109.186 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.26 140.55 24.87 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 N-CA-C 106.973 -1.972 . . . . 0.0 106.973 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.17 149.42 35.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -144.49 132.57 21.59 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.538 -1.351 . . . . 0.0 109.385 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.75 -122.1 0.59 Allowed Glycine 0 CA--C 1.518 0.28 0 CA-C-O 117.844 -1.531 . . . . 0.0 111.225 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.8 p -160.3 -168.78 2.27 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 120.725 2.263 . . . . 0.0 112.566 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.421 HD12 ' CH2' ' A' ' 23' ' ' TRP . 3.7 mt -145.22 4.52 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.32 1.448 . . . . 0.0 108.97 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.14 -25.13 63.32 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 119.806 -1.809 . . . . 0.0 111.077 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -75.27 46.15 0.32 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.557 1.543 . . . . 0.0 110.897 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mt -130.56 -61.95 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 126.293 1.837 . . . . 0.0 108.688 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.85 27.17 2.02 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.489 0.661 . . . . 0.0 110.646 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.35 11.06 4.29 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 128.88 2.872 . . . . 0.0 114.182 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.459 ' H ' ' HG3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -70.76 95.38 1.12 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.187 1.795 . . . . 0.0 109.43 -179.641 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.81 158.97 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 102.997 -2.964 . . . . 0.0 102.997 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.421 ' CH2' HD12 ' A' ' 15' ' ' ILE . 21.7 m0 -118.63 144.84 45.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 120.605 -1.309 . . . . 0.0 108.711 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.7 t -150.53 141.21 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.6 tp -75.77 119.05 19.24 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -133.06 123.2 25.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.7 t70 45.88 58.37 4.41 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.034 1.334 . . . . 0.0 112.845 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 54.23 23.9 4.59 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.021 1.329 . . . . 0.0 112.968 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.5 m -132.94 159.56 39.6 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.589 1.556 . . . . 0.0 107.607 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.716 HD11 HD11 ' A' ' 67' ' ' LEU . 7.2 mt -108.67 124.34 50.37 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 mm -127.14 141.96 44.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 O-C-N 123.87 0.731 . . . . 0.0 109.766 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.87 137.12 36.17 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.05 66.3 40.33 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.106 0.962 . . . . 0.0 108.439 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.46 -28.66 78.11 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 121.842 1.695 . . . . 0.0 112.193 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -149.54 95.61 2.37 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 125.003 1.321 . . . . 0.0 109.403 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.81 142.31 5.26 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.793 0.837 . . . . 0.0 109.55 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.52 -39.7 77.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 122.367 1.08 . . . . 0.0 108.945 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.8 tpp85 -79.4 62.67 3.8 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.494 1.518 . . . . 0.0 111.706 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.2 ptt? -126.39 168.57 14.0 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.802 1.241 . . . . 0.0 110.999 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 t -158.54 144.99 12.69 Favored Pre-proline 0 N--CA 1.452 -0.375 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.63 154.83 64.03 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 N-CA-C 107.891 -1.619 . . . . 0.0 107.891 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 23' ' ' TRP . 2.5 p -146.39 156.95 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.4 m -118.07 161.57 19.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.233 -1.348 . . . . 0.0 108.504 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.3 mm -130.32 110.73 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 C-N-CA 126.157 1.783 . . . . 0.0 111.065 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.431 ' HB3' HD12 ' A' ' 92' ' ' ILE . . . -88.87 138.59 31.27 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 176.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 tt -130.53 131.77 45.24 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.5 mt -147.32 143.29 20.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 124.862 2.267 . . . . 0.0 106.933 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.2 p -73.7 162.27 29.36 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.517 -1.674 . . . . 0.0 108.881 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.7 m -91.17 149.58 21.73 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -102.1 -23.73 14.03 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -106.49 56.32 0.66 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.1 m -75.12 -10.73 13.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 120.98 -1.075 . . . . 0.0 111.185 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -69.99 4.09 2.3 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 125.925 1.69 . . . . 0.0 114.596 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 t -129.88 13.6 5.81 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.954 0.902 . . . . 0.0 108.939 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 98.3 mt -119.97 169.3 10.3 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.789 1.236 . . . . 0.0 108.095 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.9 155.35 37.56 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.698 1.199 . . . . 0.0 109.024 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.55 -32.39 2.65 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.226 1.011 . . . . 0.0 111.66 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -64.69 -36.01 82.89 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.535 1.134 . . . . 0.0 110.082 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -65.64 -25.68 67.47 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.463 1.105 . . . . 0.0 112.472 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.532 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 135.52 -173.52 21.7 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -87.13 111.59 41.88 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 123.957 0.903 . . . . 0.0 112.569 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.3 138.44 11.1 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.374 2.049 . . . . 0.0 110.898 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.44 HG13 ' CE1' ' A' ' 107' ' ' PHE . 15.6 pt -145.21 -174.26 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 124.354 1.062 . . . . 0.0 109.402 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.642 ' CD1' HG23 ' A' ' 92' ' ' ILE . 3.7 t80 -139.44 165.37 27.4 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.044 1.338 . . . . 0.0 113.028 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.435 HD22 HD11 ' A' ' 74' ' ' LEU . 3.7 tt -163.07 159.23 22.99 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.297 1.439 . . . . 0.0 111.148 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.27 176.17 38.67 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.219 0.914 . . . . 0.0 112.1 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.716 HD11 HD11 ' A' ' 30' ' ' LEU . 4.5 mt -94.62 152.55 18.42 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.388 1.075 . . . . 0.0 109.285 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -116.85 120.41 38.4 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.38 -38.82 0.55 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.314 0.483 . . . . 0.0 112.812 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.74 31.5 1.17 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.373 1.087 . . . . 0.0 112.52 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.6 m120 50.24 79.5 0.08 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.573 1.949 . . . . 0.0 111.912 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.67 137.89 25.53 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.651 0.78 . . . . 0.0 110.141 -177.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 4.0 m -143.85 172.56 12.68 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 118.631 0.65 . . . . 0.0 110.861 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.445 HD23 HD21 ' A' ' 87' ' ' LEU . 17.7 mt -59.05 147.84 33.22 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.115 0.484 . . . . 0.0 111.501 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 mtp -157.6 139.87 14.49 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 92.3 m -115.06 115.47 26.86 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.61 -177.93 3.35 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.396 2.279 . . . . 0.0 107.118 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.4 ' HE3' ' C ' ' A' ' 81' ' ' ASP . 43.4 tttt -122.51 126.8 48.57 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.46 -25.06 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.44 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.58 -49.9 0.2 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.4 ' C ' ' HE3' ' A' ' 78' ' ' LYS . 30.7 t70 -130.04 -11.99 4.19 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.174 -1.192 . . . . 0.0 113.274 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -137.87 153.83 74.05 Favored Pre-proline 0 C--O 1.241 0.657 0 C-N-CA 123.881 0.872 . . . . 0.0 110.749 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -70.04 153.45 67.63 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.424 2.082 . . . . 0.0 108.325 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 p -149.22 158.49 44.22 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.747 HD11 HG22 ' A' ' 128' ' ' ILE . 2.3 mt -80.4 146.18 31.61 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -145.54 63.81 1.26 Allowed 'General case' 0 N--CA 1.461 0.078 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.672 ' H ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -86.33 108.51 18.47 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.92 -41.39 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.097 0.559 . . . . 0.0 111.732 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -134.45 101.69 5.07 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 126.111 1.764 . . . . 0.0 109.929 -176.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -174.25 166.89 4.12 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.1 -1.0 . . . . 0.0 109.345 179.01 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.404 ' H ' ' HD2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -141.3 135.98 31.12 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 178.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.642 HG23 ' CD1' ' A' ' 64' ' ' TYR . 3.7 mt -87.68 -43.08 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 125.388 1.475 . . . . 0.0 109.173 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.6 tpt -61.64 -23.4 66.03 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 119.11 -0.471 . . . . 0.0 110.113 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -64.95 -51.2 63.12 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.637 HD12 ' CD1' ' A' ' 64' ' ' TYR . 13.5 mt -60.9 -35.49 76.79 Favored 'General case' 0 N--CA 1.461 0.091 0 O-C-N 121.717 -0.614 . . . . 0.0 110.181 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -78.87 -17.06 56.23 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.392 -0.817 . . . . 0.0 110.638 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -89.73 -42.78 11.13 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 120.504 -1.372 . . . . 0.0 111.181 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -107.01 150.09 39.39 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.433 0.693 . . . . 0.0 111.714 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.6 46.74 1.5 Allowed 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.552 3.502 . . . . 0.0 113.695 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -112.9 75.71 2.03 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.163 0.985 . . . . 0.0 111.134 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.99 71.18 7.16 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.599 3.533 . . . . 0.0 108.932 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 73.8 t -71.01 104.43 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.375 0.67 . . . . 0.0 110.172 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -50.96 -28.67 10.34 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 125.372 1.469 . . . . 0.0 111.029 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m -63.11 -13.63 38.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.327 1.451 . . . . 0.0 112.417 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -121.67 -28.63 4.51 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.769 0.828 . . . . 0.0 109.594 177.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.49 160.89 31.93 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.687 1.195 . . . . 0.0 111.035 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.481 ' HA ' HG23 ' A' ' 121' ' ' VAL . 9.9 p90 -151.16 148.38 28.19 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.57 0.748 . . . . 0.0 111.813 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.532 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -90.1 110.52 21.52 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 128.718 2.807 . . . . 0.0 107.923 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -79.38 141.83 36.55 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.4 t -137.95 -174.3 3.75 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.692 0.797 . . . . 0.0 109.526 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -151.24 163.08 39.68 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.285 1.434 . . . . 0.0 109.533 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.8 p -137.8 14.44 2.91 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.725 1.21 . . . . 0.0 111.825 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.72 -102.46 0.69 Allowed Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 105.452 -3.059 . . . . 0.0 105.452 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.07 -3.9 58.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.136 0.968 . . . . 0.0 113.115 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -117.6 159.47 22.85 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.405 1.002 . . . . 0.0 108.894 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 m -122.36 137.58 54.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.284 1.833 . . . . 0.0 108.963 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.01 166.84 10.72 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.524 1.13 . . . . 0.0 109.372 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -147.13 118.08 7.68 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -115.83 132.18 56.72 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 125.115 1.366 . . . . 0.0 110.554 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 t -59.84 133.93 56.56 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.118 0.967 . . . . 0.0 109.219 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.481 HG23 ' HA ' ' A' ' 107' ' ' PHE . 49.1 t -72.76 -45.95 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 O-C-N 120.649 -1.282 . . . . 0.0 110.191 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.53 70.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.63 -0.669 . . . . 0.0 111.946 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.16 82.92 46.52 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.919 0.888 . . . . 0.0 110.65 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.37 144.18 55.23 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.876 1.717 . . . . 0.0 107.854 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.31 -11.22 43.55 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.705 1.621 . . . . 0.0 109.208 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 25.3 m-90 -113.62 115.53 28.06 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.209 1.404 . . . . 0.0 107.646 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -105.16 156.76 17.79 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 125.024 1.329 . . . . 0.0 110.14 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.747 HG22 HD11 ' A' ' 85' ' ' LEU . 4.4 pt -85.56 127.86 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.932 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.71 119.75 25.61 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.5 t -79.49 -21.04 12.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 127.238 2.215 . . . . 0.0 112.223 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.5 m 54.95 90.93 0.03 OUTLIER 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.966 2.106 . . . . 0.0 110.892 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.499 ' HB2' HG21 ' A' ' 149' ' ' THR . 1.4 m -135.58 43.67 2.59 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 126.174 1.79 . . . . 0.0 108.307 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -110.55 0.27 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.459 2.303 . . . . 0.0 107.036 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.32 7.46 80.64 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 117.744 1.857 . . . . 0.0 117.744 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.45 38.82 8.68 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 119.824 1.812 . . . . 0.0 112.164 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 93.6 m -77.14 163.59 64.03 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.93 1.292 . . . . 0.0 107.857 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.22 169.33 20.93 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.129 1.886 . . . . 0.0 110.5 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.3 mt -85.93 118.83 25.65 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.763 HD11 HD21 ' A' ' 148' ' ' ASN . 0.2 OUTLIER -141.69 172.86 9.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 124.407 1.083 . . . . 0.0 110.586 179.507 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 41.6 mt -91.91 163.6 13.96 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.9 t -149.09 150.14 32.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 177.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -101.79 -31.52 10.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 123.541 1.639 . . . . 0.0 108.09 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 . . . . . 0 N--CA 1.429 -1.478 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 -178.999 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.763 HD21 HD11 ' A' ' 139' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.421 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.499 HG21 ' HB2' ' A' ' 132' ' ' SER . 0.0 OUTLIER 55.98 79.45 0.17 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.517 0.599 . . . . 0.0 112.246 179.272 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.9 p -105.3 -8.33 18.32 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.058 -1.026 . . . . 0.0 111.612 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -115.52 103.14 10.44 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.091 1.356 . . . . 0.0 112.516 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.19 171.29 17.63 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.185 -1.572 . . . . 0.0 110.918 178.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -83.31 -173.27 49.57 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.96 120.76 11.24 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 14.8 m -78.91 41.94 0.45 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.896 1.679 . . . . 0.0 108.819 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -68.65 140.52 55.48 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.5 mt -115.0 162.07 17.48 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.92 1.688 . . . . 0.0 108.88 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 33.1 p90 . . . . . 0 C--O 1.245 0.849 0 C-N-CA 125.368 1.467 . . . . 0.0 108.108 178.831 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.5 p . . . . . 0 C--O 1.236 0.382 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.92 138.29 33.85 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.637 1.558 . . . . 0.0 108.866 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.39 117.47 21.45 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -114.38 143.61 44.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.39 -125.28 0.82 Allowed Glycine 0 C--O 1.226 -0.368 0 CA-C-O 117.988 -1.451 . . . . 0.0 110.356 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.4 p -154.05 -164.99 1.99 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 120.526 2.163 . . . . 0.0 113.628 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.6 mt -140.32 4.36 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.764 1.626 . . . . 0.0 108.033 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.8 -26.85 60.02 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.361 -1.462 . . . . 0.0 111.88 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -69.82 19.21 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 128.042 2.537 . . . . 0.0 113.695 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.7 mt -110.23 -60.58 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 127.165 2.186 . . . . 0.0 110.827 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -137.72 23.23 2.89 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.711 0.804 . . . . 0.0 110.524 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 61.41 36.81 17.17 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.296 1.038 . . . . 0.0 110.239 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.502 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 26.1 mmt-85 -104.19 86.36 2.54 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.904 -1.122 . . . . 0.0 110.322 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.9 t -73.88 129.36 36.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.427 ' CD2' HD11 ' A' ' 138' ' ' LEU . 32.0 m0 -81.9 137.54 35.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.044 0.938 . . . . 0.0 109.854 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.97 120.69 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-N 119.593 1.088 . . . . 0.0 109.705 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.479 HD13 HD22 ' A' ' 72' ' ' LEU . 1.0 OUTLIER -75.03 100.31 4.15 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 4.0 tt0 -89.02 -172.93 3.87 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.408 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -52.59 96.77 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 124.232 1.013 . . . . 0.0 112.306 -178.529 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 52.85 26.12 4.38 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.744 2.017 . . . . 0.0 111.937 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.1 m -154.09 128.67 9.28 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 119.172 0.897 . . . . 0.0 111.23 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.699 HD12 HD13 ' A' ' 87' ' ' LEU . 3.5 mt -84.3 131.96 34.67 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 pt -138.37 133.01 42.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 124.635 1.174 . . . . 0.0 111.134 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.07 146.36 47.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.18 80.78 15.86 Favored Pre-proline 0 N--CA 1.464 0.243 0 C-N-CA 124.031 0.932 . . . . 0.0 109.381 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.4 -31.87 21.24 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.883 1.722 . . . . 0.0 115.079 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 -165.91 84.25 0.32 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.409 1.884 . . . . 0.0 108.73 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -147.77 130.13 15.7 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -60.94 -13.62 17.21 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.308 1.043 . . . . 0.0 113.674 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -96.34 49.09 1.11 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.614 1.552 . . . . 0.0 106.922 177.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.5 mtp -65.25 156.9 30.45 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.554 -1.341 . . . . 0.0 109.402 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.3 t -159.89 87.5 1.97 Allowed Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.634 0.774 . . . . 0.0 109.841 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.42 137.23 46.18 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.015 1.81 . . . . 0.0 111.176 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 m -119.91 -174.18 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.9 m -132.62 155.25 49.06 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.2 mm -127.85 110.67 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 125.971 1.708 . . . . 0.0 108.857 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.7 139.32 30.65 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.168 1.787 . . . . 0.0 109.304 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.7 tt -134.41 129.41 35.3 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.605 1.162 . . . . 0.0 109.19 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.0 mt -144.91 127.93 11.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.932 1.293 . . . . 0.0 111.039 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.0 p -72.68 128.22 34.91 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 90.3 m -61.6 149.48 39.08 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -109.54 -10.09 14.88 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.486 1.114 . . . . 0.0 110.216 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -101.49 26.71 6.97 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.551 1.94 . . . . 0.0 109.918 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.3 m -71.22 -9.79 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 120.497 -1.377 . . . . 0.0 114.567 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.02 -35.92 48.48 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.45 1.1 . . . . 0.0 112.694 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 t -97.97 0.82 47.1 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.565 1.546 . . . . 0.0 111.821 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.484 HD22 ' HG2' ' A' ' 103' ' ' LYS . 72.7 mt -92.13 -179.58 5.3 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.02 -1.05 . . . . 0.0 109.974 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -79.52 162.03 25.65 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.556 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -139.5 -24.19 0.86 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.562 1.545 . . . . 0.0 111.586 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -78.67 9.07 4.42 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.062 1.745 . . . . 0.0 112.703 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -115.18 -50.11 2.76 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.73 -146.47 10.89 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -107.8 104.28 52.58 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.67 131.56 17.46 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.291 3.327 . . . . 0.0 111.267 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.79 177.35 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.36 0.664 . . . . 0.0 111.033 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.548 ' CD1' HD12 ' A' ' 95' ' ' LEU . 1.8 t80 -125.83 154.55 42.48 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.733 0.778 . . . . 0.0 109.963 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.409 HD22 HD11 ' A' ' 74' ' ' LEU . 1.9 tt -156.07 150.76 26.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.49 178.62 35.53 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.665 HD11 HD11 ' A' ' 30' ' ' LEU . 5.6 mt -88.25 153.75 20.97 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -119.46 116.05 25.32 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 101.246 -3.613 . . . . 0.0 101.246 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.6 -18.97 0.37 Allowed Glycine 0 C--N 1.342 0.874 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.916 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.19 26.28 0.09 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.823 1.811 . . . . 0.0 112.336 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.0 m120 60.23 62.99 1.48 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.346 1.058 . . . . 0.0 109.322 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.479 HD22 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.36 137.41 27.09 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.436 -1.415 . . . . 0.0 112.298 -178.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.438 ' H ' ' HB2' ' A' ' 90' ' ' LYS . 5.4 m -143.14 176.23 9.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.145 0.978 . . . . 0.0 111.656 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.469 HD23 HD21 ' A' ' 87' ' ' LEU . 18.6 mt -61.3 151.38 32.11 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.322 1.049 . . . . 0.0 111.052 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.478 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 4.9 tmm? -158.84 134.28 8.6 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 76.2 m -107.52 120.64 42.76 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 124.482 1.114 . . . . 0.0 109.57 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.21 -168.37 2.12 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -121.59 144.63 48.63 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.8 p -90.93 -24.17 5.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.43 -0.508 . . . . 0.0 109.668 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.24 -45.43 0.47 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -109.74 -40.75 4.72 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.421 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 2.9 pt20 -132.97 164.95 40.28 Favored Pre-proline 0 C--O 1.242 0.692 0 C-N-CA 126.158 1.783 . . . . 0.0 112.125 -177.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 82' ' ' GLN . 89.2 Cg_endo -71.23 154.34 61.72 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.632 2.222 . . . . 0.0 112.38 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.4 p -151.21 171.9 16.68 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mt -91.86 152.98 19.84 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.425 0.69 . . . . 0.0 111.663 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -145.07 65.83 1.25 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.647 0.779 . . . . 0.0 110.224 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.71 ' H ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -88.11 116.71 26.49 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -177.97 -19.27 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.7 94.82 1.49 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.478 ' HE3' ' HB2' ' A' ' 75' ' ' MET . 0.6 OUTLIER -173.65 162.63 4.15 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 121.503 1.956 . . . . 0.0 109.866 -177.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -142.77 136.79 29.23 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.849 0.459 . . . . 0.0 111.823 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.1 mp -80.91 -36.21 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.972 1.309 . . . . 0.0 110.846 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.8 mmt -59.7 -33.38 71.52 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.868 0.758 . . . . 0.0 109.831 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.8 -54.18 49.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.94 0.896 . . . . 0.0 109.159 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.548 HD12 ' CD1' ' A' ' 64' ' ' TYR . 9.9 mt -67.19 -29.67 69.41 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -80.7 -25.72 37.96 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.872 0.368 . . . . 0.0 110.698 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -83.69 -44.36 14.57 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.007 1.323 . . . . 0.0 111.524 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.48 154.71 46.53 Favored Pre-proline 0 N--CA 1.457 -0.111 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.059 -177.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.3 65.69 2.77 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 124.132 3.221 . . . . 0.0 113.01 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -119.79 69.78 13.17 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 125.054 1.342 . . . . 0.0 111.388 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.464 ' HB2' HD21 ' A' ' 55' ' ' LEU . 58.8 Cg_endo -82.39 75.84 4.46 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.361 2.707 . . . . 0.0 105.95 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 t -88.43 94.34 4.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 O-C-N 120.858 -1.151 . . . . 0.0 109.496 -177.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.484 ' HG2' HD22 ' A' ' 55' ' ' LEU . 30.5 mttt -45.08 -28.09 0.67 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.242 2.217 . . . . 0.0 114.393 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 m -63.1 -22.28 66.75 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.355 1.462 . . . . 0.0 113.107 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.423 ' CE2' ' HG2' ' A' ' 75' ' ' MET . 20.6 m-85 -109.36 -18.52 13.54 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.658 1.983 . . . . 0.0 109.581 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.1 mt -85.68 155.19 21.19 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 125.717 1.607 . . . . 0.0 113.686 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -138.57 131.72 29.95 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.914 0.886 . . . . 0.0 109.71 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.51 116.35 18.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -90.73 144.23 25.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.79 178.24 6.5 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.09 0.956 . . . . 0.0 109.11 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -150.63 154.83 38.2 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.597 1.559 . . . . 0.0 110.799 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 57.6 p -132.38 8.9 4.32 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.322 -1.763 . . . . 0.0 113.459 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.79 -47.1 1.08 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.803 1.668 . . . . 0.0 112.159 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -132.82 -2.81 3.27 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -132.83 151.17 52.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.9 m -118.09 159.89 22.46 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.2 166.14 17.63 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -147.87 112.88 5.47 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.02 133.29 55.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.487 1.515 . . . . 0.0 109.555 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.0 t -54.47 120.45 6.65 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.211 1.004 . . . . 0.0 108.652 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.4 t -65.71 -42.36 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.066 -1.021 . . . . 0.0 110.663 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.25 97.49 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -129.31 83.77 64.35 Favored Pre-proline 0 C--O 1.235 0.321 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -68.23 158.34 57.93 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.786 2.324 . . . . 0.0 108.456 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 104.34 -6.97 46.58 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 26.4 m-90 -124.28 142.15 51.49 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 126.157 1.783 . . . . 0.0 109.796 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -126.0 152.23 46.0 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.092 0.957 . . . . 0.0 111.519 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.0 pt -76.04 127.71 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.076 0.465 . . . . 0.0 110.949 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.88 110.0 20.69 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 t -68.21 -15.8 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.844 1.658 . . . . 0.0 113.882 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 m 65.79 33.13 8.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.0 1.32 . . . . 0.0 113.041 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.502 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 5.8 m -65.03 -21.1 66.79 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.353 0.597 . . . . 0.0 111.827 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -84.7 120.3 26.24 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 125.377 1.471 . . . . 0.0 107.787 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 67.57 -72.29 0.24 Allowed Glycine 0 N--CA 1.442 -0.933 0 O-C-N 125.466 1.729 . . . . 0.0 114.311 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.67 71.45 0.02 OUTLIER Glycine 0 CA--C 1.526 0.767 0 N-CA-C 105.837 -2.905 . . . . 0.0 105.837 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . 0.457 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 63.9 m -95.0 174.68 3.36 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 124.956 1.302 . . . . 0.0 111.393 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 136' ' ' CYS . 96.7 Cg_endo -75.23 165.21 31.43 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.03 1.82 . . . . 0.0 111.593 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.583 HD12 HD13 ' A' ' 30' ' ' LEU . 28.8 mt -91.59 114.01 26.43 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.956 0.903 . . . . 0.0 108.564 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.7 pp -141.21 176.6 4.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 125.255 1.422 . . . . 0.0 107.191 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 20.2 mt -100.63 165.79 11.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.8 t -147.89 162.53 39.09 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -104.63 -42.53 5.38 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 . . . . . 0 N--CA 1.441 -0.881 0 CA-C-O 122.707 1.241 . . . . 0.0 109.014 179.312 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.471 HG21 ' CD2' ' A' ' 152' ' ' PHE . 90.9 m -137.29 131.52 32.39 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.3 p -110.37 -13.29 14.31 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.874 1.269 . . . . 0.0 111.689 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -120.63 109.12 14.85 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.767 0.712 . . . . 0.0 111.519 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.471 ' CD2' HG21 ' A' ' 149' ' ' THR . 0.2 OUTLIER -161.68 173.25 14.95 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.168 1.787 . . . . 0.0 111.206 178.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.38 -166.9 31.21 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.14 140.62 46.69 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 122.076 -0.661 . . . . 0.0 109.233 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.75 28.88 1.24 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.883 1.673 . . . . 0.0 109.837 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -59.45 150.65 26.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.663 1.185 . . . . 0.0 108.523 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 43.1 mt -132.86 160.88 35.69 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.62 1.168 . . . . 0.0 108.333 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 31.2 p90 . . . . . 0 C--O 1.245 0.819 0 CA-C-O 117.198 -1.382 . . . . 0.0 108.29 178.908 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.24 0.595 0 CA-C-O 119.598 -0.239 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.34 147.94 94.09 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 N-CA-C 108.131 -1.527 . . . . 0.0 108.131 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.98 107.16 15.01 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -110.21 134.9 51.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.486 0.66 . . . . 0.0 110.388 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 156' ' ' MET . . . -161.27 -129.05 0.99 Allowed Glycine 0 N--CA 1.451 -0.356 0 O-C-N 121.186 -0.946 . . . . 0.0 111.975 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.2 p -154.23 -172.47 4.22 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.364 1.082 . . . . 0.0 112.11 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -149.81 9.18 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 124.288 1.035 . . . . 0.0 111.575 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.32 -18.03 59.13 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 119.92 -1.738 . . . . 0.0 111.377 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.14 44.85 0.6 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.23 2.612 . . . . 0.0 110.528 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mt -131.71 -64.95 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 126.111 1.764 . . . . 0.0 111.148 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -139.87 27.42 2.21 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.406 1.083 . . . . 0.0 109.855 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 64.59 15.55 9.74 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -79.05 91.03 4.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.495 ' HB ' HG23 ' A' ' 33' ' ' VAL . 53.6 t -72.24 153.49 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.43 ' HE3' HD11 ' A' ' 138' ' ' LEU . 10.1 m95 -112.1 132.56 54.78 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 120.513 -1.367 . . . . 0.0 108.798 -177.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.472 ' C ' HD23 ' A' ' 30' ' ' LEU . 39.8 t -140.62 126.12 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 119.983 1.265 . . . . 0.0 111.837 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tp -76.41 104.7 7.06 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -88.92 -170.33 2.87 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.86 97.01 0.01 OUTLIER 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.604 1.962 . . . . 0.0 109.925 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 46.51 23.09 0.2 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.893 2.477 . . . . 0.0 112.669 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 m -153.93 128.55 9.32 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 119.412 1.006 . . . . 0.0 111.523 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.545 HD13 HD12 ' A' ' 138' ' ' LEU . 2.7 mt -79.74 149.21 31.21 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.147 -0.971 . . . . 0.0 112.028 179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 16.6 pt -143.15 149.37 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.168 1.387 . . . . 0.0 110.893 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.64 143.97 25.79 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.495 HG23 ' HB ' ' A' ' 22' ' ' VAL . 28.4 m -128.47 105.32 19.32 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.015 0.926 . . . . 0.0 110.285 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.83 -50.68 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.454 2.769 . . . . 0.0 116.351 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -147.05 57.71 1.15 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.07 130.82 50.33 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.22 -55.24 37.55 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.86 0.725 . . . . 0.0 109.082 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -79.44 60.36 3.18 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.218 1.407 . . . . 0.0 111.692 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -102.64 171.62 7.32 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 176.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t -159.68 133.01 4.79 Favored Pre-proline 0 N--CA 1.452 -0.373 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.69 155.04 59.25 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 N-CA-C 108.088 -1.543 . . . . 0.0 108.088 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m -140.07 -171.03 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 125.244 1.418 . . . . 0.0 107.535 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.92 156.16 48.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.0 mm -127.34 112.55 28.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 126.158 1.783 . . . . 0.0 107.905 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.16 140.74 29.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.403 HD12 HD12 ' A' ' 65' ' ' LEU . 4.8 tt -135.47 139.75 44.3 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.0 mt -150.37 139.72 15.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.287 1.035 . . . . 0.0 108.986 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.7 p -75.14 156.4 35.98 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 94.8 m -78.34 140.06 38.79 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 119.873 -1.767 . . . . 0.0 108.681 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -101.16 -21.28 14.99 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.44 -0.788 . . . . 0.0 112.541 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -111.66 67.77 0.65 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.884 1.274 . . . . 0.0 108.255 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.619 ' HA ' HD23 ' A' ' 55' ' ' LEU . 15.2 m -101.4 2.31 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -177.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.61 -18.71 65.16 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.635 1.174 . . . . 0.0 111.526 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 t -105.16 -5.0 21.13 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.764 2.026 . . . . 0.0 113.521 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.619 HD23 ' HA ' ' A' ' 52' ' ' VAL . 3.8 mm? -80.41 -178.59 6.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.594 -0.691 . . . . 0.0 110.205 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -82.37 -38.17 24.56 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.418 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.81 1.55 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.662 1 C-N-CA 132.328 4.251 . . . . 0.0 117.148 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -93.53 -14.43 26.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 127.227 2.211 . . . . 0.0 110.399 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.406 HH12 ' HB3' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -98.95 -0.52 42.0 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.928 0.785 . . . . 0.0 111.085 175.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.66 179.86 23.09 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 125.132 1.349 . . . . 0.0 110.389 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -86.62 112.58 47.7 Favored Pre-proline 0 CA--C 1.538 0.506 0 O-C-N 121.552 -0.969 . . . . 0.0 109.051 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -66.73 133.47 31.8 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.449 2.1 . . . . 0.0 114.461 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 pp -142.77 174.02 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 120.04 1.291 . . . . 0.0 109.788 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.664 ' CD1' HD12 ' A' ' 95' ' ' LEU . 2.7 t80 -131.94 153.4 50.33 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.403 HD12 HD12 ' A' ' 46' ' ' LEU . 6.1 tt -150.76 154.43 37.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.114 1.366 . . . . 0.0 108.23 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -163.65 -173.03 31.85 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.449 HD11 HD11 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -95.64 159.99 14.72 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -135.02 92.14 2.84 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 120.43 -1.419 . . . . 0.0 110.357 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.37 -7.83 0.02 OUTLIER Glycine 0 CA--C 1.536 1.394 0 CA-C-O 117.518 -1.712 . . . . 0.0 114.872 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -164.86 24.99 0.06 Allowed 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.528 2.164 . . . . 0.0 113.312 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.7 m120 58.7 67.84 0.89 Allowed 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.531 -1.355 . . . . 0.0 109.529 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.25 131.67 23.69 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.441 1.496 . . . . 0.0 109.888 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 61.5 m -140.38 177.99 7.62 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.23 1.812 . . . . 0.0 112.059 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.7 mt -61.71 154.72 24.66 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.284 -1.51 . . . . 0.0 110.772 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.2 ttp -162.46 132.15 4.47 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 93.2 m -103.33 121.96 43.83 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.313 0.96 . . . . 0.0 110.588 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.98 -171.91 2.39 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.926 1.69 . . . . 0.0 107.678 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -146.31 130.48 17.46 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.0 m -78.46 12.08 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 123.576 0.75 . . . . 0.0 112.227 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.02 -10.51 63.94 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.847 2.165 . . . . 0.0 111.687 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -129.08 -50.96 1.21 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.926 1.69 . . . . 0.0 110.857 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -131.48 155.76 81.04 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 125.058 1.343 . . . . 0.0 113.498 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.31 144.09 40.62 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 124.157 3.238 . . . . 0.0 111.769 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.7 p -148.43 147.65 29.42 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.171 0.896 . . . . 0.0 109.5 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.3 mt -71.69 160.08 33.27 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -150.97 64.09 0.91 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.061 0.944 . . . . 0.0 108.673 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.79 ' H ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -85.09 113.01 21.17 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.5 pttp -174.9 -36.16 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.929 1.292 . . . . 0.0 112.283 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -141.64 83.4 1.85 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.841 1.2 . . . . 0.0 113.959 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.47 147.71 6.37 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.36 -1.463 . . . . 0.0 109.014 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.29 140.99 48.16 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.225 1.01 . . . . 0.0 109.958 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.1 tt -87.18 -43.59 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 125.417 1.487 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.3 tpt -62.32 -27.89 69.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.923 -0.56 . . . . 0.0 111.396 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.88 -54.51 37.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.664 HD12 ' CD1' ' A' ' 64' ' ' TYR . 18.8 mt -60.05 -32.48 70.96 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.427 -0.796 . . . . 0.0 111.248 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -81.83 -15.97 52.35 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.238 -0.914 . . . . 0.0 112.215 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -94.49 -33.16 13.19 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 120.498 -1.376 . . . . 0.0 112.374 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.422 ' HB2' ' HD2' ' A' ' 99' ' ' PRO . 3.9 pt20 -123.8 167.07 16.14 Favored Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 124.909 1.284 . . . . 0.0 110.799 -178.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 98' ' ' GLN . 58.7 Cg_endo -73.24 -139.14 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 122.81 2.34 . . . . 0.0 109.59 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 56.99 60.77 7.05 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.952 1.701 . . . . 0.0 113.575 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.49 109.37 0.85 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.03 3.153 . . . . 0.0 109.262 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.3 t -88.11 98.7 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -49.53 -29.73 7.29 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.315 1.046 . . . . 0.0 112.286 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.5 m -62.54 -16.07 54.07 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.413 1.085 . . . . 0.0 113.453 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.52 -23.64 8.17 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.141 0.882 . . . . 0.0 111.69 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.5 mt -75.15 156.06 36.34 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.086 0.955 . . . . 0.0 112.801 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -138.93 128.72 24.86 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.644 0.778 . . . . 0.0 112.517 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -77.85 126.23 30.53 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.41 147.37 36.05 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 p -136.72 -177.1 4.59 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.777 1.631 . . . . 0.0 107.52 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -139.52 165.12 28.08 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.833 0.853 . . . . 0.0 109.193 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.5 p -149.84 35.98 0.69 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.753 1.283 . . . . 0.0 112.555 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.91 -56.27 1.85 Allowed Glycine 0 C--N 1.334 0.469 0 O-C-N 120.61 -1.307 . . . . 0.0 112.504 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -131.32 -1.08 4.0 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.508 -0.995 . . . . 0.0 112.669 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -134.05 179.92 5.95 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.752 0.821 . . . . 0.0 110.007 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 p -144.51 133.15 22.23 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.117 0.967 . . . . 0.0 112.435 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.52 170.82 9.08 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.202 1.401 . . . . 0.0 109.572 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -137.6 109.58 7.2 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.294 1.837 . . . . 0.0 106.98 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -98.52 128.08 44.72 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.926 2.09 . . . . 0.0 109.241 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.1 t -61.2 131.89 51.9 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.929 1.24 . . . . 0.0 111.957 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.33 -49.86 72.37 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 O-C-N 121.845 -0.534 . . . . 0.0 110.004 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.73 -27.52 68.97 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -136.29 84.73 28.69 Favored Pre-proline 0 N--CA 1.453 -0.28 0 CA-C-N 118.179 0.445 . . . . 0.0 110.186 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.406 ' HB3' HH12 ' A' ' 59' ' ' ARG . 10.6 Cg_endo -65.36 166.45 19.32 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.113 2.542 . . . . 0.0 111.663 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.19 1.36 90.48 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.443 -0.643 . . . . 0.0 112.546 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -130.56 146.12 52.01 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.092 1.357 . . . . 0.0 107.419 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -130.87 148.95 52.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.121 1.368 . . . . 0.0 110.578 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.4 pt -78.68 129.29 37.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.569 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.86 151.95 22.46 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.2 m -103.48 -17.27 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 125.149 1.38 . . . . 0.0 113.383 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.3 m 67.98 85.39 0.14 Allowed 'General case' 0 CA--C 1.533 0.308 0 O-C-N 124.413 1.07 . . . . 0.0 109.074 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 t -120.2 13.23 11.98 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.28 -1.512 . . . . 0.0 112.228 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -79.1 -52.22 8.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -161.55 -83.39 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.97 49.75 0.56 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 120.196 1.998 . . . . 0.0 113.261 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 32.0 m -78.13 165.85 47.51 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 118.229 1.014 . . . . 0.0 109.335 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 66.0 Cg_endo -78.12 163.92 27.53 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.404 2.07 . . . . 0.0 113.189 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.545 HD12 HD13 ' A' ' 30' ' ' LEU . 37.1 mt -85.64 107.9 17.75 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.7 1.2 . . . . 0.0 110.975 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.44 -172.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 124.292 1.037 . . . . 0.0 109.557 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.54 162.86 14.68 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t -148.97 172.92 13.94 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 125.804 1.642 . . . . 0.0 109.004 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -114.89 -44.98 3.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.339 1.856 . . . . 0.0 108.283 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -178.597 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.575 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.521 HG21 ' CE2' ' A' ' 152' ' ' PHE 0.289 12.9 m -112.28 140.42 47.01 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 178.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.33 -16.76 2.71 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 128.272 2.629 . . . . 0.0 109.815 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.35 122.56 37.18 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 124.147 0.979 . . . . 0.0 111.775 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.2 OUTLIER -161.71 -173.71 3.86 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.439 1.096 . . . . 0.0 109.481 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.47 -172.42 33.59 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.3 tp -146.03 127.16 14.7 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.9 m -82.96 40.16 0.68 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.408 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 5.6 ptt? -62.75 138.46 58.52 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 44.1 mt -117.42 -177.12 3.15 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.99 1.716 . . . . 0.0 106.95 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.1 p90 . . . . . 0 C--O 1.239 0.533 0 CA-C-N 119.728 1.149 . . . . 0.0 112.301 -179.206 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.547 0.846 0 CA-C-O 121.498 0.666 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.28 103.34 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.143 2.562 . . . . 0.0 109.123 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.18 113.23 24.9 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -110.62 139.61 45.71 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.001 0.429 . . . . 0.0 110.744 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.93 -126.25 0.88 Allowed Glycine 0 C--O 1.224 -0.516 0 CA-C-O 117.618 -1.657 . . . . 0.0 112.389 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.4 p -161.68 -165.38 1.27 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 121.292 2.546 . . . . 0.0 112.376 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -142.18 0.5 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.176 0.59 . . . . 0.0 109.868 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -66.53 -20.68 66.09 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 120.34 -1.475 . . . . 0.0 111.256 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -60.58 -16.43 38.0 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.893 0.877 . . . . 0.0 112.394 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.0 mt -74.11 -69.02 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.126 0 C-N-CA 125.48 1.512 . . . . 0.0 113.958 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.04 21.27 6.83 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 67.06 30.38 7.45 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.567 1.147 . . . . 0.0 110.792 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.503 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 16.9 mmt-85 -98.3 102.87 14.74 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.068 1.347 . . . . 0.0 108.476 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.431 ' HB ' HG23 ' A' ' 33' ' ' VAL . 71.0 t -80.25 154.11 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 177.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.503 ' CH2' ' HB2' ' A' ' 21' ' ' ARG . 5.2 m95 -114.27 143.93 44.05 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.8 t -138.35 121.07 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tp -69.96 106.54 3.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -98.79 -174.19 2.72 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.52 96.29 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.893 1.224 . . . . 0.0 112.303 -178.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 45.45 28.14 0.45 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.583 2.753 . . . . 0.0 111.823 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.2 m -153.5 127.04 8.68 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.092 0.86 . . . . 0.0 110.694 -176.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.865 HD12 ' HG ' ' A' ' 87' ' ' LEU . 10.3 mt -83.27 127.9 34.04 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 120.93 -1.106 . . . . 0.0 111.164 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.9 mm -128.01 139.25 52.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 122.949 0.499 . . . . 0.0 109.788 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.18 142.81 39.46 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.431 HG23 ' HB ' ' A' ' 22' ' ' VAL . 8.0 m -119.9 77.15 22.35 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 124.662 1.185 . . . . 0.0 108.115 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.31 -37.23 10.55 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.837 2.358 . . . . 0.0 113.907 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.45 51.88 1.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.74 134.14 52.34 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -66.41 -41.68 88.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.111 0.482 . . . . 0.0 110.485 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.18 75.15 9.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -123.35 140.71 52.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.797 -1.547 . . . . 0.0 110.075 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.0 t -140.87 141.16 23.38 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.75 160.84 42.99 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 N-CA-C 108.589 -1.35 . . . . 0.0 108.589 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.0 m -143.82 166.91 13.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 126.5 1.92 . . . . 0.0 109.093 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.61 154.77 36.32 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.3 mm -129.95 109.4 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 125.648 1.579 . . . . 0.0 108.053 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.98 133.38 34.84 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.818 1.247 . . . . 0.0 108.537 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.8 tt -129.55 129.78 44.9 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.4 1.48 . . . . 0.0 109.193 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.1 mt -142.17 142.71 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.949 0.88 . . . . 0.0 109.62 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.2 p -87.21 146.78 25.85 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.42 ' O ' HG13 ' A' ' 52' ' ' VAL . 87.3 m -63.98 122.69 17.12 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.589 1.156 . . . . 0.0 110.943 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -81.77 -26.86 34.09 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.049 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -96.96 35.9 1.49 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.842 1.201 . . . . 0.0 111.474 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 49' ' ' CYS . 3.7 m -57.06 -15.98 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.583 1.153 . . . . 0.0 112.418 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.18 -13.26 11.36 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.845 2.058 . . . . 0.0 111.227 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.59 -0.89 13.51 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.57 1.548 . . . . 0.0 111.819 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 101' ' ' PRO . 3.6 mm? -113.27 164.25 13.79 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.864 1.666 . . . . 0.0 110.25 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -71.15 152.73 43.12 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.816 0.847 . . . . 0.0 109.246 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -112.18 -32.84 6.42 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -52.57 -35.0 53.04 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 128.592 2.757 . . . . 0.0 114.27 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.9 mtt85 -87.08 -1.5 57.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 118.548 -0.739 . . . . 0.0 112.785 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.73 -177.17 18.19 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -82.45 106.14 6.07 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 118.927 1.364 . . . . 0.0 111.699 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.76 134.96 20.85 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.232 2.622 . . . . 0.0 108.934 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.92 -179.16 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.717 1.607 . . . . 0.0 110.565 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -133.78 158.68 42.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.578 1.151 . . . . 0.0 110.446 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.2 tt -151.64 143.26 23.61 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.124 1.37 . . . . 0.0 109.162 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.43 -174.85 16.01 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.192 1.377 . . . . 0.0 111.344 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.854 HD11 HD11 ' A' ' 30' ' ' LEU . 10.0 mt -105.5 133.59 50.0 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -95.39 107.36 19.49 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.1 -76.77 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.073 -1.536 . . . . 0.0 111.084 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.19 22.09 16.53 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.266 1.026 . . . . 0.0 111.169 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.11 72.54 0.49 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.033 1.733 . . . . 0.0 110.206 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.13 150.29 39.25 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.775 1.23 . . . . 0.0 108.064 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.601 ' SG ' HG23 ' A' ' 92' ' ' ILE . 3.2 m -147.62 171.64 15.29 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 123.069 0.548 . . . . 0.0 109.937 178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 76.7 mt -62.13 166.11 5.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.684 0.794 . . . . 0.0 109.274 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -172.64 137.06 0.78 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.0 m -96.98 128.67 44.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.429 0.633 . . . . 0.0 110.205 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -133.87 -174.9 3.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -131.16 118.01 19.86 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 103.032 -2.951 . . . . 0.0 103.032 178.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 p -72.01 -23.31 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.4 -38.97 0.17 Allowed Glycine 0 N--CA 1.453 -0.227 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -141.8 -17.39 0.77 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.924 0.89 . . . . 0.0 112.488 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -139.47 153.26 70.47 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.836 1.254 . . . . 0.0 113.558 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.93 142.49 88.44 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 124.951 3.767 . . . . 0.0 111.973 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.8 p -147.33 163.52 36.17 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 124.738 1.215 . . . . 0.0 110.218 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 mt -86.12 156.53 20.33 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -147.18 80.08 1.52 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.638 1.975 . . . . 0.0 108.721 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.865 ' HG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -103.01 104.63 14.82 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.188 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.41 -24.79 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -144.58 87.5 1.87 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.379 1.071 . . . . 0.0 111.72 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -165.86 165.84 18.01 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 119.402 -2.061 . . . . 0.0 108.388 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -137.07 165.41 26.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.601 HG23 ' SG ' ' A' ' 73' ' ' CYS . 18.9 pt -113.98 -49.66 5.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 124.765 1.226 . . . . 0.0 110.586 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.1 mmt -62.25 -18.84 62.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 117.913 -1.042 . . . . 0.0 109.25 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -71.42 -45.22 63.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.263 1.392 . . . . 0.0 110.299 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 23.4 mt -62.6 -25.94 68.35 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.727 1.211 . . . . 0.0 109.662 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -82.76 -34.89 26.97 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.646 -0.659 . . . . 0.0 109.784 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -65.42 -37.76 87.87 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.621 -1.18 . . . . 0.0 110.859 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -136.12 158.5 73.6 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.87 82.43 2.33 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.926 2.417 . . . . 0.0 111.062 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -135.56 59.91 33.91 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.822 1.649 . . . . 0.0 107.26 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.644 ' HB2' HD21 ' A' ' 55' ' ' LEU . 61.4 Cg_endo -72.66 86.84 1.0 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.334 2.023 . . . . 0.0 108.68 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.5 t -73.35 101.74 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -53.08 -29.8 32.42 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 122.998 0.519 . . . . 0.0 111.151 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -65.84 -7.1 14.41 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 178.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -120.92 -33.14 3.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.598 1.09 . . . . 0.0 109.689 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.5 mt -68.32 153.19 44.24 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.239 0.472 . . . . 0.0 111.918 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.95 135.72 24.6 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.126 0.97 . . . . 0.0 111.264 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -74.09 113.75 11.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.716 2.407 . . . . 0.0 105.996 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -88.99 134.06 34.11 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.6 t -132.9 -178.68 5.06 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.77 146.72 20.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.943 0.897 . . . . 0.0 109.891 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.85 88.75 0.98 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.431 1.092 . . . . 0.0 111.843 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.17 61.93 1.54 Allowed Glycine 0 C--N 1.339 0.75 0 C-N-CA 124.335 0.969 . . . . 0.0 112.641 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 61.64 0.27 0.47 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.06 2.144 . . . . 0.0 110.437 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -115.28 124.9 52.51 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 m -84.72 171.67 12.14 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.096 0.958 . . . . 0.0 109.497 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.14 161.7 41.45 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.053 2.141 . . . . 0.0 108.375 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -141.22 111.93 7.06 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.582 1.153 . . . . 0.0 109.478 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -105.18 128.8 53.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.463 1.905 . . . . 0.0 109.893 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.2 t -52.74 125.58 17.2 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.028 1.731 . . . . 0.0 110.882 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.17 -45.59 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.428 1.013 . . . . 0.0 109.772 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.5 -33.68 74.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.007 -0.997 . . . . 0.0 111.619 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -136.27 83.89 31.17 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.703 1.201 . . . . 0.0 110.269 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.26 157.22 61.09 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.43 1.42 . . . . 0.0 110.342 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 103.73 -34.88 5.42 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.544 1.545 . . . . 0.0 109.5 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 15.7 m-90 -85.95 140.03 30.7 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -123.99 141.45 52.03 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.384 1.074 . . . . 0.0 109.032 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 140' ' ' LEU . 5.1 mt -78.73 143.43 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -107.08 158.92 16.69 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.6 t -110.93 1.24 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 126.991 2.117 . . . . 0.0 112.698 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.6 m 49.66 52.93 13.62 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 m -85.1 -15.4 44.06 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.034 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -58.11 -31.52 67.23 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -170.15 -79.72 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.86 57.35 0.22 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 84.3 m -88.37 163.01 38.09 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.73 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.07 164.23 34.67 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 N-CA-C 107.531 -1.757 . . . . 0.0 107.531 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.8 mt -91.29 113.8 26.16 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.2 174.15 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 124.597 1.159 . . . . 0.0 112.445 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -100.44 150.71 22.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 118.531 -0.747 . . . . 0.0 109.809 177.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.5 t -130.88 173.86 10.55 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.891 1.276 . . . . 0.0 109.307 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -114.64 -32.6 5.8 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.96 1.304 . . . . 0.0 111.028 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 . . . . . 0 C--O 1.237 0.42 0 CA-C-N 119.14 0.882 . . . . 0.0 109.816 -177.918 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.243 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.77 105.87 8.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.179 0.445 . . . . 0.0 110.644 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.5 p -97.79 -22.91 16.14 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -103.55 108.07 19.18 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.389 1.876 . . . . 0.0 112.963 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -173.36 -179.29 1.87 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.828 1.251 . . . . 0.0 111.732 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.69 -155.96 27.44 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 124.814 1.197 . . . . 0.0 112.323 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.5 tp -151.48 135.84 16.86 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.6 1.56 . . . . 0.0 107.411 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.5 m -93.74 42.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.317 1.447 . . . . 0.0 110.292 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -64.41 147.82 51.81 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.071 -1.018 . . . . 0.0 108.684 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 26.1 mt -125.0 165.29 18.4 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.612 1.565 . . . . 0.0 110.467 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 36.7 p90 . . . . . 0 C--O 1.252 1.236 0 C-N-CA 126.159 1.784 . . . . 0.0 108.785 179.474 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.445 -0.694 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.19 123.03 9.27 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 N-CA-C 106.965 -1.975 . . . . 0.0 106.965 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -114.75 110.39 19.64 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -90.17 156.63 18.2 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.987 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.8 -154.48 7.96 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.5 p -156.46 138.28 14.3 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.505 1.522 . . . . 0.0 110.048 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -98.28 1.04 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.0 0.92 . . . . 0.0 109.89 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -55.03 -36.45 65.53 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.036 -1.665 . . . . 0.0 111.412 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -4.71 0.24 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.7 mt -72.92 -61.56 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 CA-C-N 118.591 0.632 . . . . 0.0 109.78 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.73 29.92 1.1 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.489 1.116 . . . . 0.0 109.452 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 59.93 34.56 21.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.234 1.814 . . . . 0.0 111.45 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -99.86 107.77 19.87 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.4 t -88.71 160.38 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.473 ' HB3' HD22 ' A' ' 30' ' ' LEU . 4.7 m95 -113.78 139.57 49.01 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.419 0.554 . . . . 0.0 109.992 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.2 t -138.48 127.59 31.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.36 116.01 12.29 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 101.64 -3.467 . . . . 0.0 101.64 177.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -131.36 124.76 31.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.479 1.512 . . . . 0.0 108.003 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 t0 49.78 42.06 23.22 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 70.84 11.74 7.12 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.331 1.852 . . . . 0.0 113.863 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.5 m -133.05 138.55 46.8 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.602 1.546 . . . . 0.0 109.656 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.803 HD12 HD13 ' A' ' 87' ' ' LEU . 4.0 mt -83.19 125.47 31.58 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 120.688 -1.258 . . . . 0.0 108.703 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.06 147.06 30.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.84 139.6 39.3 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.317 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.32 74.69 80.09 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 123.778 0.831 . . . . 0.0 110.559 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.29 -73.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.65 1.566 . . . . 0.0 112.976 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.27 12.45 32.92 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -72.45 129.03 37.38 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.247 0.619 . . . . 0.0 112.209 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -46.33 79.62 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.515 1.126 . . . . 0.0 108.492 177.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.63 24.37 0.21 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -69.38 177.6 2.77 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.001 0.819 . . . . 0.0 109.644 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.5 t -163.52 135.52 3.87 Favored Pre-proline 0 C--O 1.237 0.408 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.57 151.85 82.0 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.858 1.705 . . . . 0.0 110.434 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.5 p -141.2 156.58 21.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 m -120.82 157.39 29.86 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.806 HG22 HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -132.05 105.81 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.206 1.002 . . . . 0.0 111.505 -178.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . . . -94.88 120.47 35.15 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.396 1.078 . . . . 0.0 111.085 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.6 tt -106.06 139.39 40.66 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 125.522 1.529 . . . . 0.0 108.754 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.9 mt -137.46 145.48 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 124.778 1.299 . . . . 0.0 108.83 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.1 p -87.37 137.53 32.26 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.7 m -57.29 112.31 1.35 Allowed 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.097 -1.002 . . . . 0.0 109.984 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -94.79 -6.55 42.67 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.433 ' CE1' ' HA ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -117.95 64.48 0.75 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.056 1.742 . . . . 0.0 106.338 179.405 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.66 ' HA ' HD23 ' A' ' 55' ' ' LEU . 4.3 m -90.95 3.35 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -178.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -50.86 -26.69 6.11 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -117.58 18.45 14.23 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.085 1.354 . . . . 0.0 110.651 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.66 HD23 ' HA ' ' A' ' 52' ' ' VAL . 3.7 mm? -114.43 171.75 7.44 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 120.205 -1.559 . . . . 0.0 108.791 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.81 165.01 16.33 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.419 ' HE2' ' HB ' ' A' ' 52' ' ' VAL . 1.9 mttm -136.43 -39.6 0.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.824 1.25 . . . . 0.0 109.683 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -73.8 -17.35 61.09 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 123.554 0.534 . . . . 0.0 111.803 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -44.99 75.78 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.418 -0.801 . . . . 0.0 109.099 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 167.64 169.33 31.04 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 127.433 2.444 . . . . 0.0 107.384 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -73.62 110.16 8.29 Favored Pre-proline 0 CA--C 1.537 0.445 0 O-C-N 120.767 -1.431 . . . . 0.0 112.388 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.68 136.38 25.54 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 CA-C-N 121.862 1.701 . . . . 0.0 109.925 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 37.7 pt -146.06 -178.14 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.965 1.706 . . . . 0.0 108.96 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -153.68 159.93 42.2 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.218 1.007 . . . . 0.0 109.969 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.806 HD22 HG22 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -140.29 154.64 46.89 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.566 1.174 . . . . 0.0 111.589 -178.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.81 159.01 26.85 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 124.757 1.17 . . . . 0.0 111.3 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.539 ' CD1' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -98.42 131.75 44.43 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.6 116.56 32.29 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.54 -36.27 0.24 Allowed Glycine 0 N--CA 1.447 -0.573 0 O-C-N 125.158 1.536 . . . . 0.0 111.91 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.08 24.41 0.83 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -178.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.03 70.77 0.61 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.286 1.434 . . . . 0.0 109.623 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.85 144.69 27.09 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 120.805 -1.184 . . . . 0.0 108.52 -178.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 34.0 m -145.76 166.67 25.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 117.352 -1.309 . . . . 0.0 111.7 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.6 mt -51.99 157.41 1.29 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.531 1.132 . . . . 0.0 110.352 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -170.39 148.27 3.16 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 68.0 m -109.55 121.34 44.99 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.119 1.768 . . . . 0.0 110.56 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.27 178.04 6.88 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.384 1.074 . . . . 0.0 109.57 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.406 ' HE3' ' C ' ' A' ' 81' ' ' ASP . 15.2 tttt -119.85 130.73 55.02 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 102.685 -3.08 . . . . 0.0 102.685 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.443 HG21 HG21 ' A' ' 84' ' ' THR . 27.2 m -128.73 38.66 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.603 0.761 . . . . 0.0 112.693 -177.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.87 54.78 0.12 Allowed Glycine 0 CA--C 1.503 -0.712 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.406 ' C ' ' HE3' ' A' ' 78' ' ' LYS . 23.0 t0 66.23 13.65 9.27 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.26 141.71 35.13 Favored Pre-proline 0 N--CA 1.448 -0.566 0 C-N-CA 125.61 1.564 . . . . 0.0 110.367 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.54 141.89 22.8 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.607 2.871 . . . . 0.0 113.236 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.443 HG21 HG21 ' A' ' 79' ' ' VAL . 72.8 p -150.42 176.82 10.57 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.506 0.723 . . . . 0.0 110.721 178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.468 HD11 HG23 ' A' ' 128' ' ' ILE . 7.9 mt -89.19 150.55 22.62 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.719 0.807 . . . . 0.0 110.845 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -146.01 65.81 1.21 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.935 1.694 . . . . 0.0 109.253 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.803 HD13 HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -93.43 96.28 9.81 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 126.323 1.849 . . . . 0.0 107.949 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.66 -26.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.996 -177.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -144.44 98.0 3.13 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.487 1.115 . . . . 0.0 109.112 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.52 160.81 0.11 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.256 1.423 . . . . 0.0 110.572 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -142.24 133.16 25.79 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.53 0.732 . . . . 0.0 109.631 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.441 HG23 ' SG ' ' A' ' 73' ' ' CYS . 7.7 pt -72.27 -44.05 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.688 1.995 . . . . 0.0 111.656 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.21 -26.03 62.33 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.023 0.929 . . . . 0.0 111.395 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -60.64 -52.02 66.93 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.446 HD11 ' CD2' ' A' ' 105' ' ' PHE . 80.6 mt -61.87 -35.19 77.59 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.717 2.407 . . . . 0.0 110.746 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -80.04 -20.59 44.94 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.195 -1.566 . . . . 0.0 109.769 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -87.27 -37.12 17.49 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.581 -1.324 . . . . 0.0 113.528 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -130.87 162.6 54.33 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 120.09 1.314 . . . . 0.0 109.511 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.03 -172.13 0.39 Allowed 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 122.13 1.887 . . . . 0.0 108.772 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.252 19.8 mm-40 92.09 71.97 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 129.119 2.968 . . . . 0.0 113.934 177.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.594 ' CB ' HD21 ' A' ' 55' ' ' LEU . 18.3 Cg_endo -61.99 103.54 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.783 2.989 . . . . 0.0 111.573 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.1 t -78.01 98.7 2.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -52.75 -34.82 54.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.002 -1.686 . . . . 0.0 109.665 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.8 m -69.51 11.67 0.23 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.044 1.338 . . . . 0.0 112.564 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.446 ' CD2' HD11 ' A' ' 95' ' ' LEU . 44.9 t80 -133.85 -21.89 1.89 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.858 1.663 . . . . 0.0 108.683 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.4 mt -84.86 153.33 22.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.806 -1.184 . . . . 0.0 110.374 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.555 ' CE2' HD11 ' A' ' 128' ' ' ILE . 95.0 m-85 -139.4 124.64 19.01 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.198 0.999 . . . . 0.0 110.128 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -72.21 122.42 21.02 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -75.18 141.68 43.6 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.69 178.57 8.05 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -164.62 153.0 12.43 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.83 1.252 . . . . 0.0 111.425 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.7 t -168.2 103.66 0.45 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.582 1.553 . . . . 0.0 113.226 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.47 49.3 5.24 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 126.322 1.915 . . . . 0.0 113.294 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 62.16 26.0 15.6 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -131.83 122.91 26.52 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 117.535 -1.221 . . . . 0.0 109.194 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.65 -177.86 3.37 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.969 1.258 . . . . 0.0 110.604 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.26 169.11 25.49 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 119.885 -1.759 . . . . 0.0 108.512 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -146.43 114.87 6.73 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.611 1.165 . . . . 0.0 111.293 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -108.6 126.6 53.13 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.42 1.488 . . . . 0.0 111.656 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.62 110.91 0.56 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.775 2.03 . . . . 0.0 109.995 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.6 t -60.78 -41.27 87.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 O-C-N 121.394 -0.816 . . . . 0.0 110.644 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.16 -45.34 92.28 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 119.529 -0.868 . . . . 0.0 112.264 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -128.62 86.71 56.92 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.1 156.49 65.6 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.997 1.798 . . . . 0.0 110.731 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.82 -27.12 11.46 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -95.35 140.36 30.34 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -119.07 146.34 45.16 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.575 1.55 . . . . 0.0 109.593 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.555 HD11 ' CE2' ' A' ' 107' ' ' PHE . 12.9 mm -73.74 121.3 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.294 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.15 143.09 27.26 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 118.719 -1.192 . . . . 0.0 109.91 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.4 m -94.3 -10.46 9.24 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 O-C-N 121.306 -0.871 . . . . 0.0 109.938 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.4 m 57.15 56.84 4.92 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 119.648 -1.907 . . . . 0.0 115.259 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.4 m -99.52 7.07 45.66 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -84.2 -75.03 0.36 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.49 1.116 . . . . 0.0 109.725 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -109.34 -36.51 2.1 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 118.46 60.19 0.28 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 14.0 m -84.86 167.46 26.32 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.44 149.95 87.42 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 N-CA-C 107.028 -1.951 . . . . 0.0 107.028 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.8 mt -66.72 125.11 24.79 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pp -148.42 167.39 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.404 0.682 . . . . 0.0 110.799 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 80.1 mt -81.35 159.63 24.34 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.24 127.81 11.56 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -83.28 -43.23 16.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 124.188 0.93 . . . . 0.0 110.471 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 C--O 1.236 0.342 0 CA-C-O 120.729 0.3 . . . . 0.0 111.035 -177.147 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.18 106.82 14.14 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.433 1.093 . . . . 0.0 108.557 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.07 -34.83 7.83 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.045 0.839 . . . . 0.0 110.633 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -96.52 100.0 11.61 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 127.991 2.516 . . . . 0.0 110.656 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -168.81 173.02 7.39 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.558 1.943 . . . . 0.0 110.277 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.32 -174.07 13.67 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 125.247 1.403 . . . . 0.0 110.425 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.49 169.85 16.92 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.169 0.509 . . . . 0.0 111.865 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 34.3 m -84.38 75.07 10.27 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.84 1.656 . . . . 0.0 109.998 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.74 153.32 35.14 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 68.6 mt -135.02 -165.24 1.64 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 129.852 3.261 . . . . 0.0 109.535 -177.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.5 p90 . . . . . 0 C--O 1.258 1.54 0 C-N-CA 125.721 1.608 . . . . 0.0 114.095 -178.603 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.54 146.97 45.14 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 N-CA-C 105.962 -2.361 . . . . 0.0 105.962 177.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.69 118.02 23.04 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.96 139.86 53.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -168.87 -119.18 0.48 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.8 p -150.19 177.63 9.74 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.202 1.501 . . . . 0.0 114.959 -177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.436 HG21 HD13 ' A' ' 15' ' ' ILE . 84.0 mt -141.79 -9.59 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 128.305 2.642 . . . . 0.0 108.253 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -58.7 -30.13 67.18 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 118.898 -2.376 . . . . 0.0 116.075 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.03 -12.96 9.32 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.44 1.496 . . . . 0.0 113.506 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.6 mt -54.97 -49.86 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 O-C-N 121.112 -0.993 . . . . 0.0 111.628 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -153.41 30.49 0.48 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.699 0.799 . . . . 0.0 109.244 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 64.59 8.0 4.11 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.127 1.771 . . . . 0.0 114.427 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.03 104.7 10.78 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 126.823 2.049 . . . . 0.0 107.022 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.5 t -82.45 175.1 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 178.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.407 ' CE2' HD11 ' A' ' 138' ' ' LEU . 40.4 m0 -123.07 134.23 54.27 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.788 -1.195 . . . . 0.0 108.264 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.9 t -132.51 133.46 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tp -71.88 112.5 8.03 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -130.76 127.46 38.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 120.457 1.481 . . . . 0.0 109.556 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.9 t0 43.79 56.01 4.82 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.212 1.005 . . . . 0.0 111.568 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.554 ' HB3' ' HE2' ' A' ' 88' ' ' LYS . 91.2 mt-30 57.41 22.28 7.76 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.13 139.7 32.23 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 125.242 1.417 . . . . 0.0 107.366 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.809 HD21 HD11 ' A' ' 67' ' ' LEU . 17.3 mt -79.36 131.31 36.08 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 120.66 -1.275 . . . . 0.0 107.816 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.2 mt -123.97 133.77 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.155 0.889 . . . . 0.0 110.086 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.519 ' HB3' ' HA2' ' A' ' 135' ' ' GLY . . . -75.91 142.57 42.04 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.58 75.16 79.84 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.245 1.418 . . . . 0.0 112.308 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.28 -74.85 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 121.746 1.63 . . . . 0.0 110.736 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -95.44 68.01 2.95 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.5 145.74 51.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -76.34 -62.54 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.54 0.686 . . . . 0.0 110.028 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 -74.27 40.94 0.13 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -75.52 165.71 24.69 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 120.794 -1.191 . . . . 0.0 108.503 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.52 144.22 20.38 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.46 166.37 28.7 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.588 2.192 . . . . 0.0 111.136 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 p -155.75 164.3 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.76 149.9 49.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mm -123.18 118.9 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.943 1.297 . . . . 0.0 110.526 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.6 135.53 37.15 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.772 1.629 . . . . 0.0 108.774 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.3 tt -131.76 135.6 46.92 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.992 1.317 . . . . 0.0 108.029 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.3 mt -141.53 147.11 22.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.35 1.06 . . . . 0.0 108.565 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 p -90.59 128.22 36.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.896 2.479 . . . . 0.0 106.301 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 74.2 m -62.2 144.34 55.6 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.428 0.558 . . . . 0.0 109.627 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -101.21 -34.36 9.7 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.237 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -88.95 41.55 1.03 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.707 1.203 . . . . 0.0 108.737 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -69.84 -13.13 16.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 O-C-N 121.708 -0.62 . . . . 0.0 111.095 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -51.67 -39.32 58.03 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.598 1.559 . . . . 0.0 112.523 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.8 t -89.38 -5.16 57.69 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.753 0.821 . . . . 0.0 112.697 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.3 mt -92.45 -145.52 0.22 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.92 1.288 . . . . 0.0 112.538 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -123.37 160.0 27.71 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 127.815 2.446 . . . . 0.0 109.958 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -137.42 -26.8 0.98 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.61 1.564 . . . . 0.0 111.967 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -61.86 -45.24 94.66 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.79 0.723 . . . . 0.0 110.268 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -58.33 -51.2 70.78 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.726 0.81 . . . . 0.0 108.823 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.3 -179.32 37.69 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 106.422 -2.671 . . . . 0.0 106.422 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -82.46 117.79 69.68 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.052 0.926 . . . . 0.0 109.489 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 108' ' ' TYR . 73.0 Cg_endo -71.93 138.29 31.01 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.981 3.12 . . . . 0.0 111.121 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.4 pt -140.73 -177.39 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.14 0.576 . . . . 0.0 110.215 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.5 ' CD1' HG23 ' A' ' 92' ' ' ILE . 3.7 t80 -143.21 157.95 44.05 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.976 -0.452 . . . . 0.0 110.55 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 tt -156.84 157.68 35.39 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.757 1.223 . . . . 0.0 109.446 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -164.93 -179.08 38.72 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.809 HD11 HD21 ' A' ' 30' ' ' LEU . 9.5 mt -94.68 160.1 14.77 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -131.95 88.44 2.56 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.9 -40.58 0.02 OUTLIER Glycine 0 CA--C 1.523 0.538 0 CA-C-O 118.93 -0.928 . . . . 0.0 111.463 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.57 23.46 2.3 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.82 0.848 . . . . 0.0 112.731 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.2 m120 59.9 73.07 0.5 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.999 1.72 . . . . 0.0 110.228 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.09 138.55 25.42 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.768 1.227 . . . . 0.0 110.203 -177.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 16.3 m -139.93 177.42 7.98 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.837 0.744 . . . . 0.0 109.604 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.889 ' HA ' HD12 ' A' ' 87' ' ' LEU . 26.8 mt -61.42 151.11 33.4 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.2 ttp -155.04 148.61 25.29 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 9.3 m -124.53 126.46 45.88 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.559 ' CB ' HE21 ' A' ' 86' ' ' GLN . . . -130.47 -178.63 4.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.916 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -132.69 118.98 19.78 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.4 m -75.25 30.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 122.966 0.507 . . . . 0.0 111.276 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.42 -3.86 61.51 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.201 -0.937 . . . . 0.0 112.087 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -127.06 -57.43 1.32 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.799 1.24 . . . . 0.0 112.071 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -145.26 164.06 28.84 Favored Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 125.59 1.556 . . . . 0.0 110.943 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.94 148.96 46.38 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.302 1.334 . . . . 0.0 113.234 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.6 p -146.06 169.83 17.89 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.575 0.75 . . . . 0.0 110.348 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.559 ' CD2' HD11 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -89.74 141.76 28.32 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.913 1.285 . . . . 0.0 109.929 179.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.559 HE21 ' CB ' ' A' ' 77' ' ' ALA . 12.2 mt-30 -140.27 68.28 1.36 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.709 0.766 . . . . 0.0 109.682 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.889 HD12 ' HA ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -85.0 106.57 16.6 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -178.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.554 ' HE2' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -163.37 -43.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 O-C-N 124.887 1.367 . . . . 0.0 112.251 -179.328 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -139.97 93.11 2.61 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -167.36 172.44 9.7 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.411 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.463 ' H ' ' HD3' ' A' ' 90' ' ' LYS . 14.9 m-20 -146.17 139.31 25.82 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 125.786 1.635 . . . . 0.0 109.356 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.5 HG23 ' CD1' ' A' ' 64' ' ' TYR . 1.8 mp -87.62 -48.14 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.05 0.94 . . . . 0.0 111.057 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -60.82 -28.27 68.67 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 118.984 -0.531 . . . . 0.0 111.098 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -65.99 -51.98 53.51 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.943 0.792 . . . . 0.0 109.702 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.443 HD12 ' CE1' ' A' ' 64' ' ' TYR . 52.6 mt -63.79 -27.22 69.03 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.021 0.529 . . . . 0.0 111.332 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -82.33 -28.06 31.86 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.531 -0.731 . . . . 0.0 110.231 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -78.14 -37.21 46.61 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.894 1.278 . . . . 0.0 111.406 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -109.12 158.09 35.28 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -77.62 50.29 3.18 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.165 2.577 . . . . 0.0 111.89 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -117.05 74.5 7.18 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 124.892 1.277 . . . . 0.0 111.06 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -78.64 81.1 2.86 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.494 2.13 . . . . 0.0 107.519 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.3 t -70.27 97.95 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -51.43 -30.44 19.44 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.812 0.845 . . . . 0.0 111.76 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -64.43 -5.93 6.26 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 125.751 1.62 . . . . 0.0 112.199 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -123.49 -31.28 3.53 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.244 1.018 . . . . 0.0 109.158 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.1 mt -70.41 162.25 29.01 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.192 1.397 . . . . 0.0 112.489 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -152.2 139.68 19.61 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.152 0.981 . . . . 0.0 109.888 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER -82.98 161.59 21.72 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-N 119.858 1.208 . . . . 0.0 108.926 177.677 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -114.2 126.0 54.56 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 128.32 2.648 . . . . 0.0 112.139 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.5 t -132.35 145.88 51.57 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.29 148.57 47.32 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.185 0.994 . . . . 0.0 109.801 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.5 p -157.67 78.98 0.86 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.32 70.77 1.2 Allowed Glycine 0 N--CA 1.467 0.753 0 C-N-CA 123.958 0.79 . . . . 0.0 112.736 177.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.4 mtm-85 61.61 9.47 2.79 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.473 1.509 . . . . 0.0 112.726 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.445 HD22 ' HA ' ' A' ' 152' ' ' PHE . 34.9 m120 -119.72 153.4 35.69 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.2 m -139.85 151.55 45.77 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 79.6 p -114.39 174.57 5.89 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.624 0.726 . . . . 0.0 111.286 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -139.82 104.45 4.89 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.927 1.691 . . . . 0.0 106.923 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.444 ' HB2' ' CD2' ' A' ' 127' ' ' PHE . 0.3 OUTLIER -117.55 130.29 56.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.668 178.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.6 m -53.26 126.21 20.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.107 1.363 . . . . 0.0 112.626 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 99.2 t -71.8 -42.86 69.99 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.889 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.6 91.6 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -128.02 82.04 69.21 Favored Pre-proline 0 C--O 1.234 0.254 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.07 153.38 78.33 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 108.679 -1.316 . . . . 0.0 108.679 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.09 -12.26 44.77 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.511 1.529 . . . . 0.0 110.888 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -113.22 135.48 53.78 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.13 1.772 . . . . 0.0 108.575 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.444 ' CD2' ' HB2' ' A' ' 119' ' ' GLU . 37.7 m-85 -122.21 150.19 42.62 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.833 1.653 . . . . 0.0 108.463 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 22.3 mt -79.52 134.49 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 123.734 0.814 . . . . 0.0 110.1 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -104.34 124.92 50.05 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 91.7 t -72.9 -19.1 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 127.708 2.403 . . . . 0.0 113.214 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.4 m 54.34 65.58 1.47 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.176 1.39 . . . . 0.0 114.325 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.5 m -88.61 -9.75 51.08 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -58.17 -76.07 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.906 2.188 . . . . 0.0 116.906 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.93 16.11 5.83 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 125.447 1.499 . . . . 0.0 113.278 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.519 ' HA2' ' HB3' ' A' ' 32' ' ' ALA . . . 82.58 56.53 2.77 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -84.33 166.69 31.56 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 117.457 0.628 . . . . 0.0 110.213 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.55 151.32 32.64 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.96 1.773 . . . . 0.0 109.005 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.407 HD11 ' CE2' ' A' ' 23' ' ' TRP . 12.8 mt -76.51 115.29 16.12 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.499 1.12 . . . . 0.0 108.114 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.06 168.87 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 125.573 1.549 . . . . 0.0 110.713 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 74.4 mt -88.1 165.43 15.14 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.1 t -153.95 137.39 15.86 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -80.23 -41.05 25.87 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.417 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 CA--C 1.504 -0.797 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 -178.066 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.4 m120 . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.31 88.99 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 129.724 3.21 . . . . 0.0 113.298 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.5 p -111.76 -2.72 15.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.151 -0.968 . . . . 0.0 111.984 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -139.17 109.8 6.64 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.445 ' HA ' HD22 ' A' ' 115' ' ' ASN . 0.3 OUTLIER -158.44 -176.99 6.21 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.199 1.8 . . . . 0.0 111.879 -178.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.62 -173.7 25.84 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.537 1.541 . . . . 0.0 110.777 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.41 HD11 HD11 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -132.66 146.61 52.02 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.621 1.169 . . . . 0.0 109.392 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.0 m -102.8 45.83 0.95 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.331 1.453 . . . . 0.0 107.159 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -67.68 154.18 42.07 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.495 1.118 . . . . 0.0 109.238 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.2 mt -129.11 172.3 11.55 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.006 1.322 . . . . 0.0 109.591 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.8 p90 . . . . . 0 C--O 1.248 0.996 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 179.403 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 119.474 -0.298 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.1 136.05 42.87 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.084 2.523 . . . . 0.0 109.576 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.79 111.11 20.73 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -109.93 145.14 37.39 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.31 -140.17 3.19 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 119.459 1.027 . . . . 0.0 112.54 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.2 p -136.68 -175.95 4.19 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.604 1.702 . . . . 0.0 113.311 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.6 mt -144.31 -6.19 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 126.696 1.999 . . . . 0.0 109.438 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.413 ' C ' ' H ' ' A' ' 18' ' ' ILE . 4.8 pt20 -73.52 -24.32 60.13 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 119.467 -2.02 . . . . 0.0 114.43 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -72.17 36.91 0.07 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.208 3.003 . . . . 0.0 110.732 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.413 ' H ' ' C ' ' A' ' 16' ' ' GLN . 45.4 mt -122.14 -71.14 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 128.674 2.79 . . . . 0.0 109.504 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -126.57 25.35 6.49 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 122.548 0.339 . . . . 0.0 111.383 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 64.83 35.82 8.31 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.623 0.725 . . . . 0.0 109.414 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.3 mmt-85 -104.16 81.65 1.86 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 120.838 -1.163 . . . . 0.0 109.809 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.65 134.12 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.566 ' CD2' HD11 ' A' ' 138' ' ' LEU . 45.8 m0 -89.95 144.66 25.73 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.8 t -144.21 131.52 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.6 tp -71.14 115.01 9.79 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -132.27 123.92 27.86 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.922 1.289 . . . . 0.0 107.731 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.3 t70 46.85 50.4 13.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.728 1.211 . . . . 0.0 112.475 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 65.86 15.76 10.19 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.2 m -137.39 152.11 49.29 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.592 HD11 HD11 ' A' ' 67' ' ' LEU . 31.4 mt -91.07 129.31 37.08 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 119.815 -1.803 . . . . 0.0 107.481 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.2 mm -127.73 138.16 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.407 0.683 . . . . 0.0 110.409 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.18 127.98 33.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.526 1.131 . . . . 0.0 108.73 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -111.26 99.12 42.47 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 124.601 1.16 . . . . 0.0 108.036 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.25 -32.16 8.59 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.287 1.991 . . . . 0.0 112.726 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -92.9 161.99 14.26 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.864 1.266 . . . . 0.0 109.816 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.04 19.44 12.84 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.542 1.137 . . . . 0.0 110.095 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -53.55 -50.82 64.71 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.282 1.401 . . . . 0.0 108.861 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.07 81.79 0.78 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 12.6 ptp -108.8 169.19 8.82 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.9 t -148.28 130.82 7.79 Favored Pre-proline 0 N--CA 1.45 -0.441 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -64.9 148.85 90.06 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.788 1.658 . . . . 0.0 107.86 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.5 m -142.03 171.5 10.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 125.591 1.556 . . . . 0.0 107.365 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.37 157.59 46.51 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mm -118.21 144.0 27.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 127.984 2.513 . . . . 0.0 105.271 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.02 129.92 52.85 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 126.597 1.959 . . . . 0.0 105.793 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.42 132.1 48.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.96 1.255 . . . . 0.0 107.699 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.5 mt -144.93 149.41 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.6 p -81.82 166.03 20.34 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.7 t -88.77 158.43 18.16 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -117.2 -3.8 11.47 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 177.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -119.05 57.36 0.88 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.417 ' HA ' HD12 ' A' ' 55' ' ' LEU . 24.0 m -83.87 -11.97 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.96 0.904 . . . . 0.0 110.837 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -64.72 -6.53 8.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.56 1.944 . . . . 0.0 112.484 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.7 t -121.8 7.89 9.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.157 1.383 . . . . 0.0 110.196 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 52' ' ' VAL . 96.0 mt -108.24 173.05 6.49 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 120.585 -1.322 . . . . 0.0 112.006 -178.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -79.77 154.92 28.17 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -126.44 -40.59 1.94 Allowed 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 116.938 -1.506 . . . . 0.0 110.846 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.28 -38.7 28.08 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.115 1.766 . . . . 0.0 114.177 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -65.63 -33.19 75.33 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 119.602 -0.237 . . . . 0.0 111.349 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.633 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 142.21 -178.14 21.03 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 126.381 1.943 . . . . 0.0 110.584 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -78.2 113.71 36.03 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -81.91 148.22 15.38 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 124.432 3.421 . . . . 0.0 111.592 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -149.84 -171.78 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 126.673 1.989 . . . . 0.0 109.067 178.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.456 ' CZ ' HD13 ' A' ' 95' ' ' LEU . 8.2 m-85 -132.86 147.11 52.3 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.928 2.091 . . . . 0.0 112.762 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.404 HD22 HD11 ' A' ' 74' ' ' LEU . 5.1 tt -156.73 134.15 10.69 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 120.474 -1.391 . . . . 0.0 109.645 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -142.02 -167.77 11.43 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.592 HD11 HD11 ' A' ' 30' ' ' LEU . 2.5 mt -100.7 159.52 15.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.89 87.56 2.78 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.61 -38.33 0.03 OUTLIER Glycine 0 C--N 1.336 0.544 0 CA-C-O 117.927 -1.485 . . . . 0.0 116.082 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.78 17.2 2.68 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.852 1.826 . . . . 0.0 111.896 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.15 69.15 0.39 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.62 146.37 29.33 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 124.784 1.233 . . . . 0.0 108.684 -177.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.401 ' SG ' HG13 ' A' ' 92' ' ' ILE . 4.4 m -145.24 -175.37 4.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.324 1.05 . . . . 0.0 112.232 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.886 ' HA ' HD12 ' A' ' 87' ' ' LEU . 45.4 mt -66.64 160.5 25.34 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.2 ttp -161.69 127.56 3.66 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.3 m -96.51 119.67 35.42 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 118.314 0.506 . . . . 0.0 110.472 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -123.39 175.85 6.49 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -137.25 120.05 16.3 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.9 m -74.18 13.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.17 -23.95 34.25 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -115.32 -39.15 3.65 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -149.64 158.45 37.63 Favored Pre-proline 0 C--O 1.24 0.575 0 C-N-CA 123.785 0.834 . . . . 0.0 111.052 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -71.01 145.31 49.63 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.219 2.613 . . . . 0.0 110.194 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 42.4 p -146.55 156.92 43.6 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.458 0.703 . . . . 0.0 110.075 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.452 ' HB3' HD11 ' A' ' 87' ' ' LEU . 7.9 mt -83.11 149.11 27.09 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -145.44 67.23 1.22 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.451 1.5 . . . . 0.0 109.437 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.886 HD12 ' HA ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -83.12 112.09 19.5 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 127.63 2.372 . . . . 0.0 108.032 -177.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.47 -29.28 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 O-C-N 125.21 1.569 . . . . 0.0 113.358 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -146.25 90.07 1.92 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 120.321 1.418 . . . . 0.0 113.21 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -166.9 160.1 14.07 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.564 1.546 . . . . 0.0 107.071 179.417 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.43 146.68 40.42 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.958 1.703 . . . . 0.0 107.688 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.464 ' HA ' HD12 ' A' ' 95' ' ' LEU . 3.0 mt -96.85 -40.28 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.737 0.815 . . . . 0.0 110.707 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -27.29 68.73 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.399 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.08 -48.28 80.89 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.836 0.827 . . . . 0.0 110.707 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 92' ' ' ILE . 13.1 mt -62.71 -27.99 69.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 127.598 2.359 . . . . 0.0 110.368 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -87.32 -20.25 27.05 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -88.27 -25.22 22.94 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 119.339 0.972 . . . . 0.0 112.678 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -137.75 157.43 73.48 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.807 1.243 . . . . 0.0 111.068 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.2 67.64 5.15 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 124.018 3.145 . . . . 0.0 114.124 -178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -118.07 73.27 9.59 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.12 0.968 . . . . 0.0 111.461 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -80.95 77.42 4.06 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.294 2.663 . . . . 0.0 108.504 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.2 t -68.62 103.17 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 126.174 1.789 . . . . 0.0 108.849 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.409 ' HA ' HD12 ' A' ' 106' ' ' LEU . 44.4 mtpt -56.3 -31.62 63.83 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.041 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.0 -9.05 42.53 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.648 1.113 . . . . 0.0 112.284 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -120.82 -18.54 7.61 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.225 0.921 . . . . 0.0 109.169 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 103' ' ' LYS . 66.6 mt -74.69 149.58 39.84 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 119.774 -1.829 . . . . 0.0 109.724 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -139.7 129.27 24.37 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.988 0.515 . . . . 0.0 110.549 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.633 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -74.68 126.8 31.64 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 177.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -95.49 117.08 29.74 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.023 0.529 . . . . 0.0 111.265 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.1 t -112.33 -176.81 3.01 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 2.1 pt20 -150.93 147.7 27.51 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.177 2.191 . . . . 0.0 110.025 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.1 p -164.63 87.66 0.47 Allowed 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.993 1.433 . . . . 0.0 113.874 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.04 70.46 1.3 Allowed Glycine 0 CA--C 1.504 -0.64 0 C-N-CA 124.899 1.238 . . . . 0.0 112.251 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.8 mtm-85 64.22 -2.32 0.61 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.686 1.995 . . . . 0.0 113.075 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -111.74 165.89 11.65 Favored 'General case' 0 CA--C 1.513 -0.442 0 C-N-CA 124.885 1.274 . . . . 0.0 110.951 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 45.6 m -132.69 162.91 30.18 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.695 1.598 . . . . 0.0 110.471 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.87 170.07 16.43 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.106 0.962 . . . . 0.0 110.222 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -139.67 109.5 6.35 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.443 1.497 . . . . 0.0 108.993 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -100.78 130.02 46.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.491 1.916 . . . . 0.0 110.134 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.4 t -58.1 126.07 25.87 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.548 0.613 . . . . 0.0 109.541 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.34 -47.99 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 O-C-N 120.938 -1.101 . . . . 0.0 110.129 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.42 -37.62 65.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.254 0.479 . . . . 0.0 110.804 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -138.19 91.0 13.18 Favored Pre-proline 0 C--O 1.234 0.269 0 C-N-CA 123.502 0.721 . . . . 0.0 109.137 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.25 174.53 8.94 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.606 2.204 . . . . 0.0 112.264 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.39 -13.76 44.26 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 126.262 1.886 . . . . 0.0 111.341 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -110.2 117.69 34.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.177 0.991 . . . . 0.0 109.553 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -99.27 132.84 44.31 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 127.521 2.328 . . . . 0.0 109.326 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 pt -71.95 120.76 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 121.762 -0.586 . . . . 0.0 109.634 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.27 166.74 16.25 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 118.181 -1.408 . . . . 0.0 111.274 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.5 m -107.28 -16.29 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 C-N-CA 125.099 1.36 . . . . 0.0 112.976 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.1 m 72.63 64.98 0.12 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 122.804 1.288 . . . . 0.0 110.728 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.08 33.09 4.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.532 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -117.05 -47.69 2.67 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.725 0.41 . . . . 0.0 111.749 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -140.46 -60.21 0.04 OUTLIER Glycine 0 C--N 1.333 0.384 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.41 51.94 0.01 OUTLIER Glycine 0 C--N 1.332 0.308 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . 0.524 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 55.9 m -88.18 177.43 2.65 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.921 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 136' ' ' CYS . 42.0 Cg_endo -81.39 169.66 15.43 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.009 2.473 . . . . 0.0 111.025 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 23' ' ' TRP . 30.3 mt -86.91 112.76 22.09 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 124.159 0.983 . . . . 0.0 110.702 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.25 -175.08 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.034 0.934 . . . . 0.0 110.15 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.09 137.03 45.94 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 15.4 t -131.19 154.36 48.48 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.562 1.545 . . . . 0.0 108.753 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -94.93 -23.36 17.45 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.373 1.469 . . . . 0.0 108.903 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 . . . . . 0 N--CA 1.441 -0.906 0 CA-C-O 123.374 1.559 . . . . 0.0 108.4 -177.757 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 . . . . . 0 C--O 1.237 0.437 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.533 HG21 ' CE2' ' A' ' 152' ' ' PHE . 3.5 m -82.69 137.34 34.47 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.523 1.929 . . . . 0.0 109.382 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 65.3 p -117.68 -23.65 7.54 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.064 1.302 . . . . 0.0 108.046 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -95.8 110.0 22.23 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.953 1.301 . . . . 0.0 113.654 -177.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.533 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.6 OUTLIER -166.52 -175.14 3.08 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.235 1.814 . . . . 0.0 108.78 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -108.85 -178.04 21.61 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.91 131.57 53.41 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 123.739 0.816 . . . . 0.0 109.558 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.5 m -79.0 31.85 0.21 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.384 1.474 . . . . 0.0 108.31 177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.9 ptt? -63.03 130.14 43.41 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.261 1.824 . . . . 0.0 107.928 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 21.5 mt -100.51 175.83 5.55 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 126.181 1.792 . . . . 0.0 108.753 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 23.9 p90 . . . . . 0 C--O 1.261 1.7 0 CA-C-O 115.615 -2.136 . . . . 0.0 108.924 -179.405 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.538 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.35 152.61 20.77 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.67 2.247 . . . . 0.0 108.328 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.12 124.44 27.53 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 178.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.92 133.81 55.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.82 -131.08 1.29 Allowed Glycine 0 CA--C 1.522 0.478 0 CA-C-O 116.825 -2.097 . . . . 0.0 110.259 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.7 p -154.97 -173.04 4.41 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 122.604 3.202 . . . . 0.0 114.715 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mt -136.36 -2.93 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.763 1.225 . . . . 0.0 108.712 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.508 ' CB ' HG22 ' A' ' 22' ' ' VAL . 4.7 pt20 -56.39 -40.86 75.33 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.099 -1.626 . . . . 0.0 112.114 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -19.98 2.36 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.712 2.005 . . . . 0.0 115.393 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.6 mm -64.91 -58.68 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 123.584 0.753 . . . . 0.0 112.324 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -138.99 24.04 2.58 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.439 0.638 . . . . 0.0 110.816 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.3 t60 62.98 40.18 9.53 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.08 1.752 . . . . 0.0 108.39 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.4 mmt-85 -109.23 85.53 2.12 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.829 -1.169 . . . . 0.0 109.46 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.508 HG22 ' CB ' ' A' ' 16' ' ' GLN . 90.9 t -78.0 154.63 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.514 ' CD2' HD11 ' A' ' 138' ' ' LEU . 54.1 m0 -105.63 144.81 31.86 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.9 t -141.27 133.4 29.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.448 HD13 ' CD2' ' A' ' 72' ' ' LEU . 4.0 tt -74.56 122.61 23.38 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -131.14 119.34 21.77 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 47.0 t0 32.49 67.17 0.17 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.034 1.734 . . . . 0.0 113.876 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 60.5 17.73 7.59 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.5 m -137.97 126.57 23.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.341 1.456 . . . . 0.0 109.813 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.537 HD12 ' HG ' ' A' ' 87' ' ' LEU . 11.8 mt -77.5 136.2 38.31 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.5 pp -127.05 145.73 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 123.574 0.749 . . . . 0.0 111.861 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.28 127.79 34.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 m -103.69 89.37 2.22 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.65 -55.1 0.3 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.34 1.36 . . . . 0.0 112.731 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -154.73 95.27 1.75 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.484 0.714 . . . . 0.0 111.993 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.43 160.84 39.97 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -69.12 -34.61 75.32 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.846 0.859 . . . . 0.0 112.281 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -82.35 58.64 4.18 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.41 0.684 . . . . 0.0 110.677 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -90.02 157.92 17.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 177.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.1 m -157.98 109.84 1.75 Allowed Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 125.89 1.676 . . . . 0.0 106.517 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.99 148.2 69.5 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 N-CA-C 107.907 -1.613 . . . . 0.0 107.907 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.07 157.58 28.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.05 156.38 19.32 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.3 mm -122.62 113.22 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 128.441 2.696 . . . . 0.0 106.288 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.71 138.56 32.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 65' ' ' LEU . 5.4 tt -137.36 130.25 30.39 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.649 1.18 . . . . 0.0 108.671 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -141.09 134.74 31.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.724 1.209 . . . . 0.0 107.975 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.4 p -66.47 158.61 29.07 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.85 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.4 m -68.79 136.99 53.62 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.214 -0.929 . . . . 0.0 112.369 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -89.28 -30.34 18.54 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 117.234 -1.365 . . . . 0.0 112.865 178.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -122.35 69.98 0.97 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 119.721 1.146 . . . . 0.0 110.809 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.0 m -78.98 -10.76 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 123.043 0.537 . . . . 0.0 110.986 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -55.07 -32.46 61.95 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.54 1.936 . . . . 0.0 114.247 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 t -104.58 9.03 35.5 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.973 0.909 . . . . 0.0 110.463 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.9 mt -111.16 168.24 9.66 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.612 1.165 . . . . 0.0 110.25 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -83.1 159.54 22.08 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.633 1.973 . . . . 0.0 108.165 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.4 -24.85 1.77 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.133 1.373 . . . . 0.0 110.872 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.86 -26.76 59.31 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.073 2.149 . . . . 0.0 112.808 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -96.08 -1.2 49.19 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 125.119 1.368 . . . . 0.0 114.17 -178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.07 161.13 11.03 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -79.12 123.29 84.91 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 121.524 -0.986 . . . . 0.0 109.138 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 108' ' ' TYR . 83.4 Cg_endo -74.85 151.68 40.64 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.196 2.597 . . . . 0.0 111.228 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.459 HD11 ' CE1' ' A' ' 118' ' ' PHE . 1.4 pt -146.34 -175.17 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 126.513 1.925 . . . . 0.0 109.706 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -127.29 143.18 51.28 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 129.094 2.957 . . . . 0.0 109.919 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 46' ' ' LEU . 8.5 tt -154.83 148.94 25.88 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.434 -1.416 . . . . 0.0 109.221 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.403 ' HA3' ' SG ' ' A' ' 73' ' ' CYS . . . -162.44 -169.0 25.2 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 120.867 -1.146 . . . . 0.0 112.458 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.444 HD11 HD21 ' A' ' 30' ' ' LEU . 14.2 mt -105.51 149.93 25.79 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.92 101.7 8.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.6 -31.45 0.08 OUTLIER Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.462 -1.188 . . . . 0.0 114.006 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.25 20.84 0.75 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.736 1.768 . . . . 0.0 112.936 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.0 m120 65.89 66.64 0.49 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.448 ' CD2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.79 132.35 20.94 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.232 1.013 . . . . 0.0 111.127 -178.051 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.403 ' SG ' ' HA3' ' A' ' 66' ' ' GLY . 17.1 m -142.76 174.63 10.48 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 123.735 0.814 . . . . 0.0 110.283 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.82 ' HA ' HD12 ' A' ' 87' ' ' LEU . 45.2 mt -55.14 157.91 3.21 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 125.826 1.651 . . . . 0.0 113.644 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -166.21 150.98 8.06 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 117.519 -1.229 . . . . 0.0 108.73 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.2 m -123.05 112.11 17.37 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.559 1.144 . . . . 0.0 111.139 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.17 143.54 50.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.67 1.123 . . . . 0.0 108.246 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -92.86 123.29 36.02 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.344 1.458 . . . . 0.0 109.702 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.91 -4.43 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.97 16.92 10.05 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -151.17 -61.05 0.18 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.283 1.833 . . . . 0.0 107.959 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -141.35 161.45 52.76 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.26 1.424 . . . . 0.0 112.03 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.09 152.53 45.77 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.456 2.77 . . . . 0.0 110.333 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.6 p -146.27 161.94 39.18 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.263 1.825 . . . . 0.0 109.362 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.83 HD22 HD11 ' A' ' 87' ' ' LEU . 4.5 mt -78.9 140.0 38.19 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.784 1.634 . . . . 0.0 110.795 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.35 67.19 1.46 Allowed 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.059 0.845 . . . . 0.0 110.811 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.83 HD11 HD22 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -92.06 118.6 30.96 Favored 'General case' 0 CA--C 1.493 -1.216 0 C-N-CA 125.183 1.393 . . . . 0.0 109.412 -178.219 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -179.42 -29.34 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 O-C-N 125.013 1.445 . . . . 0.0 113.618 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -146.04 102.25 3.61 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.401 1.48 . . . . 0.0 107.442 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.05 161.65 0.59 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 119.003 0.82 . . . . 0.0 109.041 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.69 153.0 52.19 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.71 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.98 -38.9 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.786 1.234 . . . . 0.0 108.989 178.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.6 tpt -64.6 -33.09 75.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.867 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.07 -40.55 87.07 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.507 1.049 . . . . 0.0 110.647 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.4 mt -65.21 -31.88 73.28 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.416 ' CZ ' ' HG3' ' A' ' 50' ' ' ARG . 36.3 t80 -78.58 -29.41 46.15 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.085 0.954 . . . . 0.0 110.175 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -78.09 -32.73 50.8 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.656 -1.277 . . . . 0.0 113.417 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -126.21 168.66 13.54 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 119.053 0.842 . . . . 0.0 112.017 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -80.34 68.0 8.45 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.319 2.68 . . . . 0.0 109.904 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -121.55 72.8 30.01 Favored Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 121.695 -0.628 . . . . 0.0 110.426 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.24 65.13 8.89 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.853 3.035 . . . . 0.0 108.433 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.4 t -70.98 97.66 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.076 0 C-N-CA 125.142 1.377 . . . . 0.0 107.81 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -48.18 -30.43 4.64 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.202 1.401 . . . . 0.0 112.33 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 t -63.54 -14.93 56.02 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.59 1.556 . . . . 0.0 113.445 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -126.6 -4.08 6.58 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.951 1.7 . . . . 0.0 111.122 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.4 mt -95.18 151.62 19.06 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.363 1.465 . . . . 0.0 110.025 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -139.21 133.02 30.78 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 19.5 m-85 -77.94 137.09 38.14 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.652 1.115 . . . . 0.0 108.016 177.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.78 162.47 25.1 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.5 t -161.29 178.06 9.57 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 126.168 1.787 . . . . 0.0 106.346 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 2.0 pp0? -156.47 158.53 37.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.272 1.429 . . . . 0.0 109.431 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.3 p -120.28 2.62 10.85 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.63 -50.13 0.9 Allowed Glycine 0 C--N 1.336 0.531 0 O-C-N 120.532 -1.355 . . . . 0.0 110.544 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.11 -1.81 2.36 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.673 0.789 . . . . 0.0 111.633 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -130.4 168.97 16.11 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.793 1.237 . . . . 0.0 109.115 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 2.6 m -130.16 148.13 51.97 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.552 1.141 . . . . 0.0 111.873 -178.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.79 173.01 7.74 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 127.093 2.157 . . . . 0.0 111.783 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.459 ' CE1' HD11 ' A' ' 63' ' ' ILE . 31.6 m-85 -146.01 128.84 16.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 125' ' ' GLY . 9.4 tt0 -113.52 142.27 46.14 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 126.0 1.72 . . . . 0.0 107.107 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 50.0 m -70.4 124.11 23.38 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.189 2.196 . . . . 0.0 110.985 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.7 t -69.72 -43.87 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 120.812 1.642 . . . . 0.0 112.315 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.19 -24.48 66.64 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -138.76 77.5 32.77 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 126.08 1.752 . . . . 0.0 107.207 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.51 166.21 22.58 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.787 2.325 . . . . 0.0 112.369 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.407 ' H ' ' CD ' ' A' ' 119' ' ' GLU . . . 85.86 -13.7 55.43 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.867 1.222 . . . . 0.0 111.775 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -106.48 119.91 40.53 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.286 1.834 . . . . 0.0 109.802 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -103.04 148.26 25.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.774 0.83 . . . . 0.0 110.243 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.514 HG22 HD11 ' A' ' 85' ' ' LEU . 3.4 pt -78.38 139.4 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.921 0.391 . . . . 0.0 110.891 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.94 151.75 20.98 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.404 HG13 ' HZ2' ' A' ' 23' ' ' TRP . 45.0 t -106.06 -17.01 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 127.34 2.256 . . . . 0.0 111.047 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.2 m 55.34 82.42 0.1 Allowed 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 126.438 1.895 . . . . 0.0 112.695 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.2 m -111.1 -9.75 14.36 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -54.63 -61.13 2.51 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.639 1.575 . . . . 0.0 111.352 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -139.21 -85.55 0.12 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -165.98 60.82 0.23 Allowed Glycine 0 C--N 1.333 0.378 0 O-C-N 120.694 -1.474 . . . . 0.0 110.201 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.1 m -91.37 163.6 28.08 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.73 161.71 45.1 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.595 1.53 . . . . 0.0 109.779 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.514 HD11 ' CD2' ' A' ' 23' ' ' TRP . 20.4 mt -87.5 113.03 22.83 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.21 167.18 23.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.628 1.571 . . . . 0.0 109.391 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 80.7 mt -83.91 156.15 22.52 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.79 156.13 47.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -99.24 -46.75 5.43 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 N--CA 1.425 -1.683 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 179.441 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.447 -0.6 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.582 HG21 ' CE2' ' A' ' 152' ' ' PHE . 0.2 OUTLIER -142.7 113.15 7.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 -178.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -99.48 -28.99 12.99 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.074 1.75 . . . . 0.0 110.241 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -112.41 123.93 51.36 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 123.657 0.783 . . . . 0.0 109.721 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.582 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.1 OUTLIER -158.82 -170.34 3.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.002 178.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.42 176.8 38.79 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.22 111.97 6.46 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 24.3 m -77.16 46.77 0.51 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -73.95 120.38 19.46 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.6 mt -99.07 156.57 16.87 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 123.795 0.838 . . . . 0.0 109.626 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.7 p90 . . . . . 0 C--O 1.246 0.882 0 C-N-CA 125.111 1.364 . . . . 0.0 108.554 179.772 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptm . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -62.89 165.79 6.38 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.689 0.396 . . . . 0.0 111.692 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -78.95 -92.83 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.47 93.24 1.67 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.053 1.341 . . . . 0.0 109.444 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.582 ' H ' HD23 ' A' ' 5' ' ' LEU . 1.9 pt? -133.09 174.91 9.86 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 127.82 2.448 . . . . 0.0 110.411 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -130.09 15.14 5.72 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.918 1.287 . . . . 0.0 113.271 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -130.4 26.59 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 125.869 1.668 . . . . 0.0 110.714 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -66.64 -39.02 88.08 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.383 0.673 . . . . 0.0 111.529 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -58.21 141.38 82.31 Favored Pre-proline 0 N--CA 1.45 -0.437 0 O-C-N 123.504 0.503 . . . . 0.0 110.604 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.2 138.53 61.79 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 121.476 1.451 . . . . 0.0 110.229 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.61 109.83 18.32 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.55 133.93 52.85 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.308 1.043 . . . . 0.0 109.969 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.03 -124.38 0.71 Allowed Glycine 0 CA--C 1.523 0.543 0 CA-C-O 117.458 -1.746 . . . . 0.0 109.891 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.2 p -157.96 -165.11 1.66 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 121.517 2.658 . . . . 0.0 113.604 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.9 mt -145.18 -13.8 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 125.056 1.342 . . . . 0.0 108.277 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.406 ' HG3' HG22 ' A' ' 22' ' ' VAL . 2.1 tm0? -55.17 -31.88 61.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 118.067 -0.968 . . . . 0.0 112.11 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.39 -19.12 3.12 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.584 1.554 . . . . 0.0 112.893 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.4 mt -64.06 -52.5 55.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.174 1.39 . . . . 0.0 113.47 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -148.41 31.54 0.82 Allowed 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 117.931 0.332 . . . . 0.0 110.189 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.0 m80 59.97 25.36 14.54 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.071 0.949 . . . . 0.0 112.054 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.45 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 7.0 mmt-85 -86.71 98.53 11.19 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.382 -1.449 . . . . 0.0 108.178 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.406 HG22 ' HG3' ' A' ' 16' ' ' GLN . 72.6 t -76.58 145.05 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -105.2 132.43 51.43 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.327 1.451 . . . . 0.0 109.134 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.7 t -137.05 129.69 44.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 119.168 0.895 . . . . 0.0 108.863 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.666 HD13 ' CD2' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -74.5 112.97 11.21 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 101.161 -3.644 . . . . 0.0 101.161 176.147 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -129.55 120.99 26.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.705 2.002 . . . . 0.0 108.153 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.5 t0 45.31 58.23 4.29 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.305 1.442 . . . . 0.0 110.945 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 57.15 20.11 5.35 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.637 1.975 . . . . 0.0 114.913 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.3 m -134.23 143.32 47.75 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 123.588 0.755 . . . . 0.0 109.329 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.643 HD12 HD13 ' A' ' 87' ' ' LEU . 19.2 mt -90.71 124.68 35.29 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.76 136.78 56.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.685 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.45 136.21 39.41 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -124.32 68.65 49.48 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.34 -6.24 14.47 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.828 2.352 . . . . 0.0 116.304 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.67 78.41 0.7 Allowed 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.597 1.159 . . . . 0.0 109.227 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -151.36 137.29 18.14 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 121.125 -0.984 . . . . 0.0 110.42 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -68.27 -34.6 76.46 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.816 0.846 . . . . 0.0 108.735 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.68 30.3 0.65 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.166 0.987 . . . . 0.0 112.793 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 8.7 ptp -73.33 167.2 21.72 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.7 t -153.22 121.58 3.12 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.12 151.21 49.24 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 N-CA-C 108.632 -1.334 . . . . 0.0 108.632 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.95 -174.35 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.19 154.87 50.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mm -126.72 111.44 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 C-N-CA 126.901 2.08 . . . . 0.0 108.384 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.74 130.47 41.25 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.509 1.924 . . . . 0.0 107.64 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -126.09 131.62 52.08 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.304 1.842 . . . . 0.0 108.894 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.9 mp -149.36 145.86 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 124.838 1.255 . . . . 0.0 110.664 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.79 156.38 38.97 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 125.79 1.636 . . . . 0.0 109.001 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.477 ' O ' HG13 ' A' ' 52' ' ' VAL . 85.4 m -92.78 106.47 18.44 Favored 'General case' 0 CA--C 1.523 -0.087 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -67.99 -14.89 63.32 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -98.93 29.88 3.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.988 0.813 . . . . 0.0 111.21 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.604 ' HA ' HD23 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -62.4 -7.41 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 126.228 1.811 . . . . 0.0 113.251 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -55.75 -35.63 66.41 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.072 0.949 . . . . 0.0 112.614 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.0 t -98.56 0.52 45.12 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.774 1.23 . . . . 0.0 112.491 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.642 HD21 ' HB2' ' A' ' 101' ' ' PRO . 3.7 mm? -91.0 171.39 9.3 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 123.077 1.418 . . . . 0.0 109.616 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -74.85 157.01 35.83 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.421 -1.718 . . . . 0.0 107.453 178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -129.29 -40.32 1.46 Allowed 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 118.703 -0.665 . . . . 0.0 109.956 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -50.63 -54.3 23.92 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.262 1.425 . . . . 0.0 113.313 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -60.39 -31.23 70.16 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.975 0.91 . . . . 0.0 112.293 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.24 169.45 11.75 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 125.886 1.708 . . . . 0.0 109.828 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -69.76 112.07 11.06 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 127.284 2.234 . . . . 0.0 115.763 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -80.98 131.78 8.12 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.714 2.943 . . . . 0.0 110.302 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 pp -137.82 178.44 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.669 ' CD1' HG22 ' A' ' 92' ' ' ILE . 5.0 t80 -134.92 153.77 51.94 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.712 1.142 . . . . 0.0 112.15 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.5 tt -145.68 157.03 44.0 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.284 1.434 . . . . 0.0 110.039 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.4 176.01 35.42 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.552 HD11 HD11 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -94.51 140.86 29.29 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 178.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -107.51 118.91 37.96 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 159.67 -75.67 0.2 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.02 19.59 14.86 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 60.94 72.41 0.52 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.952 1.251 . . . . 0.0 109.626 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.666 ' CD2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -146.59 136.01 22.89 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.034 0.934 . . . . 0.0 110.381 -177.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.632 ' SG ' HG23 ' A' ' 92' ' ' ILE . 17.7 m -144.97 169.67 17.63 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.184 -0.947 . . . . 0.0 110.534 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.427 HD23 HD21 ' A' ' 87' ' ' LEU . 13.5 mt -53.37 148.32 9.1 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.086 0.469 . . . . 0.0 110.39 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.0 ttp -160.71 120.99 2.81 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 93.4 m -82.12 138.15 34.83 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.2 -177.56 4.76 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.202 2.201 . . . . 0.0 106.845 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.4 tttm -143.8 140.5 29.92 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.9 m -90.15 26.64 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.45 5.9 56.59 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.259 0.933 . . . . 0.0 111.648 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -131.48 -57.03 1.01 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.976 1.71 . . . . 0.0 110.624 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -145.14 157.18 54.05 Favored Pre-proline 0 C--O 1.239 0.552 0 C-N-CA 124.416 1.086 . . . . 0.0 110.421 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.06 149.66 88.93 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.897 3.065 . . . . 0.0 113.639 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.1 p -148.61 168.35 23.04 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.908 1.683 . . . . 0.0 110.708 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mt -97.24 149.24 22.26 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.461 1.104 . . . . 0.0 108.856 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -143.83 78.1 1.58 Allowed 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.643 HD13 HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -89.43 94.1 9.76 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.69 -48.7 0.19 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.047 0.84 . . . . 0.0 112.6 -177.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -135.28 105.67 6.38 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 125.713 1.605 . . . . 0.0 107.486 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.06 154.87 0.91 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -127.66 139.98 52.38 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.669 HG22 ' CD1' ' A' ' 64' ' ' TYR . 4.0 pt -94.83 -41.51 12.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.835 1.654 . . . . 0.0 111.773 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.0 tpt -66.52 -23.14 66.19 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.757 0.708 . . . . 0.0 110.109 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.32 -52.48 18.53 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.867 -0.587 . . . . 0.0 109.525 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.523 HD12 ' CE1' ' A' ' 64' ' ' TYR . 18.1 mt -60.61 -26.22 66.83 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.175 0.988 . . . . 0.0 112.367 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -75.63 -51.19 13.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -59.67 -46.99 87.37 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.041 1.336 . . . . 0.0 112.67 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -100.74 148.92 35.68 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.706 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -75.4 68.01 6.15 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.036 2.491 . . . . 0.0 109.532 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -128.12 68.19 75.83 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 126.074 1.75 . . . . 0.0 108.556 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.642 ' HB2' HD21 ' A' ' 55' ' ' LEU . 84.1 Cg_endo -77.55 83.0 2.25 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.608 2.205 . . . . 0.0 106.552 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 97.4 t -78.17 103.14 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -52.37 -30.56 29.47 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.914 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.05 -15.67 34.99 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.136 0.88 . . . . 0.0 111.982 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -117.72 -15.91 10.08 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.584 1.154 . . . . 0.0 110.326 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.425 HD22 ' SG ' ' A' ' 49' ' ' CYS . 9.4 mt -83.59 152.61 24.74 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 120.27 1.396 . . . . 0.0 111.103 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -139.15 128.42 24.08 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.066 0.947 . . . . 0.0 110.697 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.55 123.73 21.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -94.8 136.21 35.37 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 t -135.88 -177.99 4.93 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 124.976 1.311 . . . . 0.0 109.596 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -159.65 146.51 16.52 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.734 1.214 . . . . 0.0 109.637 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -149.17 76.34 1.32 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 124.463 1.102 . . . . 0.0 111.821 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.89 78.84 0.82 Allowed Glycine 0 C--N 1.335 0.509 0 O-C-N 121.152 -0.968 . . . . 0.0 112.065 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 85.4 mtm-85 56.51 13.76 1.45 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.359 1.464 . . . . 0.0 112.763 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -121.26 151.82 39.58 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.3 m -125.25 148.45 48.66 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 125.636 1.574 . . . . 0.0 106.957 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.99 157.05 47.04 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -138.83 116.11 11.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.673 1.189 . . . . 0.0 107.833 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -112.24 133.01 54.61 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.881 1.273 . . . . 0.0 110.089 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.9 m -52.31 122.22 8.32 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.886 2.074 . . . . 0.0 110.458 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.7 t -73.34 -46.09 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 O-C-N 120.105 -1.622 . . . . 0.0 110.869 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.76 -30.83 71.88 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.034 0.834 . . . . 0.0 111.146 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -133.94 81.51 51.76 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 123.747 0.819 . . . . 0.0 110.746 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.16 159.89 44.69 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 N-CA-C 108.421 -1.415 . . . . 0.0 108.421 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.45 -17.78 30.76 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.062 0.839 . . . . 0.0 112.22 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 142' ' ' GLN . 30.9 m-90 -119.0 141.63 48.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.018 1.727 . . . . 0.0 111.245 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -118.5 142.44 47.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 128.82 2.848 . . . . 0.0 111.414 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.4 mt -69.01 134.18 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.4 114.5 28.72 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.537 0.608 . . . . 0.0 110.112 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.3 m -63.93 -19.15 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.5 m 61.19 63.6 1.21 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 115.953 1.835 . . . . 0.0 115.953 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.45 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 54.5 m -104.43 6.07 34.71 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 125.745 1.618 . . . . 0.0 113.18 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -82.01 -106.64 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.121 1.368 . . . . 0.0 107.563 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.42 -52.13 11.16 Favored Glycine 0 C--N 1.337 0.605 0 O-C-N 120.849 -1.157 . . . . 0.0 112.911 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 141.63 62.77 0.03 OUTLIER Glycine 0 CA--C 1.525 0.69 0 N-CA-C 106.491 -2.644 . . . . 0.0 106.491 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . 0.421 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 19.6 m -93.56 166.96 14.86 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 119.105 -0.474 . . . . 0.0 110.701 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 136' ' ' CYS . 87.3 Cg_endo -74.14 157.64 46.16 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.746 2.964 . . . . 0.0 110.352 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.557 HD12 HD13 ' A' ' 30' ' ' LEU . 15.2 mt -76.84 111.59 12.54 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.79 179.77 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 125.861 1.664 . . . . 0.0 110.587 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.1 mt -110.6 144.74 39.01 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.3 t -134.78 152.7 51.96 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 126' ' ' TRP . 3.0 pt20 -107.38 -32.73 7.63 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -153.2 136.99 16.13 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.4 pp -132.46 155.11 49.13 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.427 -1.715 . . . . 0.0 107.652 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -114.4 65.4 0.28 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 105.689 -2.964 . . . . 0.0 105.689 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? 41.74 45.02 2.95 Favored 'General case' 0 C--O 1.23 0.073 0 C-N-CA 127.573 2.349 . . . . 0.0 110.746 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -117.13 -11.17 10.74 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.834 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.47 -179.47 5.38 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.98 96.11 4.82 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.605 0.762 . . . . 0.0 110.626 -177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.5 p -98.52 -32.57 11.39 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.85 96.39 10.37 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.717 1.607 . . . . 0.0 112.374 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.42 175.66 13.43 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.805 -1.184 . . . . 0.0 112.661 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.79 -166.89 29.47 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.5 tp -137.67 161.59 36.09 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -120.31 34.46 5.21 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -63.38 140.38 58.87 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 18.0 mt -123.18 166.33 15.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 17.7 p90 . . . . . 0 C--O 1.244 0.796 0 CA-C-O 116.482 -1.723 . . . . 0.0 107.469 178.965 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ppp? . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -132.56 165.71 23.77 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.874 1.67 . . . . 0.0 109.363 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -75.52 29.48 0.1 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.717 1.207 . . . . 0.0 113.559 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 52.94 40.47 31.04 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.517 1.927 . . . . 0.0 113.335 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.403 ' H ' HD23 ' A' ' 5' ' ' LEU . 1.7 pt? -104.27 -170.25 1.74 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.55 1.54 . . . . 0.0 108.447 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -157.74 -35.18 0.07 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.886 1.274 . . . . 0.0 112.398 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pp -60.55 -36.4 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 128.632 2.773 . . . . 0.0 113.225 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 48.12 26.61 1.06 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.896 2.079 . . . . 0.0 113.876 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -68.59 152.03 96.9 Favored Pre-proline 0 C--O 1.235 0.291 0 O-C-N 120.986 -1.071 . . . . 0.0 109.487 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.04 129.56 15.38 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.84 1.693 . . . . 0.0 108.019 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.55 115.21 29.49 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 1.0 OUTLIER -112.61 135.65 53.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.966 0.506 . . . . 0.0 110.823 -179.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.87 -125.82 0.8 Allowed Glycine 0 N--CA 1.46 0.246 0 CA-C-O 117.882 -1.51 . . . . 0.0 109.979 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.6 p -157.03 -173.97 4.7 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 120.276 2.038 . . . . 0.0 112.709 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.436 HD11 HD11 ' A' ' 154' ' ' LEU . 8.4 mt -141.98 -19.07 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.92 1.688 . . . . 0.0 108.437 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.716 HE21 HG22 ' A' ' 22' ' ' VAL . 5.9 pt20 -47.52 -39.99 17.56 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 121.147 -0.971 . . . . 0.0 113.459 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -51.32 -33.49 29.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.847 2.059 . . . . 0.0 114.866 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.4 mm -41.94 -55.44 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 127.146 2.178 . . . . 0.0 111.047 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.64 26.48 2.11 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.709 -0.619 . . . . 0.0 109.54 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 33.9 m80 60.46 25.05 14.64 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.34 2.256 . . . . 0.0 113.279 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.448 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 20.2 mmt180 -83.58 85.07 7.32 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 126.966 2.106 . . . . 0.0 107.493 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.716 HG22 HE21 ' A' ' 16' ' ' GLN . 93.6 t -69.5 136.7 25.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 120.726 -1.233 . . . . 0.0 108.572 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -95.59 135.01 37.81 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.722 1.209 . . . . 0.0 111.701 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.4 t -141.91 131.28 23.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.484 HD13 HD22 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -75.74 95.2 3.39 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 178.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -106.94 120.02 40.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 119.619 1.099 . . . . 0.0 108.506 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.6 t0 42.06 65.84 0.82 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.267 1.427 . . . . 0.0 111.615 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 57.3 8.7 0.61 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.679 1.591 . . . . 0.0 114.861 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.3 m -124.81 133.1 53.25 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 125.185 1.394 . . . . 0.0 110.129 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.825 HD12 HD13 ' A' ' 87' ' ' LEU . 8.8 mt -82.88 122.42 28.23 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -125.72 144.39 35.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.19 133.2 34.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -128.14 64.14 65.12 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 126.665 1.986 . . . . 0.0 111.435 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.429 ' HG3' HH11 ' A' ' 21' ' ' ARG . 11.7 Cg_endo -58.14 -56.77 1.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.343 1.362 . . . . 0.0 111.693 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.6 mtp85 -117.73 109.0 16.08 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.558 1.072 . . . . 0.0 109.105 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -167.92 -162.44 0.43 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.668 1.187 . . . . 0.0 109.135 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -122.81 -50.56 1.95 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -66.13 20.66 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.66 1.984 . . . . 0.0 114.977 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.7 ptp -74.59 -178.8 3.74 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 120.49 -1.381 . . . . 0.0 109.434 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 t -174.24 128.34 0.45 Allowed Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.79 146.05 33.09 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 N-CA-C 107.224 -1.875 . . . . 0.0 107.224 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 m -133.45 171.19 18.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.63 163.92 16.65 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.514 ' CG2' HD11 ' A' ' 65' ' ' LEU . 40.3 mm -131.18 108.42 14.92 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 127.18 2.192 . . . . 0.0 108.472 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.49 124.75 44.93 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.194 1.398 . . . . 0.0 108.521 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 tt -117.2 138.06 51.94 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.308 1.843 . . . . 0.0 108.744 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 mt -142.2 146.09 22.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 126.498 1.919 . . . . 0.0 108.291 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 p -84.16 145.23 28.5 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.522 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 55.7 m -66.85 107.86 2.34 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.936 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.75 7.87 9.34 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.577 -1.327 . . . . 0.0 111.564 178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -129.71 29.33 5.03 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.552 2.341 . . . . 0.0 113.624 -177.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.41 -7.83 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 O-C-N 120.078 -1.639 . . . . 0.0 114.312 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -48.41 -51.44 26.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 119.528 1.058 . . . . 0.0 112.594 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 t -82.21 2.7 30.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.713 1.205 . . . . 0.0 112.568 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.6 mt -104.69 176.17 5.25 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 120.356 -1.465 . . . . 0.0 112.017 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -93.02 151.84 19.66 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.599 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -124.03 -25.53 4.19 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.847 1.259 . . . . 0.0 110.018 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -61.81 -20.62 63.83 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.418 0.687 . . . . 0.0 111.05 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -75.99 -20.56 57.77 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.133 0.973 . . . . 0.0 111.143 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.4 -103.41 0.4 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 125.962 1.744 . . . . 0.0 111.574 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -144.76 99.07 4.78 Favored Pre-proline 0 CA--C 1.538 0.495 0 O-C-N 121.581 -0.952 . . . . 0.0 112.885 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -71.62 131.37 18.55 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.377 2.051 . . . . 0.0 110.682 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pt -143.53 -178.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.802 0.841 . . . . 0.0 109.244 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.57 ' CD1' HD12 ' A' ' 95' ' ' LEU . 4.3 t80 -136.57 134.92 37.97 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.999 0.92 . . . . 0.0 110.076 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.514 HD11 ' CG2' ' A' ' 44' ' ' ILE . 4.2 tt -138.43 152.16 48.09 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.994 1.318 . . . . 0.0 109.214 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.56 174.51 33.61 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.807 HD11 HD11 ' A' ' 30' ' ' LEU . 8.3 mt -88.58 139.12 30.8 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -109.46 102.09 10.99 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 171.87 -26.37 0.09 OUTLIER Glycine 0 CA--C 1.529 0.953 0 CA-C-O 117.945 -1.475 . . . . 0.0 113.335 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.01 19.84 0.58 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.643 1.722 . . . . 0.0 114.421 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.2 m120 62.51 62.1 1.16 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.385 1.474 . . . . 0.0 110.91 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.484 HD22 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -135.9 133.72 37.98 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.76 1.224 . . . . 0.0 109.299 -178.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.569 ' SG ' HG23 ' A' ' 92' ' ' ILE . 6.8 m -136.64 174.65 10.39 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.654 0.661 . . . . 0.0 111.896 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.693 HD23 HD21 ' A' ' 87' ' ' LEU . 17.9 mt -64.6 150.22 47.36 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.782 0.433 . . . . 0.0 111.378 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.453 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 1.4 tmm? -160.85 144.67 13.49 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 117.999 -1.0 . . . . 0.0 108.516 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 79.2 m -110.98 122.38 47.75 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 123.961 0.788 . . . . 0.0 110.103 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.86 135.16 29.26 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.078 0.951 . . . . 0.0 110.652 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -70.02 117.79 12.03 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.0 p -69.68 -24.21 26.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.813 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.89 -70.34 0.11 Allowed Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 105.357 -3.097 . . . . 0.0 105.357 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -97.36 -23.1 16.26 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -145.4 159.53 48.17 Favored Pre-proline 0 CA--C 1.536 0.405 0 O-C-N 121.374 -0.829 . . . . 0.0 112.891 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.4 148.01 72.67 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.565 2.843 . . . . 0.0 111.681 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.5 p -145.56 170.45 16.4 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.038 1.735 . . . . 0.0 108.668 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.62 HD11 HG23 ' A' ' 128' ' ' ILE . 6.6 mt -83.96 150.88 25.37 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 122.493 0.317 . . . . 0.0 110.687 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -144.91 64.29 1.28 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.109 0.964 . . . . 0.0 110.029 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.825 HD13 HD12 ' A' ' 30' ' ' LEU . 0.6 OUTLIER -86.06 118.96 25.85 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -171.66 -42.91 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.689 0.677 . . . . 0.0 112.269 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -134.49 101.99 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.852 1.261 . . . . 0.0 109.988 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 75' ' ' MET . 0.2 OUTLIER -163.82 171.36 15.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 120.696 1.589 . . . . 0.0 109.667 179.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -142.3 109.85 5.72 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.569 HG23 ' SG ' ' A' ' 73' ' ' CYS . 19.6 pt -70.77 -36.93 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 O-C-N 121.538 -0.726 . . . . 0.0 111.168 178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -29.16 65.66 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.332 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -67.0 -50.0 63.59 Favored 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 118.61 0.641 . . . . 0.0 109.808 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.57 HD12 ' CD1' ' A' ' 64' ' ' TYR . 21.3 mt -64.28 -30.52 71.56 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -76.06 -26.85 56.93 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.545 -0.722 . . . . 0.0 109.849 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -86.87 -28.29 22.93 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -129.26 164.82 36.76 Favored Pre-proline 0 N--CA 1.456 -0.168 0 CA-C-N 121.177 1.808 . . . . 0.0 110.736 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.66 -161.65 0.13 Allowed 'Trans proline' 0 N--CA 1.445 -1.357 0 N-CA-C 107.109 -1.92 . . . . 0.0 107.109 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 77.46 70.75 0.2 Allowed Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 127.096 2.158 . . . . 0.0 109.859 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.17 107.45 0.66 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.517 2.145 . . . . 0.0 109.788 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.0 t -81.1 91.98 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -48.51 -32.32 7.73 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 125.021 1.328 . . . . 0.0 112.965 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 18.6 m -62.66 -14.33 42.31 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.333 1.053 . . . . 0.0 113.561 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -115.31 -20.87 10.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.319 1.448 . . . . 0.0 110.747 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.8 mt -80.92 154.23 27.13 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.776 0.83 . . . . 0.0 111.286 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.692 ' CD2' HD11 ' A' ' 128' ' ' ILE . 81.4 m-85 -141.69 138.97 32.81 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.281 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -81.46 131.28 35.27 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.43 119.99 32.49 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 125.84 1.656 . . . . 0.0 107.726 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 t -123.1 -172.17 2.45 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 2.1 pt20 -154.15 136.28 14.76 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.28 1.032 . . . . 0.0 108.576 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.98 69.74 1.45 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.78 -177.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.31 70.04 1.34 Allowed Glycine 0 C--N 1.338 0.656 0 O-C-N 121.274 -0.892 . . . . 0.0 113.675 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? 67.39 -10.37 0.35 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 128.013 2.525 . . . . 0.0 112.978 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -107.39 144.14 34.72 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 124.181 0.992 . . . . 0.0 108.641 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 0.4 OUTLIER -101.55 150.91 22.59 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.519 0.728 . . . . 0.0 110.929 179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.61 166.86 12.21 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.518 1.927 . . . . 0.0 110.123 -178.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -139.11 118.47 12.81 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -120.78 131.46 54.49 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.161 0.984 . . . . 0.0 110.248 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 29.8 t -52.99 116.94 2.62 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.778 1.631 . . . . 0.0 110.842 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.16 -45.82 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-N 119.227 0.921 . . . . 0.0 110.816 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.03 -26.49 68.58 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.555 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -145.9 87.19 6.86 Favored Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 119.202 0.91 . . . . 0.0 111.575 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -58.05 166.35 5.69 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.52 2.813 . . . . 0.0 114.032 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.65 -4.35 86.29 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 117.463 -1.743 . . . . 0.0 114.219 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 42.0 m95 -120.16 131.35 54.98 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.891 1.846 . . . . 0.0 107.843 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -114.9 144.37 43.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 126.037 1.735 . . . . 0.0 111.22 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.692 HD11 ' CD2' ' A' ' 107' ' ' PHE . 13.1 mt -77.11 123.32 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.737 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.74 120.09 32.17 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.38 0.609 . . . . 0.0 110.646 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.7 t -68.72 -23.29 27.55 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 C-N-CA 128.211 2.604 . . . . 0.0 111.051 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.4 m 60.9 87.0 0.09 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 122.911 1.339 . . . . 0.0 109.128 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.448 ' HA ' ' HG3' ' A' ' 21' ' ' ARG 0.271 1.7 m -109.76 4.1 21.48 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.696 -178.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -111.72 160.66 17.07 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 25.6 -87.54 0.01 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 128.043 2.735 . . . . 0.0 114.422 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -177.45 60.71 0.09 OUTLIER Glycine 0 CA--C 1.521 0.415 0 CA-C-O 117.795 -1.559 . . . . 0.0 109.38 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 4.9 m -85.08 161.42 52.53 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 119.455 1.627 . . . . 0.0 112.826 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.22 155.43 37.37 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 N-CA-C 108.553 -1.364 . . . . 0.0 108.553 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.0 mt -82.98 112.22 19.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 pp -138.0 -173.15 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.975 1.71 . . . . 0.0 109.843 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 39.4 mt -109.14 156.8 19.41 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.609 1.164 . . . . 0.0 108.244 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.37 136.66 21.24 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -81.24 -40.51 23.67 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.895 0.878 . . . . 0.0 110.855 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -161.21 100.75 1.22 Allowed 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.537 HD12 ' H ' ' A' ' 146' ' ' LYS . 2.3 pp -81.78 163.69 22.21 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.387 1.075 . . . . 0.0 111.852 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -111.29 55.11 0.52 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 124.446 1.022 . . . . 0.0 110.825 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.537 ' H ' HD12 ' A' ' 144' ' ' LEU . 0.0 OUTLIER 52.71 33.6 14.29 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.515 1.526 . . . . 0.0 111.545 179.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -122.61 -22.66 5.34 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.895 0.878 . . . . 0.0 112.889 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -110.72 145.53 37.87 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.43 100.41 10.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.101 0.56 . . . . 0.0 109.588 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.7 p -95.78 -17.77 20.93 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -115.97 131.81 56.83 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 125.004 1.322 . . . . 0.0 110.013 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.41 ' HB3' ' H ' ' A' ' 153' ' ' GLY 0.334 0.1 OUTLIER -163.49 -135.75 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 119.066 -0.492 . . . . 0.0 112.153 177.914 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.41 ' H ' ' HB3' ' A' ' 152' ' ' PHE . . . -146.22 179.33 23.3 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 125.794 1.664 . . . . 0.0 109.363 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.599 HD23 ' HB3' ' A' ' 156' ' ' MET . 0.4 OUTLIER -138.78 122.29 17.31 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.351 1.075 . . . . 0.0 110.725 -178.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.3 m -79.42 34.72 0.26 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.602 1.561 . . . . 0.0 107.987 177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.599 ' HB3' HD23 ' A' ' 154' ' ' LEU . 3.3 ptt? -63.01 131.96 50.39 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 119.865 -1.772 . . . . 0.0 107.665 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 25.5 mt -109.25 165.95 11.23 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.351 1.06 . . . . 0.0 110.841 -178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 14.7 p90 . . . . . 0 C--O 1.254 1.335 0 C-N-CA 127.099 2.16 . . . . 0.0 107.694 179.894 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 ptm . . . . . 0 N--CA 1.469 0.517 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -80.46 -172.14 3.41 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.51 0.724 . . . . 0.0 110.351 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -82.69 44.21 0.89 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.718 1.207 . . . . 0.0 113.579 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 40.0 42.57 1.12 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.658 1.583 . . . . 0.0 112.99 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -69.21 -177.92 1.2 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 113.479 -1.691 . . . . 0.0 108.588 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 6' ' ' LYS . 11.5 ptmt -145.53 1.9 0.94 Allowed 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.411 ' H ' HG13 ' A' ' 7' ' ' ILE . 1.1 pp -86.65 -25.79 6.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 124.732 1.213 . . . . 0.0 110.837 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -143.04 110.32 5.7 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 101.396 -3.557 . . . . 0.0 101.396 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.58 149.88 72.11 Favored Pre-proline 0 N--CA 1.472 0.64 0 CA-C-N 121.874 2.125 . . . . 0.0 111.534 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.39 115.71 3.49 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 124.446 3.431 . . . . 0.0 110.252 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.76 118.59 35.84 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 124.031 0.933 . . . . 0.0 111.816 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -106.5 133.68 50.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.08 0.552 . . . . 0.0 111.18 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -157.82 -139.06 2.63 Favored Glycine 0 C--O 1.225 -0.429 0 O-C-N 120.825 -1.172 . . . . 0.0 112.921 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.0 p -151.87 169.39 22.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.927 0.863 . . . . 0.0 112.055 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.541 HD12 ' CH2' ' A' ' 23' ' ' TRP . 47.3 mt -121.29 -5.59 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 O-C-N 121.236 -0.915 . . . . 0.0 111.001 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -53.1 -34.29 56.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.733 1.213 . . . . 0.0 110.732 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -51.91 -2.8 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 131.339 3.856 . . . . 0.0 115.693 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.5 mm -93.07 -80.46 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.611 1.964 . . . . 0.0 108.888 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -119.29 29.81 7.45 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.818 0.847 . . . . 0.0 112.705 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.7 t60 61.53 25.73 15.6 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.783 2.033 . . . . 0.0 112.428 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -86.36 92.15 8.73 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 120.303 -1.498 . . . . 0.0 110.808 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.4 t -69.43 141.91 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.56 ' HB3' HD22 ' A' ' 30' ' ' LEU . 43.7 m0 -107.78 144.05 35.48 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.412 ' C ' HD23 ' A' ' 30' ' ' LEU . 95.5 t -141.78 129.31 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.531 HD22 ' CD2' ' A' ' 72' ' ' LEU . 4.3 tp -72.33 106.83 4.63 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 178.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.407 ' NE2' HH11 ' A' ' 38' ' ' ARG . 0.7 OUTLIER -127.73 127.39 43.56 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.629 0.772 . . . . 0.0 108.956 -178.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t70 56.25 27.35 11.63 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 76.28 17.54 2.01 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 129.839 3.256 . . . . 0.0 112.892 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.42 131.41 43.58 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.082 1.353 . . . . 0.0 108.161 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.753 HD12 HD12 ' A' ' 87' ' ' LEU . 10.3 mt -75.42 115.96 15.63 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 120.603 -1.311 . . . . 0.0 107.71 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.01 144.19 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.337 0.655 . . . . 0.0 109.378 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.96 126.4 31.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.81 1.244 . . . . 0.0 109.446 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -126.86 70.13 73.22 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.135 1.774 . . . . 0.0 109.465 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.13 -30.67 37.88 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.843 1.695 . . . . 0.0 114.283 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -148.1 82.5 1.49 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -146.45 158.72 43.93 Favored 'General case' 0 CA--C 1.512 -0.492 0 C-N-CA 123.473 0.709 . . . . 0.0 109.222 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -76.82 -48.91 17.09 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.699 1.249 . . . . 0.0 108.905 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.407 HH11 ' NE2' ' A' ' 26' ' ' GLN . 14.0 ttm180 -77.4 52.65 0.97 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.608 1.563 . . . . 0.0 112.494 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 25.8 ptt? -108.66 165.05 11.83 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.08 -1.013 . . . . 0.0 111.072 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -156.09 134.17 7.1 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-O 118.477 -0.773 . . . . 0.0 110.236 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.45 126.14 10.71 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.985 2.456 . . . . 0.0 108.323 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.9 m -121.58 161.09 22.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 125.065 1.346 . . . . 0.0 109.733 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.71 161.19 17.8 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.6 mm -130.2 100.98 5.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 129.282 3.033 . . . . 0.0 109.318 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.48 110.63 21.01 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.725 2.01 . . . . 0.0 108.163 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tt -107.91 140.53 40.88 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.813 2.045 . . . . 0.0 109.791 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.543 HD12 ' CG2' ' A' ' 92' ' ' ILE . 0.9 OUTLIER -148.57 153.08 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.943 1.297 . . . . 0.0 109.841 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.4 p -96.88 127.35 42.76 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.184 1.394 . . . . 0.0 110.013 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 55.8 m -54.02 133.03 43.55 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.159 0.984 . . . . 0.0 109.133 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -98.95 -18.12 17.99 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 117.345 -1.312 . . . . 0.0 113.573 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -105.11 41.8 1.3 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.286 1.035 . . . . 0.0 108.772 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.5 m -69.31 -6.98 7.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 O-C-N 120.248 -1.533 . . . . 0.0 114.011 -178.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -56.06 -46.52 78.93 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.172 0.989 . . . . 0.0 111.856 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.0 t -83.46 0.66 45.3 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.7 mt -98.23 174.9 6.28 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.947 -1.096 . . . . 0.0 109.625 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -77.99 155.97 30.44 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 113.679 -1.6 . . . . 0.0 109.371 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.79 -34.62 2.38 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.869 178.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -60.68 -38.52 85.24 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.318 0.963 . . . . 0.0 110.597 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -68.26 -18.52 64.57 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.87 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.481 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 119.18 174.52 15.85 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 126.103 1.811 . . . . 0.0 110.745 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -69.53 114.76 26.62 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.716 0.806 . . . . 0.0 111.829 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -84.16 138.07 7.58 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.423 2.749 . . . . 0.0 110.035 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.418 HD12 ' N ' ' A' ' 64' ' ' TYR . 1.6 pp -140.05 -179.04 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 123.977 0.911 . . . . 0.0 109.681 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.547 ' CE1' HD12 ' A' ' 95' ' ' LEU . 1.2 t80 -138.22 155.72 48.39 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-O 122.338 1.066 . . . . 0.0 109.393 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.22 151.86 30.56 Favored 'General case' 0 CA--C 1.507 -0.684 0 O-C-N 120.938 -1.101 . . . . 0.0 108.136 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.485 ' N ' HD11 ' A' ' 92' ' ' ILE . . . -148.17 -179.89 24.5 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 114.406 -1.27 . . . . 0.0 110.119 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.436 ' CD1' HD11 ' A' ' 30' ' ' LEU . 3.1 mt -92.09 169.84 10.31 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -137.3 115.05 11.32 Favored 'General case' 0 CA--C 1.51 -0.575 0 O-C-N 120.847 -1.158 . . . . 0.0 109.557 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 155.38 -28.63 0.62 Allowed Glycine 0 CA--C 1.527 0.819 0 CA-C-O 117.992 -1.449 . . . . 0.0 112.756 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.01 30.03 0.88 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.577 1.689 . . . . 0.0 112.123 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.2 m120 51.32 74.92 0.22 Allowed 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.333 1.853 . . . . 0.0 112.51 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.531 ' CD2' HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -141.03 141.82 34.27 Favored 'General case' 0 CA--C 1.517 -0.296 0 O-C-N 121.307 -0.87 . . . . 0.0 109.322 -178.209 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.435 ' HA ' ' HA2' ' A' ' 66' ' ' GLY . 13.7 m -141.76 175.17 9.92 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 118.421 0.555 . . . . 0.0 111.007 178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.951 ' HA ' HD22 ' A' ' 87' ' ' LEU . 12.5 mt -63.24 156.71 24.65 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.3 ttp -163.64 134.43 4.53 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.2 m -93.67 132.13 38.3 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.78 131.16 19.7 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.899 0.88 . . . . 0.0 108.98 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -87.45 138.82 31.15 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.152 0.887 . . . . 0.0 109.737 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.9 m -92.37 38.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.46 -51.74 4.25 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -83.13 -54.93 4.66 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -138.08 160.75 63.06 Favored Pre-proline 0 N--CA 1.471 0.617 0 C-N-CA 125.111 1.364 . . . . 0.0 112.649 -176.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.28 151.42 43.33 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.906 2.404 . . . . 0.0 110.707 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 71.1 p -144.84 179.33 7.39 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.876 1.671 . . . . 0.0 108.856 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.596 ' CD2' HD21 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -104.15 139.97 38.46 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 127.089 2.156 . . . . 0.0 107.075 179.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -140.48 72.0 1.38 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.951 HD22 ' HA ' ' A' ' 74' ' ' LEU . 0.1 OUTLIER -90.28 104.04 16.66 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 127.994 2.518 . . . . 0.0 107.669 -178.168 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.54 -25.58 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -146.72 81.67 1.56 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.838 1.255 . . . . 0.0 111.389 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.513 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -162.89 161.1 25.7 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 120.102 -1.624 . . . . 0.0 108.621 179.326 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -137.39 139.9 41.03 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.092 1.757 . . . . 0.0 108.201 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.543 ' CG2' HD12 ' A' ' 47' ' ' ILE . 4.6 mt -89.45 -42.65 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 126.058 1.743 . . . . 0.0 109.015 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.73 -34.83 63.01 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.468 1.507 . . . . 0.0 111.758 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -62.78 -61.88 2.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 126.6 1.96 . . . . 0.0 107.976 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.547 HD12 ' CE1' ' A' ' 64' ' ' TYR . 37.7 mt -60.9 -22.37 64.27 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -87.77 -33.57 18.62 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.517 0.727 . . . . 0.0 109.206 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -69.64 -43.65 72.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.202 -0.904 . . . . 0.0 109.145 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.9 152.69 38.21 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-O 118.713 -0.661 . . . . 0.0 109.813 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.09 38.49 0.54 Allowed 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.923 3.082 . . . . 0.0 113.936 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -112.55 82.13 4.62 Favored Pre-proline 0 C--O 1.235 0.312 0 O-C-N 120.877 -1.139 . . . . 0.0 112.905 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.43 102.57 1.62 Allowed 'Trans proline' 0 N--CA 1.443 -1.444 0 N-CA-C 106.048 -2.328 . . . . 0.0 106.048 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.4 t -89.29 105.09 15.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -48.78 -31.26 6.72 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 125.366 1.466 . . . . 0.0 112.006 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.4 t -62.53 -13.58 32.29 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.6 1.16 . . . . 0.0 112.852 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -121.97 -2.09 9.26 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 119.789 1.177 . . . . 0.0 110.351 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.7 mt -94.91 153.91 17.46 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.605 1.093 . . . . 0.0 110.975 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -138.43 129.41 26.89 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.765 0.826 . . . . 0.0 109.721 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.481 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -71.13 127.26 31.99 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 104.405 -2.442 . . . . 0.0 104.405 177.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -103.88 131.87 50.68 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -136.11 -178.64 5.24 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.924 0.868 . . . . 0.0 109.948 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 0.0 OUTLIER -151.91 138.67 18.86 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.932 2.093 . . . . 0.0 107.808 179.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.48 70.33 1.17 Allowed 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.193 0.933 . . . . 0.0 112.472 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.46 64.12 0.93 Allowed Glycine 0 CA--C 1.525 0.686 0 O-C-N 121.787 -0.57 . . . . 0.0 114.198 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 67.71 -0.6 1.9 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.722 2.009 . . . . 0.0 113.24 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -120.01 155.11 33.51 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 125.386 1.474 . . . . 0.0 107.608 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 69.8 m -115.01 166.6 11.62 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.77 2.028 . . . . 0.0 110.559 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.61 164.46 32.58 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.504 1.121 . . . . 0.0 111.095 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -141.75 116.37 9.69 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 125.081 1.352 . . . . 0.0 110.605 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -115.16 122.94 47.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.635 1.574 . . . . 0.0 110.361 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.0 m -49.42 124.13 8.77 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.392 1.477 . . . . 0.0 112.488 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.5 t -70.0 -44.69 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 120.146 -1.596 . . . . 0.0 111.936 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.88 -25.56 67.23 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.398 -0.814 . . . . 0.0 112.971 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -140.39 80.17 19.67 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 125.381 1.472 . . . . 0.0 108.489 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -64.53 151.72 84.49 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.148 1.899 . . . . 0.0 110.123 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.48 -32.88 6.76 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 126.519 2.009 . . . . 0.0 110.211 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 25.5 m-90 -88.19 106.66 18.34 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 124.626 1.17 . . . . 0.0 111.006 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -91.03 152.8 20.53 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 124.724 1.21 . . . . 0.0 110.148 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 50.4 mt -82.25 131.71 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.29 132.85 43.43 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.18 0.446 . . . . 0.0 109.813 177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -81.96 -15.38 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 127.06 2.144 . . . . 0.0 111.885 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.7 m 63.29 52.28 2.47 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.914 1.285 . . . . 0.0 113.729 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.3 m -89.31 24.22 2.27 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -96.01 -83.11 0.38 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.105 0.411 . . . . 0.0 110.352 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -103.68 -44.88 1.6 Allowed Glycine 0 C--N 1.336 0.583 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.08 63.52 0.02 OUTLIER Glycine 0 CA--C 1.521 0.433 0 N-CA-C 106.264 -2.734 . . . . 0.0 106.264 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 60.9 m -82.37 170.94 13.11 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 124.358 1.063 . . . . 0.0 110.113 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.2 153.13 16.32 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.859 1.706 . . . . 0.0 109.127 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.475 HD11 ' CD2' ' A' ' 23' ' ' TRP . 16.6 mt -75.52 106.16 6.93 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.93 171.42 15.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 124.347 1.059 . . . . 0.0 111.338 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 89.6 mt -84.83 156.12 21.46 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.8 t -146.11 136.16 23.6 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -85.56 -35.94 20.75 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.563 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -169.9 62.28 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.671 1.123 . . . . 0.0 113.173 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.622 HD13 ' H ' ' A' ' 148' ' ' ASN . 1.2 pp -48.45 -54.27 14.78 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.47 ' H ' ' HG ' ' A' ' 144' ' ' LEU . . . 91.06 -65.59 2.56 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 125.942 1.734 . . . . 0.0 109.505 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.14 1.0 0.73 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.39 0.676 . . . . 0.0 111.867 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.64 -26.71 34.58 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.622 ' H ' HD13 ' A' ' 144' ' ' LEU . 8.4 m-80 -131.01 -156.62 0.77 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 120.93 1.696 . . . . 0.0 108.304 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.5 m -146.55 108.48 4.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.2 p -103.32 -15.79 15.84 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.402 1.081 . . . . 0.0 111.08 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -96.67 119.73 35.7 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 128.528 2.731 . . . . 0.0 108.178 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -157.94 -133.37 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.799 0.84 . . . . 0.0 112.893 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 177.14 -161.37 28.92 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 128.737 3.065 . . . . 0.0 108.299 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.73 142.87 23.23 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.083 1.942 . . . . 0.0 112.733 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.0 m -91.39 32.36 1.07 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.835 1.254 . . . . 0.0 107.842 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -60.0 110.71 1.26 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.464 1.906 . . . . 0.0 109.8 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 12.5 mt -89.67 160.01 16.82 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 126.226 1.811 . . . . 0.0 110.583 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 20.9 p90 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 126.023 1.729 . . . . 0.0 110.401 -179.707 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ptt? . . . . . 0 N--CA 1.472 0.64 0 CA-C-O 120.427 0.156 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -112.73 178.43 4.29 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.662 1.585 . . . . 0.0 109.172 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.46 -6.51 14.91 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.755 -1.117 . . . . 0.0 113.64 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -51.2 -47.49 62.25 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.885 1.674 . . . . 0.0 114.328 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.38 -53.86 48.84 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 pttt 48.74 18.88 0.21 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 131.027 3.731 . . . . 0.0 117.507 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.85 5.88 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -177.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -82.33 14.54 2.91 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.117 -0.99 . . . . 0.0 111.266 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.47 156.88 68.49 Favored Pre-proline 0 N--CA 1.475 0.79 0 O-C-N 119.535 -1.978 . . . . 0.0 111.419 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.14 131.54 18.13 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.329 2.019 . . . . 0.0 107.965 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.19 113.49 24.73 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.312 1.445 . . . . 0.0 109.839 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -109.49 144.94 37.05 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.191 0.996 . . . . 0.0 110.957 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.39 -131.21 1.41 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.135 1.35 . . . . 0.0 110.854 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.1 p -153.66 172.38 17.35 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-N 120.601 2.2 . . . . 0.0 113.112 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.0 mt -127.39 -12.38 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 125.005 1.322 . . . . 0.0 107.597 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -61.81 -28.22 69.31 Favored 'General case' 0 C--O 1.222 -0.388 0 O-C-N 120.413 -1.43 . . . . 0.0 112.292 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -57.34 -17.98 15.03 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.395 2.678 . . . . 0.0 115.003 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.1 mt -68.03 -69.71 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.29 1.036 . . . . 0.0 109.745 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.01 29.18 7.18 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.962 0.905 . . . . 0.0 111.102 -178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 51.48 44.66 28.88 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.303 2.241 . . . . 0.0 110.097 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.422 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 19.5 mmt180 -100.68 88.15 3.53 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.8 t -70.66 138.46 21.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.397 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -101.18 145.47 28.76 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.082 0.953 . . . . 0.0 109.523 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -148.26 134.57 12.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.63 121.0 14.95 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 103.471 -2.788 . . . . 0.0 103.471 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -134.01 117.85 17.15 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . 0.267 1.3 t0 46.72 59.49 3.91 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 124.072 1.892 . . . . 0.0 111.43 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 55.29 17.91 2.29 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 113.406 -1.725 . . . . 0.0 113.783 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.6 m -132.25 137.95 47.71 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.143 1.777 . . . . 0.0 107.812 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.531 HD13 HD12 ' A' ' 138' ' ' LEU . 9.8 mt -80.51 129.8 34.74 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.081 -1.637 . . . . 0.0 108.205 178.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.7 mm -131.36 140.47 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.653 0.66 . . . . 0.0 111.275 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.57 127.18 31.78 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.379 1.472 . . . . 0.0 109.108 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.8 m -123.09 62.8 20.51 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.213 1.805 . . . . 0.0 109.493 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -65.61 6.1 0.48 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.413 3.409 . . . . 0.0 116.641 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.4 ptt85 171.7 88.2 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 130.2 3.4 . . . . 0.0 104.92 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.85 139.13 24.75 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.8 -50.22 73.0 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -85.8 53.93 2.95 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.935 1.294 . . . . 0.0 112.663 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -104.51 155.56 18.71 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.8 t -150.97 132.69 7.87 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.94 148.61 64.28 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 N-CA-C 107.952 -1.595 . . . . 0.0 107.952 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.98 165.55 27.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -119.74 157.65 28.13 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.0 mm -115.85 147.45 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.92 130.12 47.96 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 104.659 -2.348 . . . . 0.0 104.659 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 tt -127.28 140.09 52.45 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.0 mt -146.03 138.07 19.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 125.091 1.356 . . . . 0.0 109.212 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p -79.63 132.96 36.39 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.816 0.846 . . . . 0.0 109.027 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.49 ' SG ' HD22 ' A' ' 106' ' ' LEU . 98.4 m -69.88 113.74 7.4 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 120.891 -1.13 . . . . 0.0 108.602 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.6 ptp180 -86.01 -9.96 55.89 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 118.68 -0.676 . . . . 0.0 112.443 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -97.45 34.64 1.77 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.768 1.627 . . . . 0.0 110.085 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.85 -10.74 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 127.212 2.205 . . . . 0.0 114.28 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.01 -10.75 4.54 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.202 1.801 . . . . 0.0 114.304 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.7 t -128.51 19.89 6.21 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.357 1.463 . . . . 0.0 110.417 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 90.3 mt -116.45 169.58 9.21 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.749 0.82 . . . . 0.0 109.659 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -70.88 145.88 49.95 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -116.37 -41.22 3.14 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.29 -37.24 77.2 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.619 1.568 . . . . 0.0 112.383 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -11.01 59.81 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 117.993 -1.003 . . . . 0.0 111.411 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.42 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 119.93 173.42 15.19 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -82.7 118.57 72.26 Favored Pre-proline 0 CA--C 1.542 0.64 0 O-C-N 122.039 -0.683 . . . . 0.0 111.19 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -79.85 146.5 18.6 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.87 3.047 . . . . 0.0 110.739 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 pp -139.53 177.72 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.07 1.748 . . . . 0.0 109.308 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.671 ' CD1' HG22 ' A' ' 92' ' ' ILE . 1.1 t80 -131.8 147.67 52.51 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.2 tt -144.87 148.26 33.74 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -149.6 -179.31 25.34 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.434 HD11 HD11 ' A' ' 30' ' ' LEU . 1.9 mt -98.4 145.74 26.42 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.29 105.99 14.08 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 120.341 1.428 . . . . 0.0 108.549 -178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 163.92 -24.16 0.18 Allowed Glycine 0 CA--C 1.525 0.66 0 CA-C-O 117.294 -1.837 . . . . 0.0 116.289 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.8 20.53 1.15 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 119.664 1.732 . . . . 0.0 113.273 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 62.48 64.35 0.94 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.956 2.102 . . . . 0.0 110.971 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.84 143.19 33.26 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.718 1.207 . . . . 0.0 110.562 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.726 ' SG ' HG23 ' A' ' 92' ' ' ILE . 15.3 m -144.97 179.47 7.32 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.026 0.531 . . . . 0.0 110.918 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.09 152.47 28.19 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.944 -0.473 . . . . 0.0 110.134 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.3 ttp -159.64 127.65 4.87 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 90.4 m -85.61 116.76 24.09 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.13 148.71 52.49 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -92.06 123.75 35.64 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.4 -33.48 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.94 -62.04 0.31 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 105.66 -2.976 . . . . 0.0 105.66 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -82.58 -36.36 26.29 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -145.95 166.32 17.63 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.57 142.12 47.9 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.003 2.469 . . . . 0.0 110.031 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.6 p -146.65 -174.77 4.56 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 125.311 1.444 . . . . 0.0 107.943 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.573 HD11 HG23 ' A' ' 128' ' ' ILE . 4.6 mt -103.22 145.13 30.4 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 125.043 1.337 . . . . 0.0 109.471 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -143.89 66.04 1.29 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.499 ' H ' HD12 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -80.62 115.07 19.94 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.7 pttp 179.63 -20.9 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -156.15 87.34 1.05 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.981 1.313 . . . . 0.0 110.41 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.498 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -169.2 164.97 11.1 Favored 'General case' 0 N--CA 1.462 0.163 0 O-C-N 120.568 -1.332 . . . . 0.0 108.433 178.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -141.01 125.9 18.14 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.526 1.13 . . . . 0.0 108.78 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.726 HG23 ' SG ' ' A' ' 73' ' ' CYS . 27.6 pt -79.51 -37.31 18.52 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 C-N-CA 125.935 1.694 . . . . 0.0 111.762 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.69 -36.7 81.64 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 118.476 0.58 . . . . 0.0 111.187 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -56.96 -56.24 24.33 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.47 HD12 ' CD1' ' A' ' 64' ' ' TYR . 13.5 mt -62.39 -32.87 73.76 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -71.67 -36.36 70.6 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.507 -0.745 . . . . 0.0 110.285 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -75.45 -41.01 56.76 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.527 1.131 . . . . 0.0 113.062 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -112.68 157.0 41.6 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.56 63.53 5.58 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.542 2.828 . . . . 0.0 114.142 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -124.21 63.35 32.66 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.977 1.711 . . . . 0.0 109.308 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.3 77.35 3.86 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.365 2.71 . . . . 0.0 106.289 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.94 104.59 5.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 125.388 1.475 . . . . 0.0 107.996 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -49.9 -30.25 9.76 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.373 0.669 . . . . 0.0 111.952 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.95 -8.58 23.42 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.215 1.006 . . . . 0.0 113.229 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -123.73 -3.06 8.27 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.587 1.155 . . . . 0.0 109.04 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.49 HD22 ' SG ' ' A' ' 49' ' ' CYS . 14.7 mt -103.03 149.53 24.48 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.894 1.224 . . . . 0.0 111.521 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.652 ' CD2' HD11 ' A' ' 128' ' ' ILE . 76.3 m-85 -135.32 127.08 29.2 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.172 0.989 . . . . 0.0 110.769 -178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.42 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -70.52 111.98 6.45 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 178.117 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -94.41 145.2 24.94 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.38 179.48 7.62 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.403 1.481 . . . . 0.0 108.283 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 0.0 OUTLIER -158.3 137.11 11.29 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 123.494 0.718 . . . . 0.0 109.102 178.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.32 89.37 1.57 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.03 61.04 1.22 Allowed Glycine 0 C--N 1.336 0.545 0 O-C-N 121.37 -0.831 . . . . 0.0 111.351 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 60.09 11.08 2.53 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.306 2.243 . . . . 0.0 113.901 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -125.37 159.45 31.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 123.977 0.911 . . . . 0.0 108.773 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 4.6 m -116.49 165.7 12.93 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.095 1.758 . . . . 0.0 110.024 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.81 159.14 42.83 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 126.43 1.892 . . . . 0.0 107.398 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -146.28 119.7 9.03 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.321 1.048 . . . . 0.0 109.045 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -116.82 130.45 56.72 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.943 2.097 . . . . 0.0 110.454 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.422 ' HA ' ' CD2' ' A' ' 107' ' ' PHE . 43.5 t -56.84 122.28 11.83 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.586 0.754 . . . . 0.0 109.296 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.5 t -70.27 -38.2 73.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.37 -40.28 93.34 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 118.58 -0.724 . . . . 0.0 111.684 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -129.45 79.99 72.87 Favored Pre-proline 0 N--CA 1.45 -0.462 0 C-N-CA 124.482 1.113 . . . . 0.0 110.099 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -61.68 148.32 93.3 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.812 2.341 . . . . 0.0 109.86 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.78 -14.05 26.98 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.163 1.364 . . . . 0.0 112.153 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -110.2 147.11 34.4 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.836 2.054 . . . . 0.0 109.164 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -122.23 147.4 46.25 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.816 1.646 . . . . 0.0 108.218 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.652 HD11 ' CD2' ' A' ' 107' ' ' PHE . 9.9 mm -73.5 124.18 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.46 133.85 33.69 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 119.644 1.111 . . . . 0.0 108.834 178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.2 t -85.91 -21.16 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.695 1.998 . . . . 0.0 111.907 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m 56.08 67.34 1.02 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 123.425 1.583 . . . . 0.0 112.216 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.422 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 7.1 m -96.26 16.8 17.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.385 -1.28 . . . . 0.0 112.164 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.59 146.48 49.64 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.948 1.699 . . . . 0.0 107.023 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 57.99 -81.98 0.01 OUTLIER Glycine 0 C--N 1.334 0.425 0 C-N-CA 127.005 2.24 . . . . 0.0 111.693 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.03 66.87 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.246 2 N-CA-C 102.566 -4.213 . . . . 0.0 102.566 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 79.0 m -91.48 170.24 9.94 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 118.326 1.063 . . . . 0.0 111.576 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -81.12 154.32 19.21 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.558 2.172 . . . . 0.0 112.075 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.531 HD12 HD13 ' A' ' 30' ' ' LEU . 38.4 mt -82.57 107.38 15.17 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.08 175.1 9.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 125.039 1.335 . . . . 0.0 108.325 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.7 mt -88.74 166.56 13.97 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t -160.72 125.41 3.68 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -91.2 -22.22 20.74 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 123.543 0.527 . . . . 0.0 110.104 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -166.66 91.17 0.42 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.001 0.818 . . . . 0.0 110.905 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.776 HD12 ' H ' ' A' ' 146' ' ' LYS . 2.8 pp -88.49 161.11 17.18 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.424 1.09 . . . . 0.0 109.684 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -102.82 48.51 1.03 Allowed Glycine 0 C--O 1.226 -0.372 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.776 ' H ' HD12 ' A' ' 144' ' ' LEU . 0.0 OUTLIER 66.65 2.42 2.54 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.175 2.19 . . . . 0.0 112.871 -178.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.51 -10.27 59.65 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 125.866 1.666 . . . . 0.0 115.4 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -140.22 142.14 35.86 Favored 'General case' 0 CA--C 1.512 -0.517 0 O-C-N 121.17 -0.956 . . . . 0.0 108.58 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.82 132.11 35.46 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.413 0.685 . . . . 0.0 109.225 179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 p -124.2 -9.09 7.6 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.175 0.99 . . . . 0.0 108.655 177.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -127.51 125.96 41.37 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.557 1.543 . . . . 0.0 110.059 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 176.29 178.57 0.21 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.931 2.092 . . . . 0.0 110.504 178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.34 -166.61 31.22 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.846 1.212 . . . . 0.0 111.694 -179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.61 125.71 19.91 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.289 1.436 . . . . 0.0 107.641 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.3 m -81.97 44.13 0.82 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.847 1.659 . . . . 0.0 106.88 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -67.68 147.54 52.54 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.3 mt -124.61 170.73 10.66 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.194 1.798 . . . . 0.0 108.388 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.8 p90 . . . . . 0 C--O 1.243 0.761 0 N-CA-C 104.187 -2.523 . . . . 0.0 104.187 179.422 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ptm . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 120.348 0.118 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -103.24 176.39 5.16 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -116.53 -86.09 0.62 Allowed 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -151.68 92.83 1.79 Allowed 'General case' 0 C--O 1.237 0.436 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 pp -134.97 6.49 3.39 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -160.03 25.15 0.17 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.464 1.506 . . . . 0.0 108.255 177.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.25 -22.61 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 124.322 1.049 . . . . 0.0 113.023 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -73.29 -22.79 60.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 120.234 1.379 . . . . 0.0 110.993 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -56.45 149.24 40.09 Favored Pre-proline 0 CA--C 1.528 0.098 0 CA-C-O 118.421 -0.799 . . . . 0.0 110.42 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.96 132.84 27.42 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.38 1.387 . . . . 0.0 109.534 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.46 117.34 30.1 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -112.86 146.98 37.95 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.846 0.459 . . . . 0.0 109.852 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -178.86 -125.99 0.97 Allowed Glycine 0 CA--C 1.523 0.535 0 C-N-CA 124.595 1.093 . . . . 0.0 111.883 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.8 p -156.07 -170.1 3.28 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 119.975 1.887 . . . . 0.0 112.565 -178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -146.65 1.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.225 1.01 . . . . 0.0 110.383 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -67.34 -28.92 68.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -54.61 -30.87 56.03 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.19 1.396 . . . . 0.0 111.44 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.5 mm -44.95 -67.61 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 126.749 2.02 . . . . 0.0 111.625 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.55 26.15 3.73 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.86 -0.525 . . . . 0.0 111.324 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 25.7 m170 60.93 39.56 16.55 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.425 1.49 . . . . 0.0 110.098 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.406 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 3.0 mmt-85 -109.32 97.67 7.22 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.153 0.981 . . . . 0.0 109.932 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.7 t -82.47 156.46 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -108.75 137.1 47.23 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.772 1.229 . . . . 0.0 107.707 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.97 128.03 52.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.4 100.4 1.75 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -115.62 126.21 53.89 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 126.0 1.72 . . . . 0.0 109.117 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.3 t0 42.53 58.79 2.97 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.535 1.134 . . . . 0.0 112.898 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 58.86 13.44 2.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.942 1.297 . . . . 0.0 114.363 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.7 m -131.78 149.86 52.33 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 120.688 1.586 . . . . 0.0 108.287 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.768 HD12 HD13 ' A' ' 87' ' ' LEU . 11.8 mt -89.96 125.5 35.4 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 177.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 2.5 mm -119.72 140.27 44.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.54 141.67 36.44 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.9 m -120.3 71.72 18.0 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -63.67 97.35 0.22 Allowed 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.452 2.101 . . . . 0.0 109.958 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 49.55 43.73 24.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.671 1.189 . . . . 0.0 111.165 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -88.67 148.12 24.17 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -65.89 -11.64 48.51 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . 0.259 30.0 ptt180 -117.11 25.15 10.69 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.682 0.793 . . . . 0.0 110.334 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -75.92 148.16 38.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.2 t -145.91 129.98 8.64 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -70.52 145.29 52.31 Favored 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.045 1.163 . . . . 0.0 112.123 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.4 m -126.31 175.49 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -128.35 161.72 28.76 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.4 mm -124.82 147.78 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.524 ' CB ' HD11 ' A' ' 92' ' ' ILE . . . -125.15 134.5 52.4 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 176.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.1 tt -129.01 133.88 47.92 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.833 1.253 . . . . 0.0 107.999 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.615 HG13 HD12 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -147.67 134.11 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.022 0.529 . . . . 0.0 110.59 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.519 ' HA ' HG22 ' A' ' 63' ' ' ILE . 46.8 t -72.44 159.77 33.42 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 122.514 1.149 . . . . 0.0 109.427 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.3 m -83.6 100.48 10.84 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 124.749 1.22 . . . . 0.0 109.653 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 ptt85 -82.94 13.77 3.73 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.54 -1.35 . . . . 0.0 112.428 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -132.48 33.76 3.78 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.723 2.009 . . . . 0.0 111.536 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.572 HG12 HD12 ' A' ' 55' ' ' LEU . 15.7 m -73.06 3.81 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 O-C-N 120.326 -1.484 . . . . 0.0 114.641 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -48.75 -33.46 10.33 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -102.6 0.17 32.93 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 120.114 1.325 . . . . 0.0 112.454 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.572 HD12 HG12 ' A' ' 52' ' ' VAL . 95.6 mt -95.48 163.14 13.35 Favored 'General case' 0 CA--C 1.512 -0.503 0 O-C-N 120.256 -1.528 . . . . 0.0 111.457 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.425 ' HG3' ' HE ' ' A' ' 59' ' ' ARG . 14.8 mm-40 -70.62 155.36 40.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -120.62 -23.66 5.98 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.26 -13.53 46.46 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.195 0.998 . . . . 0.0 113.507 -178.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.425 ' HE ' ' HG3' ' A' ' 56' ' ' GLU . 3.2 mtm-85 -84.29 7.64 18.63 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.452 1.101 . . . . 0.0 112.915 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.0 -173.46 15.57 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -92.62 105.35 14.17 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-O 117.708 -1.139 . . . . 0.0 109.844 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -69.67 128.92 16.81 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.239 2.626 . . . . 0.0 110.319 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.519 HG22 ' HA ' ' A' ' 48' ' ' SER . 12.5 pt -139.64 177.71 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.5 1.52 . . . . 0.0 109.218 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.681 ' CD1' HG22 ' A' ' 92' ' ' ILE . 1.2 t80 -133.01 158.62 42.25 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.6 tt -155.45 155.91 34.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.623 1.569 . . . . 0.0 108.609 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.411 ' HA3' ' SG ' ' A' ' 73' ' ' CYS . . . -162.41 178.46 38.19 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.678 HD11 HD11 ' A' ' 30' ' ' LEU . 5.4 mt -87.18 177.73 7.09 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.408 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 1.5 t-20 -140.62 111.39 6.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.062 -1.024 . . . . 0.0 108.832 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 153.39 -18.57 0.7 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-O 117.962 -1.465 . . . . 0.0 115.403 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.28 24.47 0.62 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 119.574 1.687 . . . . 0.0 111.969 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 57.24 72.96 0.48 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.324 1.85 . . . . 0.0 109.07 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.42 125.87 10.9 Favored 'General case' 0 N--CA 1.461 0.107 0 O-C-N 121.215 -0.928 . . . . 0.0 111.559 -178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.731 ' SG ' HG23 ' A' ' 92' ' ' ILE . 24.3 m -133.05 172.85 12.09 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.106 0.962 . . . . 0.0 110.936 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.9 mt -55.68 150.91 11.72 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.8 ttp -157.18 117.37 3.5 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.3 m -84.5 115.89 22.82 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 119.598 1.09 . . . . 0.0 110.97 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.462 ' HB3' ' OE1' ' A' ' 86' ' ' GLN . . . -116.86 -170.43 1.83 Allowed 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -149.35 128.57 12.85 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.1 m -81.84 38.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.59 -7.81 2.61 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 120.914 -1.116 . . . . 0.0 113.253 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -123.85 -50.63 1.83 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 127.653 2.381 . . . . 0.0 113.365 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -144.61 156.51 56.41 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 123.908 0.883 . . . . 0.0 108.965 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.46 160.03 44.83 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.467 1.445 . . . . 0.0 110.974 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.5 p -147.82 160.13 43.08 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.499 1.119 . . . . 0.0 109.394 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.558 HD11 HD12 ' A' ' 128' ' ' ILE . 3.7 mt -98.64 127.21 44.49 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.462 ' OE1' ' HB3' ' A' ' 77' ' ' ALA . 6.8 mp0 -123.67 68.09 1.02 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.717 0.807 . . . . 0.0 109.838 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.768 HD13 HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -84.18 102.68 12.78 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.3 -35.56 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.709 1.256 . . . . 0.0 111.342 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -137.3 90.92 2.56 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.61 1.164 . . . . 0.0 109.847 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.565 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -173.76 158.24 3.24 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 120.858 -1.151 . . . . 0.0 109.02 178.342 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -138.81 134.03 32.86 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.104 1.361 . . . . 0.0 107.518 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.731 HG23 ' SG ' ' A' ' 73' ' ' CYS . 37.0 pt -90.25 -33.53 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 C-N-CA 123.806 0.843 . . . . 0.0 111.003 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -32.3 73.89 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 118.299 0.5 . . . . 0.0 110.244 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -62.36 -54.31 42.26 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.624 0.647 . . . . 0.0 109.816 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.459 HD12 ' CD1' ' A' ' 64' ' ' TYR . 14.3 mt -60.22 -40.89 91.75 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -65.11 -31.54 72.79 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.06 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -77.5 -36.07 53.0 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 116.42 -1.752 . . . . 0.0 113.603 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.61 174.43 2.35 Favored Pre-proline 0 N--CA 1.472 0.637 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -175.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.6 -162.93 0.16 Allowed 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.829 2.353 . . . . 0.0 108.228 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 69.3 65.09 0.52 Allowed Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.888 1.675 . . . . 0.0 113.275 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -56.42 116.62 3.32 Favored 'Trans proline' 0 C--O 1.244 0.819 0 C-N-CA 121.903 1.736 . . . . 0.0 110.553 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.5 t -89.96 84.75 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -42.77 -33.77 0.81 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.535 1.934 . . . . 0.0 112.929 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -59.26 -15.25 14.51 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.905 1.682 . . . . 0.0 113.328 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.7 5.9 6.14 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.071 1.348 . . . . 0.0 110.438 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 39.4 mt -101.35 153.71 19.43 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 120.46 1.482 . . . . 0.0 109.208 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.589 ' CE2' HD11 ' A' ' 128' ' ' ILE . 43.3 m-85 -140.73 131.57 25.9 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 123.259 0.623 . . . . 0.0 110.686 -178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.442 ' CE1' ' HA ' ' A' ' 121' ' ' VAL . 83.3 m-85 -76.86 123.09 25.74 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.061 0.945 . . . . 0.0 109.346 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -82.4 126.22 31.94 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.9 t -120.95 170.84 9.11 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -142.42 158.77 43.34 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.718 2.007 . . . . 0.0 109.018 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 80.7 p -124.14 -4.58 7.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 114.149 -1.387 . . . . 0.0 111.854 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 126.92 -44.17 1.27 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -137.82 10.48 2.87 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.47 1.108 . . . . 0.0 112.965 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -146.84 164.1 33.93 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 106.654 -1.609 . . . . 0.0 106.654 178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 m -128.98 153.55 47.45 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.704 0.684 . . . . 0.0 110.527 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.4 170.15 11.13 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -139.19 109.29 6.4 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.916 1.686 . . . . 0.0 109.666 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -106.39 126.18 51.92 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.517 1.127 . . . . 0.0 110.164 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.9 t -50.9 127.58 18.98 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.448 0.699 . . . . 0.0 110.205 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.442 ' HA ' ' CE1' ' A' ' 108' ' ' TYR . 53.6 t -68.37 -48.12 74.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -65.71 -40.09 91.89 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.269 1.028 . . . . 0.0 112.842 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -127.94 84.74 62.44 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -69.24 160.88 48.12 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 N-CA-C 108.368 -1.436 . . . . 0.0 108.368 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.75 -32.03 7.47 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -95.82 140.28 30.83 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 118.03 0.915 . . . . 0.0 109.442 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -120.33 138.97 53.42 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 127.078 2.151 . . . . 0.0 108.597 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.589 HD11 ' CE2' ' A' ' 107' ' ' PHE . 28.3 mm -70.24 139.7 19.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -115.18 126.15 54.25 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.943 0.792 . . . . 0.0 111.399 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.8 m -73.74 -5.36 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.816 -1.178 . . . . 0.0 112.697 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.6 m 54.12 35.12 21.61 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.406 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 7.8 m -73.18 -1.97 19.75 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.807 1.243 . . . . 0.0 112.749 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -94.91 130.22 41.61 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 101.911 -3.366 . . . . 0.0 101.911 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.32 -84.78 0.05 OUTLIER Glycine 0 CA--C 1.531 1.04 0 C-N-CA 123.554 0.597 . . . . 0.0 111.913 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.33 68.0 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 129.219 3.295 . . . . 0.0 108.361 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 m -91.52 168.45 13.32 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 117.886 0.843 . . . . 0.0 110.523 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 55.7 Cg_endo -67.99 159.82 51.27 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 N-CA-C 107.888 -1.62 . . . . 0.0 107.888 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.9 mt -80.96 137.39 36.1 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -163.14 171.61 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 125.286 1.434 . . . . 0.0 109.354 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.5 mp -95.12 171.14 8.92 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.4 t -157.89 145.56 18.5 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.47 -1.394 . . . . 0.0 108.441 176.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -106.02 -26.23 11.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 118.559 0.618 . . . . 0.0 109.797 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -159.55 113.62 2.31 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.63 162.84 14.74 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.365 1.866 . . . . 0.0 109.076 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -108.36 55.88 0.49 Allowed Glycine 0 N--CA 1.46 0.283 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 46.13 43.08 10.61 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.326 1.851 . . . . 0.0 109.601 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -120.33 -10.08 9.39 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.682 1.193 . . . . 0.0 112.618 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -126.53 163.82 22.54 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.5 p -108.91 97.36 7.01 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.23 1.012 . . . . 0.0 111.611 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.8 p -93.62 -31.76 14.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 118.301 -0.857 . . . . 0.0 111.815 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.67 113.42 26.55 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 118.413 -0.803 . . . . 0.0 112.893 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -161.26 178.79 8.89 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 120.07 1.305 . . . . 0.0 112.168 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.83 173.63 21.01 Favored Glycine 0 C--O 1.24 0.485 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.6 tp -120.98 138.88 53.94 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.3 m -89.99 41.92 1.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.02 167.49 15.83 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.2 mt -136.73 151.59 49.39 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.876 1.27 . . . . 0.0 107.699 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 55.4 p90 . . . . . 0 C--O 1.254 1.339 0 C-N-CA 125.191 1.397 . . . . 0.0 109.014 179.533 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.563 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -90.37 174.52 7.52 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.867 0.867 . . . . 0.0 110.872 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -115.66 24.36 11.6 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.462 1.905 . . . . 0.0 111.812 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 51.16 45.0 28.47 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.125 1.77 . . . . 0.0 109.672 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.23 -56.94 15.7 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 117.602 -1.19 . . . . 0.0 109.366 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.3 pttp 45.5 30.23 0.72 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 128.075 2.55 . . . . 0.0 114.255 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.8 pp -142.9 -42.32 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.367 1.067 . . . . 0.0 111.86 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -87.53 84.12 7.17 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 104.167 -2.531 . . . . 0.0 104.167 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.9 p -110.72 138.66 21.12 Favored Pre-proline 0 C--N 1.328 -0.334 0 C-N-CA 126.279 1.832 . . . . 0.0 107.469 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.52 122.75 10.5 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.341 2.028 . . . . 0.0 108.982 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -103.73 138.4 40.41 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -135.19 148.44 49.67 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 119.086 0.857 . . . . 0.0 110.801 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.08 -130.43 1.26 Allowed Glycine 0 C--O 1.227 -0.339 0 CA-C-O 118.668 -1.073 . . . . 0.0 111.534 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.5 p -145.71 -177.7 5.72 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.875 1.338 . . . . 0.0 113.226 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.7 mt -140.54 -11.56 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 126.403 1.881 . . . . 0.0 109.336 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -61.04 -17.98 55.3 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 119.778 -1.826 . . . . 0.0 113.687 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.73 -7.88 5.71 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.757 2.423 . . . . 0.0 113.838 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.6 mm -91.56 -41.51 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.97 23.14 0.86 Allowed 'General case' 0 CA--C 1.514 -0.432 0 O-C-N 121.088 -1.008 . . . . 0.0 111.016 -176.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 62.59 27.83 16.38 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.629 0.728 . . . . 0.0 112.035 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.85 91.09 6.27 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.7 t -85.67 161.51 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 177.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -118.79 144.13 46.5 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 119.553 1.069 . . . . 0.0 110.953 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.7 t -142.65 134.45 25.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 tp -68.71 120.73 15.14 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 103.594 -2.743 . . . . 0.0 103.594 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -137.17 123.11 20.17 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.4 t0 47.07 49.41 15.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.001 1.32 . . . . 0.0 112.644 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 67.59 12.05 8.68 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.949 2.1 . . . . 0.0 115.623 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.1 m -132.42 143.54 49.88 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.652 1.115 . . . . 0.0 109.88 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.441 ' CD1' HD12 ' A' ' 138' ' ' LEU . 7.1 mt -81.96 121.95 27.17 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.41 -1.431 . . . . 0.0 107.872 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.79 136.76 53.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.54 136.98 40.56 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 124.59 1.182 . . . . 0.0 108.105 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 m -119.5 87.19 35.87 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.54 1.136 . . . . 0.0 108.569 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.66 -44.72 2.81 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 122.78 2.32 . . . . 0.0 112.927 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -153.22 44.13 0.63 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.49 1.516 . . . . 0.0 109.611 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.0 124.77 32.82 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -55.6 -32.95 63.51 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 123.981 0.801 . . . . 0.0 109.65 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.5 ttt-85 -89.1 31.0 0.9 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.624 1.569 . . . . 0.0 112.513 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.1 ptt? -80.2 168.06 19.55 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.068 -1.645 . . . . 0.0 109.97 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.81 147.97 18.26 Favored Pre-proline 0 N--CA 1.448 -0.56 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.39 159.58 46.37 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.286 2.657 . . . . 0.0 108.531 178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.85 160.0 9.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 125.77 1.628 . . . . 0.0 108.115 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.04 154.42 27.71 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.964 1.706 . . . . 0.0 108.111 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mm -130.12 104.35 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.193 1.397 . . . . 0.0 108.088 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -90.97 141.36 28.93 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.5 tt -132.69 140.2 48.02 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.57 145.46 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.8 p -75.65 161.9 28.7 Favored 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 124.785 1.234 . . . . 0.0 107.824 177.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.94 176.01 9.61 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 176.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.474 ' HB2' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -125.19 -7.52 7.09 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -116.69 37.64 3.72 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.5 m -60.99 -16.29 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 125.253 1.421 . . . . 0.0 113.544 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.46 -18.41 65.3 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.948 0.499 . . . . 0.0 110.094 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.14 -0.82 49.61 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.117 0.967 . . . . 0.0 112.262 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.2 mt -106.69 179.25 4.32 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 119.262 0.937 . . . . 0.0 110.343 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -92.37 157.63 16.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.909 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.77 -19.46 6.77 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.816 1.247 . . . . 0.0 112.7 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.25 -31.63 72.83 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.506 1.122 . . . . 0.0 113.44 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -86.84 -5.67 59.03 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.536 0.734 . . . . 0.0 112.707 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 127.0 -158.12 20.85 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -102.09 107.77 54.05 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.42 123.5 9.17 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.532 2.821 . . . . 0.0 109.64 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.8 pt -132.91 -171.94 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.445 1.898 . . . . 0.0 108.434 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.655 ' CD1' HG22 ' A' ' 92' ' ' ILE . 1.5 t80 -134.15 158.62 43.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.588 1.155 . . . . 0.0 108.953 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.1 tt -149.59 150.06 31.63 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.425 1.49 . . . . 0.0 108.534 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -152.67 177.19 30.52 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 124.211 0.91 . . . . 0.0 111.945 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mt -97.96 132.25 43.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -96.53 35.69 1.46 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 119.425 1.011 . . . . 0.0 112.581 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -97.7 -96.87 1.96 Allowed Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.488 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.407 ' H ' HD11 ' A' ' 72' ' ' LEU . 24.3 mt -87.8 13.87 9.82 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.885 1.674 . . . . 0.0 115.018 -177.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 m120 72.37 70.88 0.15 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.437 1.895 . . . . 0.0 109.278 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.407 HD11 ' H ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -141.44 145.89 35.83 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 125.328 1.451 . . . . 0.0 107.976 -177.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.526 ' SG ' HG23 ' A' ' 92' ' ' ILE . 56.9 m -143.72 174.05 11.14 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.202 0.91 . . . . 0.0 109.855 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.455 HD23 HD21 ' A' ' 87' ' ' LEU . 15.1 mt -59.9 150.97 27.08 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 118.015 0.37 . . . . 0.0 111.185 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.9 ttp -157.89 116.05 3.08 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 95.8 m -89.78 109.7 20.67 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 119.288 0.949 . . . . 0.0 109.46 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.53 -169.23 1.44 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -130.78 118.54 20.97 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.2 p -65.67 -9.97 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.45 -1.29 7.56 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 125.295 1.426 . . . . 0.0 110.981 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -150.09 -44.25 0.13 Allowed 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.072 0.949 . . . . 0.0 111.484 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -135.44 163.06 53.5 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 124.903 1.281 . . . . 0.0 111.504 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -71.95 146.89 48.35 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.396 2.064 . . . . 0.0 112.635 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 68.1 p -145.75 170.89 15.61 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.4 mt -98.0 132.53 43.48 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -126.15 73.35 1.36 Allowed 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.02 0.928 . . . . 0.0 108.806 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.455 HD21 HD23 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -85.84 107.82 17.84 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 178.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.08 -30.42 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.127 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -157.35 97.73 1.65 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.183 0.993 . . . . 0.0 110.666 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.48 ' CE ' ' H ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -172.84 161.54 4.64 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.509 1.524 . . . . 0.0 107.131 178.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.48 ' H ' ' CE ' ' A' ' 90' ' ' LYS . 0.9 OUTLIER -131.1 130.31 42.99 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.424 1.49 . . . . 0.0 112.431 -178.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.655 HG22 ' CD1' ' A' ' 64' ' ' TYR . 8.1 pt -82.37 -39.67 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 126.233 1.813 . . . . 0.0 111.644 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.2 tpt -64.51 -34.55 78.49 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 118.485 -0.769 . . . . 0.0 110.297 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.51 -45.88 92.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.879 0.763 . . . . 0.0 109.356 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.6 HD12 ' CD1' ' A' ' 64' ' ' TYR . 10.1 mt -65.82 -33.69 76.44 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.758 0.708 . . . . 0.0 111.278 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -79.77 -16.39 55.63 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.468 0.576 . . . . 0.0 110.403 178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -91.73 -36.42 13.59 Favored 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 125.371 1.468 . . . . 0.0 111.486 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.79 159.03 42.25 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 121.141 -0.975 . . . . 0.0 112.049 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -78.86 54.11 4.98 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.435 2.09 . . . . 0.0 112.172 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -116.24 71.85 4.63 Favored Pre-proline 0 N--CA 1.473 0.683 0 O-C-N 120.713 -1.242 . . . . 0.0 110.827 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -79.99 82.1 2.58 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.599 2.199 . . . . 0.0 109.166 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.2 t -74.36 106.01 3.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -50.98 -30.53 15.31 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.423 1.01 . . . . 0.0 111.255 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.3 m -70.83 -8.82 55.37 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -114.03 -22.6 9.98 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.159 -0.963 . . . . 0.0 109.134 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.3 mt -84.34 154.23 23.02 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.007 0.923 . . . . 0.0 113.024 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -140.28 133.17 29.2 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.022 0.929 . . . . 0.0 110.079 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -77.41 118.45 19.88 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -81.17 141.06 34.58 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.0 m -138.87 174.38 10.58 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.465 1.106 . . . . 0.0 108.175 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -153.14 150.74 29.38 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.858 0.463 . . . . 0.0 110.142 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.01 107.07 0.35 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.36 56.92 3.28 Favored Glycine 0 N--CA 1.462 0.385 0 C-N-CA 126.121 1.819 . . . . 0.0 111.756 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 11.7 mtm-85 61.87 9.04 2.74 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.6 1.96 . . . . 0.0 109.798 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -117.5 162.35 18.12 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 119.903 1.228 . . . . 0.0 110.882 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.0 m -111.78 158.79 18.94 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.213 2.205 . . . . 0.0 108.632 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.65 162.82 34.55 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.474 1.909 . . . . 0.0 108.747 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -140.83 116.21 10.05 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -108.89 130.14 55.43 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.465 1.506 . . . . 0.0 109.226 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.9 t -56.69 117.69 4.14 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.356 1.462 . . . . 0.0 110.248 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 72.2 t -62.72 -40.68 89.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 CA-C-N 119.076 0.853 . . . . 0.0 111.022 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.33 -42.02 88.78 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -133.2 86.49 41.7 Favored Pre-proline 0 C--O 1.237 0.414 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.04 168.8 11.59 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.285 2.656 . . . . 0.0 111.535 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.49 -21.67 31.2 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -101.03 118.03 36.19 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 127.444 2.298 . . . . 0.0 107.078 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -108.1 148.32 29.99 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.104 1.361 . . . . 0.0 108.902 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.4 mt -75.61 122.82 30.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.15 140.29 29.81 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.354 0.597 . . . . 0.0 110.494 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.4 m -90.58 -4.75 10.71 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 C-N-CA 124.548 1.139 . . . . 0.0 112.231 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 12.1 m 52.97 73.86 0.33 Allowed 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 123.126 1.441 . . . . 0.0 113.571 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.0 t -93.83 6.12 49.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.676 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -115.36 136.22 53.32 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 53.84 -104.48 0.23 Allowed Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 107.561 -2.216 . . . . 0.0 107.561 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -173.35 66.43 0.11 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 106.394 -2.682 . . . . 0.0 106.394 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 56.5 m -82.0 157.74 68.35 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 117.534 0.667 . . . . 0.0 110.642 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -71.14 165.75 31.39 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 121.973 1.782 . . . . 0.0 108.521 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.441 HD12 ' CD1' ' A' ' 30' ' ' LEU . 22.6 mt -87.82 113.33 23.38 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 124.642 1.177 . . . . 0.0 112.06 -177.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 pp -135.95 178.44 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 125.447 1.499 . . . . 0.0 109.455 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 35.6 mt -96.17 141.58 29.37 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.2 t -129.85 129.8 44.44 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -87.26 -23.47 24.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -160.79 93.78 1.01 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 122.315 1.055 . . . . 0.0 110.88 -177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.53 -57.32 11.84 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.471 1.108 . . . . 0.0 112.285 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 58.79 46.35 93.61 Favored Glycine 0 N--CA 1.465 0.602 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . 0.25 1.4 tmtp? 63.49 38.87 9.54 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.655 1.982 . . . . 0.0 112.588 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -132.22 -13.42 3.1 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.831 -1.077 . . . . 0.0 108.912 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -140.62 156.39 46.28 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.429 -1.419 . . . . 0.0 108.677 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 55.8 m -109.8 118.51 36.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.7 p -108.07 -11.94 15.21 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.409 1.084 . . . . 0.0 110.099 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -101.69 126.84 48.61 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.759 1.223 . . . . 0.0 109.919 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -152.72 -165.08 2.1 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.333 -0.854 . . . . 0.0 109.41 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -148.1 127.59 2.63 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 106.055 -2.818 . . . . 0.0 106.055 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.52 114.47 26.01 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.8 m -78.41 39.59 0.33 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.588 2.355 . . . . 0.0 107.716 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -64.18 148.57 49.73 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.403 1.881 . . . . 0.0 107.999 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.1 mt -129.51 162.55 27.89 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 126.244 1.818 . . . . 0.0 108.43 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 22.9 p90 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 115.361 -2.257 . . . . 0.0 109.677 -179.592 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 122.395 1.093 . . . . 0.0 108.619 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 mp0 -75.3 -172.2 1.67 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 128.871 2.869 . . . . 0.0 113.754 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.64 -31.5 3.98 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.349 1.86 . . . . 0.0 112.217 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.73 -41.36 0.06 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 122.609 1.195 . . . . 0.0 113.007 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.502 ' H ' HD23 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -86.14 -172.02 3.86 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 125.809 1.644 . . . . 0.0 109.026 179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -131.49 9.2 4.67 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.919 1.288 . . . . 0.0 113.361 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pt -135.55 38.65 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 127.5 2.32 . . . . 0.0 108.679 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -75.41 -43.04 52.07 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.631 -1.293 . . . . 0.0 112.407 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.15 155.8 91.33 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 123.327 0.651 . . . . 0.0 109.983 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.46 ' HB3' HD11 ' A' ' 47' ' ' ILE . 60.7 Cg_endo -69.94 132.15 22.45 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.442 2.094 . . . . 0.0 107.497 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.99 132.81 42.43 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 3.5 mp0 -128.89 145.98 51.07 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.14 -139.19 2.67 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 95.0 p -143.96 -172.62 3.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 118.036 0.918 . . . . 0.0 112.796 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.3 mt -140.05 -10.6 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 126.443 1.897 . . . . 0.0 109.337 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -24.02 65.31 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 119.544 -1.972 . . . . 0.0 113.268 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -58.86 -16.38 17.06 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.917 2.087 . . . . 0.0 112.706 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.5 mt -74.79 -67.11 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.138 1.375 . . . . 0.0 112.8 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -136.7 32.09 2.75 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.149 0.976 . . . . 0.0 110.535 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 58.62 37.42 25.31 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.924 0.868 . . . . 0.0 110.643 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 29.1 mmt-85 -105.72 89.67 3.16 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.824 -1.173 . . . . 0.0 109.217 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.3 t -79.11 157.25 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.418 ' CD2' HD11 ' A' ' 138' ' ' LEU . 49.8 m0 -111.47 153.78 25.66 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.988 0.915 . . . . 0.0 108.673 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.5 t -146.62 135.65 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.1 tp -76.25 106.89 8.12 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -132.16 133.51 44.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 119.843 1.201 . . . . 0.0 111.293 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t0 47.83 42.79 16.5 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 123.641 1.686 . . . . 0.0 111.28 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 61.61 26.93 16.51 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 127.223 2.209 . . . . 0.0 115.122 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 89.1 m -138.71 154.79 48.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.968 HD11 HD21 ' A' ' 67' ' ' LEU . 9.8 mt -92.94 126.45 38.02 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mt -126.97 132.16 70.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 123.141 0.576 . . . . 0.0 110.736 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.34 136.38 46.17 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.951 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.7 m -112.96 81.44 4.57 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.786 1.235 . . . . 0.0 108.117 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.12 -33.36 25.34 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.559 2.172 . . . . 0.0 111.851 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -151.33 12.73 0.65 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -62.86 138.65 58.59 Favored 'General case' 0 CA--C 1.52 -0.179 0 O-C-N 120.585 -1.322 . . . . 0.0 111.059 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -33.13 75.16 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.603 1.961 . . . . 0.0 109.038 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -102.08 71.59 1.27 Allowed 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.7 ptm -106.7 163.07 13.21 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -157.43 141.12 11.37 Favored Pre-proline 0 N--CA 1.446 -0.652 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -71.91 163.78 37.74 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 N-CA-C 108.502 -1.384 . . . . 0.0 108.502 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.8 p -155.62 154.19 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-N 115.067 -0.97 . . . . 0.0 108.437 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.46 150.99 25.53 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 126.827 2.051 . . . . 0.0 110.355 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 12' ' ' GLN . 43.3 mm -121.56 122.34 66.85 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.628 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' A' ' 68' ' ' ASN . . . -100.71 145.84 27.96 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.453 HD12 HD12 ' A' ' 65' ' ' LEU . 3.9 tt -140.18 138.01 34.82 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.473 HD12 HG12 ' A' ' 92' ' ' ILE . 80.9 mt -146.77 138.0 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 C-N-CA 126.129 1.772 . . . . 0.0 109.856 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.4 p -84.28 130.24 34.82 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 89.9 m -62.68 138.74 58.58 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -94.42 -28.36 15.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.858 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -90.85 40.73 1.03 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.2 m -68.22 -8.81 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 O-C-N 120.44 -1.412 . . . . 0.0 112.783 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -62.6 -7.37 4.61 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.032 2.133 . . . . 0.0 113.583 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 t -122.5 7.23 9.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.897 1.279 . . . . 0.0 111.605 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.6 mt -107.49 167.31 10.03 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.849 -1.157 . . . . 0.0 108.601 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -64.71 153.34 39.98 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.268 -1.333 . . . . 0.0 107.992 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -121.72 -47.01 2.22 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.091 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.16 -26.45 62.75 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 127.909 2.484 . . . . 0.0 113.315 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -85.04 -19.47 31.92 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.789 -0.57 . . . . 0.0 111.601 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 140.71 -167.44 25.59 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -97.45 102.1 11.9 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.683 0.793 . . . . 0.0 110.676 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.64 138.17 23.6 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 124.298 3.332 . . . . 0.0 112.741 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pp -146.08 -175.35 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 125.738 1.615 . . . . 0.0 110.246 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.498 ' CE1' HD12 ' A' ' 95' ' ' LEU . 3.2 t80 -134.16 156.46 48.29 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.678 0.791 . . . . 0.0 110.527 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.465 HD11 HD21 ' A' ' 154' ' ' LEU . 6.8 tt -154.3 151.82 29.55 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.599 1.56 . . . . 0.0 108.428 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.92 -176.67 34.26 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.968 HD21 HD11 ' A' ' 30' ' ' LEU . 11.0 mt -83.47 171.03 13.82 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 176.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 10.5 t-20 -137.68 47.34 2.06 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.603 -1.311 . . . . 0.0 109.6 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.83 -75.99 0.54 Allowed Glycine 0 C--N 1.337 0.63 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.381 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.21 25.11 11.43 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 -178.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.3 m120 66.88 72.96 0.36 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.662 1.185 . . . . 0.0 109.804 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.46 141.71 25.1 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.963 1.305 . . . . 0.0 110.573 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.3 m -144.04 165.48 27.67 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.02 0.827 . . . . 0.0 111.385 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.84 156.62 8.63 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.518 1.127 . . . . 0.0 110.174 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.1 tmm? -164.37 140.53 6.17 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.5 m -102.78 119.61 39.14 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.45 -171.75 2.44 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.124 1.37 . . . . 0.0 107.874 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -128.25 127.09 42.18 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.94 -8.04 10.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 123.437 0.461 . . . . 0.0 110.697 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.73 -82.44 0.1 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.392 -1.883 . . . . 0.0 108.392 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -117.17 7.66 13.05 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.968 0.89 . . . . 0.0 112.701 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -141.1 151.01 60.85 Favored Pre-proline 0 C--O 1.241 0.651 0 C-N-CA 124.807 1.243 . . . . 0.0 110.547 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.72 149.13 18.18 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.733 2.289 . . . . 0.0 108.978 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.5 p -144.14 170.61 15.64 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.957 0.903 . . . . 0.0 110.393 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.66 HD11 HG23 ' A' ' 128' ' ' ILE . 3.5 mt -91.79 151.24 20.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.399 1.08 . . . . 0.0 108.679 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -148.63 80.94 1.45 Allowed 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 125.079 1.351 . . . . 0.0 107.628 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.62 ' HG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -104.96 97.39 7.25 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 125.942 1.697 . . . . 0.0 108.858 -177.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.08 -26.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.871 0.732 . . . . 0.0 112.274 -177.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -145.24 103.59 3.86 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.541 1.537 . . . . 0.0 109.482 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.433 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER 174.11 159.25 0.16 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.133 1.373 . . . . 0.0 108.915 179.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -136.35 127.74 28.44 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.181 0.593 . . . . 0.0 110.795 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.473 HG12 HD12 ' A' ' 47' ' ' ILE . 1.1 tt -68.26 -47.17 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 125.903 1.681 . . . . 0.0 114.25 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.8 tpt -62.95 -29.73 71.03 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 118.982 -0.532 . . . . 0.0 111.268 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.22 -54.51 32.35 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.034 0.533 . . . . 0.0 109.691 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.498 HD12 ' CE1' ' A' ' 64' ' ' TYR . 42.2 mt -63.87 -30.04 71.17 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.414 ' CG ' HG21 ' A' ' 47' ' ' ILE . 52.1 t80 -74.39 -52.42 12.17 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -60.63 -45.08 95.42 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 125.682 1.593 . . . . 0.0 112.685 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -92.99 145.37 29.99 Favored Pre-proline 0 N--CA 1.447 -0.583 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.64 50.0 2.59 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.439 2.76 . . . . 0.0 112.124 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -118.12 72.73 9.4 Favored Pre-proline 0 CA--C 1.537 0.48 0 O-C-N 120.745 -1.222 . . . . 0.0 109.332 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.94 92.28 1.05 Allowed 'Trans proline' 0 N--CA 1.45 -1.037 0 N-CA-C 105.284 -2.622 . . . . 0.0 105.284 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.5 t -88.35 97.72 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.2 ptpt -50.55 -22.23 1.88 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.02 -17.34 64.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.209 0.604 . . . . 0.0 110.858 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -113.61 -22.07 10.46 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 119.164 0.893 . . . . 0.0 110.649 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.8 mt -78.97 164.37 24.46 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.698 1.199 . . . . 0.0 113.64 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.92 140.63 22.65 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 123.772 0.829 . . . . 0.0 111.016 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.43 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.5 OUTLIER -75.3 123.18 24.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 176.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.431 ' CD2' ' HB3' ' A' ' 116' ' ' SER . 3.9 t-160 -97.94 101.35 12.81 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.883 1.273 . . . . 0.0 107.577 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.51 170.9 13.0 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.925 1.29 . . . . 0.0 110.095 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -139.86 147.38 40.58 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.675 1.59 . . . . 0.0 110.044 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.4 p -135.59 15.4 3.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.823 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 119.5 -79.23 0.31 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -111.47 -1.41 15.9 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.18 0.992 . . . . 0.0 111.985 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -127.03 160.87 29.83 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.206 1.002 . . . . 0.0 108.357 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.431 ' HB3' ' CD2' ' A' ' 109' ' ' HIS . 49.9 m -132.5 151.66 51.83 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.234 1.814 . . . . 0.0 109.024 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.11 165.75 12.79 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -142.8 107.96 4.97 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -111.65 124.72 52.9 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.398 1.879 . . . . 0.0 110.056 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.8 t -53.01 130.23 33.13 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.304 -0.872 . . . . 0.0 110.032 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 67.2 t -68.87 -51.18 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.909 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.01 78.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -129.19 81.6 70.15 Favored Pre-proline 0 CA--C 1.534 0.355 0 C-N-CA 124.055 0.942 . . . . 0.0 109.903 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -65.38 161.61 37.2 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.671 2.247 . . . . 0.0 111.113 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 90.2 0.06 77.69 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.205 -0.775 . . . . 0.0 113.06 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -126.69 131.23 51.43 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 126.455 1.902 . . . . 0.0 107.753 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -113.6 149.97 33.77 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.948 1.299 . . . . 0.0 112.493 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.66 HG23 HD11 ' A' ' 85' ' ' LEU . 2.1 mt -81.51 119.25 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.609 0.764 . . . . 0.0 111.176 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.72 152.31 31.64 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.638 1.108 . . . . 0.0 109.965 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 13.9 t -103.48 -18.2 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 127.797 2.439 . . . . 0.0 109.754 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.504 ' HB3' ' H ' ' A' ' 136' ' ' CYS . 50.9 m 61.24 39.24 15.91 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.391 1.476 . . . . 0.0 114.295 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.1 m -76.76 -11.38 59.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.61 -66.99 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.77 1.628 . . . . 0.0 111.071 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -122.88 -48.49 0.25 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 124.321 0.963 . . . . 0.0 111.288 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 138.75 60.44 0.05 OUTLIER Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . 0.504 ' H ' ' HB3' ' A' ' 131' ' ' SER . 0.5 OUTLIER -90.45 174.16 4.91 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 123.95 0.9 . . . . 0.0 110.933 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.01 166.43 29.61 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 N-CA-C 108.928 -1.22 . . . . 0.0 108.928 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.418 HD11 ' CD2' ' A' ' 23' ' ' TRP . 21.9 mt -87.28 114.09 23.58 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.9 pp -137.93 172.02 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.078 1.351 . . . . 0.0 110.754 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 66.3 mt -97.72 159.89 14.65 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.37 161.33 41.22 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 125.321 1.448 . . . . 0.0 107.316 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -104.57 -45.66 4.56 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -159.88 126.7 4.45 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.667 ' HG ' ' H ' ' A' ' 145' ' ' GLY . 0.5 OUTLIER -120.3 -63.91 1.31 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.984 1.714 . . . . 0.0 111.209 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.667 ' H ' ' HG ' ' A' ' 144' ' ' LEU . . . 106.68 -70.11 0.22 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 107.118 -2.393 . . . . 0.0 107.118 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.67 -5.65 1.18 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.397 1.079 . . . . 0.0 113.382 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.93 -19.77 65.01 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -138.26 -157.81 0.8 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.4 m -146.53 107.9 4.25 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 102.088 -3.301 . . . . 0.0 102.088 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.49 -9.12 14.23 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.389 1.076 . . . . 0.0 110.546 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -123.26 112.32 17.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.94 -176.62 5.0 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.085 0.954 . . . . 0.0 111.165 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.99 -169.04 32.13 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.347 0.975 . . . . 0.0 112.675 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.465 HD21 HD11 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -145.5 130.33 18.16 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.942 1.697 . . . . 0.0 106.769 179.164 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 39.2 m -90.34 51.32 2.0 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -68.73 138.13 54.64 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 40.8 mt -123.03 170.23 10.37 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.159 2.184 . . . . 0.0 107.95 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 1.8 p90 . . . . . 0 C--O 1.255 1.347 0 CA-C-O 117.416 -1.278 . . . . 0.0 108.677 -179.842 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -84.01 -170.34 3.03 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -118.13 26.77 9.41 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 121.201 -0.937 . . . . 0.0 110.587 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 56.21 62.03 2.5 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 124.571 1.148 . . . . 0.0 110.019 -179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -110.89 -45.33 3.48 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-O 117.125 -1.417 . . . . 0.0 112.623 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.5 pttt 43.87 37.07 1.53 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.321 2.248 . . . . 0.0 112.994 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -144.02 79.99 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 125.259 1.424 . . . . 0.0 108.684 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.04 100.25 8.07 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.25 154.62 81.69 Favored Pre-proline 0 C--O 1.239 0.55 0 C-N-CA 123.753 0.821 . . . . 0.0 110.613 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.1 146.1 80.97 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.949 1.766 . . . . 0.0 107.833 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -141.23 108.77 5.59 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -111.15 145.18 39.08 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.303 0.641 . . . . 0.0 110.227 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -173.28 -117.99 0.48 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.0 p -160.45 167.58 26.97 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 119.118 1.459 . . . . 0.0 114.018 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.517 HG22 HH12 ' A' ' 21' ' ' ARG . 30.0 mt -127.19 -2.56 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 123.463 0.705 . . . . 0.0 109.37 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -62.52 -28.65 69.99 Favored 'General case' 0 C--N 1.334 -0.094 0 O-C-N 119.4 -2.062 . . . . 0.0 115.028 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.41 -19.79 16.59 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.205 1.802 . . . . 0.0 112.635 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.7 mm -56.69 -54.48 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 127.458 2.303 . . . . 0.0 115.292 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -151.27 35.17 0.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.12 16.58 3.02 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.643 1.977 . . . . 0.0 114.29 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.517 HH12 HG22 ' A' ' 15' ' ' ILE . 1.1 ptm180 -88.22 94.89 9.97 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.596 1.558 . . . . 0.0 109.78 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -75.67 157.73 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.514 ' CZ3' HD12 ' A' ' 15' ' ' ILE . 17.5 m0 -108.21 147.9 30.71 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.1 t -142.6 127.93 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.427 HD22 ' CD2' ' A' ' 72' ' ' LEU . 3.9 tp -72.31 107.62 5.01 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.774 -1.936 . . . . 0.0 105.774 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -124.88 124.82 42.88 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 120.602 1.547 . . . . 0.0 110.37 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 t0 47.81 57.24 6.19 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.443 1.116 . . . . 0.0 111.229 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 51.75 24.9 2.64 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.228 1.011 . . . . 0.0 113.542 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.3 m -142.96 127.05 17.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.463 HD11 HD11 ' A' ' 67' ' ' LEU . 14.9 mt -74.66 144.06 43.99 Favored 'General case' 0 CA--C 1.518 -0.258 0 O-C-N 119.55 -1.969 . . . . 0.0 109.306 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.4 pt -125.14 153.07 32.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 123.895 0.878 . . . . 0.0 108.862 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.36 123.02 44.05 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 106.295 -1.742 . . . . 0.0 106.295 178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.3 m -111.25 78.23 1.77 Allowed Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.043 0.937 . . . . 0.0 108.87 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.73 -50.12 2.62 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.57 1.513 . . . . 0.0 110.425 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -141.98 79.73 1.68 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.637 1.175 . . . . 0.0 108.176 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -140.98 132.78 27.42 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.39 -42.56 98.91 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.632 0.582 . . . . 0.0 112.01 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -71.73 22.34 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -73.15 163.73 27.71 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 120.444 -1.41 . . . . 0.0 110.317 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.0 t -156.53 132.43 5.81 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.14 144.99 59.29 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.841 2.361 . . . . 0.0 110.633 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.5 m -132.56 164.51 34.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.523 1.129 . . . . 0.0 108.244 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -115.49 156.2 26.11 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 mm -123.0 136.06 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.24 126.14 46.39 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 119.926 1.239 . . . . 0.0 107.944 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.1 tt -118.96 136.86 53.87 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.608 1.163 . . . . 0.0 110.481 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.3 mt -148.96 142.33 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 124.941 1.296 . . . . 0.0 109.246 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.7 p -84.83 153.69 22.78 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 43.2 m -79.53 130.2 35.17 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 120.173 -1.58 . . . . 0.0 108.117 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -79.14 -32.18 44.3 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -97.34 44.8 1.04 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.967 1.307 . . . . 0.0 110.65 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.0 m -66.22 -7.53 5.48 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 O-C-N 120.412 -1.43 . . . . 0.0 113.636 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -55.5 -28.92 57.5 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.285 0.948 . . . . 0.0 112.662 178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.4 t -95.44 -11.13 28.1 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.902 0.774 . . . . 0.0 111.569 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.52 168.24 11.67 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -82.05 154.44 25.63 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -119.84 -18.31 8.29 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.056 1.343 . . . . 0.0 111.062 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -57.51 -39.59 76.84 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 128.107 2.563 . . . . 0.0 114.191 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -85.06 -12.8 52.23 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.178 0.991 . . . . 0.0 111.396 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 136.06 -162.26 24.99 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -93.94 103.66 11.01 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 126.148 1.779 . . . . 0.0 109.862 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.08 135.73 25.74 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.447 2.098 . . . . 0.0 109.966 178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -133.15 178.06 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.633 ' CD1' HG22 ' A' ' 92' ' ' ILE . 2.1 t80 -137.76 131.4 31.19 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.033 0.533 . . . . 0.0 109.567 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.72 158.7 38.67 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.43 -170.09 22.69 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.463 HD11 HD11 ' A' ' 30' ' ' LEU . 4.3 mt -98.85 166.73 11.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -130.31 94.77 3.74 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.98 -16.23 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 CA-C-O 116.574 -2.236 . . . . 0.0 116.977 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.15 22.95 0.11 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 120.493 2.146 . . . . 0.0 111.914 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 61.45 63.37 1.2 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.786 1.634 . . . . 0.0 108.993 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.427 ' CD2' HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -136.49 127.17 27.15 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.219 -178.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.579 ' SG ' HG23 ' A' ' 92' ' ' ILE . 29.1 m -136.84 179.65 6.24 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.931 ' HA ' HD12 ' A' ' 87' ' ' LEU . 10.9 mt -64.08 153.54 37.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.185 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -161.09 133.57 6.07 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 89.6 m -101.0 125.76 47.63 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.81 -174.7 3.67 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HE2' ' HA ' ' A' ' 81' ' ' ASP . 10.2 tttt -117.48 148.39 41.87 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.7 p -121.67 -6.79 9.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 123.564 0.54 . . . . 0.0 111.458 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.5 72.31 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.436 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 8.4 t0 70.48 5.27 5.3 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.811 2.044 . . . . 0.0 114.34 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.71 143.85 42.13 Favored Pre-proline 0 C--O 1.237 0.445 0 C-N-CA 126.164 1.786 . . . . 0.0 109.356 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -74.91 162.04 37.97 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.989 2.459 . . . . 0.0 113.277 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.1 p -156.8 169.1 25.53 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.342 1.457 . . . . 0.0 109.997 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.798 HD11 HG22 ' A' ' 128' ' ' ILE . 0.9 OUTLIER -91.18 130.22 37.08 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 127.583 2.353 . . . . 0.0 105.164 178.105 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -136.99 70.38 1.4 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 122.118 0.961 . . . . 0.0 109.365 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.931 HD12 ' HA ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -89.14 113.78 24.99 Favored 'General case' 0 CA--C 1.495 -1.156 0 C-N-CA 127.458 2.303 . . . . 0.0 109.067 -178.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.64 -28.5 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.726 0 O-C-N 124.745 1.278 . . . . 0.0 113.529 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -147.65 97.68 2.86 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.361 1.465 . . . . 0.0 109.43 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.95 159.21 2.64 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -135.23 134.03 39.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.633 HG22 ' CD1' ' A' ' 64' ' ' TYR . 6.5 pt -83.62 -40.38 15.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 2.7 tpt -63.98 -31.05 72.1 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.237 -0.887 . . . . 0.0 112.424 -178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.55 -50.18 73.69 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.525 HD12 ' CD1' ' A' ' 64' ' ' TYR . 16.1 mt -63.44 -35.6 80.96 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.528 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -75.38 -26.41 58.44 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.377 -0.827 . . . . 0.0 109.931 177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -78.88 -31.45 45.47 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 120.711 -1.243 . . . . 0.0 113.217 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -112.29 158.07 38.18 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 118.949 0.795 . . . . 0.0 110.829 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -86.74 45.0 1.27 Allowed 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.287 2.658 . . . . 0.0 114.157 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -125.24 58.1 18.87 Favored Pre-proline 0 CA--C 1.553 1.064 0 O-C-N 120.608 -1.308 . . . . 0.0 112.195 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -62.21 117.96 4.83 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.946 3.097 . . . . 0.0 110.82 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.1 t -99.92 107.41 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 123.447 0.699 . . . . 0.0 110.621 -177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.431 ' HB2' HG12 ' A' ' 121' ' ' VAL . 0.0 OUTLIER -52.82 -24.28 8.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 118.182 -0.914 . . . . 0.0 112.877 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.1 m -67.69 -11.35 58.12 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.363 0.983 . . . . 0.0 111.362 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -119.62 -16.1 8.88 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.256 1.422 . . . . 0.0 110.294 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.6 mt -83.74 154.9 23.35 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.08 0.854 . . . . 0.0 111.867 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -136.88 128.14 28.08 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.483 0.713 . . . . 0.0 110.212 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -71.29 126.46 29.69 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 103.698 -2.704 . . . . 0.0 103.698 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 30.4 p-80 -104.35 145.53 30.12 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.749 0.704 . . . . 0.0 110.25 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.66 -175.22 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.854 -0.529 . . . . 0.0 109.96 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -143.99 151.05 39.22 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.884 1.674 . . . . 0.0 106.959 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.5 p -124.98 -7.11 7.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.89 -35.81 2.39 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -147.68 -5.4 0.48 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.028 1.331 . . . . 0.0 112.082 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -131.57 177.33 7.58 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 125.331 1.452 . . . . 0.0 108.787 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 m -140.64 145.82 37.11 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.552 1.541 . . . . 0.0 110.078 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.65 166.9 10.63 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.926 0.89 . . . . 0.0 108.623 178.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -147.34 114.21 6.11 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.057 1.343 . . . . 0.0 107.773 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -114.83 130.5 56.88 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 127.103 2.161 . . . . 0.0 112.11 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.3 t -53.02 124.01 13.14 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.37 0.668 . . . . 0.0 109.764 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.431 HG12 ' HB2' ' A' ' 103' ' ' LYS . 79.1 t -67.48 -54.11 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 O-C-N 121.08 -1.012 . . . . 0.0 110.137 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.44 -33.52 68.0 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.085 0.954 . . . . 0.0 113.182 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -135.95 80.91 41.0 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 124.647 1.179 . . . . 0.0 109.778 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.44 163.1 37.94 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.005 2.47 . . . . 0.0 109.848 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 96.77 -3.24 62.68 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 124.582 1.087 . . . . 0.0 110.653 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -125.63 121.82 34.63 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.731 1.612 . . . . 0.0 108.522 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -106.1 145.87 30.9 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 125.423 1.489 . . . . 0.0 109.575 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.798 HG22 HD11 ' A' ' 85' ' ' LEU . 3.4 pt -75.09 121.32 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.08 121.25 27.16 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 68.8 t -78.24 -20.06 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 127.656 2.382 . . . . 0.0 113.385 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.5 m 59.21 66.11 1.09 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.406 1.098 . . . . 0.0 110.438 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.3 m -99.36 36.7 1.69 Allowed 'General case' 0 C--N 1.323 -0.575 0 O-C-N 120.963 -1.085 . . . . 0.0 112.239 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -126.37 -98.96 0.39 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.935 0.494 . . . . 0.0 109.957 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -94.17 23.96 29.13 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-O 117.058 -1.968 . . . . 0.0 117.133 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.38 52.02 6.97 Favored Glycine 0 C--O 1.238 0.376 0 CA-C-N 119.743 1.771 . . . . 0.0 113.306 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.29 164.65 40.03 Favored Pre-proline 0 C--O 1.234 0.264 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.27 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.32 156.87 37.31 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 N-CA-C 107.04 -1.946 . . . . 0.0 107.04 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.438 HD11 ' CE2' ' A' ' 23' ' ' TRP . 17.7 mt -82.94 118.68 23.64 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 124.537 1.135 . . . . 0.0 110.862 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.439 ' C ' HD12 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -143.33 167.48 13.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 123.787 0.835 . . . . 0.0 111.458 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 28.5 mt -86.14 151.89 23.29 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.1 t -141.36 137.29 32.24 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -83.02 -33.98 26.38 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 122.154 0.978 . . . . 0.0 109.43 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.15 101.51 3.15 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -177.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.499 ' H ' HD23 ' A' ' 144' ' ' LEU . 0.7 OUTLIER -81.88 -160.1 0.34 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.707 -1.588 . . . . 0.0 108.905 178.458 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 123.74 -5.59 9.13 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 125.542 1.544 . . . . 0.0 112.417 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.18 103.94 1.47 Allowed 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 118.338 1.069 . . . . 0.0 112.279 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 80.72 -2.09 1.85 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 129.656 3.182 . . . . 0.0 114.328 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -121.52 74.95 1.15 Allowed 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 127.752 2.421 . . . . 0.0 110.276 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.444 HG21 ' CE2' ' A' ' 152' ' ' PHE . 0.3 OUTLIER -65.77 106.52 1.53 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 117.317 -1.325 . . . . 0.0 108.898 179.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.7 p -100.9 -12.99 18.53 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 122.147 2.249 . . . . 0.0 111.108 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -101.69 103.96 14.76 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 130.135 3.374 . . . . 0.0 118.072 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.444 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.8 OUTLIER -168.68 177.06 5.31 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.333 -0.854 . . . . 0.0 112.927 177.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.15 178.19 26.69 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.077 1.322 . . . . 0.0 111.675 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.427 ' HG ' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -126.77 144.91 50.81 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.474 1.509 . . . . 0.0 109.534 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.4 m -104.52 48.69 0.83 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.19 158.83 35.74 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.9 mt -129.55 159.49 36.17 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.95 1.3 . . . . 0.0 108.991 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 11.0 p90 . . . . . 0 C--O 1.245 0.834 0 CA-C-O 115.587 -2.149 . . . . 0.0 108.573 -179.858 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.41 169.11 20.92 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.594 1.088 . . . . 0.0 110.06 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -77.62 28.48 0.16 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.335 1.854 . . . . 0.0 112.291 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 56.43 33.58 22.71 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.75 1.22 . . . . 0.0 112.092 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.432 ' H ' HD23 ' A' ' 5' ' ' LEU . 2.2 pt? -74.42 168.59 19.4 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 121.665 -0.647 . . . . 0.0 109.58 178.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -138.31 -22.12 1.03 Allowed 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.84 -39.97 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 O-C-N 123.737 0.648 . . . . 0.0 111.115 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -121.79 114.27 20.84 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.57 162.49 54.48 Favored Pre-proline 0 C--O 1.238 0.499 0 C-N-CA 123.977 0.911 . . . . 0.0 108.573 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HB3' HG12 ' A' ' 47' ' ' ILE . 97.8 Cg_endo -71.63 156.12 58.03 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 N-CA-C 108.301 -1.461 . . . . 0.0 108.301 178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.36 116.84 27.02 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 pm0 -113.3 142.47 45.8 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 122.568 0.347 . . . . 0.0 110.468 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.06 -125.97 0.89 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-O 118.27 -1.295 . . . . 0.0 111.284 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 81.8 p -154.05 -159.74 1.01 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 120.918 2.359 . . . . 0.0 111.188 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -153.84 -4.5 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 126.329 1.852 . . . . 0.0 109.122 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -62.93 -29.68 70.97 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -60.74 -16.47 40.3 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.637 1.175 . . . . 0.0 113.487 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mt -61.49 -45.73 98.04 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 C-N-CA 125.666 1.586 . . . . 0.0 112.383 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -148.82 21.84 1.0 Allowed 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.091 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.8 t60 63.95 43.78 5.09 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.45 HH11 ' HB3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -113.88 94.1 4.67 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.794 0.838 . . . . 0.0 109.558 178.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.9 t -81.58 143.67 11.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -100.53 139.63 35.93 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.4 t -135.67 141.07 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.7 tp -79.98 103.29 9.76 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -126.7 134.42 50.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.3 t0 39.16 65.76 0.63 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.202 1.401 . . . . 0.0 112.148 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 44.21 31.94 0.62 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.456 1.502 . . . . 0.0 114.597 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.6 m -144.57 162.97 35.28 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.837 1.655 . . . . 0.0 106.77 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.712 HD12 HD22 ' A' ' 87' ' ' LEU . 5.5 mt -103.06 120.29 40.4 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 177.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 1.4 mm -119.08 139.66 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 118.03 0.377 . . . . 0.0 110.331 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.62 138.25 39.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.2 m -122.37 60.66 13.65 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.372 1.069 . . . . 0.0 110.336 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.45 ' HB3' HH11 ' A' ' 21' ' ' ARG . 19.8 Cg_endo -56.51 -37.64 96.97 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.199 1.933 . . . . 0.0 114.967 -178.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -136.62 13.18 3.2 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.22 128.08 34.71 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.3 1.04 . . . . 0.0 108.369 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.45 6.14 1.51 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.335 1.854 . . . . 0.0 113.094 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -129.02 40.45 3.63 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.363 -1.461 . . . . 0.0 109.881 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.7 ptp -72.58 167.72 20.11 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.836 -0.54 . . . . 0.0 110.217 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -163.13 128.73 2.19 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.85 157.7 51.25 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.517 2.145 . . . . 0.0 110.474 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.5 m -144.54 166.52 12.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.96 162.73 16.04 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.7 mm -132.05 109.76 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 C-N-CA 126.951 2.1 . . . . 0.0 107.3 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.89 136.54 34.06 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.4 tt -129.38 132.59 47.07 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.424 HG12 ' HB3' ' A' ' 10' ' ' PRO . 1.7 mt -142.26 141.34 28.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 124.797 1.239 . . . . 0.0 109.323 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.4 t -76.39 164.87 25.59 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.5 m -89.76 146.72 24.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -109.37 -20.92 12.75 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -105.75 39.84 1.69 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 122.475 1.131 . . . . 0.0 109.939 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 m -66.7 -6.03 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.52 1.128 . . . . 0.0 112.653 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -33.77 66.23 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.277 1.031 . . . . 0.0 111.855 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 t -101.79 13.67 34.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.649 1.179 . . . . 0.0 111.885 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.7 mt -107.14 179.58 4.22 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 120.713 -1.242 . . . . 0.0 111.006 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -84.3 153.07 23.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.639 1.176 . . . . 0.0 107.948 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -124.95 -37.78 2.41 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 123.606 0.762 . . . . 0.0 110.491 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -53.98 -44.28 70.67 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.741 1.216 . . . . 0.0 111.84 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -67.54 -27.28 66.83 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 117.086 -1.435 . . . . 0.0 112.2 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 138.51 178.84 16.6 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 126.415 1.959 . . . . 0.0 110.512 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.54 120.17 80.39 Favored Pre-proline 0 CA--C 1.541 0.619 0 O-C-N 121.561 -0.964 . . . . 0.0 111.883 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.63 141.79 15.76 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.51 2.807 . . . . 0.0 110.256 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 pp -143.58 -179.47 1.27 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 126.888 2.075 . . . . 0.0 108.083 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.509 ' CD1' HD12 ' A' ' 95' ' ' LEU . 2.0 t80 -136.83 151.66 49.39 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 tt -145.36 154.87 42.77 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.19 -174.78 28.34 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.43 161.15 13.94 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -130.32 105.4 7.87 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 173.07 -31.24 0.11 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-O 118.45 -1.195 . . . . 0.0 113.513 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -153.35 37.02 0.47 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 119.142 1.471 . . . . 0.0 110.402 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 49.83 78.98 0.09 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.233 2.213 . . . . 0.0 111.582 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -142.75 141.85 31.82 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.233 -177.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 36.5 m -141.16 170.07 16.42 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.323 0.965 . . . . 0.0 112.026 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 33.3 mt -56.2 149.66 15.72 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.243 1.383 . . . . 0.0 111.435 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.8 mtp -156.64 138.78 14.58 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 83.3 m -107.57 124.87 50.57 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.29 -178.94 5.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.29 1.436 . . . . 0.0 107.913 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -119.81 146.26 45.86 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 124.159 0.983 . . . . 0.0 109.219 -178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.3 p -119.28 6.63 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 O-C-N 123.893 0.746 . . . . 0.0 112.47 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 129.22 87.0 0.49 Allowed Glycine 0 C--O 1.223 -0.581 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 63.86 17.77 10.74 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.07 143.41 7.17 Favored Pre-proline 0 C--O 1.24 0.575 0 C-N-CA 123.093 0.557 . . . . 0.0 110.906 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -74.56 164.63 33.43 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.658 2.239 . . . . 0.0 112.604 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.81 160.63 34.05 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.696 1.598 . . . . 0.0 108.905 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.42 HD11 ' CG2' ' A' ' 128' ' ' ILE . 4.2 mt -75.87 148.96 37.92 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 177.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.28 33.8 2.55 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.96 0.904 . . . . 0.0 110.632 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.712 HD22 HD12 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -66.29 92.57 0.19 Allowed 'General case' 0 CA--C 1.496 -1.117 0 C-N-CA 129.686 3.195 . . . . 0.0 109.249 -179.565 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.456 ' HA ' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -159.86 -45.97 0.05 Allowed 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.691 -179.011 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -128.78 98.2 4.91 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.463 1.105 . . . . 0.0 111.137 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.491 ' HZ3' HD21 ' A' ' 95' ' ' LEU . 1.1 mmmt -176.69 152.62 1.02 Allowed 'General case' 0 N--CA 1.474 0.762 0 O-C-N 120.413 -1.429 . . . . 0.0 108.757 178.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -114.03 144.2 43.5 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.191 0.996 . . . . 0.0 109.942 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.2 tt -98.85 -44.98 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 125.166 1.386 . . . . 0.0 110.235 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -32.09 71.0 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.729 0.811 . . . . 0.0 110.406 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.3 -54.18 41.16 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.509 HD12 ' CD1' ' A' ' 64' ' ' TYR . 13.9 mt -59.66 -33.35 71.43 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 122.658 0.383 . . . . 0.0 111.699 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -73.79 -37.96 64.77 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -75.09 -36.73 61.71 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.657 1.583 . . . . 0.0 113.946 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -111.71 149.59 40.97 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 119.84 1.2 . . . . 0.0 111.718 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -76.63 56.68 5.27 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.177 3.251 . . . . 0.0 113.554 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -118.57 80.48 16.94 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.207 1.003 . . . . 0.0 108.441 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.86 74.98 5.02 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.807 3.004 . . . . 0.0 109.012 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.8 t -69.72 97.35 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 124.792 1.237 . . . . 0.0 109.314 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -52.45 -26.72 13.56 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.621 1.168 . . . . 0.0 112.9 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.0 -18.24 64.1 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.461 0.573 . . . . 0.0 112.239 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -115.96 -23.81 8.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.479 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.1 mt -72.89 153.8 40.86 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 119.162 0.892 . . . . 0.0 111.319 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -136.49 138.46 41.43 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 124.261 1.025 . . . . 0.0 110.516 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -83.98 123.15 29.68 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 103.528 -2.767 . . . . 0.0 103.528 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -103.39 143.83 32.17 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.258 0.623 . . . . 0.0 109.44 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.85 169.83 20.75 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -140.28 151.76 45.36 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 125.347 1.459 . . . . 0.0 111.601 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.19 79.18 0.75 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.901 0.858 . . . . 0.0 112.707 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.62 62.95 1.58 Allowed Glycine 0 C--N 1.334 0.46 0 O-C-N 120.954 -1.091 . . . . 0.0 111.639 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 63.32 4.13 1.58 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.72 1.208 . . . . 0.0 112.861 -178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.58 163.48 12.44 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 178.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.0 m -146.16 152.48 39.32 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.39 159.9 41.18 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -132.18 120.1 21.78 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.462 ' HB2' ' CE2' ' A' ' 127' ' ' PHE . 4.1 tt0 -112.42 131.21 55.67 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.418 1.087 . . . . 0.0 109.116 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.4 121.67 8.8 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.725 1.61 . . . . 0.0 109.705 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.8 t -70.99 -40.61 76.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 O-C-N 120.7 -1.25 . . . . 0.0 111.954 -178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.62 -38.3 77.73 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.077 0.853 . . . . 0.0 111.918 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -139.2 97.36 8.64 Favored Pre-proline 0 C--O 1.24 0.568 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -71.02 174.3 10.8 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.366 2.044 . . . . 0.0 109.208 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 91.11 -3.42 80.32 Favored Glycine 0 CA--C 1.53 1.023 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -125.19 129.74 50.72 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.033 1.333 . . . . 0.0 107.535 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 119' ' ' GLU . 79.3 m-85 -114.92 142.24 46.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.29 1.836 . . . . 0.0 108.322 179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.42 ' CG2' HD11 ' A' ' 85' ' ' LEU . 3.9 mt -74.02 136.12 25.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 O-C-N 121.999 -0.438 . . . . 0.0 110.511 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.29 141.2 30.67 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.218 0.532 . . . . 0.0 110.358 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.1 t -93.15 -13.44 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 126.557 1.943 . . . . 0.0 109.254 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.2 m 52.89 37.38 24.15 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.437 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 16.2 m -73.37 -2.01 20.49 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -74.08 -85.01 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 O-C-N 120.331 -1.481 . . . . 0.0 112.049 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -99.06 -22.52 13.04 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.659 1.123 . . . . 0.0 113.935 -178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 115.59 54.31 0.37 Allowed Glycine 0 CA--C 1.522 0.509 0 CA-C-N 118.543 1.171 . . . . 0.0 111.271 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.7 m -82.04 164.64 47.45 Favored Pre-proline 0 C--O 1.236 0.37 0 CA-C-N 117.715 0.757 . . . . 0.0 109.763 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 58.1 Cg_endo -68.93 171.59 13.29 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 N-CA-C 107.193 -1.887 . . . . 0.0 107.193 176.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.568 HD12 HD13 ' A' ' 30' ' ' LEU . 15.2 mt -96.0 109.12 21.56 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 124.073 0.949 . . . . 0.0 109.47 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.24 178.21 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.711 1.605 . . . . 0.0 110.678 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.79 169.93 10.3 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.0 t -162.06 149.88 14.53 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.109 1.364 . . . . 0.0 109.221 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -92.6 -40.38 10.8 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.894 0.878 . . . . 0.0 110.059 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -145.89 99.75 3.31 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.04 -166.52 0.16 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.441 -1.254 . . . . 0.0 107.885 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 134.6 -9.23 4.62 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-O 118.641 -1.088 . . . . 0.0 111.056 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.18 77.91 1.6 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 78.39 22.99 0.7 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 127.747 2.419 . . . . 0.0 116.323 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -129.87 74.9 1.62 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 120.578 1.535 . . . . 0.0 110.937 -178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.6 p -61.37 99.22 0.1 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.584 1.554 . . . . 0.0 112.085 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.3 p -88.13 -35.12 17.62 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 121.405 1.911 . . . . 0.0 109.355 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -78.35 101.12 7.05 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 126.102 1.761 . . . . 0.0 111.971 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -167.77 177.57 5.71 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.132 0.878 . . . . 0.0 111.888 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.6 -160.98 30.01 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.8 tp -141.62 153.42 44.74 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.52 29.73 6.29 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.874 1.67 . . . . 0.0 109.355 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -65.9 142.68 57.82 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.5 mt -127.49 158.15 38.18 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.624 1.569 . . . . 0.0 110.345 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 27.8 p90 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 115.767 -2.063 . . . . 0.0 108.612 179.911 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 119.832 -0.127 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -72.65 158.83 34.89 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -84.0 -0.62 52.35 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.102 -0.999 . . . . 0.0 111.371 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 85.27 38.06 0.02 OUTLIER 'General case' 0 C--N 1.341 0.229 0 C-N-CA 129.493 3.117 . . . . 0.0 112.012 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 5' ' ' LEU . 1.3 pt? -101.39 170.43 8.23 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.523 1.129 . . . . 0.0 110.372 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.35 -17.1 0.81 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.36 -35.81 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 126.732 2.013 . . . . 0.0 109.906 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 49.57 24.25 1.11 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 128.146 2.578 . . . . 0.0 111.848 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.17 151.31 85.85 Favored Pre-proline 0 C--O 1.224 -0.285 0 C-N-CA 126.614 1.966 . . . . 0.0 113.206 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.64 135.63 26.5 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.462 2.108 . . . . 0.0 109.271 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.405 HE21 ' HB3' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -124.36 120.49 32.28 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.69 0.796 . . . . 0.0 108.985 178.436 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.01 137.0 52.51 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.314 0.646 . . . . 0.0 111.299 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.29 -125.21 0.76 Allowed Glycine 0 C--N 1.335 0.505 0 O-C-N 121.188 -0.945 . . . . 0.0 113.735 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.3 p -152.0 -170.22 3.58 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.991 1.395 . . . . 0.0 112.59 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -150.21 6.76 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.143 0 C-N-CA 125.864 1.666 . . . . 0.0 110.952 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -59.3 -50.55 73.56 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 120.549 -1.344 . . . . 0.0 110.759 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -47.1 -0.17 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 1 C-N-CA 132.139 4.176 . . . . 0.0 118.554 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.7 mt -85.51 -60.56 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 C-N-CA 127.86 2.464 . . . . 0.0 110.492 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.05 23.31 2.05 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.392 0.677 . . . . 0.0 110.138 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 72.26 12.14 5.81 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 128.46 2.704 . . . . 0.0 113.992 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.76 95.09 7.16 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 127.272 2.229 . . . . 0.0 113.086 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.8 t -79.39 159.49 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -107.44 142.79 36.73 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.0 t -138.14 119.16 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 C-N-CA 123.851 0.861 . . . . 0.0 110.374 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 tp -75.47 108.08 8.03 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.591 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 37.6 tt0 -94.96 -175.42 3.54 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 104.262 -2.495 . . . . 0.0 104.262 176.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.591 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 3.1 t0 -46.11 90.01 0.0 OUTLIER 'General case' 0 C--O 1.234 0.243 0 C-N-CA 129.952 3.301 . . . . 0.0 109.585 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 46.46 32.92 1.74 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.841 1.656 . . . . 0.0 110.502 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 98.0 m -152.49 135.38 15.53 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.825 HD11 HD11 ' A' ' 67' ' ' LEU . 1.5 mt -96.14 137.74 34.78 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 120.897 -1.127 . . . . 0.0 108.326 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.4 pt -136.49 151.44 28.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 123.805 0.842 . . . . 0.0 111.616 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -94.98 139.51 31.26 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.461 0.704 . . . . 0.0 110.225 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.9 m -123.72 108.81 30.64 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.9 -81.03 0.01 OUTLIER 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.198 1.932 . . . . 0.0 110.871 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.13 6.65 16.41 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.631 1.573 . . . . 0.0 112.46 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -52.04 120.26 5.2 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -58.39 -31.24 67.48 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.089 0.956 . . . . 0.0 111.626 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.86 67.75 6.21 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -118.48 164.54 15.11 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.626 1.17 . . . . 0.0 108.899 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 t -141.63 135.42 14.72 Favored Pre-proline 0 N--CA 1.446 -0.636 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.81 134.78 24.45 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.544 2.829 . . . . 0.0 109.58 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.8 m -128.41 159.83 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-O 122.696 1.236 . . . . 0.0 108.413 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.15 158.29 23.48 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 113.139 -1.846 . . . . 0.0 107.64 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.0 mm -123.77 153.02 29.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.61 125.38 23.97 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.6 tt -123.45 141.33 52.11 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.653 1.181 . . . . 0.0 110.264 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.4 mt -149.93 152.9 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 126.253 1.821 . . . . 0.0 108.278 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.4 p -103.37 134.44 46.74 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.667 1.587 . . . . 0.0 109.389 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.9 m -54.53 109.34 0.49 Allowed 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.953 1.701 . . . . 0.0 114.126 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -75.95 -24.82 55.48 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 117.8 -1.095 . . . . 0.0 111.316 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -98.09 49.66 1.01 Allowed 'General case' 0 C--N 1.34 0.172 0 CA-C-N 119.777 1.171 . . . . 0.0 110.366 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 m -73.79 -1.79 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 121.099 -1.001 . . . . 0.0 112.115 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -62.99 -0.91 0.77 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.549 1.94 . . . . 0.0 112.842 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 t -132.87 -1.27 3.36 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.859 1.664 . . . . 0.0 110.913 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.28 163.4 13.41 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.745 1.259 . . . . 0.0 109.565 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -82.05 152.4 26.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 113.654 -1.612 . . . . 0.0 107.641 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -118.83 -29.81 5.24 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.334 1.054 . . . . 0.0 111.095 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -67.85 -38.56 83.3 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.136 1.774 . . . . 0.0 112.312 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -68.1 -25.89 65.54 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.559 1.144 . . . . 0.0 112.84 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 153.99 -167.65 32.26 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -102.34 97.62 9.06 Favored Pre-proline 0 N--CA 1.466 0.346 0 CA-C-O 117.554 -1.213 . . . . 0.0 109.799 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.71 122.53 9.22 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.204 2.602 . . . . 0.0 109.851 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.13 -177.45 2.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 124.612 1.165 . . . . 0.0 109.821 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.565 ' CE1' HD12 ' A' ' 95' ' ' LEU . 2.6 t80 -139.78 140.31 36.65 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 122.285 1.041 . . . . 0.0 109.51 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tt -149.01 150.37 32.7 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.716 1.206 . . . . 0.0 110.034 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -154.78 -171.77 21.89 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.446 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.825 HD11 HD11 ' A' ' 30' ' ' LEU . 18.5 mt -93.74 146.02 24.15 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -110.05 113.45 26.17 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.26 -43.84 0.51 Allowed Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.514 -1.159 . . . . 0.0 113.861 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.33 24.8 4.15 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.572 1.686 . . . . 0.0 114.659 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 m120 60.04 63.87 1.36 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.219 0.918 . . . . 0.0 111.592 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.601 HD13 HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -145.28 132.65 20.66 Favored 'General case' 0 CA--C 1.51 -0.569 0 O-C-N 120.336 -1.478 . . . . 0.0 110.405 -178.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.562 ' SG ' HG23 ' A' ' 92' ' ' ILE . 8.5 m -136.93 172.74 12.57 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.463 0.705 . . . . 0.0 112.071 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.565 HD23 HD21 ' A' ' 87' ' ' LEU . 13.9 mt -62.13 154.29 27.57 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.913 0.885 . . . . 0.0 111.699 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.556 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 3.2 tmm? -164.41 151.12 11.19 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 24.0 m -112.0 122.75 48.63 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.134 0.574 . . . . 0.0 109.608 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.25 151.26 50.43 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.226 1.01 . . . . 0.0 109.522 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.1 tttt -86.88 124.87 33.58 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.4 p -80.24 -17.19 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.48 -63.77 0.33 Allowed Glycine 0 CA--C 1.548 2.094 1 C-N-CA 133.252 5.215 . . . . 0.0 108.407 -177.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -103.34 -27.19 12.6 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 119.722 3.231 . . . . 0.0 119.722 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -133.48 155.91 80.19 Favored Pre-proline 0 CA--C 1.566 1.586 0 C-N-CA 130.001 3.32 . . . . 0.0 115.754 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -74.3 144.37 32.88 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.793 1.662 . . . . 0.0 108.971 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.9 p -140.84 169.62 17.29 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.271 1.428 . . . . 0.0 109.549 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.895 HD11 HG23 ' A' ' 128' ' ' ILE . 10.2 mt -90.71 150.22 21.73 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.27 75.69 1.52 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.765 1.226 . . . . 0.0 110.923 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.565 HD21 HD23 ' A' ' 74' ' ' LEU . 1.0 OUTLIER -94.65 116.0 28.23 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.13 -13.81 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -158.6 97.51 1.46 Allowed 'General case' 0 C--O 1.219 -0.528 0 CA-C-O 117.67 -1.157 . . . . 0.0 109.607 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.556 ' HE3' ' HB2' ' A' ' 75' ' ' MET . 0.3 OUTLIER -171.21 149.16 2.78 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 121.393 1.906 . . . . 0.0 109.655 -179.214 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -129.07 114.55 16.51 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.172 0.989 . . . . 0.0 108.847 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.562 HG23 ' SG ' ' A' ' 73' ' ' CYS . 7.8 pt -62.06 -42.58 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 120.659 -1.275 . . . . 0.0 112.871 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.3 tpt -69.17 -16.28 63.6 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.108 1.363 . . . . 0.0 112.253 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -79.4 -52.04 8.6 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.277 0.944 . . . . 0.0 108.936 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.565 HD12 ' CE1' ' A' ' 64' ' ' TYR . 35.1 mt -65.96 -21.05 66.4 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.62 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -90.81 -34.33 15.35 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -63.41 -36.76 84.79 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.452 1.478 . . . . 0.0 109.423 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.68 156.02 43.07 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.067 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.52 59.54 5.56 Favored 'Trans proline' 0 CA--C 1.546 1.083 0 C-N-CA 123.745 2.963 . . . . 0.0 111.197 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -128.14 64.61 66.94 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.846 1.258 . . . . 0.0 112.128 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.4 95.4 0.86 Allowed 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 124.942 3.761 . . . . 0.0 109.849 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.435 HG11 ' CZ ' ' A' ' 105' ' ' PHE . 47.1 t -84.78 106.36 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.273 0 O-C-N 120.983 -1.073 . . . . 0.0 109.7 -178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -51.52 -29.89 18.39 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.603 1.561 . . . . 0.0 113.269 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.4 m -67.32 -10.67 53.18 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.435 ' CZ ' HG11 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -120.52 -17.86 7.98 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.619 0.768 . . . . 0.0 110.12 178.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.6 mt -79.68 154.08 28.87 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.428 1.091 . . . . 0.0 110.397 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -140.36 133.82 30.0 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 123.248 0.619 . . . . 0.0 110.851 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -76.07 122.6 24.49 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -75.89 103.49 5.99 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.6 t -100.59 178.14 4.81 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.2 156.71 42.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.415 0.686 . . . . 0.0 111.523 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.6 p -132.27 42.13 3.15 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.14 0.976 . . . . 0.0 113.06 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.67 -55.18 2.32 Favored Glycine 0 C--N 1.333 0.396 0 O-C-N 120.215 -1.553 . . . . 0.0 113.435 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -131.19 2.13 4.25 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.644 1.222 . . . . 0.0 112.071 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -134.08 173.49 11.53 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.065 0.546 . . . . 0.0 111.237 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.8 m -116.89 153.87 31.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.846 1.658 . . . . 0.0 109.627 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.01 168.29 19.07 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -138.77 112.56 8.41 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -105.45 117.88 35.14 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 126.901 2.08 . . . . 0.0 109.651 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.9 t -51.16 122.15 7.24 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.293 0.637 . . . . 0.0 111.761 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.1 t -65.1 -45.57 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 O-C-N 121.739 -0.601 . . . . 0.0 110.34 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.23 -38.43 85.22 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 121.764 -0.585 . . . . 0.0 112.376 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -124.18 80.63 58.44 Favored Pre-proline 0 C--O 1.235 0.311 0 C-N-CA 123.583 0.753 . . . . 0.0 108.992 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -66.94 143.4 66.1 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.55 3.5 . . . . 0.0 110.87 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.81 -22.43 14.62 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 128.449 2.928 . . . . 0.0 113.067 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -99.24 131.96 44.9 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.951 1.7 . . . . 0.0 111.585 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -111.51 142.15 44.16 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.434 1.094 . . . . 0.0 110.597 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.895 HG23 HD11 ' A' ' 85' ' ' LEU . 6.3 mt -73.67 133.87 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -103.23 147.94 26.43 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 6.5 m -91.83 -17.12 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.356 1.462 . . . . 0.0 114.591 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.45 90.56 0.07 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.325 1.85 . . . . 0.0 107.209 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . 0.259 0.0 OUTLIER -107.8 7.87 28.47 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 121.416 -0.802 . . . . 0.0 111.933 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -135.5 143.41 45.8 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.325 1.05 . . . . 0.0 109.837 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 63.97 -58.26 0.06 OUTLIER Glycine 0 CA--C 1.531 1.066 0 C-N-CA 127.073 2.273 . . . . 0.0 115.848 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 132.73 45.64 0.13 Allowed Glycine 0 CA--C 1.523 0.555 0 C-N-CA 129.093 3.235 . . . . 0.0 107.352 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 83.4 m -71.91 162.43 73.4 Favored Pre-proline 0 C--O 1.24 0.576 0 CA-C-N 118.064 0.932 . . . . 0.0 110.474 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.26 162.25 28.47 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 120.766 0.977 . . . . 0.0 111.598 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.4 mt -77.88 114.96 17.25 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.701 1.201 . . . . 0.0 109.031 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pp -146.24 176.26 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 123.161 0.584 . . . . 0.0 109.75 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 20.7 mt -101.35 150.01 23.45 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.543 0.737 . . . . 0.0 109.26 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.1 t -144.52 131.68 20.58 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -82.3 -24.73 34.5 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 122.235 -0.291 . . . . 0.0 111.197 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -167.61 94.84 0.43 Allowed 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.104 1.362 . . . . 0.0 107.345 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.419 HD12 ' H ' ' A' ' 146' ' ' LYS . 0.6 OUTLIER -72.11 175.55 5.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.992 0.901 . . . . 0.0 111.635 178.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -122.84 51.64 0.79 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 126.15 1.833 . . . . 0.0 109.691 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.419 ' H ' HD12 ' A' ' 144' ' ' LEU . 0.1 OUTLIER 62.4 -0.72 0.48 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 129.286 3.034 . . . . 0.0 114.492 179.213 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -93.59 -15.69 25.14 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -128.02 99.51 5.52 Favored 'General case' 0 C--O 1.223 -0.311 0 CA-C-N 119.428 1.013 . . . . 0.0 109.119 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.451 HG21 ' CE2' ' A' ' 152' ' ' PHE . 0.8 OUTLIER -61.39 128.54 36.83 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.66 1.184 . . . . 0.0 109.906 -178.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.6 p -114.71 -22.57 9.64 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.168 1.387 . . . . 0.0 112.922 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -118.45 129.06 55.18 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.304 0.641 . . . . 0.0 112.07 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.451 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.7 OUTLIER -170.55 -176.47 2.13 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.462 1.905 . . . . 0.0 109.553 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.42 -159.75 31.07 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 108.634 -1.786 . . . . 0.0 108.634 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.7 tp -147.54 166.22 27.98 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 5.5 m -128.63 49.85 2.16 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.065 1.346 . . . . 0.0 107.921 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.2 ptt? -75.21 141.2 43.61 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 22.8 mt -108.53 167.47 10.02 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.512 1.125 . . . . 0.0 108.05 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 31.3 p90 . . . . . 0 C--O 1.251 1.171 0 C-N-CA 126.911 2.084 . . . . 0.0 106.74 -179.564 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptt? . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.419 ' HG2' ' HE3' ' A' ' 6' ' ' LYS . 2.7 mp0 -123.59 172.84 8.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.534 1.534 . . . . 0.0 107.077 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.7 tptt -127.43 42.67 3.28 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 40.8 69.98 0.29 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.962 1.705 . . . . 0.0 112.47 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.5 pp -147.45 9.0 0.92 Allowed 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 -177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.419 ' HE3' ' HG2' ' A' ' 2' ' ' GLU . 13.3 pttt -144.8 -14.16 0.55 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.71 -43.01 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 C-N-CA 125.725 1.61 . . . . 0.0 108.112 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -123.89 116.45 22.94 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.47 153.36 45.72 Favored Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.02 149.01 71.12 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 N-CA-C 107.061 -1.938 . . . . 0.0 107.061 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -127.47 115.77 19.39 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -106.77 149.1 27.68 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.371 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.08 -137.41 2.9 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 120.045 1.293 . . . . 0.0 109.98 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 97.7 p -144.84 -168.33 2.89 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 119.15 1.475 . . . . 0.0 111.214 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.7 mt -142.51 -7.03 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 126.903 2.081 . . . . 0.0 107.753 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -45.61 -42.79 11.67 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 127.0 2.12 . . . . 0.0 112.283 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -55.57 -24.13 30.88 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.0 mm -54.65 -68.84 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 123.729 0.811 . . . . 0.0 112.149 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.52 29.64 3.89 Favored 'General case' 0 CA--C 1.508 -0.644 0 O-C-N 123.718 0.637 . . . . 0.0 112.366 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.1 m80 61.8 47.86 5.85 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 -122.94 100.28 6.81 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.1 t -85.78 154.53 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -120.23 131.16 54.84 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.0 t -127.39 144.88 35.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 tp -78.14 102.04 7.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -120.48 133.95 55.34 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.7 t0 45.48 53.41 8.38 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.008 1.323 . . . . 0.0 112.373 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 52.59 29.05 6.72 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 61.7 m -143.17 159.79 41.64 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.021 1.728 . . . . 0.0 107.391 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.647 HD12 HD22 ' A' ' 87' ' ' LEU . 8.1 mt -96.49 125.48 41.01 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 119.666 -1.896 . . . . 0.0 106.325 177.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 1.2 mt -126.84 130.8 71.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 O-C-N 123.604 0.565 . . . . 0.0 110.731 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.98 135.8 49.78 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.8 m -126.56 74.21 74.42 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 123.839 0.855 . . . . 0.0 110.643 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -64.23 -43.15 15.48 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.7 2.267 . . . . 0.0 111.387 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.1 ptt85 -146.51 71.41 1.24 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.544 1.138 . . . . 0.0 108.91 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -120.84 124.22 44.5 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 102.035 -3.32 . . . . 0.0 102.035 177.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.52 -14.34 19.11 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.95 1.3 . . . . 0.0 113.312 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -113.87 30.43 7.26 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.658 1.183 . . . . 0.0 111.461 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -74.47 161.49 29.74 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.4 t -153.1 142.85 15.05 Favored Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.59 142.38 58.6 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.657 2.238 . . . . 0.0 108.767 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 t -143.61 136.23 24.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 105.915 -1.884 . . . . 0.0 105.915 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.75 162.46 16.22 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.966 0.906 . . . . 0.0 109.845 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 12' ' ' GLN . 7.2 mm -130.4 121.99 52.26 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 C-N-CA 127.525 2.33 . . . . 0.0 108.748 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.06 129.98 46.17 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 120.69 1.587 . . . . 0.0 108.461 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.2 tt -122.48 132.24 54.24 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.132 1.773 . . . . 0.0 107.546 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.535 HD13 HG21 ' A' ' 92' ' ' ILE . 3.5 mp -144.09 141.92 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 124.669 1.187 . . . . 0.0 108.826 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.6 p -79.34 138.59 37.75 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.601 ' SG ' HD22 ' A' ' 106' ' ' LEU . 58.8 m -60.11 124.06 19.08 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.419 ' HD3' ' O ' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -97.23 -0.08 47.34 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -128.32 49.91 2.13 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.964 1.305 . . . . 0.0 110.272 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.659 ' HA ' HD23 ' A' ' 55' ' ' LEU . 27.4 m -72.88 6.57 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.684 1.194 . . . . 0.0 113.794 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -49.49 -32.42 12.08 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 128.051 2.54 . . . . 0.0 116.149 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.1 t -125.63 25.44 6.96 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.903 0.881 . . . . 0.0 110.607 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 101' ' ' PRO . 2.4 mm? -116.2 155.77 27.71 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 121.183 -0.948 . . . . 0.0 108.917 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.98 152.15 46.31 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 mttm -124.99 -31.22 3.15 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 122.911 0.485 . . . . 0.0 110.644 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.45 -34.09 76.99 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.182 0.993 . . . . 0.0 112.118 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -64.24 -36.1 82.97 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.438 ' HA3' ' CD1' ' A' ' 108' ' ' TYR . . . 147.47 171.49 16.63 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 127.016 2.246 . . . . 0.0 110.755 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.51 116.38 30.84 Favored Pre-proline 0 C--O 1.238 0.484 0 O-C-N 121.463 -1.022 . . . . 0.0 109.372 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.72 136.15 18.65 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 N-CA-C 106.653 -2.095 . . . . 0.0 106.653 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . 0.258 14.0 pt -137.74 170.69 16.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -131.41 147.98 52.61 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.769 0.795 . . . . 0.0 111.202 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 tt -148.26 157.14 43.31 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.344 1.058 . . . . 0.0 110.763 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.6 -173.61 30.46 Favored Glycine 0 C--O 1.226 -0.398 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.584 HD21 HD11 ' A' ' 30' ' ' LEU . 5.4 mt -97.67 162.17 13.41 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.357 1.063 . . . . 0.0 110.441 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -132.09 84.08 2.13 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 121.234 -0.916 . . . . 0.0 108.765 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -158.44 -30.37 0.02 OUTLIER Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.795 -1.003 . . . . 0.0 113.013 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.15 19.45 0.57 Allowed 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.6 m120 68.16 68.41 0.33 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.943 1.697 . . . . 0.0 109.076 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.91 136.03 30.05 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 124.906 1.282 . . . . 0.0 109.89 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 32.2 m -142.09 175.1 10.0 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.773 0.715 . . . . 0.0 111.044 177.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.467 HD23 ' CD2' ' A' ' 87' ' ' LEU . 16.0 mt -58.75 149.95 24.98 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.899 0.772 . . . . 0.0 109.994 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.7 ttp -159.25 123.42 3.91 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 84.0 m -97.2 125.36 41.68 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 120.144 1.338 . . . . 0.0 109.079 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -145.81 146.29 31.11 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.08 0.952 . . . . 0.0 109.291 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.6 tttt -77.87 131.39 37.5 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 p -80.91 7.0 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.0 0.52 . . . . 0.0 111.508 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.82 10.35 49.96 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -148.03 -57.2 0.23 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.474 1.51 . . . . 0.0 109.772 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -140.3 162.44 49.74 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.065 1.746 . . . . 0.0 110.877 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.89 149.58 72.48 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 121.862 1.708 . . . . 0.0 110.521 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 72.9 p -147.3 166.06 28.23 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.91 1.684 . . . . 0.0 107.201 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.3 mt -92.57 148.14 22.32 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -138.97 64.87 1.46 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 103.732 -2.692 . . . . 0.0 103.732 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.647 HD22 HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -81.86 102.77 11.06 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.18 -39.44 0.07 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.143 0.977 . . . . 0.0 113.022 -178.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -145.1 104.69 3.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.755 1.622 . . . . 0.0 109.407 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.45 ' HE2' ' N ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -177.22 158.57 1.5 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 178.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.45 ' N ' ' HE2' ' A' ' 90' ' ' LYS . 1.4 m-20 -135.15 131.74 37.18 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.709 1.604 . . . . 0.0 109.687 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.535 HG21 HD13 ' A' ' 47' ' ' ILE . 1.6 mt -83.11 -37.18 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 118.175 0.443 . . . . 0.0 109.96 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.8 -25.26 66.44 Favored 'General case' 0 CA--C 1.524 -0.034 0 CA-C-O 117.982 -1.009 . . . . 0.0 112.565 -179.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -72.0 -42.77 66.03 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 93.0 mt -62.87 -33.12 74.61 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.512 1.125 . . . . 0.0 108.378 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.419 ' O ' ' HD3' ' A' ' 50' ' ' ARG . 1.2 t80 -75.8 -35.39 60.08 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 177.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -65.52 -46.0 81.32 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 121.202 -0.936 . . . . 0.0 110.767 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -125.31 152.16 70.79 Favored Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.85 83.35 1.39 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 123.621 2.881 . . . . 0.0 110.395 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -132.26 69.09 80.33 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.727 ' HB2' HD21 ' A' ' 55' ' ' LEU . 97.9 Cg_endo -74.1 76.5 3.0 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.277 3.318 . . . . 0.0 107.833 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.4 t -83.09 102.14 8.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -177.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -49.99 -28.49 6.98 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.847 0.859 . . . . 0.0 112.023 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.7 m -63.8 -12.51 36.33 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -122.45 1.64 9.58 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.345 1.058 . . . . 0.0 109.98 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.601 HD22 ' SG ' ' A' ' 49' ' ' CYS . 16.3 mt -100.46 145.77 27.85 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -142.62 123.36 14.23 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.774 0.83 . . . . 0.0 109.454 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.438 ' CD1' ' HA3' ' A' ' 60' ' ' GLY . 0.1 OUTLIER -67.7 124.96 24.73 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 127.765 2.426 . . . . 0.0 106.252 178.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -109.15 147.23 32.82 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.655 0.74 . . . . 0.0 110.052 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 t -138.64 172.14 13.32 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.12 1.768 . . . . 0.0 107.27 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.31 129.0 7.0 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.453 1.501 . . . . 0.0 109.508 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.0 p -141.94 79.54 1.68 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.05 58.85 1.54 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 124.02 0.819 . . . . 0.0 111.585 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 65.66 4.36 2.82 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.797 2.039 . . . . 0.0 112.694 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -112.86 127.92 56.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.4 m -108.68 155.54 20.6 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.197 1.399 . . . . 0.0 109.863 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 p -131.27 165.62 23.0 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.304 1.442 . . . . 0.0 111.661 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -142.65 110.31 5.81 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.607 1.163 . . . . 0.0 111.236 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -108.36 123.07 48.27 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.981 1.312 . . . . 0.0 109.462 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 59.6 m -53.64 125.71 19.2 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.747 1.219 . . . . 0.0 110.228 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 73.7 t -70.32 -41.3 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 O-C-N 121.175 -0.953 . . . . 0.0 111.623 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.47 -40.64 83.24 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.305 1.042 . . . . 0.0 112.242 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -136.3 90.61 17.63 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -65.9 165.07 24.84 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.025 1.817 . . . . 0.0 109.124 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 94.3 -18.58 56.62 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -100.85 121.08 41.1 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 118.628 1.214 . . . . 0.0 108.441 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -105.8 144.22 32.84 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 24.7 mt -71.42 142.47 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.26 113.79 27.53 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.577 0.703 . . . . 0.0 109.781 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.9 t -70.56 -10.71 14.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 C-N-CA 127.617 2.367 . . . . 0.0 112.482 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.5 m 46.02 84.31 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 118.394 2.739 . . . . 0.0 118.394 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.574 ' HB2' HG21 ' A' ' 149' ' ' THR . 47.8 m -110.6 5.57 21.17 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -79.75 -93.78 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 O-C-N 121.067 -1.021 . . . . 0.0 112.437 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -99.64 4.78 58.15 Favored Glycine 0 C--N 1.342 0.91 0 C-N-CA 125.652 1.596 . . . . 0.0 116.575 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.31 49.23 2.44 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 18.1 m -80.29 161.99 63.04 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 124.231 1.013 . . . . 0.0 110.472 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 98.5 Cg_endo -73.83 155.33 48.71 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 121.192 1.261 . . . . 0.0 109.475 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.409 HD12 HD13 ' A' ' 30' ' ' LEU . 12.6 mt -84.72 122.41 29.06 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 124.241 1.016 . . . . 0.0 109.208 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.0 -168.99 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.32 1.448 . . . . 0.0 110.848 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 37.5 mt -103.44 153.72 20.2 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.411 1.484 . . . . 0.0 107.181 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.0 t -145.8 120.49 9.84 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 122.75 1.262 . . . . 0.0 108.796 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -78.76 -30.83 45.92 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.166 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -165.88 83.73 0.32 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 122.028 0.918 . . . . 0.0 112.217 -178.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.605 ' H ' HD23 ' A' ' 144' ' ' LEU . 0.6 OUTLIER -70.66 167.25 19.04 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.06 -1.025 . . . . 0.0 109.164 178.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -141.0 21.8 2.64 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.339 0.971 . . . . 0.0 113.251 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.96 18.73 1.44 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.062 1.345 . . . . 0.0 113.428 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 52.58 42.7 31.53 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.221 1.373 . . . . 0.0 109.576 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -42.97 -35.81 1.34 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.788 1.635 . . . . 0.0 114.65 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.574 HG21 ' HB2' ' A' ' 132' ' ' SER 0.294 75.4 p 113.93 93.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.507 1 C-N-CA 135.132 5.373 . . . . 0.0 112.643 178.678 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 p -104.6 -29.54 10.56 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.284 1.033 . . . . 0.0 110.686 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -117.72 123.66 46.6 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 127.882 2.473 . . . . 0.0 110.947 -177.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -171.56 -175.62 1.63 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.503 2.321 . . . . 0.0 110.08 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -101.53 -176.89 28.58 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.505 1.05 . . . . 0.0 113.687 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.16 132.03 41.12 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 2.5 m -88.52 58.38 4.66 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 18.9 ptp -69.31 162.17 27.78 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.249 0.62 . . . . 0.0 109.518 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.1 mt -142.36 175.25 9.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.102 2.161 . . . . 0.0 106.762 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 53.0 p90 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 124.582 1.153 . . . . 0.0 110.727 179.819 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -78.71 148.79 32.93 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.7 0.762 . . . . 0.0 111.414 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -80.85 18.76 0.94 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 49.85 41.86 23.2 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.063 1.745 . . . . 0.0 109.872 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.473 HD12 ' H ' ' A' ' 7' ' ' ILE . 2.7 pp -66.2 -55.79 14.53 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 117.411 2.374 . . . . 0.0 117.411 -177.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 pttt 43.96 31.42 0.51 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 127.608 2.363 . . . . 0.0 114.023 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 5' ' ' LEU . 1.4 pp -138.44 78.15 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 123.152 0.581 . . . . 0.0 112.114 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -81.08 -6.79 59.22 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.425 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.93 159.91 83.98 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 125.307 1.443 . . . . 0.0 109.726 178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HB3' HD11 ' A' ' 47' ' ' ILE . 86.6 Cg_endo -73.33 127.96 12.39 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.166 2.578 . . . . 0.0 110.093 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.36 111.21 23.56 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 123.782 0.676 . . . . 0.0 111.35 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -104.5 148.01 26.95 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.779 0.832 . . . . 0.0 110.618 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 178.46 -139.64 4.18 Favored Glycine 0 C--O 1.226 -0.396 0 O-C-N 121.255 -0.903 . . . . 0.0 111.226 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.2 p -152.33 -174.55 4.93 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 119.029 1.414 . . . . 0.0 113.684 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.9 mt -136.67 5.28 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 125.319 1.448 . . . . 0.0 108.371 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -63.17 -38.63 91.93 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 119.923 -1.736 . . . . 0.0 109.293 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -51.5 -19.79 1.59 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 128.085 2.554 . . . . 0.0 114.086 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.2 mt -69.41 -67.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.811 1.644 . . . . 0.0 111.473 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.12 25.71 4.22 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.857 -0.527 . . . . 0.0 111.252 -178.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.252 24.3 t60 57.62 41.09 26.12 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 128.514 2.726 . . . . 0.0 108.633 -177.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.28 109.86 20.47 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 120.947 -1.095 . . . . 0.0 110.981 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.4 t -91.86 158.42 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.636 ' O ' HG21 ' A' ' 42' ' ' VAL . 2.7 m95 -115.84 106.86 14.31 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.303 1.041 . . . . 0.0 110.325 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.7 t -104.37 122.85 57.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-N 120.099 1.318 . . . . 0.0 108.578 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 30' ' ' LEU . 34.8 tp -73.33 95.72 2.21 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 124.141 0.9 . . . . 0.0 108.626 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.99 174.79 8.85 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 176.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -8.89 -65.79 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 129.063 2.945 . . . . 0.0 114.935 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -142.05 18.24 2.11 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-O 117.691 -1.147 . . . . 0.0 109.279 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.65 134.71 14.87 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 119.685 1.129 . . . . 0.0 112.546 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.575 HD21 HD11 ' A' ' 67' ' ' LEU . 1.5 mp -85.64 137.08 33.09 Favored 'General case' 0 CA--C 1.504 -0.795 0 O-C-N 121.514 -0.741 . . . . 0.0 109.27 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 mm -131.39 140.51 48.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 O-C-N 124.094 0.871 . . . . 0.0 109.927 -178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.86 130.27 40.64 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.9 m -117.36 82.27 14.72 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 124.339 1.056 . . . . 0.0 108.738 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.25 -33.1 15.35 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.014 1.809 . . . . 0.0 113.778 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.8 ttm-85 -162.02 51.42 0.21 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.12 152.23 19.0 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 124.956 1.302 . . . . 0.0 107.622 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -61.36 1.8 Allowed 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 122.617 0.367 . . . . 0.0 110.473 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.8 ttm-85 -72.8 27.52 0.06 Allowed 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.696 1.198 . . . . 0.0 112.229 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -68.02 149.51 49.61 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.1 t -140.15 138.17 18.98 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -67.64 155.21 71.02 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 N-CA-C 108.055 -1.556 . . . . 0.0 108.055 178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.636 HG21 ' O ' ' A' ' 23' ' ' TRP . 4.7 m -146.38 155.32 12.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.91 158.76 20.68 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -125.69 116.28 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 C-N-CA 125.507 1.523 . . . . 0.0 107.756 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -96.07 127.67 42.28 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.544 HD12 HD12 ' A' ' 65' ' ' LEU . 6.8 tt -125.25 145.64 49.9 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.388 1.075 . . . . 0.0 108.649 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.513 HD12 HG12 ' A' ' 92' ' ' ILE . 39.3 mt -148.03 154.22 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 126.662 1.985 . . . . 0.0 108.828 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.1 p -109.42 115.52 30.11 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 72.7 m -47.35 143.87 3.2 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 125.186 1.395 . . . . 0.0 111.915 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -103.99 -26.87 12.46 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 118.096 -0.954 . . . . 0.0 112.992 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -94.68 38.27 1.11 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.2 m -63.46 -17.18 19.45 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 O-C-N 120.597 -1.315 . . . . 0.0 111.293 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -42.8 -44.07 4.27 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 120.704 1.593 . . . . 0.0 114.203 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.7 t -78.5 -14.14 59.5 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.6 mt -88.22 -173.39 4.2 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 120.444 -1.41 . . . . 0.0 109.267 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.43 158.13 16.21 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.822 0.849 . . . . 0.0 109.485 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -124.78 -35.61 2.68 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 128.034 2.533 . . . . 0.0 111.085 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.81 -42.68 79.97 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.642 1.177 . . . . 0.0 109.35 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -62.6 -36.39 82.6 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.874 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 139.54 -171.09 23.91 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -79.08 114.78 47.38 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.91 135.2 8.69 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.619 2.879 . . . . 0.0 108.557 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.3 pt -138.26 178.28 4.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 121.372 -0.83 . . . . 0.0 110.616 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.529 ' CE1' HD12 ' A' ' 95' ' ' LEU . 3.0 t80 -134.44 154.97 51.11 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.198 0.908 . . . . 0.0 112.345 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.544 HD12 HD12 ' A' ' 46' ' ' LEU . 3.7 tt -156.91 163.48 39.11 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.237 1.015 . . . . 0.0 110.05 -178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.15 -174.43 36.98 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.825 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.737 HD21 HD22 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -100.42 135.46 41.82 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 126.105 1.762 . . . . 0.0 106.718 179.761 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -114.81 121.41 43.2 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.39 -39.68 0.26 Allowed Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.4 31.35 1.71 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.371 1.069 . . . . 0.0 113.783 -178.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.1 m120 58.17 75.15 0.4 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.808 1.243 . . . . 0.0 112.476 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.33 140.78 27.97 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 121.297 -0.877 . . . . 0.0 110.307 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.8 m -147.96 174.49 11.84 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 120.254 -1.529 . . . . 0.0 111.024 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.421 ' HA ' ' HG ' ' A' ' 87' ' ' LEU . 5.3 mt -57.68 144.3 38.37 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -155.59 124.03 5.92 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 52.1 m -91.88 121.37 33.42 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.826 0.739 . . . . 0.0 110.409 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.37 168.52 19.6 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 118.252 0.478 . . . . 0.0 110.154 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -98.52 147.11 25.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.4 p -116.3 -2.56 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.556 0.743 . . . . 0.0 111.003 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.4 81.88 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.2 t70 66.56 9.62 6.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.429 1.891 . . . . 0.0 114.49 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.14 143.03 17.61 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.43 156.95 63.84 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 124.171 3.248 . . . . 0.0 113.87 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 12.3 p -158.47 164.76 35.89 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.017 1.727 . . . . 0.0 108.972 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.533 HD11 HG23 ' A' ' 128' ' ' ILE . 3.8 mt -95.18 138.12 33.32 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -129.43 67.16 1.44 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.368 1.067 . . . . 0.0 109.995 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.737 HD22 HD21 ' A' ' 67' ' ' LEU . 2.9 mp -81.97 105.57 13.19 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.59 -39.31 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -136.39 94.18 2.98 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 119.19 0.904 . . . . 0.0 111.653 -177.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.599 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -164.61 175.26 9.96 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 121.178 -0.951 . . . . 0.0 110.968 179.592 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.489 ' H ' ' HD3' ' A' ' 90' ' ' LYS . 17.6 m-20 -140.5 143.03 35.24 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.24 1.416 . . . . 0.0 107.469 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.513 HG12 HD12 ' A' ' 47' ' ' ILE . 1.7 tt -104.77 -39.29 5.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 125.063 1.345 . . . . 0.0 110.863 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -30.94 71.55 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.884 0.474 . . . . 0.0 110.57 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -66.21 -52.78 44.59 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.529 HD12 ' CE1' ' A' ' 64' ' ' TYR . 32.4 mt -61.87 -29.24 70.06 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 123.776 0.83 . . . . 0.0 111.184 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -79.94 -28.49 39.7 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -78.36 -42.11 31.4 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.322 -0.862 . . . . 0.0 112.01 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -107.03 152.08 40.9 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 123.774 0.829 . . . . 0.0 110.31 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.97 57.89 4.0 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 124.172 3.248 . . . . 0.0 113.12 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -118.29 73.6 10.47 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.587 1.155 . . . . 0.0 110.507 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.39 86.29 1.71 Allowed 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.998 2.465 . . . . 0.0 106.179 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 66.7 t -80.74 93.93 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.45 -19.5 1.43 Allowed 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 124.367 1.067 . . . . 0.0 113.167 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -20.14 65.27 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.471 1.508 . . . . 0.0 110.596 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -115.1 -25.34 8.14 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.639 0.776 . . . . 0.0 110.756 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.6 mt -74.21 159.56 32.35 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.905 1.282 . . . . 0.0 112.093 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.424 ' HA ' HG23 ' A' ' 121' ' ' VAL . 4.4 p90 -147.65 143.46 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.194 0.998 . . . . 0.0 110.309 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.99 126.4 32.49 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 126.139 1.776 . . . . 0.0 108.644 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -102.13 150.24 23.46 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.6 t -142.02 -157.07 0.74 Allowed 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -159.53 152.0 21.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.401 1.48 . . . . 0.0 108.112 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.8 p -123.61 6.58 8.86 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.468 1.507 . . . . 0.0 112.538 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.97 -85.13 0.36 Allowed Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 104.896 -3.282 . . . . 0.0 104.896 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.481 ' HG3' HH11 ' A' ' 114' ' ' ARG . 13.8 mtt85 -94.9 -7.8 39.01 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -126.19 172.56 9.95 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 119.119 0.872 . . . . 0.0 109.533 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.6 m -135.99 130.66 33.94 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 126.964 2.106 . . . . 0.0 110.622 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.27 161.13 16.56 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.3 1.04 . . . . 0.0 108.475 178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -143.95 116.87 8.82 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -125.97 127.1 45.41 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.719 0.637 . . . . 0.0 110.06 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.6 m -51.23 131.67 28.1 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.305 1.042 . . . . 0.0 109.938 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.424 HG23 ' HA ' ' A' ' 107' ' ' PHE . 84.5 t -73.63 -53.6 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 O-C-N 122.225 -0.297 . . . . 0.0 110.915 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.55 74.54 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -124.4 80.71 59.79 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -66.63 160.01 48.21 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.868 2.378 . . . . 0.0 109.879 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.7 -20.79 48.12 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 126.399 1.952 . . . . 0.0 111.601 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -103.63 116.78 32.97 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 118.823 1.312 . . . . 0.0 110.467 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -90.11 157.02 17.96 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 125.045 1.338 . . . . 0.0 108.825 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.533 HG23 HD11 ' A' ' 85' ' ' LEU . 9.7 mm -86.06 129.03 38.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.21 117.01 30.47 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 119.321 0.964 . . . . 0.0 110.209 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.3 m -78.68 -25.66 13.51 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.304 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.2 m 67.39 55.36 0.66 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.537 1.535 . . . . 0.0 113.268 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 75.4 m -95.79 -2.91 46.7 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.334 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -68.06 -66.41 0.57 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.56 1.073 . . . . 0.0 111.353 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -124.17 -55.13 0.18 Allowed Glycine 0 C--N 1.333 0.388 0 CA-C-O 119.302 -0.721 . . . . 0.0 111.796 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.97 54.05 0.01 OUTLIER Glycine 0 CA--C 1.519 0.338 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 68.1 m -87.04 166.93 23.74 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 117.37 0.585 . . . . 0.0 110.697 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 136' ' ' CYS . 83.1 Cg_endo -74.13 168.49 24.67 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 N-CA-C 108.584 -1.352 . . . . 0.0 108.584 178.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' A' ' 23' ' ' TRP . 9.5 mt -87.0 111.26 20.68 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -146.33 -177.08 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 124.812 1.245 . . . . 0.0 110.987 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.7 mt -100.7 161.82 13.34 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -156.3 130.69 8.78 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -90.24 -38.22 13.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 119.603 -0.839 . . . . 0.0 108.764 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -152.64 102.81 2.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.034 1.734 . . . . 0.0 107.971 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.436 HD12 ' H ' ' A' ' 146' ' ' LYS . 4.6 pp -97.41 163.28 12.94 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.615 1.166 . . . . 0.0 112.122 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -109.65 62.09 0.29 Allowed Glycine 0 C--N 1.33 0.247 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.436 ' H ' HD12 ' A' ' 144' ' ' LEU . 14.1 mmmm 51.89 16.22 0.49 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.698 2.399 . . . . 0.0 113.431 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.81 -36.04 64.94 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.958 0.903 . . . . 0.0 112.837 -178.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.35 167.86 17.11 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-O 121.106 0.479 . . . . 0.0 109.787 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.422 HG21 ' CE2' ' A' ' 152' ' ' PHE . 1.5 m -100.24 136.04 40.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.3 p -131.7 7.19 4.42 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.635 1.574 . . . . 0.0 112.267 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -144.4 112.19 6.22 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.1 OUTLIER -162.98 -175.79 4.55 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.898 1.226 . . . . 0.0 113.146 -179.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.34 -174.26 27.37 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.9 tp -141.04 146.7 37.53 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.5 m -100.6 48.24 0.91 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.815 1.246 . . . . 0.0 107.658 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.54 159.69 33.86 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.954 1.302 . . . . 0.0 108.493 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 8.9 mt -145.79 153.42 40.9 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.706 2.002 . . . . 0.0 108.496 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.337 0 CA-C-N 119.884 1.22 . . . . 0.0 112.653 179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.03 158.76 16.8 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.763 1.625 . . . . 0.0 109.749 -179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -76.3 -70.12 0.46 Allowed 'General case' 0 C--O 1.238 0.479 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.921 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.06 -55.66 1.96 Allowed 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.949 0.9 . . . . 0.0 111.361 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.682 ' H ' HD23 ' A' ' 5' ' ' LEU . 0.4 OUTLIER -64.67 174.95 1.58 Allowed 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 124.338 1.023 . . . . 0.0 108.669 178.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -116.26 18.82 15.15 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.683 1.193 . . . . 0.0 112.607 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.15 25.59 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 125.584 1.554 . . . . 0.0 110.975 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.15 -17.69 60.35 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.105 0.962 . . . . 0.0 109.789 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 p -60.05 135.23 90.48 Favored Pre-proline 0 C--N 1.344 0.351 0 CA-C-O 117.459 -1.257 . . . . 0.0 109.186 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.26 140.55 24.87 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 N-CA-C 106.973 -1.972 . . . . 0.0 106.973 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.17 149.42 35.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -144.49 132.57 21.59 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.538 -1.351 . . . . 0.0 109.385 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -166.75 -122.1 0.59 Allowed Glycine 0 CA--C 1.518 0.28 0 CA-C-O 117.844 -1.531 . . . . 0.0 111.225 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.8 p -160.3 -168.78 2.27 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 120.725 2.263 . . . . 0.0 112.566 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.421 HD12 ' CH2' ' A' ' 23' ' ' TRP . 3.7 mt -145.22 4.52 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.32 1.448 . . . . 0.0 108.97 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.14 -25.13 63.32 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 119.806 -1.809 . . . . 0.0 111.077 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -75.27 46.15 0.32 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.557 1.543 . . . . 0.0 110.897 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mt -130.56 -61.95 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 126.293 1.837 . . . . 0.0 108.688 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.85 27.17 2.02 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.489 0.661 . . . . 0.0 110.646 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.35 11.06 4.29 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 128.88 2.872 . . . . 0.0 114.182 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.459 ' H ' ' HG3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -70.76 95.38 1.12 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.187 1.795 . . . . 0.0 109.43 -179.641 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.81 158.97 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 102.997 -2.964 . . . . 0.0 102.997 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.421 ' CH2' HD12 ' A' ' 15' ' ' ILE . 21.7 m0 -118.63 144.84 45.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 120.605 -1.309 . . . . 0.0 108.711 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.7 t -150.53 141.21 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.6 tp -75.77 119.05 19.24 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -133.06 123.2 25.34 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.7 t70 45.88 58.37 4.41 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.034 1.334 . . . . 0.0 112.845 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 54.23 23.9 4.59 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.021 1.329 . . . . 0.0 112.968 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.5 m -132.94 159.56 39.6 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.589 1.556 . . . . 0.0 107.607 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.716 HD11 HD11 ' A' ' 67' ' ' LEU . 7.2 mt -108.67 124.34 50.37 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 177.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 mm -127.14 141.96 44.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 O-C-N 123.87 0.731 . . . . 0.0 109.766 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.87 137.12 36.17 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.05 66.3 40.33 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.106 0.962 . . . . 0.0 108.439 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.46 -28.66 78.11 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 121.842 1.695 . . . . 0.0 112.193 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -149.54 95.61 2.37 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 125.003 1.321 . . . . 0.0 109.403 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.81 142.31 5.26 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.793 0.837 . . . . 0.0 109.55 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.52 -39.7 77.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 122.367 1.08 . . . . 0.0 108.945 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.8 tpp85 -79.4 62.67 3.8 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.494 1.518 . . . . 0.0 111.706 -178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 13.2 ptt? -126.39 168.57 14.0 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.802 1.241 . . . . 0.0 110.999 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.3 t -158.54 144.99 12.69 Favored Pre-proline 0 N--CA 1.452 -0.375 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.63 154.83 64.03 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 N-CA-C 107.891 -1.619 . . . . 0.0 107.891 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 23' ' ' TRP . 2.5 p -146.39 156.95 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.4 m -118.07 161.57 19.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.233 -1.348 . . . . 0.0 108.504 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 47.3 mm -130.32 110.73 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.472 0 C-N-CA 126.157 1.783 . . . . 0.0 111.065 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.431 ' HB3' HD12 ' A' ' 92' ' ' ILE . . . -88.87 138.59 31.27 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 176.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.7 tt -130.53 131.77 45.24 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.5 mt -147.32 143.29 20.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 124.862 2.267 . . . . 0.0 106.933 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.2 p -73.7 162.27 29.36 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.517 -1.674 . . . . 0.0 108.881 178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 45.7 m -91.17 149.58 21.73 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -102.1 -23.73 14.03 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -106.49 56.32 0.66 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.1 m -75.12 -10.73 13.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 120.98 -1.075 . . . . 0.0 111.185 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -69.99 4.09 2.3 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 125.925 1.69 . . . . 0.0 114.596 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 t -129.88 13.6 5.81 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.954 0.902 . . . . 0.0 108.939 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 98.3 mt -119.97 169.3 10.3 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.789 1.236 . . . . 0.0 108.095 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.9 155.35 37.56 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.698 1.199 . . . . 0.0 109.024 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.55 -32.39 2.65 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.226 1.011 . . . . 0.0 111.66 178.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -64.69 -36.01 82.89 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.535 1.134 . . . . 0.0 110.082 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -65.64 -25.68 67.47 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.463 1.105 . . . . 0.0 112.472 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.532 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 135.52 -173.52 21.7 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -87.13 111.59 41.88 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 123.957 0.903 . . . . 0.0 112.569 -179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.3 138.44 11.1 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.374 2.049 . . . . 0.0 110.898 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.44 HG13 ' CE1' ' A' ' 107' ' ' PHE . 15.6 pt -145.21 -174.26 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 C-N-CA 124.354 1.062 . . . . 0.0 109.402 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.642 ' CD1' HG23 ' A' ' 92' ' ' ILE . 3.7 t80 -139.44 165.37 27.4 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.044 1.338 . . . . 0.0 113.028 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.435 HD22 HD11 ' A' ' 74' ' ' LEU . 3.7 tt -163.07 159.23 22.99 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.297 1.439 . . . . 0.0 111.148 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.27 176.17 38.67 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.219 0.914 . . . . 0.0 112.1 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.716 HD11 HD11 ' A' ' 30' ' ' LEU . 4.5 mt -94.62 152.55 18.42 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.388 1.075 . . . . 0.0 109.285 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -116.85 120.41 38.4 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.38 -38.82 0.55 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.314 0.483 . . . . 0.0 112.812 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.74 31.5 1.17 Allowed 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.373 1.087 . . . . 0.0 112.52 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.6 m120 50.24 79.5 0.08 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.573 1.949 . . . . 0.0 111.912 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.67 137.89 25.53 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.651 0.78 . . . . 0.0 110.141 -177.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 4.0 m -143.85 172.56 12.68 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 118.631 0.65 . . . . 0.0 110.861 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.445 HD23 HD21 ' A' ' 87' ' ' LEU . 17.7 mt -59.05 147.84 33.22 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.115 0.484 . . . . 0.0 111.501 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 mtp -157.6 139.87 14.49 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 92.3 m -115.06 115.47 26.86 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.61 -177.93 3.35 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.396 2.279 . . . . 0.0 107.118 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.4 ' HE3' ' C ' ' A' ' 81' ' ' ASP . 43.4 tttt -122.51 126.8 48.57 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.46 -25.06 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.44 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 170.58 -49.9 0.2 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.4 ' C ' ' HE3' ' A' ' 78' ' ' LYS . 30.7 t70 -130.04 -11.99 4.19 Favored 'General case' 0 C--N 1.332 -0.172 0 O-C-N 121.174 -1.192 . . . . 0.0 113.274 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -137.87 153.83 74.05 Favored Pre-proline 0 C--O 1.241 0.657 0 C-N-CA 123.881 0.872 . . . . 0.0 110.749 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -70.04 153.45 67.63 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.424 2.082 . . . . 0.0 108.325 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 p -149.22 158.49 44.22 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.747 HD11 HG22 ' A' ' 128' ' ' ILE . 2.3 mt -80.4 146.18 31.61 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -145.54 63.81 1.26 Allowed 'General case' 0 N--CA 1.461 0.078 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.672 ' H ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -86.33 108.51 18.47 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.92 -41.39 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.097 0.559 . . . . 0.0 111.732 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -134.45 101.69 5.07 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 126.111 1.764 . . . . 0.0 109.929 -176.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.0 OUTLIER -174.25 166.89 4.12 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.1 -1.0 . . . . 0.0 109.345 179.01 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.404 ' H ' ' HD2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -141.3 135.98 31.12 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 178.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.642 HG23 ' CD1' ' A' ' 64' ' ' TYR . 3.7 mt -87.68 -43.08 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 125.388 1.475 . . . . 0.0 109.173 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.6 tpt -61.64 -23.4 66.03 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 119.11 -0.471 . . . . 0.0 110.113 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -64.95 -51.2 63.12 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.637 HD12 ' CD1' ' A' ' 64' ' ' TYR . 13.5 mt -60.9 -35.49 76.79 Favored 'General case' 0 N--CA 1.461 0.091 0 O-C-N 121.717 -0.614 . . . . 0.0 110.181 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -78.87 -17.06 56.23 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.392 -0.817 . . . . 0.0 110.638 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -89.73 -42.78 11.13 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 120.504 -1.372 . . . . 0.0 111.181 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -107.01 150.09 39.39 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 123.433 0.693 . . . . 0.0 111.714 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.6 46.74 1.5 Allowed 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.552 3.502 . . . . 0.0 113.695 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -112.9 75.71 2.03 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.163 0.985 . . . . 0.0 111.134 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.99 71.18 7.16 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.599 3.533 . . . . 0.0 108.932 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 73.8 t -71.01 104.43 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.375 0.67 . . . . 0.0 110.172 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -50.96 -28.67 10.34 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 125.372 1.469 . . . . 0.0 111.029 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m -63.11 -13.63 38.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.327 1.451 . . . . 0.0 112.417 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -121.67 -28.63 4.51 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.769 0.828 . . . . 0.0 109.594 177.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 11.8 mt -71.49 160.89 31.93 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.687 1.195 . . . . 0.0 111.035 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.481 ' HA ' HG23 ' A' ' 121' ' ' VAL . 9.9 p90 -151.16 148.38 28.19 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.57 0.748 . . . . 0.0 111.813 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.532 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.2 OUTLIER -90.1 110.52 21.52 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 128.718 2.807 . . . . 0.0 107.923 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -79.38 141.83 36.55 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.4 t -137.95 -174.3 3.75 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.692 0.797 . . . . 0.0 109.526 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -151.24 163.08 39.68 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.285 1.434 . . . . 0.0 109.533 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.8 p -137.8 14.44 2.91 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.725 1.21 . . . . 0.0 111.825 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.72 -102.46 0.69 Allowed Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 105.452 -3.059 . . . . 0.0 105.452 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.07 -3.9 58.96 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.136 0.968 . . . . 0.0 113.115 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -117.6 159.47 22.85 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.405 1.002 . . . . 0.0 108.894 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 m -122.36 137.58 54.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.284 1.833 . . . . 0.0 108.963 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.01 166.84 10.72 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.524 1.13 . . . . 0.0 109.372 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -147.13 118.08 7.68 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -115.83 132.18 56.72 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 125.115 1.366 . . . . 0.0 110.554 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 t -59.84 133.93 56.56 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.118 0.967 . . . . 0.0 109.219 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.481 HG23 ' HA ' ' A' ' 107' ' ' PHE . 49.1 t -72.76 -45.95 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 O-C-N 120.649 -1.282 . . . . 0.0 110.191 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.2 -32.53 70.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.63 -0.669 . . . . 0.0 111.946 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.16 82.92 46.52 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 123.919 0.888 . . . . 0.0 110.65 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.37 144.18 55.23 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.876 1.717 . . . . 0.0 107.854 178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.31 -11.22 43.55 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.705 1.621 . . . . 0.0 109.208 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 25.3 m-90 -113.62 115.53 28.06 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.209 1.404 . . . . 0.0 107.646 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -105.16 156.76 17.79 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 125.024 1.329 . . . . 0.0 110.14 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.747 HG22 HD11 ' A' ' 85' ' ' LEU . 4.4 pt -85.56 127.86 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.932 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.71 119.75 25.61 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.5 t -79.49 -21.04 12.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 127.238 2.215 . . . . 0.0 112.223 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.5 m 54.95 90.93 0.03 OUTLIER 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.966 2.106 . . . . 0.0 110.892 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.499 ' HB2' HG21 ' A' ' 149' ' ' THR . 1.4 m -135.58 43.67 2.59 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 126.174 1.79 . . . . 0.0 108.307 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -110.55 0.27 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 127.459 2.303 . . . . 0.0 107.036 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -87.32 7.46 80.64 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 117.744 1.857 . . . . 0.0 117.744 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 85.45 38.82 8.68 Favored Glycine 0 CA--C 1.535 1.31 0 CA-C-N 119.824 1.812 . . . . 0.0 112.164 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 93.6 m -77.14 163.59 64.03 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.93 1.292 . . . . 0.0 107.857 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.22 169.33 20.93 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.129 1.886 . . . . 0.0 110.5 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.3 mt -85.93 118.83 25.65 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.763 HD11 HD21 ' A' ' 148' ' ' ASN . 0.2 OUTLIER -141.69 172.86 9.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 124.407 1.083 . . . . 0.0 110.586 179.507 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 41.6 mt -91.91 163.6 13.96 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.9 t -149.09 150.14 32.25 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 105.185 -2.154 . . . . 0.0 105.185 177.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -101.79 -31.52 10.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 123.541 1.639 . . . . 0.0 108.09 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -164.25 130.87 3.1 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -124.83 160.33 29.0 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 125.352 1.461 . . . . 0.0 108.982 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -102.49 47.82 1.11 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 107.679 -2.168 . . . . 0.0 107.679 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.44 -9.71 0.5 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.806 2.042 . . . . 0.0 112.228 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.53 -51.09 21.44 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.555 1.542 . . . . 0.0 115.027 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.763 HD21 HD11 ' A' ' 139' ' ' ILE . 0.1 OUTLIER -60.33 -17.56 43.86 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -176.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.499 HG21 ' HB2' ' A' ' 132' ' ' SER . 0.0 OUTLIER 55.98 79.45 0.17 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.517 0.599 . . . . 0.0 112.246 179.272 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.9 p -105.3 -8.33 18.32 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.058 -1.026 . . . . 0.0 111.612 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -115.52 103.14 10.44 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.091 1.356 . . . . 0.0 112.516 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.19 171.29 17.63 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.185 -1.572 . . . . 0.0 110.918 178.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -83.31 -173.27 49.57 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.96 120.76 11.24 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 14.8 m -78.91 41.94 0.45 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.896 1.679 . . . . 0.0 108.819 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -68.65 140.52 55.48 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.5 mt -115.0 162.07 17.48 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.92 1.688 . . . . 0.0 108.88 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 33.1 p90 . . . . . 0 C--O 1.245 0.849 0 C-N-CA 125.368 1.467 . . . . 0.0 108.108 178.831 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ptm . . . . . 0 CA--C 1.513 -0.45 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.443 ' N ' ' CD ' ' A' ' 2' ' ' GLU . 12.4 mp0 -110.34 -168.36 1.3 Allowed 'General case' 0 N--CA 1.437 -1.109 0 C-N-CA 128.235 2.614 . . . . 0.0 109.465 -175.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -130.86 49.14 2.35 Favored 'General case' 0 C--O 1.226 -0.167 0 O-C-N 121.74 -0.6 . . . . 0.0 112.411 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 36.86 81.02 0.02 OUTLIER 'General case' 0 C--O 1.237 0.4 0 C-N-CA 129.305 3.042 . . . . 0.0 112.166 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 5' ' ' LEU . 1.1 pt? -134.74 -169.21 2.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 129.916 3.286 . . . . 0.0 108.633 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.5 pttt -140.96 -8.06 1.05 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.562 1.145 . . . . 0.0 113.716 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -86.2 -19.58 8.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 C-N-CA 126.601 1.96 . . . . 0.0 109.575 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 45.42 41.84 6.99 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.048 2.139 . . . . 0.0 111.422 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.5 p -54.35 150.64 15.9 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 118.51 0.595 . . . . 0.0 112.52 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.92 138.29 33.85 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.637 1.558 . . . . 0.0 108.866 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.39 117.47 21.45 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -114.38 143.61 44.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.39 -125.28 0.82 Allowed Glycine 0 C--O 1.226 -0.368 0 CA-C-O 117.988 -1.451 . . . . 0.0 110.356 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.4 p -154.05 -164.99 1.99 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 120.526 2.163 . . . . 0.0 113.628 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.6 mt -140.32 4.36 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 C-N-CA 125.764 1.626 . . . . 0.0 108.033 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.8 -26.85 60.02 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.361 -1.462 . . . . 0.0 111.88 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -69.82 19.21 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 128.042 2.537 . . . . 0.0 113.695 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.7 mt -110.23 -60.58 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 127.165 2.186 . . . . 0.0 110.827 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -137.72 23.23 2.89 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.711 0.804 . . . . 0.0 110.524 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 61.41 36.81 17.17 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.296 1.038 . . . . 0.0 110.239 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.502 ' HG3' ' HA ' ' A' ' 132' ' ' SER . 26.1 mmt-85 -104.19 86.36 2.54 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.904 -1.122 . . . . 0.0 110.322 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.9 t -73.88 129.36 36.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.427 ' CD2' HD11 ' A' ' 138' ' ' LEU . 32.0 m0 -81.9 137.54 35.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.044 0.938 . . . . 0.0 109.854 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.97 120.69 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-N 119.593 1.088 . . . . 0.0 109.705 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.479 HD13 HD22 ' A' ' 72' ' ' LEU . 1.0 OUTLIER -75.03 100.31 4.15 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 27' ' ' ASP . 4.0 tt0 -89.02 -172.93 3.87 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.408 ' H ' ' HG2' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -52.59 96.77 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 124.232 1.013 . . . . 0.0 112.306 -178.529 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 52.85 26.12 4.38 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.744 2.017 . . . . 0.0 111.937 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.1 m -154.09 128.67 9.28 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 119.172 0.897 . . . . 0.0 111.23 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.699 HD12 HD13 ' A' ' 87' ' ' LEU . 3.5 mt -84.3 131.96 34.67 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.2 -0.937 . . . . 0.0 109.481 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 pt -138.37 133.01 42.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 124.635 1.174 . . . . 0.0 111.134 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.07 146.36 47.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.18 80.78 15.86 Favored Pre-proline 0 N--CA 1.464 0.243 0 C-N-CA 124.031 0.932 . . . . 0.0 109.381 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -69.4 -31.87 21.24 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.883 1.722 . . . . 0.0 115.079 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 -165.91 84.25 0.32 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.409 1.884 . . . . 0.0 108.73 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -147.77 130.13 15.7 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -60.94 -13.62 17.21 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.308 1.043 . . . . 0.0 113.674 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -96.34 49.09 1.11 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.614 1.552 . . . . 0.0 106.922 177.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.5 mtp -65.25 156.9 30.45 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.554 -1.341 . . . . 0.0 109.402 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.3 t -159.89 87.5 1.97 Allowed Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.634 0.774 . . . . 0.0 109.841 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.42 137.23 46.18 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.015 1.81 . . . . 0.0 111.176 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 m -119.91 -174.18 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.9 m -132.62 155.25 49.06 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 104.856 -2.276 . . . . 0.0 104.856 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.2 mm -127.85 110.67 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 125.971 1.708 . . . . 0.0 108.857 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.7 139.32 30.65 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 126.168 1.787 . . . . 0.0 109.304 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.7 tt -134.41 129.41 35.3 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.605 1.162 . . . . 0.0 109.19 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.0 mt -144.91 127.93 11.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.932 1.293 . . . . 0.0 111.039 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.0 p -72.68 128.22 34.91 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 90.3 m -61.6 149.48 39.08 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -109.54 -10.09 14.88 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.486 1.114 . . . . 0.0 110.216 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -101.49 26.71 6.97 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.551 1.94 . . . . 0.0 109.918 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.3 m -71.22 -9.79 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 O-C-N 120.497 -1.377 . . . . 0.0 114.567 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -52.02 -35.92 48.48 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.45 1.1 . . . . 0.0 112.694 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 t -97.97 0.82 47.1 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.565 1.546 . . . . 0.0 111.821 -179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.484 HD22 ' HG2' ' A' ' 103' ' ' LYS . 72.7 mt -92.13 -179.58 5.3 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.02 -1.05 . . . . 0.0 109.974 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -79.52 162.03 25.65 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.556 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -139.5 -24.19 0.86 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.562 1.545 . . . . 0.0 111.586 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -78.67 9.07 4.42 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.062 1.745 . . . . 0.0 112.703 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -115.18 -50.11 2.76 Favored 'General case' 0 C--O 1.221 -0.419 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 166.73 -146.47 10.89 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 108.539 -1.824 . . . . 0.0 108.539 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -107.8 104.28 52.58 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.67 131.56 17.46 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.291 3.327 . . . . 0.0 111.267 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 pp -135.79 177.35 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.36 0.664 . . . . 0.0 111.033 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.548 ' CD1' HD12 ' A' ' 95' ' ' LEU . 1.8 t80 -125.83 154.55 42.48 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.733 0.778 . . . . 0.0 109.963 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.409 HD22 HD11 ' A' ' 74' ' ' LEU . 1.9 tt -156.07 150.76 26.02 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.49 178.62 35.53 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.665 HD11 HD11 ' A' ' 30' ' ' LEU . 5.6 mt -88.25 153.75 20.97 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -119.46 116.05 25.32 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 101.246 -3.613 . . . . 0.0 101.246 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 157.6 -18.97 0.37 Allowed Glycine 0 C--N 1.342 0.874 0 C-N-CA 119.94 -1.124 . . . . 0.0 113.916 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.19 26.28 0.09 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.823 1.811 . . . . 0.0 112.336 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.0 m120 60.23 62.99 1.48 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.346 1.058 . . . . 0.0 109.322 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.479 HD22 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.36 137.41 27.09 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.436 -1.415 . . . . 0.0 112.298 -178.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.438 ' H ' ' HB2' ' A' ' 90' ' ' LYS . 5.4 m -143.14 176.23 9.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.145 0.978 . . . . 0.0 111.656 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.469 HD23 HD21 ' A' ' 87' ' ' LEU . 18.6 mt -61.3 151.38 32.11 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.322 1.049 . . . . 0.0 111.052 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.478 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . 4.9 tmm? -158.84 134.28 8.6 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 76.2 m -107.52 120.64 42.76 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 124.482 1.114 . . . . 0.0 109.57 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.21 -168.37 2.12 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt -121.59 144.63 48.63 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.8 p -90.93 -24.17 5.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.43 -0.508 . . . . 0.0 109.668 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.24 -45.43 0.47 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -109.74 -40.75 4.72 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.421 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 2.9 pt20 -132.97 164.95 40.28 Favored Pre-proline 0 C--O 1.242 0.692 0 C-N-CA 126.158 1.783 . . . . 0.0 112.125 -177.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 82' ' ' GLN . 89.2 Cg_endo -71.23 154.34 61.72 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.632 2.222 . . . . 0.0 112.38 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.4 p -151.21 171.9 16.68 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.0 mt -91.86 152.98 19.84 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.425 0.69 . . . . 0.0 111.663 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -145.07 65.83 1.25 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.647 0.779 . . . . 0.0 110.224 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.71 ' H ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -88.11 116.71 26.49 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -177.97 -19.27 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -156.7 94.82 1.49 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.478 ' HE3' ' HB2' ' A' ' 75' ' ' MET . 0.6 OUTLIER -173.65 162.63 4.15 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 121.503 1.956 . . . . 0.0 109.866 -177.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -142.77 136.79 29.23 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.849 0.459 . . . . 0.0 111.823 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.1 mp -80.91 -36.21 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.972 1.309 . . . . 0.0 110.846 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.8 mmt -59.7 -33.38 71.52 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.868 0.758 . . . . 0.0 109.831 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.8 -54.18 49.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.94 0.896 . . . . 0.0 109.159 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.548 HD12 ' CD1' ' A' ' 64' ' ' TYR . 9.9 mt -67.19 -29.67 69.41 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -80.7 -25.72 37.96 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.872 0.368 . . . . 0.0 110.698 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -83.69 -44.36 14.57 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.007 1.323 . . . . 0.0 111.524 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -114.48 154.71 46.53 Favored Pre-proline 0 N--CA 1.457 -0.111 0 CA-C-O 118.518 -0.753 . . . . 0.0 112.059 -177.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.3 65.69 2.77 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 124.132 3.221 . . . . 0.0 113.01 -178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -119.79 69.78 13.17 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 125.054 1.342 . . . . 0.0 111.388 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.464 ' HB2' HD21 ' A' ' 55' ' ' LEU . 58.8 Cg_endo -82.39 75.84 4.46 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.361 2.707 . . . . 0.0 105.95 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 t -88.43 94.34 4.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 O-C-N 120.858 -1.151 . . . . 0.0 109.496 -177.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.484 ' HG2' HD22 ' A' ' 55' ' ' LEU . 30.5 mttt -45.08 -28.09 0.67 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 127.242 2.217 . . . . 0.0 114.393 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.7 m -63.1 -22.28 66.75 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.355 1.462 . . . . 0.0 113.107 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.423 ' CE2' ' HG2' ' A' ' 75' ' ' MET . 20.6 m-85 -109.36 -18.52 13.54 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.658 1.983 . . . . 0.0 109.581 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.1 mt -85.68 155.19 21.19 Favored 'General case' 0 C--N 1.348 0.513 0 C-N-CA 125.717 1.607 . . . . 0.0 113.686 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -138.57 131.72 29.95 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.914 0.886 . . . . 0.0 109.71 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.51 116.35 18.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -90.73 144.23 25.93 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.79 178.24 6.5 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.09 0.956 . . . . 0.0 109.11 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -150.63 154.83 38.2 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.597 1.559 . . . . 0.0 110.799 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 57.6 p -132.38 8.9 4.32 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.322 -1.763 . . . . 0.0 113.459 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.79 -47.1 1.08 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.803 1.668 . . . . 0.0 112.159 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -132.82 -2.81 3.27 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -132.83 151.17 52.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.9 m -118.09 159.89 22.46 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.2 166.14 17.63 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 106.862 -1.532 . . . . 0.0 106.862 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -147.87 112.88 5.47 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.02 133.29 55.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.487 1.515 . . . . 0.0 109.555 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.0 t -54.47 120.45 6.65 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.211 1.004 . . . . 0.0 108.652 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.4 t -65.71 -42.36 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.066 -1.021 . . . . 0.0 110.663 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.25 97.49 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -129.31 83.77 64.35 Favored Pre-proline 0 C--O 1.235 0.321 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -68.23 158.34 57.93 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 122.786 2.324 . . . . 0.0 108.456 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 104.34 -6.97 46.58 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 108.967 -1.653 . . . . 0.0 108.967 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 26.4 m-90 -124.28 142.15 51.49 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 126.157 1.783 . . . . 0.0 109.796 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -126.0 152.23 46.0 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.092 0.957 . . . . 0.0 111.519 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.0 pt -76.04 127.71 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.076 0.465 . . . . 0.0 110.949 178.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.88 110.0 20.69 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 t -68.21 -15.8 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.844 1.658 . . . . 0.0 113.882 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 m 65.79 33.13 8.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.0 1.32 . . . . 0.0 113.041 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.502 ' HA ' ' HG3' ' A' ' 21' ' ' ARG . 5.8 m -65.03 -21.1 66.79 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.353 0.597 . . . . 0.0 111.827 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -84.7 120.3 26.24 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 125.377 1.471 . . . . 0.0 107.787 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 67.57 -72.29 0.24 Allowed Glycine 0 N--CA 1.442 -0.933 0 O-C-N 125.466 1.729 . . . . 0.0 114.311 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 144.67 71.45 0.02 OUTLIER Glycine 0 CA--C 1.526 0.767 0 N-CA-C 105.837 -2.905 . . . . 0.0 105.837 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . 0.457 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 63.9 m -95.0 174.68 3.36 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 124.956 1.302 . . . . 0.0 111.393 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 136' ' ' CYS . 96.7 Cg_endo -75.23 165.21 31.43 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.03 1.82 . . . . 0.0 111.593 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.583 HD12 HD13 ' A' ' 30' ' ' LEU . 28.8 mt -91.59 114.01 26.43 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.956 0.903 . . . . 0.0 108.564 179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.7 pp -141.21 176.6 4.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 125.255 1.422 . . . . 0.0 107.191 178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 20.2 mt -100.63 165.79 11.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.536 HG21 HD23 ' A' ' 144' ' ' LEU . 8.8 t -147.89 162.53 39.09 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -104.63 -42.53 5.38 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -154.2 127.71 8.61 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 122.707 1.241 . . . . 0.0 109.014 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.536 HD23 HG21 ' A' ' 141' ' ' THR . 0.8 OUTLIER -164.29 155.25 15.39 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.477 2.711 . . . . 0.0 104.96 177.064 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.428 ' O ' ' HE3' ' A' ' 146' ' ' LYS . . . -160.93 12.22 0.15 Allowed Glycine 0 CA--C 1.53 1.009 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 177.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 145' ' ' GLY . 0.3 OUTLIER -149.09 -41.47 0.15 Allowed 'General case' 0 C--N 1.349 0.546 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -177.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.84 -31.56 72.25 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.526 ' H ' HD13 ' A' ' 144' ' ' LEU . 20.4 m-80 -146.04 -161.39 1.3 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.471 HG21 ' CD2' ' A' ' 152' ' ' PHE . 90.9 m -137.29 131.52 32.39 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.3 p -110.37 -13.29 14.31 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.874 1.269 . . . . 0.0 111.689 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -120.63 109.12 14.85 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.767 0.712 . . . . 0.0 111.519 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.471 ' CD2' HG21 ' A' ' 149' ' ' THR . 0.2 OUTLIER -161.68 173.25 14.95 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.168 1.787 . . . . 0.0 111.206 178.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.38 -166.9 31.21 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.14 140.62 46.69 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 122.076 -0.661 . . . . 0.0 109.233 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.75 28.88 1.24 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.883 1.673 . . . . 0.0 109.837 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -59.45 150.65 26.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.663 1.185 . . . . 0.0 108.523 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 43.1 mt -132.86 160.88 35.69 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.62 1.168 . . . . 0.0 108.333 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 31.2 p90 . . . . . 0 C--O 1.245 0.819 0 CA-C-O 117.198 -1.382 . . . . 0.0 108.29 178.908 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -129.33 178.54 6.37 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -118.18 50.51 1.15 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.75 1.22 . . . . 0.0 111.955 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 34.24 71.76 0.1 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.88 2.472 . . . . 0.0 111.43 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -141.3 -172.34 3.48 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 124.741 1.217 . . . . 0.0 110.128 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -143.99 14.18 1.68 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.923 1.289 . . . . 0.0 111.678 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 pp -129.68 24.61 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 C-N-CA 124.962 1.305 . . . . 0.0 109.878 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.35 -20.22 48.32 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 p -70.25 160.3 81.41 Favored Pre-proline 0 C--O 1.24 0.595 0 C-N-CA 123.469 0.708 . . . . 0.0 111.103 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.34 147.94 94.09 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 N-CA-C 108.131 -1.527 . . . . 0.0 108.131 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.98 107.16 15.01 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -110.21 134.9 51.76 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.486 0.66 . . . . 0.0 110.388 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 156' ' ' MET . . . -161.27 -129.05 0.99 Allowed Glycine 0 N--CA 1.451 -0.356 0 O-C-N 121.186 -0.946 . . . . 0.0 111.975 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 75.2 p -154.23 -172.47 4.22 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 118.364 1.082 . . . . 0.0 112.11 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -149.81 9.18 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 124.288 1.035 . . . . 0.0 111.575 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.32 -18.03 59.13 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 119.92 -1.738 . . . . 0.0 111.377 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -79.14 44.85 0.6 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.23 2.612 . . . . 0.0 110.528 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.9 mt -131.71 -64.95 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 126.111 1.764 . . . . 0.0 111.148 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -139.87 27.42 2.21 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.406 1.083 . . . . 0.0 109.855 -178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 64.59 15.55 9.74 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -79.05 91.03 4.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.495 ' HB ' HG23 ' A' ' 33' ' ' VAL . 53.6 t -72.24 153.49 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.43 ' HE3' HD11 ' A' ' 138' ' ' LEU . 10.1 m95 -112.1 132.56 54.78 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 120.513 -1.367 . . . . 0.0 108.798 -177.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.472 ' C ' HD23 ' A' ' 30' ' ' LEU . 39.8 t -140.62 126.12 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 119.983 1.265 . . . . 0.0 111.837 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tp -76.41 104.7 7.06 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -88.92 -170.33 2.87 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.86 97.01 0.01 OUTLIER 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.604 1.962 . . . . 0.0 109.925 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 46.51 23.09 0.2 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.893 2.477 . . . . 0.0 112.669 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.9 m -153.93 128.55 9.32 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 119.412 1.006 . . . . 0.0 111.523 -176.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.545 HD13 HD12 ' A' ' 138' ' ' LEU . 2.7 mt -79.74 149.21 31.21 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.147 -0.971 . . . . 0.0 112.028 179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 137' ' ' PRO . 16.6 pt -143.15 149.37 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.168 1.387 . . . . 0.0 110.893 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.64 143.97 25.79 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.495 HG23 ' HB ' ' A' ' 22' ' ' VAL . 28.4 m -128.47 105.32 19.32 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.015 0.926 . . . . 0.0 110.285 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.83 -50.68 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.454 2.769 . . . . 0.0 116.351 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -147.05 57.71 1.15 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.07 130.82 50.33 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.22 -55.24 37.55 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.86 0.725 . . . . 0.0 109.082 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -79.44 60.36 3.18 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.218 1.407 . . . . 0.0 111.692 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -102.64 171.62 7.32 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 176.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t -159.68 133.01 4.79 Favored Pre-proline 0 N--CA 1.452 -0.373 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.69 155.04 59.25 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 N-CA-C 108.088 -1.543 . . . . 0.0 108.088 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m -140.07 -171.03 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 125.244 1.418 . . . . 0.0 107.535 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.92 156.16 48.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.0 mm -127.34 112.55 28.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 126.158 1.783 . . . . 0.0 107.905 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.16 140.74 29.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.403 HD12 HD12 ' A' ' 65' ' ' LEU . 4.8 tt -135.47 139.75 44.3 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.0 mt -150.37 139.72 15.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.287 1.035 . . . . 0.0 108.986 178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.7 p -75.14 156.4 35.98 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 94.8 m -78.34 140.06 38.79 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 119.873 -1.767 . . . . 0.0 108.681 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -101.16 -21.28 14.99 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.44 -0.788 . . . . 0.0 112.541 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -111.66 67.77 0.65 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.884 1.274 . . . . 0.0 108.255 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.619 ' HA ' HD23 ' A' ' 55' ' ' LEU . 15.2 m -101.4 2.31 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 -177.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.61 -18.71 65.16 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.635 1.174 . . . . 0.0 111.526 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 t -105.16 -5.0 21.13 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.764 2.026 . . . . 0.0 113.521 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.619 HD23 ' HA ' ' A' ' 52' ' ' VAL . 3.8 mm? -80.41 -178.59 6.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.594 -0.691 . . . . 0.0 110.205 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -82.37 -38.17 24.56 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.418 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 39.81 1.55 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.662 1 C-N-CA 132.328 4.251 . . . . 0.0 117.148 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -93.53 -14.43 26.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 127.227 2.211 . . . . 0.0 110.399 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.406 HH12 ' HB3' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -98.95 -0.52 42.0 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 118.928 0.785 . . . . 0.0 111.085 175.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 146.66 179.86 23.09 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 125.132 1.349 . . . . 0.0 110.389 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -86.62 112.58 47.7 Favored Pre-proline 0 CA--C 1.538 0.506 0 O-C-N 121.552 -0.969 . . . . 0.0 109.051 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -66.73 133.47 31.8 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.449 2.1 . . . . 0.0 114.461 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 pp -142.77 174.02 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 120.04 1.291 . . . . 0.0 109.788 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.664 ' CD1' HD12 ' A' ' 95' ' ' LEU . 2.7 t80 -131.94 153.4 50.33 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.403 HD12 HD12 ' A' ' 46' ' ' LEU . 6.1 tt -150.76 154.43 37.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.114 1.366 . . . . 0.0 108.23 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -163.65 -173.03 31.85 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.449 HD11 HD11 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -95.64 159.99 14.72 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -135.02 92.14 2.84 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 120.43 -1.419 . . . . 0.0 110.357 179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.37 -7.83 0.02 OUTLIER Glycine 0 CA--C 1.536 1.394 0 CA-C-O 117.518 -1.712 . . . . 0.0 114.872 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -164.86 24.99 0.06 Allowed 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 120.528 2.164 . . . . 0.0 113.312 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.7 m120 58.7 67.84 0.89 Allowed 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.531 -1.355 . . . . 0.0 109.529 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.25 131.67 23.69 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 125.441 1.496 . . . . 0.0 109.888 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 61.5 m -140.38 177.99 7.62 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.23 1.812 . . . . 0.0 112.059 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 11.7 mt -61.71 154.72 24.66 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.284 -1.51 . . . . 0.0 110.772 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.2 ttp -162.46 132.15 4.47 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 93.2 m -103.33 121.96 43.83 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.313 0.96 . . . . 0.0 110.588 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -122.98 -171.91 2.39 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.926 1.69 . . . . 0.0 107.678 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -146.31 130.48 17.46 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.0 m -78.46 12.08 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 123.576 0.75 . . . . 0.0 112.227 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.02 -10.51 63.94 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.847 2.165 . . . . 0.0 111.687 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -129.08 -50.96 1.21 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.926 1.69 . . . . 0.0 110.857 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -131.48 155.76 81.04 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 125.058 1.343 . . . . 0.0 113.498 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.31 144.09 40.62 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 124.157 3.238 . . . . 0.0 111.769 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.7 p -148.43 147.65 29.42 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.171 0.896 . . . . 0.0 109.5 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.3 mt -71.69 160.08 33.27 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -150.97 64.09 0.91 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.061 0.944 . . . . 0.0 108.673 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.79 ' H ' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -85.09 113.01 21.17 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.5 pttp -174.9 -36.16 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.929 1.292 . . . . 0.0 112.283 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -141.64 83.4 1.85 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.841 1.2 . . . . 0.0 113.959 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.47 147.71 6.37 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 120.36 -1.463 . . . . 0.0 109.014 178.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.29 140.99 48.16 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.225 1.01 . . . . 0.0 109.958 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.1 tt -87.18 -43.59 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 125.417 1.487 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.3 tpt -62.32 -27.89 69.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.923 -0.56 . . . . 0.0 111.396 -178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.88 -54.51 37.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.664 HD12 ' CD1' ' A' ' 64' ' ' TYR . 18.8 mt -60.05 -32.48 70.96 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.427 -0.796 . . . . 0.0 111.248 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -81.83 -15.97 52.35 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.238 -0.914 . . . . 0.0 112.215 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -94.49 -33.16 13.19 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 120.498 -1.376 . . . . 0.0 112.374 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.422 ' HB2' ' HD2' ' A' ' 99' ' ' PRO . 3.9 pt20 -123.8 167.07 16.14 Favored Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 124.909 1.284 . . . . 0.0 110.799 -178.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 98' ' ' GLN . 58.7 Cg_endo -73.24 -139.14 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 122.81 2.34 . . . . 0.0 109.59 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 56.99 60.77 7.05 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 125.952 1.701 . . . . 0.0 113.575 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -62.49 109.37 0.85 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 124.03 3.153 . . . . 0.0 109.262 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.3 t -88.11 98.7 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -49.53 -29.73 7.29 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.315 1.046 . . . . 0.0 112.286 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.5 m -62.54 -16.07 54.07 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.413 1.085 . . . . 0.0 113.453 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -116.52 -23.64 8.17 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.141 0.882 . . . . 0.0 111.69 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.5 mt -75.15 156.06 36.34 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.086 0.955 . . . . 0.0 112.801 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -138.93 128.72 24.86 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.644 0.778 . . . . 0.0 112.517 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -77.85 126.23 30.53 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.41 147.37 36.05 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 p -136.72 -177.1 4.59 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.777 1.631 . . . . 0.0 107.52 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -139.52 165.12 28.08 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.833 0.853 . . . . 0.0 109.193 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.5 p -149.84 35.98 0.69 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 124.753 1.283 . . . . 0.0 112.555 -178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.91 -56.27 1.85 Allowed Glycine 0 C--N 1.334 0.469 0 O-C-N 120.61 -1.307 . . . . 0.0 112.504 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -131.32 -1.08 4.0 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.508 -0.995 . . . . 0.0 112.669 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -134.05 179.92 5.95 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.752 0.821 . . . . 0.0 110.007 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 p -144.51 133.15 22.23 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.117 0.967 . . . . 0.0 112.435 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.52 170.82 9.08 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.202 1.401 . . . . 0.0 109.572 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -137.6 109.58 7.2 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.294 1.837 . . . . 0.0 106.98 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -98.52 128.08 44.72 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.926 2.09 . . . . 0.0 109.241 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.1 t -61.2 131.89 51.9 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.929 1.24 . . . . 0.0 111.957 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.8 t -66.33 -49.86 72.37 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 O-C-N 121.845 -0.534 . . . . 0.0 110.004 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.73 -27.52 68.97 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -136.29 84.73 28.69 Favored Pre-proline 0 N--CA 1.453 -0.28 0 CA-C-N 118.179 0.445 . . . . 0.0 110.186 -178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.406 ' HB3' HH12 ' A' ' 59' ' ' ARG . 10.6 Cg_endo -65.36 166.45 19.32 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.113 2.542 . . . . 0.0 111.663 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.19 1.36 90.48 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 119.443 -0.643 . . . . 0.0 112.546 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -130.56 146.12 52.01 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.092 1.357 . . . . 0.0 107.419 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -130.87 148.95 52.7 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.121 1.368 . . . . 0.0 110.578 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.4 pt -78.68 129.29 37.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.569 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.86 151.95 22.46 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.2 m -103.48 -17.27 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 125.149 1.38 . . . . 0.0 113.383 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.3 m 67.98 85.39 0.14 Allowed 'General case' 0 CA--C 1.533 0.308 0 O-C-N 124.413 1.07 . . . . 0.0 109.074 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 t -120.2 13.23 11.98 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 120.28 -1.512 . . . . 0.0 112.228 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -79.1 -52.22 8.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -161.55 -83.39 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -149.97 49.75 0.56 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 120.196 1.998 . . . . 0.0 113.261 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 32.0 m -78.13 165.85 47.51 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 118.229 1.014 . . . . 0.0 109.335 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 31' ' ' ILE . 66.0 Cg_endo -78.12 163.92 27.53 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.404 2.07 . . . . 0.0 113.189 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.545 HD12 HD13 ' A' ' 30' ' ' LEU . 37.1 mt -85.64 107.9 17.75 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.7 1.2 . . . . 0.0 110.975 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.44 -172.22 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 124.292 1.037 . . . . 0.0 109.557 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.54 162.86 14.68 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t -148.97 172.92 13.94 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 125.804 1.642 . . . . 0.0 109.004 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -114.89 -44.98 3.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.339 1.856 . . . . 0.0 108.283 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -155.07 130.27 9.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 -178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.411 ' H ' HD23 ' A' ' 144' ' ' LEU . 1.6 pt? -139.53 -45.29 0.45 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.627 2.371 . . . . 0.0 113.174 -177.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 71.39 -61.78 1.11 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 127.536 2.493 . . . . 0.0 113.653 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.39 -17.01 2.34 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.343 1.857 . . . . 0.0 110.249 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -53.69 -34.91 60.32 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 118.455 0.571 . . . . 0.0 110.219 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.56 -175.75 5.6 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 176.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.521 HG21 ' CE2' ' A' ' 152' ' ' PHE 0.289 12.9 m -112.28 140.42 47.01 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 178.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.33 -16.76 2.71 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 128.272 2.629 . . . . 0.0 109.815 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -125.35 122.56 37.18 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 124.147 0.979 . . . . 0.0 111.775 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.2 OUTLIER -161.71 -173.71 3.86 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.439 1.096 . . . . 0.0 109.481 179.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.47 -172.42 33.59 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.3 tp -146.03 127.16 14.7 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.9 m -82.96 40.16 0.68 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.408 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 5.6 ptt? -62.75 138.46 58.52 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 44.1 mt -117.42 -177.12 3.15 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.99 1.716 . . . . 0.0 106.95 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.1 p90 . . . . . 0 C--O 1.239 0.533 0 CA-C-N 119.728 1.149 . . . . 0.0 112.301 -179.206 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.4 ptt? . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -109.93 151.77 26.68 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -89.65 20.74 3.84 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.42 1.488 . . . . 0.0 112.939 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 51.24 68.8 0.73 Allowed 'General case' 0 C--O 1.232 0.133 0 C-N-CA 125.297 1.439 . . . . 0.0 112.413 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.07 160.45 39.75 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 178.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.1 pttt 43.94 19.99 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 128.235 2.614 . . . . 0.0 114.205 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 pp -133.13 -28.61 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 124.053 0.941 . . . . 0.0 112.225 -177.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.73 -22.76 61.57 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.999 0.818 . . . . 0.0 111.338 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.95 158.84 50.94 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 126.08 1.752 . . . . 0.0 111.144 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.28 103.34 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.143 2.562 . . . . 0.0 109.123 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.18 113.23 24.9 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -110.62 139.61 45.71 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.001 0.429 . . . . 0.0 110.744 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.93 -126.25 0.88 Allowed Glycine 0 C--O 1.224 -0.516 0 CA-C-O 117.618 -1.657 . . . . 0.0 112.389 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.4 p -161.68 -165.38 1.27 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 121.292 2.546 . . . . 0.0 112.376 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -142.18 0.5 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.176 0.59 . . . . 0.0 109.868 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -66.53 -20.68 66.09 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 120.34 -1.475 . . . . 0.0 111.256 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -60.58 -16.43 38.0 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.893 0.877 . . . . 0.0 112.394 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.0 mt -74.11 -69.02 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.126 0 C-N-CA 125.48 1.512 . . . . 0.0 113.958 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.04 21.27 6.83 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -177.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 67.06 30.38 7.45 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.567 1.147 . . . . 0.0 110.792 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.503 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 16.9 mmt-85 -98.3 102.87 14.74 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.068 1.347 . . . . 0.0 108.476 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.431 ' HB ' HG23 ' A' ' 33' ' ' VAL . 71.0 t -80.25 154.11 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 177.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.503 ' CH2' ' HB2' ' A' ' 21' ' ' ARG . 5.2 m95 -114.27 143.93 44.05 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.8 t -138.35 121.07 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tp -69.96 106.54 3.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -98.79 -174.19 2.72 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -45.52 96.29 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.893 1.224 . . . . 0.0 112.303 -178.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 45.45 28.14 0.45 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.583 2.753 . . . . 0.0 111.823 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.2 m -153.5 127.04 8.68 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 119.092 0.86 . . . . 0.0 110.694 -176.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.865 HD12 ' HG ' ' A' ' 87' ' ' LEU . 10.3 mt -83.27 127.9 34.04 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 120.93 -1.106 . . . . 0.0 111.164 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.9 mm -128.01 139.25 52.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 122.949 0.499 . . . . 0.0 109.788 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.18 142.81 39.46 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.431 HG23 ' HB ' ' A' ' 22' ' ' VAL . 8.0 m -119.9 77.15 22.35 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 124.662 1.185 . . . . 0.0 108.115 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.31 -37.23 10.55 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.837 2.358 . . . . 0.0 113.907 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.45 51.88 1.06 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.74 134.14 52.34 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -66.41 -41.68 88.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.111 0.482 . . . . 0.0 110.485 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.18 75.15 9.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -123.35 140.71 52.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.797 -1.547 . . . . 0.0 110.075 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.0 t -140.87 141.16 23.38 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.75 160.84 42.99 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 N-CA-C 108.589 -1.35 . . . . 0.0 108.589 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.0 m -143.82 166.91 13.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 126.5 1.92 . . . . 0.0 109.093 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.61 154.77 36.32 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.3 mm -129.95 109.4 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 125.648 1.579 . . . . 0.0 108.053 -178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.98 133.38 34.84 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.818 1.247 . . . . 0.0 108.537 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.8 tt -129.55 129.78 44.9 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.4 1.48 . . . . 0.0 109.193 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.1 mt -142.17 142.71 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.949 0.88 . . . . 0.0 109.62 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.2 p -87.21 146.78 25.85 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.42 ' O ' HG13 ' A' ' 52' ' ' VAL . 87.3 m -63.98 122.69 17.12 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 124.589 1.156 . . . . 0.0 110.943 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -81.77 -26.86 34.09 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.157 -1.017 . . . . 0.0 112.049 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -96.96 35.9 1.49 Allowed 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.842 1.201 . . . . 0.0 111.474 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 49' ' ' CYS . 3.7 m -57.06 -15.98 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.583 1.153 . . . . 0.0 112.418 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.18 -13.26 11.36 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.845 2.058 . . . . 0.0 111.227 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.59 -0.89 13.51 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.57 1.548 . . . . 0.0 111.819 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 101' ' ' PRO . 3.6 mm? -113.27 164.25 13.79 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.864 1.666 . . . . 0.0 110.25 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -71.15 152.73 43.12 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.816 0.847 . . . . 0.0 109.246 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -112.18 -32.84 6.42 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -52.57 -35.0 53.04 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 128.592 2.757 . . . . 0.0 114.27 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.9 mtt85 -87.08 -1.5 57.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 118.548 -0.739 . . . . 0.0 112.785 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.73 -177.17 18.19 Favored Glycine 0 CA--C 1.539 1.532 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -82.45 106.14 6.07 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 118.927 1.364 . . . . 0.0 111.699 -178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.76 134.96 20.85 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.232 2.622 . . . . 0.0 108.934 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.92 -179.16 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.717 1.607 . . . . 0.0 110.565 -179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -133.78 158.68 42.74 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.578 1.151 . . . . 0.0 110.446 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.2 tt -151.64 143.26 23.61 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.124 1.37 . . . . 0.0 109.162 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.43 -174.85 16.01 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.192 1.377 . . . . 0.0 111.344 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.854 HD11 HD11 ' A' ' 30' ' ' LEU . 10.0 mt -105.5 133.59 50.0 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -95.39 107.36 19.49 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 177.1 -76.77 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.073 -1.536 . . . . 0.0 111.084 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.19 22.09 16.53 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.266 1.026 . . . . 0.0 111.169 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.11 72.54 0.49 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.033 1.733 . . . . 0.0 110.206 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.13 150.29 39.25 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 124.775 1.23 . . . . 0.0 108.064 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.601 ' SG ' HG23 ' A' ' 92' ' ' ILE . 3.2 m -147.62 171.64 15.29 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 123.069 0.548 . . . . 0.0 109.937 178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 76.7 mt -62.13 166.11 5.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.684 0.794 . . . . 0.0 109.274 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -172.64 137.06 0.78 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 94.0 m -96.98 128.67 44.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.429 0.633 . . . . 0.0 110.205 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -133.87 -174.9 3.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -131.16 118.01 19.86 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 103.032 -2.951 . . . . 0.0 103.032 178.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 p -72.01 -23.31 21.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.4 -38.97 0.17 Allowed Glycine 0 N--CA 1.453 -0.227 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -141.8 -17.39 0.77 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.924 0.89 . . . . 0.0 112.488 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -139.47 153.26 70.47 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.836 1.254 . . . . 0.0 113.558 -178.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.93 142.49 88.44 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 124.951 3.767 . . . . 0.0 111.973 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.8 p -147.33 163.52 36.17 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 124.738 1.215 . . . . 0.0 110.218 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 mt -86.12 156.53 20.33 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -147.18 80.08 1.52 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.638 1.975 . . . . 0.0 108.721 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.865 ' HG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -103.01 104.63 14.82 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.188 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.41 -24.79 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -144.58 87.5 1.87 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.379 1.071 . . . . 0.0 111.72 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -165.86 165.84 18.01 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 119.402 -2.061 . . . . 0.0 108.388 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -137.07 165.41 26.11 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.601 HG23 ' SG ' ' A' ' 73' ' ' CYS . 18.9 pt -113.98 -49.66 5.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 124.765 1.226 . . . . 0.0 110.586 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.1 mmt -62.25 -18.84 62.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 117.913 -1.042 . . . . 0.0 109.25 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -71.42 -45.22 63.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.263 1.392 . . . . 0.0 110.299 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 23.4 mt -62.6 -25.94 68.35 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.727 1.211 . . . . 0.0 109.662 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -82.76 -34.89 26.97 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.646 -0.659 . . . . 0.0 109.784 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -65.42 -37.76 87.87 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.621 -1.18 . . . . 0.0 110.859 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -136.12 158.5 73.6 Favored Pre-proline 0 CA--C 1.529 0.156 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -76.87 82.43 2.33 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.926 2.417 . . . . 0.0 111.062 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -135.56 59.91 33.91 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.822 1.649 . . . . 0.0 107.26 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.644 ' HB2' HD21 ' A' ' 55' ' ' LEU . 61.4 Cg_endo -72.66 86.84 1.0 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.334 2.023 . . . . 0.0 108.68 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 48.5 t -73.35 101.74 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -53.08 -29.8 32.42 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 122.998 0.519 . . . . 0.0 111.151 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -65.84 -7.1 14.41 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 178.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -120.92 -33.14 3.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.598 1.09 . . . . 0.0 109.689 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 20.5 mt -68.32 153.19 44.24 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.239 0.472 . . . . 0.0 111.918 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.95 135.72 24.6 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.126 0.97 . . . . 0.0 111.264 178.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -74.09 113.75 11.64 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.716 2.407 . . . . 0.0 105.996 178.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -88.99 134.06 34.11 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.6 t -132.9 -178.68 5.06 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.77 146.72 20.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.943 0.897 . . . . 0.0 109.891 178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.85 88.75 0.98 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.431 1.092 . . . . 0.0 111.843 -179.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.17 61.93 1.54 Allowed Glycine 0 C--N 1.339 0.75 0 C-N-CA 124.335 0.969 . . . . 0.0 112.641 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 61.64 0.27 0.47 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.06 2.144 . . . . 0.0 110.437 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -115.28 124.9 52.51 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 m -84.72 171.67 12.14 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.096 0.958 . . . . 0.0 109.497 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.14 161.7 41.45 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.053 2.141 . . . . 0.0 108.375 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -141.22 111.93 7.06 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.582 1.153 . . . . 0.0 109.478 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -105.18 128.8 53.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.463 1.905 . . . . 0.0 109.893 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.2 t -52.74 125.58 17.2 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.028 1.731 . . . . 0.0 110.882 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.17 -45.59 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 119.428 1.013 . . . . 0.0 109.772 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.5 -33.68 74.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.007 -0.997 . . . . 0.0 111.619 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -136.27 83.89 31.17 Favored Pre-proline 0 C--O 1.235 0.299 0 C-N-CA 124.703 1.201 . . . . 0.0 110.269 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.26 157.22 61.09 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.43 1.42 . . . . 0.0 110.342 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 103.73 -34.88 5.42 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.544 1.545 . . . . 0.0 109.5 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 15.7 m-90 -85.95 140.03 30.7 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -123.99 141.45 52.03 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.384 1.074 . . . . 0.0 109.032 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 140' ' ' LEU . 5.1 mt -78.73 143.43 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -107.08 158.92 16.69 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 7.6 t -110.93 1.24 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 126.991 2.117 . . . . 0.0 112.698 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.6 m 49.66 52.93 13.62 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 m -85.1 -15.4 44.06 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.034 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -58.11 -31.52 67.23 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -170.15 -79.72 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.86 57.35 0.22 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 84.3 m -88.37 163.01 38.09 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.73 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.07 164.23 34.67 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 N-CA-C 107.531 -1.757 . . . . 0.0 107.531 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.8 mt -91.29 113.8 26.16 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.2 174.15 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 124.597 1.159 . . . . 0.0 112.445 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 128' ' ' ILE . 0.2 OUTLIER -100.44 150.71 22.35 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 118.531 -0.747 . . . . 0.0 109.809 177.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.615 HG21 HD23 ' A' ' 144' ' ' LEU . 11.5 t -130.88 173.86 10.55 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.891 1.276 . . . . 0.0 109.307 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -114.64 -32.6 5.8 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 124.96 1.304 . . . . 0.0 111.028 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -166.1 106.15 0.69 Allowed 'General case' 0 C--O 1.237 0.42 0 CA-C-N 119.14 0.882 . . . . 0.0 109.816 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.615 HD23 HG21 ' A' ' 141' ' ' THR . 1.5 pp -143.21 164.03 31.29 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.522 1.129 . . . . 0.0 111.221 178.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.63 23.04 0.22 Allowed Glycine 0 CA--C 1.524 0.601 0 CA-C-O 118.427 -1.207 . . . . 0.0 111.74 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.557 ' CE ' ' HA ' ' A' ' 146' ' ' LYS . 0.3 OUTLIER -175.06 -35.28 0.01 OUTLIER 'General case' 0 C--N 1.347 0.481 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 178.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.44 -31.14 71.7 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.7 -169.69 3.14 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.77 105.87 8.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.179 0.445 . . . . 0.0 110.644 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.5 p -97.79 -22.91 16.14 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -103.55 108.07 19.18 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.389 1.876 . . . . 0.0 112.963 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -173.36 -179.29 1.87 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.828 1.251 . . . . 0.0 111.732 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.69 -155.96 27.44 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 124.814 1.197 . . . . 0.0 112.323 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.5 tp -151.48 135.84 16.86 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.6 1.56 . . . . 0.0 107.411 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 6.5 m -93.74 42.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.317 1.447 . . . . 0.0 110.292 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -64.41 147.82 51.81 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.071 -1.018 . . . . 0.0 108.684 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 26.1 mt -125.0 165.29 18.4 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.612 1.565 . . . . 0.0 110.467 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 36.7 p90 . . . . . 0 C--O 1.252 1.236 0 C-N-CA 126.159 1.784 . . . . 0.0 108.785 179.474 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.472 0.625 0 CA-C-O 119.836 -0.126 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -90.83 -161.73 0.84 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.913 1.285 . . . . 0.0 108.858 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -139.73 -75.08 0.35 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.267 1.827 . . . . 0.0 106.783 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.35 82.87 1.48 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 122.96 0.504 . . . . 0.0 111.2 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -158.35 156.51 30.66 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 125.649 1.58 . . . . 0.0 108.996 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.7 pttp 47.63 20.37 0.19 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 128.315 2.646 . . . . 0.0 115.753 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 pp -141.03 10.33 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 125.327 1.451 . . . . 0.0 112.704 -178.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -88.43 -18.2 28.83 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 119.909 1.231 . . . . 0.0 110.182 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 p -71.59 156.63 91.12 Favored Pre-proline 0 N--CA 1.445 -0.694 0 C-N-CA 124.483 1.113 . . . . 0.0 109.443 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -71.19 123.03 9.27 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 N-CA-C 106.965 -1.975 . . . . 0.0 106.965 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -114.75 110.39 19.64 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -90.17 156.63 18.2 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.987 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.8 -154.48 7.96 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 112.079 -0.408 . . . . 0.0 112.079 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.5 p -156.46 138.28 14.3 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.505 1.522 . . . . 0.0 110.048 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.1 mt -98.28 1.04 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.0 0.92 . . . . 0.0 109.89 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -55.03 -36.45 65.53 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.036 -1.665 . . . . 0.0 111.412 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -4.71 0.24 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 -178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.7 mt -72.92 -61.56 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 CA-C-N 118.591 0.632 . . . . 0.0 109.78 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.73 29.92 1.1 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.489 1.116 . . . . 0.0 109.452 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 59.93 34.56 21.63 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.234 1.814 . . . . 0.0 111.45 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 6.5 mmt180 -99.86 107.77 19.87 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.4 t -88.71 160.38 2.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.473 ' HB3' HD22 ' A' ' 30' ' ' LEU . 4.7 m95 -113.78 139.57 49.01 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.419 0.554 . . . . 0.0 109.992 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.2 t -138.48 127.59 31.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.36 116.01 12.29 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 101.64 -3.467 . . . . 0.0 101.64 177.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -131.36 124.76 31.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.479 1.512 . . . . 0.0 108.003 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.6 t0 49.78 42.06 23.22 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 70.84 11.74 7.12 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.331 1.852 . . . . 0.0 113.863 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.5 m -133.05 138.55 46.8 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.602 1.546 . . . . 0.0 109.656 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.803 HD12 HD13 ' A' ' 87' ' ' LEU . 4.0 mt -83.19 125.47 31.58 Favored 'General case' 0 CA--C 1.509 -0.633 0 O-C-N 120.688 -1.258 . . . . 0.0 108.703 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.06 147.06 30.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.84 139.6 39.3 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.317 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -130.32 74.69 80.09 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 123.778 0.831 . . . . 0.0 110.559 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.29 -73.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.65 1.566 . . . . 0.0 112.976 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.27 12.45 32.92 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -72.45 129.03 37.38 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.247 0.619 . . . . 0.0 112.209 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -46.33 79.62 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.515 1.126 . . . . 0.0 108.492 177.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.63 24.37 0.21 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -69.38 177.6 2.77 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.001 0.819 . . . . 0.0 109.644 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.5 t -163.52 135.52 3.87 Favored Pre-proline 0 C--O 1.237 0.408 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.57 151.85 82.0 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.858 1.705 . . . . 0.0 110.434 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.5 p -141.2 156.58 21.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 m -120.82 157.39 29.86 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.806 HG22 HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -132.05 105.81 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.206 1.002 . . . . 0.0 111.505 -178.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 12' ' ' GLN . . . -94.88 120.47 35.15 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.396 1.078 . . . . 0.0 111.085 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.6 tt -106.06 139.39 40.66 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 125.522 1.529 . . . . 0.0 108.754 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.9 mt -137.46 145.48 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 124.778 1.299 . . . . 0.0 108.83 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.1 p -87.37 137.53 32.26 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 73.7 m -57.29 112.31 1.35 Allowed 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.097 -1.002 . . . . 0.0 109.984 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -94.79 -6.55 42.67 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.433 ' CE1' ' HA ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -117.95 64.48 0.75 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.056 1.742 . . . . 0.0 106.338 179.405 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.66 ' HA ' HD23 ' A' ' 55' ' ' LEU . 4.3 m -90.95 3.35 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -178.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -50.86 -26.69 6.11 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 116.0 1.852 . . . . 0.0 116.0 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -117.58 18.45 14.23 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.085 1.354 . . . . 0.0 110.651 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.66 HD23 ' HA ' ' A' ' 52' ' ' VAL . 3.7 mm? -114.43 171.75 7.44 Favored 'General case' 0 CA--C 1.512 -0.481 0 O-C-N 120.205 -1.559 . . . . 0.0 108.791 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.81 165.01 16.33 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.419 ' HE2' ' HB ' ' A' ' 52' ' ' VAL . 1.9 mttm -136.43 -39.6 0.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.824 1.25 . . . . 0.0 109.683 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -73.8 -17.35 61.09 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 123.554 0.534 . . . . 0.0 111.803 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -44.99 75.78 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.418 -0.801 . . . . 0.0 109.099 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 167.64 169.33 31.04 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 127.433 2.444 . . . . 0.0 107.384 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -73.62 110.16 8.29 Favored Pre-proline 0 CA--C 1.537 0.445 0 O-C-N 120.767 -1.431 . . . . 0.0 112.388 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.68 136.38 25.54 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 CA-C-N 121.862 1.701 . . . . 0.0 109.925 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 37.7 pt -146.06 -178.14 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.965 1.706 . . . . 0.0 108.96 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -153.68 159.93 42.2 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.218 1.007 . . . . 0.0 109.969 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.806 HD22 HG22 ' A' ' 44' ' ' ILE . 0.4 OUTLIER -140.29 154.64 46.89 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 122.566 1.174 . . . . 0.0 111.589 -178.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.81 159.01 26.85 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 124.757 1.17 . . . . 0.0 111.3 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.539 ' CD1' HD11 ' A' ' 30' ' ' LEU . 0.2 OUTLIER -98.42 131.75 44.43 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.6 116.56 32.29 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 166.54 -36.27 0.24 Allowed Glycine 0 N--CA 1.447 -0.573 0 O-C-N 125.158 1.536 . . . . 0.0 111.91 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.08 24.41 0.83 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -178.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.03 70.77 0.61 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.286 1.434 . . . . 0.0 109.623 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.85 144.69 27.09 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 120.805 -1.184 . . . . 0.0 108.52 -178.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 87' ' ' LEU . 34.0 m -145.76 166.67 25.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 117.352 -1.309 . . . . 0.0 111.7 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.6 mt -51.99 157.41 1.29 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.531 1.132 . . . . 0.0 110.352 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -170.39 148.27 3.16 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 68.0 m -109.55 121.34 44.99 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.119 1.768 . . . . 0.0 110.56 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.27 178.04 6.88 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.384 1.074 . . . . 0.0 109.57 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.406 ' HE3' ' C ' ' A' ' 81' ' ' ASP . 15.2 tttt -119.85 130.73 55.02 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 102.685 -3.08 . . . . 0.0 102.685 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.443 HG21 HG21 ' A' ' 84' ' ' THR . 27.2 m -128.73 38.66 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.603 0.761 . . . . 0.0 112.693 -177.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.87 54.78 0.12 Allowed Glycine 0 CA--C 1.503 -0.712 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.406 ' C ' ' HE3' ' A' ' 78' ' ' LYS . 23.0 t0 66.23 13.65 9.27 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -137.26 141.71 35.13 Favored Pre-proline 0 N--CA 1.448 -0.566 0 C-N-CA 125.61 1.564 . . . . 0.0 110.367 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.54 141.89 22.8 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.607 2.871 . . . . 0.0 113.236 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.443 HG21 HG21 ' A' ' 79' ' ' VAL . 72.8 p -150.42 176.82 10.57 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.506 0.723 . . . . 0.0 110.721 178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.468 HD11 HG23 ' A' ' 128' ' ' ILE . 7.9 mt -89.19 150.55 22.62 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.719 0.807 . . . . 0.0 110.845 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -146.01 65.81 1.21 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.935 1.694 . . . . 0.0 109.253 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.803 HD13 HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -93.43 96.28 9.81 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 126.323 1.849 . . . . 0.0 107.949 -179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.66 -26.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.996 -177.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -144.44 98.0 3.13 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.487 1.115 . . . . 0.0 109.112 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.52 160.81 0.11 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.256 1.423 . . . . 0.0 110.572 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -142.24 133.16 25.79 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.53 0.732 . . . . 0.0 109.631 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.441 HG23 ' SG ' ' A' ' 73' ' ' CYS . 7.7 pt -72.27 -44.05 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.688 1.995 . . . . 0.0 111.656 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.21 -26.03 62.33 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.023 0.929 . . . . 0.0 111.395 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -60.64 -52.02 66.93 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.446 HD11 ' CD2' ' A' ' 105' ' ' PHE . 80.6 mt -61.87 -35.19 77.59 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 127.717 2.407 . . . . 0.0 110.746 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -80.04 -20.59 44.94 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.195 -1.566 . . . . 0.0 109.769 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -87.27 -37.12 17.49 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.581 -1.324 . . . . 0.0 113.528 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -130.87 162.6 54.33 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 120.09 1.314 . . . . 0.0 109.511 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.03 -172.13 0.39 Allowed 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 122.13 1.887 . . . . 0.0 108.772 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . 0.252 19.8 mm-40 92.09 71.97 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 129.119 2.968 . . . . 0.0 113.934 177.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.594 ' CB ' HD21 ' A' ' 55' ' ' LEU . 18.3 Cg_endo -61.99 103.54 0.3 Allowed 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 123.783 2.989 . . . . 0.0 111.573 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.1 t -78.01 98.7 2.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -52.75 -34.82 54.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 120.002 -1.686 . . . . 0.0 109.665 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.8 m -69.51 11.67 0.23 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.044 1.338 . . . . 0.0 112.564 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.446 ' CD2' HD11 ' A' ' 95' ' ' LEU . 44.9 t80 -133.85 -21.89 1.89 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 125.858 1.663 . . . . 0.0 108.683 178.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.4 mt -84.86 153.33 22.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.806 -1.184 . . . . 0.0 110.374 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.555 ' CE2' HD11 ' A' ' 128' ' ' ILE . 95.0 m-85 -139.4 124.64 19.01 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.198 0.999 . . . . 0.0 110.128 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -72.21 122.42 21.02 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 178.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.9 t60 -75.18 141.68 43.6 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.69 178.57 8.05 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -164.62 153.0 12.43 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.83 1.252 . . . . 0.0 111.425 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.7 t -168.2 103.66 0.45 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.582 1.553 . . . . 0.0 113.226 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.47 49.3 5.24 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 126.322 1.915 . . . . 0.0 113.294 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 62.16 26.0 15.6 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -131.83 122.91 26.52 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 117.535 -1.221 . . . . 0.0 109.194 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.65 -177.86 3.37 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.969 1.258 . . . . 0.0 110.604 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.26 169.11 25.49 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 119.885 -1.759 . . . . 0.0 108.512 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -146.43 114.87 6.73 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.611 1.165 . . . . 0.0 111.293 -178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -108.6 126.6 53.13 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.42 1.488 . . . . 0.0 111.656 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.62 110.91 0.56 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.775 2.03 . . . . 0.0 109.995 178.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.6 t -60.78 -41.27 87.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 O-C-N 121.394 -0.816 . . . . 0.0 110.644 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.16 -45.34 92.28 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 119.529 -0.868 . . . . 0.0 112.264 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -128.62 86.71 56.92 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.1 156.49 65.6 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 121.997 1.798 . . . . 0.0 110.731 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.82 -27.12 11.46 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -95.35 140.36 30.34 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -119.07 146.34 45.16 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.575 1.55 . . . . 0.0 109.593 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.555 HD11 ' CE2' ' A' ' 107' ' ' PHE . 12.9 mm -73.74 121.3 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 118.69 -0.672 . . . . 0.0 110.294 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -88.15 143.09 27.26 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 118.719 -1.192 . . . . 0.0 109.91 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.4 m -94.3 -10.46 9.24 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 O-C-N 121.306 -0.871 . . . . 0.0 109.938 177.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.4 m 57.15 56.84 4.92 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 119.648 -1.907 . . . . 0.0 115.259 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.4 m -99.52 7.07 45.66 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -84.2 -75.03 0.36 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.49 1.116 . . . . 0.0 109.725 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -109.34 -36.51 2.1 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 118.46 60.19 0.28 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 14.0 m -84.86 167.46 26.32 Favored Pre-proline 0 CA--C 1.541 0.63 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -65.44 149.95 87.42 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 N-CA-C 107.028 -1.951 . . . . 0.0 107.028 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 19.8 mt -66.72 125.11 24.79 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.1 pp -148.42 167.39 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.404 0.682 . . . . 0.0 110.799 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 80.1 mt -81.35 159.63 24.34 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.24 127.81 11.56 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -83.28 -43.23 16.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 124.188 0.93 . . . . 0.0 110.471 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -156.08 83.11 1.0 Allowed 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.729 0.3 . . . . 0.0 111.035 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.406 HD12 ' H ' ' A' ' 146' ' ' LYS . 4.2 pp -70.32 154.68 41.63 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.921 0.867 . . . . 0.0 110.922 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -114.14 64.12 0.3 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 107.408 -2.277 . . . . 0.0 107.408 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.406 ' H ' HD12 ' A' ' 144' ' ' LEU . 0.0 OUTLIER 48.89 37.99 11.25 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.874 1.67 . . . . 0.0 110.842 -179.385 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -118.34 -4.03 10.94 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.616 0.366 . . . . 0.0 110.681 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -142.51 173.24 11.71 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 120.404 -1.435 . . . . 0.0 107.998 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.18 106.82 14.14 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 124.433 1.093 . . . . 0.0 108.557 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.07 -34.83 7.83 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.045 0.839 . . . . 0.0 110.633 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -96.52 100.0 11.61 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 127.991 2.516 . . . . 0.0 110.656 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -168.81 173.02 7.39 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.558 1.943 . . . . 0.0 110.277 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.32 -174.07 13.67 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 125.247 1.403 . . . . 0.0 110.425 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.49 169.85 16.92 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.169 0.509 . . . . 0.0 111.865 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 34.3 m -84.38 75.07 10.27 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 125.84 1.656 . . . . 0.0 109.998 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.74 153.32 35.14 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 177.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 68.6 mt -135.02 -165.24 1.64 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 129.852 3.261 . . . . 0.0 109.535 -177.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.5 p90 . . . . . 0 C--O 1.258 1.54 0 C-N-CA 125.721 1.608 . . . . 0.0 114.095 -178.603 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.341 0 CA-C-O 119.507 -0.282 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -91.75 148.63 22.1 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -90.44 -0.19 57.55 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 -177.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 75.54 79.78 0.1 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.812 1.645 . . . . 0.0 108.563 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.6 pp -155.92 7.87 0.23 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.748 1.619 . . . . 0.0 113.397 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -153.95 13.03 0.45 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.395 1.478 . . . . 0.0 110.432 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 pt -144.48 34.62 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 129.411 3.084 . . . . 0.0 107.096 -177.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -85.0 -22.59 29.02 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.037 1.335 . . . . 0.0 110.583 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.25 165.46 38.47 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 177.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.54 146.97 45.14 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 N-CA-C 105.962 -2.361 . . . . 0.0 105.962 177.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.69 118.02 23.04 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.96 139.86 53.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -168.87 -119.18 0.48 Allowed Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.8 p -150.19 177.63 9.74 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.202 1.501 . . . . 0.0 114.959 -177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.436 HG21 HD13 ' A' ' 15' ' ' ILE . 84.0 mt -141.79 -9.59 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 128.305 2.642 . . . . 0.0 108.253 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -58.7 -30.13 67.18 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 118.898 -2.376 . . . . 0.0 116.075 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.03 -12.96 9.32 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.44 1.496 . . . . 0.0 113.506 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.6 mt -54.97 -49.86 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 O-C-N 121.112 -0.993 . . . . 0.0 111.628 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -153.41 30.49 0.48 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.699 0.799 . . . . 0.0 109.244 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 64.59 8.0 4.11 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.127 1.771 . . . . 0.0 114.427 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -80.03 104.7 10.78 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 126.823 2.049 . . . . 0.0 107.022 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.5 t -82.45 175.1 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 104.658 -2.349 . . . . 0.0 104.658 178.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.407 ' CE2' HD11 ' A' ' 138' ' ' LEU . 40.4 m0 -123.07 134.23 54.27 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.788 -1.195 . . . . 0.0 108.264 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.9 t -132.51 133.46 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tp -71.88 112.5 8.03 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 178.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -130.76 127.46 38.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 120.457 1.481 . . . . 0.0 109.556 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.9 t0 43.79 56.01 4.82 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.212 1.005 . . . . 0.0 111.568 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.554 ' HB3' ' HE2' ' A' ' 88' ' ' LYS . 91.2 mt-30 57.41 22.28 7.76 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.13 139.7 32.23 Favored 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 125.242 1.417 . . . . 0.0 107.366 178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.809 HD21 HD11 ' A' ' 67' ' ' LEU . 17.3 mt -79.36 131.31 36.08 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 120.66 -1.275 . . . . 0.0 107.816 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.2 mt -123.97 133.77 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.155 0.889 . . . . 0.0 110.086 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.519 ' HB3' ' HA2' ' A' ' 135' ' ' GLY . . . -75.91 142.57 42.04 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.58 75.16 79.84 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.245 1.418 . . . . 0.0 112.308 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.28 -74.85 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 121.746 1.63 . . . . 0.0 110.736 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -95.44 68.01 2.95 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.5 145.74 51.91 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -76.34 -62.54 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.54 0.686 . . . . 0.0 110.028 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 -74.27 40.94 0.13 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -75.52 165.71 24.69 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 120.794 -1.191 . . . . 0.0 108.503 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.52 144.22 20.38 Favored Pre-proline 0 N--CA 1.447 -0.608 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.46 166.37 28.7 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.588 2.192 . . . . 0.0 111.136 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 p -155.75 164.3 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.76 149.9 49.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mm -123.18 118.9 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.943 1.297 . . . . 0.0 110.526 -178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.6 135.53 37.15 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.772 1.629 . . . . 0.0 108.774 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.3 tt -131.76 135.6 46.92 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.992 1.317 . . . . 0.0 108.029 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.3 mt -141.53 147.11 22.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.35 1.06 . . . . 0.0 108.565 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.2 p -90.59 128.22 36.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.896 2.479 . . . . 0.0 106.301 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 74.2 m -62.2 144.34 55.6 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.428 0.558 . . . . 0.0 109.627 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -101.21 -34.36 9.7 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.237 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -88.95 41.55 1.03 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.707 1.203 . . . . 0.0 108.737 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.1 m -69.84 -13.13 16.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 O-C-N 121.708 -0.62 . . . . 0.0 111.095 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -51.67 -39.32 58.03 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.598 1.559 . . . . 0.0 112.523 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.8 t -89.38 -5.16 57.69 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.753 0.821 . . . . 0.0 112.697 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.3 mt -92.45 -145.52 0.22 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.92 1.288 . . . . 0.0 112.538 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -123.37 160.0 27.71 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 127.815 2.446 . . . . 0.0 109.958 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.4 mttm -137.42 -26.8 0.98 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.61 1.564 . . . . 0.0 111.967 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -61.86 -45.24 94.66 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.79 0.723 . . . . 0.0 110.268 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -58.33 -51.2 70.78 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.726 0.81 . . . . 0.0 108.823 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.3 -179.32 37.69 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 106.422 -2.671 . . . . 0.0 106.422 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -82.46 117.79 69.68 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.052 0.926 . . . . 0.0 109.489 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 108' ' ' TYR . 73.0 Cg_endo -71.93 138.29 31.01 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.981 3.12 . . . . 0.0 111.121 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.4 pt -140.73 -177.39 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 123.14 0.576 . . . . 0.0 110.215 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.5 ' CD1' HG23 ' A' ' 92' ' ' ILE . 3.7 t80 -143.21 157.95 44.05 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.976 -0.452 . . . . 0.0 110.55 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 tt -156.84 157.68 35.39 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.757 1.223 . . . . 0.0 109.446 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -164.93 -179.08 38.72 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.809 HD11 HD21 ' A' ' 30' ' ' LEU . 9.5 mt -94.68 160.1 14.77 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -131.95 88.44 2.56 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 177.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.9 -40.58 0.02 OUTLIER Glycine 0 CA--C 1.523 0.538 0 CA-C-O 118.93 -0.928 . . . . 0.0 111.463 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.57 23.46 2.3 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.82 0.848 . . . . 0.0 112.731 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.2 m120 59.9 73.07 0.5 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.999 1.72 . . . . 0.0 110.228 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.09 138.55 25.42 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.768 1.227 . . . . 0.0 110.203 -177.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 90' ' ' LYS . 16.3 m -139.93 177.42 7.98 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.837 0.744 . . . . 0.0 109.604 177.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.889 ' HA ' HD12 ' A' ' 87' ' ' LEU . 26.8 mt -61.42 151.11 33.4 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.2 ttp -155.04 148.61 25.29 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 9.3 m -124.53 126.46 45.88 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.559 ' CB ' HE21 ' A' ' 86' ' ' GLN . . . -130.47 -178.63 4.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.916 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -132.69 118.98 19.78 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 104.133 -2.543 . . . . 0.0 104.133 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.4 m -75.25 30.58 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 122.966 0.507 . . . . 0.0 111.276 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.42 -3.86 61.51 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.201 -0.937 . . . . 0.0 112.087 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -127.06 -57.43 1.32 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.799 1.24 . . . . 0.0 112.071 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -145.26 164.06 28.84 Favored Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 125.59 1.556 . . . . 0.0 110.943 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.94 148.96 46.38 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.302 1.334 . . . . 0.0 113.234 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.6 p -146.06 169.83 17.89 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.575 0.75 . . . . 0.0 110.348 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.559 ' CD2' HD11 ' A' ' 87' ' ' LEU . 0.5 OUTLIER -89.74 141.76 28.32 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.913 1.285 . . . . 0.0 109.929 179.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.559 HE21 ' CB ' ' A' ' 77' ' ' ALA . 12.2 mt-30 -140.27 68.28 1.36 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.709 0.766 . . . . 0.0 109.682 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.889 HD12 ' HA ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -85.0 106.57 16.6 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -178.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.554 ' HE2' ' HB3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -163.37 -43.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 O-C-N 124.887 1.367 . . . . 0.0 112.251 -179.328 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -139.97 93.11 2.61 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.471 ' HB3' ' HB2' ' A' ' 73' ' ' CYS . 0.1 OUTLIER -167.36 172.44 9.7 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.411 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.463 ' H ' ' HD3' ' A' ' 90' ' ' LYS . 14.9 m-20 -146.17 139.31 25.82 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 125.786 1.635 . . . . 0.0 109.356 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.5 HG23 ' CD1' ' A' ' 64' ' ' TYR . 1.8 mp -87.62 -48.14 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 124.05 0.94 . . . . 0.0 111.057 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -60.82 -28.27 68.67 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 118.984 -0.531 . . . . 0.0 111.098 -178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -65.99 -51.98 53.51 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.943 0.792 . . . . 0.0 109.702 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.443 HD12 ' CE1' ' A' ' 64' ' ' TYR . 52.6 mt -63.79 -27.22 69.03 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.021 0.529 . . . . 0.0 111.332 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -82.33 -28.06 31.86 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.531 -0.731 . . . . 0.0 110.231 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -78.14 -37.21 46.61 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.894 1.278 . . . . 0.0 111.406 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -109.12 158.09 35.28 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -77.62 50.29 3.18 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.165 2.577 . . . . 0.0 111.89 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -117.05 74.5 7.18 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 124.892 1.277 . . . . 0.0 111.06 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -78.64 81.1 2.86 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.494 2.13 . . . . 0.0 107.519 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.3 t -70.27 97.95 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -51.43 -30.44 19.44 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.812 0.845 . . . . 0.0 111.76 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -64.43 -5.93 6.26 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 125.751 1.62 . . . . 0.0 112.199 179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -123.49 -31.28 3.53 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.244 1.018 . . . . 0.0 109.158 177.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.1 mt -70.41 162.25 29.01 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.192 1.397 . . . . 0.0 112.489 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -152.2 139.68 19.61 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.152 0.981 . . . . 0.0 109.888 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER -82.98 161.59 21.72 Favored 'General case' 0 C--O 1.247 0.954 0 CA-C-N 119.858 1.208 . . . . 0.0 108.926 177.677 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -114.2 126.0 54.56 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 128.32 2.648 . . . . 0.0 112.139 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.5 t -132.35 145.88 51.57 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 177.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.29 148.57 47.32 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.185 0.994 . . . . 0.0 109.801 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.5 p -157.67 78.98 0.86 Allowed 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.32 70.77 1.2 Allowed Glycine 0 N--CA 1.467 0.753 0 C-N-CA 123.958 0.79 . . . . 0.0 112.736 177.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.4 mtm-85 61.61 9.47 2.79 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.473 1.509 . . . . 0.0 112.726 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.445 HD22 ' HA ' ' A' ' 152' ' ' PHE . 34.9 m120 -119.72 153.4 35.69 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.2 m -139.85 151.55 45.77 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 79.6 p -114.39 174.57 5.89 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.624 0.726 . . . . 0.0 111.286 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -139.82 104.45 4.89 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.927 1.691 . . . . 0.0 106.923 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.444 ' HB2' ' CD2' ' A' ' 127' ' ' PHE . 0.3 OUTLIER -117.55 130.29 56.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.668 178.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.6 m -53.26 126.21 20.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.107 1.363 . . . . 0.0 112.626 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 99.2 t -71.8 -42.86 69.99 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 119.954 -0.698 . . . . 0.0 109.889 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.6 91.6 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -128.02 82.04 69.21 Favored Pre-proline 0 C--O 1.234 0.254 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.07 153.38 78.33 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 N-CA-C 108.679 -1.316 . . . . 0.0 108.679 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.09 -12.26 44.77 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.511 1.529 . . . . 0.0 110.888 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -113.22 135.48 53.78 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.13 1.772 . . . . 0.0 108.575 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.444 ' CD2' ' HB2' ' A' ' 119' ' ' GLU . 37.7 m-85 -122.21 150.19 42.62 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.833 1.653 . . . . 0.0 108.463 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 22.3 mt -79.52 134.49 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 123.734 0.814 . . . . 0.0 110.1 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -104.34 124.92 50.05 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 91.7 t -72.9 -19.1 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 127.708 2.403 . . . . 0.0 113.214 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.4 m 54.34 65.58 1.47 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.176 1.39 . . . . 0.0 114.325 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 6.5 m -88.61 -9.75 51.08 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -58.17 -76.07 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 116.906 2.188 . . . . 0.0 116.906 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.93 16.11 5.83 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 125.447 1.499 . . . . 0.0 113.278 -178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.519 ' HA2' ' HB3' ' A' ' 32' ' ' ALA . . . 82.58 56.53 2.77 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -84.33 166.69 31.56 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 117.457 0.628 . . . . 0.0 110.213 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.55 151.32 32.64 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 121.96 1.773 . . . . 0.0 109.005 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.407 HD11 ' CE2' ' A' ' 23' ' ' TRP . 12.8 mt -76.51 115.29 16.12 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.499 1.12 . . . . 0.0 108.114 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -138.06 168.87 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 125.573 1.549 . . . . 0.0 110.713 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 74.4 mt -88.1 165.43 15.14 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.1 t -153.95 137.39 15.86 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -80.23 -41.05 25.87 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.417 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -161.03 102.91 1.28 Allowed 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 -178.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.635 ' H ' HD23 ' A' ' 144' ' ' LEU . 2.0 pt? -64.06 149.58 47.24 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -119.78 -4.06 11.9 Favored Glycine 0 C--N 1.318 -0.45 0 CA-C-O 118.534 -1.148 . . . . 0.0 111.845 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.32 -140.57 0.21 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.155 1.382 . . . . 0.0 108.606 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -107.4 37.71 2.33 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.226 1.81 . . . . 0.0 109.771 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -55.13 -12.77 0.99 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.649 1.58 . . . . 0.0 114.16 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.31 88.99 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 129.724 3.21 . . . . 0.0 113.298 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.5 p -111.76 -2.72 15.2 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.151 -0.968 . . . . 0.0 111.984 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -139.17 109.8 6.64 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.445 ' HA ' HD22 ' A' ' 115' ' ' ASN . 0.3 OUTLIER -158.44 -176.99 6.21 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.199 1.8 . . . . 0.0 111.879 -178.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.62 -173.7 25.84 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.537 1.541 . . . . 0.0 110.777 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.41 HD11 HD11 ' A' ' 15' ' ' ILE . 0.3 OUTLIER -132.66 146.61 52.02 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.621 1.169 . . . . 0.0 109.392 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 3.0 m -102.8 45.83 0.95 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.331 1.453 . . . . 0.0 107.159 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -67.68 154.18 42.07 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.495 1.118 . . . . 0.0 109.238 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.2 mt -129.11 172.3 11.55 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.006 1.322 . . . . 0.0 109.591 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.8 p90 . . . . . 0 C--O 1.248 0.996 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 179.403 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 ptm . . . . . 0 N--CA 1.469 0.516 0 CA-C-O 123.247 1.498 . . . . 0.0 110.621 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.1 mp0 -82.17 177.13 8.97 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 127.475 2.31 . . . . 0.0 108.739 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -98.74 -64.23 1.05 Allowed 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -170.45 111.17 0.4 Allowed 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -152.78 168.51 25.47 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 126.631 1.972 . . . . 0.0 107.524 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -113.29 -23.55 9.85 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.029 0.932 . . . . 0.0 113.213 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pt -68.29 -25.55 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 117.832 -1.08 . . . . 0.0 112.03 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -55.84 -45.86 78.31 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.829 0.74 . . . . 0.0 109.397 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.37 130.1 94.02 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 118.262 0.483 . . . . 0.0 110.879 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.1 136.05 42.87 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.084 2.523 . . . . 0.0 109.576 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.79 111.11 20.73 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -109.93 145.14 37.39 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -174.31 -140.17 3.19 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 119.459 1.027 . . . . 0.0 112.54 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 65.2 p -136.68 -175.95 4.19 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.604 1.702 . . . . 0.0 113.311 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.6 mt -144.31 -6.19 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 126.696 1.999 . . . . 0.0 109.438 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.413 ' C ' ' H ' ' A' ' 18' ' ' ILE . 4.8 pt20 -73.52 -24.32 60.13 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 119.467 -2.02 . . . . 0.0 114.43 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -72.17 36.91 0.07 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.208 3.003 . . . . 0.0 110.732 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.413 ' H ' ' C ' ' A' ' 16' ' ' GLN . 45.4 mt -122.14 -71.14 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 128.674 2.79 . . . . 0.0 109.504 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -126.57 25.35 6.49 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 122.548 0.339 . . . . 0.0 111.383 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 64.83 35.82 8.31 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.623 0.725 . . . . 0.0 109.414 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.3 mmt-85 -104.16 81.65 1.86 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 120.838 -1.163 . . . . 0.0 109.809 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.1 t -71.65 134.12 30.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.566 ' CD2' HD11 ' A' ' 138' ' ' LEU . 45.8 m0 -89.95 144.66 25.73 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 178.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.8 t -144.21 131.52 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.6 tp -71.14 115.01 9.79 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 177.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -132.27 123.92 27.86 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.922 1.289 . . . . 0.0 107.731 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.3 t70 46.85 50.4 13.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.728 1.211 . . . . 0.0 112.475 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.1 mp0 65.86 15.76 10.19 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.2 m -137.39 152.11 49.29 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.592 HD11 HD11 ' A' ' 67' ' ' LEU . 31.4 mt -91.07 129.31 37.08 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 119.815 -1.803 . . . . 0.0 107.481 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.2 mm -127.73 138.16 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.407 0.683 . . . . 0.0 110.409 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.18 127.98 33.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.526 1.131 . . . . 0.0 108.73 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -111.26 99.12 42.47 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 124.601 1.16 . . . . 0.0 108.036 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -73.25 -32.16 8.59 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.287 1.991 . . . . 0.0 112.726 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -92.9 161.99 14.26 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.864 1.266 . . . . 0.0 109.816 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.04 19.44 12.84 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.542 1.137 . . . . 0.0 110.095 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -53.55 -50.82 64.71 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.282 1.401 . . . . 0.0 108.861 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.07 81.79 0.78 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 12.6 ptp -108.8 169.19 8.82 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.9 t -148.28 130.82 7.79 Favored Pre-proline 0 N--CA 1.45 -0.441 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -64.9 148.85 90.06 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.788 1.658 . . . . 0.0 107.86 177.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.5 m -142.03 171.5 10.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 125.591 1.556 . . . . 0.0 107.365 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.37 157.59 46.51 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 mm -118.21 144.0 27.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 127.984 2.513 . . . . 0.0 105.271 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.02 129.92 52.85 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 126.597 1.959 . . . . 0.0 105.793 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.6 tt -128.42 132.1 48.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.96 1.255 . . . . 0.0 107.699 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.5 mt -144.93 149.41 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.6 p -81.82 166.03 20.34 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 49.7 t -88.77 158.43 18.16 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -117.2 -3.8 11.47 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 177.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -119.05 57.36 0.88 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.417 ' HA ' HD12 ' A' ' 55' ' ' LEU . 24.0 m -83.87 -11.97 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.96 0.904 . . . . 0.0 110.837 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -64.72 -6.53 8.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.56 1.944 . . . . 0.0 112.484 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.7 t -121.8 7.89 9.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.157 1.383 . . . . 0.0 110.196 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 52' ' ' VAL . 96.0 mt -108.24 173.05 6.49 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 120.585 -1.322 . . . . 0.0 112.006 -178.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -79.77 154.92 28.17 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -126.44 -40.59 1.94 Allowed 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 116.938 -1.506 . . . . 0.0 110.846 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.28 -38.7 28.08 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.115 1.766 . . . . 0.0 114.177 -178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -65.63 -33.19 75.33 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 119.602 -0.237 . . . . 0.0 111.349 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.633 ' HA3' ' CE1' ' A' ' 108' ' ' TYR . . . 142.21 -178.14 21.03 Favored Glycine 0 N--CA 1.438 -1.191 0 C-N-CA 126.381 1.943 . . . . 0.0 110.584 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -78.2 113.71 36.03 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 116.63 2.085 . . . . 0.0 116.63 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -81.91 148.22 15.38 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 124.432 3.421 . . . . 0.0 111.592 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -149.84 -171.78 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 126.673 1.989 . . . . 0.0 109.067 178.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.456 ' CZ ' HD13 ' A' ' 95' ' ' LEU . 8.2 m-85 -132.86 147.11 52.3 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.928 2.091 . . . . 0.0 112.762 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.404 HD22 HD11 ' A' ' 74' ' ' LEU . 5.1 tt -156.73 134.15 10.69 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 120.474 -1.391 . . . . 0.0 109.645 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -142.02 -167.77 11.43 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.592 HD11 HD11 ' A' ' 30' ' ' LEU . 2.5 mt -100.7 159.52 15.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.89 87.56 2.78 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.61 -38.33 0.03 OUTLIER Glycine 0 C--N 1.336 0.544 0 CA-C-O 117.927 -1.485 . . . . 0.0 116.082 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.78 17.2 2.68 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.852 1.826 . . . . 0.0 111.896 -179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.15 69.15 0.39 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.62 146.37 29.33 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 124.784 1.233 . . . . 0.0 108.684 -177.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.401 ' SG ' HG13 ' A' ' 92' ' ' ILE . 4.4 m -145.24 -175.37 4.67 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.324 1.05 . . . . 0.0 112.232 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.886 ' HA ' HD12 ' A' ' 87' ' ' LEU . 45.4 mt -66.64 160.5 25.34 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.2 ttp -161.69 127.56 3.66 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 72.3 m -96.51 119.67 35.42 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 118.314 0.506 . . . . 0.0 110.472 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -123.39 175.85 6.49 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -137.25 120.05 16.3 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.9 m -74.18 13.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.17 -23.95 34.25 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -115.32 -39.15 3.65 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -149.64 158.45 37.63 Favored Pre-proline 0 C--O 1.24 0.575 0 C-N-CA 123.785 0.834 . . . . 0.0 111.052 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -71.01 145.31 49.63 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.219 2.613 . . . . 0.0 110.194 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 42.4 p -146.55 156.92 43.6 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.458 0.703 . . . . 0.0 110.075 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.452 ' HB3' HD11 ' A' ' 87' ' ' LEU . 7.9 mt -83.11 149.11 27.09 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -145.44 67.23 1.22 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.451 1.5 . . . . 0.0 109.437 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.886 HD12 ' HA ' ' A' ' 74' ' ' LEU . 0.0 OUTLIER -83.12 112.09 19.5 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 127.63 2.372 . . . . 0.0 108.032 -177.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.47 -29.28 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 O-C-N 125.21 1.569 . . . . 0.0 113.358 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -146.25 90.07 1.92 Allowed 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 120.321 1.418 . . . . 0.0 113.21 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -166.9 160.1 14.07 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.564 1.546 . . . . 0.0 107.071 179.417 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.43 146.68 40.42 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.958 1.703 . . . . 0.0 107.688 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.464 ' HA ' HD12 ' A' ' 95' ' ' LEU . 3.0 mt -96.85 -40.28 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.737 0.815 . . . . 0.0 110.707 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -27.29 68.73 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.399 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.08 -48.28 80.89 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.836 0.827 . . . . 0.0 110.707 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 92' ' ' ILE . 13.1 mt -62.71 -27.99 69.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 127.598 2.359 . . . . 0.0 110.368 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -87.32 -20.25 27.05 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -88.27 -25.22 22.94 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 119.339 0.972 . . . . 0.0 112.678 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -137.75 157.43 73.48 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.807 1.243 . . . . 0.0 111.068 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.2 67.64 5.15 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 124.018 3.145 . . . . 0.0 114.124 -178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -118.07 73.27 9.59 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.12 0.968 . . . . 0.0 111.461 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -80.95 77.42 4.06 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.294 2.663 . . . . 0.0 108.504 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 57.2 t -68.62 103.17 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 126.174 1.789 . . . . 0.0 108.849 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.409 ' HA ' HD12 ' A' ' 106' ' ' LEU . 44.4 mtpt -56.3 -31.62 63.83 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.041 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.0 -9.05 42.53 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.648 1.113 . . . . 0.0 112.284 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -120.82 -18.54 7.61 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.225 0.921 . . . . 0.0 109.169 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 103' ' ' LYS . 66.6 mt -74.69 149.58 39.84 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 119.774 -1.829 . . . . 0.0 109.724 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -139.7 129.27 24.37 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.988 0.515 . . . . 0.0 110.549 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.633 ' CE1' ' HA3' ' A' ' 60' ' ' GLY . 0.3 OUTLIER -74.68 126.8 31.64 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 177.766 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -95.49 117.08 29.74 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.023 0.529 . . . . 0.0 111.265 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.1 t -112.33 -176.81 3.01 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 2.1 pt20 -150.93 147.7 27.51 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.177 2.191 . . . . 0.0 110.025 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.1 p -164.63 87.66 0.47 Allowed 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 124.993 1.433 . . . . 0.0 113.874 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.04 70.46 1.3 Allowed Glycine 0 CA--C 1.504 -0.64 0 C-N-CA 124.899 1.238 . . . . 0.0 112.251 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.8 mtm-85 64.22 -2.32 0.61 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.686 1.995 . . . . 0.0 113.075 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -111.74 165.89 11.65 Favored 'General case' 0 CA--C 1.513 -0.442 0 C-N-CA 124.885 1.274 . . . . 0.0 110.951 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 45.6 m -132.69 162.91 30.18 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.695 1.598 . . . . 0.0 110.471 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.87 170.07 16.43 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.106 0.962 . . . . 0.0 110.222 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -139.67 109.5 6.35 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.443 1.497 . . . . 0.0 108.993 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -100.78 130.02 46.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.491 1.916 . . . . 0.0 110.134 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.4 t -58.1 126.07 25.87 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.548 0.613 . . . . 0.0 109.541 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.1 t -69.34 -47.99 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 O-C-N 120.938 -1.101 . . . . 0.0 110.129 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -54.42 -37.62 65.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.254 0.479 . . . . 0.0 110.804 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -138.19 91.0 13.18 Favored Pre-proline 0 C--O 1.234 0.269 0 C-N-CA 123.502 0.721 . . . . 0.0 109.137 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.25 174.53 8.94 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.606 2.204 . . . . 0.0 112.264 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 83.39 -13.76 44.26 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 126.262 1.886 . . . . 0.0 111.341 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -110.2 117.69 34.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.177 0.991 . . . . 0.0 109.553 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -99.27 132.84 44.31 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 127.521 2.328 . . . . 0.0 109.326 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 pt -71.95 120.76 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 121.762 -0.586 . . . . 0.0 109.634 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.27 166.74 16.25 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 118.181 -1.408 . . . . 0.0 111.274 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.5 m -107.28 -16.29 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 C-N-CA 125.099 1.36 . . . . 0.0 112.976 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.1 m 72.63 64.98 0.12 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 122.804 1.288 . . . . 0.0 110.728 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.08 33.09 4.82 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.532 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -117.05 -47.69 2.67 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.725 0.41 . . . . 0.0 111.749 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -140.46 -60.21 0.04 OUTLIER Glycine 0 C--N 1.333 0.384 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 157.41 51.94 0.01 OUTLIER Glycine 0 C--N 1.332 0.308 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . 0.524 ' HB3' ' HD2' ' A' ' 137' ' ' PRO . 55.9 m -88.18 177.43 2.65 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.921 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 136' ' ' CYS . 42.0 Cg_endo -81.39 169.66 15.43 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.009 2.473 . . . . 0.0 111.025 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 23' ' ' TRP . 30.3 mt -86.91 112.76 22.09 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 124.159 0.983 . . . . 0.0 110.702 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.25 -175.08 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.034 0.934 . . . . 0.0 110.15 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.09 137.03 45.94 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 15.4 t -131.19 154.36 48.48 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.562 1.545 . . . . 0.0 108.753 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -94.93 -23.36 17.45 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.373 1.469 . . . . 0.0 108.903 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -131.11 95.0 3.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 123.374 1.559 . . . . 0.0 108.4 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.47 179.03 7.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 113.841 -1.527 . . . . 0.0 111.125 178.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 61.84 5.37 7.14 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 123.936 0.779 . . . . 0.0 111.758 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.778 ' HE3' ' HA ' ' A' ' 146' ' ' LYS . 0.1 OUTLIER -97.39 -92.1 0.24 Allowed 'General case' 0 N--CA 1.425 -1.689 0 C-N-CA 126.436 1.895 . . . . 0.0 108.75 -178.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -90.3 -16.11 29.9 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 117.306 -1.331 . . . . 0.0 109.589 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -158.11 145.91 18.44 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-N 119.95 1.25 . . . . 0.0 109.293 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.533 HG21 ' CE2' ' A' ' 152' ' ' PHE . 3.5 m -82.69 137.34 34.47 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.523 1.929 . . . . 0.0 109.382 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 65.3 p -117.68 -23.65 7.54 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 120.064 1.302 . . . . 0.0 108.046 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -95.8 110.0 22.23 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.953 1.301 . . . . 0.0 113.654 -177.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.533 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.6 OUTLIER -166.52 -175.14 3.08 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.235 1.814 . . . . 0.0 108.78 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -108.85 -178.04 21.61 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.91 131.57 53.41 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 123.739 0.816 . . . . 0.0 109.558 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 1.5 m -79.0 31.85 0.21 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.384 1.474 . . . . 0.0 108.31 177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.9 ptt? -63.03 130.14 43.41 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.261 1.824 . . . . 0.0 107.928 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 21.5 mt -100.51 175.83 5.55 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 126.181 1.792 . . . . 0.0 108.753 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 23.9 p90 . . . . . 0 C--O 1.261 1.7 0 CA-C-O 115.615 -2.136 . . . . 0.0 108.924 -179.405 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -68.06 159.58 30.56 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.055 0.455 . . . . 0.0 111.286 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -85.12 -91.43 0.09 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.33 91.8 2.3 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.839 1.256 . . . . 0.0 110.384 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.96 166.78 31.91 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.984 2.114 . . . . 0.0 108.149 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.6 pttt 45.88 24.6 0.24 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 129.076 2.951 . . . . 0.0 115.04 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 pp -139.1 -43.13 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.618 1.167 . . . . 0.0 111.1 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -87.33 120.44 28.62 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.17 162.23 25.42 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 125.362 1.465 . . . . 0.0 109.318 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.35 152.61 20.77 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.67 2.247 . . . . 0.0 108.328 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.12 124.44 27.53 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 178.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.92 133.81 55.29 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.82 -131.08 1.29 Allowed Glycine 0 CA--C 1.522 0.478 0 CA-C-O 116.825 -2.097 . . . . 0.0 110.259 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.7 p -154.97 -173.04 4.41 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 122.604 3.202 . . . . 0.0 114.715 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 mt -136.36 -2.93 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.763 1.225 . . . . 0.0 108.712 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.508 ' CB ' HG22 ' A' ' 22' ' ' VAL . 4.7 pt20 -56.39 -40.86 75.33 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 120.099 -1.626 . . . . 0.0 112.114 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.23 -19.98 2.36 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.712 2.005 . . . . 0.0 115.393 -178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.6 mm -64.91 -58.68 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 123.584 0.753 . . . . 0.0 112.324 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -138.99 24.04 2.58 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.439 0.638 . . . . 0.0 110.816 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.3 t60 62.98 40.18 9.53 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.08 1.752 . . . . 0.0 108.39 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.4 mmt-85 -109.23 85.53 2.12 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.829 -1.169 . . . . 0.0 109.46 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.508 HG22 ' CB ' ' A' ' 16' ' ' GLN . 90.9 t -78.0 154.63 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.514 ' CD2' HD11 ' A' ' 138' ' ' LEU . 54.1 m0 -105.63 144.81 31.86 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.9 t -141.27 133.4 29.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.448 HD13 ' CD2' ' A' ' 72' ' ' LEU . 4.0 tt -74.56 122.61 23.38 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 104.273 -2.492 . . . . 0.0 104.273 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -131.14 119.34 21.77 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 47.0 t0 32.49 67.17 0.17 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.034 1.734 . . . . 0.0 113.876 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 60.5 17.73 7.59 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.5 m -137.97 126.57 23.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.341 1.456 . . . . 0.0 109.813 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.537 HD12 ' HG ' ' A' ' 87' ' ' LEU . 11.8 mt -77.5 136.2 38.31 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.5 pp -127.05 145.73 34.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 123.574 0.749 . . . . 0.0 111.861 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.28 127.79 34.45 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 m -103.69 89.37 2.22 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.65 -55.1 0.3 Allowed 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.34 1.36 . . . . 0.0 112.731 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -154.73 95.27 1.75 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 123.484 0.714 . . . . 0.0 111.993 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.43 160.84 39.97 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -69.12 -34.61 75.32 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.846 0.859 . . . . 0.0 112.281 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -82.35 58.64 4.18 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.41 0.684 . . . . 0.0 110.677 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -90.02 157.92 17.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 177.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.1 m -157.98 109.84 1.75 Allowed Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 125.89 1.676 . . . . 0.0 106.517 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.99 148.2 69.5 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 N-CA-C 107.907 -1.613 . . . . 0.0 107.907 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.07 157.58 28.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.05 156.38 19.32 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.3 mm -122.62 113.22 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 128.441 2.696 . . . . 0.0 106.288 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.71 138.56 32.38 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 65' ' ' LEU . 5.4 tt -137.36 130.25 30.39 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 124.649 1.18 . . . . 0.0 108.671 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -141.09 134.74 31.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.724 1.209 . . . . 0.0 107.975 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.4 p -66.47 158.61 29.07 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.85 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.4 m -68.79 136.99 53.62 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.214 -0.929 . . . . 0.0 112.369 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -89.28 -30.34 18.54 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 117.234 -1.365 . . . . 0.0 112.865 178.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -122.35 69.98 0.97 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 119.721 1.146 . . . . 0.0 110.809 -178.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.0 m -78.98 -10.76 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 123.043 0.537 . . . . 0.0 110.986 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -55.07 -32.46 61.95 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.54 1.936 . . . . 0.0 114.247 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 t -104.58 9.03 35.5 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.973 0.909 . . . . 0.0 110.463 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.9 mt -111.16 168.24 9.66 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.612 1.165 . . . . 0.0 110.25 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -83.1 159.54 22.08 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 126.633 1.973 . . . . 0.0 108.165 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.4 -24.85 1.77 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.133 1.373 . . . . 0.0 110.872 178.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.86 -26.76 59.31 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.073 2.149 . . . . 0.0 112.808 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -96.08 -1.2 49.19 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 125.119 1.368 . . . . 0.0 114.17 -178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 124.07 161.13 11.03 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 107.278 -2.329 . . . . 0.0 107.278 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -79.12 123.29 84.91 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 121.524 -0.986 . . . . 0.0 109.138 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 108' ' ' TYR . 83.4 Cg_endo -74.85 151.68 40.64 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.196 2.597 . . . . 0.0 111.228 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.459 HD11 ' CE1' ' A' ' 118' ' ' PHE . 1.4 pt -146.34 -175.17 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.067 0 C-N-CA 126.513 1.925 . . . . 0.0 109.706 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -127.29 143.18 51.28 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 129.094 2.957 . . . . 0.0 109.919 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.458 HD12 HD12 ' A' ' 46' ' ' LEU . 8.5 tt -154.83 148.94 25.88 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.434 -1.416 . . . . 0.0 109.221 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.403 ' HA3' ' SG ' ' A' ' 73' ' ' CYS . . . -162.44 -169.0 25.2 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 120.867 -1.146 . . . . 0.0 112.458 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.444 HD11 HD21 ' A' ' 30' ' ' LEU . 14.2 mt -105.51 149.93 25.79 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -118.92 101.7 8.24 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.6 -31.45 0.08 OUTLIER Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.462 -1.188 . . . . 0.0 114.006 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.25 20.84 0.75 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 119.736 1.768 . . . . 0.0 112.936 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.0 m120 65.89 66.64 0.49 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.448 ' CD2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -144.79 132.35 20.94 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.232 1.013 . . . . 0.0 111.127 -178.051 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.403 ' SG ' ' HA3' ' A' ' 66' ' ' GLY . 17.1 m -142.76 174.63 10.48 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 123.735 0.814 . . . . 0.0 110.283 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.82 ' HA ' HD12 ' A' ' 87' ' ' LEU . 45.2 mt -55.14 157.91 3.21 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 125.826 1.651 . . . . 0.0 113.644 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.6 tmm? -166.21 150.98 8.06 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 117.519 -1.229 . . . . 0.0 108.73 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.2 m -123.05 112.11 17.37 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.559 1.144 . . . . 0.0 111.139 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.17 143.54 50.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.67 1.123 . . . . 0.0 108.246 178.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -92.86 123.29 36.02 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.344 1.458 . . . . 0.0 109.702 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.91 -4.43 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.97 16.92 10.05 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -151.17 -61.05 0.18 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.283 1.833 . . . . 0.0 107.959 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -141.35 161.45 52.76 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.26 1.424 . . . . 0.0 112.03 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.09 152.53 45.77 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.456 2.77 . . . . 0.0 110.333 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.6 p -146.27 161.94 39.18 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.263 1.825 . . . . 0.0 109.362 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.83 HD22 HD11 ' A' ' 87' ' ' LEU . 4.5 mt -78.9 140.0 38.19 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.784 1.634 . . . . 0.0 110.795 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.35 67.19 1.46 Allowed 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.059 0.845 . . . . 0.0 110.811 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.83 HD11 HD22 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -92.06 118.6 30.96 Favored 'General case' 0 CA--C 1.493 -1.216 0 C-N-CA 125.183 1.393 . . . . 0.0 109.412 -178.219 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -179.42 -29.34 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 O-C-N 125.013 1.445 . . . . 0.0 113.618 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -146.04 102.25 3.61 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.401 1.48 . . . . 0.0 107.442 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.05 161.65 0.59 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 119.003 0.82 . . . . 0.0 109.041 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.69 153.0 52.19 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.71 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.98 -38.9 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.786 1.234 . . . . 0.0 108.989 178.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 5.6 tpt -64.6 -33.09 75.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.504 -0.76 . . . . 0.0 110.867 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.07 -40.55 87.07 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.507 1.049 . . . . 0.0 110.647 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.4 mt -65.21 -31.88 73.28 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.416 ' CZ ' ' HG3' ' A' ' 50' ' ' ARG . 36.3 t80 -78.58 -29.41 46.15 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.085 0.954 . . . . 0.0 110.175 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -78.09 -32.73 50.8 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 120.656 -1.277 . . . . 0.0 113.417 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -126.21 168.66 13.54 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 119.053 0.842 . . . . 0.0 112.017 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -80.34 68.0 8.45 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.319 2.68 . . . . 0.0 109.904 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -121.55 72.8 30.01 Favored Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 121.695 -0.628 . . . . 0.0 110.426 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.24 65.13 8.89 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.853 3.035 . . . . 0.0 108.433 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.4 t -70.98 97.66 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.076 0 C-N-CA 125.142 1.377 . . . . 0.0 107.81 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -48.18 -30.43 4.64 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.202 1.401 . . . . 0.0 112.33 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 t -63.54 -14.93 56.02 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.59 1.556 . . . . 0.0 113.445 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -126.6 -4.08 6.58 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.951 1.7 . . . . 0.0 111.122 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.4 mt -95.18 151.62 19.06 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.363 1.465 . . . . 0.0 110.025 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -139.21 133.02 30.78 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 19.5 m-85 -77.94 137.09 38.14 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.652 1.115 . . . . 0.0 108.016 177.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.78 162.47 25.1 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.5 t -161.29 178.06 9.57 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 126.168 1.787 . . . . 0.0 106.346 177.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 2.0 pp0? -156.47 158.53 37.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.272 1.429 . . . . 0.0 109.431 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.3 p -120.28 2.62 10.85 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 130.63 -50.13 0.9 Allowed Glycine 0 C--N 1.336 0.531 0 O-C-N 120.532 -1.355 . . . . 0.0 110.544 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.11 -1.81 2.36 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.673 0.789 . . . . 0.0 111.633 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -130.4 168.97 16.11 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.793 1.237 . . . . 0.0 109.115 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 111' ' ' GLN . 2.6 m -130.16 148.13 51.97 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.552 1.141 . . . . 0.0 111.873 -178.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.79 173.01 7.74 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 127.093 2.157 . . . . 0.0 111.783 -178.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.459 ' CE1' HD11 ' A' ' 63' ' ' ILE . 31.6 m-85 -146.01 128.84 16.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 125' ' ' GLY . 9.4 tt0 -113.52 142.27 46.14 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 126.0 1.72 . . . . 0.0 107.107 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 50.0 m -70.4 124.11 23.38 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.189 2.196 . . . . 0.0 110.985 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 63.7 t -69.72 -43.87 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 120.812 1.642 . . . . 0.0 112.315 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.19 -24.48 66.64 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -138.76 77.5 32.77 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 126.08 1.752 . . . . 0.0 107.207 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.51 166.21 22.58 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.787 2.325 . . . . 0.0 112.369 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.407 ' H ' ' CD ' ' A' ' 119' ' ' GLU . . . 85.86 -13.7 55.43 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.867 1.222 . . . . 0.0 111.775 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -106.48 119.91 40.53 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 126.286 1.834 . . . . 0.0 109.802 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -103.04 148.26 25.93 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.774 0.83 . . . . 0.0 110.243 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.514 HG22 HD11 ' A' ' 85' ' ' LEU . 3.4 pt -78.38 139.4 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-O 120.921 0.391 . . . . 0.0 110.891 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.94 151.75 20.98 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.404 HG13 ' HZ2' ' A' ' 23' ' ' TRP . 45.0 t -106.06 -17.01 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 127.34 2.256 . . . . 0.0 111.047 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 19.2 m 55.34 82.42 0.1 Allowed 'General case' 0 CA--C 1.512 -0.519 0 C-N-CA 126.438 1.895 . . . . 0.0 112.695 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.2 m -111.1 -9.75 14.36 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -54.63 -61.13 2.51 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.639 1.575 . . . . 0.0 111.352 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -139.21 -85.55 0.12 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 106.268 -2.733 . . . . 0.0 106.268 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -165.98 60.82 0.23 Allowed Glycine 0 C--N 1.333 0.378 0 O-C-N 120.694 -1.474 . . . . 0.0 110.201 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.1 m -91.37 163.6 28.08 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.73 161.71 45.1 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.595 1.53 . . . . 0.0 109.779 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.514 HD11 ' CD2' ' A' ' 23' ' ' TRP . 20.4 mt -87.5 113.03 22.83 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.21 167.18 23.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 125.628 1.571 . . . . 0.0 109.391 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 80.7 mt -83.91 156.15 22.52 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.79 156.13 47.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 177.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -99.24 -46.75 5.43 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -159.74 142.33 13.67 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -150.18 177.81 9.57 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 129.486 3.114 . . . . 0.0 108.553 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -162.48 -32.48 0.02 OUTLIER Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.863 1.697 . . . . 0.0 109.79 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.3 5.9 1.1 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -91.47 -22.72 20.27 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 120.445 1.475 . . . . 0.0 114.024 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -160.75 -161.13 0.81 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.582 HG21 ' CE2' ' A' ' 152' ' ' PHE . 0.2 OUTLIER -142.7 113.15 7.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 -178.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -99.48 -28.99 12.99 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 126.074 1.75 . . . . 0.0 110.241 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -112.41 123.93 51.36 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 123.657 0.783 . . . . 0.0 109.721 -178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.582 ' CE2' HG21 ' A' ' 149' ' ' THR . 0.1 OUTLIER -158.82 -170.34 3.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.002 178.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.42 176.8 38.79 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.22 111.97 6.46 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 24.3 m -77.16 46.77 0.51 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -73.95 120.38 19.46 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.6 mt -99.07 156.57 16.87 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 123.795 0.838 . . . . 0.0 109.626 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.7 p90 . . . . . 0 C--O 1.246 0.882 0 C-N-CA 125.111 1.364 . . . . 0.0 108.554 179.772 . . . . . . . . 0 0 . 1 stop_ save_